{
  "drugs": [
    {
      "fdaUniiCode": "21K6M2I7AG",
      "id": "Interferon_Gamma-1b",
      "preferredName": "Interferon Gamma-1b",
      "synonyms": [
        "Actimmune",
        "IFN-g-1b",
        "IFN-gamma 1b",
        "IFNg-1b",
        "INTERFERON GAMMA-1B",
        "Interferon Gamma-1b",
        "Interferon gamma-1b, Recombinant",
        "N(Sup 2)-L-Methionyl-1-139-Interferon G",
        "N(sup 2)-L-Methionyl-1-139-interferon gamma (Human Lymphocyte Protein Moiety Reduced)",
        "Recombinant Interferon Gamma-1b",
        "gamma Interferon 1B"
      ]
    },
    {
      "fdaUniiCode": "WE1X5A83B9",
      "id": "Naratuximab_Emtansine",
      "preferredName": "Naratuximab Emtansine",
      "synonyms": [
        "IMGN529",
        "MP 529",
        "MP-529",
        "MP529",
        "NARATUXIMAB EMTANSINE",
        "Naratuximab Emtansine"
      ]
    },
    {
      "fdaUniiCode": "16VY3TM7ZO",
      "id": "Antineoplaston_A10",
      "preferredName": "Antineoplaston A10",
      "synonyms": [
        "3-Phenylacetylamino-2, 6-piperidinedione",
        "3-Phenylacetylamino-2,6-piperidinedione",
        "A10",
        "ANTINEOPLASTON A10",
        "Antineoplaston A10",
        "Atengenal",
        "Benzeneacetamide, N-(2,6-dioxo-3-piperidinyl)-, (S)-"
      ]
    },
    {
      "fdaUniiCode": "S7V92P67HO",
      "id": "Arsenic_Trioxide",
      "preferredName": "Arsenic Trioxide",
      "synonyms": [
        "ARSENIC TRIOXIDE",
        "ATO",
        "Arsenic (III) Oxide",
        "Arsenic Sesquioxide",
        "Arsenic Trioxide",
        "Arsenous Acid",
        "Arsenous Acid Anhydride",
        "Arsenous Oxide",
        "Trisenox",
        "White Arsenic",
        "arsenic trioxide"
      ]
    },
    {
      "fdaUniiCode": "186TH42ZNH",
      "id": "Azapicyl",
      "preferredName": "Azapicyl",
      "synonyms": [
        "1-ACETYL-2-PICOLINOYLHYDRAZINE",
        "1-Acetyl-2-picolinoylhydrazine",
        "1-acetyl-2-picolinoylhydrazine",
        "2-acetylhydrazide-2-pyridinecarboxylic acid",
        "Azapicyl",
        "P-2292"
      ]
    },
    {
      "fdaUniiCode": "K1U80DO9EB",
      "id": "Azaribine",
      "preferredName": "Azaribine",
      "synonyms": [
        "1,2,4-Triazine-3,5(2H,4H)-dione, 2-Beta-D-ribofuranosyl-",
        "2',3',4'-azauridine triacetate",
        "2-(2,3,5-Tri-O-acetyl-beta-D-ribofuranosyl)-as-triazine-3,5(2H,4H)-dione",
        "6-Azauridine Triacetate",
        "6-Azauridine triacetate",
        "AZARIBINE",
        "Azaribine",
        "Azauridine Triacetate",
        "Azauridine triacetate",
        "CB 304",
        "SKI 28426",
        "Triacetyl 6-azauridine",
        "Triacetyl 6-azuridine",
        "Triacetyl-6-azuridine",
        "Triazure"
      ]
    },
    {
      "fdaUniiCode": "54P5FEX9FH",
      "id": "Ethyleneimine",
      "preferredName": "Ethyleneimine",
      "synonyms": [
        "AZIRIDINE",
        "Aminoethylene",
        "Azacyclopropane",
        "Azirane",
        "Aziridine",
        "Dimethyleneimine",
        "Dimethylenimine",
        "Ethyleneimine",
        "Ethylenimine",
        "Ethylimine"
      ]
    },
    {
      "fdaUniiCode": "26S048LS2R",
      "id": "Beauvericin",
      "preferredName": "Beauvericin",
      "synonyms": [
        "BEAUVERICIN",
        "Beauvericin"
      ]
    },
    {
      "fdaUniiCode": "06IVK87M04",
      "id": "Zelavespib",
      "preferredName": "Zelavespib",
      "synonyms": [
        "9H-Purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-",
        "Hsp90 Inhibitor PU-H71",
        "PU-H-71",
        "PU-H71",
        "PUH71",
        "ZELAVESPIB",
        "Zelavespib"
      ]
    },
    {
      "fdaUniiCode": "P48P97V001",
      "id": "Valecobulin",
      "preferredName": "Valecobulin",
      "synonyms": [
        "(S)-N-(4-(3-(1H-1,2,4-Triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl)thiazol-2-yl)-2-amino-3-methylbutanamide Hydrochloride",
        "CKD-516",
        "Tubulin Polymerization Inhibitor CKD-516",
        "VALECOBULIN",
        "Valecobulin"
      ]
    },
    {
      "fdaUniiCode": "31N550RD05",
      "id": "Danvatirsen",
      "preferredName": "Danvatirsen",
      "synonyms": [
        "AZD9150",
        "DANVATIRSEN",
        "Danvatirsen",
        "ISIS 481464",
        "ISIS-STAT3rx"
      ]
    },
    {
      "fdaUniiCode": "I0J33N5627",
      "id": "Ubenimex",
      "preferredName": "Ubenimex",
      "synonyms": [
        "Bestatin",
        "L-Leucine, N-(3-amino-2-hydroxy-1-oxo-4-phenylbutyl)-, [S-(R*,S*)]-",
        "N-[(2S,3R)-4-phenyl-3-amino-2-hydroxybutyryl]-L-leucine",
        "NK 421",
        "UBENIMEX",
        "Ubenimex",
        "[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]-L-leucine",
        "[S-(R*,S*)]-N-(3-amino-2-hydroxy-1-oxo-4-phenylbutyl)-L-leucine"
      ]
    },
    {
      "fdaUniiCode": "3NU609VYNF",
      "id": "Edicotinib",
      "preferredName": "Edicotinib",
      "synonyms": [
        "1H-Imidazole-2-carboxamide, 5-Cyano-N-(2-(4,4-dimethyl-1-cyclohexen-1-yl)-6-(tetrahydro-2,2,6,6-tetramethyl-2H-pyran-4-yl)-3-pyridinyl)-",
        "4-Cyano-1H-imidazole-2-carboxylic acid N-(2-(4,4-dimethylcyclohex-1-enyl)-6-(2,2,6,6-tetramethyltetrahydropyran-4-yl)pyridin-3-yl)amide",
        "4-Cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyl-tetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide",
        "EDICOTINIB",
        "Edicotinib",
        "JNJ-40346527"
      ]
    },
    {
      "fdaUniiCode": "LPT9GX4OUB",
      "id": "Anti-DLL4_Monoclonal_Antibody_MEDI0639",
      "preferredName": "Anti-DLL4 Monoclonal Antibody MEDI0639",
      "synonyms": [
        "Anti-DLL4 Monoclonal Antibody MEDI0639",
        "MEDI-0639",
        "MEDI0639"
      ]
    },
    {
      "fdaUniiCode": "3F0FR4W3H8",
      "id": "Indusatumab_Vedotin",
      "preferredName": "Indusatumab Vedotin",
      "synonyms": [
        "INDUSATUMAB VEDOTIN",
        "Indusatumab Vedotin",
        "MLN0264"
      ]
    },
    {
      "fdaUniiCode": "C79B5A73C4",
      "id": "TRPV6_Calcium_Channel_Inhibitor_SOR-C13",
      "preferredName": "TRPV6 Calcium Channel Inhibitor SOR-C13",
      "synonyms": [
        "SOR-C13",
        "TRPV6 Calcium Channel Inhibitor SOR-C13"
      ]
    },
    {
      "fdaUniiCode": "5QIO6SRZ2R",
      "id": "Molibresib",
      "preferredName": "Molibresib",
      "synonyms": [
        "GSK-525762A",
        "GSK525762",
        "I-BET 762",
        "MOLIBRESIB",
        "Molibresib"
      ]
    },
    {
      "fdaUniiCode": "01YAE03M7J",
      "id": "Beta-Carotene",
      "preferredName": "Beta-Carotene",
      "synonyms": [
        ".beta.-Carotene",
        "3,7,12,16-tetramethyl-1,18-bis(2,6,6-trimethyl-1-cyclohexenyl)-octadeca-1,3,5,7,9,11,13,15,17-nonaene",
        "BETA CAROTENE",
        "Beta Carotene",
        "Beta-Carotene",
        "Beta-carotene",
        "CAROTENE, BETA",
        "Lumitene",
        "Solatene",
        "beta carotene",
        "beta-Carotene"
      ]
    },
    {
      "fdaUniiCode": "A49037RP1E",
      "id": "Multi-AGC_Kinase_Inhibitor_AT13148",
      "preferredName": "Multi-AGC Kinase Inhibitor AT13148",
      "synonyms": [
        "AT-13148",
        "AT13148",
        "Multi-AGC Kinase Inhibitor AT13148"
      ]
    },
    {
      "fdaUniiCode": "LIJ4CT1Z3Y",
      "id": "Alectinib",
      "preferredName": "Alectinib",
      "synonyms": [
        "5H-benzo(b)carbazole-3-carbonitrile, 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-(4-(4-morpholinyl)-1-piperidinyl)-11-oxo-",
        "AF-802",
        "AF802",
        "ALECTINIB",
        "Alecensa",
        "Alectinib",
        "CH5424802",
        "RG7853",
        "RO5424802"
      ]
    },
    {
      "fdaUniiCode": "CHL9B67L95",
      "id": "Olmutinib",
      "preferredName": "Olmutinib",
      "synonyms": [
        "2-Propenamide, N-(3-((2-((4-(4-methyl-1-piperazinyl)phenyl)amino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)-",
        "BI 1482694",
        "HM61713",
        "OLMUTINIB",
        "Olmutinib"
      ]
    },
    {
      "fdaUniiCode": "5F1CN52GFM",
      "id": "Elgemtumab",
      "preferredName": "Elgemtumab",
      "synonyms": [
        "ELGEMTUMAB",
        "Elgemtumab",
        "LJM-716",
        "LJM716"
      ]
    },
    {
      "fdaUniiCode": "39C34M111K",
      "id": "Bisantrene",
      "preferredName": "Bisantrene",
      "synonyms": [
        "9,10-Anthracenedicarboxakdehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone]",
        "9,10-Anthracenedicarboxaldehyde Bis(2-imidazolin-2-yl)hydrazone",
        "BISANTRENE",
        "Bisantrene"
      ]
    },
    {
      "fdaUniiCode": "9I50NF4AQ2",
      "id": "Emitefur",
      "preferredName": "Emitefur",
      "synonyms": [
        "(2) m-[[3-(Ethoxymethyl)-5-fluoro-3,6-dihydro-2,6-dioxo-1(2H)-pyrimidinyl]carbonyl]benzoic Acid, 2-Ester with 2,6-Dihydroxynicotinonitrile Benzoate (Ester)",
        "3-((3-(Ethoxymethyl)-5-fluoro-3,6-dihydro-2,6-dioxo-1(2H)-pyrimidinyl)carbonyl)benzoic acid, 6-(benzoyloxy)-3-cyano-2-pyridinyl ester",
        "3-[3-(6-Benzoyloxy-3-cyrano-2-pyridyloxycarbonyl)benzoyl]-1-(ethoxymethyl)-5-fluorouracil",
        "BOF-A2",
        "EMITEFUR",
        "Emitefur",
        "Last-F",
        "[[Ethoxymethyl-5-fluoro-3,6-dihydro-2,6-dioxo-1(2H)-pyrimidinyl]carbonyl]benzoic Acid, 6-(Benzoyloxy)-3-cyano-2-pyridinyl Ester",
        "emitefur"
      ]
    },
    {
      "fdaUniiCode": "841P9W25WA",
      "id": "Anti-ErbB3_Monoclonal_Antibody_AV-203",
      "preferredName": "Anti-ErbB3 Monoclonal Antibody AV-203",
      "synonyms": [
        "AV 203",
        "AV-203",
        "AV203",
        "Anti-ErbB3 MoAb AV-203",
        "Anti-ErbB3 Monoclonal Antibody AV-203",
        "CAN-017"
      ]
    },
    {
      "fdaUniiCode": "31TZ62FO8F",
      "id": "Selinexor",
      "preferredName": "Selinexor",
      "synonyms": [
        "2-Propenoic Acid, 3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-, 2-(2-Pyrazinyl)hydrazide, (2Z)-",
        "ATG-010",
        "CRM1 Nuclear Export Inhibitor KPT-330",
        "KPT-330",
        "SELINEXOR",
        "SINE KPT-330",
        "Selective Inhibitor of Nuclear Export KPT-330",
        "Selinexor",
        "Xpovio"
      ]
    },
    {
      "fdaUniiCode": "WFR23M21IE",
      "id": "Capivasertib",
      "preferredName": "Capivasertib",
      "synonyms": [
        "AZD5363",
        "CAPIVASERTIB",
        "Capivasertib"
      ]
    },
    {
      "fdaUniiCode": "2N71QUE3NL",
      "id": "Ipafricept",
      "preferredName": "Ipafricept",
      "synonyms": [
        "Fusion Protein For Immune Applications (fpia) Comprising Homo Sapiens FZD8 (Frizzled Family Receptor 8, Frizzled-8) Extracellular Domain, Fused With Homo Sapiens Immunoglobulin G1 Fc Fragment",
        "Fzd8-Fc",
        "IPAFRICEPT",
        "Ipafricept",
        "OMP 54F28",
        "OMP-54F28"
      ]
    },
    {
      "fdaUniiCode": "98DE7VN88D",
      "id": "Mirvetuximab_Soravtansine",
      "preferredName": "Mirvetuximab Soravtansine",
      "synonyms": [
        "IMGN853",
        "M9346A-sulfo-SPDB-DM4",
        "MIRVETUXIMAB SORAVTANSINE",
        "Mirvetuximab Soravtansine"
      ]
    },
    {
      "fdaUniiCode": "SO0RV2V6EJ",
      "id": "Recombinant_EphB4-HSA_Fusion_Protein",
      "preferredName": "Recombinant EphB4-HSA Fusion Protein",
      "synonyms": [
        "Recombinant EphB4-HSA Fusion Protein",
        "SEPHB4-HSA",
        "sEphB4-HSA"
      ]
    },
    {
      "fdaUniiCode": "37O2X55Y9E",
      "id": "Bryostatin_1",
      "preferredName": "Bryostatin 1",
      "synonyms": [
        "B705008K112",
        "BRYOSTATIN 1",
        "Bryostatin 1",
        "Bryostatin I",
        "bryostatin 1"
      ]
    },
    {
      "fdaUniiCode": "9X5A2QIA7C",
      "id": "PARPTankyrase_Inhibitor_2X-121",
      "preferredName": "PARP/Tankyrase Inhibitor 2X-121 ",
      "synonyms": [
        "2X-121",
        "E-7449",
        "E7449",
        "PARP/TNKS Inhibitor 2X-121",
        "PARP/Tankyrase Inhibitor 2X-121",
        "PARP/Tankyrase Inhibitor 2X-121 "
      ]
    },
    {
      "fdaUniiCode": "I17GWP65CE",
      "id": "Fosgemcitabine_Palabenamide",
      "preferredName": "Fosgemcitabine Palabenamide",
      "synonyms": [
        "Acelarin",
        "FOSGEMCITABINE PALABENAMIDE",
        "Fosgemcitabine Palabenamide",
        "Gemictabine ProTide",
        "NUC 1031",
        "NUC-1031"
      ]
    },
    {
      "fdaUniiCode": "SMA5ZS5B22",
      "id": "Ensartinib",
      "preferredName": "Ensartinib",
      "synonyms": [
        "6-Amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]- N-{4-[(3R,5S)-3,5-dimethylpiperazine- 1-carbonyl]phenyl}pyridazine-3-carboxamide",
        "ENSARTINIB",
        "Ensartinib",
        "X-396"
      ]
    },
    {
      "fdaUniiCode": "Q6C9WHR03O",
      "id": "Tisagenlecleucel",
      "preferredName": "Tisagenlecleucel",
      "synonyms": [
        "CART-19",
        "CART19",
        "CTL019",
        "CTL019 T-cells",
        "Kymriah",
        "TISAGENLECLEUCEL",
        "Tisagenlecleucel",
        "Tisagenlecleucel-T"
      ]
    },
    {
      "fdaUniiCode": "M9BYU8XDQ6",
      "id": "Sacituzumab_Govitecan",
      "preferredName": "Sacituzumab Govitecan",
      "synonyms": [
        "IMMU-132",
        "RS7-SN38",
        "SACITUZUMAB GOVITECAN",
        "Sacituzumab Govitecan",
        "Sacituzumab Govitecan-hziy",
        "Trodelvy",
        "hRS7-SN38 Antibody Drug Conjugate"
      ]
    },
    {
      "fdaUniiCode": "X8JR0I7JE1",
      "id": "Talacotuzumab",
      "preferredName": "Talacotuzumab",
      "synonyms": [
        "Anti-IL-3 Receptor Alpha Monoclonal Antibody CSL362",
        "CSL 362",
        "CSL362",
        "JNJ-56022473",
        "JNJ56022473",
        "TALACOTUZUMAB",
        "Talacotuzumab"
      ]
    },
    {
      "fdaUniiCode": "OR3S9IF86U",
      "id": "Ulinastatin",
      "preferredName": "Ulinastatin",
      "synonyms": [
        "Bikunin",
        "Trypsin Inhibitor, Bikunin",
        "ULINASTATIN",
        "UTI",
        "Ulinastatin",
        "Urinary Trypsin Inhibitor"
      ]
    },
    {
      "fdaUniiCode": "49DXG3M5ZW",
      "id": "Fruquintinib",
      "preferredName": "Fruquintinib",
      "synonyms": [
        "6-(6,7-Dimethoxyquinazolin-4-yl)oxy-N,2-dimethyl-1-benzofuran-3-carboxamide",
        "Elunate",
        "FRUQUINTINIB",
        "Fruquintinib",
        "HMPL-013",
        "VEGFR-1/2/3 Inhibitor HMPL-013"
      ]
    },
    {
      "fdaUniiCode": "UP0K5026VB",
      "id": "CYP17CYP11B2_Inhibitor_LAE001",
      "preferredName": "CYP17/CYP11B2 Inhibitor LAE001",
      "synonyms": [
        "CFG 920",
        "CFG-920",
        "CFG920",
        "CYP17/CYP11B2 Inhibitor LAE001",
        "LAE 001",
        "LAE-001",
        "LAE001"
      ]
    },
    {
      "fdaUniiCode": "YLR364XYSA",
      "id": "Gemcitabine_Prodrug_LY2334737",
      "preferredName": "Gemcitabine Prodrug LY2334737",
      "synonyms": [
        "Gemcitabine Prodrug LY2334737",
        "LY-2334737",
        "LY2334737"
      ]
    },
    {
      "fdaUniiCode": "LXG44NDL2T",
      "id": "Tirabrutinib",
      "preferredName": "Tirabrutinib",
      "synonyms": [
        "6-Amino-9-((3R)-1-(2-butynoyl)-3-pyrrolidinyl)-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one",
        "8H-Purin-8-one,6-amino-7,9-dihydro-9-((3R)-1-(1-oxo-2-butyn-1-yl)-3-pyrrolidinyl)-7-(4-phenoxyphenyl)",
        "GS-4059",
        "ONO-4059",
        "ONO4059",
        "TIRABRUTINIB",
        "Tirabrutinib"
      ]
    },
    {
      "fdaUniiCode": "VFH55IZ5VI",
      "id": "Olinvacimab",
      "preferredName": "Olinvacimab",
      "synonyms": [
        "OLINVACIMAB",
        "Olinvacimab",
        "TTAC-0001"
      ]
    },
    {
      "fdaUniiCode": "C3059TG1KN",
      "id": "Thioureidobutyronitrile",
      "preferredName": "Thioureidobutyronitrile",
      "synonyms": [
        "4-ISOTHIOUREIDOBUTYRONITRILE",
        "4-Isothioureidobutyronitrile",
        "Carbamimidothioic Acid, 3-Cyanopropyl Ester",
        "Kevetrin",
        "Thioureidobutyronitrile"
      ]
    },
    {
      "fdaUniiCode": "EEY8DZS103",
      "id": "Buthionine_Sulfoximine",
      "preferredName": "Buthionine Sulfoximine",
      "synonyms": [
        "2-Amino-4-(S-butylsulfonimidoyl) Butanoic Acid",
        "BSO",
        "BUTHIONINE SULFOXIMINE, L-",
        "Butanoic Acid, 2-Amino-4-(S-butylsulfonimidoyl)-",
        "Butanoic acid, 2-amino-4-(S-butylsulfonimidoyl)-",
        "Buthionine Sulfoximine",
        "Buthionine Sulphoximine",
        "L-Buthionine Sulfoximine",
        "L-Buthionine sulfoximine",
        "S-(3-Amino-3-carboxypropyl)-S-butylsulfoximine",
        "S-(n-Butyl)homocysteine Sulfoximine",
        "buthionine sulfoximine"
      ]
    },
    {
      "fdaUniiCode": "VC1D38AGN9",
      "id": "Anti-ENPP3_Antibody-Drug_Conjugate_AGS-16C3F",
      "preferredName": "Anti-ENPP3 Antibody-Drug Conjugate AGS-16C3F",
      "synonyms": [
        "ADC AGS-16C3F",
        "AGS-16C3F",
        "Anti-ENPP3 Antibody-Drug Conjugate AGS-16C3F"
      ]
    },
    {
      "fdaUniiCode": "K2I4B6I9L1",
      "id": "Iodine_I_131_Rituximab",
      "preferredName": "Iodine I 131 Rituximab",
      "synonyms": [
        "(131)I-Rituximab",
        "131I-Rituxan",
        "Iodine I 131 Rituximab",
        "RITUXIMAB I-131"
      ]
    },
    {
      "fdaUniiCode": "MK2A783ZUT",
      "id": "Piritrexim",
      "preferredName": "Piritrexim",
      "synonyms": [
        "2,4-Diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine",
        "6-((2,5-Dimethoxyphenyl)methyl)-5-methylpyrido(2,3-d)pyrimidine-2,4-diamine",
        "6-[(2,5-Dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine",
        "BW 301U",
        "BW-301U",
        "PIRITREXIM",
        "Piritrexim",
        "piritrexim"
      ]
    },
    {
      "fdaUniiCode": "N54AIC43PW",
      "id": "Venetoclax",
      "preferredName": "Venetoclax",
      "synonyms": [
        "4-(4-((2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzamide",
        "ABT-0199",
        "ABT-199",
        "ABT199",
        "GDC-0199",
        "RG7601",
        "VENETOCLAX",
        "Venclexta",
        "Venclyxto",
        "Venetoclax"
      ]
    },
    {
      "fdaUniiCode": "8V9YR09EF3",
      "id": "Pinometostat",
      "preferredName": "Pinometostat",
      "synonyms": [
        "DOT1L Inhibitor EPZ-5676",
        "EPZ-5676",
        "PINOMETOSTAT",
        "Pinometostat"
      ]
    },
    {
      "fdaUniiCode": "SR717JCM7M",
      "id": "Tumor-Cells_Apoptosis_Factor_Hormone-Peptide",
      "preferredName": "Tumor-Cells Apoptosis Factor Hormone-Peptide",
      "synonyms": [
        "NEROFE",
        "Nerofe",
        "Tumor-Cells Apoptosis Factor Hormone-Peptide"
      ]
    },
    {
      "fdaUniiCode": "28X28X9OKV",
      "id": "Durvalumab",
      "preferredName": "Durvalumab",
      "synonyms": [
        "DURVALUMAB",
        "Durvalumab",
        "Imfinzi",
        "Immunoglobulin G1, Anti-(Human Protein B7-H1) (Human Monoclonal MEDI4736 Heavy Chain), Disulfide with Human Monoclonal MEDI4736 Kappa-chain, Dimer",
        "MEDI-4736",
        "MEDI4736"
      ]
    },
    {
      "fdaUniiCode": "0OCC969V50",
      "id": "Cactinomycin",
      "preferredName": "Cactinomycin",
      "synonyms": [
        "ACTINOMYCIN C",
        "Actinomycin C",
        "CACTINOMYCIN",
        "Cactinomycin"
      ]
    },
    {
      "fdaUniiCode": "890E37NHMV",
      "id": "Erdafitinib",
      "preferredName": "Erdafitinib",
      "synonyms": [
        "1,2-Ethanediamine, N1-(3,5-dimethoxyphenyl)-N2-(1-methylethyl)-N1-(3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl)-",
        "Balversa",
        "ERDAFITINIB",
        "Erdafitinib",
        "JNJ-42756493"
      ]
    },
    {
      "fdaUniiCode": "UNY2TQA40E",
      "id": "Brontictuzumab",
      "preferredName": "Brontictuzumab",
      "synonyms": [
        "BRONTICTUZUMAB",
        "Brontictuzumab",
        "Immunoglobulin G2-lambda, Anti-(homo Sapiens Notch1 (Notch 1, Translocation-associated Notch-1, TAN-1,Tan1)), Humanized Monoclonal Antibody",
        "OMP-52M51"
      ]
    },
    {
      "fdaUniiCode": "OVW60IDW1D",
      "id": "Acalisib",
      "preferredName": "Acalisib",
      "synonyms": [
        "6-Fluoro-3-phenyl-2-((1S)-1-(7H-purin-6-ylamino)ethyl)quinazolin-4(3H)-one",
        "ACALISIB",
        "Acalisib",
        "CAL-120",
        "GS-9820"
      ]
    },
    {
      "fdaUniiCode": "X40LKS49S3",
      "id": "Birabresib",
      "preferredName": "Birabresib",
      "synonyms": [
        "6H-Thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine-6-acetamide, 4-(4-Chlorophenyl)-N-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6S)-",
        "BIRABRESIB",
        "BRD 2/3/4 Inhibitor OTX015",
        "Birabresib",
        "MK-8628",
        "OTX015"
      ]
    },
    {
      "fdaUniiCode": "H74F6J185A",
      "id": "Caracemide",
      "preferredName": "Caracemide",
      "synonyms": [
        "Acetamide, N-[(Methylamino)carbonyl]-N-[[(methylamino)carbonyl]oxy]-(9CI)",
        "Acetamide, N-[(methylamino)carbonyl]-N-[[(methylamino)carbonyl]oxy]- (9CI)",
        "CARACEMIDE",
        "Caracemide",
        "N-Acetyl-N-(methylcarbamoyloxy)-N'-methylurea"
      ]
    },
    {
      "fdaUniiCode": "FJQ44KPA4J",
      "id": "Carbogen",
      "preferredName": "Carbogen",
      "synonyms": [
        "CARBOGEN",
        "Carbogen",
        "carbogen"
      ]
    },
    {
      "fdaUniiCode": "S9XDI9W918",
      "id": "Lirilumab",
      "preferredName": "Lirilumab",
      "synonyms": [
        "BMS-986015",
        "IPH2102",
        "LIRILUMAB",
        "Lirilumab"
      ]
    },
    {
      "fdaUniiCode": "KWH46ZDG32",
      "id": "Smac_Mimetic_GDC-0917",
      "preferredName": "Smac Mimetic GDC-0917",
      "synonyms": [
        "CUDC 427",
        "CUDC-427",
        "CUDC427",
        "GDC-0917",
        "IAP Antagonist GDC-0917",
        "L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(2-(2-oxazolyl)-4-phenyl-5-thiazolyl)-",
        "RG 7459",
        "RG-7459",
        "RG7459",
        "SMAC/DIABLO Mimetic GDC-0917",
        "Smac Mimetic GDC-0917"
      ]
    },
    {
      "fdaUniiCode": "QY8BWX1LJ5",
      "id": "Taladegib",
      "preferredName": "Taladegib",
      "synonyms": [
        "4-Fluoro-N-methyl-N-(1-(4-(1-methyl-1H-pyrazol-5-yl)phthalazin-1-yl)piperidin-4-yl)-2-(trifluoromethyl)benzamide",
        "Benzamide, 4-Fluoro-N-methyl-N-(1-(4-(1-methyl-1H-pyrazol-5-yl)-1-phthalazinyl)-4-piperidinyl)-2-(trifluoromethyl)-",
        "LY-2940680",
        "LY2940680",
        "TALADEGIB",
        "Taladegib"
      ]
    },
    {
      "fdaUniiCode": "9J6SW7G28J",
      "id": "Pasotuxizumab",
      "preferredName": "Pasotuxizumab",
      "synonyms": [
        "AMG-212",
        "BAY2010112",
        "MT112",
        "PASOTUXIZUMAB",
        "Pasotuxizumab"
      ]
    },
    {
      "fdaUniiCode": "XLR461MD3M",
      "id": "Istiratumab",
      "preferredName": "Istiratumab",
      "synonyms": [
        "ISTIRATUMAB",
        "Istiratumab",
        "MM-005",
        "MM-141"
      ]
    },
    {
      "fdaUniiCode": "051R55X44C",
      "id": "Carzinophilin",
      "preferredName": "Carzinophilin",
      "synonyms": [
        "CARZINOPHILIN",
        "CARZINOPHILIN A",
        "CZP",
        "Cardinophillin",
        "Cardinophyllin",
        "Carzinophilin",
        "Carzinophyllin"
      ]
    },
    {
      "fdaUniiCode": "3S9RX35S5X",
      "id": "Fimepinostat",
      "preferredName": "Fimepinostat",
      "synonyms": [
        "CUDC-907",
        "FIMEPINOSTAT",
        "Fimepinostat"
      ]
    },
    {
      "fdaUniiCode": "1K9EYK92PQ",
      "id": "Telapristone_Acetate",
      "preferredName": "Telapristone Acetate",
      "synonyms": [
        "(8S,11R,13S,14S,17R)-11-(4-(Dimethylamino)phenyl)-17-(2-methoxyacetyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl Acetate",
        "CDB-4124",
        "Proellex",
        "Progenta",
        "TELAPRISTONE ACETATE",
        "Telapristone Acetate"
      ]
    },
    {
      "fdaUniiCode": "65703MV349",
      "id": "Telapristone",
      "preferredName": "Telapristone",
      "synonyms": [
        "11Beta-(4-(dimethylamino)phenyl)-17-hydroxy-21-methoxy-19- norpregna-4,9-diene-3,20-dione",
        "TELAPRISTONE",
        "Telapristone"
      ]
    },
    {
      "fdaUniiCode": "Y6M3205516",
      "id": "Lumretuzumab",
      "preferredName": "Lumretuzumab",
      "synonyms": [
        "LUMRETUZUMAB",
        "Lumretuzumab",
        "RO5479599"
      ]
    },
    {
      "fdaUniiCode": "KG6VO684Z6",
      "id": "Polatuzumab_Vedotin",
      "preferredName": "Polatuzumab Vedotin",
      "synonyms": [
        "ADC DCDS4501A",
        "Antibody-Drug Conjugate DCDS4501A",
        "DCDS4501A",
        "FCU 2711",
        "POLATUZUMAB VEDOTIN",
        "Polatuzumab Vedotin",
        "Polivy",
        "RG7596",
        "Ro 5541077-000",
        "polatuzumab vedotin-piiq"
      ]
    },
    {
      "fdaUniiCode": "6KA1906BLC",
      "id": "Pinatuzumab_Vedotin",
      "preferredName": "Pinatuzumab Vedotin",
      "synonyms": [
        "ADC DCDT2980S",
        "Antibody-Drug Conjugate DCDT2980S",
        "DCDT2980S",
        "PINATUZUMAB VEDOTIN",
        "Pinatuzumab Vedotin"
      ]
    },
    {
      "fdaUniiCode": "22F97PC79G",
      "id": "Imalumab",
      "preferredName": "Imalumab",
      "synonyms": [
        "BAX-69",
        "BAX069",
        "BAX69",
        "IMALUMAB",
        "Imalumab",
        "Immunoglobulin G1-kappa, Anti-(Homo sapiens MIF (Macrophage Migration Inhibitory Factor, Glycosylation-inhibiting Factor, GlIF, GIF)), Homo sapiens Monoclonal Antibody"
      ]
    },
    {
      "fdaUniiCode": "N9B0H171MJ",
      "id": "Derazantinib",
      "preferredName": "Derazantinib",
      "synonyms": [
        "ARQ 087",
        "ARQ-087",
        "DERAZANTINIB",
        "Derazantinib"
      ]
    },
    {
      "fdaUniiCode": "064LI0IBFL",
      "id": "Iridium_Ir_192",
      "preferredName": "Iridium Ir 192",
      "synonyms": [
        "IRIDIUM IR-192",
        "Ir-192",
        "Iridium Ir 192",
        "Iridium-192"
      ]
    },
    {
      "fdaUniiCode": "S9WA04F921",
      "id": "Panulisib",
      "preferredName": "Panulisib",
      "synonyms": [
        "AK15176",
        "P7170",
        "PANULISIB",
        "PI3K/mTOR/ALK-1/DNA-PK Inhibitor P7170",
        "Panulisib"
      ]
    },
    {
      "fdaUniiCode": "H0Q44H4ECQ",
      "id": "Fadrozole_Hydrochloride",
      "preferredName": "Fadrozole Hydrochloride",
      "synonyms": [
        "4-(5,6,7,8-Tetrahydroimidazo(1,5-a)pyridin-5-yl)benzonitrile Hydrochloride",
        "4-(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile Monohydrochloride",
        "Afema",
        "Arensin",
        "CGS-16949A",
        "FADROZOLE HYDROCHLORIDE",
        "Fadrozole Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "1J0593208B",
      "id": "Roneparstat",
      "preferredName": "Roneparstat",
      "synonyms": [
        "100NA,RO-H",
        "RONEPARSTAT",
        "Roneparstat",
        "SST0001"
      ]
    },
    {
      "fdaUniiCode": "38073MQB2A",
      "id": "Umbralisib",
      "preferredName": "Umbralisib",
      "synonyms": [
        "2-((1S)-1-(4-Amino-3-(3-fluoro-4-(1-methylethoxy)phenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-6-fluoro-3-(3-fluorophenyl)-4H-1-benzopyran-4-one",
        "RP-5264",
        "RP5264",
        "TGR-1202",
        "UMBRALISIB",
        "Umbralisib"
      ]
    },
    {
      "fdaUniiCode": "2A2DA6857R",
      "id": "Savolitinib",
      "preferredName": "Savolitinib",
      "synonyms": [
        "AZD 6094",
        "AZD6094",
        "HMPL-504",
        "SAVOLITINIB",
        "Savolitinib",
        "Volitinib"
      ]
    },
    {
      "fdaUniiCode": "16ZDH50O1U",
      "id": "Ulixertinib",
      "preferredName": "Ulixertinib",
      "synonyms": [
        "1H-Pyrrole-2-carboxamide, 4-(5-chloro-2-((1-methylethyl)amino)-4-pyridinyl)-N-((1S)-1-(3-chlorophenyl)-2-hydroxyethyl)-",
        "BVD-523",
        "ULIXERTINIB",
        "Ulixertinib",
        "VRT752271"
      ]
    },
    {
      "fdaUniiCode": "GLY8ABW25V",
      "id": "Amcasertib",
      "preferredName": "Amcasertib",
      "synonyms": [
        "AMCASERTIB",
        "Amcasertib",
        "BBI503"
      ]
    },
    {
      "fdaUniiCode": "X05U0N2RCO",
      "id": "Darolutamide",
      "preferredName": "Darolutamide",
      "synonyms": [
        "Antiandrogen ODM-201",
        "BAY 1841788",
        "BAY-1841788",
        "BAY1841788",
        "DAROLUTAMIDE",
        "Darolutamide",
        "Nubeqa",
        "ODM 201",
        "ODM-201"
      ]
    },
    {
      "fdaUniiCode": "3053LTY75Z",
      "id": "Chlorozotocin",
      "preferredName": "Chlorozotocin",
      "synonyms": [
        "1-(2-chloroethyl)-1-nitroso-3-(D-glucos-2-yl)urea",
        "2-[3-(2-chloroethyl)-3-nitrosoureido]-2-deoxy-D-glucopyranose",
        "2-[[[(2-chloroethyl)nitrosamino]carbonyl]amino]-2-deoxy-D-glucose",
        "CHLOROZOTOCIN",
        "CHLZ",
        "CZT",
        "Chlorozotocin",
        "Chlorozotocyna",
        "D-Glucopyranose",
        "D-Glucopyranose, 2-[[[(2-chloroethyl)nitrosoamino]carbonyl]amino]-2-deoxy-",
        "D-Glucose, 2-[[[(2-chloroethyl)nitrosoamino]carbonyl]amino]-2-deoxy- (9CI)",
        "D-glucopyranose, 2-[[[(2-chloroethyl)nitrosoamino]carbonyl]amino]-2-deoxy",
        "D-glucose, 2-[[[(2-chloroethyl)nitrosoamino]carbonyl]amino]-2-deoxy- (9CI)",
        "DCNU"
      ]
    },
    {
      "fdaUniiCode": "649R3P169I",
      "id": "Asulacrine_Isethionate",
      "preferredName": "Asulacrine Isethionate",
      "synonyms": [
        "9-(2-Methoxy-4-(methylsulfonylamino)phenylamino)-N,5-dimethyl-4-acridinecarboxamide 2-hydroxyethanesulfonate",
        "ASULACRINE ISETHIONATE",
        "Asulacrine Isethionate",
        "CI-921"
      ]
    },
    {
      "fdaUniiCode": "H5324S1M7H",
      "id": "Denintuzumab_Mafodotin",
      "preferredName": "Denintuzumab Mafodotin",
      "synonyms": [
        "ADC SGN-19A",
        "DENINTUZUMAB MAFODOTIN",
        "Denintuzumab Mafodotin",
        "Immunoglobulin G1-kappa Auristatin F Conjugate, Anti-(homosapiens CD19 (B Lymphocyte Surface Antigen B4, leu-12)), Humanized Monoclonal Antibody",
        "SGN-19A",
        "SGN-CD19A"
      ]
    },
    {
      "fdaUniiCode": "H1250JIK0A",
      "id": "Clarithromycin",
      "preferredName": "Clarithromycin",
      "synonyms": [
        "6-O-Methylerythromycin",
        "Abbott-56268",
        "Biaxin",
        "CLARITHROMYCIN",
        "Clarithromycin",
        "clarithromycin"
      ]
    },
    {
      "fdaUniiCode": "OSV3KVO1BT",
      "id": "2-Hydroxyoleic_Acid",
      "preferredName": "2-Hydroxyoleic Acid",
      "synonyms": [
        "2-HYDROXYOLEIC ACID",
        "2-Hydroxyoleic Acid",
        "2-OHOA",
        "2OHOA",
        "Minerval"
      ]
    },
    {
      "fdaUniiCode": "6I3O3W6O3B",
      "id": "Entospletinib",
      "preferredName": "Entospletinib",
      "synonyms": [
        "6-(1H-Indazol-6-yl)-N-(4-(morpholin-4-yl)phenyl)imidazo(1,2-a)pyrazin-8-amine",
        "ENTO",
        "ENTOSPLETINIB",
        "Entospletinib",
        "GS 9973",
        "GS-9973",
        "Imidazo(1,2-a)pyrazin-8-amine, 6-(1H-indazol-6-yl)-N-(4-(4-morpholinyl)phenyl)-"
      ]
    },
    {
      "fdaUniiCode": "CPW7BR9UY7",
      "id": "Lutetium_Lu_177_DOTA-Tetulomab",
      "preferredName": "Lutetium Lu 177 DOTA-Tetulomab",
      "synonyms": [
        "177Lu-DOTA-HH1",
        "177Lu-Dota-Tetulomab",
        "177Lu-HH1",
        "Lutetium Lu 177 DOTA-Tetulomab",
        "TETULOMAB TETRAXETAN LU-177"
      ]
    },
    {
      "fdaUniiCode": "ILE26V76EB",
      "id": "Custirsen_Sodium",
      "preferredName": "Custirsen Sodium",
      "synonyms": [
        "(3'-5')d(P-thio)([2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2- methoxyethyl)]rG-[2'-O-(2-methoxyethyl)]m5rC-A-G-C-A-G-A-G-T-C-T-T-C-A-[2'-O-(2- methoxyethyl)]m5rU-[2'-O-(2-methoxyethyl)]m5rC-[2'-O-(2-methoxyethyl)]rA-[2'-O-(2- methoxyethyl)]m5rU), Eicosasodium Salt",
        "Antisense TRPM-2",
        "Antisense Testosterone-Repressed Prostate Message 2",
        "CUSTIRSEN SODIUM",
        "Clusterin Antisense Oligonucleotide",
        "Custirsen Sodium",
        "ISIS 112989",
        "OGX-011",
        "TRPM-2 Antisense",
        "custirsen sodium"
      ]
    },
    {
      "fdaUniiCode": "F3R7A4P04N",
      "id": "Depatuxizumab_Mafodotin",
      "preferredName": "Depatuxizumab Mafodotin",
      "synonyms": [
        "ABT-414",
        "DEPATUXIZUMAB MAFODOTIN",
        "Depatuxizumab Mafodotin"
      ]
    },
    {
      "fdaUniiCode": "GZ8VF4M2J8",
      "id": "Cordycepin",
      "preferredName": "Cordycepin",
      "synonyms": [
        "3'-Deoxyadenosine",
        "3'-dA-CE Phosphoramidite",
        "3-dAdenosine",
        "9-Cordyceposidoadenine",
        "COR",
        "CORDYCEPIN",
        "Cordycepin",
        "Cordycepine",
        "Kordicepin",
        "cordycepin"
      ]
    },
    {
      "fdaUniiCode": "883WKN7W8X",
      "id": "Cortisone_Acetate",
      "preferredName": "Cortisone Acetate",
      "synonyms": [
        "21-(Acetyloxy)-17-hydroxypregn-4-ene-3,11,20-trione",
        "6alpha,9Difluoro-11beta,17,21-trihydroxypregna-1,4- diene-3,20-dione 21-acetate 17- Butyrate",
        "CORTISONE ACETATE",
        "Cortisone Acetate",
        "Cortisone acetate",
        "Cortogen",
        "Cortone",
        "Cortone acetate"
      ]
    },
    {
      "fdaUniiCode": "571045EIM4",
      "id": "Andecaliximab",
      "preferredName": "Andecaliximab",
      "synonyms": [
        "ANDECALIXIMAB",
        "Andecaliximab",
        "GS-5745"
      ]
    },
    {
      "fdaUniiCode": "3VF50SU4RZ",
      "id": "Zotiraciclib_Citrate",
      "preferredName": "Zotiraciclib Citrate",
      "synonyms": [
        "20-Oxa-5,7,14,27-tetraazatetracyclo(19.3.1.12,6.18,12)heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene, 14-Methyl-, 2-Hydroxy-1,2,3-propanetricarboxylate (1:1)",
        "SB1317 Citrate",
        "TG02 Citrate",
        "ZOTIRACICLIB CITRATE",
        "Zotiraciclib Citrate"
      ]
    },
    {
      "fdaUniiCode": "QUW7B71FO9",
      "id": "Ralimetinib_Mesylate",
      "preferredName": "Ralimetinib Mesylate",
      "synonyms": [
        "3H-Imidazo(4,5-b)pyridin-2-amine, 5-(2-(1,1-dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-(2,2-dimethylpropyl)-, Methanesulfonate (1:2)",
        "LY-2228820",
        "LY2228820",
        "LY2228820 Dimesylate",
        "RALIMETINIB MESYLATE",
        "Ralimetinib Dimesylate",
        "Ralimetinib Mesylate"
      ]
    },
    {
      "fdaUniiCode": "4KM2BN5JHF",
      "id": "Cyproterone_Acetate",
      "preferredName": "Cyproterone Acetate",
      "synonyms": [
        "3'H-Cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione, 17-(Acetyloxy)-6-chloro-1,2-dihydro-, (1beta,2beta)-",
        "6-Chloro-1b,2b-dihydro-17a-hydroxy-3'H-cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione Acetate",
        "Andro-Diane",
        "Androcur",
        "CYPROTERONE ACETATE",
        "Chloro-6-hydroxy-17 Alpha Methylene-1 Alpha, 2 Alpha Pregnadiene-4,6 Dione-3, 20 Acetate",
        "CyPat",
        "Cyprone",
        "Cyprostat",
        "Cyproteronazetat",
        "Cyproterone Acetate",
        "Cyproteroni Acetas",
        "Diane",
        "Dianette",
        "SH 714",
        "SH-714",
        "cyproterone acetate"
      ]
    },
    {
      "fdaUniiCode": "RR5U4UFJ8L",
      "id": "Cusatuzumab",
      "preferredName": "Cusatuzumab",
      "synonyms": [
        "ARGX-110",
        "Anti-CD70 Monoclonal Antibody ARGX-110",
        "CUSATUZUMAB",
        "Cusatuzumab"
      ]
    },
    {
      "fdaUniiCode": "X86Z1O656G",
      "id": "Xentuzumab",
      "preferredName": "Xentuzumab",
      "synonyms": [
        "BI 836845",
        "Immunoglobulin G1, Anti-(Human Insulin-like Growth Factor I) (Human Monoclonal PS05388 Heavy Chain), Disulfide with Human Monoclonal PS05388 Light Chain, Dimer",
        "XENTUZUMAB",
        "Xentuzumab"
      ]
    },
    {
      "fdaUniiCode": "2X3CKG601L",
      "id": "Sofituzumab_Vedotin",
      "preferredName": "Sofituzumab Vedotin",
      "synonyms": [
        "DMUC5754A",
        "SOFITUZUMAB VEDOTIN",
        "Sofituzumab Vedotin"
      ]
    },
    {
      "fdaUniiCode": "YDU8YIP30L",
      "id": "Duborimycin",
      "preferredName": "Duborimycin",
      "synonyms": [
        "13-Hydroxydaunomycin",
        "5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, (8S-cis)-, hydrochloride",
        "DAUNORUBICINOL",
        "Daunomycinol",
        "Daunomycinol HCl",
        "Daunorubicineal",
        "Daunorubicinol",
        "Duborimycin",
        "Duborimycin Hydrochloride",
        "Duborimycine",
        "Duborimycine, Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "MC4B01024K",
      "id": "Crenolanib_Besylate",
      "preferredName": "Crenolanib Besylate",
      "synonyms": [
        "4-Piperidinamine, 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1Hbenzimidazol-1-yl]-8-quinolinyl]-, Benzenesulfonate (1:1)",
        "CP-868,596-26",
        "CP-86859626",
        "CRENOLANIB BESYLATE",
        "Crenolanib Besylate",
        "[1-[2-[5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine Monobenzenesulfonate"
      ]
    },
    {
      "fdaUniiCode": "9MM2R1A06R",
      "id": "Brilanestrant",
      "preferredName": "Brilanestrant",
      "synonyms": [
        "ARN-810",
        "BRILANESTRANT",
        "Brilanestrant",
        "GDC-0810",
        "RO7056118",
        "SERD ARN-810"
      ]
    },
    {
      "fdaUniiCode": "52CMI0WC3Y",
      "id": "Atezolizumab",
      "preferredName": "Atezolizumab",
      "synonyms": [
        "ATEZOLIZUMAB",
        "Atezolizumab",
        "Immunoglobulin G1, Anti-(human CD Antigen cd274) (Human Monoclonal MPDL3280A Heavy Chain), Disulfide with Human Monoclonal MPDL3280A Kappa-chain, Dimer",
        "MPDL 3280A",
        "MPDL 328OA",
        "MPDL-3280A",
        "MPDL3280A",
        "MPDL328OA",
        "RG7446",
        "RO5541267",
        "Tecentriq"
      ]
    },
    {
      "fdaUniiCode": "9TG5O4V25H",
      "id": "PIM_Kinase_Inhibitor_LGH447",
      "preferredName": "PIM Kinase Inhibitor LGH447",
      "synonyms": [
        "LGH-447",
        "LGH447",
        "PIM 447",
        "PIM Kinase Inhibitor LGH447",
        "PIM-447",
        "PIM447"
      ]
    },
    {
      "fdaUniiCode": "R15ZW356HN",
      "id": "Telisotuzumab",
      "preferredName": "Telisotuzumab",
      "synonyms": [
        "ABT-700",
        "Anti-c-Met Monoclonal Antibody ABT-700",
        "TELISOTUZUMAB",
        "Telisotuzumab"
      ]
    },
    {
      "fdaUniiCode": "B6M586T6SD",
      "id": "Anti-CD27L_Antibody-Drug_Conjugate_AMG_172",
      "preferredName": "Anti-CD27L Antibody-Drug Conjugate AMG 172",
      "synonyms": [
        "AMG 172",
        "AMG-172",
        "Anti-CD27L Antibody-Drug Conjugate AMG 172"
      ]
    },
    {
      "fdaUniiCode": "3YH0N35CE3",
      "id": "Mocravimod_Hydrochloride",
      "preferredName": "Mocravimod Hydrochloride",
      "synonyms": [
        "2-Amino-2-propanediol Hydrochloride",
        "KRP-203",
        "KRP203",
        "MOCRAVIMOD HYDROCHLORIDE",
        "Mocravimod Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "A3749M6582",
      "id": "Anlotinib_Hydrochloride",
      "preferredName": "Anlotinib Hydrochloride",
      "synonyms": [
        "1-((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-quinolyl)oxymethyl)cyclopropanamine, Dihydrochloride",
        "ALTN HCl",
        "Anlotinib Hydrochloride",
        "CATEQUENTINIB DIHYDROCHLORIDE",
        "Cyclopropanamine, 1-(((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-quinolinyl)oxy)methyl)-, Hydrochloride (1:2)"
      ]
    },
    {
      "fdaUniiCode": "DPT0O3T46P",
      "id": "Pembrolizumab",
      "preferredName": "Pembrolizumab",
      "synonyms": [
        "Immunoglobulin G4, Anti-(Human Programmed Cell Death 1); Humanized Mouse Monoclonal (228-L-proline(H10-S>P))gamma 4 Heavy Chain (134-218')-disulfide with Humanized Mouse Monoclonal Kappa Light Chain Dimer (226-226'':229-229'')-bisdisulfide",
        "Keytruda",
        "Lambrolizumab",
        "MK-3475",
        "PEMBROLIZUMAB",
        "Pembrolizumab",
        "SCH 900475"
      ]
    },
    {
      "fdaUniiCode": "822EC3XEJZ",
      "id": "Detorubicin",
      "preferredName": "Detorubicin",
      "synonyms": [
        "14-Diethoxyacetoxydaunorubicin",
        "DETORUBICIN",
        "Detorubicin",
        "Diethoxy-,2-(4-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl)-2-oxoethyl ester,(2S-cis) Acetic Acid"
      ]
    },
    {
      "fdaUniiCode": "5R9F9NE9Z2",
      "id": "Iproplatin",
      "preferredName": "Iproplatin",
      "synonyms": [
        "(OC-6-33)-dichlorodihydroxybis(2-propanamine)platinum",
        "CHIP",
        "Diisopropylammine-trans-dihydroxymalonatoplatinum(IV)",
        "IPROPLATIN",
        "Iproplatin",
        "JM-9",
        "Platinum, dichlorodihydroxybis(2-propanamine)-, (oc-6-33)-"
      ]
    },
    {
      "fdaUniiCode": "Y3834SIK5F",
      "id": "Porfimer_Sodium",
      "preferredName": "Porfimer Sodium",
      "synonyms": [
        "CL-184116",
        "DHE",
        "Dihematoporphyrin Ester",
        "Dihematoporphyrin Ether",
        "PORFIMER SODIUM",
        "Photofrin II",
        "Porfimer Sodium",
        "dihematoporphyrin ether",
        "porfimer sodium"
      ]
    },
    {
      "fdaUniiCode": "96B0BRI1JU",
      "id": "Benzaldehyde_Dimethane_Sulfonate",
      "preferredName": "Benzaldehyde Dimethane Sulfonate",
      "synonyms": [
        "BEN",
        "Benzaldehyde Dimethane Sulfonate",
        "DMS-612",
        "DMS612",
        "NSC 281612"
      ]
    },
    {
      "fdaUniiCode": "78I4VEX88N",
      "id": "Agerafenib",
      "preferredName": "Agerafenib",
      "synonyms": [
        "1-(3-(6,7-Dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea Hydrochloride",
        "AC013773",
        "AGERAFENIB",
        "Agerafenib",
        "CEP-32496",
        "RXDX-105"
      ]
    },
    {
      "fdaUniiCode": "6M27443B0N",
      "id": "Milademetan_Tosylate",
      "preferredName": "Milademetan Tosylate",
      "synonyms": [
        "DS-3032 Tosylate",
        "DS-3032b",
        "DS-3032b Tosylate",
        "MILADEMETAN TOSYLATE",
        "Milademetan Tosylate"
      ]
    },
    {
      "fdaUniiCode": "V7U0JSO7FH",
      "id": "Anti-5T4_Antibody-Drug_Conjugate_PF-06263507",
      "preferredName": "Anti-5T4 Antibody-Drug Conjugate PF-06263507",
      "synonyms": [
        "Anti-5T4 Antibody-Drug Conjugate PF-06263507",
        "PF-06263507"
      ]
    },
    {
      "fdaUniiCode": "7TK323DLA0",
      "id": "Nogapendekin_Alfa",
      "preferredName": "Nogapendekin Alfa",
      "synonyms": [
        "ALT 803",
        "ALT-803",
        "ALT803",
        "Fusion Protein Consisting of IL-15N72D and IL-15RaSu/FC",
        "IL-15N72D/IL-15Ra-Fc",
        "IL-15N72D:IL-15RaSu/Fc Fusion Complex",
        "N 803",
        "N-803",
        "N803",
        "NOGAPENDEKIN ALFA",
        "Nogapendekin Alfa",
        "Superagonist Interleukin-15:Interleukin-15 Receptor AlphaSu/Fc Fusion Complex Alt-803"
      ]
    },
    {
      "fdaUniiCode": "QH36X20ODG",
      "id": "Recombinant_Human_Adenovirus_Type_5_H101",
      "preferredName": "Recombinant Human Adenovirus Type 5 H101",
      "synonyms": [
        "H-101",
        "H101",
        "Oncorine",
        "Recombinant Human Adenovirus Type 5 H101",
        "rAd5 H101"
      ]
    },
    {
      "fdaUniiCode": "Q40W93WPE1",
      "id": "Tazemetostat",
      "preferredName": "Tazemetostat",
      "synonyms": [
        "E7438",
        "EPZ-6438",
        "EPZ6438",
        "N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(oxan-4-yl)amino)-4-methyl-4'-((morpholin-4-yl)methyl)(1,1'-biphenyl)-3-carboxamide",
        "N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide",
        "TAZEMETOSTAT",
        "Tazemetostat"
      ]
    },
    {
      "fdaUniiCode": "U549S98QLW",
      "id": "Bufalin",
      "preferredName": "Bufalin",
      "synonyms": [
        "3,14-Dihydroxy-Bufa-20,22-Dienolide",
        "3-Beta,14-Dihydroxy-5-Beta-Bufa-20,22-Dienolide",
        "3beta,14beta-Dihydroxy-5beta-Bufa-20,22-Dienolide",
        "5-Beta-Bufa-20,22-Dienolide, 3-Beta,14-Dihydroxy-",
        "5beta-Bufa-20,22-Dienolide, 3beta,14-Dihydroxy- (8CI)",
        "BUFALIN",
        "Bufa-20,22-Dienolide, 3,14-Dihydroxy-, (3-Beta,5-Beta)- (9CI)",
        "Bufa-20,22-Dienolide, 3,14-Dihydroxy-, (3beta,5beta)- (9CI)",
        "Bufalin"
      ]
    },
    {
      "fdaUniiCode": "0KC57I4UNB",
      "id": "Dicycloplatin",
      "preferredName": "Dicycloplatin",
      "synonyms": [
        "DCP",
        "DICYCLOPLATIN",
        "Dicycloplatin"
      ]
    },
    {
      "fdaUniiCode": "P256HB60FF",
      "id": "Rovalpituzumab_Tesirine",
      "preferredName": "Rovalpituzumab Tesirine",
      "synonyms": [
        "ROVALPITUZUMAB TESIRINE",
        "Rova-T",
        "Rovalpituzumab Tesirine",
        "SC0002",
        "SC16LD6.5"
      ]
    },
    {
      "fdaUniiCode": "F70C5K4786",
      "id": "Melphalan_Flufenamide",
      "preferredName": "Melphalan Flufenamide",
      "synonyms": [
        "Ethyl (2S)-2-((2S)-2-Amino-3-(4-(bis(2-chloroethyl)amino)phenyl)propanamido)-3-(4-fluorophenyl)propanoate",
        "J-1",
        "J1",
        "L-melphalanyl-p-L-fluorophenylalanine Ethyl Ester",
        "MELPHALAN FLUFENAMIDE",
        "Melflufen",
        "Melphalan Flufenamide",
        "Prodrug J1",
        "Ygalo"
      ]
    },
    {
      "fdaUniiCode": "GK8781218Z",
      "id": "Aprutumab",
      "preferredName": "Aprutumab",
      "synonyms": [
        "AGC-2500",
        "APRUTUMAB",
        "Aprutumab",
        "BAY-1179470",
        "BAY1179470"
      ]
    },
    {
      "fdaUniiCode": "2K59L7G59M",
      "id": "Dezapelisib",
      "preferredName": "Dezapelisib",
      "synonyms": [
        "5H-Thiazolo(3,2-a)pyrimidin-5-one, 6-(3-Fluorophenyl)-3-methyl-7-((1S)-1-(9H-purin-6-ylamino)ethyl)-",
        "DEZAPELISIB",
        "Dezapelisib",
        "INCB040093"
      ]
    },
    {
      "fdaUniiCode": "X20UZ57G4O",
      "id": "Dromostanolone_Propionate",
      "preferredName": "Dromostanolone Propionate",
      "synonyms": [
        "2 Alpha-Methyldihydrotestosterone Propionate",
        "2-Alpha-Methyldihydrotestosterone Propionate",
        "2.alpha.-Methyldihydrotestosterone propionate",
        "Compound 32379",
        "DROMOSTANOLONE PROPIONATE",
        "Drolban",
        "Dromostanolone Propionate",
        "Drostanolone Propionate",
        "Drostanolone propionate",
        "Emdisterone",
        "Masterid",
        "Masteril",
        "Masteron",
        "Masterone",
        "Permastril"
      ]
    },
    {
      "fdaUniiCode": "49EEF6HRUS",
      "id": "Brequinar_Sodium",
      "preferredName": "Brequinar Sodium",
      "synonyms": [
        "BREQUINAR SODIUM",
        "Brequinar Sodium",
        "Brequinar sodium",
        "DUP-785",
        "DUP785",
        "Sodium 6-Fluoro-2-(2'-fluoro-4-biphenylyl)-3-methyl-4-quinolinecarboxylate"
      ]
    },
    {
      "fdaUniiCode": "D3G8N2863A",
      "id": "Dynemicin_A",
      "preferredName": "Dynemicin A",
      "synonyms": [
        "DYNEMICIN A",
        "Dynemicin A"
      ]
    },
    {
      "fdaUniiCode": "ZTV0FOB6NU",
      "id": "Elsamitrucin",
      "preferredName": "Elsamitrucin",
      "synonyms": [
        "10-O-Elsaminosylelsarosylchartarin",
        "BBM 2478A",
        "BMY-28090",
        "BRN 5214813",
        "Benzo(h)(1)benzopyrano(5,4,3-cde)(1)ebnzopyran-5,12-dione,10((2-O-(2-amino-2,6-dideoxy-3-O-methyl-alpha-D-galactopyranosyl)-6-deoxy-3-C-methyl-beta-D-galactopyranosyl)oxy)-6-hydroxy-1-methyl",
        "ELSAMITRUCIN",
        "Elsamicin A",
        "Elsamitrucin",
        "Elsamitrucina",
        "Elsamitrucine",
        "Elsamitrucinum"
      ]
    },
    {
      "fdaUniiCode": "H464ZO600O",
      "id": "Apaziquone",
      "preferredName": "Apaziquone",
      "synonyms": [
        "3-hydroxymethyl-5-aziridinyl-1-methyl-2-(1H-indole-4,7-dione) prop-beta-en-alpha-ol",
        "APAZIQUONE",
        "Apaziquone",
        "E O9",
        "EO9",
        "Eoquin",
        "Neoquin",
        "Qapzola"
      ]
    },
    {
      "fdaUniiCode": "YE7586973L",
      "id": "Epitiostanol",
      "preferredName": "Epitiostanol",
      "synonyms": [
        "10275-S",
        "EPITIOSTANOL",
        "Epitiostanol"
      ]
    },
    {
      "fdaUniiCode": "OKG364O896",
      "id": "Estradiol_Valerate",
      "preferredName": "Estradiol Valerate",
      "synonyms": [
        "Delestrogen",
        "ESTRADIOL VALERATE",
        "Estradiol Valerate"
      ]
    },
    {
      "fdaUniiCode": "30DKA3Q1HL",
      "id": "Etanidazole",
      "preferredName": "Etanidazole",
      "synonyms": [
        "1H-Imidazole-1-acetamide, N-(2-hydroxyethyl)-2-nitro-",
        "2-Nitroimidazole-1-acetamide, N-(2-hydroxyethyl)-",
        "ETANIDAZOLE",
        "Etanidazole",
        "SR-2508",
        "etanidazole"
      ]
    },
    {
      "fdaUniiCode": "528XYJ8L1N",
      "id": "Etoposide_Phosphate",
      "preferredName": "Etoposide Phosphate",
      "synonyms": [
        "ETOPOSIDE PHOSPHATE",
        "Etopophos",
        "Etoposide Phosphate",
        "etoposide phosphate"
      ]
    },
    {
      "fdaUniiCode": "P2K93U8740",
      "id": "Fludarabine",
      "preferredName": "Fludarabine",
      "synonyms": [
        "2-Fluoro-9-beta-arabinofuranosyladenine",
        "2-Fluorovidarabine",
        "9-Beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine",
        "9-Beta-D-arabinofuranosyl-2-fluoroadenine",
        "FLUDARABINE",
        "Fludarabine",
        "Fluradosa",
        "fludarabine"
      ]
    },
    {
      "fdaUniiCode": "5V71D8JOKK",
      "id": "Fazarabine",
      "preferredName": "Fazarabine",
      "synonyms": [
        "1,3, 5-Triazin-2(1H)-one, 4-Amino-1-beta-D- arabinofuranosyl- (9CI)",
        "1,3, 5-Triazin-2(1H)-one, 4-amino-1-.beta.-D- arabinofuranosyl- (9CI)",
        "1-.beta.-D-Arabinofuranosyl-5-azacytosine",
        "1-Beta-D-arabinofuranosyl-5-azacytosine",
        "Ara AC",
        "FAZARABINE",
        "Fazarabine",
        "Kymarabine",
        "ara-AC",
        "fazarabine"
      ]
    },
    {
      "fdaUniiCode": "NY22HMQ4BX",
      "id": "Exemestane",
      "preferredName": "Exemestane",
      "synonyms": [
        "6-Methyleneandrosta-1,4-diene-3,17-dione",
        "Aromasin",
        "EXEMESTANE",
        "Exemestane",
        "FCE-24304",
        "exemestane"
      ]
    },
    {
      "fdaUniiCode": "187EJ7QEXL",
      "id": "Fenretinide",
      "preferredName": "Fenretinide",
      "synonyms": [
        "4-(all-trans-retino-yl)aminophenol",
        "4-HPR",
        "4-Hydroxyphenylretinamide",
        "All-trans-4'-Hydroxyretinanilide",
        "FENRETINIDE",
        "Fenretinide",
        "Fenretinimide",
        "HPR-4",
        "McN-R-1967",
        "N-(4-hydroxyphenyl)retinamide",
        "all-trans-4'-hydroxyretinanilide",
        "all-trans-N-(4-Hydroxyphenyl)retinamide",
        "all-trans-N-4'-hydroxyretinanilide",
        "fenretinide"
      ]
    },
    {
      "fdaUniiCode": "X230G6E63B",
      "id": "Mitoflaxone",
      "preferredName": "Mitoflaxone",
      "synonyms": [
        "2-Phenyl-8-(carboxymethyl)-benzopyran-4-one",
        "4H-1-Benzopyran-8-acetic acid, 4-oxo-2-phenyl-",
        "4H-1-benzopyran-8-acetic Acid, 4-Oxo-2-phenyl",
        "FAA",
        "Flavone Acetic Acid",
        "Flavone acetic acid",
        "Flavone-8-Acetic Acid",
        "LM 975",
        "MITOFLAXONE",
        "Mitoflaxone"
      ]
    },
    {
      "fdaUniiCode": "1X9VK9O1SC",
      "id": "Fludarabine_Phosphate",
      "preferredName": "Fludarabine Phosphate",
      "synonyms": [
        "2-F-ara-AMP",
        "9H-Purin-6-amine, 2-fluoro-9-(5-O-phosphono-.beta.-D-arabinofuranosyl)-",
        "9H-purin-6-amine, 2-fluoro-9-(5-O-phosphono-beta-D-arabinofuranosyl)",
        "Beneflur",
        "FLUDARABINE PHOSPHATE",
        "Fludara",
        "Fludarabine Phosphate",
        "Fludarabine-5'-Monophosphate",
        "Oforta",
        "SH T 586",
        "fludarabine phosphate"
      ]
    },
    {
      "fdaUniiCode": "GQ7JL9P5I2",
      "id": "Fotemustine",
      "preferredName": "Fotemustine",
      "synonyms": [
        "1-[N-(2-chloroethyl)-N-nitrosoureido]ethylphosphonic acid diethyl ester",
        "FOTEMUSTINE",
        "Fotemustine",
        "Muphoran",
        "S 10036",
        "[1-[[[(2-chloroethyl)nitrosamino]-carbonyl]amino]ethyl]phosphonic acid diethyl ester",
        "diethyl[1-[3-(2-chloroethyl)-3-nitrosoureido]ethyl]phosphonate",
        "fotemustine"
      ]
    },
    {
      "fdaUniiCode": "FUI2V09E1C",
      "id": "Ganglioside_GD2",
      "preferredName": "Ganglioside GD2",
      "synonyms": [
        "DISIALOGANGLIOSIDE GD-2",
        "Disialoganglioside GD-2",
        "GD2",
        "GD2 ganglioside",
        "GalNAc(beta 1->4)-[NeuAc(alpha 2->8)NeuAc(alpha 2->3)]Gal(beta 1->4)GlcCer",
        "Ganglioside GD2"
      ]
    },
    {
      "fdaUniiCode": "T13V17U431",
      "id": "Vadastuximab_Talirine",
      "preferredName": "Vadastuximab Talirine",
      "synonyms": [
        "SGN-CD33A",
        "VADASTUXIMAB TALIRINE",
        "Vadastuximab Talirine"
      ]
    },
    {
      "fdaUniiCode": "63V8AIE65T",
      "id": "STAT3_Inhibitor_WP1066",
      "preferredName": "STAT3 Inhibitor WP1066",
      "synonyms": [
        "(S,E)-3-(6-Bromopyridin-2-yl)-2-cyano-N-(1-phenylethyl)acrylamide",
        "STAT3 Inhibitor WP1066",
        "WP 1066",
        "WP-1066",
        "WP1066"
      ]
    },
    {
      "fdaUniiCode": "Z3K3VJ16KU",
      "id": "Geldanamycin",
      "preferredName": "Geldanamycin",
      "synonyms": [
        "Antibiotic (U-29,135)",
        "Antibiotic U 29135",
        "GELDANAMYCIN",
        "Geldanamycin"
      ]
    },
    {
      "fdaUniiCode": "DH2M523P0H",
      "id": "Genistein",
      "preferredName": "Genistein",
      "synonyms": [
        "4',5, 7-Trihydroxyisoflavone",
        "4',5,7-Trihydroxyisoflavone",
        "5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one",
        "GENISTEIN",
        "Genestein",
        "Genistein",
        "Genisteol",
        "Prunetol",
        "genistein"
      ]
    },
    {
      "fdaUniiCode": "VY778IXU5T",
      "id": "MELK_Inhibitor_OTS167",
      "preferredName": "MELK Inhibitor OTS167",
      "synonyms": [
        "MELK Inhibitor OTS167",
        "OTS-167",
        "OTS167"
      ]
    },
    {
      "fdaUniiCode": "3T1SS4E7AG",
      "id": "Enasidenib",
      "preferredName": "Enasidenib",
      "synonyms": [
        "AG-221",
        "CC-90007 Free Base",
        "ENASIDENIB",
        "Enasidenib"
      ]
    },
    {
      "fdaUniiCode": "O3MNS8782H",
      "id": "ALK-FAK_Inhibitor_CEP-37440",
      "preferredName": "ALK-FAK Inhibitor CEP-37440",
      "synonyms": [
        "ALK-FAK Inhibitor CEP-37440",
        "CEP-37440"
      ]
    },
    {
      "fdaUniiCode": "R60QEP13IC",
      "id": "Rice_Bran",
      "preferredName": "Rice Bran",
      "synonyms": [
        "RICE BRAN",
        "Rice Bran"
      ]
    },
    {
      "fdaUniiCode": "6Q2E32HVE7",
      "id": "Selatinib_Ditosilate",
      "preferredName": "Selatinib Ditosilate",
      "synonyms": [
        "SELATINIB DITOSILATE",
        "Selatinib Ditosilate"
      ]
    },
    {
      "fdaUniiCode": "S7RL72610R",
      "id": "Gossypol_Acetic_Acid",
      "preferredName": "Gossypol Acetic Acid",
      "synonyms": [
        "GOSSYPOL ACETIC ACID",
        "Gossypol Acetate",
        "Gossypol Acetic Acid",
        "gossypol acetic acid"
      ]
    },
    {
      "fdaUniiCode": "981TME683S",
      "id": "Ropeginterferon_Alfa-2B",
      "preferredName": "Ropeginterferon Alfa-2B",
      "synonyms": [
        "AOP2014",
        "Besremi",
        "P-1101",
        "P1101",
        "PEG-P-IFN-Alfa-2b",
        "PEG-P-IFN-Alpha-2b",
        "PEG-Proline-Interferon Alfa-2b",
        "ROPEGINTERFERON ALFA-2B",
        "Ropeginterferon Alfa-2B"
      ]
    },
    {
      "fdaUniiCode": "CJN36EQM0H",
      "id": "Pyrotinib",
      "preferredName": "Pyrotinib",
      "synonyms": [
        "PYROTINIB",
        "Pyrotinib"
      ]
    },
    {
      "fdaUniiCode": "6Z3QHB00LB",
      "id": "Bimiralisib",
      "preferredName": "Bimiralisib",
      "synonyms": [
        "2-Pyridinamine, 5-(4,6-Di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)-",
        "BIMIRALISIB",
        "Bimiralisib",
        "PQR-309",
        "PQR309"
      ]
    },
    {
      "fdaUniiCode": "U4017GUQ06",
      "id": "Pelabresib",
      "preferredName": "Pelabresib",
      "synonyms": [
        "BET Inhibitor CPI-0610",
        "CPI-0610",
        "CPI-232",
        "CPI-267232",
        "PELABRESIB",
        "Pelabresib"
      ]
    },
    {
      "fdaUniiCode": "7J0LQD86OG",
      "id": "Laprituximab_Emtansine",
      "preferredName": "Laprituximab Emtansine",
      "synonyms": [
        "Anti-EGFR-SMCC-DM1",
        "IMGN289",
        "LAPRITUXIMAB EMTANSINE",
        "Laprituximab Emtansine"
      ]
    },
    {
      "fdaUniiCode": "85RE35306Z",
      "id": "Ceralasertib",
      "preferredName": "Ceralasertib",
      "synonyms": [
        "AZD6738",
        "CERALASERTIB",
        "Ceralasertib"
      ]
    },
    {
      "fdaUniiCode": "AF75XOF6W3",
      "id": "Relatlimab",
      "preferredName": "Relatlimab",
      "synonyms": [
        "BMS-986016",
        "BMS986016",
        "Immunoglobulin G4, Anti-(human Lymphocyte Activation Gene-3 Protein) (Human Heavy Chain), Disulfide with Human Light Chain, Dimer",
        "RELATLIMAB",
        "Relatlimab"
      ]
    },
    {
      "fdaUniiCode": "L31MM1385E",
      "id": "Halofuginone",
      "preferredName": "Halofuginone",
      "synonyms": [
        "HALOFUGINONE",
        "Halofuginone",
        "trans-(+/-)-7-Bromo-6-chloro-3-[3-(3-hydroxy-2-piperidinyl)-2-oxopropyl]-4(3H)-quinazolinone"
      ]
    },
    {
      "fdaUniiCode": "VM4G5D1A60",
      "id": "Ladiratuzumab_Vedotin",
      "preferredName": "Ladiratuzumab Vedotin",
      "synonyms": [
        "LADIRATUZUMAB VEDOTIN",
        "Ladiratuzumab Vedotin",
        "SGN-LIV1A"
      ]
    },
    {
      "fdaUniiCode": "5TNV87ICD2",
      "id": "HDAC_Inhibitor_CXD101",
      "preferredName": "HDAC Inhibitor CXD101",
      "synonyms": [
        "AZD 9468",
        "AZD9468",
        "CXD-101",
        "CXD101",
        "HDAC Inhibitor CXD101",
        "Histone Deacetylase Inhibitor CXD101"
      ]
    },
    {
      "fdaUniiCode": "98BSN6N516",
      "id": "Rogaratinib",
      "preferredName": "Rogaratinib",
      "synonyms": [
        "4-((4-Amino-6-(methoxymethyl)-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)pyrrolo(2,1-f)(1,2,4)triazin-7-yl)methyl)piperazin-2-one",
        "BAY-1163877",
        "BAY1163877",
        "ROGARATINIB",
        "Rogaratinib"
      ]
    },
    {
      "fdaUniiCode": "815WDV2HST",
      "id": "Herbimycin",
      "preferredName": "Herbimycin",
      "synonyms": [
        "17-Demethoxy-15-methoxy-11-O-methylgeldanamycin, (15R)-",
        "HERBIMYCIN A",
        "Herbimycin",
        "Herbimycin A"
      ]
    },
    {
      "fdaUniiCode": "LA133J59VU",
      "id": "Hexamethylene_Bisacetamide",
      "preferredName": "Hexamethylene Bisacetamide",
      "synonyms": [
        "Acetamide, N,N'-1, 6-hexanediylbis-",
        "Acetamide, N,N'-hexamethylenebis-",
        "HEXAMETHYLENE BISACETAMIDE",
        "HMBA",
        "Hexamethylene Bisacetamide",
        "Hexamethylene bisacetamide",
        "Hexamethylenebisacetamide",
        "Hexamethylenediacetamide",
        "N, N'-Diacetylhexamethylenediamine",
        "N,N'-1,6-Hexanediylbisacetamide",
        "N,N'-Hexamethylenebisacetamide"
      ]
    },
    {
      "fdaUniiCode": "TA3QN7788D",
      "id": "BET_Inhibitor_RO6870810",
      "preferredName": "BET Inhibitor RO6870810",
      "synonyms": [
        "BET Inhibitor RO6870810",
        "Bromodomain and Extra-Terminal Protein Inhibitor RO6870810",
        "RG 6146",
        "RG6146",
        "RO-6870810",
        "RO6870810",
        "TEN 010",
        "TEN-010"
      ]
    },
    {
      "fdaUniiCode": "6FG8041S5B",
      "id": "Omacetaxine_Mepesuccinate",
      "preferredName": "Omacetaxine Mepesuccinate",
      "synonyms": [
        "CGX-635",
        "Ceflatonin",
        "Cephalotaxine, 4-Methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (Ester)",
        "Cephalotaxine, 4-Methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (Ester), [3(R)]- (9CI)",
        "Cephalotaxine, 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester), [3(R)]- (9CI)",
        "HHT",
        "OMACETAXINE MEPESUCCINATE",
        "Omacetaxine Mepesuccinate",
        "Synribo",
        "homoharringtonine"
      ]
    },
    {
      "fdaUniiCode": "G162GK9U4W",
      "id": "Leflunomide",
      "preferredName": "Leflunomide",
      "synonyms": [
        "4-Isoxazolecarboxamide, 5-Methyl-N-(4-(trifluoromethyl)phenyl)-",
        "Arava",
        "LEFLUNOMIDE",
        "Leflunomide",
        "SU101",
        "leflunomide"
      ]
    },
    {
      "fdaUniiCode": "8QR88H79VX",
      "id": "Mivavotinib",
      "preferredName": "Mivavotinib",
      "synonyms": [
        "3H-Pyrrolo(3,4-C)pyridin-3-one, 6-(((1R,2S)-2-aminocyclohexyl)amino)-7-fluoro-1,2-dihydro-4-(1-methyl-1H-pyrazol-4-yl)-",
        "MIVAVOTINIB",
        "Mivavotinib",
        "Spleen Tyrosine Kinase Inhibitor TAK-659",
        "Spleen Tyrosine Kinase Inhibitor TAK659",
        "TAK-659",
        "TAK659",
        "syk Inhibitor TAK-659",
        "syk Inhibitor TAK659",
        "syk-Inhibitor TAK-659",
        "syk-Inhibitor TAK659"
      ]
    },
    {
      "fdaUniiCode": "T41737F88A",
      "id": "Tisotumab_Vedotin",
      "preferredName": "Tisotumab Vedotin",
      "synonyms": [
        "HuMax-TF-ADC",
        "TISOTUMAB VEDOTIN",
        "Tisotumab Vedotin",
        "Tisotumab Vedotin-tftv",
        "Tivdak"
      ]
    },
    {
      "fdaUniiCode": "D1LXQ45S1O",
      "id": "Cerdulatinib",
      "preferredName": "Cerdulatinib",
      "synonyms": [
        "CERDULATINIB",
        "Cerdulatinib",
        "PRT-062070",
        "PRT062070",
        "Syk-JAK Inhibitor PRT062070",
        "Syk/JAK Inhibitor PRT062070"
      ]
    },
    {
      "fdaUniiCode": "ZU8OM8V5WF",
      "id": "P-p68_Inhibitor_RX-5902",
      "preferredName": "P-p68 Inhibitor RX-5902",
      "synonyms": [
        "P-p68 Inhibitor RX-5902",
        "RX-5902",
        "SUPINOXIN",
        "Supinoxin"
      ]
    },
    {
      "fdaUniiCode": "5Z9850I25F",
      "id": "Pegilodecakin",
      "preferredName": "Pegilodecakin",
      "synonyms": [
        "AM-0010",
        "AM0010",
        "PEG-rHuIL-10 AM0010",
        "PEGILODECAKIN",
        "Pegilodecakin"
      ]
    },
    {
      "fdaUniiCode": "00X6I56YXR",
      "id": "Anti-ErbB3_Monoclonal_Antibody_CDX-3379",
      "preferredName": "Anti-ErbB3 Monoclonal Antibody CDX-3379",
      "synonyms": [
        "Anti-ErbB3 Monoclonal Antibody CDX-3379",
        "CDX 3379",
        "CDX-3379",
        "CDX3379",
        "KTN 3379",
        "KTN-3379",
        "KTN3379"
      ]
    },
    {
      "fdaUniiCode": "2261HH611H",
      "id": "Tenalisib",
      "preferredName": "Tenalisib",
      "synonyms": [
        "3-(3-Fluorophenyl)-2-((1S)-1-((7H-purin-6-yl)amino)propyl)-4H-1-benzopyran-4-one",
        "4H-1-Benzopyran-4-one, 3-(3-fluorophenyl)-2-((1S)-1-(9H-purin-6-ylamino)propyl)-",
        "RP 6530",
        "RP-6530",
        "RP6530",
        "TENALISIB",
        "Tenalisib"
      ]
    },
    {
      "fdaUniiCode": "OS7097575K",
      "id": "Parsaclisib",
      "preferredName": "Parsaclisib",
      "synonyms": [
        "(4R)-4-(3-((1S)-1-(4-Amino-3-methyl-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one",
        "INCB 50465",
        "INCB-50465",
        "INCB050465",
        "INCB50465",
        "PARSACLISIB",
        "Parsaclisib",
        "WHO 10589"
      ]
    },
    {
      "fdaUniiCode": "I42748ELQW",
      "id": "Acalabrutinib",
      "preferredName": "Acalabrutinib",
      "synonyms": [
        "ACALABRUTINIB",
        "ACP-196",
        "Acalabrutinib",
        "Benzamide, 4-(8-Amino-3-((2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl)imidazo(1,5-a)pyrazin-1-yl)-N-2-pyridinyl-",
        "Bruton Tyrosine Kinase Inhibitor ACP-196",
        "Calquence"
      ]
    },
    {
      "fdaUniiCode": "0Z4A82I0JO",
      "id": "Roducitabine",
      "preferredName": "Roducitabine",
      "synonyms": [
        "4-Amino-1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl)pyrimidin-2(1H)-one",
        "Cytidine Analog RX-3117",
        "Fluorocyclopentenylcytosine",
        "RODUCITABINE",
        "RX-3117",
        "Roducitabine",
        "TV-1360"
      ]
    },
    {
      "fdaUniiCode": "FK2WI4Y35P",
      "id": "Ovapuldencel-T",
      "preferredName": "Ovapuldencel-T",
      "synonyms": [
        "OVAPULDENCEL-T",
        "Ovapuldencel-T"
      ]
    },
    {
      "fdaUniiCode": "8S5OIN36X4",
      "id": "Seviteronel",
      "preferredName": "Seviteronel",
      "synonyms": [
        "1H-1,2,3-Triazole-5-methanol, Alpha-(6,7-bis(difluoromethoxy)-2-naphthalenyl)-alpha-(1-methylethyl)-, (AlphaS)-",
        "SEVITERONEL",
        "Seviteronel",
        "VT-464"
      ]
    },
    {
      "fdaUniiCode": "9IE620X9FY",
      "id": "Vesigenurtucel-L",
      "preferredName": "Vesigenurtucel-L",
      "synonyms": [
        "HS-410",
        "VESIGENURTUCEL-L",
        "Vesigenurtucel-L"
      ]
    },
    {
      "fdaUniiCode": "OSP71S83EU",
      "id": "Lorlatinib",
      "preferredName": "Lorlatinib",
      "synonyms": [
        "2H-4,8-Methenopyrazolo(4,3-H)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile, 7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-, (10R)-",
        "7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile",
        "LORLATINIB",
        "Lorbrena",
        "Lorlatinib",
        "PF-06463922"
      ]
    },
    {
      "fdaUniiCode": "7OI79TB6KN",
      "id": "Anti-CD98_Monoclonal_Antibody_IGN523",
      "preferredName": "Anti-CD98 Monoclonal Antibody IGN523",
      "synonyms": [
        "Anti-CD98 Monoclonal Antibody IGN523",
        "IGN-523",
        "IGN523"
      ]
    },
    {
      "fdaUniiCode": "KX7ZYR6OQW",
      "id": "Enadenotucirev",
      "preferredName": "Enadenotucirev",
      "synonyms": [
        "Chimeric Oncolytic Adenovirus Ad3/Ad11p Containing Two Deletions in the Viral Genome in the E3 Region (2444 bp) and in the E4 Region (24 bp) and 197 Non-homologous Nucleotides in the E2B Region",
        "ColoAd-1",
        "ColoAd1",
        "ColoAd1 Oncolytic Virus",
        "ENADENOTUCIREV",
        "EnAd",
        "Enadenotucirev"
      ]
    },
    {
      "fdaUniiCode": "V9GGV0YCDI",
      "id": "UAE_Inhibitor_TAK-243",
      "preferredName": "UAE Inhibitor TAK-243",
      "synonyms": [
        "AOB87172",
        "MLN7243",
        "TAK-243",
        "UAE Inhibitor  TAK-243",
        "UAE Inhibitor TAK-243"
      ]
    },
    {
      "fdaUniiCode": "926SHL95NC",
      "id": "Navoximod",
      "preferredName": "Navoximod",
      "synonyms": [
        "5H-Imidazo(5,1-a)isoindole-5-ethanol, 6-Fluoro-alpha-(trans-4-hydroxycyclohexyl)-, (AlphaR,5S)-",
        "GDC-0919",
        "NAVOXIMOD",
        "NLG-919",
        "NLG919",
        "Navoximod",
        "RG6078",
        "RO7077339-001"
      ]
    },
    {
      "fdaUniiCode": "AK8DKI0KMN",
      "id": "Mitomycin_C_Analog_KW-2149",
      "preferredName": "Mitomycin C Analog KW-2149",
      "synonyms": [
        "7-N-(2-((2-(gamma-L-Glutamylamino)ethyl)dithio)ethyl)mitomycin C",
        "KT6149",
        "KW 2149",
        "KW-2149",
        "Mitomycin C Analog KW-2149"
      ]
    },
    {
      "fdaUniiCode": "6ST3ZF52WB",
      "id": "Carboxyamidotriazole",
      "preferredName": "Carboxyamidotriazole",
      "synonyms": [
        "1H-1,2,3-Triazole-4-carboxamide, 5-amino-1-((3,5-dichloro-4(4-chlorobenzoyl)phenyl)methyl)",
        "5-Amino-1-((3,5-dichloro-4-(4-chlorobenzoyl)phenyl)methyl)-1H-1,2,3-triazole-4-carboxamide",
        "CAI",
        "CARBOXYAMIDOTRIAZOLE",
        "Carboxyamido-triazole",
        "Carboxyamidotriazole",
        "Carboxyaminoimidazole",
        "L651582",
        "carboxyamidotriazole"
      ]
    },
    {
      "fdaUniiCode": "3Y0G32G2RV",
      "id": "Lavendustin_A",
      "preferredName": "Lavendustin A",
      "synonyms": [
        "5-(((2,5-Dihydroxyphenyl)methyl)((2-hydroxyphenyl)methyl)amino)-2-hydroxy Benzoic Acid",
        "Benzoic acid, 5-[[(2, 5-dihydroxyphenyl)methyl][(2-hydroxyphenyl)methyl]amino]-2-hydroxy -",
        "LAVENDUSTIN A",
        "Lavendustin A"
      ]
    },
    {
      "fdaUniiCode": "4B93MGE4AL",
      "id": "Futibatinib",
      "preferredName": "Futibatinib",
      "synonyms": [
        "2-Propen-1-one, 1-((3S)-3-(4-Amino-3-(2-(3,5-dimethoxyphenyl)ethynyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)-1-pyrrolidinyl)-",
        "FUTIBATINIB",
        "Futibatinib",
        "TAS-120"
      ]
    },
    {
      "fdaUniiCode": "DB1041CXDG",
      "id": "Belantamab_Mafodotin",
      "preferredName": "Belantamab Mafodotin",
      "synonyms": [
        "BELANTAMAB MAFODOTIN",
        "Belantamab Mafodotin",
        "Belantamab Mafodotin-blmf",
        "Blenrep",
        "GSK2857916",
        "J6M0-mcMMAF"
      ]
    },
    {
      "fdaUniiCode": "U6CL98GLP4",
      "id": "Telaglenastat",
      "preferredName": "Telaglenastat",
      "synonyms": [
        "CB-839",
        "TELAGLENASTAT",
        "Telaglenastat",
        "WHO 10815"
      ]
    },
    {
      "fdaUniiCode": "ZP3QP1H44W",
      "id": "Redaporfin",
      "preferredName": "Redaporfin",
      "synonyms": [
        "LUZ 11",
        "REDAPORFIN",
        "Redaporfin"
      ]
    },
    {
      "fdaUniiCode": "Q2PCN8MAM6",
      "id": "Ivosidenib",
      "preferredName": "Ivosidenib",
      "synonyms": [
        "AG-120",
        "IVOSIDENIB",
        "Ivosidenib",
        "Tibsovo"
      ]
    },
    {
      "fdaUniiCode": "Z5NFR173NV",
      "id": "BH3_Mimetic_ABT-737",
      "preferredName": "BH3 Mimetic ABT-737",
      "synonyms": [
        "ABT-737",
        "BH3 Mimetic ABT-737",
        "Benzamide, 4-(4-((4'-Chloro(1,1'-biphenyl)-2-yl)methyl)-1-piperazinyl)-n-((4-(((1r)-3-(dimethylamino)-1-((phenylthio)methyl)propyl)amino)-3-nitrophenyl)sulfonyl)-"
      ]
    },
    {
      "fdaUniiCode": "L1F3R18W77",
      "id": "Asciminib",
      "preferredName": "Asciminib",
      "synonyms": [
        "ABL001",
        "ASCIMINIB",
        "Asciminib"
      ]
    },
    {
      "fdaUniiCode": "P76B05O5V6",
      "id": "Relugolix",
      "preferredName": "Relugolix",
      "synonyms": [
        "N-(4-(1-((2,6-Difluorophenyl)methyl)-5-((dimethylamino)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-N'-methoxyurea",
        "Orgovyx",
        "RELUGOLIX",
        "Relugolix",
        "TAK 385",
        "TAK-385",
        "Urea, N-(4-(1-((2,6-difluorophenyl)methyl)-5-((dimethylamino)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-N'-methoxy-"
      ]
    },
    {
      "fdaUniiCode": "639NVQ0SXF",
      "id": "Lutetium_Lu_177_PP-F11N",
      "preferredName": "Lutetium Lu 177 PP-F11N",
      "synonyms": [
        "177Lu-PP-F11N",
        "Lutetium Lu 177 PP-F11N",
        "PP-F11N LUTETIUM LU-177"
      ]
    },
    {
      "fdaUniiCode": "DLE8519RWM",
      "id": "Enfortumab_Vedotin",
      "preferredName": "Enfortumab Vedotin",
      "synonyms": [
        "AGS 22ME",
        "AGS-22M6E",
        "ASG-22CE",
        "Anti-Nectin 4 ADC ASG-22CE",
        "Anti-nectin-4 Monoclonal Antibody-Drug Conjugate AGS-22M6E",
        "ENFORTUMAB VEDOTIN",
        "Enfortumab Vedotin",
        "Enfortumab Vedotin-ejfv",
        "Padcev"
      ]
    },
    {
      "fdaUniiCode": "2U46M95B5M",
      "id": "Bazlitoran",
      "preferredName": "Bazlitoran",
      "synonyms": [
        "BAZLITORAN",
        "Bazlitoran",
        "IMO-8400",
        "Oligonucleotide IMO-8400"
      ]
    },
    {
      "fdaUniiCode": "07802BU06S",
      "id": "RNR_Inhibitor_COH29",
      "preferredName": "RNR Inhibitor COH29",
      "synonyms": [
        "COH-29",
        "COH29",
        "N-(4-(3,4-dihydroxyphenyl)-5-phenylthiazol-2-yl)-3,4-dihydroxybenzamide",
        "RNR Inhibitor COH29",
        "Ribonucleotide Reductase Holoenzyme Inhibitor COH29"
      ]
    },
    {
      "fdaUniiCode": "A59HL2Q48U",
      "id": "Etoposide_Toniribate",
      "preferredName": "Etoposide Toniribate",
      "synonyms": [
        "CAP7.1",
        "EDO-S7.1",
        "ETOPOSIDE TONIRIBATE",
        "Etoposide Toniribate"
      ]
    },
    {
      "fdaUniiCode": "L5ORF0AN1I",
      "id": "Entrectinib",
      "preferredName": "Entrectinib",
      "synonyms": [
        "ENTRECTINIB",
        "Entrectinib",
        "N-(5-(3,5-Difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide",
        "RXDX 101",
        "RXDX-101",
        "RXDX101",
        "Rozlytrek"
      ]
    },
    {
      "fdaUniiCode": "5970HH9923",
      "id": "Mafosfamide",
      "preferredName": "Mafosfamide",
      "synonyms": [
        "MAFOSFAMIDE",
        "Mafosfamide",
        "mafosfamide"
      ]
    },
    {
      "fdaUniiCode": "RB8MSD888P",
      "id": "Stapuldencel-T",
      "preferredName": "Stapuldencel-T ",
      "synonyms": [
        "DCVAC/PCa",
        "Prostate Tumor Antigen-activated Autologous Dendritic Cell Vaccine",
        "STAPULDENCEL",
        "Stapuldencel-T "
      ]
    },
    {
      "fdaUniiCode": "KE7K32EME8",
      "id": "Nazartinib",
      "preferredName": "Nazartinib",
      "synonyms": [
        "EGF 816",
        "EGF816",
        "NAZARTINIB",
        "Nazartinib"
      ]
    },
    {
      "fdaUniiCode": "47DD4548PB",
      "id": "Naquotinib",
      "preferredName": "Naquotinib",
      "synonyms": [
        "2-Pyrazinecarboxamide, 6-Ethyl-3-((4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-(((3R)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl)oxy)-",
        "ASP8273",
        "NAQUOTINIB",
        "Naquotinib"
      ]
    },
    {
      "fdaUniiCode": "K7ODU55HT6",
      "id": "Belapectin",
      "preferredName": "Belapectin",
      "synonyms": [
        "BELAPECTIN",
        "Belapectin",
        "GR-MD-02",
        "Galactoarabino-rhamnogalacturonate"
      ]
    },
    {
      "fdaUniiCode": "K418KG2GET",
      "id": "Ceritinib",
      "preferredName": "Ceritinib",
      "synonyms": [
        "2,4-Pyrimidinediamine, 5-chloro-N4-(2-((1-methylethyl)sulfonyl)phenyl)-N2-(5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl)-",
        "CERITINIB",
        "Ceritinib",
        "LDK 378",
        "LDK378",
        "Zykadia"
      ]
    },
    {
      "fdaUniiCode": "3296X8L13E",
      "id": "Marcellomycin",
      "preferredName": "Marcellomycin",
      "synonyms": [
        "1-Naphthacenecarboxylic acid, 4-[[O-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl-(1-4)-O-2, 6-dideoxy-alpha-L-lyxo-hexopyranosyl-(1-4)-2,3, 6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy]-2-e thyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-, methyl ester, (1R-(1alpha,2beta,4beta))- (9CI)",
        "MARCELLOMYCIN",
        "Marcellomycin",
        "Rhodirubin E"
      ]
    },
    {
      "fdaUniiCode": "H75J14AA89",
      "id": "Carbendazim",
      "preferredName": "Carbendazim",
      "synonyms": [
        "1H-Benzimidazol-2-yl-carbamic Acid, Methyl Ester",
        "1H-benzimidazol-2-ylcarbamic Acid Methyl Ester",
        "2-(Methoxycarbonylamino)benzimidazole",
        "2-Benzimidazolecarcamic Acid Methyl Ester",
        "2-Methyl benzimidazolecarbamate",
        "BAS 3460",
        "BAS-3460",
        "BAS-67054",
        "BCM",
        "BMC",
        "Bavistin",
        "CARBENDAZIM",
        "CTR 6669",
        "CTR-6669",
        "Carbendazim",
        "Carbendazole",
        "Derosal",
        "FB642",
        "HOE 17411",
        "HOE-17411",
        "MBC",
        "Methyl 2-Benzimidazolecarbamate",
        "Methyl 2-benzimidazolecarbamate",
        "Methyl Benzimidazol-2-ylcarbamate",
        "Methyl-1H-benzimidazol-2-yl Carbamate",
        "Methyl-2-benzimidazole Carbamate",
        "Methyl-2-benzimidazolecarbamate",
        "Methyl-alpha-benzimidazole Carbamate",
        "carbendazim"
      ]
    },
    {
      "fdaUniiCode": "C2QI4IOI2G",
      "id": "Medroxyprogesterone_Acetate",
      "preferredName": "Medroxyprogesterone Acetate",
      "synonyms": [
        "(6alpha)-17-(Acetyloxy)-6-methylpregn-4-ene-3,20-dione",
        "17-(Acetyloxy)-6alpha-methylpregn-4-ene-3,20-dione",
        "17-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione Acetate",
        "17Alpha-acetoxy-6alpha-methylprogesterone",
        "6-Alpha-methyl-17alpha-acetoxyprogesterone",
        "Amen",
        "Aragest",
        "Ciclotal",
        "Clinofem",
        "Clinovir",
        "Cycrin",
        "Depo-Clinovir",
        "Depo-Provera",
        "Depo-provera",
        "Depot-Medroxyprogestereone Acetate",
        "Farlutal",
        "G-Farlutal",
        "Gestapuran",
        "Hysron",
        "Lutoral",
        "MEDROXYPROGESTERONE ACETATE",
        "MPA",
        "Medroxyprogesterone 17-Acetate",
        "Medroxyprogesterone Acetate",
        "Medroxyprogesterone acetate",
        "Medroxyprogesteroni Acetas",
        "Methylacetoxyprogesterone",
        "Metipregnone",
        "Nadigest",
        "Nadigest (vet)",
        "Nidaxin",
        "Nidaxin (vet)",
        "Oragest",
        "Perlutex",
        "Prodasone",
        "Provera",
        "Sodelut G",
        "Veramix",
        "medroxyprogesterone acetate"
      ]
    },
    {
      "fdaUniiCode": "TJ2M0FR8ES",
      "id": "Megestrol_Acetate",
      "preferredName": "Megestrol Acetate",
      "synonyms": [
        "(9beta,10alpha)-17-(Acetyloxy)-6-methylpregna-4,6-diene-3,20-dione",
        "17 Alpha-acetoxy-6-methylpregna-4,6-diene-3,20-dione",
        "17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione Acetate",
        "17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate",
        "17.alpha.-Acetoxy-6-methylpregna-4,6-diene-3,20-dione",
        "6-Dehydro-6-methyl-17 alpha-acetoxyprogesterone",
        "6-Dehydro-6-methyl-17.alpha.-acetoxyprogesterone",
        "6-Methyl-6-dehydro-17.alpha.-acetoxyprogesterone",
        "6-Methyl-delta-4,6-pregnadien-17 alpha-ol-3,20-dione Acetate",
        "BDH 1298",
        "BDH-1298",
        "MEGESTROL ACETATE",
        "Maygace",
        "Megace",
        "Megestat",
        "Megestil",
        "Megestrol Acetate",
        "Niagestin",
        "Ovaban",
        "Pallace",
        "SC-10363"
      ]
    },
    {
      "fdaUniiCode": "PF9462I9HX",
      "id": "Larotrectinib",
      "preferredName": "Larotrectinib",
      "synonyms": [
        "1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)-",
        "3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine- 1-carboxamide",
        "ARRY 470",
        "LAROTRECTINIB",
        "LOXO 101",
        "LOXO-101",
        "Larotrectinib"
      ]
    },
    {
      "fdaUniiCode": "B2K5L1L8S9",
      "id": "Sulfatinib",
      "preferredName": "Sulfatinib",
      "synonyms": [
        "HMPL-012",
        "SURUFATINIB",
        "Sulfatinib",
        "Surufatinib"
      ]
    },
    {
      "fdaUniiCode": "21970JMA97",
      "id": "Lupartumab_Amadotin",
      "preferredName": "Lupartumab Amadotin",
      "synonyms": [
        "BAY112-9980",
        "BAY1129980",
        "LUPARTUMAB AMADOTIN",
        "Lupartumab Amadotin"
      ]
    },
    {
      "fdaUniiCode": "02Y3Z2756M",
      "id": "Empesertib",
      "preferredName": "Empesertib",
      "synonyms": [
        "(2R)-2-(4-Fluorophenyl)-N-(4-(2-((2-methoxy-4-(methylsulfonyl)phenyl)amino)(1,2,4)triazolo(1,5-a)pyridin-6-yl)phenyl)propanamide",
        "BAY116-1909",
        "BAY1161909",
        "EMPESERTIB",
        "Empesertib"
      ]
    },
    {
      "fdaUniiCode": "2L9RKX796Q",
      "id": "Metoprine",
      "preferredName": "Metoprine",
      "synonyms": [
        "BW 197U",
        "DDMP",
        "METOPRINE",
        "Metoprine"
      ]
    },
    {
      "fdaUniiCode": "XPE4G7Y986",
      "id": "N-Methylformamide",
      "preferredName": "N-Methylformamide",
      "synonyms": [
        "EK 7011",
        "Formamide, N-methyl",
        "Monomethylformamide",
        "N-METHYLFORMAMIDE",
        "N-Methylformamide",
        "NMF",
        "X 188",
        "formylmethylamine",
        "monomethylformamide"
      ]
    },
    {
      "fdaUniiCode": "0282IF4JC8",
      "id": "Siremadlin",
      "preferredName": "Siremadlin",
      "synonyms": [
        "HDM201",
        "NVP-HDM 201",
        "SIREMADLIN",
        "Siremadlin"
      ]
    },
    {
      "fdaUniiCode": "3S31QX1Q6J",
      "id": "Androgen_Receptor_Antisense_Oligonucleotide_AZD5312",
      "preferredName": "Androgen Receptor Antisense Oligonucleotide AZD5312",
      "synonyms": [
        "AZD-5312",
        "AZD5312",
        "Androgen Receptor Antisense Oligonucleotide AZD5312",
        "ISIS-ARRx",
        "ISIS-AZ1Rx"
      ]
    },
    {
      "fdaUniiCode": "L423PRV3V3",
      "id": "Berzosertib",
      "preferredName": "Berzosertib",
      "synonyms": [
        "2-Pyrazinamine, 3-(3-(4-((Methylamino)methyl)phenyl)-5-isoxazolyl)-5-(4-((1-methylethyl)sulfonyl)phenyl)-",
        "BERZOSERTIB",
        "Berzosertib",
        "M 6620",
        "M6620",
        "VX 970",
        "VX-970",
        "VX970"
      ]
    },
    {
      "fdaUniiCode": "6T4O391P5Y",
      "id": "Vactosertib",
      "preferredName": "Vactosertib",
      "synonyms": [
        "TEW-7197",
        "TEW7197",
        "TGFBR1 Inhibitor TEW-7197",
        "VACTOSERTIB",
        "Vactosertib"
      ]
    },
    {
      "fdaUniiCode": "3C06JJ0Z2O",
      "id": "Osimertinib",
      "preferredName": "Osimertinib",
      "synonyms": [
        "2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-",
        "AZD-9291",
        "AZD9291",
        "Mereletinib",
        "OSIMERTINIB",
        "Osimertinib",
        "Tagrisso"
      ]
    },
    {
      "fdaUniiCode": "87TMG6FJHV",
      "id": "Mitomycin_A",
      "preferredName": "Mitomycin A",
      "synonyms": [
        "Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-6,8a-dimethoxy-5-methyl-, carbamate (ester)",
        "MITOMYCIN A",
        "Mitomycin A"
      ]
    },
    {
      "fdaUniiCode": "E3U7286V3W",
      "id": "Mitozolomide",
      "preferredName": "Mitozolomide",
      "synonyms": [
        "Azolastone",
        "Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3-(2-chloroethyl)-3,4-dihydro-4-oxo-",
        "MITOZOLOMIDE",
        "Mitozolomide",
        "imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3-(2-chloroethyl)-3,4-dihydro-4-oxo"
      ]
    },
    {
      "fdaUniiCode": "9G2MP84A8W",
      "id": "2-Deoxy-D-glucose",
      "preferredName": "2-Deoxy-D-glucose",
      "synonyms": [
        "2-DEOXYGLUCOSE",
        "2-DG",
        "2-Deoxy-D-glucose",
        "Deoxyglucose"
      ]
    },
    {
      "fdaUniiCode": "6YY8O697VF",
      "id": "Utomilumab",
      "preferredName": "Utomilumab",
      "synonyms": [
        "PF 05082566",
        "PF 5082566",
        "PF-05082566",
        "PF-2566",
        "UTOMILUMAB",
        "Utomilumab"
      ]
    },
    {
      "fdaUniiCode": "7R7G6EH5UL",
      "id": "MDM2_Inhibitor_KRT-232",
      "preferredName": "MDM2 Inhibitor KRT-232",
      "synonyms": [
        "(3R,5R,6S)-5-(3-Chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-((1S)-2-methyl-1-(((1-methylethyl)sulfonyl)methyl)propyl)-2-oxo-3-piperidineacetic Acid",
        "AMG 232",
        "AMG-232",
        "KRT 232",
        "KRT-232",
        "KRT232",
        "MDM2 Inhibitor KRT-232"
      ]
    },
    {
      "fdaUniiCode": "78LXD26OX3",
      "id": "Angiopoietin-2-specific_Fusion_Protein_PF-04856884",
      "preferredName": "Angiopoietin-2-specific Fusion Protein PF-04856884",
      "synonyms": [
        "Angiopoietin-2-specific Fusion Protein PF-04856884",
        "CVX-060",
        "PF-04856884"
      ]
    },
    {
      "fdaUniiCode": "8PMF8YQX2T",
      "id": "Duligotuzumab",
      "preferredName": "Duligotuzumab",
      "synonyms": [
        "DULIGOTUZUMAB",
        "Duligotumab",
        "Duligotuzumab",
        "MEHD 7945A",
        "MEHD-7945A",
        "MEHD7945A",
        "RG 7597"
      ]
    },
    {
      "fdaUniiCode": "2BN89552WP",
      "id": "Ifabotuzumab",
      "preferredName": "Ifabotuzumab",
      "synonyms": [
        "Fibatuzumab",
        "IFABOTUZUMAB",
        "Ifabotuzumab",
        "KB 004",
        "KB-004",
        "KB004"
      ]
    },
    {
      "fdaUniiCode": "Q87RWM02HX",
      "id": "Anti-hepcidin_Monoclonal_Antibody_LY2787106",
      "preferredName": "Anti-hepcidin Monoclonal Antibody LY2787106",
      "synonyms": [
        "Anti-hepcidin Monoclonal Antibody LY2787106",
        "LY-2787106",
        "LY2787106"
      ]
    },
    {
      "fdaUniiCode": "91JHE0ANN8",
      "id": "Rocakinogene_Sifuplasmid",
      "preferredName": "Rocakinogene Sifuplasmid",
      "synonyms": [
        "DNA Plasmid Encoding Interleukin-12 INO-9012",
        "INO-9012",
        "ROCAKINOGENE SIFUPLASMID",
        "Rocakinogene Sifuplasmid"
      ]
    },
    {
      "fdaUniiCode": "4Q2EZS1IWG",
      "id": "Ethaselen",
      "preferredName": "Ethaselen",
      "synonyms": [
        "1, 2-[Bis (1, 2-Benzisoselenazolone-3 (2H) -Ketone)] Ethane",
        "BBSKE",
        "ETHASELEN",
        "Ethaselen"
      ]
    },
    {
      "fdaUniiCode": "66D92MGC8M",
      "id": "Gilteritinib",
      "preferredName": "Gilteritinib",
      "synonyms": [
        "6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide",
        "ASP-2215",
        "ASP2215",
        "GILTERITINIB",
        "Gilteritinib"
      ]
    },
    {
      "fdaUniiCode": "K47C68D94B",
      "id": "iNOS_Dimerization_Inhibitor_FK-330",
      "preferredName": "iNOS Dimerization Inhibitor FK-330",
      "synonyms": [
        "FK-330",
        "FR-260330",
        "iNOS Dimerization Inhibitor ASP9853",
        "iNOS Dimerization Inhibitor FK-330"
      ]
    },
    {
      "fdaUniiCode": "6L5D03D975",
      "id": "Ilorasertib",
      "preferredName": "Ilorasertib",
      "synonyms": [
        "1-(4-(4-Amino-7-(1-(2-hydroxyethyl)-1H-pyrazol-4-yl)thieno[3,2-c]pyridin-3-yl)phenyl)-3-(3-fluorophenyl)urea",
        "A-968660.0",
        "ABT-348",
        "ILORASERTIB",
        "Ilorasertib"
      ]
    },
    {
      "fdaUniiCode": "JA7I0QFJ17",
      "id": "Anti-CD33_Monoclonal_Antibody_BI_836858",
      "preferredName": "Anti-CD33 Monoclonal Antibody BI 836858",
      "synonyms": [
        "Anti-CD33 Monoclonal Antibody BI 836858",
        "BI 836858",
        "BI-836858"
      ]
    },
    {
      "fdaUniiCode": "7IUT83FK6S",
      "id": "Lifastuzumab_Vedotin",
      "preferredName": "Lifastuzumab Vedotin",
      "synonyms": [
        "ADC DNIB0600A",
        "DNIB0600A",
        "LIFASTUZUMAB VEDOTIN",
        "Lifastuzumab Vedotin",
        "RG-7599"
      ]
    },
    {
      "fdaUniiCode": "44OUQ00D1U",
      "id": "Vandortuzumab_Vedotin",
      "preferredName": "Vandortuzumab Vedotin",
      "synonyms": [
        "DSTP3086S",
        "MSTP2109A",
        "RG7450",
        "Thio-anti-STEAP1-MC-vc-PAB-MMAE",
        "VANDORTUZUMAB VEDOTIN",
        "Vandortuzumab Vedotin"
      ]
    },
    {
      "fdaUniiCode": "F27LAH6D5O",
      "id": "Dilpacimab",
      "preferredName": "Dilpacimab",
      "synonyms": [
        "ABT-165",
        "DILPACIMAB",
        "DVD-Ig ABT-165",
        "Dilpacimab",
        "Immunoglobulin, Anti-(Notch Ligand DLL4/Vascular Endothelial Growth Factor) (Synthetic Human PR-1283233 Heavy Chain), Disulfide with Synthetic Human PR-1283233 Light Chain, Dimer",
        "PR-1283233",
        "WHO 10863"
      ]
    },
    {
      "fdaUniiCode": "ZN2GQ3II96",
      "id": "Ianalumab",
      "preferredName": "Ianalumab",
      "synonyms": [
        "HuCAL-based Antibody VAY736",
        "Human Combinatorial Antibody Library-based Monoclonal Antibody VAY736",
        "IANALUMAB",
        "Ianalumab",
        "VAY 736",
        "VAY736"
      ]
    },
    {
      "fdaUniiCode": "HLI827Z1ST",
      "id": "Diethylnorspermine",
      "preferredName": "Diethylnorspermine",
      "synonyms": [
        "CI-1006",
        "DENSPM",
        "DIETHYLNORSPERMINE",
        "Diethylnorspermine",
        "N(1),N(11)-diethylnorspermine",
        "N1,N11-bis(ethyl)norspermine"
      ]
    },
    {
      "fdaUniiCode": "E9L2885WUL",
      "id": "Fenebrutinib",
      "preferredName": "Fenebrutinib",
      "synonyms": [
        "Bruton Tyrosine Kinase Inhibitor GDC-0853",
        "FENEBRUTINIB",
        "Fenebrutinib",
        "GDC-0853"
      ]
    },
    {
      "fdaUniiCode": "19J3781LPM",
      "id": "Itacitinib",
      "preferredName": "Itacitinib",
      "synonyms": [
        "3-Azetidineacetonitrile, 1-(1-((3-Fluoro-2-(trifluoromethyl)-4-pyridinyl)carbonyl)-4-piperidinyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)-",
        "INCB 039110",
        "INCB-039110",
        "INCB039110",
        "ITACITINIB",
        "Itacitinib"
      ]
    },
    {
      "fdaUniiCode": "ANC71R916O",
      "id": "Gandotinib",
      "preferredName": "Gandotinib",
      "synonyms": [
        "3-(4-Chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(Morpholinomethyl)imidazo(1,2-b)pyridazin-6-amine",
        "GANDOTINIB",
        "Gandotinib",
        "LY 2784544",
        "LY2784544"
      ]
    },
    {
      "fdaUniiCode": "1GDT36RARO",
      "id": "Pan-RAF_Inhibitor_LY3009120",
      "preferredName": "Pan-RAF Inhibitor LY3009120",
      "synonyms": [
        "DP-4978",
        "LY-3009120",
        "LY3009120",
        "Pan-RAF Inhibitor LY3009120"
      ]
    },
    {
      "fdaUniiCode": "JMH6YR91PG",
      "id": "Vofatamab",
      "preferredName": "Vofatamab",
      "synonyms": [
        "B-701",
        "MFGR-1877S",
        "MFGR1877A",
        "MFGR1877S",
        "RG-7444",
        "VOFATAMAB",
        "Vofatamab"
      ]
    },
    {
      "fdaUniiCode": "KXG2PJ551I",
      "id": "Avelumab",
      "preferredName": "Avelumab",
      "synonyms": [
        "AVELUMAB",
        "Avelumab",
        "Bavencio",
        "Immunoglobulin G1-lambda1, Anti-(Homo sapiens CD274 (Programmed Death Ligand 1, PDL1, pd-l1, B7 Homolog 1, B7H1)), Homo sapiens Monoclonal Antibody",
        "MSB-0010718C",
        "MSB0010718C"
      ]
    },
    {
      "fdaUniiCode": "E1M30YOE59",
      "id": "Simotaxel",
      "preferredName": "Simotaxel",
      "synonyms": [
        "5Beta,20-epoxy-1,2alpa,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one-4-acetate 2-benzoate Ester with (2R,3S)-N-Isopropoxycarbonyl-3-(2-thienyl) Isoserine",
        "MST-997",
        "SIMOTAXEL",
        "Simotaxel",
        "TL-909",
        "Taxane-997"
      ]
    },
    {
      "fdaUniiCode": "DRL23N424R",
      "id": "Osugacestat",
      "preferredName": "Osugacestat",
      "synonyms": [
        "AL 101",
        "AL-101",
        "AL101",
        "BM-0018",
        "BM0018",
        "BMS-906024",
        "GS/pan-Notch Inhibitor AL101",
        "OSUGACESTAT",
        "Osugacestat"
      ]
    },
    {
      "fdaUniiCode": "L08J2O299M",
      "id": "Taselisib",
      "preferredName": "Taselisib",
      "synonyms": [
        "GDC-0032",
        "RO5537381",
        "TASELISIB",
        "Taselisib"
      ]
    },
    {
      "fdaUniiCode": "P5DKZ70636",
      "id": "Paxalisib",
      "preferredName": "Paxalisib",
      "synonyms": [
        "GDC-0084",
        "GDC0084",
        "PAXALISIB",
        "PI3K Inhibitor GDC-0084",
        "Paxalisib"
      ]
    },
    {
      "fdaUniiCode": "0T69CA5LQA",
      "id": "Anti-CD44_Monoclonal_Antibody_RO5429083",
      "preferredName": "Anti-CD44 Monoclonal Antibody RO5429083",
      "synonyms": [
        "Anti-CD44 Monoclonal Antibody RO5429083",
        "RG 7356",
        "RO-5429083",
        "RO5429083"
      ]
    },
    {
      "fdaUniiCode": "3OKH1W5LZE",
      "id": "Galunisertib",
      "preferredName": "Galunisertib",
      "synonyms": [
        "4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide",
        "GALUNISERTIB",
        "Galunisertib",
        "LY-2157299",
        "LY2157299"
      ]
    },
    {
      "fdaUniiCode": "53EY29W7EC",
      "id": "Miltefosine",
      "preferredName": "Miltefosine",
      "synonyms": [
        "2-[[(Hexadecycloxy)hydroxyphosphinyl]oxy]-N,N,N-trimethylethanaminium Inner Salt",
        "Choline Phosphate Hexadecyl Ester, Hydroxide, Inner Salt",
        "D-18506",
        "Hexadecyl 2-(N,N,N-trimethylamino)ethyl Phosphate",
        "Hexadecylphosphocholine",
        "MILTEFOSINE",
        "Miltefosin",
        "Miltefosina",
        "Miltefosine",
        "Miltefosinum",
        "Miltex",
        "n-Hexadecylphosphorylcholine"
      ]
    },
    {
      "fdaUniiCode": "DSS3BE2ZXN",
      "id": "Tusamitamab_Ravtansine",
      "preferredName": "Tusamitamab Ravtansine",
      "synonyms": [
        "ADC SAR408701",
        "Anti-CEACAM5 Antibody-Drug Conjugate SAR408701",
        "SAR408701",
        "TUSAMITAMAB RAVTANSINE",
        "Tusamitamab Ravtansine"
      ]
    },
    {
      "fdaUniiCode": "JW7FJR3ZLY",
      "id": "Alpha-tocopheryloxyacetic_Acid",
      "preferredName": "Alpha-tocopheryloxyacetic Acid",
      "synonyms": [
        ".ALPHA.-TOCOPHERYLOXYACETIC ACID",
        "2,5,7,8-Tetramethyl-(2R-(4R,8R,12-trimethyltridecyl) chroman-6-yloxy) Acetic Acid",
        "Alpha-tocopheryloxyacetic Acid",
        "a-TEA",
        "alpha-TEA"
      ]
    },
    {
      "fdaUniiCode": "UGI01OSA4N",
      "id": "VEGFHGF-targeting_DARPin_MP0250",
      "preferredName": "VEGF/HGF-targeting DARPin MP0250",
      "synonyms": [
        "Bispecific VEGF/HGF-targeting Darpin",
        "MP-0250",
        "MP0250",
        "VEGF/HGF-targeting DARPin MP0250"
      ]
    },
    {
      "fdaUniiCode": "0AHT0IC02G",
      "id": "Flotetuzumab",
      "preferredName": "Flotetuzumab",
      "synonyms": [
        "CD123 x CD3 DART Bi-Specific Antibody MGD006",
        "CD123 x CD3 Dual Affinity Re-Targeting Bi-Specific Antibody MGD006",
        "FLOTETUZUMAB",
        "Flotetuzumab",
        "MGD006",
        "RES234",
        "S80880"
      ]
    },
    {
      "fdaUniiCode": "AKV2GM43DD",
      "id": "Agonistic_Anti-OX40_Monoclonal_Antibody_MEDI6469",
      "preferredName": "Agonistic Anti-OX40 Monoclonal Antibody MEDI6469",
      "synonyms": [
        "Agonistic Anti-CD134 Monoclonal Antibody MEDI6469",
        "Agonistic Anti-OX40 Monoclonal Antibody MEDI6469",
        "MEDI-6469",
        "MEDI6469"
      ]
    },
    {
      "fdaUniiCode": "51G6I8B902",
      "id": "Nilutamide",
      "preferredName": "Nilutamide",
      "synonyms": [
        "1-(3'-Trifluoromethyl-4'-nitrophenyl)-4,4-dimethylimidazoline-3,5-dione",
        "5,5-Dimethyl-3-[4-nitro-3-(trifluoro-methyl)phenyl]-2,4-imidazolidinedione",
        "Anandron",
        "NILUTAMIDE",
        "Nilandron",
        "Nilutamide",
        "RU-23908",
        "nilutamide"
      ]
    },
    {
      "fdaUniiCode": "6N510JUL1Y",
      "id": "Oltipraz",
      "preferredName": "Oltipraz",
      "synonyms": [
        "3H-1,2-Dithiole-3-thione, 4-methyl-5-pyrazinyl-",
        "3H-1,2-Dithiole-3-thione,4-methyl-5-pyrazinyl",
        "4-Methyl-5-(pyrazinyl)-3H-1,2-dithiole-3-thione",
        "4-Methyl-5-pyrazinyl-3H-1,2-dithiole-3-thione",
        "5-(2-Pyrazinyl)-4-methyl-1,2-dithiol-3-thione",
        "5-[2-Pyrazinyl]-4-methyl-1,2-3-thione",
        "OLTIPRAZ",
        "Oltipraz",
        "RP-35,972",
        "oltipraz"
      ]
    },
    {
      "fdaUniiCode": "95Y8L63NBC",
      "id": "Flumatinib_Mesylate",
      "preferredName": "Flumatinib Mesylate",
      "synonyms": [
        "4-(4-Methyl-piperazin-1-ylmethyl)-N-[6-methyl-5-(4-pyridin-3-yl-pyrimidin-2-ylamino)-pyridin-3-yl]-3-trifluoromethyl-benzamide Mesylate",
        "FLUMATINIB MESYLATE",
        "Flumatinib Mesylate",
        "HH-GV-678 Mesylate",
        "HH-GV678 Mesylate"
      ]
    },
    {
      "fdaUniiCode": "8PX1X7UG4D",
      "id": "Idecabtagene_Vicleucel",
      "preferredName": "Idecabtagene Vicleucel",
      "synonyms": [
        "Abecma",
        "Anti-BCMA CAR T Cells BB2121",
        "Anti-BCMA-CAR-transduced T Cells BB2121",
        "BB2121",
        "BCMA-specific CAR-expressing T Lymphocytes BB2121",
        "IDECABTAGENE VICLEUCEL",
        "Ide-cel",
        "Idecabtagene Vicleucel"
      ]
    },
    {
      "fdaUniiCode": "90YIEHRFJ9",
      "id": "Magrolimab",
      "preferredName": "Magrolimab",
      "synonyms": [
        "Hu5F9-G4",
        "MAGROLIMAB",
        "Magrolimab"
      ]
    },
    {
      "fdaUniiCode": "YFZ7N482WG",
      "id": "Anti-CD70_Antibody-drug_Conjugate_SGN-CD70A",
      "preferredName": "Anti-CD70 Antibody-drug Conjugate SGN-CD70A",
      "synonyms": [
        "Anti-CD70 Antibody-drug Conjugate SGN-CD70A",
        "SGN-CD70A"
      ]
    },
    {
      "fdaUniiCode": "CWG62Q1VTB",
      "id": "Sitravatinib",
      "preferredName": "Sitravatinib",
      "synonyms": [
        "1,1-Cyclopropanedicarboxamide, N-(3-Fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)-2-pyridinyl)thieno(3,2-b)pyridin-7-yl)oxy)phenyl)-N'-(4-fluorophenyl)-",
        "MGCD516",
        "SITRAVATINIB",
        "Sitravatinib"
      ]
    },
    {
      "fdaUniiCode": "27JT06E6GR",
      "id": "Tilarginine",
      "preferredName": "Tilarginine",
      "synonyms": [
        "L-NMMA",
        "Monomethylarginine",
        "N-Methylarginine",
        "N5-(Methylamidino)-L-ornithine",
        "NG-Monomethyl-L-Arginine",
        "NG-monomethyl-L-arginine",
        "NMA",
        "TILARGININE",
        "Targinine",
        "Tilarginine",
        "omega-N-Monomethylarginine"
      ]
    },
    {
      "fdaUniiCode": "7M0A29CD8B",
      "id": "Nelipepimut-S",
      "preferredName": "Nelipepimut-S",
      "synonyms": [
        "E75 Peptide",
        "Human Receptor Tyrosine-Protein Kinase erbB-2 (Proto-Oncogene Neu, Tyrosine Kinase- type Cell Surface Receptor HER2, CD340)-(347-355)-Peptide",
        "L-Leucine, L-lysyl-L-isoleucyl-L-phenylalanylglycyl-L-seryl-L-leucyl-L-alanyl-L- phenylalanyl-",
        "NELIPEPIMUT-S",
        "Nelipepimut S",
        "Nelipepimut-S",
        "NeuVax"
      ]
    },
    {
      "fdaUniiCode": "04ZR38536J",
      "id": "Oxaliplatin",
      "preferredName": "Oxaliplatin",
      "synonyms": [
        "1-OHP",
        "Ai Heng",
        "Aiheng",
        "DACPLAT",
        "Dacotin",
        "Dacplat",
        "Diaminocyclohexane Oxalatoplatinum",
        "ELOXATIN",
        "Eloxatin",
        "Eloxatine",
        "JM-83",
        "OXALIPLATIN",
        "Oxalatoplatin",
        "Oxalatoplatinum",
        "Oxaliplatin",
        "RP 54780",
        "RP-54780",
        "SR-96669",
        "[(1R,-2R)-1,2-cyclohexanediamine-N,N'][oxalato (2--)-O,O']platinum",
        "[SP-4-2-(1R-trans)]-(1,2,cyclohexanediamine-N,N')[ethanedioato(2--)-O,O']platinum",
        "oxalato (1R,2R-cyclohexanediamine)platinum(II)",
        "oxalato (trans-l-1,2-diaminocyclohexane)platinum(II)",
        "oxaliplatin",
        "trans-l DACH oxalatoplatinum",
        "trans-l diaminocyclohexane oxalatoplatinum"
      ]
    },
    {
      "fdaUniiCode": "YL4TY9WH22",
      "id": "Piroxantrone",
      "preferredName": "Piroxantrone",
      "synonyms": [
        "Anthra(1,9-cd)pyrazol-6(2H)-one, 5-((3-aminopropyl)amino)-7,10-dihydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)",
        "CI-942",
        "Oxanthrazole",
        "Oxantrazole",
        "PD-111815",
        "PIROXANTRONE",
        "Piroxantrone",
        "Piroxantrone HCl"
      ]
    },
    {
      "fdaUniiCode": "K85WE44TZ7",
      "id": "Anti-MetEGFR_Monoclonal_Antibody_LY3164530",
      "preferredName": "Anti-Met/EGFR Monoclonal Antibody LY3164530",
      "synonyms": [
        "Anti-Met/EGFR Monoclonal Antibody LY3164530",
        "LY-3164530",
        "LY3164530"
      ]
    },
    {
      "fdaUniiCode": "1MH7C2X8KE",
      "id": "Efizonerimod",
      "preferredName": "Efizonerimod",
      "synonyms": [
        "EFIZONERIMOD",
        "Efizonerimod",
        "Efizonerimod Alfa",
        "Immunoglobulin G4 (10-proline) (Human Heavy Chain Fc Fragment) Fusion Protein with Tumor Necrosis Factor Receptor-associated Factor TRAF2 (Human C-C  Domain Fragment) Fusion Protein with CD252 Antigen (Human Extracellular Domain Fragment), Hexamer",
        "MEDI6383"
      ]
    },
    {
      "fdaUniiCode": "FEH7RQ7B3J",
      "id": "Cirmtuzumab",
      "preferredName": "Cirmtuzumab",
      "synonyms": [
        "CIRMTUZUMAB",
        "Cirmtuzumab",
        "UC-961"
      ]
    },
    {
      "fdaUniiCode": "67SX9H68W2",
      "id": "Zorifertinib",
      "preferredName": "Zorifertinib",
      "synonyms": [
        "AZD3759",
        "ZORIFERTINIB",
        "Zorifertinib"
      ]
    },
    {
      "fdaUniiCode": "T678746713",
      "id": "Altiratinib",
      "preferredName": "Altiratinib",
      "synonyms": [
        "1,1-Cyclopropanedicarboxamide, N-(4-((2-((cyclopropylcarbonyl)amino)-4-pyridinyl)oxy)-2,5-difluorophenyl)-N'-(4-fluorophenyl)-",
        "ALTIRATINIB",
        "Altiratinib",
        "DCC-2701"
      ]
    },
    {
      "fdaUniiCode": "3DD771JO2H",
      "id": "Ropocamptide",
      "preferredName": "Ropocamptide",
      "synonyms": [
        "Antimicrobial Peptide, Human LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES",
        "Cathelicidin LL-37",
        "LL-37",
        "ROPOCAMPTIDE",
        "Ropocamptide"
      ]
    },
    {
      "fdaUniiCode": "41XGO0VS1U",
      "id": "Donafenib",
      "preferredName": "Donafenib",
      "synonyms": [
        "2-Pyridinecarboxamide, 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-(methyl-d3)-",
        "4-(4-((4-Chloro-3-(trifluoromethyl)phenyl)carbamoylamino)phenoxy)-N-(trideuteriomethyl)pyridine-2-carboxamide",
        "CM-4307",
        "DONAFENIB",
        "Donafenib"
      ]
    },
    {
      "fdaUniiCode": "ZE15FIT23E",
      "id": "Ranpirnase",
      "preferredName": "Ranpirnase",
      "synonyms": [
        "Onconase",
        "P-30",
        "P-30 Protein",
        "P-30 protein",
        "P30",
        "P30 Protein",
        "RANPIRNASE",
        "Ranpirnase"
      ]
    },
    {
      "fdaUniiCode": "OZ8N9U6CEH",
      "id": "Anti-gpA33CD3_Monoclonal_Antibody_MGD007",
      "preferredName": "Anti-gpA33/CD3 Monoclonal Antibody MGD007",
      "synonyms": [
        "Anti-gpA33/CD3 Monoclonal Antibody MGD007",
        "Humanized gpA33 x CD3 DART (TM) Protein MGD007",
        "MGD-007",
        "MGD007"
      ]
    },
    {
      "fdaUniiCode": "Q8PK97HY9B",
      "id": "Anti-fucosyl-GM1_Monoclonal_Antibody_BMS-986012",
      "preferredName": "Anti-fucosyl-GM1 Monoclonal Antibody BMS-986012",
      "synonyms": [
        "Anti-fucosyl-GM1 Monoclonal Antibody BMS-986012",
        "BMS-986012"
      ]
    },
    {
      "fdaUniiCode": "KQR4YN4C28",
      "id": "Gamboge_Resin_Extract_TSB-9-W1",
      "preferredName": "Gamboge Resin Extract TSB-9-W1",
      "synonyms": [
        "GARCINIA HANBURYI ROOT RESIN",
        "Gamboge Resin Extract TSB-9-W1",
        "Garcinia Hanburyi Rhizome Resin",
        "Garcinia Hanburyi Root Resin",
        "TSB-9-W1"
      ]
    },
    {
      "fdaUniiCode": "19GBJ60SN5",
      "id": "Cannabidiol",
      "preferredName": "Cannabidiol",
      "synonyms": [
        "1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-",
        "CANNABIDIOL",
        "CBD",
        "CBD Oil",
        "Cannabidiol",
        "Epidiolex",
        "GWP42003-P"
      ]
    },
    {
      "fdaUniiCode": "976X9VXC3Z",
      "id": "Telisotuzumab_Vedotin",
      "preferredName": "Telisotuzumab Vedotin",
      "synonyms": [
        "ABBV 399",
        "ABBV-399",
        "ABT 399",
        "ABT-399",
        "ABT-700-VCMMAE",
        "TELISOTUZUMAB VEDOTIN",
        "Telisotuzumab Vedotin"
      ]
    },
    {
      "fdaUniiCode": "B800Z06O8K",
      "id": "Vanucizumab",
      "preferredName": "Vanucizumab",
      "synonyms": [
        "Ang2-VEGF-A CrossMab RO5520985",
        "Immunoglobulin Recombined G1-kappa/lambda, Anti-(Homo sapiens Angpt2 (Angiopoietin 2, Ang2))/Anti-Homo sapiens VEGFa (Vascular Endothelial Growth Factor A, VEGF-a, VEGF)), Humanized Monoclonal Antibody",
        "RG-7221",
        "RG7221",
        "RO-5520985",
        "RO5520985",
        "VANUCIZUMAB",
        "Vanucizumab"
      ]
    },
    {
      "fdaUniiCode": "AZW59V4Q3B",
      "id": "PCNU",
      "preferredName": "PCNU",
      "synonyms": [
        "1-(2-CHLOROETHYL)-3-(2,6-DIOXO-3-PIPERIDYL)-1-NITROSOUREA",
        "1-(2-Chloroethyl)-3-(2,6-Dioxo-3-Piperidyl)-1-Nitrourea",
        "PCNU",
        "Urea, N-(2-chloroethyl)-N'-(2,6-dioxo-3-piperidinyl)-N-nitroso-"
      ]
    },
    {
      "fdaUniiCode": "TN7CUD1NGA",
      "id": "FGFFGFR_Pathway_Inhibitor_E7090",
      "preferredName": "FGF/FGFR Pathway Inhibitor E7090",
      "synonyms": [
        "E-7090",
        "E7090",
        "FGF/FGFR Pathway Inhibitor E7090"
      ]
    },
    {
      "fdaUniiCode": "XCR2BZ80N7",
      "id": "Trastuzumab_Duocarmazine",
      "preferredName": "Trastuzumab Duocarmazine",
      "synonyms": [
        "ADC SYD985",
        "Antibody-drug Conjugate SYD985",
        "SYD985",
        "TRASTUZUMAB DUOCARMAZINE",
        "Trastuzumab Duocarmazine",
        "Trastuzumab VC-seco-DUBA",
        "Trastuzumab-drug Conjugate SYD985",
        "vic-Trastuzumab Duocarmazine"
      ]
    },
    {
      "fdaUniiCode": "5KAI8N485T",
      "id": "Penberol",
      "preferredName": "Penberol",
      "synonyms": [
        "PENBEROL",
        "Penberol",
        "cis-beta-4-pentoxy-benzoyl-beta-bromoacrylic acid",
        "cis-beta-4-pentoxybenzoyl-beta-bromoacrylic acid"
      ]
    },
    {
      "fdaUniiCode": "66Q80IL7CW",
      "id": "Penclomedine",
      "preferredName": "Penclomedine",
      "synonyms": [
        "3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl) pyridine",
        "CRC 88-04",
        "PEN",
        "PENCLOMEDINE",
        "Penclomedine",
        "Pyridine, 3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)-",
        "penclomedine"
      ]
    },
    {
      "fdaUniiCode": "UEF6R96K8R",
      "id": "Pentamethylmelamine",
      "preferredName": "Pentamethylmelamine",
      "synonyms": [
        "1,3,5-Triazine-2,4,6-triamine, N,N,N',N', N''-pentamethyl-, monohydrochloride (9CI)",
        "Melamine",
        "Melamine, N2,N2,N4,N4,N6-pentamethyl-, monohydrochloride",
        "N,N,N',N',N\"-pentamethyl-1,3,5-triazine",
        "PENTAMETHYLMELAMINE",
        "PMM",
        "Pentamethylmelamine",
        "Pentamethylmelamine MonoHCl",
        "Pentamethylmelamine Monohydrochloride",
        "Pentamethylmelamine monoHCl",
        "Pentamethylmelamine monohydrochloride",
        "melamine, N2,N2,N4,N4,N6-pentamethyl-, monohydrochloride"
      ]
    },
    {
      "fdaUniiCode": "W4141180YD",
      "id": "Taletrectinib",
      "preferredName": "Taletrectinib",
      "synonyms": [
        "AB 106",
        "AB-106",
        "AB106",
        "DS-6051b",
        "TALETRECTINIB",
        "Taletrectinib"
      ]
    },
    {
      "fdaUniiCode": "Z27ZI1MZY9",
      "id": "HER2-targeting_Antibody_Fc_Fragment_FS102",
      "preferredName": "HER2-targeting Antibody Fc Fragment FS102",
      "synonyms": [
        "Anti-HER2 FCAB FS102",
        "BMS-986186",
        "FS-102",
        "FS102",
        "Fcab FS102",
        "HER2-targeting Antibody Fc Fragment FS102"
      ]
    },
    {
      "fdaUniiCode": "34021JC2Z6",
      "id": "Phenesterin",
      "preferredName": "Phenesterin",
      "synonyms": [
        "(3-beta)-cholest-5-en-3-ol 4-(bis(2-chloroethyl)amino)benzeneacetate",
        "(4-(bis(2-chloroethyl)amino)phenyl)acetic acid cholesteryl ester",
        "(p-(bis(2-chloroethyl)amino)phenyl) acetate cholesterol",
        "(p-(bis(2-chloroethyl)amino)phenyl)acetic acid cholesteryl ester",
        "5-Cholesten-3-beta-ol 3-(p-(bis(2-chloroethyl)amino)phenyl)acetate",
        "Cholest-5-en-3-ol, (3.beta.)-, 4-[bis(2-chloroethyl)amino]benzeneacetate",
        "Cholest-5-en-3beta-ol 4-(bis(2-chloroethyl)amino)benzeneacetate",
        "Cholesteryl p-bis(2-chloroethyl)aminophenylacetate",
        "Fenesterin",
        "Fenestrin",
        "NCI-C01558",
        "PHENESTERINE",
        "Phenesterin",
        "Phenesterine",
        "p-bis(2-chloroethyl)amino phenylacetate cholesterol"
      ]
    },
    {
      "fdaUniiCode": "8R5CM46UIO",
      "id": "Odronextamab",
      "preferredName": "Odronextamab",
      "synonyms": [
        "Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody REGN1979",
        "ODRONEXTAMAB",
        "Odronextamab",
        "REGN1979",
        "WHO 11035"
      ]
    },
    {
      "fdaUniiCode": "FV0JG1SX76",
      "id": "Suratadenoturev",
      "preferredName": "Suratadenoturev",
      "synonyms": [
        "OBP-301",
        "SURATADENOTUREV",
        "Suratadenoturev",
        "Telomelycin",
        "Telomelysin",
        "Telomerase-specific Type 5 Adenovirus OBP-301"
      ]
    },
    {
      "fdaUniiCode": "1W14T9L25W",
      "id": "Navicixizumab",
      "preferredName": "Navicixizumab",
      "synonyms": [
        "Immunoglobulin G2-kappa, Anti-(Homo sapiens DLL4(delta-like 4)) and Anti-(Homo sapiens VEGFA (Vascular Endothelial Growth Factor A,VEGF-a, VEGF)), Humanized and Chimeric Monoclonal Antibody, Bispecific",
        "NAVICIXIZUMAB",
        "Navicixizumab",
        "OMP 305B83",
        "OMP-305B83",
        "OMP305B83"
      ]
    },
    {
      "fdaUniiCode": "5RZZ0Z1GJT",
      "id": "Gilteritinib_Fumarate",
      "preferredName": "Gilteritinib Fumarate",
      "synonyms": [
        "2-Pyrazinecarboxamide, 6-ethyl-3-((3-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)-, (2E)-2-Butenedioate (2:1)",
        "ASP-2215 Hemifumarate",
        "ASP2215 Hemifumarate",
        "GILTERITINIB FUMARATE",
        "Gilteritinib Fumarate",
        "Gilteritinib Hemifumarate",
        "Xospata"
      ]
    },
    {
      "fdaUniiCode": "D58G680W0G",
      "id": "Pirarubicin",
      "preferredName": "Pirarubicin",
      "synonyms": [
        "(2\"R)-4'-O-Tetrahydropyranyladriamycin",
        "(8S,10S)-10-[[3-Amino-2,3,6-trideoxy-4-O-(tetrahydro-2H-pyran-3-yl)-alpha-L-lyxo-hexopyranosyl]oxy]-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione",
        "1609RB",
        "4'-O-Tetrahydropyranyl Doxorubicin",
        "PIRARUBICIN",
        "Pinorubicin",
        "Pirarubicin",
        "THP-ADM",
        "THP-Adriamycin",
        "THP-DOX",
        "THP-Doxorubicin",
        "Tepirubicin",
        "Tetrahydropyranyl-Doxorubicin",
        "Theprubicin",
        "Theprubicine",
        "Therarubicin",
        "[8S-[8Alpha,10alpha(S*)]]-10-[[3-amino-2,3,6-trideoxy-4-O-(tetrahydro-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione"
      ]
    },
    {
      "fdaUniiCode": "S8GQZ8LF0D",
      "id": "hTERT-encoding_DNA_Vaccine_INVAC-1",
      "preferredName": "hTERT-encoding DNA Vaccine INVAC-1",
      "synonyms": [
        "INVAC-1",
        "INVAC-1, A DOUBLE STRANDED DNA PLASMID VACCINE CONSTRUCT ENCODING UBIQUITIN-HUMAN TELOMERASE REVERSE TRANSCRIPTASE (HTERT) FUSION PROTEIN",
        "hTERT-encoding DNA Vaccine INVAC-1"
      ]
    },
    {
      "fdaUniiCode": "0O39RGI33V",
      "id": "Selicrelumab",
      "preferredName": "Selicrelumab",
      "synonyms": [
        "RO7009789",
        "SELICRELUMAB",
        "Selicrelumab"
      ]
    },
    {
      "fdaUniiCode": "PE952ANF83",
      "id": "Uproleselan",
      "preferredName": "Uproleselan",
      "synonyms": [
        "GMI-1271",
        "UPROLESELAN",
        "Uproleselan"
      ]
    },
    {
      "fdaUniiCode": "G9WJT6RD29",
      "id": "Burosumab",
      "preferredName": "Burosumab",
      "synonyms": [
        "Anti-FGF23 IgG1 Monoclonal Antibody KRN23",
        "BUROSUMAB",
        "Burosumab",
        "Burosumab-TWZA",
        "Crysvita",
        "KRN23",
        "UX023"
      ]
    },
    {
      "fdaUniiCode": "NC1XBS5AET",
      "id": "Globo_H-DT_Vaccine_OBI-833",
      "preferredName": "Globo H-DT Vaccine OBI-833",
      "synonyms": [
        "Globo H-CRM197 Vaccine",
        "Globo H-DT Vaccine OBI-833",
        "OBI-833"
      ]
    },
    {
      "fdaUniiCode": "7D96IR0PPM",
      "id": "Pegaspargase",
      "preferredName": "Pegaspargase",
      "synonyms": [
        "(Monomethoxypolyethylene Glycol Succinimidyl)74-L-Asparaginase",
        "L-Asparaginase with Polyethylene Glycol",
        "Oncaspar",
        "Oncaspar-IV",
        "PEG-Asparaginase",
        "PEG-L-Asparaginase",
        "PEG-L-Asparaginase (Enzon - Kyowa Hakko)",
        "PEG-asparaginase",
        "PEGASPARGASE",
        "PEGLA",
        "Pegaspargase",
        "Polyethylene Glycol L-Asparaginase",
        "Polyethylene Glycol-L-Asparaginase",
        "pegaspargase"
      ]
    },
    {
      "fdaUniiCode": "GN429E725A",
      "id": "Peposertib",
      "preferredName": "Peposertib",
      "synonyms": [
        "(S)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol",
        "3-Pyridazinemethanol, alpha-(2-Chloro-4-fluoro-5-(7-(4-morpholinyl)-4-quinazolinyl)phenyl)-6-methoxy-, (alphaS)-",
        "M 3814",
        "M-3814",
        "M3814",
        "MSC 2490484A",
        "MSC-2490484A",
        "MSC2490484A",
        "Nedisertib",
        "PEPOSERTIB",
        "Peposertib"
      ]
    },
    {
      "fdaUniiCode": "RJW23BQ0KW",
      "id": "Bemarituzumab",
      "preferredName": "Bemarituzumab",
      "synonyms": [
        "BEMARITUZUMAB",
        "Bemarituzumab",
        "FPA144"
      ]
    },
    {
      "fdaUniiCode": "4LU9B48U4D",
      "id": "Tavolimab",
      "preferredName": "Tavolimab",
      "synonyms": [
        "Anti-OX40 Monoclonal Antibody MEDI0562",
        "MEDI-0562",
        "MEDI0562",
        "TAVOLIMAB",
        "Tavolimab",
        "Tavolixizumab"
      ]
    },
    {
      "fdaUniiCode": "95E1ZQM329",
      "id": "Anti-CEACAM6_AFAIKL2_Antibody_FragmentJack_Bean_Urease_Immunoconjugate_L-DOS47",
      "preferredName": "Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47",
      "synonyms": [
        "Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47",
        "L-DOS47"
      ]
    },
    {
      "fdaUniiCode": "ZAM5J1ATF2",
      "id": "Cibisatamab",
      "preferredName": "Cibisatamab",
      "synonyms": [
        "CIBISATAMAB",
        "Cibisatamab",
        "RG-7802",
        "RG7802",
        "RO6958688",
        "WHO 10636"
      ]
    },
    {
      "fdaUniiCode": "M64JF6WMSA",
      "id": "Roblitinib",
      "preferredName": "Roblitinib",
      "synonyms": [
        "FGF401",
        "FGFR4 Inhibitor FGF401",
        "ROBLITINIB",
        "Roblitinib"
      ]
    },
    {
      "fdaUniiCode": "449MIE2SD6",
      "id": "Letolizumab",
      "preferredName": "Letolizumab",
      "synonyms": [
        "BMS-986004",
        "BMS986004",
        "Fc-Fusion Protein BMS986004",
        "LETOLIZUMAB",
        "Letolizumab"
      ]
    },
    {
      "fdaUniiCode": "M2LBQ7RN2X",
      "id": "Eltrapuldencel-T",
      "preferredName": "Eltrapuldencel-T",
      "synonyms": [
        "Autologous DCs Loaded with Irradiated Autologous Tumor Cells in GM-CSF",
        "Autologous Dendritic Cells Loaded with Irradiated Autologous Tumor Cells in Granulocyte-macrophage Colony-stimulating Factor",
        "DC-TC",
        "ELTRAPULDENCEL-T",
        "Eltrapuldencel-T",
        "Melapuldencel-T",
        "NBS-20",
        "NBS20"
      ]
    },
    {
      "fdaUniiCode": "3ZXZ2V0588",
      "id": "Monalizumab",
      "preferredName": "Monalizumab",
      "synonyms": [
        "IPH-2201",
        "IPH2201",
        "Immunoglobulin G4-kappa, Anti-(Homo sapiens KLRC1 (Killer Cell Lectin-like Receptor Subfamily C Member 1, NKG2-a, NKG2a, CD159A, CD94)), Humanized Monoclonal Antibody",
        "MONALIZUMAB",
        "Monalizumab",
        "NN-8765",
        "NN8765",
        "NN8765-3658"
      ]
    },
    {
      "fdaUniiCode": "FM6A2627A8",
      "id": "Elacestrant",
      "preferredName": "Elacestrant",
      "synonyms": [
        "(6R)-6-(2-(Ethyl((4-(2- (ethylamino)ethyl)phenyl)methyl)amino)-4-methoxyphenyl)- 5,6,7,8-tetrahydronaphthalen-2-ol",
        "ELACESTRANT",
        "ER-306323",
        "Elacestrant",
        "RAD1901",
        "SERD/SERM RAD1901"
      ]
    },
    {
      "fdaUniiCode": "W1NYL2IRDR",
      "id": "Palbociclib_Isethionate",
      "preferredName": "Palbociclib Isethionate",
      "synonyms": [
        "6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino(pyrido(2,3-d)pyrimidin-7(8h)-one mono(2-hydroxyethanesulfonate)",
        "PALBOCICLIB ISETHIONATE",
        "PD 0332991-0054",
        "PF-00080665-73",
        "Palbociclib Isethionate"
      ]
    },
    {
      "fdaUniiCode": "JTP97OR4LL",
      "id": "Anti-CEACAM1_Monoclonal_Antibody_CM-24",
      "preferredName": "Anti-CEACAM1 Monoclonal Antibody CM-24",
      "synonyms": [
        "Anti-CEACAM1 Monoclonal Antibody CM-24",
        "CM-24"
      ]
    },
    {
      "fdaUniiCode": "YXX2180047",
      "id": "Mavelertinib",
      "preferredName": "Mavelertinib",
      "synonyms": [
        "2-Propenamide, N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)-3-pyrrolidinyl)-",
        "MAVELERTINIB",
        "Mavelertinib",
        "PF-06747775"
      ]
    },
    {
      "fdaUniiCode": "U2I8T43Y7R",
      "id": "Axicabtagene_Ciloleucel",
      "preferredName": "Axicabtagene Ciloleucel",
      "synonyms": [
        "AXICABTAGENE CILOLEUCEL",
        "Axicabtagene Ciloleucel",
        "KTE C19",
        "KTE-C19",
        "KTE-C19 CAR",
        "Yescarta"
      ]
    },
    {
      "fdaUniiCode": "2T6D2HPX7Q",
      "id": "S-equol",
      "preferredName": "S-equol",
      "synonyms": [
        "(-)-Equol",
        "(3S)-3,4-dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol",
        "2H-1-benzopyran-7-ol, 3,4-Dihydro-3-(4-hydroxyphenyl)-, (3S)-",
        "EQUOL, (-)-",
        "S-equol"
      ]
    },
    {
      "fdaUniiCode": "SJ5857RRL3",
      "id": "2-Methoxyestrone",
      "preferredName": "2-Methoxyestrone",
      "synonyms": [
        "2-METHOXYESTRONE",
        "2-MeE1",
        "2-MeOE1",
        "2-Methoxyestrone",
        "2-OMeE1",
        "3-Hydroxy-2-Methoxyestra-1,3,5(10)-Trien-17-One"
      ]
    },
    {
      "fdaUniiCode": "AYU2L67YUU",
      "id": "2-Hydroxyestradiol",
      "preferredName": "2-Hydroxyestradiol",
      "synonyms": [
        "(17beta)-Estra-1,3,5(10)-Triene-2,3,17-Triol",
        "2-HYDROXYESTRADIOL",
        "2-Hydroxy-17beta-Estradiol",
        "2-Hydroxyestradiol",
        "2-Hydroxyestradiol-17beta",
        "2-OH-E2",
        "2-OH-Estradiol",
        "2-OHE2"
      ]
    },
    {
      "fdaUniiCode": "Q718FS1C7X",
      "id": "Idetrexed",
      "preferredName": "Idetrexed",
      "synonyms": [
        "BGC 945",
        "IDETREXED",
        "Idetrexed",
        "N-[4-[2-Propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-l-gamma-glutamyl-d-glutamic Acid",
        "ONX 0801",
        "ONX-0801",
        "alpha-Folate Receptor-targeting Thymidylate Synthase Inhibitor ONX-0801"
      ]
    },
    {
      "fdaUniiCode": "R0835E18NH",
      "id": "Lifileucel",
      "preferredName": "Lifileucel",
      "synonyms": [
        "Autologous TIL LN-144",
        "Autologous Tumor Infiltrating Lymphocytes LN-144",
        "Contego",
        "LIFILEUCEL",
        "LN-144",
        "Lifileucel"
      ]
    },
    {
      "fdaUniiCode": "8375F9S90C",
      "id": "Pamiparib",
      "preferredName": "Pamiparib",
      "synonyms": [
        "5,6,7a,11-Tetraazacyclohepta(def)cyclopenta(a)fluoren-4(7H)-one, 2-Fluoro-5,8,9,10,10a,11-hexahydro-10a-methyl-, (10aR)-",
        "BGB-290",
        "PAMIPARIB",
        "PARP Inhibitor BGB-290",
        "Pamiparib"
      ]
    },
    {
      "fdaUniiCode": "P45C2W27DU",
      "id": "Tomaralimab",
      "preferredName": "Tomaralimab",
      "synonyms": [
        "Anti-TLR2 Monoclonal Antibody OPN-305",
        "OPN-305",
        "TOMARALIMAB",
        "Tomaralimab"
      ]
    },
    {
      "fdaUniiCode": "17C83BVV62",
      "id": "Losatuxizumab_Vedotin",
      "preferredName": "Losatuxizumab Vedotin",
      "synonyms": [
        "ABBV-221",
        "LOSATUXIZUMAB VEDOTIN",
        "Losatuxizumab Vedotin"
      ]
    },
    {
      "fdaUniiCode": "G674PEN33T",
      "id": "Anti-DR5_Agonistic_Antibody_DS-8273a",
      "preferredName": "Anti-DR5 Agonistic Antibody DS-8273a",
      "synonyms": [
        "Anti-DR5 Agonistic Antibody DS-8273a",
        "DS 8273",
        "DS-8273A",
        "DS-8273a"
      ]
    },
    {
      "fdaUniiCode": "DDD2AB5TWK",
      "id": "Aprutumab_Ixadotin",
      "preferredName": "Aprutumab Ixadotin",
      "synonyms": [
        "ADC BAY1187982",
        "APRUTUMAB IXADOTIN",
        "Aprutumab Ixadotin",
        "BAY 1187982",
        "BAY1187982"
      ]
    },
    {
      "fdaUniiCode": "M9ALI41OQR",
      "id": "BET_Inhibitor_BAY1238097",
      "preferredName": "BET Inhibitor BAY1238097",
      "synonyms": [
        "BAY 1238097",
        "BAY-1238097",
        "BAY1238097",
        "BET Inhibitor BAY1238097"
      ]
    },
    {
      "fdaUniiCode": "Y96MQM21V9",
      "id": "Rebeccamycin",
      "preferredName": "Rebeccamycin",
      "synonyms": [
        "5H-Indolo[2, 3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione, 1,11-dichloro-12, 13-dihydro-12-(4-O-methyl-.beta.-D-glucopyranosyl)-",
        "5H-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione,1,11-dichloro-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl)",
        "BRN 4732638",
        "REBECCAMYCIN",
        "Rebeccamycin",
        "rebeccamycin"
      ]
    },
    {
      "fdaUniiCode": "F5I3T42BXC",
      "id": "Imifoplatin",
      "preferredName": "Imifoplatin",
      "synonyms": [
        "Cyclohexanediamine Pyrophosphatoplatinum(II), (1R,2R)-",
        "IMIFOPLATIN",
        "Imifoplatin",
        "PT 112",
        "PT-112",
        "Phosphaplatin PT-112"
      ]
    },
    {
      "fdaUniiCode": "C78148TF1D",
      "id": "Vonlerolizumab",
      "preferredName": "Vonlerolizumab",
      "synonyms": [
        "Anti-OX40 Monoclonal Antibody MOXR0916",
        "MOXR0916",
        "Pogalizumab",
        "RG 7888",
        "RG-7888",
        "RG7888",
        "RO7021608",
        "VONLEROLIZUMAB",
        "Vonlerolizumab"
      ]
    },
    {
      "fdaUniiCode": "B5ME4ZU4BS",
      "id": "Letetresgene_Autoleucel",
      "preferredName": "Letetresgene Autoleucel",
      "synonyms": [
        "Autologous Anti-NY-ESO-1/LAGE-1 TCR-transduced c259 T Lymphocytes GSK3377794",
        "Autologous T-Cells Expressing Enhanced TCRs Specific for NY-ESO-1/LAGE-1a GSK3377794",
        "Genetically Engineered NY-ESO-1 Specific [c259] T Cells GSK3377794",
        "Genetically Engineered NY-ESO-1/LAGE-1 Specific (c259) T Cells GSK3377794",
        "LETETRESGENE AUTOLEUCEL",
        "Letetresgene Autoleucel",
        "NY-ESO-1c259 T Cells GSK3377794"
      ]
    },
    {
      "fdaUniiCode": "63Q7F59W0V",
      "id": "Atuveciclib",
      "preferredName": "Atuveciclib",
      "synonyms": [
        "1,3,5-Triazin-2-amine, 4-(4-Fluoro-2-methoxyphenyl)-N-(3-((S-methylsulfonimidoyl)methyl)phenyl)-, (+)-",
        "ATUVECICLIB",
        "Atuveciclib",
        "BAY 1143572",
        "BAY1143572"
      ]
    },
    {
      "fdaUniiCode": "Q369O8926L",
      "id": "Resveratrol",
      "preferredName": "Resveratrol",
      "synonyms": [
        "(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol",
        "3,4',5-Stilbenetriol",
        "RESVERATROL",
        "Resveratrol",
        "resveratrol"
      ]
    },
    {
      "fdaUniiCode": "Q9J81E7VFM",
      "id": "Mitazalimab",
      "preferredName": "Mitazalimab",
      "synonyms": [
        "ADC 1013",
        "ADC-1013",
        "ADC1013",
        "JNJ 7107",
        "JNJ-64457107",
        "MITAZALIMAB",
        "Mitazalimab"
      ]
    },
    {
      "fdaUniiCode": "6QVL057INT",
      "id": "Cemiplimab",
      "preferredName": "Cemiplimab",
      "synonyms": [
        "CEMIPLIMAB",
        "Cemiplimab",
        "Cemiplimab RWLC",
        "Cemiplimab-rwlc",
        "Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal REGN2810 Heavy Chain), Disulfide with Human Monoclonal REGN2810 kappa-chain, Dimer",
        "Libtayo",
        "REGN2810"
      ]
    },
    {
      "fdaUniiCode": "Y6BX7BL23K",
      "id": "Pemigatinib",
      "preferredName": "Pemigatinib",
      "synonyms": [
        "2H-Pyrrolo(3',2':5,6)pyrido(4,3-d)pyrimidin-2-one, 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-1,3,4,7-tetrahydro-8-(4-morpholinylmethyl)-",
        "INCB054828",
        "PEMIGATINIB",
        "Pemazyre",
        "Pemigatinib"
      ]
    },
    {
      "fdaUniiCode": "3LE3D9D6OY",
      "id": "Retinyl_Acetate",
      "preferredName": "Retinyl Acetate",
      "synonyms": [
        "Retinol Acetate",
        "Retinyl Acetate",
        "Retinyl acetate",
        "VITAMIN A ACETATE",
        "Vitamin A, acetate",
        "vitamin A acetate"
      ]
    },
    {
      "fdaUniiCode": "QOG25L6Z8Z",
      "id": "Spartalizumab",
      "preferredName": "Spartalizumab",
      "synonyms": [
        "PDR-001",
        "PDR001",
        "SPARTALIZUMAB",
        "Spartalizumab"
      ]
    },
    {
      "fdaUniiCode": "455J2479FY",
      "id": "Lirametostat",
      "preferredName": "Lirametostat",
      "synonyms": [
        "CPI-1205",
        "EZH2 Inhibitor CPI-1205",
        "LIRAMETOSTAT",
        "Lirametostat"
      ]
    },
    {
      "fdaUniiCode": "441P620G3P",
      "id": "Citarinostat",
      "preferredName": "Citarinostat",
      "synonyms": [
        "2-((2-Chlorophenyl)phenylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)-5-pyrimidinecarboxamide",
        "5-Pyrimidinecarboxamide, 2-((2-Chlorophenyl)phenylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)-",
        "ACY-241",
        "CC-96241",
        "CITARINOSTAT",
        "Citarinostat",
        "HDAC-IN-2",
        "Histone Deacetylase Inhibitor ACY-241"
      ]
    },
    {
      "fdaUniiCode": "Z4HZ70S62Q",
      "id": "Unesbulin",
      "preferredName": "Unesbulin",
      "synonyms": [
        "PTC596",
        "Polycomb Ring Finger Oncogene Inhibitor PTC596",
        "UNESBULIN",
        "Unesbulin"
      ]
    },
    {
      "fdaUniiCode": "31M3WLJ3KG",
      "id": "Belvarafenib",
      "preferredName": "Belvarafenib",
      "synonyms": [
        "BELVARAFENIB",
        "Belvarafenib",
        "HM95573"
      ]
    },
    {
      "fdaUniiCode": "D6AT024T4P",
      "id": "Anti-mesothelin-Pseudomonas_Exotoxin_24_Cytolytic_Fusion_Protein_LMB-100",
      "preferredName": "Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100",
      "synonyms": [
        "Anti-MSLN-PE24 cFP LMB-100",
        "Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100",
        "LMB-100",
        "RG 7787",
        "RG-7787",
        "RG7787",
        "RO 6927005",
        "RO6927005"
      ]
    },
    {
      "fdaUniiCode": "84I5UEP321",
      "id": "Taminadenant",
      "preferredName": "Taminadenant",
      "synonyms": [
        "4-Pyrimidinamine, 5-Bromo-2,6-di-1H-pyrazol-1-yl-",
        "A2AR Antagonist PBF-509",
        "PBF-509",
        "TAMINADENANT",
        "Taminadenant"
      ]
    },
    {
      "fdaUniiCode": "1D1K0N0VVC",
      "id": "Retinyl_Palmitate",
      "preferredName": "Retinyl Palmitate",
      "synonyms": [
        "Palmitate-1-14C",
        "Retinol Hexadecanoate",
        "Retinol Palmitate",
        "Retinol-15-3H",
        "Retinyl Palmitate",
        "Retinyl-10,11-14C2",
        "VITAMIN A PALMITATE",
        "Vitamin A Palmitate",
        "retinyl palmitate"
      ]
    },
    {
      "fdaUniiCode": "0KVO411B3N",
      "id": "Tislelizumab",
      "preferredName": "Tislelizumab",
      "synonyms": [
        "BGB-A317",
        "TISLELIZUMAB",
        "Tislelizumab"
      ]
    },
    {
      "fdaUniiCode": "C1V1Y784E4",
      "id": "Rhizoxin",
      "preferredName": "Rhizoxin",
      "synonyms": [
        "RHIZOXIN",
        "Rhizoxin",
        "WF-1360",
        "rhizoxin"
      ]
    },
    {
      "fdaUniiCode": "C88817F47Y",
      "id": "Samotolisib",
      "preferredName": "Samotolisib",
      "synonyms": [
        "2H-Imidazo(4,5-C)quinolin-2-one, 1,3-Dihydro-8-(5-(1-hydroxy-1-methylethyl)-3-pyridinyl)-1-((2S)-2-methoxypropyl)-3-methyl-",
        "LY 3023414",
        "LY-3023414",
        "LY3023414",
        "PI3K/mTOR Inhibitor LY3023414",
        "SAMOTOLISIB",
        "Samotolisib",
        "WHO 10889"
      ]
    },
    {
      "fdaUniiCode": "VR86R11J7J",
      "id": "Mivebresib",
      "preferredName": "Mivebresib",
      "synonyms": [
        "ABBV-075",
        "Ethanesulfonamide, N-(4-(2,4-difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo(2,3-C)pyridin-4-yl)phenyl)-",
        "MIVEBRESIB",
        "Mivebresib"
      ]
    },
    {
      "fdaUniiCode": "X8BW0MQ5PI",
      "id": "BET_Inhibitor_BMS-986158",
      "preferredName": "BET Inhibitor BMS-986158",
      "synonyms": [
        "BET Inhibitor BMS-986158",
        "BMS-986158"
      ]
    },
    {
      "fdaUniiCode": "MG94W1I5XW",
      "id": "Cetuximab_Sarotalocan",
      "preferredName": "Cetuximab Sarotalocan",
      "synonyms": [
        "ASP 1929",
        "ASP-1929",
        "ASP1929",
        "CETUXIMAB SAROTALOCAN",
        "Cet-IR700",
        "Cetuximab Sarotalocan",
        "Cetuximab-IR700 Conjugate RM-1929",
        "RM-1929"
      ]
    },
    {
      "fdaUniiCode": "05J61265PX",
      "id": "Fursultiamine",
      "preferredName": "Fursultiamine",
      "synonyms": [
        "FURSULTIAMINE",
        "Formamide, N-((4-amino-2-methyl-5-pyrimidinyl)methyl)-N-(4-hydroxy-1-methyl-2-(((tetrahydro-2-furanyl)methyl)dithio)-1-butenyl)-",
        "Fursultiamine",
        "TTFD",
        "Thiamine Tetrahydrofurfuryl Disulfide"
      ]
    },
    {
      "fdaUniiCode": "0ICW2LX8AS",
      "id": "Bemcentinib",
      "preferredName": "Bemcentinib",
      "synonyms": [
        "1H-1,2,4-Triazole-3,5-diamine, 1-(6,7-Dihydro-5H-benzo(6,7)cyclohepta(1,2-C)pyridazin-3-yl)-N3-((7S)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5H-benzocyclohepten-2-yl)-",
        "AXL Inhibitor BGB324",
        "BEMCENTINIB",
        "BGB 324",
        "BGB-324",
        "BGB324",
        "Bemcentinib",
        "R-428",
        "R428",
        "WHO 10631"
      ]
    },
    {
      "fdaUniiCode": "APS3IS9D6W",
      "id": "Ivuxolimab",
      "preferredName": "Ivuxolimab",
      "synonyms": [
        "Anti-OX40 Agonist Monoclonal Antibody PF-04518600",
        "IVUXOLIMAB",
        "Ivuxolimab",
        "PF-04518600",
        "PF-8600",
        "PF04518600"
      ]
    },
    {
      "fdaUniiCode": "NS3988A2TC",
      "id": "Selonsertib",
      "preferredName": "Selonsertib",
      "synonyms": [
        "GS-4997",
        "SELONSERTIB",
        "Selonsertib"
      ]
    },
    {
      "fdaUniiCode": "LYJ1AEJ9YH",
      "id": "Camidanlumab_Tesirine",
      "preferredName": "Camidanlumab Tesirine",
      "synonyms": [
        "ADC ADCT-301",
        "ADCT-301",
        "CAMIDANLUMAB TESIRINE",
        "Camidanlumab Tesirine"
      ]
    },
    {
      "fdaUniiCode": "T4467YT1NT",
      "id": "Xanthohumol",
      "preferredName": "Xanthohumol",
      "synonyms": [
        "3'-[3,3-Dimethyl allyl]-2',4',4-trihydroxy-6'-methoxychalcone",
        "XANTHOHUMOL",
        "Xanthohumol"
      ]
    },
    {
      "fdaUniiCode": "62GA3K28B6",
      "id": "Atamestane",
      "preferredName": "Atamestane",
      "synonyms": [
        "ATAMESTANE",
        "Atamestane",
        "atamestane"
      ]
    },
    {
      "fdaUniiCode": "J545GSE96Y",
      "id": "Duvortuxizumab",
      "preferredName": "Duvortuxizumab",
      "synonyms": [
        "CD19 x CD3 DART Protein JNJ-64052781",
        "DUVORTUXIZUMAB",
        "Duvortuxizumab",
        "JNJ-64052781",
        "MGD011",
        "RES192M1.2",
        "hBU12(2.4)-hXR32-MP3 M1.2"
      ]
    },
    {
      "fdaUniiCode": "V7I58RC5EJ",
      "id": "Monomethyl_Auristatin_E",
      "preferredName": "Monomethyl Auristatin E",
      "synonyms": [
        "(S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamide",
        "L-Valinamide, N-methyl-L-valyl-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-hydroxy-1- methyl-2-phenylethyl)amino)-1-methoxy-2-methyl-3-oxopropyl)-1-pyrrolidinyl)-2- methoxy-1-((1S)-1-methylpropyl)-4-oxobutyl)-N-methyl-",
        "MMAE",
        "MONOMETHYL AURISTATIN E",
        "Monomethyl Auristatin E",
        "Monomethylauristatin E",
        "N(sup 2)-(N-methyl-L-valyl)-N(sup 1)-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-hydroxy-1-methyl-2- phenylethyl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-2-methoxy-1-((1S)-1-methylpropyl)-4-oxobutyl)-N(sup 1)-methyl-L-valinamide"
      ]
    },
    {
      "fdaUniiCode": "URS0374MIV",
      "id": "Ripertamab",
      "preferredName": "Ripertamab",
      "synonyms": [
        "Anti-CD20 Monoclonal Antibody SCT400",
        "RIPERTAMAB",
        "Ripertamab",
        "SCT400"
      ]
    },
    {
      "fdaUniiCode": "OI8P0SFD4R",
      "id": "Ieramilimab",
      "preferredName": "Ieramilimab",
      "synonyms": [
        "IERAMILIMAB",
        "IMP-701",
        "Ieramilimab",
        "LAG 525",
        "LAG525"
      ]
    },
    {
      "fdaUniiCode": "6XQ9TM3U2G",
      "id": "Azintuxizumab_Vedotin",
      "preferredName": "Azintuxizumab Vedotin",
      "synonyms": [
        "ABBV-838",
        "ADC ABBV-838",
        "AZINTUXIZUMAB VEDOTIN",
        "Azintuxizumab Vedotin"
      ]
    },
    {
      "fdaUniiCode": "LB090AB8DB",
      "id": "Anti-CD37_Monoclonal_Antibody_BI_836826",
      "preferredName": "Anti-CD37 Monoclonal Antibody BI 836826",
      "synonyms": [
        "Anti-CD37 Monoclonal Antibody BI 836826",
        "BI 836826",
        "BI-836826",
        "MAb 37.1"
      ]
    },
    {
      "fdaUniiCode": "DA9P7LN909",
      "id": "Selective_Estrogen_Receptor_Degrader_AZD9496",
      "preferredName": "Selective Estrogen Receptor Degrader AZD9496",
      "synonyms": [
        "(E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid",
        "AZD 9496",
        "AZD-9496",
        "AZD9496",
        "SERD AZD9496",
        "Selective Estrogen Receptor Degrader AZD9496"
      ]
    },
    {
      "fdaUniiCode": "VD026R6TCI",
      "id": "Rosmantuzumab",
      "preferredName": "Rosmantuzumab",
      "synonyms": [
        "OMP-131R10",
        "ROSMANTUZUMAB",
        "Rosmantuzumab"
      ]
    },
    {
      "fdaUniiCode": "1F01P3Y61E",
      "id": "Spirogermanium",
      "preferredName": "Spirogermanium",
      "synonyms": [
        "2-[3-(Dimethyl-amino)propyl]-8,8-diethyl-2-aza-8-germaspiro[4,5]decane",
        "8,8-Diethyl-N,N-dimethyl-3-aza-8-germaspiro[4,5]decane-2-propanamine",
        "S 99 A",
        "SPG",
        "SPIROGERMANIUM",
        "Spiro 32",
        "Spiro-32",
        "Spirogermanium",
        "Spirogermanium Compound",
        "Spirogermanium compound"
      ]
    },
    {
      "fdaUniiCode": "G9F0G3YL28",
      "id": "Anti-ICOS_Monoclonal_Antibody_MEDI-570",
      "preferredName": "Anti-ICOS Monoclonal Antibody MEDI-570",
      "synonyms": [
        "Anti-ICOS Monoclonal Antibody MEDI-570",
        "MEDI-570"
      ]
    },
    {
      "fdaUniiCode": "U6072DO9XG",
      "id": "Trilaciclib",
      "preferredName": "Trilaciclib",
      "synonyms": [
        "2'-((5-(4-Methylpiperazin-1-yl)pyridin-2-yl)amino)-7',8'-dihydro-6'H-spiro(cyclohexane-1,9'-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one",
        "G1T28",
        "Spiro(cyclohexane-1,9'(6'H)-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one, 7',8'-dihydro-2'-((5-(4-methyl-1-piperazinyl)-2-pyridinyl)amino)-",
        "TRILACICLIB",
        "Trilaciclib"
      ]
    },
    {
      "fdaUniiCode": "J3HB83X76Z",
      "id": "Spiromustine",
      "preferredName": "Spiromustine",
      "synonyms": [
        "1,3-diazaspiro(4,5)decane-2,4-dione,3-(2-(bis-chloroethyl)amino)ethyl",
        "SHM",
        "SPIROMUSTINE",
        "Spirohydantoin Mustard",
        "Spirohydantoin mustard",
        "Spiromustine"
      ]
    },
    {
      "fdaUniiCode": "6Z4B5PJ4OP",
      "id": "Eluvixtamab",
      "preferredName": "Eluvixtamab",
      "synonyms": [
        "AMG 330",
        "AMG330",
        "Anti-CD33/CD3 BiTE Antibody AMG 330",
        "BiTE Antibody AMG 330",
        "Bispecific T-cell Engager Antibody AMG 330",
        "CD33/CD3-directed Bispecific T-cell Engager Antibody AMG 330",
        "ELUVIXTAMAB",
        "Eluvixtamab"
      ]
    },
    {
      "fdaUniiCode": "H2V318W7LE",
      "id": "Spiroplatin",
      "preferredName": "Spiroplatin",
      "synonyms": [
        "Cis-1,1-diamino-methylcyclohexane sulfato-platinum",
        "Platinum, (1,1-cyclohexanedimethanamine-n,n')(sulfato(2-)-O,O')-, (sp-4-2)-",
        "SPIROPLATIN",
        "Spiroplatin",
        "TNO-6"
      ]
    },
    {
      "fdaUniiCode": "H88EPA0A3N",
      "id": "Staurosporine",
      "preferredName": "Staurosporine",
      "synonyms": [
        "(9alpha,10beta,11beta,13alpha)-(+)-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H-9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one",
        "8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)-, (8alpha,9beta,10beta,12alpha)-(+)-",
        "AM-2282",
        "Antibiotic 230",
        "Antibiotic AM 2282",
        "CGP-39360",
        "STAUROSPORINE",
        "Staurosporine",
        "staurosporine"
      ]
    },
    {
      "fdaUniiCode": "JEA93WJ5DG",
      "id": "Sotigalimab",
      "preferredName": "Sotigalimab",
      "synonyms": [
        "APX 005",
        "APX 005M",
        "APX-005M",
        "APX005M",
        "CD40 Agonistic Monoclonal Antibody APX005M",
        "EPI-0050",
        "SOTIGALIMAB",
        "Sotigalimab"
      ]
    },
    {
      "fdaUniiCode": "88928BS57E",
      "id": "Mosedipimod",
      "preferredName": "Mosedipimod",
      "synonyms": [
        "1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol",
        "9,12-Octadecadienoic acid (9Z,12Z)-, 1-((Acetyloxy)methyl)-2-((1-oxohexadecyl)oxy)ethyl Ester",
        "EC-18",
        "MOSEDIPIMOD",
        "Mosedipimod"
      ]
    },
    {
      "fdaUniiCode": "5R78837D4A",
      "id": "Strontium_Chloride_Sr-89",
      "preferredName": "Strontium Chloride Sr-89",
      "synonyms": [
        "Metastron",
        "STRONTIUM CHLORIDE SR-89",
        "Strontium Chloride Sr-89",
        "strontium chloride Sr 89"
      ]
    },
    {
      "fdaUniiCode": "73096E137E",
      "id": "Camrelizumab",
      "preferredName": "Camrelizumab",
      "synonyms": [
        "AiRuiKa (TM)",
        "CAMRELIZUMAB",
        "Camrelizumab",
        "Carrizumab",
        "HR-301210",
        "SHR 1210",
        "SHR-1210",
        "SHR1210"
      ]
    },
    {
      "fdaUniiCode": "2X2DNM7NGX",
      "id": "Foslinanib",
      "preferredName": "Foslinanib",
      "synonyms": [
        "4(1H)-Quinolinone, 2-(3-Fluorophenyl)-6-methoxy-5-(phosphonooxy)-",
        "CVM 1118",
        "CVM-1118",
        "CVM1118",
        "FOSLINANIB",
        "Foslinanib",
        "TRX 818",
        "TRX-818",
        "TRX818",
        "WHO 10721"
      ]
    },
    {
      "fdaUniiCode": "5Q7R99CKV2",
      "id": "Fisogatinib",
      "preferredName": "Fisogatinib",
      "synonyms": [
        "2-Propenamide, N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl)amino)tetrahydro-2H-pyran-4-yl)-",
        "BLU 554",
        "BLU-554",
        "BLU554",
        "CS 3008",
        "CS-3008",
        "CS3008",
        "FISOGATINIB",
        "Fibroblast Growth Factor Receptor 4 Inhibitor BLU-554",
        "Fisogatinib",
        "N-((3S,4S)-3-((6-(2,6-Dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)oxan-4-yl)prop-2-enamide"
      ]
    },
    {
      "fdaUniiCode": "513P80B4YJ",
      "id": "Avapritinib",
      "preferredName": "Avapritinib",
      "synonyms": [
        "(S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1Hpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-yl)pyrimidin-5-yl)ethan-1-amine",
        "AVAPRITINIB",
        "AYVAKIT",
        "Avapritinib",
        "BLU-285",
        "CS3007",
        "PDGFR alpha/KIT Mutant-specific Inhibitor BLU-285"
      ]
    },
    {
      "fdaUniiCode": "249EAP69MT",
      "id": "Cofetuzumab_Pelidotin",
      "preferredName": "Cofetuzumab Pelidotin",
      "synonyms": [
        "ADC PF-06647020",
        "ADC PF-7020",
        "COFETUZUMAB PELIDOTIN",
        "Cofetuzumab Pelidotin",
        "Immunoglobulin G1, Anti-(human protein tyrosine kinase 7) (humanized Mus musculus clone hu24 gamma-chain), Disulfide with humanized Mus musculus clone hu24 kappa-chain, Dimer, Thioether with N-(((4-((N-(6-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl)-L-valyl-N5-(aminocarbonyl)-L-ornithyl)amino)phenyl)methoxy)carbonyl)-2-methylalanyl-N-((1S,2R)-2-methoxy-4-((2S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((1S)-2-phenyl-1-(2-thiazolyl)ethyl)amino)propyl)-1-pyrrolidinyl)-1-((1S)-1-methylpropyl)-4-oxobutyl)-N-methyl-L-valinamide",
        "PF 06647020",
        "PF 7020",
        "PF-06647020",
        "PF-7020",
        "PF06647020",
        "h6M24-vc0101"
      ]
    },
    {
      "fdaUniiCode": "GP2L3N7FIM",
      "id": "Anti-FGFR3_Antibody-drug_Conjugate_LY3076226",
      "preferredName": "Anti-FGFR3 Antibody-drug Conjugate LY3076226",
      "synonyms": [
        "ADC LY3076226",
        "Anti-FGFR3 ADC LY3076226",
        "Anti-FGFR3 Antibody-drug Conjugate LY3076226",
        "Anti-fibroblast Growth Factor Receptor 3 Antibody-Drug Conjugate LY3076226",
        "LY-3076226",
        "LY3076226"
      ]
    },
    {
      "fdaUniiCode": "5FJL6W0640",
      "id": "Cabiralizumab",
      "preferredName": "Cabiralizumab",
      "synonyms": [
        "Anti-CSF1R FPA008",
        "BMS-986227",
        "CABIRALIZUMAB",
        "Cabiralizumab",
        "FPA 008",
        "FPA-008",
        "FPA008"
      ]
    },
    {
      "fdaUniiCode": "KKC12PIF16",
      "id": "Trodusquemine",
      "preferredName": "Trodusquemine",
      "synonyms": [
        "(24R)-3beta-((3-((4-((3-aminopropyl)amino)butyl)amino)propyl)amino)-7alpha-hydroxy-5alpha-cholestan-24-yl Hydrogen Sulfate",
        "Cholestane-7,24-diol, 3-((3-((4-((3-aminopropyl)amino)butyl)amino)propyl)amino)-, 24-(Hydrogen Sulfate), (3beta,5alpha,7alpha,24R)-",
        "MSI-1436",
        "MSI-1436C",
        "TRODUSQUEMINE",
        "Trodusquemine"
      ]
    },
    {
      "fdaUniiCode": "K619IIG2R9",
      "id": "Exisulind",
      "preferredName": "Exisulind",
      "synonyms": [
        "(Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfonyl)phenyl]methylene]-1H-indene-3-acetic Acid",
        "1H-Indene-3-acetic Acid, 5-Fluoro-2-methyl-1-((4-(methylsulfonyl)phenyl)methylene), (Z)",
        "Aptosyn",
        "EXISULIND",
        "Exisulind",
        "FGN-1",
        "Sulindac Sulfone",
        "Sulindac sulfone",
        "exisulind"
      ]
    },
    {
      "fdaUniiCode": "YET2XNU791",
      "id": "Fadraciclib",
      "preferredName": "Fadraciclib",
      "synonyms": [
        "CYC065",
        "Cyclin Dependent Kinase Inhibitor 2/5/9 CYC065",
        "FADRACICLIB",
        "Fadraciclib"
      ]
    },
    {
      "fdaUniiCode": "2LHZ9ZC3YO",
      "id": "Tolinapant",
      "preferredName": "Tolinapant",
      "synonyms": [
        "ASTX 660",
        "ASTX660",
        "TOLINAPANT",
        "Tolinapant",
        "XIAP/cIAP1 Antagonist ASTX660"
      ]
    },
    {
      "fdaUniiCode": "5CRY01URYQ",
      "id": "Oleclumab",
      "preferredName": "Oleclumab",
      "synonyms": [
        "Anti-CD73 Monoclonal Antibody MEDI9447",
        "MEDI9447",
        "OLECLUMAB",
        "Oleclumab"
      ]
    },
    {
      "fdaUniiCode": "N7FO1V18PR",
      "id": "Anti-CD20_Monoclonal_Antibody-Interferon-alpha_Fusion_Protein_IGN002",
      "preferredName": "Anti-CD20 Monoclonal Antibody-Interferon-alpha Fusion Protein IGN002",
      "synonyms": [
        "Anti-CD20 Monoclonal Antibody-IFN-a Fusion Protein IGN002",
        "Anti-CD20 Monoclonal Antibody-Interferon-alpha Fusion Protein IGN002",
        "IGN-002",
        "IGN002"
      ]
    },
    {
      "fdaUniiCode": "NL06848HBQ",
      "id": "Anti-PR1HLA-A2_Monoclonal_Antibody_Hu8F4",
      "preferredName": "Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4",
      "synonyms": [
        "Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4",
        "HU8F4",
        "Hu8F4"
      ]
    },
    {
      "fdaUniiCode": "8Z28M5SX0X",
      "id": "Zandelisib",
      "preferredName": "Zandelisib",
      "synonyms": [
        "ME 401",
        "ME-401",
        "PI3K-delta Inhibitor PWT143",
        "PWT-143",
        "PWT143",
        "ZANDELISIB",
        "Zandelisib"
      ]
    },
    {
      "fdaUniiCode": "H2CDQ1PWN7",
      "id": "Audencel",
      "preferredName": "Audencel",
      "synonyms": [
        "AUDENCEL",
        "AV0113",
        "AV0113 DC-CIT",
        "AV0113 Dendritic Cell Cancer Immunotherapeutic",
        "Audencel",
        "Autologous DC-based Immunotherapeutic AV0113"
      ]
    },
    {
      "fdaUniiCode": "PA05MFH3I7",
      "id": "8-Chloroadenosine",
      "preferredName": "8-Chloroadenosine",
      "synonyms": [
        "8-CHLOROADENOSINE",
        "8-Chloro-adenosine",
        "8-Chloroadenosine",
        "8-Cl-Ado",
        "8-Cl-adenosine",
        "Adenosine, 8-Chloro-"
      ]
    },
    {
      "fdaUniiCode": "LZZ0IC2EWP",
      "id": "Sasanlimab",
      "preferredName": "Sasanlimab",
      "synonyms": [
        "Anti-PD-1 PF-06801591",
        "PF-06801591",
        "SASANLIMAB",
        "Sasanlimab",
        "WHO 11161"
      ]
    },
    {
      "fdaUniiCode": "9XW757O13D",
      "id": "Ripretinib",
      "preferredName": "Ripretinib",
      "synonyms": [
        "1-N'-[2,5-difluoro-4-[2-(1-methylpyrazol-4-yl)pyridin-4-yl]oxyphenyl]-1-N'-phenylcyclopropane-1,1-dicarboxamide",
        "DCC-2618",
        "DCC2618",
        "KIT/PDGFR Inhibitor DCC-2618",
        "Qinlock",
        "RIPRETINIB",
        "Ripretinib"
      ]
    },
    {
      "fdaUniiCode": "J9F5ZPH7NB",
      "id": "Grapiprant",
      "preferredName": "Grapiprant",
      "synonyms": [
        "AAT-007",
        "AT-001",
        "CJ 023,423",
        "CJ-023,423",
        "CJ023,423",
        "GRAPIPRANT",
        "Grapiprant",
        "N-[[2,4-(2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenylethylamino]carbonyl]-4-methyl-benzenesulfonamide",
        "RQ-00000007",
        "RQ-07"
      ]
    },
    {
      "fdaUniiCode": "GM0RU5SU0E",
      "id": "Tamrintamab_Pamozirine",
      "preferredName": "Tamrintamab Pamozirine",
      "synonyms": [
        "ADC SC-003",
        "Immunoglobulin G1(226-serine), Anti-(Human Dipeptidase 3)(Human-mus musculus Monoclonal sc34.28SS1 Gamma1-chain), Compd. with Human-mus musculus Monoclonal sc34.28SS1 Kappa-chain, Dimer, Bis(thioether) with N-(6-(3-mercapto-2, 5-dioxo-1-pyrrolidinyl)-1",
        "SC 003",
        "SC-003",
        "SC003",
        "TAMRINTAMAB PAMOZIRINE",
        "Tamrintamab Pamozirine"
      ]
    },
    {
      "fdaUniiCode": "SY5HF6N5MB",
      "id": "Samrotamab_Vedotin",
      "preferredName": "Samrotamab Vedotin",
      "synonyms": [
        "ABBV-085",
        "ADC ABBV-085",
        "PR-1498487 PAB-MMAE",
        "SAMROTAMAB VEDOTIN",
        "Samrotamab Vedotin"
      ]
    },
    {
      "fdaUniiCode": "3JKW7CI9IU",
      "id": "Cobomarsen",
      "preferredName": "Cobomarsen",
      "synonyms": [
        "COBOMARSEN",
        "Cobomarsen",
        "MRG-106"
      ]
    },
    {
      "fdaUniiCode": "0237X8153Q",
      "id": "Uzansertib",
      "preferredName": "Uzansertib",
      "synonyms": [
        "INCB 053914",
        "INCB053914",
        "INCB53914",
        "Pan-PIM Inhibitor INCB053914",
        "Pan-PIM Kinase Inhibitor INCB053914",
        "UZANSERTIB",
        "Uzansertib"
      ]
    },
    {
      "fdaUniiCode": "N0YWS8X3S9",
      "id": "Anti-IL-8_Monoclonal_Antibody_BMS-986253",
      "preferredName": "Anti-IL-8 Monoclonal Antibody BMS-986253",
      "synonyms": [
        "Anti-IL-8 Monoclonal Antibody BMS-986253",
        "BMS 986253",
        "BMS-986253",
        "BMS986253",
        "HUMAX-IL8",
        "HuMax-IL-8",
        "HuMax-IL8",
        "MDX 018",
        "MDX-018"
      ]
    },
    {
      "fdaUniiCode": "NW9K8C1JN3",
      "id": "Bintrafusp_Alfa",
      "preferredName": "Bintrafusp Alfa",
      "synonyms": [
        "Anti-PD-L1/TGFbetaRII Fusion Protein M7824",
        "Anti-PDL1/TGFb Trap MSB0011359C",
        "BINTRAFUSP ALFA",
        "Bintrafusp Alfa",
        "M7824",
        "MSB0011359C"
      ]
    },
    {
      "fdaUniiCode": "YF1K15M17Y",
      "id": "Temozolomide",
      "preferredName": "Temozolomide",
      "synonyms": [
        "3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide",
        "8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one",
        "CCRG-81045",
        "Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-",
        "M & B 39831",
        "M and B 39831",
        "Methazolastone",
        "RP-46161",
        "SCH 52365",
        "TEMOZOLOMIDE",
        "TMZ",
        "Temcad",
        "Temodal",
        "Temodar",
        "Temomedac",
        "Temozolomide",
        "imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-",
        "temozolomide"
      ]
    },
    {
      "fdaUniiCode": "16598XQ2BT",
      "id": "Telratolimod",
      "preferredName": "Telratolimod",
      "synonyms": [
        "3M 052",
        "3M-052",
        "MEDI 9197",
        "MEDI-9197",
        "MEDI9197",
        "TELRATOLIMOD",
        "TLR7/TLR8 Dual Agonist MEDI9197",
        "Telratolimod",
        "Toll-like Receptor 7/8 Agonist MEDI9197"
      ]
    },
    {
      "fdaUniiCode": "L10K286T2H",
      "id": "Ralaniten_Acetate",
      "preferredName": "Ralaniten Acetate",
      "synonyms": [
        "1,2-Propanediol, 3-(4-(1-(4-((2S)-2-(acetyloxy)-3-chloropropoxy)phenyl)-1-methylethyl)phenoxy)-, 1,2-Diacetate, (2S)-",
        "AR Inhibitor EPI-506",
        "EPI-506",
        "RALANITEN ACETATE",
        "Ralaniten Acetate"
      ]
    },
    {
      "fdaUniiCode": "CT69TVL1KE",
      "id": "Anti-OX40_Monoclonal_Antibody_GSK3174998",
      "preferredName": "Anti-OX40 Monoclonal Antibody GSK3174998",
      "synonyms": [
        "Anti-OX40 Monoclonal Antibody GSK3174998",
        "GSK-3174998",
        "GSK3174998"
      ]
    },
    {
      "fdaUniiCode": "E0YF0M8O09",
      "id": "Darovasertib",
      "preferredName": "Darovasertib",
      "synonyms": [
        "DAROVASERTIB",
        "Darovasertib",
        "IDE 196",
        "IDE-196",
        "IDE196",
        "LXS196",
        "PKC Inhibitor IDE196",
        "Protein Kinase C Inhibitor IDE196",
        "Protein Kinase C Inhibitor LXS196"
      ]
    },
    {
      "fdaUniiCode": "S2EGO8116S",
      "id": "Pemlimogene_Merolisbac",
      "preferredName": "Pemlimogene Merolisbac",
      "synonyms": [
        "ADU-214",
        "JNJ-64041757",
        "LADD Listeria monocytogenes JNJ-64041757",
        "PEMLIMOGENE MEROLISBAC",
        "Pemlimogene Merolisbac"
      ]
    },
    {
      "fdaUniiCode": "3L7R886Y06",
      "id": "Sabatolimab",
      "preferredName": "Sabatolimab",
      "synonyms": [
        "Anti-TIM-3 Monoclonal Antibody MBG453",
        "Anti-TIM3 Checkpoint Inhibitor MBG453",
        "MBG 453",
        "MBG453",
        "SABATOLIMAB",
        "Sabatolimab"
      ]
    },
    {
      "fdaUniiCode": "CAX3X53UL6",
      "id": "Lutetium_Lu_177_Satoreotide_Tetraxetan",
      "preferredName": "Lutetium Lu 177 Satoreotide Tetraxetan",
      "synonyms": [
        "177Lu-DOTA-Cpa-c[d-Cys-Aph(Hor)-d-Aph(Cbm)-Lys-Thr-Cys]-d-Tyr-NH2",
        "177Lu-DOTA-JR11",
        "177Lu-DOTA-[Cpa-c(DCys-Aph(Hor)-DAph(Cbm)-Lys-Thr-Cys)-DTyr-NH2]",
        "Lu-177 OPS-201",
        "Lutetium Lu 177 Satoreotide Tetraxetan",
        "SATOREOTIDE TETRAXETAN LUTETIUM-177",
        "SOMther",
        "Satoreotide Tetraxetan Lutetium-177"
      ]
    },
    {
      "fdaUniiCode": "S3OPE9IA3Q",
      "id": "pan_FGFR_Inhibitor_PRN1371",
      "preferredName": "pan FGFR Inhibitor PRN1371",
      "synonyms": [
        "FGFR 1-4 Inhibitor PRN1371",
        "PRN 1371",
        "PRN-1371 FREE BASE",
        "PRN1371",
        "Pan-FGFR Tyrosine Kinase Inhibitor PRN1371",
        "pan FGFR Inhibitor PRN1371"
      ]
    },
    {
      "fdaUniiCode": "0JSR7Z0NB6",
      "id": "Amivantamab",
      "preferredName": "Amivantamab",
      "synonyms": [
        "AMIVANTAMAB",
        "Amivantamab",
        "Amivantamab-vmjw",
        "Anti-EGFR/c-Met Bispecific Antibody JNJ-61186372",
        "CNTO-4424",
        "JNJ-611",
        "JNJ-61186372",
        "JNJ61186372",
        "Rybrevant"
      ]
    },
    {
      "fdaUniiCode": "8762XZS5ZF",
      "id": "Lifirafenib",
      "preferredName": "Lifirafenib",
      "synonyms": [
        "BGB 283",
        "BGB-283",
        "Begeine-283",
        "LIFIRAFENIB",
        "Lifirafenib"
      ]
    },
    {
      "fdaUniiCode": "N8O7MY0VNS",
      "id": "Lacutamab",
      "preferredName": "Lacutamab",
      "synonyms": [
        "Anti-KIR3DL2 Monoclonal Antibody IPH4102",
        "Anti-KIR3DL2 mAb IPH4102",
        "IPH-4102",
        "IPH4102",
        "LACUTAMAB",
        "Lacutamab"
      ]
    },
    {
      "fdaUniiCode": "SFK1SGY8V1",
      "id": "Ormaplatin",
      "preferredName": "Ormaplatin",
      "synonyms": [
        "ORMAPLATIN",
        "Ormaplatin",
        "Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, (OC-6-22-(trans))-",
        "Tetraplatin",
        "tetrachloro(1,2-cyclohexanediamine-N,N')-, (OC-6-22-(trans))Platinum"
      ]
    },
    {
      "fdaUniiCode": "15JL80DG6H",
      "id": "Naporafenib",
      "preferredName": "Naporafenib",
      "synonyms": [
        "LXH 254",
        "LXH-254",
        "LXH254",
        "NAPORAFENIB",
        "Naporafenib",
        "Raf Family Kinase Inhibitor LXH254",
        "pan-RAF Inhibitor LXH254",
        "pan-RAF Kinase Inhibitor LXH254"
      ]
    },
    {
      "fdaUniiCode": "U2H19X4WBV",
      "id": "Tomivosertib",
      "preferredName": "Tomivosertib",
      "synonyms": [
        "EFT-508",
        "Spiro(cyclohexane-1,3'(2'H)-imidazo(1,5-a)pyridine)-1',5'-dione, 6'-((6-Amino-4-pyrimidinyl)amino)-8'-methyl-",
        "TOMIVOSERTIB",
        "Tomivosertib",
        "eFT508"
      ]
    },
    {
      "fdaUniiCode": "I6CNU8SY0F",
      "id": "Tilsotolimod_Sodium",
      "preferredName": "Tilsotolimod Sodium",
      "synonyms": [
        "IMO 2125",
        "IMO-2125",
        "TILSOTOLIMOD SODIUM",
        "TLR9 Agonist IMO-2125",
        "Tilsotolimod Sodium"
      ]
    },
    {
      "fdaUniiCode": "IE4X6497XK",
      "id": "Lenzilumab",
      "preferredName": "Lenzilumab",
      "synonyms": [
        "Immunoglobulin G1-kappa, Anti-(Homo sapiens CSF2 (Colony Stimulating Factor 2 (Granulocyte-Macrophage), Granulocyte Macrophage Colony Stimulating Factor, GM-CSF)), Homo sapiens Monoclonal Antibody",
        "KB 003",
        "KB003",
        "LENZILUMAB",
        "Lenzilumab"
      ]
    },
    {
      "fdaUniiCode": "4YV4KW88GD",
      "id": "Pegzilarginase",
      "preferredName": "Pegzilarginase",
      "synonyms": [
        "AEB-1102",
        "AEB1102",
        "Co-ArgI-PEG",
        "PEGZILARGINASE",
        "Pegylated Recombinant Arginase AEB1102",
        "Pegzilarginase"
      ]
    },
    {
      "fdaUniiCode": "7K2YOJ14X0",
      "id": "Lisocabtagene_Maraleucel",
      "preferredName": "Lisocabtagene Maraleucel",
      "synonyms": [
        "Anti-CD19-CAR Genetically Engineered Autologous T Lymphocytes JCAR017",
        "Anti-CD19-CAR Genetically Engineered Autologous T-lymphocytes JCAR017",
        "Autologous Anti-CD19-EGFRt-4-1BB-zeta-modified CAR CD8+ and CD4+ T-lymphocytes JCAR017",
        "Breyanzi",
        "JCAR 017",
        "JCAR017",
        "LISOCABTAGENE MARALEUCEL",
        "Lisocabtagene Maraleucel"
      ]
    },
    {
      "fdaUniiCode": "Q59IQJ9NTK",
      "id": "Eltanexor",
      "preferredName": "Eltanexor",
      "synonyms": [
        "(2E)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-2-(pyrimidin-5-yl)prop-2-enamide",
        "ATG 016",
        "ATG-016",
        "ATG016",
        "ELTANEXOR",
        "Eltanexor",
        "Exportin 1 Inhibitor KPT-8602",
        "KPT-8602",
        "Selective Inhibitor of Nuclear Export KPT-8602",
        "XPO1-inhibiting SINE Compound KPT-8602"
      ]
    },
    {
      "fdaUniiCode": "ULJ82834RE",
      "id": "Tiazofurin",
      "preferredName": "Tiazofurin",
      "synonyms": [
        "2-.beta.-D-Ribofuranosyl-4-thiazolecarboxamide",
        "2-.beta.-D-Ribofuranosylthiazole-4-carboxamide",
        "2-Beta-D-ribofuranosyl-4-thiazolecarboxamide",
        "2-Beta-D-ribofuranosylthiazole-4-carboxamide",
        "4-Thiazolecarboxamide, 2-.beta.-D-ribofuranosyl- (9CI)",
        "4-Thiazolecarboxamide, 2-Beta-D-ribofuranosyl- (9CI)",
        "Riboxamide",
        "TCAR",
        "TIAZOFURIN",
        "Tiazofurin",
        "Tiazofurine",
        "tiazofurin"
      ]
    },
    {
      "fdaUniiCode": "FOF5155FMZ",
      "id": "Eganelisib",
      "preferredName": "Eganelisib",
      "synonyms": [
        "EGANELISIB",
        "Eganelisib",
        "IPI 549",
        "IPI-549"
      ]
    },
    {
      "fdaUniiCode": "6FY6EI1X8R",
      "id": "Emactuzumab",
      "preferredName": "Emactuzumab",
      "synonyms": [
        "EMACTUZUMAB",
        "Emactuzumab",
        "RG-7155",
        "RG7155",
        "RO-5509554",
        "RO5509554"
      ]
    },
    {
      "fdaUniiCode": "7K5O7P6QIU",
      "id": "Loncastuximab_Tesirine",
      "preferredName": "Loncastuximab Tesirine",
      "synonyms": [
        "ADC ADCT-402",
        "ADCT-402",
        "Anti-CD19 PBD-conjugate ADCT-402",
        "LONCASTUXIMAB TESIRINE",
        "Loncastuximab Tesirine",
        "Loncastuximab Tesirine-lpyl",
        "Zynlonta"
      ]
    },
    {
      "fdaUniiCode": "7NFE54O27T",
      "id": "Toremifene",
      "preferredName": "Toremifene",
      "synonyms": [
        "(Z)-2-[4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine",
        "(Z)-4-Chloro-1,2-diphenyl-1[4-[2-(N,N-dimethylamino)ethoxy]phenyl]-1-butene",
        "Farestone",
        "TOREMIFENE",
        "Toremifene",
        "toremifene"
      ]
    },
    {
      "fdaUniiCode": "2GWZ8HN70W",
      "id": "P-cadherin-targeting_Agent_PF-06671008",
      "preferredName": "P-cadherin-targeting Agent PF-06671008",
      "synonyms": [
        "P-cadherin-targeting Agent PF-06671008",
        "PF-06671008"
      ]
    },
    {
      "fdaUniiCode": "DF2O3JG5D2",
      "id": "Anti-c-KIT_Monoclonal_Antibody_CDX_0158",
      "preferredName": "Anti-c-KIT Monoclonal Antibody CDX 0158",
      "synonyms": [
        "Anti-c-KIT Monoclonal Antibody CDX 0158",
        "Anti-c-KIT Monoclonal Antibody KTN0158",
        "CDX 0158",
        "CDX-0158",
        "CDX0158",
        "KTN 0158",
        "KTN-0158",
        "KTN0158"
      ]
    },
    {
      "fdaUniiCode": "2O95SM11L5",
      "id": "Opolimogene_Capmilisbac",
      "preferredName": "Opolimogene Capmilisbac",
      "synonyms": [
        "ADU-741",
        "JNJ-64041809",
        "JNJ-809",
        "OPOLIMOGENE CAPMILISBAC",
        "Opolimogene Capmilisbac"
      ]
    },
    {
      "fdaUniiCode": "8KFO2187CP",
      "id": "Ciforadenant",
      "preferredName": "Ciforadenant",
      "synonyms": [
        "3H-1,2,3-Triazolo(4,5-d)pyrimidin-5-amine, 7-(5-Methyl-2-furanyl)-3-((6-((((3S)-tetrahydro-3-furanyl)oxy)methyl)-2-pyridinyl)methyl)-",
        "Adenosine-A2A Receptor-Targeting Agent CPI-444",
        "CIFORADENANT",
        "CPI-444",
        "Ciforadenant",
        "V81444"
      ]
    },
    {
      "fdaUniiCode": "CO61ER3EPI",
      "id": "Treosulfan",
      "preferredName": "Treosulfan",
      "synonyms": [
        "(S-(R*,R*))-1,2,3,4-butanetetrol,1,4-dimethanesulfonate",
        "1,2,3, 4-Butanetetrol, 1,4-dimethanesulfonate, [R-(R*,S*)]-",
        "Dihydroxybusulfan",
        "L-Threitol 1,4-dimethanesulfonate",
        "Ovastat",
        "TREOSULFAN",
        "Trecondi",
        "Treosulfan",
        "Treosulphan",
        "Tresulfon",
        "treosulfan"
      ]
    },
    {
      "fdaUniiCode": "YE6R3UY9IV",
      "id": "Anti-CD33_Antibody-drug_Conjugate_IMGN779",
      "preferredName": "Anti-CD33 Antibody-drug Conjugate IMGN779",
      "synonyms": [
        "ADC IMGN779",
        "Anti-CD33 ADC IMGN779",
        "Anti-CD33 Antibody-drug Conjugate IMGN779",
        "IMGN-779",
        "IMGN779"
      ]
    },
    {
      "fdaUniiCode": "Q8A4U1Z9N2",
      "id": "Ontorpacept",
      "preferredName": "Ontorpacept",
      "synonyms": [
        "ONTORPACEPT",
        "Ontorpacept",
        "SIRPa-Fc Fusion Protein TTI-621",
        "SIRPaFc",
        "TTI 621",
        "TTI-621"
      ]
    },
    {
      "fdaUniiCode": "W758F1L9ND",
      "id": "BRD4_Inhibitor_PLX51107",
      "preferredName": "BRD4 Inhibitor PLX51107",
      "synonyms": [
        "BRD4 Inhibitor PLX51107",
        "PLX 51107",
        "PLX-51107",
        "PLX51107"
      ]
    },
    {
      "fdaUniiCode": "DD99Y262WC",
      "id": "Triazinate",
      "preferredName": "Triazinate",
      "synonyms": [
        "BAF",
        "Baker's Antifol",
        "Baker's Antifol soluble",
        "Baker's Antifolate",
        "Bakers Antifol",
        "Bakers Antifolate",
        "Benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4, 6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI)",
        "Ethanesulfonic Acid Compound",
        "Ethanesulfonic acid, compd. with 3-chloro-4-[4-[2-chloro-4-(4, 6-diamino-2, 2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI)",
        "Ethanesulfonic acid, compd. with 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2, 2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride",
        "Ethanesulfonic acid, compd. with 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3, 5-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (9CI)",
        "Soluble Baker's Antifol",
        "TRIAZINATE",
        "TZT",
        "Triazinate",
        "alpha-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-trizin-1(2H)-yl)phenoxy)-N,N-dimethyl-m-toluamide ethanesulfonic acid",
        "benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4, 6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI)",
        "ethanesulfonic acid compound with 3-((2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy)methyl)-N,N-dimethylben zamide (1:1)",
        "ethanesulfonic acid, compd. with 3-chloro-4-[4-[2-chloro-4-(4, 6-diamino-2, 2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1)(8CI)",
        "ethanesulfonic acid, compd. with 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2, 2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride",
        "ethanesulfonic acid, compd. with 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3, 5-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1)(9CI)"
      ]
    },
    {
      "fdaUniiCode": "5ZHA5P4PFX",
      "id": "Dalpiciclib",
      "preferredName": "Dalpiciclib",
      "synonyms": [
        "CDK4/6 Inhibitor SHR6390",
        "DALPICICLIB",
        "Dalpiciclib",
        "SHR-6390",
        "SHR6390"
      ]
    },
    {
      "fdaUniiCode": "KEX1QY18OH",
      "id": "Anti-CA19-9_Monoclonal_Antibody_5B1",
      "preferredName": "Anti-CA19-9 Monoclonal Antibody 5B1",
      "synonyms": [
        "5B1",
        "Anti-CA19-9 Monoclonal Antibody 5B1",
        "HuMab 5B1",
        "HuMab-5B1",
        "MVT-5873"
      ]
    },
    {
      "fdaUniiCode": "FMW9ZVF53N",
      "id": "STING-activating_Cyclic_Dinucleotide_Agonist_MIW815",
      "preferredName": "STING-activating Cyclic Dinucleotide Agonist MIW815",
      "synonyms": [
        "ADU-S100",
        "CDN Agonist ADU-S100",
        "MIW815",
        "STING-activating Cyclic Dinucleotide Agonist MIW815"
      ]
    },
    {
      "fdaUniiCode": "FN12T66RMN",
      "id": "CD24_Extracellular_Domain-IgG1_Fc_Domain_Recombinant_Fusion_Protein_CD24Fc",
      "preferredName": "CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc",
      "synonyms": [
        "CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc",
        "CD24FC",
        "CD24Fc",
        "CD24Fc CD24IgG",
        "MK-7110"
      ]
    },
    {
      "fdaUniiCode": "S05LZ624MF",
      "id": "Tributyrin",
      "preferredName": "Tributyrin",
      "synonyms": [
        "1,2,3-Propanetriyl Butanoate",
        "1,2,3-Tributyrylglycerol",
        "Butanoic Acid 1,2,3-Propanetriyl Ester",
        "Butanoic Acid, 1,2,3-Propanetriyl Ester",
        "Butyryl Triglyceride",
        "Glyceryl Tributyrate",
        "Glyceryl tributyrate",
        "TB",
        "TRIBUTYRIN",
        "Tributyrin",
        "tributyrin"
      ]
    },
    {
      "fdaUniiCode": "KLF1HS0SXJ",
      "id": "Scopoletin",
      "preferredName": "Scopoletin",
      "synonyms": [
        "2H-1-Benzopyran-2-One, 7-Hydroxy-6-Methoxy-",
        "2H-1-Benzopyran-2-One, 7-Hydroxy-6-Methoxy- (9CI)",
        "6-Methoxyumbelliferone",
        "6-Methylesculetin",
        "6-O-Methylesculetin",
        "7-Hydroxy-5-Methoxycoumarin",
        "7-Hydroxy-6-Methoxychromen-2-One",
        "7-Hydroxy-6-Methoxycoumarin",
        "Chrysatropic Acid",
        "Coumarin, 7-Hydroxy-6-Methoxy-",
        "Escopoletin",
        "Esculetin-6-Methyl Ether",
        "Gelseminic Acid",
        "Methylesculetin",
        "Murrayetin",
        "SCOPOLETIN",
        "Scopoletin",
        "Scopoletine",
        "Scopoletol"
      ]
    },
    {
      "fdaUniiCode": "29DKI2H2NY",
      "id": "Tinostamustine",
      "preferredName": "Tinostamustine",
      "synonyms": [
        "1H-Benzimidazole-2-heptanamide, 5-(Bis(2-chloroethyl)amino)-N-hydroxy-1-methyl-",
        "7-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)-N-hydroxyheptanamide",
        "EDO-S 101",
        "EDO-S-101",
        "EDO-S101",
        "TINOSTAMUSTINE",
        "Tinostamustine"
      ]
    },
    {
      "fdaUniiCode": "FE7L22H028",
      "id": "Zalifrelimab",
      "preferredName": "Zalifrelimab",
      "synonyms": [
        "AGEN-1884",
        "AGEN1884",
        "Anti-CTLA-4 Monoclonal Antibody AGEN1884",
        "ZALIFRELIMAB",
        "Zalifrelimab"
      ]
    },
    {
      "fdaUniiCode": "5L5GE3DV88",
      "id": "Triciribine_Phosphate",
      "preferredName": "Triciribine Phosphate",
      "synonyms": [
        "1, 5-Dihydro-5-methyl-1-(5-O-phosphono-.beta.-D-ribofuranosyl)-1,4,5, 6,8-pentaazaacenaphthylen-3-amine",
        "1, 5-dihydro-5-methyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1,4,5, 6,8-pentaazaacenaphthylen-3-amine",
        "1,4, 5,6,8-Pentaazaacenaphthylen-3-amine, 1, 5-dihydro-5-methyl-1-(5-O-phosphono-.beta.-D-ribofuranosyl)- (9CI)",
        "1,4, 5,6,8-pentaazaacenaphthylen-3-amine, 1, 5-dihydro-5-methyl-1-(5-O-phosphono-beta-D-ribofuranosyl)- (9CI)",
        "1,4,5,6, 8-Pentaazaacenaphthalen-3-amine, 1, 5-dihydro-5-methyl-1-(5-O-phosphono-.beta.-D-ribofuranosyl)-",
        "1,4,5,6, 8-pentaazaacenaphthalen-3-amine, 1, 5-dihydro-5-methyl-1-(5-O-phosphono-beta-D-ribofuranosyl)",
        "3-Amino-1, 5-dihydro-5-methyl-1-.beta.-D-ribofuranosyl-1,4,5,6, 8-pentaazaacenaphthylene 5'-(dihydrogen phosphate)",
        "3-amino-1, 5-dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6, 8-pentaazaacenaphthylene 5'-(dihydrogen phosphate)",
        "TCN",
        "TRICIRIBINE PHOSPHATE",
        "Triciribine",
        "Triciribine Phosphate",
        "Tricyclic Nucleoside 5'-Phosphate",
        "Tricycloside Phosphate"
      ]
    },
    {
      "fdaUniiCode": "TWF0ML1CK8",
      "id": "Fluzoparib",
      "preferredName": "Fluzoparib",
      "synonyms": [
        "4-((3-((5,6-Dihydro-2-(trifluoromethyl)(1,2,4)triazolo(1,5-a)pyrazin-7(8H)-yl)carbonyl)-4-fluorophenyl)methyl)-1(2H)-phthalazinone",
        "FLUZOPARIB",
        "Fluzoparib",
        "SHR-3162",
        "SHR3162"
      ]
    },
    {
      "fdaUniiCode": "ZAM3L34SEW",
      "id": "Anti-HER2_Antibody-drug_Conjugate_MEDI4276",
      "preferredName": "Anti-HER2 Antibody-drug Conjugate MEDI4276",
      "synonyms": [
        "ADC MEDI4276",
        "Anti-HER2 Antibody-drug Conjugate MEDI4276",
        "MEDI-4276",
        "MEDI4276"
      ]
    },
    {
      "fdaUniiCode": "333BVY614O",
      "id": "Trimethylcolchicinic_Acid",
      "preferredName": "Trimethylcolchicinic Acid",
      "synonyms": [
        "Colchicinic Acid, Trimethyl-",
        "Desacetyl Colchicine D-tartrate",
        "Desacetylcholchiceine",
        "N-Deacetylcolchiceine",
        "SKF 284",
        "TMCA",
        "TRIMETHYLCOLCHICINIC ACID",
        "Trimethylcolchicinic Acid",
        "Trimethylcolchicinic Acid Methyl Ether d-tartrate",
        "Trimethylcolchicinic acid"
      ]
    },
    {
      "fdaUniiCode": "L137U4A79K",
      "id": "Trimetrexate_Glucuronate",
      "preferredName": "Trimetrexate Glucuronate",
      "synonyms": [
        "2,4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline mono-D-glucuronate",
        "Neutrexin",
        "TMTX",
        "TRIMETREXATE GLUCURONATE",
        "Trimetrexate Glucuronate",
        "trimetrexate glucuronate"
      ]
    },
    {
      "fdaUniiCode": "R0130F043H",
      "id": "Trioxifene",
      "preferredName": "Trioxifene",
      "synonyms": [
        "(3,4-Dihydro-2-(4-methoxyphenyl)-1-naphthalenyl)(4-(2-(1-pyrrolidinyl)ethoxy)phenyl) Methanone",
        "TRIOXIFENE",
        "Trioxifene"
      ]
    },
    {
      "fdaUniiCode": "3QBL0BLP3D",
      "id": "Alobresib",
      "preferredName": "Alobresib",
      "synonyms": [
        "(2-Cyclopropyl-6-(3,5-dimethyl-1,2-oxazol-4-yl)-1hbenzimidazol-4-yl)(dipyridin-2-yl)methanol",
        "ALOBRESIB",
        "Alobresib",
        "GS 5829",
        "GS-5829",
        "GS5829"
      ]
    },
    {
      "fdaUniiCode": "LST350G3XU",
      "id": "Simurosertib",
      "preferredName": "Simurosertib",
      "synonyms": [
        "Cell Division Cycle 7 Inhibitor TAK-931",
        "SIMUROSERTIB",
        "Simurosertib",
        "TAK 931",
        "TAK-931",
        "Thieno(3,2-d)pyrimidin-4(3H)-one, 2-(2S)-1-Azabicyclo(2.2.2)oct-2-yl-6-(3-methyl-1H-pyrazol-4-yl)-"
      ]
    },
    {
      "fdaUniiCode": "O440IW9NHN",
      "id": "Ragifilimab",
      "preferredName": "Ragifilimab",
      "synonyms": [
        "Anti-GITR Agonistic Monoclonal Antibody INCAGN01876",
        "INCAGN 01876",
        "INCAGN 1876",
        "INCAGN-1876",
        "INCAGN01876",
        "RAGIFILIMAB",
        "Ragifilimab"
      ]
    },
    {
      "fdaUniiCode": "IS7N1X9TSW",
      "id": "Anti-VEGFANG2_Nanobody_BI_836880",
      "preferredName": "Anti-VEGF/ANG2 Nanobody BI 836880",
      "synonyms": [
        "Anti-VEGF/ANG2 BI 836880",
        "Anti-VEGF/ANG2 Nanobody BI 836880",
        "BI 836880",
        "BI-836880",
        "Bi-specific Anti-VEGF/Ang2 Nanobody BI 836880"
      ]
    },
    {
      "fdaUniiCode": "0G9LGB5O2W",
      "id": "Mavorixafor",
      "preferredName": "Mavorixafor",
      "synonyms": [
        "(S)-N1-((1H-benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine",
        "AMD-070",
        "AMD-11070",
        "AMD11070",
        "MAVORIXAFOR",
        "Mavorixafor",
        "X4P 001",
        "X4P-001",
        "X4P001"
      ]
    },
    {
      "fdaUniiCode": "15KFN616FK",
      "id": "Rineterkib",
      "preferredName": "Rineterkib",
      "synonyms": [
        "ERK Inhibitor LTT462",
        "LTT 462",
        "LTT462",
        "RINETERKIB",
        "Rineterkib"
      ]
    },
    {
      "fdaUniiCode": "267H8I71ZT",
      "id": "BCG_Tokyo-172_Strain_Solution",
      "preferredName": "BCG Tokyo-172 Strain Solution",
      "synonyms": [
        "BACILLUS CALMETTE-GUERIN SUBSTRAIN TOKYO 172-1 LIVE ANTIGEN",
        "BCG Tokyo-172 Strain Solution",
        "BCG Tokyo-172 Strain Vaccine",
        "Bacillus Calmette-Guerin Tokyo-172 Strain Solution",
        "Immunobladder"
      ]
    },
    {
      "fdaUniiCode": "9081Y98W2V",
      "id": "Triptorelin",
      "preferredName": "Triptorelin",
      "synonyms": [
        "6-D-Tryptophan-LH-RH",
        "6-D-Tryptophanluteinizing Hormone-releasing Factor",
        "AY-25650",
        "CL-118,532",
        "Detryptoreline",
        "TRIPTORELIN",
        "Triptorelin",
        "triptorelin"
      ]
    },
    {
      "fdaUniiCode": "39HBQ4A67L",
      "id": "Mobocertinib",
      "preferredName": "Mobocertinib",
      "synonyms": [
        "AP 32788",
        "AP-32788",
        "AP32788",
        "EGFR/HER2 Inhibitor TAK-788",
        "MOBOCERTINIB",
        "Mobocertinib",
        "TAK 788",
        "TAK-788",
        "TAK788"
      ]
    },
    {
      "fdaUniiCode": "1Z701W789S",
      "id": "26-Dimethoxyquinone",
      "preferredName": "2,6-Dimethoxyquinone",
      "synonyms": [
        "2,5-Cyclohexadiene-1,4-Dione, 2,6-Dimethoxy-",
        "2,5-Cyclohexadiene-1,4-Dione, 2,6-Dimethoxy- (9CI)",
        "2,6-DIMETHOXYQUINONE",
        "2,6-DMBQ",
        "2,6-Dimethoxy-1,4-Benzoquinone",
        "2,6-Dimethoxy-p-Benzoquinone",
        "2,6-Dimethoxy-p-Quinone",
        "2,6-Dimethoxybenzoquinone",
        "2,6-Dimethoxycyclohexa-2,5-Diene-1,4-Dione",
        "2,6-Dimethoxyquinone",
        "p-Benzoquinone, 2,6-Dimethoxy-"
      ]
    },
    {
      "fdaUniiCode": "3R4C5YLB9I",
      "id": "Pidnarulex",
      "preferredName": "Pidnarulex",
      "synonyms": [
        "2-(4-Methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",
        "2-(4-Methyl-1,4-diazepan-1-yl)-N-[(5-methylpyrazin-2-yl)methyl]-5-oxo-[1,3]benzothiazolo[3,2-a][1,8]naphthyridine-6-carboxamide",
        "5H-Benzothiazolo[3,2-a][1,8]naphthyridine-6-carboxamide, 2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-N-[(5-methyl-2-pyrazinyl)methyl]-5-oxo-",
        "CX-5461",
        "CX5461",
        "PIDNARULEX",
        "Pidnarulex",
        "Pol I Inhibitor CX5461",
        "RNA Pol I Inhibitor CX5461"
      ]
    },
    {
      "fdaUniiCode": "P0GVQ9A4S5",
      "id": "Dostarlimab",
      "preferredName": "Dostarlimab",
      "synonyms": [
        "ANB011",
        "DOSTARLIMAB",
        "Dostarlimab",
        "Dostarlimab-gxly",
        "Immunoglobulin G4, Anti-programmed Cell Death Protein 1 (PDCD1) (Humanized Clone ABT1 Gamma4-chain), Disulfide with Humanized Clone ABT1 Kappa-chain, Dimer",
        "Jemperli",
        "TSR 042",
        "TSR-042",
        "TSR042"
      ]
    },
    {
      "fdaUniiCode": "H64JRU6GJ0",
      "id": "Trofosfamide",
      "preferredName": "Trofosfamide",
      "synonyms": [
        "2-[bis(2-chloroethyl)amino]-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxaphosphorine 2-oxide",
        "2H-1,3,2-Oxazaphosphorin-2-amine, N,N, 3-tris(2-chloroethyl)tetrahydro-, 2-oxide, (+)-",
        "2H-1,3,2-Oxazaphosphorin-2-amine, N,N, 3-tris(2-chloroethyl)tetrahydro-, 2-oxide, (-)-",
        "A-4828",
        "Genoxal Trofosfamida",
        "Ixoten",
        "N,N,3-tris(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide",
        "N,N,N'-tris(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide",
        "TROFOSFAMIDE",
        "Trilophosphamide",
        "Trofosfamid",
        "Trofosfamide",
        "Trophosphamide",
        "Z 4828",
        "Z-4828"
      ]
    },
    {
      "fdaUniiCode": "OUP4QB2A3R",
      "id": "Feladilimab",
      "preferredName": "Feladilimab",
      "synonyms": [
        "Anti-ICOS Agonist Antibody GSK3359609",
        "FELADILIMAB",
        "Feladilimab",
        "GSK3359609"
      ]
    },
    {
      "fdaUniiCode": "EJ48MR05C3",
      "id": "Ordesekimab",
      "preferredName": "Ordesekimab",
      "synonyms": [
        "AMG 714",
        "AMG714",
        "Anti-IL-15 Monoclonal Antibody AMG 714",
        "HUMAX-IL 15",
        "HuMab-IL15 AMG 714",
        "ORDESEKIMAB",
        "Ordesekimab"
      ]
    },
    {
      "fdaUniiCode": "ISP4442I3Y",
      "id": "Baricitinib",
      "preferredName": "Baricitinib",
      "synonyms": [
        "3-Azetidineacetonitrile, 1-(Ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)-",
        "BARICITINIB",
        "Baricitinib",
        "INCB 028050",
        "INCB028050",
        "LY 3009104",
        "LY3009104",
        "Olumiant"
      ]
    },
    {
      "fdaUniiCode": "7BU5H4V94A",
      "id": "7-Hydroxystaurosporine",
      "preferredName": "7-Hydroxystaurosporine",
      "synonyms": [
        "(+)-UCN-01",
        "2,3,9,10,11,12-Hexahydro-3-hydroxy-9-methoxy-8-methyl-10-(methylamino)-8,12-epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)triinden-1-one",
        "7-HYDROXYSTAUROSPORINE",
        "7-Hydroxy-staurosporine",
        "7-Hydroxystaurosporine",
        "8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo[a, g]cyclonona[cde] Trinden-1-one, 2,3,9,10,11, 12-hexahydro-3-hydroxy-9-methoxy-8-methyl-10-(methylamino)",
        "UCN-01"
      ]
    },
    {
      "fdaUniiCode": "60RD0234VE",
      "id": "Valemetostat",
      "preferredName": "Valemetostat",
      "synonyms": [
        "DS 3201",
        "DS-3201",
        "DS3201",
        "VALEMETOSTAT",
        "Valemetostat"
      ]
    },
    {
      "fdaUniiCode": "14D65TV20J",
      "id": "Dubermatinib",
      "preferredName": "Dubermatinib",
      "synonyms": [
        "2-((5-Chloro-2-((4-((4-methylpiperazin-1-yl)methyl)phenyl)amino)pyrimidin-4-yl)amino)-N,N-dimethylbenzenesulfonamide",
        "DUBERMATINIB",
        "Dubermatinib",
        "TP 0903",
        "TP-0903",
        "TP0903"
      ]
    },
    {
      "fdaUniiCode": "JD56EJA59S",
      "id": "Vibecotamab",
      "preferredName": "Vibecotamab",
      "synonyms": [
        "Anti-CD123/Anti-CD3 Bispecific Antibody XmAb14045",
        "VIBECOTAMAB",
        "Vibecotamab",
        "XmAb14045"
      ]
    },
    {
      "fdaUniiCode": "1UI8F5IIZ4",
      "id": "Onvatilimab",
      "preferredName": "Onvatilimab",
      "synonyms": [
        "Immunoglobulin G1, Anti-(Human Protein Vista (v-domain Immunoglobulin Suppressor of T Cell Activation)) (Human Clone JNJ 61610588 gamma1-chain), Disulfide with Human Clone JNJ",
        "JNJ 61610588",
        "JNJ-61610588",
        "ONVATILIMAB",
        "Onvatilimab",
        "WHO 10758"
      ]
    },
    {
      "fdaUniiCode": "W3375J6V0Y",
      "id": "Vinepidine",
      "preferredName": "Vinepidine",
      "synonyms": [
        "4'-Deoxyepivincristine",
        "VINEPIDINE",
        "Vinepidine"
      ]
    },
    {
      "fdaUniiCode": "Q6C979R91Y",
      "id": "Vinorelbine",
      "preferredName": "Vinorelbine",
      "synonyms": [
        "3',4'-Didehydro-4'-deoxy-C'-norvincaleukoblastine",
        "5'-Nor-Anhydrovinblastine",
        "Dihydroxydeoxynorvinkaleukoblastine",
        "VINORELBINE",
        "Vinorelbine",
        "nor-5'-Anhydrovinblastine",
        "vinorelbine"
      ]
    },
    {
      "fdaUniiCode": "533U947V6Q",
      "id": "Vinzolidine",
      "preferredName": "Vinzolidine",
      "synonyms": [
        "2H-3,7-Methanoazacycloundecino(5,4-b)indole-9-carboxylic acid, 9-((2-beta,3-beta,4-beta,5-alpha,12-beta,19-alpha)-4-(acetyloxy)-3'-(2-chloroethyl)-6,7-didehydro-16-methoxy-1-methyl-2',4'-dioxospiro(aspidospermidine-3,5'-oxazolidin)-15-yl)-5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-, methyl ester, (3R-(3R*,5S*,7R*,9S*))-",
        "VINZOLIDINE",
        "Vinzolidine"
      ]
    },
    {
      "fdaUniiCode": "97W7N9T08G",
      "id": "Tapotoclax",
      "preferredName": "Tapotoclax",
      "synonyms": [
        "AMG 176",
        "TAPOTOCLAX",
        "Tapotoclax"
      ]
    },
    {
      "fdaUniiCode": "2158753C7E",
      "id": "Relacorilant",
      "preferredName": "Relacorilant",
      "synonyms": [
        "((4aR)-1-(4-Fluorophenyl)-6-(1-methyl-1H-pyrazole-4-sulfonyl)-1,4,5,6,7,8-hexahydro-4aH-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone",
        "CORT-125134",
        "CORT125134",
        "Methanone, ((4aR)-1-(4-Fluorophenyl)-1,4,5,6,7,8-hexahydro-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4aH-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)-",
        "RELACORILANT",
        "Relacorilant"
      ]
    },
    {
      "fdaUniiCode": "5DY91Y7601",
      "id": "Pingyangmycin",
      "preferredName": "Pingyangmycin",
      "synonyms": [
        "BLEOMYCIN A5",
        "Bleomycetin",
        "Bleomycin A5",
        "N1-(3-((4-Aminobutyl)amino)propyl)bleomycinamide",
        "Pingyangmycin",
        "Zhengguangmycin A5"
      ]
    },
    {
      "fdaUniiCode": "29BY7HQV0T",
      "id": "Topoisomerase-1_Inhibitor_LMP744",
      "preferredName": "Topoisomerase-1 Inhibitor LMP744",
      "synonyms": [
        "5H-(1,3)Dioxolo(5,6)indeno(1,2-C)isoquinoline-5,12(6H)-dione, 6-(3-((2-Hydroxyethyl)amino)propyl)-2,3-dimethoxy-",
        "Indenoisoquinoline LMP744",
        "LMP-744",
        "LMP744",
        "Topoisomerase-1 Inhibitor LMP744"
      ]
    },
    {
      "fdaUniiCode": "P9XVH8H2HF",
      "id": "Anti-OX40_Antibody_BMS_986178",
      "preferredName": "Anti-OX40 Antibody BMS 986178",
      "synonyms": [
        "Anti-OX40 Antibody BMS 986178",
        "BMS 986178",
        "BMS-986178"
      ]
    },
    {
      "fdaUniiCode": "WYJ05POC5C",
      "id": "Anti-GITR_Monoclonal_Antibody_GWN_323",
      "preferredName": "Anti-GITR Monoclonal Antibody GWN 323",
      "synonyms": [
        "Anti-GITR Monoclonal Antibody GWN 323",
        "GWN 323",
        "GWN-323",
        "GWN323"
      ]
    },
    {
      "fdaUniiCode": "L2S469LM49",
      "id": "Defactinib_Hydrochloride",
      "preferredName": "Defactinib Hydrochloride",
      "synonyms": [
        "Benzamide, N-methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)-2-pyrazinyl)methyl)amino)-5-(trifluoromethyl)-2-pyrimidinyl)amino)-, Hydrochloride (1:1)",
        "DEFACTINIB HYDROCHLORIDE",
        "Defactinib Hydrochloride",
        "PF-04554878",
        "VS-6063"
      ]
    },
    {
      "fdaUniiCode": "1DKC476797",
      "id": "Brostacillin_Hydrochloride",
      "preferredName": "Brostacillin Hydrochloride",
      "synonyms": [
        "4-(2-Bromoacrylamido)-N'''-(2-guanidinoethyl)-1,1',1',1'''-tetramethyl-N,4':N',4':N',4'''-quater(pyrrole-2-carboxamide) Hydrochloride",
        "BROSTALLICIN HYDROCHLORIDE",
        "Brostacillin Hydrochloride",
        "PNU-166196 Hydrochloride",
        "brostallicin hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "B6DC89I63E",
      "id": "Dabrafenib_Mesylate",
      "preferredName": "Dabrafenib Mesylate",
      "synonyms": [
        "DABRAFENIB MESYLATE",
        "Dabrafenib Mesylate",
        "Dabrafenib Methanesulfonate",
        "GSK2118436 Methane Sulfonate Salt",
        "GSK2118436B",
        "Tafinlar"
      ]
    },
    {
      "fdaUniiCode": "7ZX1Q9SJ1F",
      "id": "Nemvaleukin_Alfa",
      "preferredName": "Nemvaleukin Alfa",
      "synonyms": [
        "ALKS 4230",
        "Intermediate-affinity IL-2R Agonist ALKS 4230",
        "Intermediate-affinity Interleukin-2 Receptor Agonist ALKS 4230",
        "NEMVALEUKIN ALFA",
        "Nemvaleukin Alfa",
        "RDB 1450",
        "RDB-1450"
      ]
    },
    {
      "fdaUniiCode": "NR4MAD6PPB",
      "id": "Lodapolimab",
      "preferredName": "Lodapolimab",
      "synonyms": [
        "Anti-PD-L1 Checkpoint Antibody LY3300054",
        "Anti-PD-L1 Monoclonal Antibody LY3300054",
        "Anti-Programmed Cell Death Ligand 1 Checkpoint Antibody LY3300054",
        "LODAPOLIMAB",
        "LY3300054",
        "Lodapolimab",
        "WHO 11185"
      ]
    },
    {
      "fdaUniiCode": "BG3F62OND5",
      "id": "Carboplatin",
      "preferredName": "Carboplatin",
      "synonyms": [
        "(SP-4-2)-diammine[1,1-cyclobutanedicarboxylato(2--)-O,O']platinum",
        "1,1-cyclobutanedicarboxylic acid platinum complex",
        "Blastocarb",
        "CARBOPLATIN",
        "CBDCA",
        "Carboplat",
        "Carboplatin",
        "Carboplatin Hexal",
        "Carboplatino",
        "Carboplatinum",
        "Carbosin",
        "Carbosol",
        "Carbotec",
        "Cis-Diammine(cyclobutane-1,1-dicarboxylato)platinum",
        "Displata",
        "Ercar",
        "JM-8",
        "Nealorin",
        "Novoplatinum",
        "Paraplat",
        "Paraplatin",
        "Paraplatin AQ",
        "Paraplatine",
        "Platinwas",
        "Ribocarbo",
        "carboplatin",
        "cis-diammine(1,1-cyclobutanedicarboxylato) platinum(II)",
        "cis-diammine(cyclobutanedicarboxylato)platinum II",
        "platinum, diammine(1,1-cyclobutanedicarboxylato(2-))-, (SP-4-2)"
      ]
    },
    {
      "fdaUniiCode": "3K5H4TX2KP",
      "id": "Cobolimab",
      "preferredName": "Cobolimab",
      "synonyms": [
        "Anti-TIM3 Checkpoint Inhibitor TSR-022",
        "Anti-TIM3 Monoclonal Antibody TSR-022",
        "COBOLIMAB",
        "Cobolimab",
        "Immunoglobulin G4, Anti-(Hepatitis A Virus Cellular Receptor 2 (havcr2)) (Humanized Clone ABT2 Gamma4-chain), Disulfide with Humanized Clone ABT2 Kappa-chain, Dimer",
        "TSR-022"
      ]
    },
    {
      "fdaUniiCode": "H5669VNZ7V",
      "id": "mTOR_Kinase_Inhibitor_PP242",
      "preferredName": "mTOR Kinase Inhibitor PP242",
      "synonyms": [
        "2-(4-Amino-1-isopropyl-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-1H-indol-5-ol",
        "PP-242",
        "PP242",
        "mTOR Kinase Inhibitor PP242"
      ]
    },
    {
      "fdaUniiCode": "S276568KOY",
      "id": "Gadopiclenol",
      "preferredName": "Gadopiclenol",
      "synonyms": [
        "(alpha3,alpha6,alpha9-Tris(3-((2,3-dihydroxypropyl)amino)-3-oxopropyl)-3,6,9,15-tetraazabicyclo(9.3.1)pentadeca-1(15),11,13-triene-3,6,9-triacetato(3-)-kappaN3,kappaN6,kappaN9,kappaN15,kappaO3,kappaO6,kappaO9)gadolinium",
        "GADOPICLENOL",
        "GBCA P03277",
        "Gadolinium-based Magnetic Resonance Contrast Agent P03277",
        "Gadopiclenol",
        "P 03277",
        "P03277",
        "WHO 10744"
      ]
    },
    {
      "fdaUniiCode": "5384HK7574",
      "id": "Trastuzumab_Deruxtecan",
      "preferredName": "Trastuzumab Deruxtecan",
      "synonyms": [
        "DS-8201",
        "DS-8201a",
        "Enhertu",
        "Fam-trastuzumab Deruxtecan-nxki",
        "TRASTUZUMAB DERUXTECAN",
        "Trastuzumab Deruxtecan",
        "WHO 10516"
      ]
    },
    {
      "fdaUniiCode": "9WS5RD66HZ",
      "id": "Simeprevir",
      "preferredName": "Simeprevir",
      "synonyms": [
        "HSDB 8227",
        "N-(17-(2-(4-isopropylthiazole-2-yl)-7-methoxy-8-methylquinolin-4-yloxy)-13-methyl-2,14-dioxo-3,13-diazatricyclo(13.3.0.04,6)octadec-7-ene-4-carbonyl)(cyclopropyl)sulfonamide",
        "Olysio",
        "SIMEPREVIR",
        "Simeprevir",
        "TMC 435",
        "TMC-435",
        "TMC435"
      ]
    },
    {
      "fdaUniiCode": "8V66F27X44",
      "id": "Iberdomide",
      "preferredName": "Iberdomide",
      "synonyms": [
        "(S)-3-(4-((4-(Morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione",
        "CC 220",
        "CC-220",
        "IBERDOMIDE",
        "Iberdomide"
      ]
    },
    {
      "fdaUniiCode": "3FO6689MSD",
      "id": "Tesidolumab",
      "preferredName": "Tesidolumab",
      "synonyms": [
        "LFG-316",
        "LFG316",
        "NOV-4",
        "TESIDOLUMAB",
        "Tesidolumab"
      ]
    },
    {
      "fdaUniiCode": "F9670LP52I",
      "id": "Baltaleucel-T",
      "preferredName": "Baltaleucel-T",
      "synonyms": [
        "BALTALEUCEL-T",
        "Baltaleucel T",
        "Baltaleucel-T",
        "CMD-003",
        "Epstein Barr Virus-specific LMP1/LMP2/EBNABARF1-targeting Autologous Cytotoxic T-lymphocytes"
      ]
    },
    {
      "fdaUniiCode": "FL08SGO9XA",
      "id": "Simlukafusp_Alfa",
      "preferredName": "Simlukafusp Alfa",
      "synonyms": [
        "Anti-FAP/Interleukin-2 Fusion Protein RO6874281",
        "FAP-IL2v FP RO6874281",
        "FAP-IL2v RO6874281",
        "RG 7461",
        "RG-7461",
        "RG7461",
        "RO 6874281",
        "RO-6874281",
        "RO6874281",
        "SIMLUKAFUSP ALFA",
        "Simlukafusp Alfa",
        "aFAP-IL2v RO6874281"
      ]
    },
    {
      "fdaUniiCode": "O3Y80ZF13F",
      "id": "Thymopentin",
      "preferredName": "Thymopentin",
      "synonyms": [
        "Immunox",
        "Mepentil",
        "N-(N-(N-(N(2)-L-Arginyl-L-Lysyl)-L-alpha-Aspartyl)-L-Valyl)-L-Tyrosine",
        "N-[N-[N-(N{2}-L-Arginyl-L-lysyl)-L-alpha-aspartyl]-L-valyl]-L-tyrosine",
        "ORF-15244",
        "Sintomodulina",
        "THYMOPENTIN",
        "Thymopentin",
        "Timunox"
      ]
    },
    {
      "fdaUniiCode": "GJV1PP34M2",
      "id": "Antibody-drug_Conjugate_Anti-TIM-1-vcMMAE_CDX-014",
      "preferredName": "Antibody-drug Conjugate Anti-TIM-1-vcMMAE CDX-014",
      "synonyms": [
        "ADC Anti-TIM-1-vcMMAE CDX-014",
        "ADC CDX-014",
        "Antibody-drug Conjugate Anti-TIM-1-vcMMAE CDX-014",
        "Antibody-drug Conjugate CDX-014",
        "CDX-014",
        "CR014-vc-MMAE",
        "CR014-vcMMAE"
      ]
    },
    {
      "fdaUniiCode": "66226JUH2I",
      "id": "Onalespib_Lactate",
      "preferredName": "Onalespib Lactate",
      "synonyms": [
        "AT-13387 Lactate",
        "ATI-13387A",
        "ATI-13387AU",
        "ONALESPIB LACTATE",
        "Onalespib Lactate",
        "Propanoic Acid, 2-Hydroxy-, (2S)-, Compound with (1,3-Dihydro-5-((4-methyl-1-piperazinyl)methyl)-2H-isoindol-2-yl)(2,4-dihydroxy-5-(1-methylethyl)phenyl)methanone (1:1)"
      ]
    },
    {
      "fdaUniiCode": "LYK98WP91F",
      "id": "Cetrelimab",
      "preferredName": "Cetrelimab",
      "synonyms": [
        "CETRELIMAB",
        "Cetrelimab",
        "JNJ 63723283",
        "JNJ-63723283",
        "JNJ63723283",
        "WHO 10757"
      ]
    },
    {
      "fdaUniiCode": "89ATB9I3D2",
      "id": "Anti-CD123-Pyrrolobenzodiazepine_Dimer_Antibody_Drug_Conjugate_SGN-CD123A",
      "preferredName": "Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A",
      "synonyms": [
        "ADC SGN-CD123A",
        "Anti-CD123 ADC SGN-CD123A",
        "Anti-CD123-PBD ADC SGN-CD123A",
        "Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A",
        "Antibody-drug Conjugate SGN-CD123A",
        "SGN CD123A",
        "SGN-CD123A"
      ]
    },
    {
      "fdaUniiCode": "SWS48LJU3T",
      "id": "Lirentelimab",
      "preferredName": "Lirentelimab",
      "synonyms": [
        "AK 002",
        "AK002",
        "LIRENTELIMAB",
        "Lirentelimab",
        "Monoclonal Antibody AK 002"
      ]
    },
    {
      "fdaUniiCode": "7W3V82OQ0P",
      "id": "CSF-1R_Inhibitor_BLZ945",
      "preferredName": "CSF-1R Inhibitor BLZ945",
      "synonyms": [
        "4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)benzo[d]thiazol-6-yl)oxy)-N-methylpicolinamide",
        "4-[2((1R,2R)-2-Hydroxycyclohexylamino)-benzothiazol-6-yloxyl]-pyridine- 2-carboxylic Acid Methylamide",
        "BLZ 945",
        "BLZ-945",
        "BLZ945",
        "CSF-1R Inhibitor BLZ945"
      ]
    },
    {
      "fdaUniiCode": "0T4IMT8S5Z",
      "id": "Olutasidenib",
      "preferredName": "Olutasidenib",
      "synonyms": [
        "2-Pyridinecarbonitrile, 5-(((1S)-1-(6-chloro-1,2-dihydro-2-oxo-3-quinolinyl)ethyl)amino)-1,6-dihydro-1-methyl-6-oxo-",
        "FT 2102",
        "FT-2102",
        "IDH1-R132 Inhibitor FT-2102",
        "OLUTASIDENIB",
        "Olutasidenib"
      ]
    },
    {
      "fdaUniiCode": "LDJ89SS0YG",
      "id": "Mosunetuzumab",
      "preferredName": "Mosunetuzumab",
      "synonyms": [
        "Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody BTCT4465A",
        "BTCT 4465A",
        "BTCT-4465A",
        "BTCT4465A",
        "CD20/CD3 BiMAb BTCT4465A",
        "MOSUNETUZUMAB",
        "Mosunetuzumab",
        "RG 7828",
        "RG-7828",
        "RG7828",
        "RO7030816"
      ]
    },
    {
      "fdaUniiCode": "3796H63LII",
      "id": "Botanical_Agent_LEAC-102",
      "preferredName": "Botanical Agent LEAC-102",
      "synonyms": [
        "Botanical Agent LEAC-102",
        "LEAC 102",
        "LEAC-102",
        "TAIWANOFUNGUS CAMPHORATUS FRUITING BODY"
      ]
    },
    {
      "fdaUniiCode": "ES1M06M6QH",
      "id": "Envafolimab",
      "preferredName": "Envafolimab",
      "synonyms": [
        "Anti-PD-L1 MoAb KN035",
        "ENVAFOLIMAB",
        "Envafolimab",
        "KN 035",
        "KN035"
      ]
    },
    {
      "fdaUniiCode": "2WZP8A9VFN",
      "id": "Vebreltinib",
      "preferredName": "Vebreltinib",
      "synonyms": [
        "6-(1-Cyclopropyl-1h-pyrazol-4-yl)-3-(difluoro(6-fluoro-2-methyl-2H-indazol-5-yl)methyl)-1,2,4-triazolo(4,3-b)pyridazine",
        "APL-101",
        "APL101",
        "Bozitinib",
        "CBI-3103",
        "CBT-101",
        "PLB-1001",
        "PLB1001",
        "VEBRELTINIB",
        "Vebreltinib"
      ]
    },
    {
      "fdaUniiCode": "X47GR46481",
      "id": "O-Chloroacetylcarbamoylfumagillol",
      "preferredName": "O-Chloroacetylcarbamoylfumagillol",
      "synonyms": [
        "(3R,4S,5S,6R)-5-Methoxy-4- [(2R,3R)-2-methyl-3-(3-methyl-2-butenyl) -oxiranyl]-1-oxaspiro [2,5] oct-6-yl(chloroacetyl) Carbamate",
        "5-methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2,5)oct-6-yl(chloroacetyl) carbamate",
        "AGM-1470",
        "O-Chloroacetylcarbamoylfumagillol",
        "TNP-470",
        "[3R-[3alpha,4alpha(2R*,3R*),5beta,6beta]]-5-Methoxy-4-[2-methyl-3-(3-methyl-2-butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl (chloroacetyl)carbamate"
      ]
    },
    {
      "fdaUniiCode": "QXN20J93AH",
      "id": "Vopratelimab",
      "preferredName": "Vopratelimab",
      "synonyms": [
        "Anti-ICOS Agonist MAb JTX-2011",
        "Anti-ICOS Agonist Monoclonal Antibody JTX-2011",
        "ICOS Agonist Monoclonal Antibody JTX-2011",
        "JTX-2011",
        "VOPRATELIMAB",
        "Vopratelimab"
      ]
    },
    {
      "fdaUniiCode": "PGF2HXQ0D3",
      "id": "Anti-Glypican_3CD3_Bispecific_Antibody_ERY974",
      "preferredName": "Anti-Glypican 3/CD3 Bispecific Antibody ERY974",
      "synonyms": [
        "Anti-GPC3/CD3 BiAb ERY974",
        "Anti-GPC3/CD3 Bispecific Antibody ERY974",
        "Anti-Glypican 3/CD3 Bispecific Antibody ERY974",
        "ERY-974",
        "ERY974"
      ]
    },
    {
      "fdaUniiCode": "37I4D4Q7S2",
      "id": "Anti-FLT3_Antibody-drug_Conjugate_AGS62P1",
      "preferredName": "Anti-FLT3 Antibody-drug Conjugate AGS62P1",
      "synonyms": [
        "ADC AGS62P1",
        "AGS62P1",
        "Anti-FLT3 Antibody-drug Conjugate AGS62P1"
      ]
    },
    {
      "fdaUniiCode": "EI946JT51X",
      "id": "Dolastatin_10",
      "preferredName": "Dolastatin 10",
      "synonyms": [
        "B720389K560",
        "DOLASTATIN 10",
        "Dolastatin 10",
        "Dolastatin-10",
        "L-Valinamide, N,N-dimethyl-L-valyl-N-[2-methoxy-4-[2-[1- methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(2-thiazolyl)ethyl]amino]propyl]-1-pyrrolidinyl]-1-(1-methylpropyl)-4-oxobutyl]-N-methyl-, [2S-[1[1R*(R*),2S*],2R*[1S*,2S*,3(R*)]]]",
        "dolastatin 10"
      ]
    },
    {
      "fdaUniiCode": "Z20OC92TDI",
      "id": "Zanidatamab",
      "preferredName": "Zanidatamab",
      "synonyms": [
        "Anti-HER2/HER2 Bispecific Antibody ZW25",
        "HER2 x HER2 Bispecific Antibody ZW25",
        "ZANIDATAMAB",
        "ZW-25",
        "ZW25",
        "Zanidatamab"
      ]
    },
    {
      "fdaUniiCode": "QX6O64GP40",
      "id": "Proxalutamide",
      "preferredName": "Proxalutamide",
      "synonyms": [
        "GT-0918",
        "GT0918",
        "Proxalutamide"
      ]
    },
    {
      "fdaUniiCode": "5ENX424FNF",
      "id": "Plamotamab",
      "preferredName": "Plamotamab",
      "synonyms": [
        "PLAMOTAMAB",
        "Plamotamab",
        "XmAb13676"
      ]
    },
    {
      "fdaUniiCode": "PLX8T21X8G",
      "id": "Esperamicin_A1",
      "preferredName": "Esperamicin A1",
      "synonyms": [
        "ESPERAMICIN A1",
        "Esperamicin A1"
      ]
    },
    {
      "fdaUniiCode": "01KC87F8FE",
      "id": "O6-Benzylguanine",
      "preferredName": "O6-Benzylguanine",
      "synonyms": [
        "2-amino-6-(benzyloxy)purine",
        "2-amino-6-(phenylmethoxy)-9h-purine",
        "6-O-BENZYLGUANINE",
        "6-O-Benzylguanine",
        "O(6)-Benzylguanine",
        "O(6)-benzylguanine",
        "O-6-Benzylguanine",
        "O6-BG",
        "O6-Benzylguanine"
      ]
    },
    {
      "fdaUniiCode": "BNO1JG5MZC",
      "id": "Bempegaldesleukin",
      "preferredName": "Bempegaldesleukin",
      "synonyms": [
        "Aldesleukin Prodrug NKTR-214",
        "BEMPEGALDESLEUKIN",
        "Bempegaldesleukin",
        "NKTR-214"
      ]
    },
    {
      "fdaUniiCode": "ZX1I49XP7L",
      "id": "Anti-CD352_Antibody-drug_Conjugate_SGN-CD352A",
      "preferredName": "Anti-CD352 Antibody-drug Conjugate SGN-CD352A",
      "synonyms": [
        "ADC SGN-CD352A",
        "Anti-CD352 Antibody-drug Conjugate SGN-CD352A",
        "PBD Dimer ADC SGN-CD352A",
        "PBD-based Anti-CD352 ADC SGN-CD352A",
        "PBD-based Anti-CD352 Antibody-drug Conjugate SGN-CD352A",
        "SGN-CD352A"
      ]
    },
    {
      "fdaUniiCode": "41AX9SJ8KO",
      "id": "Rucaparib_Camsylate",
      "preferredName": "Rucaparib Camsylate",
      "synonyms": [
        "8-Fluoro-2-(4-((methylamino)methyl)phenyl)-1,3,4,5-tetrahydro-6H-pyrrolo(4,3,2-ef)(2)benzazepin-6-one (7,7-dimethyl-2-oxobicyclo(2.2.1)heptan-1-yl)methanesulfonate (1:1)",
        "8-Fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one ((1S,4R)-7,7dimethyl-2-oxobicyclo[2.2.1]hept-1-yl)methanesulfonic Acid Salt",
        "Bicyclo(2.2.1)heptane-1-methanesulfonic acid, 7,7-dimethyl-2-oxo-, (1S,4R)-, Compound with 8-Fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)-6H-pyrrolo(4,3,2-ef)(2)benzazepin-6-one (1:1)",
        "C0-338",
        "RUCAPARIB CAMSYLATE",
        "Rubraca",
        "Rucaparib Camsylate",
        "Rucaparib Phosphate"
      ]
    },
    {
      "fdaUniiCode": "6XG22YQM2Z",
      "id": "Tiragolumab",
      "preferredName": "Tiragolumab",
      "synonyms": [
        "MTIG7192A",
        "RG6058",
        "TIRAGOLUMAB",
        "Tiragolumab"
      ]
    },
    {
      "fdaUniiCode": "LPN433P0EA",
      "id": "Cintirorgon",
      "preferredName": "Cintirorgon",
      "synonyms": [
        "CINTIRORGON",
        "Cintirorgon",
        "LYC-55716",
        "LYC55716",
        "RORg Agonist LYC-55716"
      ]
    },
    {
      "fdaUniiCode": "OZS4TXB9VO",
      "id": "Anti-HA_Epitope_Monoclonal_Antibody_MEDI8852",
      "preferredName": "Anti-HA Epitope Monoclonal Antibody MEDI8852",
      "synonyms": [
        "Anti-HA Epitope Monoclonal Antibody MEDI8852",
        "Anti-Influenza A Hemagglutinin Epitope mAb MEDI8852",
        "MEDI 8852",
        "MEDI-8852",
        "MEDI8852",
        "pan-Influenza A mAb MEDI8852"
      ]
    },
    {
      "fdaUniiCode": "W6F4FRQ5QC",
      "id": "Pulrodemstat",
      "preferredName": "Pulrodemstat",
      "synonyms": [
        "CC 90011",
        "CC-90011",
        "CC90011",
        "LSD1 Inhibitor CC-90011",
        "Lysine-specific Demethylase 1 Inhibitor CC-90011",
        "PULRODEMSTAT",
        "Pulrodemstat"
      ]
    },
    {
      "fdaUniiCode": "8JXN261VVA",
      "id": "Toripalimab",
      "preferredName": "Toripalimab",
      "synonyms": [
        "Anti-PD-1 Monoclonal Antibody JS001",
        "JS001",
        "TAB 001",
        "TAB-001",
        "TORIPALIMAB",
        "Toripalimab"
      ]
    },
    {
      "fdaUniiCode": "V0Q46LFE6F",
      "id": "Temuterkib",
      "preferredName": "Temuterkib",
      "synonyms": [
        "ERK1/2 Inhibitor LY3214996",
        "LY 3214996",
        "LY-3214996",
        "LY3214996",
        "TEMUTERKIB",
        "Temuterkib"
      ]
    },
    {
      "fdaUniiCode": "UPN4ITI8T4",
      "id": "Trimetrexate",
      "preferredName": "Trimetrexate",
      "synonyms": [
        "2,4-Quinazolinediamine, 5-methyl-6-[[(3,4,5-trimethoxyphenyl)amino]methyl]-",
        "5-Methyl-6-[[(3,4,5-trimethoxyphenyl)amino]methyl]-2,4-quinazolinediamine",
        "CI-898",
        "TMQ",
        "TRIMETREXATE",
        "Trimetrexate",
        "Trimexate"
      ]
    },
    {
      "fdaUniiCode": "94ZE6ON35F",
      "id": "Anti-CDH6_Antibody-drug_Conjugate_HKT288",
      "preferredName": "Anti-CDH6 Antibody-drug Conjugate HKT288",
      "synonyms": [
        "Anti-CDH6 ADC HKT288",
        "Anti-CDH6 Antibody-drug Conjugate HKT288",
        "HKT 288",
        "HKT-288",
        "HKT288",
        "Maytansine-based ADC HKT-288"
      ]
    },
    {
      "fdaUniiCode": "5YL4IQ1078",
      "id": "Osilodrostat",
      "preferredName": "Osilodrostat",
      "synonyms": [
        "(R)-4-(6,7-Dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)-3-fluorobenzonitrile",
        "LCI 699",
        "LCI-699",
        "LCI699",
        "OSILODROSTAT",
        "Osilodrostat"
      ]
    },
    {
      "fdaUniiCode": "V6W1OW12H2",
      "id": "Anti-PD-L1_Monoclonal_Antibody_FAZ053",
      "preferredName": "Anti-PD-L1 Monoclonal Antibody FAZ053",
      "synonyms": [
        "Anti-PD-L1 Monoclonal Antibody FAZ053",
        "FAZ 053",
        "FAZ-053",
        "FAZ053"
      ]
    },
    {
      "fdaUniiCode": "L8993M383E",
      "id": "Nendratareotide_Uzatansine",
      "preferredName": "Nendratareotide Uzatansine",
      "synonyms": [
        "NENDRATAREOTIDE UZATANSINE",
        "Nendratareotide Uzatansine",
        "PEN 221",
        "PEN-221",
        "PEN221",
        "SSTR2-targeting Protein/DM1 Conjugate PEN-221",
        "SSTR2PEN-221"
      ]
    },
    {
      "fdaUniiCode": "7TS9C20ZWA",
      "id": "Anti-CXCR4_Monoclonal_Antibody_PF-06747143",
      "preferredName": "Anti-CXCR4 Monoclonal Antibody PF-06747143",
      "synonyms": [
        "Anti-CXCR4 IgG1 Antibody PF-06747143",
        "Anti-CXCR4 Monoclonal Antibody PF-06747143",
        "PF 06747143",
        "PF-06747143"
      ]
    },
    {
      "fdaUniiCode": "8HW4YBZ748",
      "id": "Oxidopamine",
      "preferredName": "Oxidopamine",
      "synonyms": [
        "2,4,5-Trihydroxyphenethylamine",
        "5-(2-Aminoethyl)-1,2,4-benzenetriol",
        "6-Hydroxydopamine",
        "6-OHDA",
        "OXIDOPAMINE",
        "Oxidopamine"
      ]
    },
    {
      "fdaUniiCode": "7DM27RQ9V0",
      "id": "Iodine_I_131_MIP-1095",
      "preferredName": "Iodine I 131 MIP-1095",
      "synonyms": [
        "((S)-2-(3-((S)-1-carboxy-5-(3-(4-[(131)I]iodophenyl)ureido)pentyl)ureido)pentanedioic Acid",
        "(131) I-MIP-1095",
        "131I-MIP-1095",
        "I-131 MIP-1095",
        "Iodine I 131 MIP-1095",
        "MIP-1095 I-131"
      ]
    },
    {
      "fdaUniiCode": "Y2T4ALDEAT",
      "id": "Bomedemstat",
      "preferredName": "Bomedemstat",
      "synonyms": [
        "BOMEDEMSTAT",
        "Bomedemstat",
        "IMG 7289",
        "IMG-7289",
        "LSD-1 Inhibitor IMG-7289",
        "Lysine-specific Demethylase 1 Inhibitor IMG-7289"
      ]
    },
    {
      "fdaUniiCode": "37JNS02E7V",
      "id": "Leuprolide_Acetate",
      "preferredName": "Leuprolide Acetate",
      "synonyms": [
        "6-D-Leucine-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor (Pig) Monoacetate",
        "6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig) Monoacetate",
        "A-43818",
        "Abbott 43818",
        "Abbott-43818",
        "Carcinil",
        "Depo-Eligard",
        "Eligard",
        "Enanton",
        "Enantone",
        "Enantone-Gyn",
        "Ginecrin",
        "LEUP",
        "LEUPROLIDE ACETATE",
        "Leuplin",
        "Leuprolide Acetate",
        "Leuprorelin Acetate",
        "Lucrin",
        "Lucrin Depot",
        "Lupron",
        "Lupron Depot",
        "Lupron Depot-3 Month",
        "Lupron Depot-4 Month",
        "Lupron Depot-Ped",
        "Lutrate",
        "Procren",
        "Procrin",
        "Prostap",
        "TAP-144",
        "Trenantone",
        "Uno-Enantone",
        "Viadur",
        "leuprolide acetate"
      ]
    },
    {
      "fdaUniiCode": "81J55YFQ16",
      "id": "Anti-TIGIT_Monoclonal_Antibody_BMS-986207",
      "preferredName": "Anti-TIGIT Monoclonal Antibody BMS-986207",
      "synonyms": [
        "Anti-TIGIT Monoclonal Antibody BMS-986207",
        "BMS-986207"
      ]
    },
    {
      "fdaUniiCode": "54T74394F8",
      "id": "Iadademstat",
      "preferredName": "Iadademstat",
      "synonyms": [
        "1,4-Cyclohexanediamine, N1-((1R,2S)-2-Phenylcyclopropyl)-, trans-",
        "IADADEMSTAT",
        "Iadademstat",
        "ORY 1001",
        "ORY-1001",
        "RG 6016",
        "RG6016",
        "RO 7051790",
        "RO7051790",
        "trans-N1-((1R,2S)-2-Phenylcyclopropyl)-1,4-cyclohexanediamine"
      ]
    },
    {
      "fdaUniiCode": "Q26B92650V",
      "id": "Abequolixron",
      "preferredName": "Abequolixron",
      "synonyms": [
        "ABEQUOLIXRON",
        "Abequolixron",
        "LXR-b Agonist RGX-104",
        "Liver X Receptor beta Agonist RGX-104",
        "RGX 104",
        "RGX-104",
        "RGX104",
        "SB-742881"
      ]
    },
    {
      "fdaUniiCode": "43HH4XYH2N",
      "id": "Enapotamab_Vedotin",
      "preferredName": "Enapotamab Vedotin",
      "synonyms": [
        "Anti-AXL/MMAE ADC",
        "Anti-AXL/MMAE Antibody-Drug Conjugate",
        "ENAPOTAMAB VEDOTIN",
        "Enapotamab Vedotin",
        "HuMax-AXL-ADC",
        "Immunoglobulin G1, Anti-(Human Growth Factor Receptor axl)(Human Humax-axl Gamma1-chain), Disulfide with Human Humax-axl Kappa-chain, Dimer Tetrakis(thioether) with Vedotin"
      ]
    },
    {
      "fdaUniiCode": "708TLB8J3Y",
      "id": "EGFR_Mutant-specific_Inhibitor_CK-101",
      "preferredName": "EGFR Mutant-specific Inhibitor CK-101",
      "synonyms": [
        "CK 101",
        "CK-101",
        "CK101",
        "EGFR Mutant-specific Inhibitor CK-101",
        "OLAFERTINIB",
        "RX-518"
      ]
    },
    {
      "fdaUniiCode": "L4C1UY2NYH",
      "id": "Inavolisib",
      "preferredName": "Inavolisib",
      "synonyms": [
        "GDC 0077",
        "GDC-0077",
        "GDC0077",
        "INAVOLISIB",
        "Inavolisib",
        "PI3K Inhibitor GDC0077",
        "RG 6114",
        "RG-6114",
        "RG6114",
        "RO 7113755"
      ]
    },
    {
      "fdaUniiCode": "ZXP96ZI2RA",
      "id": "Pacmilimab",
      "preferredName": "Pacmilimab",
      "synonyms": [
        "CX 072",
        "CX-072",
        "PACMILIMAB",
        "PD-L1 Probody Therapeutic CX-072",
        "Pacmilimab",
        "Probody CX-072"
      ]
    },
    {
      "fdaUniiCode": "W2OR26S7UE",
      "id": "Anti-TGF-beta_Monoclonal_Antibody_NIS793",
      "preferredName": "Anti-TGF-beta Monoclonal Antibody NIS793",
      "synonyms": [
        "Anti-TGF-beta Monoclonal Antibody NIS793",
        "NIS-793",
        "NIS793"
      ]
    },
    {
      "fdaUniiCode": "5V1UI86573",
      "id": "Ezabenlimab",
      "preferredName": "Ezabenlimab",
      "synonyms": [
        "Anti-PD-1 Monoclonal Antibody BI 754091",
        "BI 754091",
        "EZABENLIMAB",
        "Ezabenlimab"
      ]
    },
    {
      "fdaUniiCode": "7PO9B4VQ1U",
      "id": "Anti-CD73_Monoclonal_Antibody_BMS-986179",
      "preferredName": "Anti-CD73 Monoclonal Antibody BMS-986179",
      "synonyms": [
        "Anti-CD73 Monoclonal Antibody BMS-986179",
        "BMS 986179",
        "BMS-986179"
      ]
    },
    {
      "fdaUniiCode": "R7988D03JM",
      "id": "Oxeclosporin",
      "preferredName": "Oxeclosporin",
      "synonyms": [
        "Cyclo(((2S,3R,4R,6E)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl)-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-O-(2-hydroxyethyl)-D-seryl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl)",
        "Cyclosporin A, 2-(O-(2-hydroxyethyl)-D-serine)-",
        "OXECLOSPORIN",
        "Oxeclosporin"
      ]
    },
    {
      "fdaUniiCode": "D19V7048JK",
      "id": "Teverelix",
      "preferredName": "Teverelix",
      "synonyms": [
        "ANB019",
        "Ac-D-Nal-D-cpa-D-pal-ser-tyr-D-hci-leu-lys(ipr)-pro-D-ala-NH2",
        "D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N6-(aminocarbonyl)-D-lysyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-",
        "EP 24332",
        "TEVERELIX",
        "Teverelix"
      ]
    },
    {
      "fdaUniiCode": "1WPE73O1WV",
      "id": "Pralsetinib",
      "preferredName": "Pralsetinib",
      "synonyms": [
        "(cis)-N-((S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-1-methoxy-4-(4-methyl-6-(5-methyl-1H-pyrazol-3-ylamino)pyrimidin-2-yl)cyclohexanecarboxamide",
        "BLU-667",
        "BLU667",
        "Gavreto",
        "PRALSETINIB",
        "Pralsetinib"
      ]
    },
    {
      "fdaUniiCode": "OX5LRQ5H6K",
      "id": "Fianlimab",
      "preferredName": "Fianlimab",
      "synonyms": [
        "Anti-LAG-3 MoAb REGN3767",
        "FIANLIMAB",
        "Fianlimab",
        "REGN 3767",
        "REGN3767",
        "WHO 11182"
      ]
    },
    {
      "fdaUniiCode": "82F2G7BL4E",
      "id": "Doxorubicin_Hydrochloride",
      "preferredName": "Doxorubicin Hydrochloride",
      "synonyms": [
        "14-Hydroxydaunorubicin Hydrochloride",
        "3-Hydroxyacetyldaunorubicin Hydrochloride",
        "5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI)",
        "5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,hydrochloride, (8S-cis)-(9CI)",
        "ADM",
        "ADRIAMYCIN, HYDROCHLORIDE",
        "Adriacin",
        "Adriamycin",
        "Adriamycin Hydrochloride",
        "Adriamycin PFS",
        "Adriamycin RDF",
        "Adriamycin hydrochloride",
        "Adriamycine",
        "Adriblastina",
        "Adriblastine",
        "Adrimedac",
        "Chloridrato de Doxorrubicina",
        "DOX",
        "DOXO-CELL",
        "DOXORUBICIN HYDROCHLORIDE",
        "Doxolem",
        "Doxorubicin HCl",
        "Doxorubicin Hydrochloride",
        "Doxorubicin hydrochloride",
        "Doxorubicin.HCl",
        "Doxorubin",
        "FI 106",
        "FI-106",
        "Farmiblastina",
        "L-Lyxo-hexopyranoside, 3b-glycol-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-, hydrochloride",
        "Rubex",
        "doxorubicin hydrochloride",
        "hydroxydaunorubicin"
      ]
    },
    {
      "fdaUniiCode": "05ME7P8ZBJ",
      "id": "Detirelix",
      "preferredName": "Detirelix",
      "synonyms": [
        "BRN 6564671",
        "D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-D-tryptophyl-L-seryl-L-tyrosyl-N(sup 6)-(bis(ethylamino)methylene)-D-lysyl-L-leucyl-L-arginyl-L-prolyl-",
        "DETIRELIX",
        "Detirelix",
        "N-Ac-D-Nal(2)1,D-pCl-Phe2,D-Trp3,D-hArg(Et2)6,D-Ala(10)-GnRH"
      ]
    },
    {
      "fdaUniiCode": "X7K762X1IJ",
      "id": "CD47_Antagonist_ALX148",
      "preferredName": "CD47 Antagonist ALX148",
      "synonyms": [
        "ALX 148",
        "ALX-148",
        "ALX148",
        "CD47 Antagonist ALX148",
        "CD47/SIRPa-blocking Agent ALX148",
        "SIRPa Variant ALX148"
      ]
    },
    {
      "fdaUniiCode": "8FU7FQ8UPK",
      "id": "Sintilimab",
      "preferredName": "Sintilimab",
      "synonyms": [
        "Anti-PD-1 Monoclonal Antibody IBI308",
        "Anti-PDCD1 Monoclonal Antibody IBI308",
        "IBI 308",
        "IBI308",
        "SINTILIMAB",
        "Sintilimab"
      ]
    },
    {
      "fdaUniiCode": "68OJX9I7DT",
      "id": "Proapoptotic_Sulindac_Analog_CP-461",
      "preferredName": "Proapoptotic Sulindac Analog CP-461",
      "synonyms": [
        "1H-Indene-3-acetamide, 5-Fluoro-2-methyl-N-(phenylmethyl)-1-(4-pyridinylmethylene)-, Monohydrochloride, (1Z)-",
        "CEL 031",
        "CP 461",
        "CP-461",
        "CP461",
        "OSI 461",
        "Proapoptotic Sulindac Analog CP-461"
      ]
    },
    {
      "fdaUniiCode": "801XYWHNOS",
      "id": "Mcl-1_Inhibitor_MIK665",
      "preferredName": "Mcl-1 Inhibitor MIK665",
      "synonyms": [
        "MIK 665",
        "MIK-665",
        "MIK665",
        "Mcl-1 Inhibitor MIK665",
        "S 64315",
        "S-64315",
        "S64315"
      ]
    },
    {
      "fdaUniiCode": "195Q483UZD",
      "id": "Niraparib_Tosylate_Monohydrate",
      "preferredName": "Niraparib Tosylate Monohydrate",
      "synonyms": [
        "2H-Indazole-7-carboxamide, 2-(4-(3S)-3-piperidinylphenyl)-, 4-Methylbenzenesulfonate, Hydrate (1:1:1)",
        "NIRAPARIB TOSYLATE MONOHYDRATE",
        "Niraparib Tosylate Monohydrate",
        "Zejula"
      ]
    },
    {
      "fdaUniiCode": "048L81261F",
      "id": "Dexrazoxane",
      "preferredName": "Dexrazoxane",
      "synonyms": [
        "(+)-(S)-4,4'-(1-Methyl-1,2-ethanediyl)di(2,6-piperazinedione)",
        "2, 6-Piperazinedione, 4,4'-propylenedi-, (P)- (8CI)",
        "2,6-Piperazinedione, 4, 4'-(1-methyl-1,2-ethanediyl)bis-, (S)- (9CI)",
        "2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-,(S)-(9CI)",
        "2,6-Piperazinedione, 4,4'propylenedi-,(P)-(8CI)",
        "ADR-529",
        "DEXRAZOXANE",
        "Dexrazoxane",
        "ICRF-187",
        "Razoxane (+)-form",
        "Soluble ICRF (L-isomer)",
        "dexrazoxane"
      ]
    },
    {
      "fdaUniiCode": "47M74X9YT5",
      "id": "Cladribine",
      "preferredName": "Cladribine",
      "synonyms": [
        "2-CdA",
        "2-Chloro-2-Deoxyadenosine",
        "2-Chlorodeoxyadenosine",
        "2CDA",
        "CLADRIBINE",
        "CdA",
        "Cladribina",
        "Cladribine",
        "Leustat",
        "Leustatin",
        "Leustatine",
        "RWJ-26251",
        "cladribine"
      ]
    },
    {
      "fdaUniiCode": "T4RS462G19",
      "id": "Almonertinib",
      "preferredName": "Almonertinib",
      "synonyms": [
        "ALMONERTINIB",
        "Almonertinib",
        "EGFR Tyrosine Kinase Inhibitor HS-10296",
        "HS-10296"
      ]
    },
    {
      "fdaUniiCode": "A4O2H9W17Y",
      "id": "Vadacabtagene_Leraleucel",
      "preferredName": "Vadacabtagene Leraleucel",
      "synonyms": [
        "Anti-CD19/CD28/zeta Modified CAR CD3+ T Lymphocytes JCAR015",
        "JCAR 015",
        "JCAR 15",
        "JCAR015",
        "VADACABTAGENE LERALEUCEL",
        "Vadacabtagene Leraleucel"
      ]
    },
    {
      "fdaUniiCode": "Q09ZKD19V0",
      "id": "Alflutinib_Mesylate",
      "preferredName": "Alflutinib Mesylate",
      "synonyms": [
        "ALFLUTINIB MESYLATE",
        "ASK120067",
        "AST 2818 Mesylate",
        "AST2818 Mesylate",
        "Alflutinib Mesylate",
        "Furmonertinib Mesylate"
      ]
    },
    {
      "fdaUniiCode": "08O3FQ4UNP",
      "id": "Repotrectinib",
      "preferredName": "Repotrectinib",
      "synonyms": [
        "ALK/ROS1/NTRK/SRC/FAK Multikinase Inhibitor TPX-0005",
        "Multi-kinase Inhibitor TPX-0005",
        "Multikinase Inhibitor TPX-0005",
        "REPOTRECTINIB",
        "Repotrectinib",
        "TPX-0005"
      ]
    },
    {
      "fdaUniiCode": "2C6NUM6878",
      "id": "Valrubicin",
      "preferredName": "Valrubicin",
      "synonyms": [
        "AD 32",
        "AD-32",
        "N-Trifluoroacetyladriamycin-14-valerate",
        "VALRUBICIN",
        "Valrubicin",
        "Valstar",
        "Valtaxin",
        "valrubicin"
      ]
    },
    {
      "fdaUniiCode": "PNT6041ST1",
      "id": "Ametantrone",
      "preferredName": "Ametantrone",
      "synonyms": [
        "1,4-bis[[2-[(2-Hydroxyethyl)amino]ethyl]amino]9,10-anthracenedione",
        "9, 10-Anthracenedione, 1, 4-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-",
        "AMETANTRONE",
        "Ametantrone"
      ]
    },
    {
      "fdaUniiCode": "PLO044MUDZ",
      "id": "Pimitespib",
      "preferredName": "Pimitespib",
      "synonyms": [
        "3-Ethyl-4-(3-(1-methylethyl)-4-(4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl)-1H-pyrazolo(3,4-b)pyridin-1-yl)benzamide",
        "HSP90alpha/beta Inhibitor TAS-116",
        "Heat Shock Protein 90 alpha/beta Inhibitor TAS-116",
        "PIMITESPIB",
        "Pimitespib",
        "TAS-116",
        "TAS116"
      ]
    },
    {
      "fdaUniiCode": "8742T8ZQZA",
      "id": "Pamidronate_Disodium",
      "preferredName": "Pamidronate Disodium",
      "synonyms": [
        "Aminomux",
        "Aredia",
        "GCP-23339A",
        "PAMIDRONATE DISODIUM",
        "Pamidronate Disodium"
      ]
    },
    {
      "fdaUniiCode": "RD2I59M9FC",
      "id": "Praluzatamab_Ravtansine",
      "preferredName": "Praluzatamab Ravtansine",
      "synonyms": [
        "ADC CX-2009",
        "Anti-CD166-DM4 CX-2009",
        "CX-2009",
        "PDC CX-2009",
        "PRALUZATAMAB RAVTANSINE",
        "Praluzatamab Ravtansine"
      ]
    },
    {
      "fdaUniiCode": "4NJ842U6BZ",
      "id": "Azimexon",
      "preferredName": "Azimexon",
      "synonyms": [
        "2-Aziridinecarboxamide, 1-[1-(2-cyano-1-aziridinyl)-1-methylethyl]",
        "2-Cyanaziridinyl-2-carbamoyl-aziridinyl-1-propane",
        "AZ",
        "AZIMEXON",
        "Azimexon",
        "Azimexone",
        "BM 12.531",
        "BM12531"
      ]
    },
    {
      "fdaUniiCode": "CEGM9YBNGD",
      "id": "Selpercatinib",
      "preferredName": "Selpercatinib",
      "synonyms": [
        "6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo(3.1.1)heptan-3-yl)pyridin-3-yl)pyrazolo(1,5-a)pyridine-3-carbonitril",
        "LOXO-292",
        "RET Inhibitor LOXO-292",
        "RET Kinase Inhibitor LOXO-292",
        "Retevmo",
        "SELPERCATINIB",
        "Selpercatinib",
        "WHO 10967"
      ]
    },
    {
      "fdaUniiCode": "A678KM0M0N",
      "id": "Carbetimer",
      "preferredName": "Carbetimer",
      "synonyms": [
        "CARBETIMER",
        "Carbetimer",
        "N-137",
        "NED-137",
        "carbethimer",
        "carboxyaminidate"
      ]
    },
    {
      "fdaUniiCode": "7K28NB895L",
      "id": "Belzutifan",
      "preferredName": "Belzutifan",
      "synonyms": [
        "BELZUTIFAN",
        "Belzutifan",
        "HIF-2alpha Inhibitor PT2977",
        "MK 6482",
        "MK-6482",
        "MK6482",
        "PT2977",
        "Welireg"
      ]
    },
    {
      "fdaUniiCode": "56FUB33G5M",
      "id": "Anti-CD33_AntigenCD3_Receptor_Bispecific_Monoclonal_Antibody_AMV564",
      "preferredName": "Anti-CD33 Antigen/CD3 Receptor Bispecific Monoclonal Antibody AMV564",
      "synonyms": [
        "AMV 564",
        "AMV-564",
        "AMV564",
        "Anti-CD33 Antigen/CD3 Receptor Bispecific Monoclonal Antibody AMV564",
        "CD33 x CD3 Tandem Diabody AMV-56",
        "CD33/CD3 TandAbs AMV564"
      ]
    },
    {
      "fdaUniiCode": "8J08028R66",
      "id": "Mivobulin_Isethionate",
      "preferredName": "Mivobulin Isethionate",
      "synonyms": [
        "CI 980",
        "CI-980",
        "CI980",
        "MIVOBULIN ISETHIONATE",
        "Mivobulin Isethionate",
        "mivobulin isethionate"
      ]
    },
    {
      "fdaUniiCode": "69MO0NDN8K",
      "id": "Cyclopentenyl_Cytosine",
      "preferredName": "Cyclopentenyl Cytosine",
      "synonyms": [
        "2(1H)-Pyrimidinone, 4-amino-1-[4, 5-dihydroxy- 3-(hydroxymethyl)-2-cyclopenten-1-yl]-",
        "CPE-C",
        "CYCLOPENTENYL CYTOSINE",
        "Cyclopentenyl Cytosine",
        "Cyclopentenylcytosine",
        "Cyclopentenylcytosine Triphosphate"
      ]
    },
    {
      "fdaUniiCode": "FQL5EUP13W",
      "id": "Diaziquone",
      "preferredName": "Diaziquone",
      "synonyms": [
        "1,4-Cyclohexadiene-1,4-dicarbamic acid, 2, 5-bis(1-aziridinyl)-3,6-dioxo-, diethyl ester",
        "1,4-cyclohexadiene-1,4-dicarbamic acid, 2, 5-bis(1-aziridinyl)-3,6-dioxo-, diethyl ester",
        "1,4-cyclohexadiene-1,4-dicarbamic acid,2,5-bis(1-aziridinyl)-3,6-dioxo,-diethyl ester",
        "2,5-bis(1-aciridinyl)-3,6-bis(ethoxycarbonylamino)-1,4-benzoquinone",
        "2,5-bis(1-aziridinyl)-3,6-bis(ethoxycarbonylamino)-1,4-benzoquinone",
        "2,5-bis(1-aziridinyl)-3,6-dioxo-1,4-cyclohexadiene-1,4-dicarbamic acid diethyl ester",
        "2,5-diaziridinyl-3,6-bis(ethoxycarbonyl-amino)-1,4-benzoquinone",
        "AZQ",
        "Aziridinyl Benzoquinone",
        "Aziridinylbenzoquinone",
        "Aziridinylbenzoquinone carbamic acid",
        "CI-904",
        "Carbamic acid, [2,5-bis(1-aziridinyl)-3,6-dioxo-1, 4-cyclohexadiene-1,4-diyl]bis-, diethyl ester (9CI)",
        "DIAZIQUONE",
        "Diaziquone",
        "[2,5-bis(1-aziridinyl)-3,6-dioxo-1,4-cyclohexadiene-1,4-diyl]biscarbamic acid diethyl ester",
        "carbamic acid, [2,5-bis(1-aziridinyl)-3,6-dioxo-1, 4-cyclohexadiene-1,4-diyl]bis-, diethyl ester (9CI)",
        "diaziquone"
      ]
    },
    {
      "fdaUniiCode": "PQ7O0OB5GU",
      "id": "Vecabrutinib",
      "preferredName": "Vecabrutinib",
      "synonyms": [
        "BIIB-062",
        "BIIB062",
        "BSK-4841",
        "FP-182",
        "SNS 062",
        "SNS-062",
        "SNS062",
        "VECABRUTINIB",
        "Vecabrutinib"
      ]
    },
    {
      "fdaUniiCode": "X6L6R3CFT8",
      "id": "Anti-GD3_Antibody-drug_Conjugate_PF-06688992",
      "preferredName": "Anti-GD3 Antibody-drug Conjugate PF-06688992",
      "synonyms": [
        "Anti-GD3 ADC PF-06688992",
        "Anti-GD3 Antibody-drug Conjugate PF-06688992",
        "GD3 ADC PF-06688992",
        "PF 06688992",
        "PF-06688992"
      ]
    },
    {
      "fdaUniiCode": "1Q2QT5M7EO",
      "id": "Balstilimab",
      "preferredName": "Balstilimab",
      "synonyms": [
        "AGEN 2034",
        "AGEN-2034",
        "AGEN2034",
        "BALSTILIMAB",
        "Balstilimab"
      ]
    },
    {
      "fdaUniiCode": "H9B41234P4",
      "id": "Elliptinium_Acetate",
      "preferredName": "Elliptinium Acetate",
      "synonyms": [
        "6H-Pyrido[4, 3-b]carbazolium, 9-hydroxy-2,5,11-trimethyl-acetate (salt)",
        "9-Hydroxy-2,5,11-trimethyl-6H-pyrido[4,3-b]carbazolium Acetate (Salt)",
        "9-Hydroxy-2-methylellipticinium Acetate",
        "9-Hydroxy-2-methylellipticinium acetate",
        "Celiptium",
        "ELLIPTINIUM ACETATE",
        "Elliptinium Acetate",
        "N-2-Methyl-9-hydroxyellipticinium Acetate"
      ]
    },
    {
      "fdaUniiCode": "293BGU7HL8",
      "id": "Antibody-drug_Conjugate_SC-006",
      "preferredName": "Antibody-drug Conjugate SC-006",
      "synonyms": [
        "ADC SC-006",
        "Antibody-drug Conjugate SC-006",
        "SC 006",
        "SC-006",
        "SC006"
      ]
    },
    {
      "fdaUniiCode": "EBA1W201ZY",
      "id": "Antibody-drug_Conjugate_SC-004",
      "preferredName": "Antibody-drug Conjugate SC-004",
      "synonyms": [
        "ADC SC-004",
        "Antibody-drug Conjugate SC-004",
        "SC 004",
        "SC-004",
        "SC004"
      ]
    },
    {
      "fdaUniiCode": "54534MX6Z9",
      "id": "Teclistamab",
      "preferredName": "Teclistamab",
      "synonyms": [
        "JNJ 64007957",
        "JNJ-64007957",
        "JNJ64007957",
        "TECLISTAMAB",
        "Teclistamab"
      ]
    },
    {
      "fdaUniiCode": "9RM7XY23ZS",
      "id": "Neratinib_Maleate",
      "preferredName": "Neratinib Maleate",
      "synonyms": [
        "2-Butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:1)",
        "HKI-272 Maleate",
        "NERATINIB MALEATE",
        "Neratinib Maleate",
        "Nerlynx"
      ]
    },
    {
      "fdaUniiCode": "YE8XXF1SDZ",
      "id": "Obrindatamab",
      "preferredName": "Obrindatamab",
      "synonyms": [
        "B7-H3 x CD3 DART Protein",
        "B7-H3 x CD3 Dual-affinity Re-targeting Protein MGD009",
        "DART Protein MGD009",
        "Dual-affinity B7-H3/CD3-targeted Protein MGD009",
        "MGD 009",
        "MGD-009",
        "MGD009",
        "OBRINDATAMAB",
        "Obrindatamab"
      ]
    },
    {
      "fdaUniiCode": "3XPI7EG4W8",
      "id": "Patritumab_Deruxtecan",
      "preferredName": "Patritumab Deruxtecan",
      "synonyms": [
        "Anti-HER3 Antibody-drug Conjugate U3 1402",
        "PATRITUMAB DERUXTECAN",
        "Patritumab Deruxtecan",
        "U3 1402",
        "U3-1402",
        "U3-1402a"
      ]
    },
    {
      "fdaUniiCode": "FD6QP9BP8U",
      "id": "Fosquidone",
      "preferredName": "Fosquidone",
      "synonyms": [
        "FOSQUIDONE",
        "Fosquidone",
        "GR 63178A"
      ]
    },
    {
      "fdaUniiCode": "ZO1648L551",
      "id": "Fostriecin",
      "preferredName": "Fostriecin",
      "synonyms": [
        "2H-pyran-2-one,5,6-dihydro-6-(3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11,-tridecatetraenyl)-,trans",
        "FOSTRIECIN",
        "FST",
        "Fostriecin",
        "Phosphotrienin"
      ]
    },
    {
      "fdaUniiCode": "0F65R8P09N",
      "id": "Goserelin",
      "preferredName": "Goserelin",
      "synonyms": [
        "6-[O-(1,1-Dimethylethyl)-D-serine]-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig) 2-(aminocarbonyl)hydrazide",
        "GOSERELIN",
        "Goserelin",
        "ICI-118630",
        "goserelin"
      ]
    },
    {
      "fdaUniiCode": "6VDO4TY3OO",
      "id": "Budigalimab",
      "preferredName": "Budigalimab",
      "synonyms": [
        "ABBV 181",
        "ABBV-181",
        "ABBV181",
        "BUDIGALIMAB",
        "Budigalimab"
      ]
    },
    {
      "fdaUniiCode": "8237F3U7EH",
      "id": "Rucaparib",
      "preferredName": "Rucaparib",
      "synonyms": [
        "6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-Fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)-",
        "8-Fluoro-2-(4-((methylamino)methyl)phenyl)-1,3,4,5-tetrahydro-6H-azepino(5,4,3-cd)indol-6-one",
        "RUCAPARIB",
        "Rucaparib"
      ]
    },
    {
      "fdaUniiCode": "XZ66R08EI3",
      "id": "Antibody-drug_Conjugate_MEDI7247",
      "preferredName": "Antibody-drug Conjugate MEDI7247",
      "synonyms": [
        "ADC MEDI7247",
        "Antibody-drug Conjugate MEDI7247",
        "MEDI 7247",
        "MEDI-7247",
        "MEDI7247"
      ]
    },
    {
      "fdaUniiCode": "22X328QOC4",
      "id": "Fulvestrant",
      "preferredName": "Fulvestrant",
      "synonyms": [
        "7a-[9-[(4,4,5,5,5,-Pentafluoropentyl)sulphinyl]nonyl]-estra-1,3,5(10)-triene-3,17b-diol",
        "FULVESTRANT",
        "Faslodex",
        "Faslodex(ICI 182,780)",
        "Fulvestrant",
        "ICI 182,780",
        "ICI 182780",
        "ZD9238",
        "fulvestrant"
      ]
    },
    {
      "fdaUniiCode": "4O87Q44KNC",
      "id": "Vosilasarm",
      "preferredName": "Vosilasarm",
      "synonyms": [
        "RAD 140",
        "RAD-140",
        "RAD140",
        "SARM RAD140",
        "Selective Androgen Receptor Modulator RAD140",
        "Testolone",
        "VOSILASARM",
        "Vosilasarm"
      ]
    },
    {
      "fdaUniiCode": "25TA76U16O",
      "id": "Rolinsatamab_Talirine",
      "preferredName": "Rolinsatamab Talirine",
      "synonyms": [
        "ABBV 176",
        "ABBV-176",
        "ABBV176",
        "ADC ABBV-176",
        "ROLINSATAMAB TALIRINE",
        "Rolinsatamab Talirine"
      ]
    },
    {
      "fdaUniiCode": "31Z82G8ME1",
      "id": "Edodekin_alfa",
      "preferredName": "Edodekin alfa",
      "synonyms": [
        "Cytotoxic Lymphocyte Maturation Factor",
        "EDODEKIN ALFA",
        "Edodekin alfa",
        "IL-12",
        "Interleukin 12",
        "Interleukin-12",
        "NM-IL-12",
        "Natural Killer Cell Stimulatory Factor",
        "Recombinant human interleukin-12 (IL-12) cytokine",
        "Ro 24-7472",
        "interleukin-12"
      ]
    },
    {
      "fdaUniiCode": "JTZ51LIXN4",
      "id": "Nemtabrutinib",
      "preferredName": "Nemtabrutinib",
      "synonyms": [
        "ARQ 531",
        "ARQ-531",
        "ARQ531",
        "BTK Inhibitor ARQ 531",
        "Bruton's Tyrosine Kinase Inhibitor ARQ 531",
        "MK-1026",
        "NEMTABRUTINIB",
        "Nemtabrutinib"
      ]
    },
    {
      "fdaUniiCode": "042LAQ1IIS",
      "id": "Irinotecan_Hydrochloride",
      "preferredName": "Irinotecan Hydrochloride",
      "synonyms": [
        "CPT 11",
        "CPT-11",
        "Campto",
        "Camptosar",
        "Camptothecin 11",
        "Camptothecin-11",
        "IRINOTECAN HYDROCHLORIDE",
        "Irinomedac",
        "Irinotecan Hydrochloride",
        "Irinotecan Hydrochloride Trihydrate",
        "Irinotecan Monohydrochloride Trihydrate",
        "U-101440E",
        "irinotecan hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "0J45910S3X",
      "id": "Selitrectinib",
      "preferredName": "Selitrectinib",
      "synonyms": [
        "(13E,14E,22R,6R)-35-fluoro-6-methyl-7-aza-1(5,3)-pyrazolo[1,5-a]pyrimidina-3(3,2)-pyridina-2(1,2)-pyrrolidinacyclooctaphan-8-one",
        "BAY 2731954",
        "LOXO 195",
        "LOXO-195",
        "LOXO195",
        "SELITRECTINIB",
        "Selitrectinib",
        "TRK Inhibitor LOXO-195"
      ]
    },
    {
      "fdaUniiCode": "WBH8AY6ENB",
      "id": "Lerociclib",
      "preferredName": "Lerociclib",
      "synonyms": [
        "7',8'-Dihydro-2'-((5-(4-(1-methylethyl)-1-piperazinyl)-2-pyridinyl)amino)spiro(cyclohexane-1,9'(6'H)-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one",
        "CDK4/6 Inhibitor G1T38",
        "G1T38",
        "G1T38 Free Base",
        "LEROCICLIB",
        "Lerociclib"
      ]
    },
    {
      "fdaUniiCode": "8JSV4O30HQ",
      "id": "Menogaril",
      "preferredName": "Menogaril",
      "synonyms": [
        "7(R)-O-Methylnogarol",
        "7-(R)-O-methylnogarol",
        "7-OMEN",
        "7-con-O-Methylnogarol",
        "7-con-O-methylnogarol",
        "7-con-O-methylnorgarol",
        "MEN",
        "MENOGARIL",
        "Menogaril",
        "Menogarol",
        "OMEN,7-",
        "TUT-7",
        "U-52047",
        "[2R-(2alpha,3beta,4alpha,5beta,6alpha,11alpha,13alpha)]-4-(dimethylamino)-3,4,5,6,11,12,13,14-octahydro-3,5,8,10,13-pentahydroxy-11-methoxy-6,13-dimethyl-2,6-epoxy-2H-naphthaceno[1,2-b]oxocin-9,16-dione"
      ]
    },
    {
      "fdaUniiCode": "R4009Y24AI",
      "id": "Flumatinib",
      "preferredName": "Flumatinib",
      "synonyms": [
        "4-(4-Methyl-piperazin-1-ylmethyl)-N-[6-methyl-5-(4-pyridin-3-yl-pyrimidin-2-ylamino)-pyridin-3-yl]-3-trifluoromethyl-benzamide",
        "FLUMATINIB",
        "Flumatinib",
        "HH-GV-678",
        "HH-GV678"
      ]
    },
    {
      "fdaUniiCode": "YWB9IF596V",
      "id": "Merbarone",
      "preferredName": "Merbarone",
      "synonyms": [
        "MERBARONE",
        "Merbarone"
      ]
    },
    {
      "fdaUniiCode": "RQU6X0IM9R",
      "id": "Micellar_Nanoparticle-encapsulated_Epirubicin",
      "preferredName": "Micellar Nanoparticle-encapsulated Epirubicin",
      "synonyms": [
        "Epirubicin-incorporating Micelle",
        "K-912",
        "Micellar Nanoparticle-encapsulated Epirubicin",
        "NC-6300",
        "Nanoparticle Epirubicin"
      ]
    },
    {
      "fdaUniiCode": "VT1IGL3D7V",
      "id": "Mitomycin_B",
      "preferredName": "Mitomycin B",
      "synonyms": [
        "Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 1,1a,2,8,8a,8b-hexahydro-8a-hydroxy-8-(hydroxymethyl)-6-methoxy-1,5-dimethyl-, 8-carbamate",
        "MITOMYCIN B",
        "Mitomycin B"
      ]
    },
    {
      "fdaUniiCode": "1LM890Q4FY",
      "id": "Mifamurtide",
      "preferredName": "Mifamurtide",
      "synonyms": [
        "CGP 19835A Lipid",
        "Junovan",
        "L-Alaninamide, N-(N-acetylmuramoyl)-L-alanyl-D-alpha-glutaminyl-N-((7R)-4-hydroxy-4-oxido-10-oxo-7-((1-oxohexadecyl)oxy)-3,5,9-trioxa-4-phosphapentacos-1-yl)-, Monosodium Salt, Hydrate",
        "L-MTP-PE",
        "MEPACT",
        "MIFAMURTIDE",
        "MTP-PE Liposome",
        "Mepact",
        "Mifamurtide",
        "Muramyl Tripeptide Phosphatidylethanolamine Liposome",
        "MuramylNAc-Ala-isoGln-Lys-tripeptide-PE",
        "mifamurtide",
        "muramyl tripeptide phosphatidylethanolamine"
      ]
    },
    {
      "fdaUniiCode": "253GQW851Q",
      "id": "Vinorelbine_Tartrate",
      "preferredName": "Vinorelbine Tartrate",
      "synonyms": [
        "Biovelbin",
        "Eunades",
        "KW-2307",
        "NVB",
        "Navelbine",
        "Navelbine Ditartrate",
        "Navelbine ditartrate",
        "VINORELBINE TARTRATE",
        "Vinorelbine Ditartrate",
        "Vinorelbine Tartrate",
        "vinorelbine tartrate"
      ]
    },
    {
      "fdaUniiCode": "P86BHN01VE",
      "id": "Cevostamab",
      "preferredName": "Cevostamab",
      "synonyms": [
        "Anti-FCRH5 x Anti-CD3 Bi-specific T-cell Engager BFCR4350A",
        "Anti-FCRH5/CD3 BiTE Antibody BFCR4350A",
        "Anti-FCRH5/CD3 TDB BFCR4350A",
        "BFCR4350A",
        "CEVOSTAMAB",
        "Cevostamab",
        "FCRH5/CD3 T Cell Dependent Bispecific Antibody BFCR4350A",
        "FCRH5/CD3 TDB Antibody BFCR4350A",
        "RO7187797",
        "Recombinant Anti-FCRH5 x Anti-CD3 Bi-specific T-cell Engager BFCR4350A"
      ]
    },
    {
      "fdaUniiCode": "704LW082GI",
      "id": "Mevociclib",
      "preferredName": "Mevociclib",
      "synonyms": [
        "CDK7 Inhibitor SY-1365",
        "MEVOCICLIB",
        "Mevociclib",
        "SY-1365",
        "SY1365"
      ]
    },
    {
      "fdaUniiCode": "W6C58X3BFH",
      "id": "Giloralimab",
      "preferredName": "Giloralimab",
      "synonyms": [
        "ABBV-927",
        "Agonistic Anti-CD40 Monoclonal Antibody ABBV-927",
        "Anti-CD40 Agonist Monoclonal Antibody ABBV-927",
        "Anti-CD40 Monoclonal Antibody ABBV-927",
        "GILORALIMAB",
        "Giloralimab",
        "PR-1614645"
      ]
    },
    {
      "fdaUniiCode": "78QVZ7RG8L",
      "id": "Sparfosic_Acid",
      "preferredName": "Sparfosic Acid",
      "synonyms": [
        "L-Aspartic acid, N-(phosphonoacetyl)-",
        "N-Phosphonacetyl-L-aspartate",
        "N-phosphonacetyl-L-aspartate",
        "PALA",
        "Phosphonacetyl-L-aspartic Acid",
        "SPARFOSIC ACID",
        "Sparfosate",
        "Sparfosic Acid"
      ]
    },
    {
      "fdaUniiCode": "56H9L80NIZ",
      "id": "Peplomycin",
      "preferredName": "Peplomycin",
      "synonyms": [
        "(S)-n1-[3-[(1-phenylethyl)amino]propyl]bleomycinamide",
        "PEP",
        "PEPLEOMYCIN",
        "PEPLOMYCIN",
        "Pepleomycin",
        "Peplomycin",
        "n1-[3[[(S)-alpha-methylbenzyl]amino]propyl]bleomycinamide"
      ]
    },
    {
      "fdaUniiCode": "6A668951HW",
      "id": "Peplomycin_Sulfate",
      "preferredName": "Peplomycin Sulfate",
      "synonyms": [
        "N1-(3-(((S)-(alpha-methylbenzyl))amino)propyl)bleomycinamide Sulfate (1:1) (Salt)",
        "NK-631",
        "PEPLOMYCIN SULFATE",
        "Pepleo",
        "Peplomycin Sulfate"
      ]
    },
    {
      "fdaUniiCode": "5XO3JF0FEK",
      "id": "Vibostolimab",
      "preferredName": "Vibostolimab",
      "synonyms": [
        "MK 7684",
        "MK-7684",
        "MK7684",
        "T-cell Immunoglobulin and Immunoreceptor Tyrosine-based Inhibitory Motif Inhibitor MK-7684",
        "TIGIT Inhibitor MK-7684",
        "TIGIT-targeting Agent MK-7684",
        "VIBOSTOLIMAB",
        "Vibostolimab"
      ]
    },
    {
      "fdaUniiCode": "TN8CEX4UT2",
      "id": "Modakafusp_Alfa",
      "preferredName": "Modakafusp Alfa",
      "synonyms": [
        "Anti-CD38-targeted IgG4-attenuated IFNa TAK-573",
        "Anti-CD38-targeted IgG4-attenuated Interferon Alpha TAK-573",
        "CD38-targeted IgG4 Fused with Attenuated IFNa",
        "MODAKAFUSP ALFA",
        "Modakafusp Alfa",
        "TAK-573",
        "TEV-48573"
      ]
    },
    {
      "fdaUniiCode": "Q7ZP55KF3X",
      "id": "Valspodar",
      "preferredName": "Valspodar",
      "synonyms": [
        "6-[(2S,4R,6E)-4-Methyl-2-(methylamino)-3-oxo-6-octenoic Acid]cyclosporin D",
        "Amdray",
        "Cyclo((2S,4R,6E)-4-methyl-2-(methylamino)-3-oxo-6-octenoyl)-L-valyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-me",
        "PSC 833",
        "PSC-833",
        "PSC833",
        "SZD PSC 833",
        "VALSPODAR",
        "VP16",
        "Valspodar"
      ]
    },
    {
      "fdaUniiCode": "SA4H7K0SW2",
      "id": "Anti-PSMAPBD_ADC_MEDI3726",
      "preferredName": "Anti-PSMA/PBD ADC MEDI3726",
      "synonyms": [
        "ADC MEDI3726",
        "ADCT 401",
        "ADCT-401",
        "ADCT401",
        "Anti-PSMA/PBD ADC MEDI3726",
        "MEDI 3726",
        "MEDI-3726",
        "MEDI3726"
      ]
    },
    {
      "fdaUniiCode": "P88XT4IS4D",
      "id": "Paclitaxel",
      "preferredName": "Paclitaxel",
      "synonyms": [
        "5Beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one, 4,10-Diacetate 2-Benzoate 13-Ester with (2R,3S)-N-Benzoyl-3-phenylisoserine",
        "Anzatax",
        "Asotax",
        "Bristaxol",
        "PACLITAXEL",
        "Paclitaxel",
        "Praxel",
        "Taxol",
        "Taxol Konzentrat",
        "[2aR-[2a Alpha,4beta,4a beta,6beta,9alpha(alphaR*,betaS*),-11alpha,12alpha,12a alpha,12b alpha]]-beta-(benzoylamino)-alpha-hydroxybenzene-propanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-1a,33,4,-41,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-41,8,-12,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester",
        "paclitaxel"
      ]
    },
    {
      "fdaUniiCode": "0A7729F42K",
      "id": "Linrodostat",
      "preferredName": "Linrodostat",
      "synonyms": [
        "(R)-N-(4-chlorophenyl)-2-((1S,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl)propenamide",
        "BMS 986205",
        "BMS-986205",
        "BMS986205",
        "IDO-1 Inhibitor BMS-986205",
        "Indoleamine-pyrrole 2,3-Dioxygenase Inhibitor BMS-986205",
        "LINRODOSTAT",
        "Linrodostat",
        "ONO-7701"
      ]
    },
    {
      "fdaUniiCode": "7M7YKX2N15",
      "id": "Topotecan",
      "preferredName": "Topotecan",
      "synonyms": [
        "(s)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione",
        "9-[(dimethylamino)methyl]-10-hydroxy-(20S)-camptothecin",
        "Hycamptamine",
        "TOPOTECAN",
        "Topotecan",
        "Topotecan Lactone",
        "topotecan"
      ]
    },
    {
      "fdaUniiCode": "TB50XV90MW",
      "id": "Anti-TIGIT_Monoclonal_Antibody_ASP8374",
      "preferredName": "Anti-TIGIT Monoclonal Antibody ASP8374",
      "synonyms": [
        "ASP 8374",
        "ASP-8374",
        "ASP8374",
        "Anti-TIGIT Monoclonal Antibody ASP8374",
        "PTZ-201"
      ]
    },
    {
      "fdaUniiCode": "AG9MHG098Z",
      "id": "Zanubrutinib",
      "preferredName": "Zanubrutinib",
      "synonyms": [
        "(S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide",
        "BGB-3111",
        "BTK-InhB",
        "Brukinsa",
        "ZANUBRUTINIB",
        "Zanubrutinib"
      ]
    },
    {
      "fdaUniiCode": "W66XP666AM",
      "id": "Voruciclib",
      "preferredName": "Voruciclib",
      "synonyms": [
        "2-(2-Chloro-4-(trifluoromethyl)phenyl)-5,7-dihydroxy-8-((2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl)-4H-1-benzopyran-4-one",
        "P1446A-05",
        "VORUCICLIB",
        "Voruciclib"
      ]
    },
    {
      "fdaUniiCode": "48FCG62C25",
      "id": "Cergutuzumab_Amunaleukin",
      "preferredName": "Cergutuzumab Amunaleukin",
      "synonyms": [
        "CEA-IL-2variant",
        "CEA-IL2v",
        "CERGUTUZUMAB AMUNALEUKIN",
        "Cergutuzumab Amunaleukin",
        "RG-7813",
        "RG7813",
        "RO-6895882",
        "RO6895882"
      ]
    },
    {
      "fdaUniiCode": "6YUU2PV0U8",
      "id": "Goserelin_Acetate",
      "preferredName": "Goserelin Acetate",
      "synonyms": [
        "D-Ser(bu(t))(6)azgly(10)-LHRH Acetate",
        "GOSERELIN ACETATE",
        "Goserelin Acetate",
        "ZDX",
        "Zoladex"
      ]
    },
    {
      "fdaUniiCode": "H1396W7D1H",
      "id": "Favezelimab",
      "preferredName": "Favezelimab",
      "synonyms": [
        "Anti-LAG-3 Monoclonal Antibody MK-4280",
        "Anti-LAG3 Monoclonal Antibody MK-4280",
        "FAVEZELIMAB",
        "Favezelimab",
        "MK 4280",
        "MK-4280",
        "MK4280"
      ]
    },
    {
      "fdaUniiCode": "1ER2O3UZ4W",
      "id": "Fascin_Inhibitor_NP-G2-044",
      "preferredName": "Fascin Inhibitor NP-G2-044",
      "synonyms": [
        "2-Methyl-N-(1-((4-(trifluoromethyl)phenyl)methyl)-1H-indazol-3-yl)-3-furancarboxamide",
        "Fascin Inhibitor NP-G2-044",
        "NP G2 044",
        "NP-G2-044"
      ]
    },
    {
      "fdaUniiCode": "2Y3T5IF01Z",
      "id": "Retifanlimab",
      "preferredName": "Retifanlimab",
      "synonyms": [
        "INCMGA 0012",
        "INCMGA-0012",
        "INCMGA00012",
        "INCMGA0012",
        "MGA 012",
        "MGA-012",
        "MGA012",
        "RETIFANLIMAB",
        "Retifanlimab"
      ]
    },
    {
      "fdaUniiCode": "473BOU89F3",
      "id": "Lutetium_Lu_177_Anti-CA19-9_Monoclonal_Antibody_5B1",
      "preferredName": "Lutetium Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1",
      "synonyms": [
        "177Lu Human Monoclonal Antibody 5B1",
        "177Lu-CHX-A''-DTPA-HuMab-5B1",
        "Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1",
        "Lutetium Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1",
        "MVT-1075"
      ]
    },
    {
      "fdaUniiCode": "VXT8SZ6875",
      "id": "Pemrametostat",
      "preferredName": "Pemrametostat",
      "synonyms": [
        "EPZ015938",
        "GSK-3326595",
        "GSK3326595",
        "PEMRAMETOSTAT",
        "PRMT5 Inhibitor GSK3326595",
        "Pemrametostat",
        "Protein Arginine Methyltransferase 5 Inhibitor GSK3326595"
      ]
    },
    {
      "fdaUniiCode": "U880A4FUDA",
      "id": "Perfosfamide",
      "preferredName": "Perfosfamide",
      "synonyms": [
        "2-[bis(2-chloroethyl)amino]-4-hydroperoxytetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide",
        "4'-Hydroperoxycyclophosphamide",
        "4-HC",
        "4-Hydroperoxycyclophosphamide",
        "4-Pergamid",
        "Hydroperoxycyclophosphamide",
        "PERFOSFAMIDE",
        "Perfosfamide",
        "Pergamid",
        "cis-2-[bis(2-chloroethyl)amino]tetrahydro-3H-1,3,2-oxazaphosphorin-4-yl hydroperoxide P-oxide",
        "cis-4-hydroperoxycyclophosphamide"
      ]
    },
    {
      "fdaUniiCode": "GA49J4310U",
      "id": "Sulforaphane",
      "preferredName": "Sulforaphane",
      "synonyms": [
        "(+/-)-Sulforaphane",
        "1-Isothiocyanato-4-(methylsulfinyl)butane",
        "1-isothiocyanato-4-methylsulfinyl-butane",
        "SULFORAPHANE",
        "Sulfaforaphane",
        "Sulforafan",
        "Sulforaphane",
        "Sulphoraphane"
      ]
    },
    {
      "fdaUniiCode": "14P4QR28QF",
      "id": "Rogletimide",
      "preferredName": "Rogletimide",
      "synonyms": [
        "Pyridoglutethimide",
        "ROGLETIMIDE",
        "Rogletimide"
      ]
    },
    {
      "fdaUniiCode": "FC1ZF28VIT",
      "id": "Etigilimab",
      "preferredName": "Etigilimab",
      "synonyms": [
        "Anti-TIGIT OMP-313M32",
        "ETIGILIMAB",
        "Etigilimab",
        "Immunoglobulin G1, Anti-(Human Receptor TIGIT(T-cell Immunoreceptor with Ig and iTIM Domains)) (Humanized Mouse Monoclonal OMP-313M32 Gamma1-chain), Disulfide with Humanized Mouse Monoclonal OMP-313M32 Kappa-chain, Dimer",
        "OMP 313M32",
        "OMP-313M32",
        "WHO 10742"
      ]
    },
    {
      "fdaUniiCode": "L1R0M8P1GD",
      "id": "Monoclonal_Antibody_TRK-950",
      "preferredName": "Monoclonal Antibody TRK-950",
      "synonyms": [
        "Monoclonal Antibody TRK-950",
        "TRK 950",
        "TRK-950"
      ]
    },
    {
      "fdaUniiCode": "S7H48S6K7H",
      "id": "Troriluzole",
      "preferredName": "Troriluzole",
      "synonyms": [
        "BHV 4157",
        "BHV-4157",
        "Glycinamide, Glycylglycyl-N2-methyl-N-(6-(trifluoromethoxy)-2-benzothiazolyl)-",
        "TRORILUZOLE",
        "Trigriluzole",
        "Troriluzole"
      ]
    },
    {
      "fdaUniiCode": "K45ZNW8WU9",
      "id": "Anti-PD-1_Monoclonal_Antibody_Sym021",
      "preferredName": "Anti-PD-1 Monoclonal Antibody Sym021",
      "synonyms": [
        "Anti-PD-1 Monoclonal Antibody Sym021",
        "Anti-PD1 Monoclonal Antibody Sym021",
        "SYM-021",
        "Sym021"
      ]
    },
    {
      "fdaUniiCode": "IFD73D535A",
      "id": "Numidargistat",
      "preferredName": "Numidargistat",
      "synonyms": [
        "Arginase Inhibitor INCB001158",
        "CB-1158",
        "CB1158",
        "INCB001158",
        "NUMIDARGISTAT",
        "Numidargistat"
      ]
    },
    {
      "fdaUniiCode": "21Z359Z1CV",
      "id": "Cinrebafusp_Alfa",
      "preferredName": "Cinrebafusp Alfa",
      "synonyms": [
        "Anti-HER2 Monoclonal Antibody/Anti-CD137Anticalin Bispecific Fusion Protein PRS-343",
        "CINREBAFUSP ALFA",
        "Cinrebafusp Alfa",
        "PRS-343"
      ]
    },
    {
      "fdaUniiCode": "2PK59M9GFF",
      "id": "Vapreotide",
      "preferredName": "Vapreotide",
      "synonyms": [
        "BMY-41606",
        "Docrised",
        "RC-160",
        "VAPREOTIDE",
        "Vapreotide",
        "vapreotide"
      ]
    },
    {
      "fdaUniiCode": "N151VZIIPD",
      "id": "Encelimab",
      "preferredName": "Encelimab",
      "synonyms": [
        "Anti-LAG-3 Monoclonal Antibody TSR-033",
        "Anti-LAG3 Monoclonal Antibody TSR-033",
        "Anti-Lymphocyte Activation Gene 3 Protein Monoclonal Antibody TSR-033",
        "ENCELIMAB",
        "Encelimab",
        "TSR 033",
        "TSR-033",
        "TSR033"
      ]
    },
    {
      "fdaUniiCode": "P1QW714R7M",
      "id": "Imiquimod",
      "preferredName": "Imiquimod",
      "synonyms": [
        "1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-",
        "4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline",
        "Aldara",
        "IMIQUIMOD",
        "Imiquimod",
        "R 837",
        "S 26308",
        "Zyclara",
        "imiquimod"
      ]
    },
    {
      "fdaUniiCode": "G3NJ7M8N4H",
      "id": "Tabelecleucel",
      "preferredName": "Tabelecleucel",
      "synonyms": [
        "ATA 129",
        "ATA129",
        "Allogeneic EBV-specific CTLs ATA129",
        "Allogeneic EBV-specific Cytotoxic T-lymphocytes",
        "CTLs ATA129",
        "EBV-CTLs",
        "TABELECLEUCEL",
        "Tabelecleucel",
        "Teb-cel"
      ]
    },
    {
      "fdaUniiCode": "67RM91WDHQ",
      "id": "Onvansertib",
      "preferredName": "Onvansertib",
      "synonyms": [
        "'PLK1 Inhibitor PCM-075",
        "NMS-1286937",
        "ONVANSERTIB",
        "Onvansertib",
        "PCM 075",
        "PCM-075",
        "PLK-1 Inhibitor PCM-075",
        "Polo-like Kinase 1 Inhibitor NMS-1286937",
        "Polo-like Kinase 1 Inhibitor PCM-075"
      ]
    },
    {
      "fdaUniiCode": "Z45N070N3S",
      "id": "Sulofenur",
      "preferredName": "Sulofenur",
      "synonyms": [
        "LY186641",
        "SULOFENUR",
        "Sulofenur"
      ]
    },
    {
      "fdaUniiCode": "K0Q29TGV9Y",
      "id": "Liarozole",
      "preferredName": "Liarozole",
      "synonyms": [
        "1H-Benzimidazole, 5-((3-chlorophenyl)-1H-imidazol-1-ylmethyl)-",
        "LIAROZOLE",
        "Liarozole",
        "Liazal",
        "R 75251",
        "R-61405",
        "liarozole"
      ]
    },
    {
      "fdaUniiCode": "OX5XK1JD8C",
      "id": "Lobaplatin",
      "preferredName": "Lobaplatin",
      "synonyms": [
        "1,2-diammino-methy lcyclobutane-platinum (II) lactate",
        "D-19466",
        "LOBAPLATIN",
        "Lobaplatin",
        "lobaplatin"
      ]
    },
    {
      "fdaUniiCode": "60KQZ0388Y",
      "id": "Troxacitabine",
      "preferredName": "Troxacitabine",
      "synonyms": [
        "2(1H)-Pyrimidinone, 4-amino-1-((2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl)-",
        "BCH-4556",
        "L-Oddc",
        "TROXACITABINE",
        "Troxacitabine",
        "Troxatyl",
        "troxacitabine"
      ]
    },
    {
      "fdaUniiCode": "J9ZKS885H5",
      "id": "Dolastatin_15",
      "preferredName": "Dolastatin 15",
      "synonyms": [
        "DOLASTATIN 15",
        "Dolastatin 15",
        "L-Proline, 1-(1-(N-(N-(N,N-dimethyl-L-valyl)-L-valyl)-N-methyl-L-valyl)-L-prolyl)-, 1-((2,5-dihydro-3-methoxy-5-oxo-2-(phenylmethyl)-1H-pyrrol-1-yl)carbonyl)-2-methylpropyl ester, (S-(R*,R*))-"
      ]
    },
    {
      "fdaUniiCode": "L62556GPXB",
      "id": "Tebotelimab",
      "preferredName": "Tebotelimab",
      "synonyms": [
        "Anti-PD-1/Anti-LAG-3 DART Protein MGD013",
        "Bispecific DART Protein MGD013",
        "Dual-affinity Retargeting Protein MGD013",
        "MGD 013",
        "MGD-013",
        "MGD013",
        "PD-1 x LAG-3 Bispecific DART Molecule MGD013",
        "PD-1 x LAG-3 DART Molecule MGD013",
        "PD-1 x LAG-3 DART Protein MGD013",
        "TEBOTELIMAB",
        "Tebotelimab"
      ]
    },
    {
      "fdaUniiCode": "NT6K61736T",
      "id": "Sodium_Phenylbutyrate",
      "preferredName": "Sodium Phenylbutyrate",
      "synonyms": [
        "4-Phenylbutyric Acid, Sodium Salt",
        "Buphenyl",
        "Phenylbutyrate Sodium",
        "SODIUM PHENYLBUTYRATE",
        "SPB11",
        "Sodium 4-Phenylbutyrate",
        "Sodium 4-phenylbutyrate",
        "Sodium Phenylbutyrate",
        "phenylbutyrate"
      ]
    },
    {
      "fdaUniiCode": "668UF07O1P",
      "id": "Carzelesin",
      "preferredName": "Carzelesin",
      "synonyms": [
        "2-Benzofurancarboxamide, N-(2-((1-(chloromethyl)-1,6-dihydro-8-methyl-5-(((phenylamino)carbonyl)oxy)benzo(1,2-b:4,3-b')dipyrrol-3(2H)-yl)carbonyl)-1H-indol-5-yl)-6-(diethylamino)-, (S)-",
        "CARZELESIN",
        "Carzelesin",
        "U-80244",
        "carzelesin"
      ]
    },
    {
      "fdaUniiCode": "X0N4EFN4AI",
      "id": "Morpholinodoxorubicin",
      "preferredName": "Morpholinodoxorubicin",
      "synonyms": [
        "5,12-Naphthacenedione, 7, 8, 9, 10-tetrahydro-6, 8, 11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2, 3, 6-trideoxy-3-(4-morpholinyl)-alpha-L-lyxo-hexopyranosyl] oxy]-, hydrochloride, (8S-cis)-",
        "MORPHOLINODOXORUBICIN",
        "Morpholinodoxorubicin",
        "morpholino-ADR",
        "morpholino-adriamycin"
      ]
    },
    {
      "fdaUniiCode": "WXM8D9M6DE",
      "id": "Zorubicin_Hydrochloride",
      "preferredName": "Zorubicin Hydrochloride",
      "synonyms": [
        "(2S-cis)-Benzoic Acid[1-[4-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3-naphthacenyl]ethylidene]hydrazide",
        "Benzoyl Hydrazone Daunorubicin",
        "Daunorubicin Benzoylhydrazone Hydrochloride",
        "RP 22,050 Hydrochloride",
        "RP 22050",
        "Rubidazone",
        "ZORUBICIN HYDROCHLORIDE",
        "Zorubicin Hydrochloride",
        "Zorubicin hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "319R5C7293",
      "id": "Perillyl_Alcohol",
      "preferredName": "Perillyl Alcohol",
      "synonyms": [
        "(S)-(-)-Perillyl Alcohol",
        "(S)-(-)-Perillyl alcohol",
        "(S)-4-Isopropenyl-1-cyclohexenylmethanol",
        "1-Cyclohexene-1-methanol",
        "4-(1-Methylethenyl)",
        "4-(1-Methylethenyl)-1-cyclohexene-1-methanol",
        "4-Isopropenylcyclohex-1-ene-1-methanol",
        "Dihydrocuminyl Alcohol",
        "NEO100",
        "PERILLYL ALCOHOL",
        "POH",
        "Perilla Alcohol",
        "Perilla alcohol",
        "Perillic Alcohol",
        "Perillic alcohol",
        "Perillol",
        "Perillyl Alcohol",
        "[(4S)-4-prop-1-en-2-yl-1-cyclohexenyl]methanol",
        "p-Mentha-1,8-dien-7-ol",
        "perillyl alcohol"
      ]
    },
    {
      "fdaUniiCode": "9RJ5N8VE7Z",
      "id": "Dihydrolenperone",
      "preferredName": "Dihydrolenperone",
      "synonyms": [
        "1-Butanone, 1-(4-fluorophenyl)-4-[4-[(4-fluorophenyl)hydroxymethyl]-1-piperidi nyl]-",
        "1-Butanone, 1-(4-fluorophenyl)-4-[4-[(4-fluorophenyl)hydroxymethyl]-1-piperidinyl]-",
        "DIHYDROLENPERONE",
        "Dihydro-lenperone",
        "Dihydrolenperone",
        "RMI 11974"
      ]
    },
    {
      "fdaUniiCode": "1UD32YR59G",
      "id": "Tirapazamine",
      "preferredName": "Tirapazamine",
      "synonyms": [
        "3-Amino-1,2,4-benzotriazine-1,4-dioxide",
        "SR 4233",
        "SR4233",
        "TIRAPAZAMINE",
        "Tirapazamine",
        "Tirazone",
        "WIN 59075",
        "tirapazamine"
      ]
    },
    {
      "fdaUniiCode": "LA88IH4O02",
      "id": "Mezigdomide",
      "preferredName": "Mezigdomide",
      "synonyms": [
        "CC 92480",
        "CC-92480",
        "CELMoD CC-92480",
        "Cereblon E3 Ligase Modulation Drug CC-92480",
        "Cereblon E3 Ubiquitin Ligase Modulating Agent CC-92480",
        "Cereblon Modulator CC-92480",
        "MEZIGDOMIDE",
        "Mezigdomide"
      ]
    },
    {
      "fdaUniiCode": "7N13IK9LNH",
      "id": "Elimusertib",
      "preferredName": "Elimusertib",
      "synonyms": [
        "ATR Inhibitor BAY1895344",
        "ATR Kinase Inhibitor BAY1895344",
        "BAY 1895344",
        "BAY-1895344",
        "BAY1895344",
        "ELIMUSERTIB",
        "Elimusertib"
      ]
    },
    {
      "fdaUniiCode": "88635FW2QX",
      "id": "Tidutamab",
      "preferredName": "Tidutamab",
      "synonyms": [
        "Anti-SSTR2 x Anti-CD3 Monoclonal Antibody XmAb18087",
        "TIDUTAMAB",
        "Tidutamab",
        "XmAb 18087",
        "XmAb-18087",
        "XmAb18087"
      ]
    },
    {
      "fdaUniiCode": "WR4J8FV2SM",
      "id": "Etevritamab",
      "preferredName": "Etevritamab",
      "synonyms": [
        "AMG 596",
        "AMG-596",
        "AMG596",
        "Anti-EGFRvIII x Anti-CD3 Bi-specific T-cell Engager AMG 596",
        "Anti-EGFRvIII/CD3 BiTE Antibody AMG 596",
        "BiTE Antibody AMG 596",
        "Bispecific BITE Antibody AMG 596",
        "EGFRvIII specific BiTE Antibody AMG 596",
        "ETEVRITAMAB",
        "Etevritamab"
      ]
    },
    {
      "fdaUniiCode": "Q1K9TTP1WS",
      "id": "Eftozanermin_Alfa",
      "preferredName": "Eftozanermin Alfa",
      "synonyms": [
        "ABBV 621",
        "ABBV-621",
        "ABBV621",
        "APG880",
        "EFTOZANERMIN ALFA",
        "Eftozanermin Alfa",
        "HERA Ligand ABBV-621",
        "Hexavalent TRAIL Receptor Agonist ABBV-621",
        "TRAIL Receptor Agonist ABBV-621",
        "TRAIL-Fc Protein ABBV-621",
        "TRAIL-receptor Agonist Fusion Protein ABBV-621"
      ]
    },
    {
      "fdaUniiCode": "L0HR9A577V",
      "id": "Anti-CD3Anti-BCMA_Bispecific_Monoclonal_Antibody_PF-06863135",
      "preferredName": "Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody PF-06863135",
      "synonyms": [
        "Anti-CD3/Anti-BCMA Bispecific Antibody PF-06863135",
        "Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody PF-06863135",
        "B-cell Maturation Antigen-CD3 Bispecific Antibody PF-06863135",
        "BCMA x CD3 Bispecific Antibody PF-06863135",
        "BCMA-CD3 Bispecific Ab PF-06863135",
        "PF 06863135",
        "PF-06863135",
        "PF06863135"
      ]
    },
    {
      "fdaUniiCode": "7EFI23P78R",
      "id": "Anti-TGF-beta_Monoclonal_Antibody_SAR-439459",
      "preferredName": "Anti-TGF-beta Monoclonal Antibody SAR-439459",
      "synonyms": [
        "Anti-TGF-beta Monoclonal Antibody SAR-439459",
        "Anti-TGFb SAR-439459",
        "Anti-transforming Growth Factor-beta mAb SAR439459",
        "SAR 439459",
        "SAR-439459",
        "SAR439459"
      ]
    },
    {
      "fdaUniiCode": "GLR3JG8TZU",
      "id": "Pavurutamab",
      "preferredName": "Pavurutamab",
      "synonyms": [
        "AMG 701",
        "AMG-701",
        "AMG701",
        "Anti-BCMA x Anti-CD3 BiTE AMG 701",
        "Anti-BCMA/CD3 BiTE Antibody AMG 701",
        "BCMA/CD3-directed Bispecific T-cell Engager Antibody AMG 701",
        "BiTE Antibody AMG 701",
        "Bispecific T-cell Engager Antibody AMG 701",
        "PAVURUTAMAB",
        "Pavurutamab"
      ]
    },
    {
      "fdaUniiCode": "4NP0CFH7QL",
      "id": "Antibody-drug_Conjugate_SC-007",
      "preferredName": "Antibody-drug Conjugate SC-007",
      "synonyms": [
        "ADC SC-007",
        "Antibody-drug Conjugate SC-007",
        "SC-007"
      ]
    },
    {
      "fdaUniiCode": "28P3DU6DB3",
      "id": "Giredestrant",
      "preferredName": "Giredestrant",
      "synonyms": [
        "GDC 9545",
        "GDC-49545",
        "GIREDESTRANT",
        "Giredestrant",
        "RG6171",
        "SERD GDC-9545",
        "Selective Estrogen Receptor Degrader GDC-9545",
        "Selective Estrogen Receptor Downregulator GDC-9545"
      ]
    },
    {
      "fdaUniiCode": "L0O9OBI87E",
      "id": "Bizelesin",
      "preferredName": "Bizelesin",
      "synonyms": [
        "BIZELESIN",
        "Benzo(1,2-b:4,3-b')dipyrrol-4-ol, 6,6'-(carbonylbis(imino-1H-indole-5,2-diylcarbonyl))bis(8-(chloromethyl)-3,6,7,8-tetrahydro-1-methyl-, (S-(R*,R*)))-",
        "Benzo[1,2-b:4,3-b']dipyrrol-4-ol, 6, 6'-[carbonylbis(imino- 1H-indole-5, 2-diylcarbonyl)]bis[8-(chloromethyl)-3,6,7,8-tetrahydro-1-methyl-, (S-(R*,R*))]",
        "Bizelesin",
        "U-77779",
        "bizelesin"
      ]
    },
    {
      "fdaUniiCode": "D43WWD6RDZ",
      "id": "cEt_KRAS_Antisense_Oligonucleotide_AZD4785",
      "preferredName": "cEt KRAS Antisense Oligonucleotide AZD4785",
      "synonyms": [
        "ASO AZD4785",
        "AZD 4785",
        "AZD-4785",
        "AZD4785",
        "Generation 2.5 Drug AZD4785",
        "IONIS-KRAS-2.5Rx",
        "cEt KRAS ASO AZD4785",
        "cEt KRAS Antisense Oligonucleotide AZD4785"
      ]
    },
    {
      "fdaUniiCode": "K8RW1TW3EM",
      "id": "Orvacabtagene_Autoleucel",
      "preferredName": "Orvacabtagene Autoleucel",
      "synonyms": [
        "Autologous Anti-BCMA CAR-T Cells JCARH 125",
        "Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing CD4+/CD8+ T-lymphocytes JCARH125",
        "Autologous BCMA 41BBz CAR-T Cell JCARH-125",
        "Autologous BCMA-specific CAR-T Cells JCARH125",
        "Autologous BCMA-specific CAR4-1BB-CD3zeta-expressing CD4+/CD8+ T Lymphocytes JCARH 125",
        "JCARH 125",
        "JCARH-125",
        "JCARH125",
        "ORVACABTAGENE AUTOLEUCEL",
        "Orvacabtagene Autoleucel"
      ]
    },
    {
      "fdaUniiCode": "7H3Q0M9END",
      "id": "Anti-CD38CD3_Bispecific_Monoclonal_Antibody_GBR_1342",
      "preferredName": "Anti-CD38/CD3 Bispecific Monoclonal Antibody GBR 1342",
      "synonyms": [
        "Anti-CD38 x Anti-CD3 Bispecific Monoclonal Antibody GBR 1342",
        "Anti-CD38/Anti-CD3 Bispecific Monoclonal Antibody GBR 1342",
        "Anti-CD38/CD3 Bispecific Monoclonal Antibody GBR 1342",
        "BEAT GBR 1342",
        "CD38xCD3 BsAb GBR 1342",
        "GBR 1342",
        "GBR-1342",
        "GBR1342"
      ]
    },
    {
      "fdaUniiCode": "Q4MDA7821L",
      "id": "Upifitamab_Rilsodotin",
      "preferredName": "Upifitamab Rilsodotin",
      "synonyms": [
        "ADC XMT-1536",
        "Anti-NaPi2b ADC XMT-1536",
        "Anti-NaPi2b/Auristatin F-HPA ADC XMT-1536",
        "UPIFITAMAB RILSODOTIN",
        "Upifitamab Rilsodotin",
        "XMT 1536",
        "XMT-1536",
        "XMT1536"
      ]
    },
    {
      "fdaUniiCode": "15OY7NA275",
      "id": "Upifitamab",
      "preferredName": "Upifitamab",
      "synonyms": [
        "Anti-NaPi2b MoAb XMT-1535",
        "Anti-NaPi2b Monoclonal Antibody XMT-1535",
        "MoAb XMT-1535",
        "UPIFITAMAB",
        "Upifitamab",
        "XMT 1535",
        "XMT-1535",
        "XMT1535"
      ]
    },
    {
      "fdaUniiCode": "25E79B5CTM",
      "id": "Denileukin_Diftitox",
      "preferredName": "Denileukin Diftitox",
      "synonyms": [
        "DAB(389)-Interleukin-2",
        "DAB(389)IL-2",
        "DAB389 Interleukin-2",
        "DAB389 Interleukin-2 Immunotoxin",
        "DAB389IL-2",
        "DAB389IL2",
        "DENILEUKIN DIFTITOX",
        "Denileukin Diftitox",
        "Interleukin-2 Fusion Protein",
        "Interleukin-2 Fusion Toxin",
        "LY335348",
        "Ontak",
        "denileukin diftitox"
      ]
    },
    {
      "fdaUniiCode": "770140J08A",
      "id": "Imaradenant",
      "preferredName": "Imaradenant",
      "synonyms": [
        "A2AR Antagonist AZD4635",
        "AZD-4635",
        "AZD4635",
        "Adenosine A2A Receptor Antagonist AZD4635",
        "HTL-1071",
        "IMARADENANT",
        "Imaradenant"
      ]
    },
    {
      "fdaUniiCode": "P339Q7RL7K",
      "id": "Anti-TIM-3_Antibody_BMS-986258",
      "preferredName": "Anti-TIM-3 Antibody BMS-986258",
      "synonyms": [
        "Anti-TIM-3 Antibody BMS-986258",
        "Anti-TIM3 Antibody BMS-986258",
        "BMS 986258",
        "BMS-986258"
      ]
    },
    {
      "fdaUniiCode": "0D8BWL78LD",
      "id": "Anti-CD74_Antibody-drug_Conjugate_STRO-001",
      "preferredName": "Anti-CD74 Antibody-drug Conjugate STRO-001",
      "synonyms": [
        "ADC STRO-001",
        "Anti-CD74 ADC STRO-001",
        "Anti-CD74 Antibody-drug Conjugate STRO-001",
        "SP7675",
        "STRO-001"
      ]
    },
    {
      "fdaUniiCode": "0XMR8L9LOL",
      "id": "Mezagitamab",
      "preferredName": "Mezagitamab",
      "synonyms": [
        "Anti-CD38 MAb TAK-079",
        "MEZAGITAMAB",
        "Mezagitamab",
        "TAK 079",
        "TAK-079",
        "TAK079"
      ]
    },
    {
      "fdaUniiCode": "LK0H7J2V3C",
      "id": "Tepoditamab",
      "preferredName": "Tepoditamab",
      "synonyms": [
        "Anti-CLEC12A x CD3 Bispecific Antibody MCLA117",
        "Anti-CLEC12A/Anti-CD3 Bispecific Antibody MCLA117",
        "Bispecific Antibody MCLA-117",
        "Immunoglobulin G1, Bispecific, Anti-(C-type lectin CLEC12A and CD3 Antigen) (Human Monoclonal MCLA-117 Gamma1-chain), Disulfide with Human Monoclonal MCLA-117 Kappa-chain, Dimer",
        "MCLA 117",
        "MCLA-117",
        "MCLA117",
        "TEPODITAMAB",
        "Tepoditamab"
      ]
    },
    {
      "fdaUniiCode": "G6UF363ECX",
      "id": "Lutetium_Lu_177__Vipivotide_Tetraxetan",
      "preferredName": "Lutetium Lu 177  Vipivotide Tetraxetan",
      "synonyms": [
        "177Lu-PSMA-617",
        "177Lu-labeled PSMA-617",
        "LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN",
        "Lu177-PSMA-617",
        "Lutetium Lu 177  Vipivotide Tetraxetan",
        "Lutetium Lu 177-PSMA-617"
      ]
    },
    {
      "fdaUniiCode": "4A2Y23XK11",
      "id": "Lazertinib",
      "preferredName": "Lazertinib",
      "synonyms": [
        "GNS-1480",
        "LAZERTINIB",
        "Lazertinib",
        "N-{5-[(4-{4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl}pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl}prop-2-enamide",
        "YH 25448",
        "YH-25448",
        "YH25448"
      ]
    },
    {
      "fdaUniiCode": "W05CP6IT8R",
      "id": "Prolgolimab",
      "preferredName": "Prolgolimab",
      "synonyms": [
        "BCD 100",
        "BCD-100",
        "BCD100",
        "PROLGOLIMAB",
        "Prolgolimab"
      ]
    },
    {
      "fdaUniiCode": "3C28VJ95EV",
      "id": "Anti-BCMA_Antibody_SEA-BCMA",
      "preferredName": "Anti-BCMA Antibody SEA-BCMA",
      "synonyms": [
        "Anti-BCMA Afucosylated Monoclonal Antibody SEA-BCMA",
        "Anti-BCMA Antibody SEA-BCMA",
        "SEA-BCMA"
      ]
    },
    {
      "fdaUniiCode": "4WE915J1KX",
      "id": "Squalamine_Lactate",
      "preferredName": "Squalamine Lactate",
      "synonyms": [
        "3beta-N-1-(N-(3-(4-Aminobutyl))-1,3-diaminopropane)-7alpha,24-dihydroxy-5alpha-cholestane 24-sulfate",
        "MSI-1256F",
        "SQUALAMINE LACTATE",
        "Squalamine",
        "Squalamine Lactate",
        "squalamine lactate"
      ]
    },
    {
      "fdaUniiCode": "GD1ZWN2I2Y",
      "id": "MVA-BN-Brachyury-TRICOM_Vaccine",
      "preferredName": "MVA-BN-Brachyury-TRICOM Vaccine",
      "synonyms": [
        "MVA-BN-BRACHYURY-TRICOM VACCINE",
        "MVA-BN-Brachyury",
        "MVA-BN-Brachyury Prime Vaccine",
        "MVA-BN-Brachyury-TRICOM Vaccine"
      ]
    },
    {
      "fdaUniiCode": "3ZQ57V6YWZ",
      "id": "Delolimogene_Mupadenorepvec",
      "preferredName": "Delolimogene Mupadenorepvec",
      "synonyms": [
        "DELOLIMOGENE MUPADENOREPVEC",
        "Delolimogene Mupadenorepvec",
        "LOAd 703",
        "LOAd-703",
        "LOAd703",
        "Oncolytic Adenovirus LOAd703"
      ]
    },
    {
      "fdaUniiCode": "0L1F17908Q",
      "id": "Ciltacabtagene_Autoleucel",
      "preferredName": "Ciltacabtagene Autoleucel",
      "synonyms": [
        "Autologous Anti-BCMA CAR-T Cells JNJ-68284528",
        "Autologous Bi-epitope BCMA-targeted CAR T-cells JNJ-68284528",
        "Autologous Bi-epitope CAR T-cells JNJ-68284528",
        "CILTACABTAGENE AUTOLEUCEL",
        "Cilta-cel",
        "Ciltacabtagene Autoleucel",
        "JNJ-68284528",
        "LCAR-B38M",
        "LCAR-B38M-transduced CAR-T Cells JNJ-68284528",
        "LCAR-B38M-transduced Car-T Cells JNJ-68284528"
      ]
    },
    {
      "fdaUniiCode": "H19C446XXB",
      "id": "Rubitecan",
      "preferredName": "Rubitecan",
      "synonyms": [
        "9-NC",
        "9-Nitro-20(S)-camptothecin",
        "9-nitrocamptothecin",
        "Camptogen",
        "Nitrocamptothecin",
        "Orathecin",
        "RFS 2000",
        "RUBITECAN",
        "Rubitecan",
        "nitrocamptothecin"
      ]
    },
    {
      "fdaUniiCode": "1WX8O5XV4R",
      "id": "Aurora_A_Kinase_Inhibitor_LY3295668",
      "preferredName": "Aurora A Kinase Inhibitor LY3295668",
      "synonyms": [
        "AK 01",
        "AK-01",
        "Aurora A Kinase Inhibitor LY3295668",
        "LY 3295668",
        "LY-3295668",
        "LY3295668"
      ]
    },
    {
      "fdaUniiCode": "IN59K53GI9",
      "id": "Vilaprisan",
      "preferredName": "Vilaprisan",
      "synonyms": [
        "(8S,11R,13S,14S,17S)-17-hydroxy-13-methyl-11-(4-methylsulfonylphenyl)-17-(1,1,2,2,2-pentafluoroethyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one",
        "BAY 1002670",
        "BAY-1002670",
        "BAY1002670",
        "VILAPRISAN",
        "Vilaprisan"
      ]
    },
    {
      "fdaUniiCode": "91PZ0ZWR8S",
      "id": "Anti-EGFRDM1_Antibody-drug_Conjugate_AVID100",
      "preferredName": "Anti-EGFR/DM1 Antibody-drug Conjugate AVID100",
      "synonyms": [
        "ADC AVID100",
        "AVID-100",
        "AVID100",
        "Anti-EGFR/DM1 Antibody-drug Conjugate AVID100",
        "Antibody-drug Conjugate AVID100"
      ]
    },
    {
      "fdaUniiCode": "RM15YYQ1CI",
      "id": "mTORC_12_Inhibitor_LXI-15029",
      "preferredName": "mTORC 1/2 Inhibitor LXI-15029",
      "synonyms": [
        "LXI-15029",
        "LXI15029",
        "MTI-31",
        "SCC-31",
        "mTORC 1/2 Inhibitor LXI-15029"
      ]
    },
    {
      "fdaUniiCode": "R7I5725FES",
      "id": "Ningetinib_Tosylate",
      "preferredName": "Ningetinib Tosylate",
      "synonyms": [
        "CT-053 Tosylate",
        "CT-053-PTSA",
        "CT-053PTSA",
        "NINGETINIB TOSYLATE",
        "Ningetinib Tosylate"
      ]
    },
    {
      "fdaUniiCode": "1XBY50W1OX",
      "id": "Adebrelimab",
      "preferredName": "Adebrelimab",
      "synonyms": [
        "ADEBRELIMAB",
        "Adebrelimab",
        "HTI-1088",
        "SHR-1316"
      ]
    },
    {
      "fdaUniiCode": "5MB77ICE2Q",
      "id": "Aminocamptothecin",
      "preferredName": "Aminocamptothecin",
      "synonyms": [
        "9-AC",
        "9-AMINOCAMPTOTHECIN",
        "9-Amino-20-(S)-camptothecin",
        "9-amino-20(S)-camptothecin",
        "9-amino-20-camptothecin",
        "9-amino-CPT",
        "9-amino-camptothecin",
        "9-aminocamptothecin",
        "Aminocamptothecin",
        "aminocamptothecin"
      ]
    },
    {
      "fdaUniiCode": "5TAA004E22",
      "id": "Sargramostim",
      "preferredName": "Sargramostim",
      "synonyms": [
        "23-L-Leucinecolony-Stimulating Factor 2",
        "DRG-0012",
        "Leukine",
        "Prokine",
        "SARGRAMOSTIM",
        "Sagramostim",
        "Sargramostatin",
        "Sargramostim",
        "rhu GM-CFS",
        "sargramostim"
      ]
    },
    {
      "fdaUniiCode": "8D7B37T28G",
      "id": "Satraplatin",
      "preferredName": "Satraplatin",
      "synonyms": [
        "(OC-6-43)-bis(acetato)amminedichloro(cyclohexylamine)platinum",
        "(OC-6-43)-bis(acetato-O)amminedichloro(cyclohexanamine)platinum",
        "BMS-182751",
        "BMY-45594",
        "JM 216",
        "JM-216",
        "Orplatna",
        "SATRAPLATIN",
        "Satraplatin",
        "platinum,bis(acetato-O)amminedichloro(cyclohexanamine)-,(OC-6-43)",
        "satraplatin"
      ]
    },
    {
      "fdaUniiCode": "79T6JRG308",
      "id": "Arcitumomab",
      "preferredName": "Arcitumomab",
      "synonyms": [
        "ARCITUMOMAB",
        "Arcitumomab",
        "CEA-Scan",
        "IMMU-4",
        "Immunoglobulin G 1 (mouse monoclonal IMMU-4 Fab' fragment gamma-chain anti-human antigen CEA), disulfide with mouse Monoclonal IMMU-4 Light Chain"
      ]
    },
    {
      "fdaUniiCode": "FB2CIN6HMI",
      "id": "Intoplicine",
      "preferredName": "Intoplicine",
      "synonyms": [
        "7H-benzo(e)pyrido(4,3-b)indol-3-ol, 11-((3-(dimethylamino)propyl)amino)-8-methyl",
        "INTOPLICINE",
        "Intoplicine",
        "intoplicine"
      ]
    },
    {
      "fdaUniiCode": "M89N0Q7EQR",
      "id": "Aldesleukin",
      "preferredName": "Aldesleukin",
      "synonyms": [
        "125-L-Serine-2-133-interleukin 2",
        "ALDESLEUKIN",
        "Aldesleukin",
        "Proleukin",
        "Recombinant Human IL-2",
        "Recombinant Human Interleukin-2",
        "aldesleukin",
        "r-serHuIL-2",
        "recombinant human interleukin-2"
      ]
    },
    {
      "fdaUniiCode": "355G9R500Y",
      "id": "Phenyl_Acetate",
      "preferredName": "Phenyl Acetate",
      "synonyms": [
        "Acetic Acid Phenyl Ester",
        "Acetylphenol",
        "PHENYL ACETATE",
        "Phenyl Acetate",
        "Phenyl acetate",
        "phenylacetate"
      ]
    },
    {
      "fdaUniiCode": "YQ4C0NDW44",
      "id": "Anti-BCMAPBD_ADC_MEDI2228",
      "preferredName": "Anti-BCMA/PBD ADC MEDI2228",
      "synonyms": [
        "ADC MEDI2228",
        "Anti-BCMA ADC MEDI2228",
        "Anti-BCMA/PBD ADC MEDI2228",
        "Anti-BCMA/PBD MEDI2228",
        "Antibody-drug Conjugate MEDI2228",
        "MEDI 2228",
        "MEDI-2228",
        "MEDI2228"
      ]
    },
    {
      "fdaUniiCode": "CI43QFE22O",
      "id": "ATM_Kinase_Inhibitor_AZD1390",
      "preferredName": "ATM Kinase Inhibitor AZD1390",
      "synonyms": [
        "7-Fluoro-1-isopropyl-3-methyl-8-(6-(3-(piperidin-1-yl)propoxy)pyridin-3-yl)-1H-imidazo[4,5-c]quinolin-2(3H)-one",
        "ATM Kinase Inhibitor AZD1390",
        "AZD-1390",
        "AZD1390"
      ]
    },
    {
      "fdaUniiCode": "11267UI968",
      "id": "APE1Ref-1_Redox_Inhibitor_APX3330",
      "preferredName": "APE1/Ref-1 Redox Inhibitor APX3330",
      "synonyms": [
        "APE1/Ref-1 Inhibitor APX3330",
        "APE1/Ref-1 Redox Inhibitor APX3330",
        "APX 3330",
        "APX-3330",
        "APX3330",
        "E 3330",
        "E3330",
        "[(2E)-2-[(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene]-undecanoic Acid"
      ]
    },
    {
      "fdaUniiCode": "65ILH3Y0MI",
      "id": "Selective_Human_Estrogen-receptor_Alpha_Partial_Agonist_TTC-352",
      "preferredName": "Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352",
      "synonyms": [
        "3-(4-Fluorophenyl)-2-(4-hydroxyphenoxy)benzo[b]thiophen-6-ol",
        "ERa Partial Agonist TTC-352",
        "SEM TTC-352",
        "Selective Estrogen Mimic TTC-352",
        "Selective Estrogen Modulator TTC-352",
        "Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352",
        "ShERPA TTC-352",
        "TTC 352",
        "TTC-352"
      ]
    },
    {
      "fdaUniiCode": "089658A12D",
      "id": "Guselkumab",
      "preferredName": "Guselkumab",
      "synonyms": [
        "CNTO 1959",
        "GUSELKUMAB",
        "Guselkumab",
        "Tremfya"
      ]
    },
    {
      "fdaUniiCode": "NVCTROPV3P",
      "id": "Miptenalimab",
      "preferredName": "Miptenalimab",
      "synonyms": [
        "Anti-LAG3 Monoclonal Antibody BI 754111",
        "Anti-Lymphocyte Activation Gene 3 Protein Monoclonal Antibody BI 754111",
        "BI 754111",
        "BI-754111",
        "BI754111",
        "MIPTENALIMAB",
        "Miptenalimab"
      ]
    },
    {
      "fdaUniiCode": "B33561JJ61",
      "id": "Telaglenastat_Hydrochloride",
      "preferredName": "Telaglenastat Hydrochloride",
      "synonyms": [
        "2-Pyridineacetamide, N-(5-(4-(6-((2-(3-(trifluoromethoxy)phenyl)acetyl)amino)-3-pyridazinyl)butyl)-1,3,4-thiadiazol-2-yl)-, Hydrochloride (1:1)",
        "CB-839 HCl",
        "Glutaminase Inhibitor CB-839 Hydrochloride",
        "TELAGLENASTAT HYDROCHLORIDE",
        "Telaglenastat Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "VSS4ZDZ2IE",
      "id": "Radgocitabine_Hydrochloride",
      "preferredName": "Radgocitabine Hydrochloride",
      "synonyms": [
        "2'-Cyano-2'-deoxy-1-(beta-D-arabinofuranosyl)cytosine Monohydrochloride",
        "CNDAC Hydrochloride",
        "Deoxycytidine Analogue TAS-109 Hydrochloride",
        "RADGOCITABINE HYDROCHLORIDE",
        "Radgocitabine Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "4I9I5X3Z6N",
      "id": "Vudalimab",
      "preferredName": "Vudalimab",
      "synonyms": [
        "Anti-PD-1/Anti-CTLA-4 XmAb20717",
        "Anti-PD1/CTLA4 Bispecific Antibody XmAb20717",
        "PD-1 x CTLA-4 Bispecific Antibody XmAb20717",
        "PD-1 x CTLA-4 Dual Checkpoint Inhibitor XmAb20717",
        "VUDALIMAB",
        "Vudalimab",
        "XmAb 20717",
        "XmAb20717"
      ]
    },
    {
      "fdaUniiCode": "7W0O278T12",
      "id": "Serclutamab_Talirine",
      "preferredName": "Serclutamab Talirine",
      "synonyms": [
        "ABBV 321",
        "ABBV-321",
        "ABBV321",
        "ADC ABBV-321",
        "Anti-EGFR/PBD ADC ABBV-321",
        "SERCLUTAMAB TALIRINE",
        "Serclutamab Talirine"
      ]
    },
    {
      "fdaUniiCode": "GG0AN49Y59",
      "id": "Quavonlimab",
      "preferredName": "Quavonlimab",
      "synonyms": [
        "Anti-CTLA-4 Monoclonal Antibody MK-1308",
        "MK 1308",
        "MK-1308",
        "MK1308",
        "QUAVONLIMAB",
        "Quavonlimab"
      ]
    },
    {
      "fdaUniiCode": "44D51T6SZH",
      "id": "SIRPa-IgG4-Fc_Fusion_Protein_TTI-622",
      "preferredName": "SIRPa-IgG4-Fc Fusion Protein TTI-622",
      "synonyms": [
        "SIRPa-IgG4 Fc",
        "SIRPa-IgG4 Fc TTI-622",
        "SIRPa-IgG4-Fc Fusion Protein TTI-622",
        "TTI 622",
        "TTI-622",
        "TTI622"
      ]
    },
    {
      "fdaUniiCode": "RYH2T97J77",
      "id": "Ranimustine",
      "preferredName": "Ranimustine",
      "synonyms": [
        "Cymer",
        "Cymerin",
        "MCNU",
        "RANIMUSTINE",
        "Ranimustine",
        "Ranomustine",
        "alpha-D-glucopyranoside, methyl 6-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-6-deoxy-",
        "methyl 6-((((2-chloroethyl)nitrosoamino)carbonyl) amino)-6-deoxy-alpha-D-glucopyranoside",
        "methyl 6-(3-(2-chloroethyl)-3-nitrosoiureido)-6-deoxy-alpha-D-glucopyranoside",
        "methyl 6-(3-(2-chloroethyl)-3-nitrosoureido)-6-deoxy-alpha-D-glucopyranoside"
      ]
    },
    {
      "fdaUniiCode": "80O63P88IS",
      "id": "Stallimycin",
      "preferredName": "Stallimycin",
      "synonyms": [
        "DISTAMYCIN A",
        "Distamycin 3",
        "Distamycin A",
        "Herperetin",
        "STALLIMYCIN",
        "Stallimycin"
      ]
    },
    {
      "fdaUniiCode": "YX9162EO3I",
      "id": "Raloxifene",
      "preferredName": "Raloxifene",
      "synonyms": [
        "Keoxifene",
        "LY 139481",
        "RALOXIFENE",
        "Raloxifene",
        "[6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone",
        "raloxifene"
      ]
    },
    {
      "fdaUniiCode": "372T2944C0",
      "id": "Roquinimex",
      "preferredName": "Roquinimex",
      "synonyms": [
        "1,2-Dihydro-4-hydroxy-N,1-dimethyl-2-oxo-3-quinolinecarboxanilide",
        "1,2-Dihydro-4-hydroxy-N,1-dimethyl-2-oxo-N-phenyl-3-quinolinecarboxamide",
        "FCF 89",
        "LS 2616",
        "Linomide",
        "N-Phenyl-N-methyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxoquinoline-3-carboxamide",
        "ROQUINIMEX",
        "Roquinimex"
      ]
    },
    {
      "fdaUniiCode": "L0QBZ37386",
      "id": "Cinobufotalin",
      "preferredName": "Cinobufotalin",
      "synonyms": [
        "14,15b-Epoxy-3b,5a,16b-trihydroxy-5b,20(22)-bufadienolide 16-Acetate",
        "5-Beta-bufa-20,22-dienolide, 14,15-beta-epoxy-3-beta,5,16-beta-trihydroxy-, 16-Acetate",
        "5b,20(22)-Bufadienolide-14,15b-epoxy-3b,5a,16b-triol 16-Acetate",
        "CB",
        "CINOBUFOTALIN",
        "Cinobufotalin"
      ]
    },
    {
      "fdaUniiCode": "KZ3DLD11RQ",
      "id": "STAT3_Inhibitor_C-188-9",
      "preferredName": "STAT3 Inhibitor C-188-9",
      "synonyms": [
        "C-188-9",
        "C188-9",
        "STAT3 Inhibitor C-188-9",
        "STAT3 Inhibitor TTI-101",
        "STAT3 Inhibitor XIII",
        "TTI 101",
        "TTI-101",
        "TTI101"
      ]
    },
    {
      "fdaUniiCode": "UQE6KP7T0D",
      "id": "Onilcamotide",
      "preferredName": "Onilcamotide",
      "synonyms": [
        "ONILCAMOTIDE",
        "Onilcamotide",
        "RV 001",
        "RV 001V",
        "RV001 Vaccine",
        "RV001V",
        "RhoC Peptide Vaccine RV001V"
      ]
    },
    {
      "fdaUniiCode": "PNW7GBB44P",
      "id": "Cosibelimab",
      "preferredName": "Cosibelimab",
      "synonyms": [
        "CK 301",
        "CK-301",
        "COSIBELIMAB",
        "Cosibelimab"
      ]
    },
    {
      "fdaUniiCode": "E5GE91Q5FX",
      "id": "CD16IL15CD33_Trispecific_Killer_Cell_Engager_OXS-3550",
      "preferredName": "CD16/IL15/CD33 Trispecific Killer Cell Engager OXS-3550",
      "synonyms": [
        "161533",
        "161533 TRIKE",
        "CD16/IL-15/CD33 161533 Tri-Specific Killer Engagers",
        "CD16/IL15/CD33 TriKE OXS-3550",
        "CD16/IL15/CD33 Trispecific Killer Cell Engager OXS-3550",
        "OXIS3550",
        "OXS 3550",
        "OXS-3550",
        "OXS3550"
      ]
    },
    {
      "fdaUniiCode": "K424WH3WU0",
      "id": "Trotabresib",
      "preferredName": "Trotabresib",
      "synonyms": [
        "4-(2-(Cyclopropylmethoxy)-5-methylsulfonylphenyl)-2-methylisoquinolin-1-one",
        "BET Inhibitor CC-90010",
        "CC 90010",
        "CC-90010",
        "CC90010",
        "TROTABRESIB",
        "Trotabresib"
      ]
    },
    {
      "fdaUniiCode": "OJ72N0B4UC",
      "id": "Glyco-engineered_Anti-CD20_Monoclonal_Antibody_CHO_H01",
      "preferredName": "Glyco-engineered Anti-CD20 Monoclonal Antibody CHO H01",
      "synonyms": [
        "CHO H01",
        "CHO-H01",
        "Glyco-engineered Anti-CD20 Monoclonal Antibody CHO H01"
      ]
    },
    {
      "fdaUniiCode": "56DL1J49LR",
      "id": "HSP90-targeted_SN-38_Conjugate_PEN-866",
      "preferredName": "HSP90-targeted SN-38 Conjugate PEN-866",
      "synonyms": [
        "HDC SN-38",
        "HSP90-targeted SN-38 Conjugate PEN-866",
        "PEN 866",
        "PEN-866",
        "PEN866",
        "STA-12-8666",
        "STA-8666"
      ]
    },
    {
      "fdaUniiCode": "GD2OWY1DTK",
      "id": "Datopotamab_Deruxtecan",
      "preferredName": "Datopotamab Deruxtecan",
      "synonyms": [
        "ADC DS-1062a",
        "Anti-TROP2/DXd Antibody-drug Conjugate DS-1062a",
        "DATOPOTAMAB DERUXTECAN",
        "DS-1062",
        "DS-1062a",
        "Datopotamab Deruxtecan"
      ]
    },
    {
      "fdaUniiCode": "3B512HJD65",
      "id": "Ebvaciclib",
      "preferredName": "Ebvaciclib",
      "synonyms": [
        "CDK Inhibitor PF-06873600",
        "EBVACICLIB",
        "Ebvaciclib",
        "PF 06873600",
        "PF-06873600"
      ]
    },
    {
      "fdaUniiCode": "96521WL61B",
      "id": "Teloxantrone",
      "preferredName": "Teloxantrone",
      "synonyms": [
        "Anthra(1,9-cd)pyrazol-6(2H)-one,7,10-dihydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)-5-((2-(methylamino)ethyl)amino)-",
        "CI-937",
        "Moxantrazole",
        "TELOXANTRONE",
        "Teloxantrone"
      ]
    },
    {
      "fdaUniiCode": "1W7BD1M08N",
      "id": "Modotuximab",
      "preferredName": "Modotuximab",
      "synonyms": [
        "1024 DS",
        "1024-DS",
        "Immunoglobulin G1, Anti-(human epidermal growth factor receptor extracellular domain III) (human-mus musculus monoclonal 1024 DS heavy chain), Disulfide with human-mus musculus monoclonal 1024 DS light chain, Dimer",
        "MODOTUXIMAB",
        "Modotuximab",
        "Zatuximab"
      ]
    },
    {
      "fdaUniiCode": "47KPH00809",
      "id": "Losoxantrone",
      "preferredName": "Losoxantrone",
      "synonyms": [
        "Biantrazole",
        "CI-941",
        "DuP 941",
        "LOSOXANTRONE",
        "Losoxantrone",
        "losoxantrone"
      ]
    },
    {
      "fdaUniiCode": "I66ZZ0ZN0E",
      "id": "Troglitazone",
      "preferredName": "Troglitazone",
      "synonyms": [
        "5-((4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy)phenyl)methyl)-2,4-Thiazolidinedione",
        "5-[4-[(6-Hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy]benzyl]-2,4-thiazolidinedione",
        "CI-991",
        "CS-045",
        "Prelay",
        "Rezulin",
        "Romozin",
        "TROGLITAZONE",
        "Troglitazone"
      ]
    },
    {
      "fdaUniiCode": "4RKY41TBTF",
      "id": "Silibinin",
      "preferredName": "Silibinin",
      "synonyms": [
        "SILIBININ",
        "Silibinin"
      ]
    },
    {
      "fdaUniiCode": "91W7VLK7J3",
      "id": "Liarozole_Fumarate",
      "preferredName": "Liarozole Fumarate",
      "synonyms": [
        "(+-)-5-(m-Chloro-alpha-imidazol-1-ylbenzyl)benzimidazole Fumarate (2:3)",
        "1H-Benzimidazole, 5-((3-chlorophenyl)-1H-imidazol-1-ylmethyl)-, (+-)-, (E)-2-butenedioate (2:3)",
        "LIAROZOLE FUMARATE",
        "Liarozole Fumarate",
        "R85246"
      ]
    },
    {
      "fdaUniiCode": "ZAU91150SB",
      "id": "Tefinostat",
      "preferredName": "Tefinostat",
      "synonyms": [
        "CHR 2845",
        "CHR-2845",
        "CHR2845",
        "TEFINOSTAT",
        "Tefinostat"
      ]
    },
    {
      "fdaUniiCode": "15H5577CQD",
      "id": "Docetaxel",
      "preferredName": "Docetaxel",
      "synonyms": [
        "DOCETAXEL",
        "Docecad",
        "Docetaxel",
        "N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol",
        "RP56976",
        "Taxotere",
        "Taxotere Injection Concentrate",
        "[2aR-[2a alphaa,4beta,4a beta,6beta,9alpha,(alphaR*,betaS*),-11alpha,12alpha,12a alpha,12b alpha]]-beta-[[(1,1-dimethylethoxy)carbonyl]-amino]-alpha-hydroxybenzemepropanoic Acid 12b-(Acetyloxy)-12(benzyloxy)-2a,3,4,4a,5,6,8,10,11,12,12a,12b-dodecahydeo-4,-6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester",
        "docetaxel"
      ]
    },
    {
      "fdaUniiCode": "R1ZJT87990",
      "id": "Tigilanol_Tiglate",
      "preferredName": "Tigilanol Tiglate",
      "synonyms": [
        "EBC-46",
        "EBI-46",
        "TIGILANOL TIGLATE",
        "Tigilanol Tiglate"
      ]
    },
    {
      "fdaUniiCode": "7LKK855W8I",
      "id": "Letrozole",
      "preferredName": "Letrozole",
      "synonyms": [
        "4,4'-(1H-1,2,4triazol-1-ylmethylene)dibenzonitrile",
        "CGS 20267",
        "Femara",
        "LETROZOLE",
        "Letrozole",
        "letrozole"
      ]
    },
    {
      "fdaUniiCode": "BSB9VJ5TUT",
      "id": "Trametinib_Dimethyl_Sulfoxide",
      "preferredName": "Trametinib Dimethyl Sulfoxide",
      "synonyms": [
        "Mekinist",
        "TRAMETINIB DIMETHYL SULFOXIDE",
        "Trametinib Dimethyl Sulfoxide"
      ]
    },
    {
      "fdaUniiCode": "FU8XW5V3FS",
      "id": "Umbralisib_Tosylate",
      "preferredName": "Umbralisib Tosylate",
      "synonyms": [
        "UMBRALISIB TOSYLATE",
        "Ukoniq",
        "Umbralisib Tosylate"
      ]
    },
    {
      "fdaUniiCode": "BK349F52C9",
      "id": "Batimastat",
      "preferredName": "Batimastat",
      "synonyms": [
        "(2R,3S)-N{4}-Hydroxy-N{1}-[(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]butanediamide",
        "BATIMASTAT",
        "BB-94",
        "BB94",
        "Batimastat",
        "Butanediamide, N4-hydroxy-N1-(2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl)-2-(2-methylpropyl)-3-((2-thienylthio)methyl)-, (2R-(1(S*),2R*,3S*))-",
        "[4-(N-Hydroxyamino)-2R-isobutyl-3S-(2-thienylthiomethyl)-succinyl]-L-phenylalanine-N-methylamide",
        "[4-(N-Hydroxyamino)-2R-isobutyl-3S-(thiophen-2-ylthiomethyl)-succinyl]-L-phenylalanine-N-methylamide",
        "batimastat"
      ]
    },
    {
      "fdaUniiCode": "789Q85GA8P",
      "id": "Vorasidenib",
      "preferredName": "Vorasidenib",
      "synonyms": [
        "AG 881",
        "AG-881",
        "AG881",
        "VORASIDENIB",
        "Vorasidenib"
      ]
    },
    {
      "fdaUniiCode": "AE72RB1W1X",
      "id": "Zenocutuzumab",
      "preferredName": "Zenocutuzumab",
      "synonyms": [
        "Anti-HER2 x Anti-HER3 Bispecific Monoclonal Antibody MCLA-128",
        "Anti-HER2/Anti-HER3 Bispecific Monoclonal Antibody MCLA-128",
        "MCLA 128",
        "MCLA-128",
        "MCLA128",
        "ZENOCUTUZUMAB",
        "Zenocutuzumab"
      ]
    },
    {
      "fdaUniiCode": "B37J680LX0",
      "id": "Futuximab",
      "preferredName": "Futuximab",
      "synonyms": [
        "992 DS",
        "992-DS",
        "992DS",
        "FUTUXIMAB",
        "Futuximab",
        "Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Extracellular Domain III) (Human-Mus Musculus Monoclonal 992 DS Heavy Chain), Disulfide with Human-Mus Musculus Monoclonal 992 DS Light Chain, Dimer"
      ]
    },
    {
      "fdaUniiCode": "2138WW3F3R",
      "id": "Epitinib_Succinate",
      "preferredName": "Epitinib Succinate",
      "synonyms": [
        "EPITINIB SUCCINATE",
        "Epitinib Succinate",
        "HMPL 813",
        "HMPL-813",
        "HMPL813"
      ]
    },
    {
      "fdaUniiCode": "6BUL1G4D60",
      "id": "Anti-MUC16CD3_Bispecific_Antibody_REGN4018",
      "preferredName": "Anti-MUC16/CD3 Bispecific Antibody REGN4018",
      "synonyms": [
        "Anti-MUC16 x Anti-CD3 REGN4018",
        "Anti-MUC16/CD3 Bispecific Antibody REGN4018",
        "REGN 4018",
        "REGN-4018",
        "REGN4018"
      ]
    },
    {
      "fdaUniiCode": "C416JC9CX0",
      "id": "Anti-NY-ESO1LAGE-1A_TCRscFv_Anti-CD3_IMCnyeso",
      "preferredName": "Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso",
      "synonyms": [
        "Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso",
        "Bispecific NY-ESO-1- and LAGE-1A-specific TCR/Anti-CD3",
        "HLA- A*0201-Restricted NY-ESO-1- and LAGE-1A-specific Soluble TCR/Anti-CD3 Bispecific Molecule",
        "IMCNYESO",
        "IMCnyeso"
      ]
    },
    {
      "fdaUniiCode": "H6KN31H3XF",
      "id": "Anti-PD-1_Monoclonal_Antibody_LZM009",
      "preferredName": "Anti-PD-1 Monoclonal Antibody LZM009",
      "synonyms": [
        "ANTI-PD-1 MONOCLONAL ANTIBODY LZM009",
        "Anti-PD-1 Monoclonal Antibody LZM009",
        "LZM 009",
        "LZM-009",
        "LZM009"
      ]
    },
    {
      "fdaUniiCode": "1BU5EGF80S",
      "id": "Tilogotamab",
      "preferredName": "Tilogotamab",
      "synonyms": [
        "DR5 HexaBody Agonist GEN1029",
        "GEN 1029",
        "GEN1029",
        "HexaBody-DR5-01/DR5-05",
        "HexaBody-DR5/DR5",
        "Hx-DR5-01/05",
        "TILOGOTAMAB",
        "Tilogotamab"
      ]
    },
    {
      "fdaUniiCode": "JI5TBH62QP",
      "id": "Anti-Globo_H_Monoclonal_Antibody_OBI-888",
      "preferredName": "Anti-Globo H Monoclonal Antibody OBI-888",
      "synonyms": [
        "Anti-Globo H Monoclonal Antibody OBI-888",
        "OBI 888",
        "OBI-888",
        "OBI888"
      ]
    },
    {
      "fdaUniiCode": "2PKU919BA9",
      "id": "Pemetrexed_Disodium",
      "preferredName": "Pemetrexed Disodium",
      "synonyms": [
        "Alimta",
        "Almita",
        "LY231514",
        "N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid Disodium Salt",
        "PEMETREXED DISODIUM",
        "Pemetrexed Disodium",
        "pemetrexed disodium"
      ]
    },
    {
      "fdaUniiCode": "GTB859B7K8",
      "id": "Exicorilant",
      "preferredName": "Exicorilant",
      "synonyms": [
        "CORT 125281",
        "CORT-1252",
        "CORT125281",
        "EXICORILANT",
        "Exicorilant",
        "Glucocorticoid Receptor Antagonist CORT125281",
        "Methanone, ((4aR,8aS)-1-(4-Fluorophenyl)-1,4,5,6,7,8,8a,9-octahydro-6-((2-methyl-2H-1,2,3-triazol-4-yl)sulfonyl)-4ah-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)-",
        "WHO 10854"
      ]
    },
    {
      "fdaUniiCode": "2UG29YVL56",
      "id": "Guretolimod",
      "preferredName": "Guretolimod",
      "synonyms": [
        "(((4-((2-Amino-4-(((3s)-1-hydroxyhexan-3-yl)amino)-6-methylpyrimidin-5-yl)methyl)-3- methoxyphenyl)methyl)(2,2,2-trifluoroethyl)amino)acetic Acid",
        "DSP 0509",
        "DSP-0509",
        "DSP0509",
        "GURETOLIMOD",
        "Guretolimod",
        "TLR7 Agonist DSP-0509",
        "Toll-like Receptor 7 Agonist DSP-0509"
      ]
    },
    {
      "fdaUniiCode": "JL7V54Z2BR",
      "id": "Aspacytarabine",
      "preferredName": "Aspacytarabine",
      "synonyms": [
        "ASPACYTARABINE",
        "Ara-C Asparagine Conjugate",
        "Aspacytarabine",
        "Asparagine Ara-C Conjugate",
        "Asparagine Cytarabine Conjugate",
        "Astarabine",
        "BST 236",
        "BST-236",
        "BST236",
        "Cytarabine Asparagine Conjugate"
      ]
    },
    {
      "fdaUniiCode": "26R60S6A5I",
      "id": "Pterostilbene",
      "preferredName": "Pterostilbene",
      "synonyms": [
        "3',5'-Dimethoxy-4-stilbenol",
        "3,5-Dimethoxy-4'-hydroxystilbene",
        "PTEROSTILBENE",
        "Phenol, 4-(2-(3,5-Dimethoxyphenyl)ethenyl)-, (E)-",
        "Pterostilbene",
        "Trans-3,5-dimethoxy-4-hydroxystilbene"
      ]
    },
    {
      "fdaUniiCode": "5B2546MB5Z",
      "id": "Elagolix",
      "preferredName": "Elagolix",
      "synonyms": [
        "ABT-620",
        "Butanoic Acid, 4-(((1R)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl)-1-phenylethyl)amino)-",
        "ELAGOLIX",
        "Elagolix",
        "NBI 56418",
        "NBI-56418",
        "Orilissa"
      ]
    },
    {
      "fdaUniiCode": "ND296JF21I",
      "id": "Nidanilimab",
      "preferredName": "Nidanilimab",
      "synonyms": [
        "CAN 04",
        "CAN-04",
        "CAN04",
        "NIDANILIMAB",
        "Nidanilimab"
      ]
    },
    {
      "fdaUniiCode": "6FYG1DS4NW",
      "id": "Anti-PD-1CTLA-4_Bispecific_Antibody_AK104",
      "preferredName": "Anti-PD-1/CTLA-4 Bispecific Antibody AK104",
      "synonyms": [
        "AK 104",
        "AK-104",
        "AK104",
        "Anti-PD-1 x CTLA-4 Bispecific Antibody AK104",
        "Anti-PD-1/CTLA-4 Bispecific Antibody AK104",
        "Anti-PD1/Anti-CTLA4 Bispecific Antibody AK104",
        "PD-1 x CTLA-4 Dual Checkpoint Inhibitor AK104"
      ]
    },
    {
      "fdaUniiCode": "U2PTN0RZF6",
      "id": "5-Aza-4-thio-2-deoxycytidine",
      "preferredName": "5-Aza-4'-thio-2'-deoxycytidine",
      "synonyms": [
        "5-AZA-4'-THIO-2'-DEOXYCYTIDINE",
        "5-Aza-4'-thio-2'-deoxycytidine",
        "5-Aza-4-thio-2-deoxycytidine",
        "5-Aza-TdCyd",
        "Aza-TdC",
        "Aza-TdCyd"
      ]
    },
    {
      "fdaUniiCode": "UCC4EQS7WL",
      "id": "Tezacitabine",
      "preferredName": "Tezacitabine",
      "synonyms": [
        "2'-Deoxy-2'-(fluoromethylene)cytidine",
        "FMdC",
        "MDL 101,731",
        "TEZACITABINE",
        "Tezacitabine"
      ]
    },
    {
      "fdaUniiCode": "IHK933KCIC",
      "id": "Pibrozelesin",
      "preferredName": "Pibrozelesin",
      "synonyms": [
        "Benzo(1,2-b:4,3-b')dipyrrole-1-carboxylic Acid, 8-(bromomethyl)-3,6,7,8-tetrahydro-2-methy-4-(((4-methyl-1-piperazinyl)carbonyl)oxy)-6-((5,6,7,-trimethoxy-1H-indol-2-yl)carbonyl)-, Methyl Ester (S)",
        "Duocamycin B2 Analog",
        "KW 2189",
        "KW-2189",
        "KW2189",
        "PIBROZELESIN",
        "Pibrozelesin"
      ]
    },
    {
      "fdaUniiCode": "U65F5M6BD5",
      "id": "Rezivertinib",
      "preferredName": "Rezivertinib",
      "synonyms": [
        "BPI 7711",
        "BPI-7711",
        "BPI7711",
        "EGFR Mutant-specific Inhibitor BPI-7711",
        "REZIVERTINIB",
        "Rezivertinib"
      ]
    },
    {
      "fdaUniiCode": "2B2VM6UC8G",
      "id": "Sotorasib",
      "preferredName": "Sotorasib",
      "synonyms": [
        "AMG 510",
        "AMG-510",
        "AMG510",
        "Lumakras",
        "SOTORASIB",
        "Sotorasib"
      ]
    },
    {
      "fdaUniiCode": "TYH386V3WJ",
      "id": "Seclidemstat",
      "preferredName": "Seclidemstat",
      "synonyms": [
        "LSD1 Inhibitor SP-2577",
        "SECLIDEMSTAT",
        "SP 2577",
        "SP-2577",
        "SP2577",
        "Seclidemstat"
      ]
    },
    {
      "fdaUniiCode": "CX3T89XQBK",
      "id": "Romidepsin",
      "preferredName": "Romidepsin",
      "synonyms": [
        "Antibiotic FR 901228",
        "Depsipeptide",
        "FK228",
        "FR901228",
        "Istodax",
        "L-Valine, N- (3-hydroxy-7-mercapto-1-oxo-4-heptenyl)valyl- cysteinyl-2, 3-didehydro-2-aminobutanoyl-,xi-lactone, cyclic (1-2)-disulfide",
        "L-Valine, N-(3-Hydroxy-7-Mercapto-1-Oxo-4-Heptenyl)-D-Valyl-D-Cysteinyl-(Z)-2,3 -Didehydro-2-Aminobutanoyl-, xi-Lactone, Cyclic (1-2)-Disulfide, (S-(E))-",
        "N-[(3S,4E)-3-Hydroxy-7-mercapto-1-oxo-4-heptenyl]-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoyl-L-valine, (4-1) Lactone, Cyclic",
        "N-[(3S,4E)-3-Hydroxy-7-mercapto-1-oxo-4-heptenyl]-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoyl-L-valine, (4->1) Lactone, Cyclic",
        "ROMIDEPSIN",
        "Romidepsin",
        "depsipeptide",
        "romidepsin"
      ]
    },
    {
      "fdaUniiCode": "844ZJE6I55",
      "id": "Bosutinib_Monohydrate",
      "preferredName": "Bosutinib Monohydrate",
      "synonyms": [
        "3-Quinolinecarbonitrile, 4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-, Hydrate (1:1)",
        "BOSUTINIB MONOHYDRATE",
        "Bosulif",
        "Bosutinib Monohydrate",
        "SKI-606 Monohydrate"
      ]
    },
    {
      "fdaUniiCode": "90IQR2I6TR",
      "id": "Sugemalimab",
      "preferredName": "Sugemalimab",
      "synonyms": [
        "Anti-PD-L1 Monoclonal Antibody CS1001",
        "Anti-PD-L1 Monoclonal Antibody WBP 3155",
        "CS 1001",
        "CS-1001",
        "CS1001",
        "SUGEMALIMAB",
        "Sugemalimab",
        "WBP 315",
        "WBP-315",
        "WBP315"
      ]
    },
    {
      "fdaUniiCode": "BT8F8AD6WO",
      "id": "Antibody-drug_Conjugate_SC-005",
      "preferredName": "Antibody-drug Conjugate SC-005",
      "synonyms": [
        "Antibody-drug Conjugate SC-005",
        "SC 005",
        "SC-005"
      ]
    },
    {
      "fdaUniiCode": "0KYI9U9FSJ",
      "id": "Edrecolomab",
      "preferredName": "Edrecolomab",
      "synonyms": [
        "EDRECOLOMAB",
        "Edrecolomab",
        "Immunoglobulin G2A (Mouse Monoclonal 17-1A Gamma-Chain Anti-Human Colon Cancer Tumor-Associated Antigen), Disulfide With Mouse Monoclonal 17-1A Light Chain, Dimer",
        "MOAB 17-1A",
        "Monoclonal Antibody 17-1A",
        "Panorex",
        "edrecolomab"
      ]
    },
    {
      "fdaUniiCode": "46D4HS9ODA",
      "id": "Samuraciclib",
      "preferredName": "Samuraciclib",
      "synonyms": [
        "CDK7 Inhibitor CT7001",
        "CT 7001",
        "CT-7001",
        "CT7001",
        "SAMURACICLIB",
        "Samuraciclib"
      ]
    },
    {
      "fdaUniiCode": "CSJ7UEQ4D9",
      "id": "Garivulimab",
      "preferredName": "Garivulimab",
      "synonyms": [
        "Anti-PD-L1 Monoclonal Antibody BGB-A333",
        "BGB A333",
        "BGB-A333",
        "BGBA333",
        "GARIVULIMAB",
        "Garivulimab"
      ]
    },
    {
      "fdaUniiCode": "ER09HM7LIR",
      "id": "Autologous_Mesothelin-specific_Human_mRNA_CAR-transfected_PBMCs_MCY-M11",
      "preferredName": "Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11",
      "synonyms": [
        "Anti-mesothelin mRNA-transfected Autologous PBMCs MCY-M11",
        "Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11",
        "MCY-M11"
      ]
    },
    {
      "fdaUniiCode": "3XVL385Q0M",
      "id": "Filgotinib",
      "preferredName": "Filgotinib",
      "synonyms": [
        "FILGOTINIB",
        "Filgotinib",
        "GLPG 0634",
        "GLPG0634",
        "GS-6034"
      ]
    },
    {
      "fdaUniiCode": "R96Z451BMC",
      "id": "Axatilimab",
      "preferredName": "Axatilimab",
      "synonyms": [
        "AXATILIMAB",
        "Anti-M-CSFR Monoclonal Antibody SNDX-6352",
        "Axatilimab",
        "SNDX 6352",
        "SNDX-6352",
        "SNDX6352",
        "UCB6352"
      ]
    },
    {
      "fdaUniiCode": "K5CXA4X5U8",
      "id": "Relmacabtagene_Autoleucel",
      "preferredName": "Relmacabtagene Autoleucel",
      "synonyms": [
        "Autologous Anti-CD19 CAR T-cells JWCAR029",
        "Autologous CD19-targeted CAR T Cells JWCAR029",
        "JWCAR 029",
        "JWCAR-029",
        "JWCAR029",
        "RELMACABTAGENE AUTOLEUCEL",
        "Relma-cel",
        "Relmacabtagene Autoleucel"
      ]
    },
    {
      "fdaUniiCode": "IBS1BZ4E4I",
      "id": "Penpulimab",
      "preferredName": "Penpulimab",
      "synonyms": [
        "AK 105",
        "AK-105",
        "AK105",
        "Anti-PD-1 Monoclonal Antibody AK105",
        "PENPULIMAB",
        "Penpulimab"
      ]
    },
    {
      "fdaUniiCode": "18AP231HUP",
      "id": "Tegavivint",
      "preferredName": "Tegavivint",
      "synonyms": [
        "9,10-Anthracenedione, 2,7-bis(((3R,5S)-3,5-dimethyl-1-piperidinyl)sulfonyl)-, 9,10-dioxime, rel-",
        "BC 2059",
        "BC-2059",
        "BC2059",
        "TEGAVIVINT",
        "Tegatrabetan",
        "Tegavivint"
      ]
    },
    {
      "fdaUniiCode": "1E55T9OY5I",
      "id": "Anti-HER2PBD-MA_Antibody-drug_Conjugate_DHES0815A",
      "preferredName": "Anti-HER2/PBD-MA Antibody-drug Conjugate DHES0815A",
      "synonyms": [
        "ADC DHES0815A",
        "Anti-HER2/PBD-MA ADC DHES0815A",
        "Anti-HER2/PBD-MA Antibody-drug Conjugate DHES0815A",
        "Anti-HER2/PBD-Monoamide ADC DHES0815A",
        "DHES-0815A",
        "DHES0815A"
      ]
    },
    {
      "fdaUniiCode": "U8LYN0Y118",
      "id": "Alsevalimab",
      "preferredName": "Alsevalimab",
      "synonyms": [
        "ALSEVALIMAB",
        "Alsevalimab",
        "Anti-B7-H4 Monoclonal Antibody FPA150",
        "FPA 150",
        "FPA-150",
        "FPA150"
      ]
    },
    {
      "fdaUniiCode": "W6284A5K8N",
      "id": "Urabrelimab",
      "preferredName": "Urabrelimab",
      "synonyms": [
        "Anti-CD47 Monoclonal Antibody SRF231",
        "SRF 231",
        "SRF-231",
        "SRF231",
        "URABRELIMAB",
        "Urabrelimab"
      ]
    },
    {
      "fdaUniiCode": "22OG9ZC9MN",
      "id": "Thorium_Th_227_Anetumab_Corixetan",
      "preferredName": "Thorium Th 227 Anetumab Corixetan",
      "synonyms": [
        "227Th Anetumab Corixetan",
        "ANETUMAB CORIXETAN THORIUM TH-227",
        "BAY 2287411",
        "BAY2287411",
        "Thorium Th 227 Anetumab Corixetan",
        "Thorium Th 227 Monoclonal Antibody BAY2287411",
        "Thorium-227 Labeled Anetumab",
        "Thorium-227 Labeled Antibody-chelator Conjugate BAY2287411"
      ]
    },
    {
      "fdaUniiCode": "5XL19F49H6",
      "id": "Brequinar",
      "preferredName": "Brequinar",
      "synonyms": [
        "6-Fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-methyl-4-quinolinecarboxylic Acid",
        "BREQUINAR",
        "Bipenquinate",
        "Brequinar"
      ]
    },
    {
      "fdaUniiCode": "B6840JH4EB",
      "id": "Batiraxcept",
      "preferredName": "Batiraxcept",
      "synonyms": [
        "AVB S6 500",
        "AVB-500",
        "AVB-S6-500",
        "AVBS6500",
        "AXL Fc Fusion Protein AVB-S6-500",
        "Anti-AXL Fusion Protein AVB-S6-500",
        "BATIRAXCEPT",
        "Batiraxcept",
        "RUGA-S6"
      ]
    },
    {
      "fdaUniiCode": "23ET6940RM",
      "id": "Mupadolimab",
      "preferredName": "Mupadolimab",
      "synonyms": [
        "Anti-CD73 Monoclonal Antibody CPI-006",
        "CPI 006",
        "CPI-006",
        "CPI006",
        "CPX-006",
        "MUPADOLIMAB",
        "Mupadolimab"
      ]
    },
    {
      "fdaUniiCode": "SA09JNQ24D",
      "id": "Vulinacimab",
      "preferredName": "Vulinacimab",
      "synonyms": [
        "Anti-VEGFR2 Monoclonal Antibody HLX06",
        "HLX 06",
        "HLX-06",
        "HLX06",
        "VULINACIMAB",
        "Vulinacimab"
      ]
    },
    {
      "fdaUniiCode": "WJA5UO9E10",
      "id": "Orelabrutinib",
      "preferredName": "Orelabrutinib",
      "synonyms": [
        "BTK Inhibitor ICP-022",
        "ICP 022",
        "ICP-022",
        "ICP022",
        "ORELABRUTINIB",
        "Orelabrutinib"
      ]
    },
    {
      "fdaUniiCode": "7TQ52FVC2L",
      "id": "Anti-LAG-3_Monoclonal_Antibody_Sym022",
      "preferredName": "Anti-LAG-3 Monoclonal Antibody Sym022",
      "synonyms": [
        "Anti-LAG-3 Monoclonal Antibody Sym022",
        "SYM-022",
        "Sym 022",
        "Sym-022",
        "Sym022"
      ]
    },
    {
      "fdaUniiCode": "XQ43H3V6M1",
      "id": "Subasumstat",
      "preferredName": "Subasumstat",
      "synonyms": [
        "SUBASUMSTAT",
        "Subasumstat",
        "TAK 981",
        "TAK-981",
        "TAK981"
      ]
    },
    {
      "fdaUniiCode": "MF4P7VQ2K8",
      "id": "Tavokinogene_Telseplasmid",
      "preferredName": "Tavokinogene Telseplasmid",
      "synonyms": [
        "IT-Tavo-EP",
        "Plasmid IL-12 pUMVC3-hIL-12-NGVL3",
        "TAVOKINOGENE TELSEPLASMID",
        "Tavo",
        "Tavokinogene Telseplasmid"
      ]
    },
    {
      "fdaUniiCode": "41E6FO0DX2",
      "id": "Monoclonal_Antibody_NEO-201",
      "preferredName": "Monoclonal Antibody NEO-201",
      "synonyms": [
        "Monoclonal Antibody NEO-201",
        "NEO 201",
        "NEO-201",
        "NEO201",
        "Neoantigen-targeting Antibody NEO-201",
        "h16C3",
        "h16C3 Antibody"
      ]
    },
    {
      "fdaUniiCode": "P9I9Z3MF7Z",
      "id": "Anti-FLT3CD3_BiTE_Antibody_AMG_427",
      "preferredName": "Anti-FLT3/CD3 BiTE Antibody AMG 427",
      "synonyms": [
        "AMG 427",
        "AMG-427",
        "AMG427",
        "Anti-FLT3 x Anti-CD3 BiTE AMG 427",
        "Anti-FLT3/CD3 BiTE Antibody AMG 427",
        "BiTE Antibody AMG 427",
        "Bispecific T-cell Engager Antibody AMG 427",
        "FLT3/CD3-directed Bispecific T-cell Engager Antibody AMG 427"
      ]
    },
    {
      "fdaUniiCode": "L24XJN68OW",
      "id": "Pyrazoloacridine",
      "preferredName": "Pyrazoloacridine",
      "synonyms": [
        "PYRAZOLOACRIDINE",
        "Pyrazoloacridine",
        "pyrazoloacridine"
      ]
    },
    {
      "fdaUniiCode": "552U6E1NIW",
      "id": "Sibrotuzumab",
      "preferredName": "Sibrotuzumab",
      "synonyms": [
        "HuMoAb F19",
        "Humanized F19 Monoclonal Antibody",
        "SIBROTUZUMAB",
        "Sibrotuzumab"
      ]
    },
    {
      "fdaUniiCode": "24S6PA0WXW",
      "id": "Anti-CD32B_Monoclonal_Antibody_BI-1206",
      "preferredName": "Anti-CD32B Monoclonal Antibody BI-1206",
      "synonyms": [
        "Anti-CD32B Monoclonal Antibody BI-1206",
        "Anti-hFcgRIIB Monoclonal Antibody BI-1206",
        "Anti-hFcgammaRIIB mAb BI-1206",
        "BI 1206",
        "BI-1206",
        "BI1206"
      ]
    },
    {
      "fdaUniiCode": "I92BM16NTD",
      "id": "Bapotulimab",
      "preferredName": "Bapotulimab",
      "synonyms": [
        "Anti-ILDR2 Inhibitor BAY1905254",
        "Anti-ILDR2 Monoclonal Antibody BAY 1905254",
        "Anti-immunoglobulin-like Domain Containing Receptor 2 MoAb BAY1905254",
        "BAPOTULIMAB",
        "BAY 1905254",
        "BAY-1905254",
        "BAY1905254",
        "Bapotulimab",
        "ILDR2 Function-blocking Antibody BAY1905254",
        "Immune Checkpoint Inhibitor BAY1905254"
      ]
    },
    {
      "fdaUniiCode": "4YO6QT3SZ9",
      "id": "Fosifloxuridine_Nafalbenamide",
      "preferredName": "Fosifloxuridine Nafalbenamide",
      "synonyms": [
        "5-FU Analog Prodrug NUC-3373",
        "FOSIFLOXURIDINE NAFALBENAMIDE",
        "Fosifloxuridine Nafalbenamide",
        "L-Alanine, N-(-2'-Deoxy-2',2'-difluoro-p-1-naphthalenyl-5'-cytidylyl)-, Phenylmethyl Ester",
        "NUC 3373",
        "NUC-3373",
        "NUC3373",
        "Nucleotide Analog NUC-3373",
        "Phosphoramidate-FUDR-MP Prodrug NUC-3373"
      ]
    },
    {
      "fdaUniiCode": "ZAA5KE2UAS",
      "id": "PSMACD3_Tri-specific_T-cell_Activating_Construct_HPN424",
      "preferredName": "PSMA/CD3 Tri-specific T-cell Activating Construct HPN424",
      "synonyms": [
        "Anti-PSMA/CD3 TriTAC HPN424",
        "HPN 424",
        "HPN-424",
        "HPN424",
        "PSMA/CD3 Tri-specific T-cell Activating Construct HPN424",
        "PSMA/CD3 TriTAC HPN424",
        "PSMA/CD3-specific TriTAC HPN424",
        "TriTAC HPN424"
      ]
    },
    {
      "fdaUniiCode": "7JTT036WGX",
      "id": "Glumetinib",
      "preferredName": "Glumetinib",
      "synonyms": [
        "GLUMETINIB",
        "Glumetinib",
        "SCC 244",
        "SCC-244",
        "SCC244"
      ]
    },
    {
      "fdaUniiCode": "F8Z9VSZ0K1",
      "id": "Runimotamab",
      "preferredName": "Runimotamab",
      "synonyms": [
        "Anti-HER2 x Anti-CD3 Bispecific Monoclonal Antibody BTRC 4017A",
        "Anti-HER2 x Anti-CD3 Bispecific Monoclonal Antibody RG 6194",
        "Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody 4017A",
        "Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody BTRC 4017A",
        "BTRC 4017A",
        "BTRC-4017A",
        "BTRC4017A",
        "RG 6194",
        "RG-6194",
        "RG6194",
        "RUNIMOTAMAB",
        "Runimotamab"
      ]
    },
    {
      "fdaUniiCode": "QCA97P3GSS",
      "id": "Anti-GCC_Antibody-Drug_Conjugate_TAK-164",
      "preferredName": "Anti-GCC Antibody-Drug Conjugate TAK-164",
      "synonyms": [
        "Anti-GCC ADC TAK-164",
        "Anti-GCC Antibody-Drug Conjugate TAK-164",
        "TAK 164",
        "TAK-164",
        "TAK164"
      ]
    },
    {
      "fdaUniiCode": "22Z53X5LHF",
      "id": "Itacnosertib",
      "preferredName": "Itacnosertib",
      "synonyms": [
        "ACVR1 Inhibitor TP-0184",
        "ALK-2 Inhibitor TP-0184",
        "ALK2 Inhibitor TP-0184",
        "ITACNOSERTIB",
        "Itacnosertib",
        "TP 0184",
        "TP-0184",
        "TP0184"
      ]
    },
    {
      "fdaUniiCode": "7V3BY6G538",
      "id": "Navarixin",
      "preferredName": "Navarixin",
      "synonyms": [
        "2-Hydroxy-N,N-dimethyl-3-((2-((1R)-1-(5-methylfuran-2-yl)propyl)amine)-3,4- dioxocyclobut-1-enyl)amino)benzamide Monohydrate",
        "MK-7123",
        "NAVARIXIN",
        "Navarixin",
        "PS291822",
        "SCH 527123"
      ]
    },
    {
      "fdaUniiCode": "894KSI08XK",
      "id": "Nurulimab",
      "preferredName": "Nurulimab",
      "synonyms": [
        "Anti-CTLA-4 Monoclonal Antibody BCD-145",
        "BCD 145",
        "BCD-145",
        "BCD145",
        "NURULIMAB",
        "Nurulimab"
      ]
    },
    {
      "fdaUniiCode": "S3GQZ2K36V",
      "id": "Serplulimab",
      "preferredName": "Serplulimab",
      "synonyms": [
        "HLX 10",
        "HLX-10",
        "HLX10",
        "SERPLULIMAB",
        "Serplulimab"
      ]
    },
    {
      "fdaUniiCode": "BO0V7196L2",
      "id": "Murizatoclax",
      "preferredName": "Murizatoclax",
      "synonyms": [
        "AMG 397",
        "AMG-397",
        "AMG397",
        "MCL-1 inhibitor AMG 397",
        "MURIZATOCLAX",
        "Murizatoclax",
        "Myeloid Cell Leukemia 1 Inhibitor AMG 397"
      ]
    },
    {
      "fdaUniiCode": "U3OZ7HX207",
      "id": "Manelimab",
      "preferredName": "Manelimab",
      "synonyms": [
        "BCD 135",
        "BCD-135",
        "BCD135",
        "MANELIMAB",
        "Manelimab"
      ]
    },
    {
      "fdaUniiCode": "S4L4MM20B6",
      "id": "EZH2_Inhibitor_PF-06821497",
      "preferredName": "EZH2 Inhibitor PF-06821497",
      "synonyms": [
        "1(2H)-Isoquinolinone, 5,8-Dichloro-2-((1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl)-3,4-dihydro-7-((R)-methoxy-3-oxetanylmethyl)-",
        "EZH2 Inhibitor PF-06821497",
        "PF 06821497",
        "PF-06821497",
        "PF06821497"
      ]
    },
    {
      "fdaUniiCode": "IAY02XUV7L",
      "id": "Anti-PVRIG_Monoclonal_Antibody_COM701",
      "preferredName": "Anti-PVRIG Monoclonal Antibody COM701",
      "synonyms": [
        "Anti-PVRIG Monoclonal Antibody COM701",
        "Anti-poliovirus Receptor-related Immunoglobulin COM701",
        "COM 701",
        "COM-701",
        "COM701",
        "PVRIG Inhibitor COM701"
      ]
    },
    {
      "fdaUniiCode": "ND1SOF0DLU",
      "id": "Elraglusib",
      "preferredName": "Elraglusib",
      "synonyms": [
        "9 ING 41",
        "9-ING-41",
        "ELRAGLUSIB",
        "Elraglusib",
        "GSK-3 Inhibitor 9-ING-41",
        "Glycogen Synthase Kinase-3 Inhibitor 9-ING-41"
      ]
    },
    {
      "fdaUniiCode": "OWA98U788S",
      "id": "Safingol",
      "preferredName": "Safingol",
      "synonyms": [
        "(2S,3S)-2-Amino-1,3-Octadecanediol",
        "Kynacyte",
        "L-(-)-threo-Sphingnine",
        "L-Threo-Dihydrosphingosine",
        "L-threo-2-Amino-1,3-octadecanediol",
        "L-threo-dihydrosphingosine",
        "SAFINGOL",
        "SPC-100270",
        "Safingol",
        "Sphinganine",
        "safingol"
      ]
    },
    {
      "fdaUniiCode": "00NT1ETN9K",
      "id": "Anti-CD22_ADC_TRPH-222",
      "preferredName": "Anti-CD22 ADC TRPH-222",
      "synonyms": [
        "Anti-CD22 ADC TRPH-222",
        "Anti-CD22 Antibody-drug Conjugate TRPH-222",
        "Anti-CD22-4AP ADC TRPH-222",
        "CAT-02-106",
        "TRPH 222",
        "TRPH-222",
        "TRPH222"
      ]
    },
    {
      "fdaUniiCode": "RDF76R62ID",
      "id": "Larotrectinib_Sulfate",
      "preferredName": "Larotrectinib Sulfate",
      "synonyms": [
        "(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide;sulfuric acid",
        "1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)-, Sulfate (1:1)",
        "ARRY 470 Sulfate",
        "LAROTRECTINIB SULFATE",
        "LOXO 101 Sulfate",
        "LOXO-101 Sulfate",
        "Larotrectinib Sulfate",
        "Vitrakvi"
      ]
    },
    {
      "fdaUniiCode": "CUJ2MVI71Y",
      "id": "Daclizumab",
      "preferredName": "Daclizumab",
      "synonyms": [
        "Anti-Tac",
        "Anti-Tac Humanized Monoclonal Antibody",
        "Anti-Tac Monoclonal Antibody",
        "DACLIZUMAB",
        "Dacliximab",
        "Daclizumab",
        "Humanized Anti-Tac Monoclonal Antibody",
        "Monoclonal Antibody Anti-Tac",
        "Zenapax",
        "daclizumab"
      ]
    },
    {
      "fdaUniiCode": "7SQY4ZUD30",
      "id": "Dinutuximab",
      "preferredName": "Dinutuximab",
      "synonyms": [
        "Ch 14.18UTC",
        "Ch14.18",
        "DINUTUXIMAB",
        "Dinutuximab",
        "MOAB Ch14.18",
        "Unituxin",
        "monoclonal antibody Ch14.18"
      ]
    },
    {
      "fdaUniiCode": "603H2FWG4N",
      "id": "Anti-PD-L1TIM-3_Bispecific_Antibody_LY3415244",
      "preferredName": "Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244",
      "synonyms": [
        "Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244",
        "LY 3415244",
        "LY-3415244",
        "LY3415244"
      ]
    },
    {
      "fdaUniiCode": "Z8R4A37V9Q",
      "id": "Arfolitixorin",
      "preferredName": "Arfolitixorin",
      "synonyms": [
        "(6R)-5,10-Methylenetetrahydrofolate",
        "6R-5,10-methyleneTHF",
        "6R-5-10-Methylenetetrahydrofolate",
        "6R-MTHF",
        "6R-methylene THF",
        "ARFOLITIXORIN",
        "Arfolitixorin",
        "Methylenetetrahydrofolic Acid, L-(+)-",
        "Modufolin",
        "Rescufolin",
        "[6R] 5,10-methylenetetrahydrofolate",
        "[6R]-5,10-methylene-tetrahydrofolate"
      ]
    },
    {
      "fdaUniiCode": "D48MS3A6N9",
      "id": "Alvocidib_Hydrochloride",
      "preferredName": "Alvocidib Hydrochloride",
      "synonyms": [
        "(-)-2-(2-Chlorophenyl)-5,7-dihydroxy-8-[(3R,4S)-3-hydroxy-1-methyl-4-piperidinyl]-4H-1-benzopyran-4-one Hydrochloride",
        "4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-5, 7-dihydroxy-8-(3-hydroxy-1-methyl-4-piperidinyl)-, hydrochloride, (-)-cis-",
        "ALVOCIDIB HYDROCHLORIDE",
        "Alvocidib Hydrochloride",
        "Flavopiridol Hydrochloride",
        "HL-275",
        "HMR 1275",
        "L-86-8275",
        "L-868275",
        "MDL 107,826A",
        "MDL-107826A"
      ]
    },
    {
      "fdaUniiCode": "Z0A08C63DF",
      "id": "Anti-LAG-3_Monoclonal_Antibody_INCAGN02385",
      "preferredName": "Anti-LAG-3 Monoclonal Antibody INCAGN02385",
      "synonyms": [
        "Anti-LAG-3 Monoclonal Antibody INCAGN02385",
        "Anti-LAG3 Monoclonal Antibody INCAGN02385",
        "INCAGN 02385",
        "INCAGN 2385",
        "INCAGN-02385",
        "INCAGN02385",
        "INCAGN2385"
      ]
    },
    {
      "fdaUniiCode": "53YMC3A1CU",
      "id": "Anti-TIM-3_Monoclonal_Antibody_BGB-A425",
      "preferredName": "Anti-TIM-3 Monoclonal Antibody BGB-A425",
      "synonyms": [
        "Anti-TIM-3 Monoclonal Antibody BGB-A425",
        "BGB A425",
        "BGB-A425",
        "BGBA425"
      ]
    },
    {
      "fdaUniiCode": "DNP8BBW84R",
      "id": "Anti-CD123CD3_Bispecific_Antibody_APVO436",
      "preferredName": "Anti-CD123/CD3 Bispecific Antibody APVO436",
      "synonyms": [
        "APVO 436",
        "APVO-436",
        "APVO436",
        "Anti-CD123 x Anti-CD3 Bispecific Antibody APVO436",
        "Anti-CD123/CD3 Bispecific Antibody APVO436",
        "Bispecific Anti-CD123 x Anti-CD3 Antibody APVO436",
        "CD123 x CD3 Targeting Bispecific Antibody APVO436"
      ]
    },
    {
      "fdaUniiCode": "TY49T0B03B",
      "id": "Mirzotamab_Clezutoclax",
      "preferredName": "Mirzotamab Clezutoclax",
      "synonyms": [
        "ABBV 155",
        "ABBV-155",
        "ABBV155",
        "ADC ABBV-155",
        "Antibody-drug Conjugate ABBV-155",
        "MIRZOTAMAB CLEZUTOCLAX",
        "Mirzotamab Clezutoclax"
      ]
    },
    {
      "fdaUniiCode": "98YK326XZ6",
      "id": "Inodiftagene_Vixteplasmid",
      "preferredName": "Inodiftagene Vixteplasmid",
      "synonyms": [
        "BC 819",
        "BC-819",
        "BC819",
        "Diphtheria-toxin-A-H19",
        "INODIFTAGENE VIXTEPLASMID",
        "Inodiftagene Vixteplasmid",
        "dT-A-H19"
      ]
    },
    {
      "fdaUniiCode": "82LKS4QV2Y",
      "id": "Poliglusam",
      "preferredName": "Poliglusam",
      "synonyms": [
        "Chitosan",
        "Deacetylchitin",
        "POLIGLUSAM",
        "Poliglusam"
      ]
    },
    {
      "fdaUniiCode": "BDN84I1TFE",
      "id": "Letaplimab",
      "preferredName": "Letaplimab",
      "synonyms": [
        "Anti-CD47 Monoclonal Antibody IBI188",
        "IBI 188",
        "IBI-188",
        "IBI188",
        "LETAPLIMAB",
        "Letaplimab"
      ]
    },
    {
      "fdaUniiCode": "1UA8E65KDZ",
      "id": "Alitretinoin",
      "preferredName": "Alitretinoin",
      "synonyms": [
        "3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-trans-4-trans-6-cis-8-trans-nonatetraenoic Acid",
        "9-Cis-Retinoic Acid",
        "9-cRA",
        "9-cis Retinoic Acid",
        "9-cis retinoic acid",
        "9-cis-RA",
        "9-cis-Retinoic Acid",
        "ALITRETINOIN",
        "ALRT1057",
        "Alitretinoin",
        "LGD1057",
        "Panretin",
        "Panretyn",
        "Panrexin",
        "Retinoicacid-9-cis"
      ]
    },
    {
      "fdaUniiCode": "MA05AF40UO",
      "id": "Pimivalimab",
      "preferredName": "Pimivalimab",
      "synonyms": [
        "Anti-PD-1 Monoclonal Antibody JTX-4014",
        "JTX 4014",
        "JTX-4014",
        "JTX4014",
        "PIMIVALIMAB",
        "Pimivalimab"
      ]
    },
    {
      "fdaUniiCode": "8EOO6HQF8Y",
      "id": "KRAS_G12C_Inhibitor_MRTX849",
      "preferredName": "KRAS G12C Inhibitor MRTX849",
      "synonyms": [
        "KRAS G12C Inhibitor MRTX849",
        "MRTX 849",
        "MRTX-849",
        "MRTX849"
      ]
    },
    {
      "fdaUniiCode": "Q1I6YZ0NGF",
      "id": "Troxacitabine_Nucleotide_Prodrug_MIV-818",
      "preferredName": "Troxacitabine Nucleotide Prodrug MIV-818",
      "synonyms": [
        "MIV 818",
        "MIV-818",
        "MIV818",
        "Troxacitabine Nucleotide Prodrug MIV-818",
        "Troxacitabine Prodrug MIV-818"
      ]
    },
    {
      "fdaUniiCode": "9D2R4T39AY",
      "id": "Izuralimab",
      "preferredName": "Izuralimab",
      "synonyms": [
        "Anti-PD1/Anti-ICOS Bispecific Monoclonal Antibody XmAb23104",
        "Anti-PD1/ICOS Bispecific Monoclonal Antibody XmAb23104",
        "IZURALIMAB",
        "Izuralimab",
        "PD1 x ICOS Bispecific Monoclonal Antibody XmAb23104",
        "XmAb 23104",
        "XmAb-23104",
        "XmAb23104"
      ]
    },
    {
      "fdaUniiCode": "X9GSL37ED0",
      "id": "Sedoxantrone_Trihydrochloride",
      "preferredName": "Sedoxantrone Trihydrochloride",
      "synonyms": [
        "2H-(1)Benzothiopyrano(4,3,2-cd)indazol-8-ol, 5-((2-aminoethyl)amino)-2-(2-(diethylamino)ethyl)-, Trihydrochloride",
        "CI 958",
        "CI-958",
        "LEDOXANTRONE TRIHYDROCHLORIDE",
        "Ledoxantrone Trihydrochloride",
        "Sedoxantrone Trihydrochloride",
        "sedoxantrone trihydrochloride"
      ]
    },
    {
      "fdaUniiCode": "WH9EXQ390Z",
      "id": "Lutetium_Lu_177_Zalsenertant_Tetraxetan",
      "preferredName": "Lutetium Lu 177 Zalsenertant Tetraxetan",
      "synonyms": [
        "177Lu-3BP-227",
        "177Lu-DOTA-3BP-227",
        "177Lu-DOTA-IPN01087",
        "177Lu-IPN01087",
        "Lutetium Lu 177 DOTA-3BP-227",
        "Lutetium Lu 177 DOTA-IPN01087",
        "Lutetium Lu 177 Zalsenertant Tetraxetan",
        "ZALSENERTANT TETRAXETAN LUTETIUM LU-177"
      ]
    },
    {
      "fdaUniiCode": "9NP50O6YSA",
      "id": "Erfonrilimab",
      "preferredName": "Erfonrilimab",
      "synonyms": [
        "Anti-PD-L1 x CTLA-4 Bispecific Antibody KN046",
        "Anti-PD-L1/Anti-CTLA-4 Bispecific Antibody KN046",
        "Anti-PD-L1/CTLA-4 Bispecific Antibody KN046",
        "ERFONRILIMAB",
        "Erfonrilimab",
        "KN 046",
        "KN-046",
        "KN046"
      ]
    },
    {
      "fdaUniiCode": "1XA69O733O",
      "id": "Nolatrexed_Dihydrochloride",
      "preferredName": "Nolatrexed Dihydrochloride",
      "synonyms": [
        "3,4-Dihydro-2-amino-6-methyl-4-oxy-5-(4-pyridylthio)-quinazoline Dihydrochloride",
        "AG-337",
        "AG337",
        "NOLATREXED DIHYDROCHLORIDE",
        "Nolatrexed Dihydrochloride",
        "Nolatrexed Hydrochloride",
        "Thymitaq",
        "nolatrexed"
      ]
    },
    {
      "fdaUniiCode": "4NH22NDW9H",
      "id": "Eflornithine_Hydrochloride",
      "preferredName": "Eflornithine Hydrochloride",
      "synonyms": [
        "2-(Difluoromethyl)-dl-ornithine Hydrochloride, Monohydrate",
        "2-Difluoromethyl-dl-ornithine, Monohydrochloride, Monohydrate",
        "EFLORNITHINE HYDROCHLORIDE",
        "Eflornithine Hydrochloride",
        "Eflornithine hydrochloride",
        "Eflornithine.HCl",
        "MDL 71782",
        "Ornidyl",
        "RMI-71782",
        "Vaniqa",
        "alpha-Difluoromethylornithine hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "45KLN7N6UV",
      "id": "Vusolimogene_Oderparepvec",
      "preferredName": "Vusolimogene Oderparepvec",
      "synonyms": [
        "Genetically Modified HSV-1 Oncolytic Immunotherapeutic RP1",
        "HSV-1 Engineered RP1",
        "HSV-1 Oncolytic Viral Strain RP1",
        "HSV-1 RP1",
        "Oncolytic Virus RP1",
        "RP-1",
        "RP1",
        "VUSOLIMOGENE ODERPAREPVEC",
        "Vusolimogene Oderparepvec"
      ]
    },
    {
      "fdaUniiCode": "G86X5QQ7M5",
      "id": "Anti-EGFRc-Met_Bispecific_Antibody_EMB-01",
      "preferredName": "Anti-EGFR/c-Met Bispecific Antibody EMB-01",
      "synonyms": [
        "Anti-EGFR/Anti-c-Met Bispecific Antibody EMB-01",
        "Anti-EGFR/c-Met Bispecific Antibody EMB-01",
        "Anti-cMET/EGFR Bispecific Antibody EMB-01",
        "Bispecific Antibody EMB-01",
        "EMB 01",
        "EMB-01",
        "EMB01",
        "FIT-013a"
      ]
    },
    {
      "fdaUniiCode": "EP0P7SHM0U",
      "id": "Zeteletinib",
      "preferredName": "Zeteletinib",
      "synonyms": [
        "BOS 172738",
        "BOS-172738",
        "BOS172738",
        "DS 5010",
        "DS-5010",
        "DS5010",
        "RET Inhibitor DS-5010",
        "ZETELETINIB",
        "Zeteletinib"
      ]
    },
    {
      "fdaUniiCode": "2M0F9Q9SZ2",
      "id": "Anti-CD73_Monoclonal_Antibody_NZV930",
      "preferredName": "Anti-CD73 Monoclonal Antibody NZV930",
      "synonyms": [
        "Anti-CD73 Monoclonal Antibody NZV930",
        "NZV 930",
        "NZV-930",
        "NZV930",
        "SRF 373",
        "SRF-373",
        "SRF373"
      ]
    },
    {
      "fdaUniiCode": "4V3R166MB3",
      "id": "Carubicin_Hydrochloride",
      "preferredName": "Carubicin Hydrochloride",
      "synonyms": [
        "CARUBICIN HYDROCHLORIDE",
        "Carubicin Hydrochloride",
        "Carubicin hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "UD984I04LZ",
      "id": "Daunorubicin_Hydrochloride",
      "preferredName": "Daunorubicin Hydrochloride",
      "synonyms": [
        "5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-, hydrochloride",
        "5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-(9CI)",
        "CERUBIDINE",
        "Cerubidin",
        "Cerubidine",
        "Cloridrato de Daunorubicina",
        "DAUNORUBICIN HYDROCHLORIDE",
        "Daunoblastin",
        "Daunoblastina",
        "Daunoblastine",
        "Daunomycin Hydrochloride",
        "Daunomycin hydrochloride",
        "Daunomycin, hydrochloride",
        "Daunorubicin Hydrochloride",
        "Daunorubicin hydrochloride",
        "Daunorubicin.HCl",
        "Daunorubicini Hydrochloridum",
        "FI-6339",
        "L-lyxo-Hexopyranoside, 3beta-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-metldioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-,alpha-,hydrochloride",
        "Ondena",
        "RP-13057",
        "Rubidomycin Hydrochloride",
        "Rubilem",
        "daunomycin hydrochloride",
        "daunorubicin hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "8RV18E4A94",
      "id": "Nivatrotamab",
      "preferredName": "Nivatrotamab",
      "synonyms": [
        "Anti-GD2 hu3F8/Anti-CD3 huOKT3 Bispecific Antibody",
        "Humanized 3F8 Bispecific Antibody",
        "Humanized Anti-GD2 x Anti-CD3 Bispecific Antibody",
        "NIVATROTAMAB",
        "Nivatrotamab",
        "hu3F8 x huOKT3 Bispecific Antibody",
        "hu3F8-BsAb"
      ]
    },
    {
      "fdaUniiCode": "DT958C4NWR",
      "id": "Cudarolimab",
      "preferredName": "Cudarolimab",
      "synonyms": [
        "Anti-OX40 Monoclonal Antibody IBI101",
        "CUDAROLIMAB",
        "Cudarolimab",
        "IBI 101",
        "IBI-101",
        "IBI101"
      ]
    },
    {
      "fdaUniiCode": "05HYK3CV9N",
      "id": "Linperlisib",
      "preferredName": "Linperlisib",
      "synonyms": [
        "LINPERLISIB",
        "Linperlisib",
        "PI3K-delta Inhibitor YY-20394",
        "YY 20394",
        "YY-20394",
        "YY20394"
      ]
    },
    {
      "fdaUniiCode": "0AWH8BFG9A",
      "id": "Polidocanol",
      "preferredName": "Polidocanol",
      "synonyms": [
        "Aethoxysklerol",
        "Asclera",
        "Dodecylnonaoxyethylene Glycol Monoether",
        "Laureth 9",
        "Laureth-9",
        "Lauromacrogol 400",
        "Nonaethylene Glycol Monododecyl Ether",
        "POLIDOCANOL",
        "Polidocanol"
      ]
    },
    {
      "fdaUniiCode": "1Z5YC3ME5N",
      "id": "Botensilimab",
      "preferredName": "Botensilimab",
      "synonyms": [
        "AGEN 1181",
        "AGEN-1181",
        "AGEN1181",
        "Anti-CTLA-4 Monoclonal Antibody AGEN1181",
        "BOTENSILIMAB",
        "Botensilimab"
      ]
    },
    {
      "fdaUniiCode": "PFZ3AP93TA",
      "id": "Azercabtagene_Zapreleucel",
      "preferredName": "Azercabtagene Zapreleucel",
      "synonyms": [
        "AZERCABTAGENE ZAPRELEUCEL",
        "Allogeneic Anti-CD19-CAR T-cells PBCAR0191",
        "Allogeneic Anti-CD19-CAR T-lymphocytes PBCAR0191",
        "Anti-CD19-CAR Allogeneic T-cells PBCAR0191",
        "Azercabtagene Zapreleucel",
        "PBCAR0191"
      ]
    },
    {
      "fdaUniiCode": "JCL936W835",
      "id": "PI3K-alpha_Inhibitor_MEN1611",
      "preferredName": "PI3K-alpha Inhibitor MEN1611",
      "synonyms": [
        "5-(7-Methylsulfonyl-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine",
        "Alpha-selective PI3K Inhibitor MEN1611",
        "CH 5132799",
        "CH-5132799",
        "CH5132799",
        "MEN 1611",
        "MEN-1611",
        "MEN1611",
        "PA 799",
        "PA-799",
        "PA799",
        "PI3K-alpha Inhibitor MEN1611",
        "PI3Kalpha Inhibitor MEN1611"
      ]
    },
    {
      "fdaUniiCode": "JNA39I7ZVB",
      "id": "Pirtobrutinib",
      "preferredName": "Pirtobrutinib",
      "synonyms": [
        "5-Amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-((2S)-1,1,1-trifluoropropan-2-yl)-1h-pyrazole-4-carboxamide",
        "BTK Inhibitor LOXO-305",
        "LOXO 305",
        "LOXO-305",
        "LOXO305",
        "LY3527727",
        "PIRTOBRUTINIB",
        "Pirtobrutinib"
      ]
    },
    {
      "fdaUniiCode": "5VV3MDU5IE",
      "id": "Idarubicin_Hydrochloride",
      "preferredName": "Idarubicin Hydrochloride",
      "synonyms": [
        "IDARUBICIN HYDROCHLORIDE",
        "IMI-30",
        "Idamycin",
        "Idamycin PFS",
        "Idarubicin HCl",
        "Idarubicin Hydrochloride",
        "Idarubicin hydrochloride",
        "SC-33428",
        "Zavedos"
      ]
    },
    {
      "fdaUniiCode": "M9SE4M9U1V",
      "id": "Barecetamab",
      "preferredName": "Barecetamab",
      "synonyms": [
        "Anti-ErbB3 Antibody ISU104",
        "Anti-HER3 Antibody ISU104",
        "BARECETAMAB",
        "Barecetamab",
        "ISU 104",
        "ISU-104",
        "ISU104"
      ]
    },
    {
      "fdaUniiCode": "49X2Q41T99",
      "id": "Pegsitacianine",
      "preferredName": "Pegsitacianine",
      "synonyms": [
        "Indocyanine Green-labeled Polymeric Micelles ONM-100",
        "ONM 100",
        "ONM-100",
        "ONM100",
        "PEGSITACIANINE",
        "Pegsitacianine"
      ]
    },
    {
      "fdaUniiCode": "XZG407XE0Y",
      "id": "Itacitinib_Adipate",
      "preferredName": "Itacitinib Adipate",
      "synonyms": [
        "INCB-039110 Adipate",
        "INCB039110 Adipate",
        "ITACITINIB ADIPATE",
        "Itacitinib Adipate"
      ]
    },
    {
      "fdaUniiCode": "3OX1DBR75G",
      "id": "Uliledlimab",
      "preferredName": "Uliledlimab",
      "synonyms": [
        "Anti-CD73 Monoclonal Antibody TJ4309",
        "TJ 004309",
        "TJ 4309",
        "TJ-004309",
        "TJ-4309",
        "TJ004309",
        "TJ4309",
        "TJD5",
        "ULILEDLIMAB",
        "Uliledlimab"
      ]
    },
    {
      "fdaUniiCode": "2ZK3D69DQJ",
      "id": "Anti-B7H3_Antibody-drug_Conjugate_MGC018",
      "preferredName": "Anti-B7H3 Antibody-drug Conjugate MGC018",
      "synonyms": [
        "Anti-B7H3 ADC",
        "Anti-B7H3 Antibody-drug Conjugate MGC018",
        "MG-C018",
        "MGC 018",
        "MGC-018",
        "MGC018"
      ]
    },
    {
      "fdaUniiCode": "3PT70X17VS",
      "id": "Pavunalimab",
      "preferredName": "Pavunalimab",
      "synonyms": [
        "Anti-CTLA-4/Anti-LAG-3 Bispecific Monoclonal Antibody XmAb22841",
        "Anti-CTLA-4/LAG-3 Bispecific Antibody XmAb22841",
        "CTLA-4  x LAG-3 Bispecific Antibody XmAb22841",
        "PAVUNALIMAB",
        "Pavunalimab",
        "XmAb 22841",
        "XmAb-22841",
        "XmAb22841"
      ]
    },
    {
      "fdaUniiCode": "SA0O2AK3LA",
      "id": "Bexmarilimab",
      "preferredName": "Bexmarilimab",
      "synonyms": [
        "Anti-stabilin-1 Monoclonal Antibody FP-1305",
        "BEXMARILIMAB",
        "Bexmarilimab",
        "Clevegen",
        "FP 1305",
        "FP-1305",
        "FP1305"
      ]
    },
    {
      "fdaUniiCode": "ZBL7O904IL",
      "id": "Zimberelimab",
      "preferredName": "Zimberelimab",
      "synonyms": [
        "AB 122",
        "AB-122",
        "AB122",
        "Anti-PD-1 Monoclonal Antibody GLS-010",
        "GLS 010",
        "GLS-010",
        "GLS010",
        "WBP-3055",
        "ZIMBERELIMAB",
        "Zimberelimab"
      ]
    },
    {
      "fdaUniiCode": "W0ZE0NT8IF",
      "id": "Etrumadenant",
      "preferredName": "Etrumadenant",
      "synonyms": [
        "A2AR/A2BR Antagonist AB928",
        "AB 928",
        "AB-928",
        "AB928",
        "Adenosine A2A/A2B Receptor Antagonist AB928",
        "Dual A2AR/A2BR Antagonist AB928",
        "Etrumadenant"
      ]
    },
    {
      "fdaUniiCode": "102VUR9WQE",
      "id": "Pacanalotamab",
      "preferredName": "Pacanalotamab",
      "synonyms": [
        "AMG 420",
        "AMG-420",
        "AMG420",
        "Anti-BCMA x Anti-CD3 BiTE AMG 420",
        "Anti-BCMA/CD3 BiTE Antibody AMG 420",
        "BCMA/CD3-directed Bispecific T-cell Engager Antibody AMG 420",
        "BI 836909",
        "BI-836909",
        "BI836909",
        "BiTE Antibody AMG 420",
        "Bispecific T-cell Engager Antibody AMG 420",
        "PACANALOTAMAB",
        "Pacanalotamab"
      ]
    },
    {
      "fdaUniiCode": "5DVS457HEG",
      "id": "Cantrixil",
      "preferredName": "Cantrixil",
      "synonyms": [
        "Cantrixil",
        "TRX E 002 1",
        "TRX-E-002-1",
        "TRXE0021",
        "cis-4-(para-hydroxyphenyl)-7,4'-dihydroxy-3',5'-dimethoxy-8-methylisoflavan"
      ]
    },
    {
      "fdaUniiCode": "6CGQ1X5Y6V",
      "id": "Anti-CTLA-4_Monoclonal_Antibody_REGN4659",
      "preferredName": "Anti-CTLA-4 Monoclonal Antibody REGN4659",
      "synonyms": [
        "Anti-CTLA-4 Monoclonal Antibody REGN4659",
        "REGN 4659",
        "REGN-4659",
        "REGN4659"
      ]
    },
    {
      "fdaUniiCode": "QZS4144IO0",
      "id": "Gusperimus_Trihydrochloride",
      "preferredName": "Gusperimus Trihydrochloride",
      "synonyms": [
        "(+-)-15-Deoxyspergualin",
        "1-Amino-19-guanidino-11-hydroxy-4,9,12-triazanonadecane-10,13-dione",
        "15-Deoxyspergualin",
        "15-Deoxyspergualin Hydrochloride",
        "7-[(Aminoiminomethyl)amino]-N-[2-[[4-[(3-aminopropyl)amino]butyl]amnio]-1-hydroxy-2-oxoethyl]heptanamide",
        "BMS-181173",
        "BMY-42215-1",
        "DSG",
        "Deoxyspergualin",
        "Deoxyspergualin Hydrochloride",
        "GUSPERIMUS TRIHYDROCHLORIDE",
        "Gusperimus Trihydrochloride",
        "N-[[[4-[(3-Aminopropyl)amino]-butyl]carbamoyl]hydroxymethyl]-7-guanidinoheptanamide",
        "NKT-01",
        "Spanidin"
      ]
    },
    {
      "fdaUniiCode": "6EX05GL2VK",
      "id": "TGFbeta_Receptor_Ectodomain-IgG_Fc_Fusion_Protein_BMS-986416",
      "preferredName": "TGFbeta Receptor Ectodomain-IgG Fc Fusion Protein BMS-986416",
      "synonyms": [
        "AVID 200",
        "AVID-200",
        "AVID200",
        "BMS 986416",
        "BMS-986416",
        "BMS986416",
        "TGF-beta 1/3 Inhibitor AVID200",
        "TGFb Inhibitor AVID200",
        "TGFbeta Ligand Trap AVID200",
        "TGFbeta Receptor Ectodomain-IgG Fc Fusion Protein BMS-986416",
        "TGFbeta-neutralizing Agent AVID200"
      ]
    },
    {
      "fdaUniiCode": "A0Z3NAU9DP",
      "id": "Bicalutamide",
      "preferredName": "Bicalutamide",
      "synonyms": [
        "(+/-)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide",
        "4'-Cyano-alpha,alpha,alpha-trifuloro-3-[(p-fluorophenyl)sulfonyl]-2-methyl-m-lactotoluidide",
        "4-Cyano-3-trifluoromethyl-N-(3-p-fluorophenylsulfonyl-2-hydroxy-2-methylpropionyl)aniline",
        "BICALUTAMIDE",
        "Bicalutamide",
        "Casodex",
        "Cosudex",
        "ICI 176,334",
        "ICI 176334",
        "N-[4-Cyano-3-(trifluoromethyl)phenyl]3-3[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-propanamide",
        "bicalutamide"
      ]
    },
    {
      "fdaUniiCode": "K04D7I4BCH",
      "id": "Molibresib_Besylate",
      "preferredName": "Molibresib Besylate",
      "synonyms": [
        "2-((4S)-6-(4-Chlorophenyl)-8-methoxy-1-methyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepin-4-yl)-N-ethylacetamide monobenzenesulfonate salt",
        "GSK525762C",
        "MOLIBRESIB BESYLATE",
        "Molibresib Besylate"
      ]
    },
    {
      "fdaUniiCode": "EOB0N7BOY4",
      "id": "PIM_Kinase_Inhibitor_TP-3654",
      "preferredName": "PIM Kinase Inhibitor TP-3654",
      "synonyms": [
        "2-((1R,4R)-4-((3-(3-(trifluoromethyl)phenyl)imidazo[1,2-b]pyridazin-6-yl)amino)cyclohexyl)propan-2-ol",
        "PIM Inhibitor TP-3654",
        "PIM Kinase Inhibitor TP-3654",
        "SGI 9481",
        "SGI-9481",
        "SGI9481",
        "TP 3654",
        "TP-3654",
        "TP3654"
      ]
    },
    {
      "fdaUniiCode": "71193OXG6S",
      "id": "Tallimustine",
      "preferredName": "Tallimustine",
      "synonyms": [
        "FCE 24517",
        "PNU-152241",
        "TALLIMUSTINE",
        "Tallimustine"
      ]
    },
    {
      "fdaUniiCode": "301EY96MDU",
      "id": "Anti-HER2_Immune_Stimulator-antibody_Conjugate_NJH395",
      "preferredName": "Anti-HER2 Immune Stimulator-antibody Conjugate NJH395",
      "synonyms": [
        "Anti-HER2 ISAC NJH395",
        "Anti-HER2 Immune Stimulator-antibody Conjugate NJH395",
        "NJH 395",
        "NJH-395",
        "NJH395"
      ]
    },
    {
      "fdaUniiCode": "JUP57A8EPZ",
      "id": "Camizestrant",
      "preferredName": "Camizestrant",
      "synonyms": [
        "AZ-14066724",
        "AZD 9833",
        "AZD-9833",
        "AZD9833",
        "CAMIZESTRANT",
        "Camizestrant",
        "N-(1-(3-Fluoropropyl)-3-azetidinyl)-6-((6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo(4,3-f)isoquinolin-6-yl)-3-pyridinamine",
        "SERD AZD9833",
        "Selective Estrogen Receptor Degrader AZD9833"
      ]
    },
    {
      "fdaUniiCode": "91U3TGV99T",
      "id": "Tetrathiomolybdate",
      "preferredName": "Tetrathiomolybdate",
      "synonyms": [
        "CCRIS 9412",
        "Molybdate(2-), Tetrathioxo-, (T-4)- (9CI)",
        "TIOMOLIBDATE ION",
        "TM",
        "Tetrathiomolybdate",
        "Tetrathioxomolybdate(2-)"
      ]
    },
    {
      "fdaUniiCode": "Y3HMF6G24B",
      "id": "LOXL2_Inhibitor_GB2064",
      "preferredName": "LOXL2 Inhibitor GB2064",
      "synonyms": [
        "GB 2064",
        "GB-2064",
        "GB2064",
        "LOXL2 Inhibitor GB2064",
        "Lysyl Oxidase-like Protein 2 Inhibitor PAT-1251",
        "PAT 1251",
        "PAT-1251",
        "PAT1251"
      ]
    },
    {
      "fdaUniiCode": "2Z07MYW1AZ",
      "id": "Anastrozole",
      "preferredName": "Anastrozole",
      "synonyms": [
        "2,2'-[5-(1H-1,2,4-Triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropionitrile)",
        "ANASTROZOLE",
        "Alpha,alpha,alpha', alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile",
        "Anastrazole",
        "Anastrozole",
        "Arimidex",
        "ICI D1033",
        "ICI-D1033",
        "ZD-1033",
        "anastrozole"
      ]
    },
    {
      "fdaUniiCode": "9GAH9VG7IP",
      "id": "Anti-PD-1TIM-3_Bispecific_Antibody_RO7121661",
      "preferredName": "Anti-PD-1/TIM-3 Bispecific Antibody RO7121661",
      "synonyms": [
        "Anti-PD-1 x TIM-3 Bispecific Antibody RO7121661",
        "Anti-PD-1/Anti-TIM-3 Bispecific Antibody RO7121661",
        "Anti-PD-1/TIM-3 Bispecific Antibody RO7121661",
        "RO 7121661",
        "RO-7121661",
        "RO7121661"
      ]
    },
    {
      "fdaUniiCode": "I4QM8E7Y2R",
      "id": "Anti-CD137_Agonistic_Monoclonal_Antibody_ADG106",
      "preferredName": "Anti-CD137 Agonistic Monoclonal Antibody ADG106",
      "synonyms": [
        "4-1BB-directed Agonistic Monoclonal Antibody ADG106",
        "ADG 106",
        "ADG-106",
        "ADG106",
        "Anti-4-1BB Agonistic Monoclonal Antibody ADG106",
        "Anti-CD137 Agonistic Monoclonal Antibody ADG106",
        "CD137-directed Agonistic Monoclonal Antibody ADG106"
      ]
    },
    {
      "fdaUniiCode": "CGA81G3KR5",
      "id": "Pucotenlimab",
      "preferredName": "Pucotenlimab",
      "synonyms": [
        "Anti-PD-1 Monoclonal Antibody HX008",
        "HX 008",
        "HX-008",
        "HX008",
        "PUCOTENLIMAB",
        "Pucotenlimab"
      ]
    },
    {
      "fdaUniiCode": "NP6CFH3G8H",
      "id": "Gavocabtagene_Autoleucel",
      "preferredName": "Gavocabtagene Autoleucel",
      "synonyms": [
        "Autologous Anti-mesothelin T-cell Receptor Fusion Construct T-cells TC-210",
        "Autologous Anti-mesothelin TRuC T-cells TC-210",
        "GAVOCABTAGENE AUTOLEUCEL",
        "Gavo-cel",
        "Gavocabtagene Autoleucel",
        "TC 210",
        "TC-210",
        "TC-210 T Cells",
        "TC210"
      ]
    },
    {
      "fdaUniiCode": "28DZS29F59",
      "id": "Avadomide",
      "preferredName": "Avadomide",
      "synonyms": [
        "2,6-Piperidinedione, 3-(5-amino-2-methyl-4-oxo-3(4H)-quinazolinyl)-",
        "AVADOMIDE",
        "Avadomide",
        "CC 122",
        "CC-122",
        "CC122"
      ]
    },
    {
      "fdaUniiCode": "4J1L80T08I",
      "id": "Lurtotecan",
      "preferredName": "Lurtotecan",
      "synonyms": [
        "7-(4-methylpiperazinomethylene)-10,11-ethylenedioxy-20(S)-camptothecin",
        "GG 211",
        "GI147211",
        "LURTOTECAN",
        "Lurtotecan",
        "lurtotecan"
      ]
    },
    {
      "fdaUniiCode": "1W5N8SZD9A",
      "id": "Glufosfamide",
      "preferredName": "Glufosfamide",
      "synonyms": [
        "Beta-D-Glucosyl-Ifosfamide Mustard",
        "D-19575",
        "GLUFOSFAMIDE",
        "Glufosfamide",
        "glc-IPM",
        "glufosfamide"
      ]
    },
    {
      "fdaUniiCode": "8VH13L5K20",
      "id": "KRN5500",
      "preferredName": "KRN5500",
      "synonyms": [
        "6-[4-Deoxy-4-[(2E,4E)-tetradecadienoylglycyl]amino-L-glycero-beta-L-mannohepto-pyranosyl]amino-9H-purine",
        "KRN-5500",
        "KRN5500"
      ]
    },
    {
      "fdaUniiCode": "HL580335SI",
      "id": "Elinafide",
      "preferredName": "Elinafide",
      "synonyms": [
        "ELINAFIDE",
        "Elinafide",
        "LU 79553",
        "LU-79553",
        "N,N'-(Trimethylenebis(iminoethylene))dinaphthalimide"
      ]
    },
    {
      "fdaUniiCode": "DX474PAV6P",
      "id": "Zeluvalimab",
      "preferredName": "Zeluvalimab",
      "synonyms": [
        "AMG 404",
        "AMG-404",
        "AMG404",
        "Anti-PD-1 Monoclonal Antibody AMG 404",
        "ZELUVALIMAB",
        "Zeluvalimab"
      ]
    },
    {
      "fdaUniiCode": "12R66419FZ",
      "id": "Galinpepimut-S",
      "preferredName": "Galinpepimut-S",
      "synonyms": [
        "GALINPEPIMUT-S",
        "Galinpepimut-S",
        "SLS 001",
        "SLS-001",
        "SLS001",
        "WT-1 Analog Peptide Vaccine SLS-001"
      ]
    },
    {
      "fdaUniiCode": "2Y83Y2ORD3",
      "id": "Revdofilimab",
      "preferredName": "Revdofilimab",
      "synonyms": [
        "ABBV 368",
        "ABBV-368",
        "ABBV368",
        "Agonistic Anti-OX40 Monoclonal Antibody ABBV-368",
        "Anti-OX40 Agonist Monoclonal Antibody ABBV-368",
        "Anti-OX40 Agonistic Monoclonal Antibody ABBV-368",
        "PR1628103",
        "REVDOFILIMAB",
        "Revdofilimab"
      ]
    },
    {
      "fdaUniiCode": "A60X6MBU6G",
      "id": "Becatecarin",
      "preferredName": "Becatecarin",
      "synonyms": [
        "1,11-Dichloro-6-[2-(diethylamino)ethyl]-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione",
        "5H-Indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione, 1,11-dichloro-6-(2-(diethylamino)ethyl)-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl)-",
        "BECATECARIN",
        "BMS-181176",
        "BMY-27557-14",
        "Becatecarin",
        "DEAE-Rebeccamycin",
        "NSC 655649",
        "Rebeccamycin Analogue",
        "Rebeccamycin Analogue, Tartrate Salt",
        "Rebeccamycin analog",
        "XL119",
        "rebeccamycin analog"
      ]
    },
    {
      "fdaUniiCode": "UEC0H0URSE",
      "id": "Patupilone",
      "preferredName": "Patupilone",
      "synonyms": [
        "(-)-Epothilone B",
        "(1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione",
        "EPO-906A",
        "EPO906",
        "Epothilone B",
        "PATUPILONE",
        "Patupilone",
        "epothilone B"
      ]
    },
    {
      "fdaUniiCode": "0361Z8214O",
      "id": "Src_Kinase_Inhibitor_M475271",
      "preferredName": "Src Kinase Inhibitor M475271",
      "synonyms": [
        "4-Quinazolinamine, N-(2-chloro-5-methoxyphenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-",
        "AZM 475271",
        "AZM-475271",
        "AZM475271",
        "M 475271",
        "M-475271",
        "M475271",
        "N-(2-Chloro-5-methoxyphenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine",
        "Src Kinase Inhibitor M475271"
      ]
    },
    {
      "fdaUniiCode": "FQK825B5DX",
      "id": "FGFR4_Inhibitor_BLU_9931",
      "preferredName": "FGFR4 Inhibitor BLU 9931",
      "synonyms": [
        "2-Propenamide, N-(2-((6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl)amino)-3-methylphenyl)-",
        "BLU 9931",
        "BLU-9931",
        "BLU9931",
        "FGFR4 Inhibitor BLU 9931",
        "N-(2-((6-(2,6-Dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl)amino)-3-methylphenyl)-2-propenamide"
      ]
    },
    {
      "fdaUniiCode": "Z3S2Z6H7B0",
      "id": "Vascular_Disrupting_Agent_BNC105",
      "preferredName": "Vascular Disrupting Agent BNC105",
      "synonyms": [
        "2-Methyl-7-hydroxy-3-(3,4,5-trimethoxybenzoyl)-6-methoxybenzofuran",
        "BNC 105",
        "BNC-105",
        "BNC105",
        "Vascular Disrupting Agent BNC105"
      ]
    },
    {
      "fdaUniiCode": "2222ATS339",
      "id": "Combretastatin_A-1",
      "preferredName": "Combretastatin A-1",
      "synonyms": [
        "1,2-Benzenediol, 3-Methoxy-6-(2-(3,4,5-trimethoxyphenyl)ethenyl)-, (Z)-",
        "CA1",
        "COMBRETASTATIN A-1",
        "Combretastatin A-1",
        "Combretastatin A1"
      ]
    },
    {
      "fdaUniiCode": "U54GT9151S",
      "id": "Dactolisib_Tosylate",
      "preferredName": "Dactolisib Tosylate",
      "synonyms": [
        "2-Methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo(4,5-c)quinolin-1-yl)phenyl)propanenitrile 4-Methylbenzenesulfonate",
        "Benzeneacetonitrile, 4-(2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo(4,5-c)quinolin-1-yl)-alpha,alpha-dimethyl-, 4-Methylbenzenesulfonate (1:1)",
        "DACTOLISIB TOSYLATE",
        "Dactolisib Tosylate",
        "NVP-BEZ235-ANA",
        "NVP-BEZ235-NX"
      ]
    },
    {
      "fdaUniiCode": "Y76278R9RJ",
      "id": "Exatecan_Mesylate_Anhydrous",
      "preferredName": "Exatecan Mesylate Anhydrous",
      "synonyms": [
        "10H,13H-Benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10,13-dione, 1-Amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-, (1S,9S)-, Methanesulfonate (1:1)",
        "EXATECAN MESYLATE ANHYDROUS",
        "Exatecan Mesylate Anhydrous"
      ]
    },
    {
      "fdaUniiCode": "420K487FSG",
      "id": "Dupilumab",
      "preferredName": "Dupilumab",
      "synonyms": [
        "DUPILUMAB",
        "Dupilumab",
        "Dupixent",
        "REGN 668",
        "REGN-668",
        "REGN668",
        "SAR 231893",
        "SAR-231893",
        "SAR231893"
      ]
    },
    {
      "fdaUniiCode": "KKT462Q807",
      "id": "Abemaciclib_Mesylate",
      "preferredName": "Abemaciclib Mesylate",
      "synonyms": [
        "ABEMACICLIB MESYLATE",
        "Abemaciclib Mesylate",
        "LY-2835219 Methanesulfonate",
        "LY-2835219 methanesulfonate"
      ]
    },
    {
      "fdaUniiCode": "D2OPG50FF7",
      "id": "Alomfilimab",
      "preferredName": "Alomfilimab",
      "synonyms": [
        "ALOMFILIMAB",
        "Alomfilimab",
        "Anti-ICOS Monoclonal Antibody KY1044",
        "KY 1044",
        "KY-1044",
        "KY1044"
      ]
    },
    {
      "fdaUniiCode": "EUY2631TAL",
      "id": "Tubulin_Inhibitor_ALB-109564",
      "preferredName": "Tubulin Inhibitor ALB-109564",
      "synonyms": [
        "ALB 109564",
        "ALB-109564",
        "ALB109564",
        "Tubulin Inhibitor ALB-109564"
      ]
    },
    {
      "fdaUniiCode": "E53VN70K2X",
      "id": "IAP_Inhibitor_APG-1387",
      "preferredName": "IAP Inhibitor APG-1387",
      "synonyms": [
        "APG 1387",
        "APG-1387",
        "APG1387",
        "IAP Antagonist APG-1387",
        "IAP Inhibitor APG-1387",
        "Pyrrolo(1,2-a)(1,5)diazocine-8-carboxamide, 3,3'-(1,3-phenylenebis(sulfonyl))bis(N-(diphenylmethyl)decahydro-5-(((2S)-2-(methylamino)-1-oxopropyl)amino)-6-oxo-, (5S,5'S,8S,8'S,10aR,10'ar)-",
        "SM-1387",
        "SMAC-mimetic APG-1387"
      ]
    },
    {
      "fdaUniiCode": "PL21OR4LXE",
      "id": "Lorukafusp_alfa",
      "preferredName": "Lorukafusp alfa",
      "synonyms": [
        "APN 301",
        "APN-301",
        "APN301",
        "EMD 273063",
        "EMD-273063",
        "Hu14.18-IL2",
        "LORUKAFUSP ALFA",
        "Lorukafusp alfa"
      ]
    },
    {
      "fdaUniiCode": "7149VX7891",
      "id": "Aranose",
      "preferredName": "Aranose",
      "synonyms": [
        "3-(alpha-L-Arabinopyranosyl)-1-methyl-1-nitrosourea",
        "ARANOSE",
        "Aranose",
        "Aranoza",
        "CRC 0510375",
        "CRC-0510375"
      ]
    },
    {
      "fdaUniiCode": "6ZZ3B7NZ0B",
      "id": "Xiliertinib",
      "preferredName": "Xiliertinib",
      "synonyms": [
        "HMPL 309",
        "HMPL-309",
        "HMPL309",
        "Theliatinib",
        "XILIERTINIB",
        "Xiliertinib"
      ]
    },
    {
      "fdaUniiCode": "85KUE857XM",
      "id": "Pyrotinib_Dimaleate",
      "preferredName": "Pyrotinib Dimaleate",
      "synonyms": [
        "PYROTINIB MALEATE",
        "Pyrotinib Dimaleate",
        "Pyrotinib Maleate",
        "SHR-1258 Maleate"
      ]
    },
    {
      "fdaUniiCode": "WFG29AB872",
      "id": "Puquitinib",
      "preferredName": "Puquitinib",
      "synonyms": [
        "PUQUITINIB",
        "Puquitinib",
        "XC-302 Free Base"
      ]
    },
    {
      "fdaUniiCode": "Z4NA6BNF2L",
      "id": "Puquitinib_Mesylate",
      "preferredName": "Puquitinib Mesylate",
      "synonyms": [
        "PUQUITINIB MESYLATE",
        "Puquitinib Mesylate",
        "XC-302 Anhydrous"
      ]
    },
    {
      "fdaUniiCode": "054ZP16K2Q",
      "id": "Lutetium_Lu_177_Lilotomab-satetraxetan",
      "preferredName": "Lutetium Lu 177 Lilotomab-satetraxetan",
      "synonyms": [
        "177Lu Lilotomab Satetraxetan",
        "177Lu-Lilotomab-satetraxetan",
        "Betalutin",
        "LILOTOMAB SATETRAXETAN LUTETIUM LU-177",
        "Lutetium Lu 177 Lilotomab-satetraxetan",
        "Lutetium Lu-177 Lilotomab Satetraxetan",
        "Lutetium Lu-177 Lilotomab-satetraxetan"
      ]
    },
    {
      "fdaUniiCode": "6R0MAC137G",
      "id": "Luminespib_Mesylate",
      "preferredName": "Luminespib Mesylate",
      "synonyms": [
        "LUMINESPIB MESYLATE",
        "Luminespib Mesilate",
        "Luminespib Mesylate",
        "Luminespib Mesylate Hydrate",
        "NVP-AUY922-AGB"
      ]
    },
    {
      "fdaUniiCode": "E223Z0KWCC",
      "id": "Infigratinib_Mesylate",
      "preferredName": "Infigratinib Mesylate",
      "synonyms": [
        "BGJ 398 Mesylate",
        "BGJ-398 Mesylate",
        "INFIGRATINIB MESYLATE",
        "Infigratinib Mesylate"
      ]
    },
    {
      "fdaUniiCode": "TQ6PBX1JU0",
      "id": "Luxeptinib",
      "preferredName": "Luxeptinib",
      "synonyms": [
        "32,72,74,76-Tetrafluoro-14-methyl-21,23-dihydro-11h-4,6-diaza-2(4,7)-isoindola- 1(2)-imidazola-3(1,4),7(1)-dibenzenaheptaphane-2,35-dione",
        "CG 806",
        "CG'806",
        "CG-026806",
        "CG-806",
        "CG806",
        "FLT3/BTK Inhibitor CG 806",
        "LUXEPTINIB",
        "Luxeptinib",
        "Pan-FLT3/BTK Multi-Kinase Inhibitor CG 806",
        "Pan-FLT3/Pan-BTK Inhibitor CG-806",
        "Pan-FLT3/Pan-BTK Multi-kinase Inhibitor CG-806"
      ]
    },
    {
      "fdaUniiCode": "RHS90QRF9E",
      "id": "Anbenitamab",
      "preferredName": "Anbenitamab",
      "synonyms": [
        "ANBENITAMAB",
        "Anbenitamab",
        "Anti-HER-2 Bispecific Antibody KN026",
        "Anti-HER2 Heterodimeric Antibody KN026",
        "HER2 Bispecific Antibody KN026",
        "KN 026",
        "KN-026",
        "KN026"
      ]
    },
    {
      "fdaUniiCode": "THY6RIW44R",
      "id": "Etalocib",
      "preferredName": "Etalocib",
      "synonyms": [
        "2-[2-Propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]propoxy]phenoxy]benzoic Acid",
        "2-[3-[3-[(5-Ethyl-4'-fluoro-2-hydroxy[1,1'-biphenyl]-4-yl)oxy]propoxy]-2-propylphenoxy]benzoic Acid",
        "ETALOCIB",
        "Etalocib",
        "LY293111"
      ]
    },
    {
      "fdaUniiCode": "45X7OU8C4J",
      "id": "Domvanalimab",
      "preferredName": "Domvanalimab",
      "synonyms": [
        "AB 154",
        "AB-154",
        "AB154",
        "Anti-TIGIT Monoclonal Antibody AB154",
        "DOMVANALIMAB",
        "Domvanalimab"
      ]
    },
    {
      "fdaUniiCode": "1P05PW62F3",
      "id": "Conbercept",
      "preferredName": "Conbercept",
      "synonyms": [
        "CONBERCEPT",
        "Conbercept",
        "FP 3",
        "FP-3",
        "FP3",
        "KH 902",
        "KH 903",
        "KH-902",
        "KH-903",
        "KH902",
        "KH903"
      ]
    },
    {
      "fdaUniiCode": "L9P2881C3H",
      "id": "Plevitrexed",
      "preferredName": "Plevitrexed",
      "synonyms": [
        "(alphaS)-alpha-[[4-[[(1,4-Dihydro-2,7-dimethyl-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]-2-fluorobenzoyl]amino]-1H-tetrazole-5-butanoic Acid",
        "BGC 9331",
        "PLEVITREXED",
        "Plevitrexed",
        "Vamidex",
        "Vamydex",
        "ZD9331"
      ]
    },
    {
      "fdaUniiCode": "M355PGI1TG",
      "id": "Anti-PSMACD28_Bispecific_Antibody_REGN5678",
      "preferredName": "Anti-PSMA/CD28 Bispecific Antibody REGN5678",
      "synonyms": [
        "Anti-PSMA/Anti-CD28 Bispecific Antibody REGN5678",
        "Anti-PSMA/CD28 Bispecific Antibody REGN5678",
        "Anti-PSMAxCD28 Antibody REGN5678",
        "REGN 5678",
        "REGN-5678",
        "REGN5678"
      ]
    },
    {
      "fdaUniiCode": "UH9J2HBQWJ",
      "id": "Fedratinib_Hydrochloride",
      "preferredName": "Fedratinib Hydrochloride",
      "synonyms": [
        "Benzenesulfonamide, N-(1,1-Dimethylethyl)-3-((5-methyl-2-((4-(2-(1-pyrrolidinyl)ethoxy)phenyl)amino)-4-pyrimidinyl)amino)-, Hydrochloride, Hydrate (1:2:1)",
        "FEDRATINIB HYDROCHLORIDE",
        "Fedratinib Dihydrochloride Monohydrate",
        "Fedratinib Hydrochloride",
        "Inrebic",
        "N-tert-butyl-3-((5-methyl-2-((4-(2-pyrrolidin-1-ylethoxy)phenyl)amino)pyrimidin-4-yl)amino) Benzenesulfonamide Dihydrochloride Monohydrate",
        "SAR302503a"
      ]
    },
    {
      "fdaUniiCode": "DW4CE8MKS9",
      "id": "Avdoralimab",
      "preferredName": "Avdoralimab",
      "synonyms": [
        "AVDORALIMAB",
        "Anti-C5aR-215",
        "Avdoralimab",
        "IPH 5401",
        "IPH-5401",
        "IPH5401",
        "NN 8210"
      ]
    },
    {
      "fdaUniiCode": "D6OMY2L0WA",
      "id": "Epcoritamab",
      "preferredName": "Epcoritamab",
      "synonyms": [
        "Anti-CD20/CD3 Bispecific Antibody GEN3013",
        "DuoBody-CD3xCD20",
        "EPCORITAMAB",
        "Epcoritamab",
        "GEN 3013",
        "GEN-3013",
        "GEN3013"
      ]
    },
    {
      "fdaUniiCode": "240Y4YO0TN",
      "id": "Diarylsulfonylurea_Compound_ILX-295501",
      "preferredName": "Diarylsulfonylurea Compound ILX-295501",
      "synonyms": [
        "Diarylsulfonylurea Compound ILX-295501",
        "ILX 295501",
        "ILX-295501",
        "ILX295501",
        "LY 295501",
        "LY-295501",
        "LY295501",
        "N-(((3,4-Dichlorophenyl)amino)carbonyl)-2,3-dihydro-5-benzofuransulfonamide",
        "N-(5-(2,3-Dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea"
      ]
    },
    {
      "fdaUniiCode": "4LJQ1IXS6C",
      "id": "Cemadotin_Hydrochloride",
      "preferredName": "Cemadotin Hydrochloride",
      "synonyms": [
        "CEMADOTIN HYDROCHLORIDE",
        "Cemadotin Hydrochloride",
        "LU-103793",
        "LU103793"
      ]
    },
    {
      "fdaUniiCode": "A61RXM4375",
      "id": "Bexarotene",
      "preferredName": "Bexarotene",
      "synonyms": [
        "3-methyl TTNEB",
        "4-[1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]benzoic Acid",
        "BEXAROTENE",
        "Bexarotene",
        "LGD1069",
        "Targretin",
        "bexarotene"
      ]
    },
    {
      "fdaUniiCode": "I5X6L61HUT",
      "id": "Iodine_I-131",
      "preferredName": "Iodine I-131",
      "synonyms": [
        "131-Iodine",
        "Bound Iodide I-131",
        "I 131",
        "I-131",
        "IODINE I-131",
        "Iodide I-131",
        "Iodide, I-131",
        "Iodine 131",
        "Iodine I-131",
        "Iodotope",
        "Iodotrope"
      ]
    },
    {
      "fdaUniiCode": "0H2XLR2IKW",
      "id": "Lemzoparlimab",
      "preferredName": "Lemzoparlimab",
      "synonyms": [
        "Anti-CD47 Monoclonal Antibody TJC4",
        "LEMZOPARLIMAB",
        "Lemzoparlimab",
        "TJ 011133",
        "TJ-011133",
        "TJ011133",
        "TJC4"
      ]
    },
    {
      "fdaUniiCode": "N8VKI8FPW0",
      "id": "Onametostat",
      "preferredName": "Onametostat",
      "synonyms": [
        "JNJ 64619178",
        "JNJ-64619178",
        "JNJ64619178",
        "ONAMETOSTAT",
        "Onametostat",
        "PRMT5 Inhibitor JNJ-64619178",
        "Protein Arginine Methyltransferase 5 Inhibitor JNJ-64619178"
      ]
    },
    {
      "fdaUniiCode": "5V1Y8T4RB6",
      "id": "Pimurutamab",
      "preferredName": "Pimurutamab",
      "synonyms": [
        "Anti-EGFR Monoclonal Antibody HLX-07",
        "Cetuximab Biobetter HLX07",
        "HLX 07",
        "HLX-07",
        "HLX07",
        "PIMURUTAMAB",
        "Pimurutamab"
      ]
    },
    {
      "fdaUniiCode": "Z6BYC0F36E",
      "id": "Avotaciclib",
      "preferredName": "Avotaciclib",
      "synonyms": [
        "AVOTACICLIB",
        "Avotaciclib",
        "BEY 1107",
        "BEY-1107",
        "BEY-A",
        "BEY1107",
        "BEY1107G",
        "BEY1107P",
        "CDK1 Inhibitor BEY1107"
      ]
    },
    {
      "fdaUniiCode": "8X5F5LAF7B",
      "id": "Foslinanib_Disodium",
      "preferredName": "Foslinanib Disodium",
      "synonyms": [
        "4(1H)-Quinolinone, 2-(3-Fluorophenyl)-6-methoxy-5-(phosphonooxy)-, Sodium Salt (1:2)",
        "CVM-1118 Disodium",
        "FOSLINANIB DISODIUM",
        "Foslinanib Disodium",
        "TRX-818",
        "TRX818 Disodium"
      ]
    },
    {
      "fdaUniiCode": "39IS23Q1EW",
      "id": "Cedazuridine",
      "preferredName": "Cedazuridine",
      "synonyms": [
        "(4R)-2'-Deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridine",
        "CDA Inhibitor E7727",
        "CEDAZURIDINE",
        "Cedazuridine",
        "E7727",
        "Uridine, 2'-Deoxy-2',2'-difluoro-3,4,5,6-tetrahydro-, (4R)"
      ]
    },
    {
      "fdaUniiCode": "4MOD1F4ENC",
      "id": "Menin-MLL_Interaction_Inhibitor_KO_539",
      "preferredName": "Menin-MLL Interaction Inhibitor KO 539",
      "synonyms": [
        "KO 539",
        "KO-539",
        "KO539",
        "Menin-KMT2A Inhibitor KO 539",
        "Menin-MLL Inhibitor KO-539",
        "Menin-MLL Interaction Inhibitor KO 539",
        "Menin-Mixed Lineage Leukemia Protein-Protein Interaction Inhibitor KO 539"
      ]
    },
    {
      "fdaUniiCode": "P188ANX8CK",
      "id": "Trastuzumab",
      "preferredName": "Trastuzumab",
      "synonyms": [
        "ABP 980",
        "ALT02",
        "Anti-ERB-2",
        "Anti-HER2/c-erbB2 Monoclonal Antibody",
        "Anti-c-ERB-2",
        "Anti-c-erbB2 Monoclonal Antibody",
        "Anti-erbB-2",
        "Anti-erbB2 Monoclonal Antibody",
        "Anti-p185-HER2",
        "HER2 Monoclonal Antibody",
        "Herceptin",
        "Herceptin Biosimilar PF-05280014",
        "Herceptin Trastuzumab Biosimilar PF-05280014",
        "Herzuma",
        "Immunoglobulin G 1 (Human-Mouse Monoclonal RhuMab HER2gamma1-Chain Antihuman p185(Sup c-erbB2) Receptor), Disulfide with Human-Mouse Monoclonal RhuMab HER2 Light Chain, Dimer",
        "Kanjinti",
        "MoAb HER2",
        "Monoclonal Antibody HER2",
        "Monoclonal Antibody c-erb-2",
        "Ogivri",
        "Ontruzant",
        "PF-05280014",
        "RO0452317",
        "SB3",
        "TRASTUZUMAB",
        "Trastuzumab",
        "Trastuzumab Biosimilar ABP 980",
        "Trastuzumab Biosimilar ALT02",
        "Trastuzumab Biosimilar HLX02",
        "Trastuzumab Biosimilar PF-05280014",
        "Trastuzumab Biosimilar SB3",
        "Trastuzumab Biosimilar SIBP-01",
        "Trastuzumab-anns",
        "Trastuzumab-dkst",
        "Trastuzumab-dttb",
        "Trastuzumab-pkrb",
        "Trastuzumab-qyyp",
        "Trazimera",
        "c-erb-2 Monoclonal Antibody",
        "rhuMAb HER2",
        "trastuzumab",
        "trastuzumab biosimilar EG12014"
      ]
    },
    {
      "fdaUniiCode": "7B646RJ70F",
      "id": "Peldesine",
      "preferredName": "Peldesine",
      "synonyms": [
        "4H-Pyrrolo(3,2-d)pyrimidin-4-one,1,5-dihydro-2-amino-7-(3-pyridinylmethyl)",
        "9-(3-Pyridinylmethyl)-7H-9-deazaguanine",
        "BCX-34",
        "PELDESINE",
        "Peldesina",
        "Peldesine",
        "peldesine"
      ]
    },
    {
      "fdaUniiCode": "0A85BJ22L6",
      "id": "Motexafin_Lutetium",
      "preferredName": "Motexafin Lutetium",
      "synonyms": [
        "Antrin",
        "Lu tex",
        "Lu-Tex",
        "Lutetium Texaphrin",
        "Lutetium Texaphyrin",
        "Lutetium texaphyrin",
        "Lutex",
        "Lutrin",
        "MOTEXAFIN LUTETIUM",
        "Motexafin Lutetium",
        "Optrin",
        "PCI-0123",
        "lutetium texaphyrin",
        "motexafin lutetium"
      ]
    },
    {
      "fdaUniiCode": "F3HG38I0T1",
      "id": "Anti-CD20Anti-CD3_Bispecific_IgM_Antibody_IGM2323",
      "preferredName": "Anti-CD20/Anti-CD3 Bispecific IgM Antibody IGM2323",
      "synonyms": [
        "Anti-CD20/Anti-CD3 Bispecific IgM Antibody IGM2323",
        "Bispecific CD20xCD3 IgM Antibody IGM2323",
        "Bispecific IgM Antibody IGM2323",
        "IGM 2323",
        "IGM-2323",
        "IGM2323",
        "IgM Pentamer IGM2323"
      ]
    },
    {
      "fdaUniiCode": "D5EQV23TDS",
      "id": "Marimastat",
      "preferredName": "Marimastat",
      "synonyms": [
        "(2S,3R)-3-(((1S)-2,2-Dimethyl-1-(methylcarbamoxy)propyl)carboyl)-2-hydroxy-5-methylhexanohydroxamic Acid",
        "(2S,3R)-3-{(S)-[2,2-Dimethyl-1-(methylcarbamoyl) propyl]carbamoyl}-2-hydroxy-5-methylhexanohydroxamic acid",
        "BB 2516",
        "BB-2516",
        "MARIMASTAT",
        "Marimastat",
        "Marimistat",
        "TA-2516",
        "marimastat"
      ]
    },
    {
      "fdaUniiCode": "20ZE3P16HV",
      "id": "Opucolimab",
      "preferredName": "Opucolimab",
      "synonyms": [
        "Anti-PD-L1 Monoclonal Antibody HLX20",
        "HLX 20",
        "HLX-20",
        "HLX20",
        "OPUCOLIMAB",
        "Opucolimab",
        "PD-L1-targeting Monoclonal Antibody HLX20"
      ]
    },
    {
      "fdaUniiCode": "ICY00EMP8P",
      "id": "Pictilisib",
      "preferredName": "Pictilisib",
      "synonyms": [
        "2-(1H-indazol-4-yl)-6-((4-(methanesulfonyl)piperazin-1-yl)methyl)-4-(morpholin-4-yl)thieno(3,2-d)pyrimidine",
        "4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno(3,2-d)pyrimidin-4-yl)morpholine",
        "GDC 0941",
        "GDC-0941",
        "GDC0941",
        "PICTILISIB",
        "Pictilisib"
      ]
    },
    {
      "fdaUniiCode": "GMV2GFP3G2",
      "id": "Zevorcabtagene_Autoleucel",
      "preferredName": "Zevorcabtagene Autoleucel",
      "synonyms": [
        "Anti-BCMA-CAR-41BB-CD3zeta-expressing T-cells CT053",
        "Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells CT053",
        "BCMA Car-T (CT053)",
        "CAR-BCMA T-cells CT053",
        "CT 053",
        "CT-053",
        "CT053",
        "CT053 CAR-BCMA T",
        "CT053 CAR-BCMA T Cells",
        "ZEVORCABTAGENE AUTOLEUCEL",
        "Zevorcabtagene Autoleucel"
      ]
    },
    {
      "fdaUniiCode": "KV1M7Q3CBP",
      "id": "Olverembatinib",
      "preferredName": "Olverembatinib",
      "synonyms": [
        "BCR-ABL/KIT/AKT/ERK Inhibitor HQP1351",
        "GZD-824",
        "HQP 1351",
        "HQP-1351",
        "HQP1351",
        "Multi-kinase Inhibitor HQP1351",
        "OLVEREMBATINIB",
        "Olverembatinib"
      ]
    },
    {
      "fdaUniiCode": "58I6YNR7BV",
      "id": "Lilotomab",
      "preferredName": "Lilotomab",
      "synonyms": [
        "Anti-CD37 Monoclonal Antibody HH1",
        "HH1",
        "LILOTOMAB",
        "Lilotomab"
      ]
    },
    {
      "fdaUniiCode": "2EWN8Z05CN",
      "id": "Zotatifin",
      "preferredName": "Zotatifin",
      "synonyms": [
        "4-((5aR,6S,7S,8R,8aS)-7-((Dimethylamino)methyl)-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-6,7,8,8a-tetrahydro-5aH-cyclopenta(4,5)furo(3,2-C)pyridin-5a-yl)benzonitrile",
        "ZOTATIFIN",
        "Zotatifin",
        "eFT 226",
        "eFT-226"
      ]
    },
    {
      "fdaUniiCode": "BK3WC9ZP7A",
      "id": "Anti-CD47CD19_Bispecific_Monoclonal_Antibody_TG-1801",
      "preferredName": "Anti-CD47/CD19 Bispecific Monoclonal Antibody TG-1801",
      "synonyms": [
        "Anti-CD47/CD19 Bispecific Monoclonal Antibody TG-1801",
        "Bispecific Monoclonal Antibody TG-1801",
        "TG 1801",
        "TG-1801",
        "TG1801"
      ]
    },
    {
      "fdaUniiCode": "S0GJ8VM4P9",
      "id": "Parsaclisib_Hydrochloride",
      "preferredName": "Parsaclisib Hydrochloride",
      "synonyms": [
        "(4R)-4-(3-((1S)-1-(4-amino-3-methyl-1h-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-onehydrochloric Acid (1:1)",
        "2-Pyrrolidinone, 4-(3-((1S)-1-(4-amino-3-methyl-1h-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)-, Hydrochloride (1:1), (4R)-",
        "INCB 50465 Hydrochloride",
        "INCB050465 Hydrochloride",
        "PARSACLISIB HYDROCHLORIDE",
        "Parsaclisib Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "FU21S769PF",
      "id": "Temoporfin",
      "preferredName": "Temoporfin",
      "synonyms": [
        "5,10,15,20-Tetra-(m-hydroxyphenyl)chlorin",
        "Foscan",
        "TEMOPORFIN",
        "Temoporfin",
        "m-Tetrahydroxyphenyl-chlorin",
        "mTHPC",
        "meta-Tetrahydroxyphenyl Chlorin",
        "meta-Tetrahydroxyphenylchlorin",
        "temoporfin"
      ]
    },
    {
      "fdaUniiCode": "6HXC0O6JMV",
      "id": "Onfekafusp_Alfa",
      "preferredName": "Onfekafusp Alfa",
      "synonyms": [
        "Fibromun",
        "L19-TNF-alpha",
        "ONFEKAFUSP ALFA",
        "Onfekafusp Alfa",
        "Recombinant Human Fusion Protein L19TNFalpha"
      ]
    },
    {
      "fdaUniiCode": "J12U072QL0",
      "id": "Ibandronate_Sodium",
      "preferredName": "Ibandronate Sodium",
      "synonyms": [
        "Bondronate",
        "Boniva",
        "IBANDRONATE SODIUM",
        "Ibandronate Sodium",
        "ibandronate"
      ]
    },
    {
      "fdaUniiCode": "J6K8WSV73A",
      "id": "Quemliclustat",
      "preferredName": "Quemliclustat",
      "synonyms": [
        "AB 680",
        "AB-680",
        "AB680",
        "CD73 Inhibitor AB680",
        "QUEMLICLUSTAT",
        "Quemliclustat"
      ]
    },
    {
      "fdaUniiCode": "CEB05S0B9I",
      "id": "Sardomozide",
      "preferredName": "Sardomozide",
      "synonyms": [
        "2-[4-(Aminoiminomethyl)-2,3-dihydro-1H-inden-1-ylidene]hydrazinecarboximidamide",
        "Amidinoindan-1-one.2'-amidinohydrazone",
        "CGP 48664",
        "CGP-48664",
        "SAM 486A",
        "SARDOMOZIDE",
        "Sardomozide"
      ]
    },
    {
      "fdaUniiCode": "D2VJ1CC26Q",
      "id": "Exatecan_Mesylate",
      "preferredName": "Exatecan Mesylate",
      "synonyms": [
        "10H,13H-Benzo(de)pyrano(3'm4':6,7)indolizino(1,2-b)quinoline-10,13-dione, 1-amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-, (1S-trans)-, Methanesulfonate (1:1) (Salt), Dihydrate",
        "DX-8951f",
        "EXATECAN MESYLATE",
        "Exatecan Mesylate",
        "Exatecan Mesylate Dihydrate",
        "Exatecan Mesylate Hydrate",
        "exatecan mesylate"
      ]
    },
    {
      "fdaUniiCode": "X08H9UZ7TO",
      "id": "Iboctadekin",
      "preferredName": "Iboctadekin",
      "synonyms": [
        "Human Interleukin-18 (Recombinant, Expressed in Escherichia coli)",
        "Human Recombinant Interleukin-18",
        "IBOCTADEKIN",
        "IFN-Gamma-Inducing Factor",
        "IL-18",
        "Iboctadekin",
        "Interferon-Gamma-Inducing Factor",
        "Interleukin-18",
        "Recombinant Interleukin-18",
        "SB 485232",
        "SB-485232"
      ]
    },
    {
      "fdaUniiCode": "3A189DH42V",
      "id": "Alemtuzumab",
      "preferredName": "Alemtuzumab",
      "synonyms": [
        "ALEMTUZUMAB",
        "Alemtuzumab",
        "Anti-CD52 Monoclonal Antibody",
        "Campath",
        "Campath-1H",
        "LDP-03",
        "Lemtrada",
        "MabCampath",
        "Monoclonal Antibody Campath-1H",
        "alemtuzumab"
      ]
    },
    {
      "fdaUniiCode": "L65E7T81M5",
      "id": "Dulanermin",
      "preferredName": "Dulanermin",
      "synonyms": [
        "114-281-protein TRAIL",
        "AMG 951",
        "APO2L/TRAIL",
        "DULANERMIN",
        "Dulanermin",
        "RG3639",
        "rTRAIL"
      ]
    },
    {
      "fdaUniiCode": "MNZ4OP95CF",
      "id": "Senaparib",
      "preferredName": "Senaparib",
      "synonyms": [
        "IMP 4297",
        "IMP-4297",
        "IMP4297",
        "PARP 1/2 Inhibitor IMP4297",
        "SENAPARIB",
        "Senaparib"
      ]
    },
    {
      "fdaUniiCode": "D40H7X1YZ0",
      "id": "Icatolimab",
      "preferredName": "Icatolimab",
      "synonyms": [
        "Anti-B- and T-lymphocyte Attenuator Monoclonal Antibody TAB004",
        "Anti-BTLA Monoclonal Antibody TAB004",
        "ICATOLIMAB",
        "Icatolimab",
        "JS 004",
        "JS-004",
        "JS004",
        "TAB 004",
        "TAB-004",
        "TAB004"
      ]
    },
    {
      "fdaUniiCode": "8A1O1M485B",
      "id": "Imatinib_Mesylate",
      "preferredName": "Imatinib Mesylate",
      "synonyms": [
        "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide Monomethanesulfonate",
        "CGP 57148",
        "CGP57148B",
        "Gleevec",
        "Glivec",
        "IMATINIB MESYLATE",
        "Imatinib Mesylate",
        "STI 571",
        "STI-571",
        "STI571",
        "imatinib mesylate"
      ]
    },
    {
      "fdaUniiCode": "Y76ID234HW",
      "id": "Plitidepsin",
      "preferredName": "Plitidepsin",
      "synonyms": [
        "APLD",
        "Aplidin",
        "Aplidine",
        "DDB",
        "Dehydrodemnin B",
        "Dehydrodidemnin B",
        "N-[1-(1,2-Dioxopropyl)-L-prolyl]didemnin A",
        "PLITIDEPSIN",
        "Plitidepsin",
        "aplidine"
      ]
    },
    {
      "fdaUniiCode": "WK58XJB6UK",
      "id": "CD80-Fc_Fusion_Protein_FPT155",
      "preferredName": "CD80-Fc Fusion Protein FPT155",
      "synonyms": [
        "CD80-Fc Fusion Protein FPT155",
        "FPT 155",
        "FPT-155",
        "FPT155"
      ]
    },
    {
      "fdaUniiCode": "ID0YZQ2TCP",
      "id": "Trabectedin",
      "preferredName": "Trabectedin",
      "synonyms": [
        "ET-743",
        "Ecteinascidin",
        "Ecteinascidin 743",
        "Spiro(6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo(7,8)isoquino(3,2,-b)(3)benzazocine-20,1'(2'H)-isoquinolin)-19-one, 3',4',6,6a,7,13,14,16-Octahydro-5-(acetyloxy)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-, (6R-(6-alpha,6a-beta,7-beta,13-beta,14-beta,16-alpha,20R*))-",
        "TRABECTEDIN",
        "Trabectedin",
        "Yondelis",
        "ecteinascidin 743",
        "trabectedin"
      ]
    },
    {
      "fdaUniiCode": "690284A407",
      "id": "Phosphorus_P-32",
      "preferredName": "Phosphorus P-32",
      "synonyms": [
        "P-32",
        "P32",
        "PHOSPHORUS P-32",
        "Phosphorus P 32",
        "Phosphorus P-32",
        "phosphorus-32"
      ]
    },
    {
      "fdaUniiCode": "6XC1PAD3KF",
      "id": "Zoledronic_Acid",
      "preferredName": "Zoledronic Acid",
      "synonyms": [
        "CGP 42446",
        "CGP42446A",
        "NDC-Zoledronate",
        "Reclast",
        "ZOL 446",
        "ZOLEDRONIC ACID",
        "Zoledronic Acid",
        "Zometa",
        "[1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bisphosphonic Acid",
        "zoledronic acid"
      ]
    },
    {
      "fdaUniiCode": "4F4X42SYQ6",
      "id": "Rituximab",
      "preferredName": "Rituximab",
      "synonyms": [
        "ABP 798",
        "BI 695500",
        "C2B8 Monoclonal Antibody",
        "CT-P10",
        "Chimeric Anti-CD20 Antibody",
        "IDEC-102",
        "IDEC-C2B8",
        "IDEC-C2B8 Monoclonal Antibody",
        "MabThera",
        "Monoclonal Antibody IDEC-C2B8",
        "PF-05280586",
        "RITUXIMAB",
        "RTXM83",
        "Rituxan",
        "Rituximab",
        "Rituximab ABBS",
        "Rituximab Biosimilar ABP 798",
        "Rituximab Biosimilar BI 695500",
        "Rituximab Biosimilar CT-P10",
        "Rituximab Biosimilar GB241",
        "Rituximab Biosimilar IBI301",
        "Rituximab Biosimilar JHL1101",
        "Rituximab Biosimilar PF-05280586",
        "Rituximab Biosimilar RTXM83",
        "Rituximab Biosimilar SAIT101",
        "Rituximab Biosimilar SIBP-02",
        "Truxima",
        "rituximab",
        "rituximab biosimilar TQB2303",
        "rituximab-abbs"
      ]
    },
    {
      "fdaUniiCode": "Y8KTZ6Y35U",
      "id": "Pegcrisantaspase",
      "preferredName": "Pegcrisantaspase",
      "synonyms": [
        "JZP 416",
        "JZP-416",
        "JZP416",
        "PEGCRISANTASPASE",
        "Pegcrisantaspase",
        "Pegylated Erwinia asparaginase"
      ]
    },
    {
      "fdaUniiCode": "MAT637500A",
      "id": "Tipifarnib",
      "preferredName": "Tipifarnib",
      "synonyms": [
        "(+)-6-[Amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone",
        "R115777",
        "TIPIFARNIB",
        "Tipifarnib",
        "Zarnestra",
        "tipifarnib"
      ]
    },
    {
      "fdaUniiCode": "SU9AMV39DB",
      "id": "Rasdegafusp_Alfa",
      "preferredName": "Rasdegafusp Alfa",
      "synonyms": [
        "CDX-1401",
        "DEC-205/NY-ESO-1 Fusion Protein CDX-1401",
        "RASDEGAFUSP ALFA",
        "Rasdegafusp Alfa"
      ]
    },
    {
      "fdaUniiCode": "R6AXV96CRH",
      "id": "Ravoxertinib",
      "preferredName": "Ravoxertinib",
      "synonyms": [
        "ERK Inhibitor GDC-0994",
        "GDC-0994",
        "RAVOXERTINIB",
        "Ravoxertinib"
      ]
    },
    {
      "fdaUniiCode": "60158CV180",
      "id": "Nelarabine",
      "preferredName": "Nelarabine",
      "synonyms": [
        "2-Amino, 6-Methoxypurine Arabinoside",
        "2-Amino-6-methoxypurine arabinoside",
        "2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine",
        "506U78",
        "Arranon",
        "Compound 506U78",
        "GW506U78",
        "NELARABINE",
        "Nelarabine",
        "nelarabine"
      ]
    },
    {
      "fdaUniiCode": "4MD2J2T8SJ",
      "id": "Brexucabtagene_Autoleucel",
      "preferredName": "Brexucabtagene Autoleucel",
      "synonyms": [
        "Anti-CD19 Autologous CAR-CD28 T-cells KTE-X19",
        "BREXUCABTAGENE AUTOLEUCEL",
        "Brexucabtagene Autoleucel",
        "KTE X19",
        "KTE-X19",
        "KTEX19",
        "Tecartus"
      ]
    },
    {
      "fdaUniiCode": "AM1ZX94EXH",
      "id": "Tanomastat",
      "preferredName": "Tanomastat",
      "synonyms": [
        "(S)-3-[(4'-Chloro-4-biphenylyl)carbonyl]-2-[(phenylthio)methyl]propionic acid",
        "4-[4-(chlorophenyl)phenyl]-4-oxo-2S-(phenylthiomethyl) butanoic acid",
        "BAY 12-9566",
        "BAY-12-9566",
        "TANOMASTAT",
        "Tanomastat"
      ]
    },
    {
      "fdaUniiCode": "XS499WOZ93",
      "id": "Sabarubicin",
      "preferredName": "Sabarubicin",
      "synonyms": [
        "(7S,9S)-7-{(4-O-(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)oxy}-6,9,11-trihydroxy-9-(hydroxyacetyl)-7,8,9,10-tetrahydrotetracene-5,12-dione",
        "BMS-195615",
        "MEN-10755",
        "SABARUBICIN",
        "Sabarubicin"
      ]
    },
    {
      "fdaUniiCode": "LQX7RFK8MZ",
      "id": "Alofanib",
      "preferredName": "Alofanib",
      "synonyms": [
        "ALOFANIB",
        "Alofanib",
        "Benzoic Acid, 3-(((4-Methyl-2-nitro-5-(3-pyridinyl)phenyl)amino)sulfonyl)-",
        "ES000835",
        "FGFR4 Antagonist ICP-105",
        "RPT 835",
        "RPT-835",
        "RPT835"
      ]
    },
    {
      "fdaUniiCode": "533Z4G2286",
      "id": "Finotonlimab",
      "preferredName": "Finotonlimab",
      "synonyms": [
        "Anti-PD-1 Monoclonal Antibody SCT-I10A",
        "FINOTONLIMAB",
        "Finotonlimab",
        "SCT I10A",
        "SCT-I10A",
        "SCTI10A"
      ]
    },
    {
      "fdaUniiCode": "B1MW2ME77A",
      "id": "Atamparib",
      "preferredName": "Atamparib",
      "synonyms": [
        "ATAMPARIB",
        "Atamparib",
        "PARP7 Inhibitor RBN-2397",
        "RBN 2397",
        "RBN-2397",
        "RBN2397"
      ]
    },
    {
      "fdaUniiCode": "7JNY4KV3NK",
      "id": "Ociperlimab",
      "preferredName": "Ociperlimab",
      "synonyms": [
        "Anti-TIGIT Monoclonal Antibody BGB-A1217",
        "BGB A1217",
        "BGB-A1217",
        "BGBA1217",
        "OCIPERLIMAB",
        "Ociperlimab"
      ]
    },
    {
      "fdaUniiCode": "V00Y10W60W",
      "id": "Lintuzumab",
      "preferredName": "Lintuzumab",
      "synonyms": [
        "Hu-M195 monoclonal antibody",
        "HuG1-M195 monoclonal antibody",
        "Humanized M195",
        "LINTUZUMAB",
        "Lintuzumab",
        "MoAb HuG1-M195",
        "MoAb HuM195",
        "Monoclonal Antibody HuG1-M195",
        "Monoclonal Antibody HuM195",
        "SGN-33",
        "SMART M195",
        "Zamyl",
        "lintuzumab",
        "monoclonal antibody HuM195 HuG1-M195"
      ]
    },
    {
      "fdaUniiCode": "EH1713MN4K",
      "id": "ALK_Inhibitor_TAE684",
      "preferredName": "ALK Inhibitor TAE684",
      "synonyms": [
        "5-Chloro-n4-(2-(isopropylsulfonyl)phenyl)-n2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine",
        "ALK Inhibitor TAE684",
        "NPM-ALK Inhibitor TAE684",
        "NVP-TAE684",
        "TAE 684",
        "TAE-684",
        "TAE684"
      ]
    },
    {
      "fdaUniiCode": "6B799IH05A",
      "id": "Irofulven",
      "preferredName": "Irofulven",
      "synonyms": [
        "(R)-6'-Hydroxy-3'-(hydroxymethyl)-2',4',6'-trimethylspiro(cyclopropane-1,5'(5H)-inden)-7'(6'H)-one",
        "6-Hydroxymethylacylfulvene",
        "6-hydroxymethylacylfulvene",
        "HMAF",
        "Hydroxymethylacylfulvene",
        "IROFULVEN",
        "Irofulven",
        "MGI 114",
        "MGI-114",
        "irofulven"
      ]
    },
    {
      "fdaUniiCode": "4W3KFI3TN3",
      "id": "Talquetamab",
      "preferredName": "Talquetamab",
      "synonyms": [
        "Anti-CD3/Anti-GPRC5D Bispecific Monoclonal Antibody JNJ-64407564",
        "GPRC5D x CD3 Bispecific Antibody JNJ-64407564",
        "GPRC5D x CD3 DuoBody Antibody JNJ-64407564",
        "GPRC5D/CD3 DuoBody Antibody JNJ-64407564",
        "Humanized GPRC5D x CD3 DuoBody Antibody JNJ-64407564",
        "JNJ 64407564",
        "JNJ-64407564",
        "JNJ64407564",
        "TALQUETAMAB",
        "Talquetamab"
      ]
    },
    {
      "fdaUniiCode": "923X28214S",
      "id": "Crenigacestat",
      "preferredName": "Crenigacestat",
      "synonyms": [
        "4,4,4-Trifluoro-N-((S)-1-(((S)-5-(2-hydroxyethyl)-6-oxo-6,7-dihydro-5H-benzo[d]pyrido[2,3-b]azepin-7-yl)amino)-1-oxopropan-2-yl)butanamide",
        "BMS-986405",
        "CRENIGACESTAT",
        "Crenigacestat",
        "Gamma-Secretase Inhibitor LY3039478",
        "JSMD194",
        "LY 3039478",
        "LY-3039478",
        "LY3039478"
      ]
    },
    {
      "fdaUniiCode": "963AI80S1B",
      "id": "Borofalan_10B",
      "preferredName": "Borofalan (10B)",
      "synonyms": [
        "BOROFALAN B-10",
        "Borofalan (10B)",
        "Boron B 10 BPA",
        "Boron B 10 Boronophenylalanine",
        "Boron B 10-condensed Boronophenylalanine",
        "Boronophenylalanine B-10",
        "SPM 011",
        "SPM-011",
        "SPM011"
      ]
    },
    {
      "fdaUniiCode": "HQ700V0X06",
      "id": "Inupadenant",
      "preferredName": "Inupadenant",
      "synonyms": [
        "A2A Receptor Antagonist EOS100850",
        "EOS 100850",
        "EOS-100850",
        "EOS100850",
        "INUPADENANT",
        "Inupadenant"
      ]
    },
    {
      "fdaUniiCode": "PQX0D8J21J",
      "id": "Cetuximab",
      "preferredName": "Cetuximab",
      "synonyms": [
        "CETUXIMAB",
        "Cetuximab",
        "Cetuximab Biosimilar CDP-1",
        "Cetuximab Biosimilar CMAB009",
        "Cetuximab Biosimilar KL 140",
        "Chimeric Anti-EGFR Monoclonal Antibody",
        "Chimeric MoAb C225",
        "Chimeric Monoclonal Antibody C225",
        "Erbitux",
        "IMC-C225",
        "cetuximab"
      ]
    },
    {
      "fdaUniiCode": "2GWV496552",
      "id": "Perifosine",
      "preferredName": "Perifosine",
      "synonyms": [
        "4-[[Hydroxy(octadecyloxy)phosphinyl]oxy]-1,1-dimethylpiperidinium, Inner Salt",
        "D21266",
        "Octadecyl-(N,N-dimethylpiperidino-4-yl)phosphate",
        "Octadecylphosphopiperidine",
        "PERIFOSINE",
        "Perifosine",
        "perifosine"
      ]
    },
    {
      "fdaUniiCode": "760HJB0YRD",
      "id": "Obecabtagene_Autoleucel",
      "preferredName": "Obecabtagene Autoleucel",
      "synonyms": [
        "AUTO 1",
        "AUTO-1",
        "AUTO1",
        "AUTO1 CAR-T Cells",
        "Autologous Anti-CD19 CAR T-cells AUTO1",
        "Autologous Anti-CD19 Chimeric Antigen Receptor T-cells AUTO1",
        "Autologous Anti-CD19 Chimeric Antigen Receptor T-lymphocytes AUTO1",
        "Autologous CD19-targeted CAR T-cells AUTO1",
        "CD19CAR T-cells AUTO1",
        "CD19CAT-41BBZ CAR T-cells AUTO1",
        "OBECABTAGENE AUTOLEUCEL",
        "Obe-cel",
        "Obecabtagene Autoleucel"
      ]
    },
    {
      "fdaUniiCode": "JCX84Q7J1L",
      "id": "Celecoxib",
      "preferredName": "Celecoxib",
      "synonyms": [
        "4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide",
        "Benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-",
        "CELECOXIB",
        "Celebrex",
        "Celecoxib",
        "SC-58635",
        "YM 177",
        "celecoxib"
      ]
    },
    {
      "fdaUniiCode": "P3M2575F3F",
      "id": "Ursolic_Acid",
      "preferredName": "Ursolic Acid",
      "synonyms": [
        "(3beta)-3-Hydroxyurs-12-en-28-oic Acid",
        "URSOLIC ACID",
        "Ursolic Acid"
      ]
    },
    {
      "fdaUniiCode": "3IG1E710ZN",
      "id": "Methotrexate_Sodium",
      "preferredName": "Methotrexate Sodium",
      "synonyms": [
        "METHOTREXATE SODIUM",
        "Methotrexate Sodium",
        "Sodium Methotrexate",
        "Trexall",
        "Xatmep"
      ]
    },
    {
      "fdaUniiCode": "8CZ82ZYY9X",
      "id": "Tolebrutinib",
      "preferredName": "Tolebrutinib",
      "synonyms": [
        "BTK Inhibitor SAR442168",
        "Bruton's Tyrosine Kinase Inhibitor SAR442168",
        "SAR 442168",
        "SAR-442168",
        "SAR442168",
        "TOLEBRUTINIB",
        "Tolebrutinib"
      ]
    },
    {
      "fdaUniiCode": "TU8J357395",
      "id": "MVA-BN_Smallpox_Vaccine",
      "preferredName": "MVA-BN Smallpox Vaccine",
      "synonyms": [
        "Imvamune",
        "Imvanex",
        "JYNNEOS",
        "MVA Smallpox Vaccine",
        "MVA-BN Smallpox Vaccine",
        "Modified Vaccinia Ankara - Bavarian Nordic Smallpox Vaccine",
        "Modified Vaccinia Ankara Smallpox Vaccine",
        "VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN"
      ]
    },
    {
      "fdaUniiCode": "J2Y9QT3BWL",
      "id": "Frenlosirsen",
      "preferredName": "Frenlosirsen",
      "synonyms": [
        "Anti-IRF4 ASO ION251",
        "Anti-IRF4 ASO IONIS-IRF4-2.5Rx",
        "Anti-IRF4 Antisense Oligonucleotide ION251",
        "FRENLOSIRSEN",
        "Frenlosirsen",
        "ION 251",
        "ION-251",
        "ION251",
        "IONIS-IRF4-2.5Rx",
        "ON-935918"
      ]
    },
    {
      "fdaUniiCode": "XO25H8E4QP",
      "id": "Taniraleucel",
      "preferredName": "Taniraleucel",
      "synonyms": [
        "Allogeneic CD56+/CD3- Natural Killer Cells CYNK-001",
        "Allogeneic CD56-positive CD3-negative Natural Killer Cells CYNK-001",
        "Allogeneic Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells CYNK-001",
        "CD56+/CD3- NK Cells CYNK-001 (SY); Natural Killer Cells CYNK-001",
        "CYNK 001",
        "CYNK-001",
        "CYNK001",
        "Human Placental HSC-derived CD56+/CD3- NKs CYNK-001",
        "TANIRALEUCEL",
        "Taniraleucel"
      ]
    },
    {
      "fdaUniiCode": "T5IRO3534A",
      "id": "Vincristine_Sulfate",
      "preferredName": "Vincristine Sulfate",
      "synonyms": [
        "Kyocristine",
        "Leurocristine Sulfate",
        "Leurocristine sulfate",
        "Leurocristine, sulfate",
        "Oncovin",
        "VINCRISTINE SULFATE",
        "Vincasar",
        "Vincasar PFS",
        "Vincosid",
        "Vincrex",
        "Vincristine Sulfate",
        "Vincristine, sulfate",
        "vincristine sulfate"
      ]
    },
    {
      "fdaUniiCode": "9GGE6A0ZMK",
      "id": "Sirpiglenastat",
      "preferredName": "Sirpiglenastat",
      "synonyms": [
        "(S)-Isopropyl 2-((S)-2-acetamido-3-(1h-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate",
        "DRP 104",
        "DRP-104",
        "DRP104",
        "Glutamine Antagonist DRP-104",
        "SIRPIGLENASTAT",
        "Sirpiglenastat"
      ]
    },
    {
      "fdaUniiCode": "N8Q12KU2SW",
      "id": "Vodobatinib",
      "preferredName": "Vodobatinib",
      "synonyms": [
        "4-Methyl-3-quinolin-3-ylethynylbenzoic Acid N'-(2-chloro-6-methylbenzoyl) Hydrazide",
        "Bcr-Abl Kinase Inhibitor K0706",
        "K-0706",
        "K0706",
        "SCO-088",
        "SUN K706",
        "SUN-K0706",
        "SUN-K706",
        "VODOBATINIB",
        "Vodobatinib",
        "WHO 11506"
      ]
    },
    {
      "fdaUniiCode": "TBF1NHY02O",
      "id": "Amcenestrant",
      "preferredName": "Amcenestrant",
      "synonyms": [
        "AMCENESTRANT",
        "Amcenestrant",
        "SAR 439859",
        "SAR-439859",
        "SAR439859",
        "Selective Estrogen Receptor Degrader SAR439859",
        "Selective Estrogen Receptor Downregulator SAR439859"
      ]
    },
    {
      "fdaUniiCode": "58BH47BV6S",
      "id": "Infigratinib_Phosphate",
      "preferredName": "Infigratinib Phosphate",
      "synonyms": [
        "INFIGRATINIB PHOSPHATE",
        "Infigratinib Phosphate",
        "N'-(2,6-Dichloro-3,5-dimethoxyphenyl)-N-(6-(4-(4-ethylpiperazin-1-yl)anilino)pyrimidin-4-yl)-N-methylurea Phosphate (1:1)",
        "Truseltiq"
      ]
    },
    {
      "fdaUniiCode": "L4D9X59F34",
      "id": "Zelenoleucel",
      "preferredName": "Zelenoleucel",
      "synonyms": [
        "Allogeneic MultiTAA-specific T-lymphocytes MT-401",
        "Donor-Derived Multi-Tumor-Associated Antigen-specific T Cells",
        "MT 401",
        "MT-401",
        "MT401",
        "ZELENOLEUCEL",
        "Zelenoleucel"
      ]
    },
    {
      "fdaUniiCode": "2498Y783QT",
      "id": "Toremifene_Citrate",
      "preferredName": "Toremifene Citrate",
      "synonyms": [
        "(Z)-2-[4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine 2-Hydroxy-1,2,3-propanetricarboxylate (1:1)",
        "2-(p-[(Z)-4-chloro-1,2-diphenyl-1-butenyl]-phenoxy)- N,N-dimethylethylamine citrate (1:1)",
        "Acapodene",
        "FC-1157a",
        "Fareston",
        "GTx-006",
        "TOREMIFENE CITRATE",
        "Toremifene Citrate",
        "Toremifene citrate"
      ]
    },
    {
      "fdaUniiCode": "G8FR269QPQ",
      "id": "Fosciclopirox",
      "preferredName": "Fosciclopirox",
      "synonyms": [
        "CPX POM",
        "CPX-POM",
        "CPXPOM",
        "Ciclopirox Prodrug",
        "Ciclopirox Prodrug CPX-POM",
        "Ciclopirox-POM",
        "FOSCICLOPIROX",
        "Fosciclopirox"
      ]
    },
    {
      "fdaUniiCode": "3412470A0V",
      "id": "Melphalan_Flufenamide_Hydrochloride",
      "preferredName": "Melphalan Flufenamide Hydrochloride",
      "synonyms": [
        "MELPHALAN FLUFENAMIDE HYDROCHLORIDE",
        "Melphalan Flufenamide Hydrochloride",
        "Pepaxto"
      ]
    },
    {
      "fdaUniiCode": "IZK2TH7X5M",
      "id": "Tilvestamab",
      "preferredName": "Tilvestamab",
      "synonyms": [
        "BGB 149",
        "BGB-149",
        "BGB149",
        "TILVESTAMAB",
        "Tilvestamab"
      ]
    },
    {
      "fdaUniiCode": "HN0T99OO4V",
      "id": "Panobinostat_Lactate",
      "preferredName": "Panobinostat Lactate",
      "synonyms": [
        "Farydak",
        "PANOBINOSTAT LACTATE",
        "Panobinostat Lactate"
      ]
    },
    {
      "fdaUniiCode": "4F86W47BR6",
      "id": "Raloxifene_Hydrochloride",
      "preferredName": "Raloxifene Hydrochloride",
      "synonyms": [
        "(6-Hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone Hydrochloride",
        "Evista",
        "Keoxifene Hydrochloride",
        "LY-156758",
        "Optruma",
        "RALOXIFENE HYDROCHLORIDE",
        "Raloxifene HCl",
        "Raloxifene Hydrochloride",
        "Raloxifene hydrochloride",
        "Raloxifene.HCl",
        "raloxifene hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "56588OP40D",
      "id": "Interferon_Alfacon-1",
      "preferredName": "Interferon Alfacon-1",
      "synonyms": [
        "Advaferon",
        "CIFN",
        "Consensus Interferon",
        "IFN Alfacon-1",
        "INTERFERON ALFACON-1",
        "Infergen",
        "Interferon Alfacon-1",
        "Interferon Consensus, Methionyl",
        "Methionyl Interferon Consensus",
        "Methionyl-Interferon-Consensus",
        "Recombinant Consensus Interferon",
        "Recombinant methionyl human consensus interferon",
        "interferon consensus, methionyl",
        "methionyl interferon consensus",
        "r-metHuIFN-Con1"
      ]
    },
    {
      "fdaUniiCode": "X4Z7U6JL1C",
      "id": "Poziotinib_Hydrochloride",
      "preferredName": "Poziotinib Hydrochloride",
      "synonyms": [
        "HM781-36B",
        "NOV-1201 Hydrochloride",
        "NOV120101 Hydrochloride",
        "POZIOTINIB HYDROCHLORIDE",
        "Poziotinib HCl",
        "Poziotinib Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "E4G31X93ZA",
      "id": "Atrasentan_Hydrochloride",
      "preferredName": "Atrasentan Hydrochloride",
      "synonyms": [
        "(+)-A 127722",
        "(2R,3R,4S)-4-(1,3-Benzodioxo-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic Acid Monohydrochloride",
        "ABT-627",
        "ATRASENTAN HYDROCHLORIDE",
        "Atrasentan Hydrochloride",
        "Xinlay"
      ]
    },
    {
      "fdaUniiCode": "VY5DPN1TDU",
      "id": "Piposulfan",
      "preferredName": "Piposulfan",
      "synonyms": [
        "A 20968",
        "A-20968",
        "PIPOSULFAN",
        "Piposulfan"
      ]
    },
    {
      "fdaUniiCode": "HX101E7L6S",
      "id": "Oregovomab",
      "preferredName": "Oregovomab",
      "synonyms": [
        "B43.13",
        "MoAb B43.13",
        "Monoclonal Antibody B43.13",
        "OREGOVOMAB",
        "Oregovomab",
        "OvaRex",
        "OvaRex Monoclonal Antibody B43.13",
        "oregovomab"
      ]
    },
    {
      "fdaUniiCode": "CAN96F6UCF",
      "id": "Anti-OX40CD137_Bispecific_Antibody_FS120",
      "preferredName": "Anti-OX40/CD137 Bispecific Antibody FS120",
      "synonyms": [
        "Anti-OX40/Anti-CD137 Bispecific Antibody FS120",
        "Anti-OX40/CD137 Bispecific Antibody FS120",
        "Bispecific Antibody FS120",
        "FS 120",
        "FS-120",
        "FS120",
        "OX40 x CD137 Bispecific Antibody FS120"
      ]
    },
    {
      "fdaUniiCode": "FMT95051CQ",
      "id": "Aprinocarsen",
      "preferredName": "Aprinocarsen",
      "synonyms": [
        "APRINOCARSEN",
        "Affinitac",
        "Affinitak",
        "Aprinocarsen",
        "CGP 64128A",
        "DNA, d(P-thio)(G-T-T-C-T-C-G-C-T-G-G-T-G-A-G-T-T-T-C-A)",
        "DNA, d(P-thio)(GTTCTCGCTGGTGAGTTTCA)",
        "ISIS 3521",
        "LY900003",
        "Protein Kinase C-Alpha Antisense"
      ]
    },
    {
      "fdaUniiCode": "B72HH48FLU",
      "id": "Infliximab",
      "preferredName": "Infliximab",
      "synonyms": [
        "Avakine",
        "INFLIXIMAB",
        "Infliximab",
        "Remicade",
        "Remsima",
        "cA2",
        "infliximab"
      ]
    },
    {
      "fdaUniiCode": "84MI6OYN4Z",
      "id": "Omacetaxine",
      "preferredName": "Omacetaxine",
      "synonyms": [
        "Cephalotaxine",
        "OMACETAXINE",
        "Omacetaxine"
      ]
    },
    {
      "fdaUniiCode": "E35ZN95LMT",
      "id": "SERD_ZB-716",
      "preferredName": "SERD ZB-716",
      "synonyms": [
        "Borestrant",
        "SERD ZB-716",
        "Selective Estrogen Receptor Alpha Degrader ZB716",
        "Selective Estrogen Receptor Degrader ZB716",
        "ZB 716",
        "ZB-716",
        "ZB716"
      ]
    },
    {
      "fdaUniiCode": "CX0M5RO7CY",
      "id": "Allitinib",
      "preferredName": "Allitinib",
      "synonyms": [
        "ALLITINIB",
        "ALS 1306",
        "ALS-1306",
        "ALS1306",
        "AST 1306",
        "AST-1306",
        "AST1306",
        "Allitinib",
        "N-(4-(4-(3-Fluorobenzyloxy)-3-chlorophenylamino)quinazolin-6-yl) Acrylamide",
        "N-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]prop-2-enamide"
      ]
    },
    {
      "fdaUniiCode": "6804DJ8Z9U",
      "id": "Capecitabine",
      "preferredName": "Capecitabine",
      "synonyms": [
        "5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-cytidine",
        "CAPECITABINE",
        "Capecitabine",
        "Ro 09-1978/000",
        "Xeloda",
        "capecitabine"
      ]
    },
    {
      "fdaUniiCode": "TQ64FZ98ZN",
      "id": "Paclitaxel_Poliglumex",
      "preferredName": "Paclitaxel Poliglumex",
      "synonyms": [
        "CT-2103",
        "CT2103",
        "PACLITAXEL POLIGLUMEX",
        "PG-TXL",
        "Paclitaxel Poliglumex",
        "Paclitaxel Polyglutamate",
        "Paclitaxel-Polyglutamate Polymer",
        "Poly-L-Glutamic acid-Paclitaxel Conjugate",
        "Polyglutamic Acid Paclitaxel",
        "Xyotax",
        "paclitaxel poliglumex",
        "paclitaxel polyglutamate"
      ]
    },
    {
      "fdaUniiCode": "58IFB293JI",
      "id": "Vorinostat",
      "preferredName": "Vorinostat",
      "synonyms": [
        "L-001079038",
        "MSK-390",
        "N-Hydroxy-N'-phenyloctanediamide",
        "SAHA",
        "Suberanilohydroxamic Acid",
        "Suberoylanilide Hydroxamic Acid",
        "VORINOSTAT",
        "Vorinostat",
        "Zolinza",
        "suberoylanilide hydroxamic acid",
        "vorinostat"
      ]
    },
    {
      "fdaUniiCode": "J5OUL9SHW5",
      "id": "Teverelix_Trifluoroacetate",
      "preferredName": "Teverelix Trifluoroacetate",
      "synonyms": [
        "TEVERELIX TRIFLUOROACETATE",
        "Teverelix TFA",
        "Teverelix Trifluoroacetate",
        "d-Alaninamide, N-acetyl-3-(2-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-l-tyrosyl-N6-(aminocarbonyl)-d-lysyl-l-leucyl-n6-(1-methylethyl)-l-lysyl-l-prolyl-, Bis(trifluoroacetate) (Salt)"
      ]
    },
    {
      "fdaUniiCode": "41W9MFI160",
      "id": "Etaracizumab",
      "preferredName": "Etaracizumab",
      "synonyms": [
        "Abegrin",
        "ETARACIZUMAB",
        "Etaracizumab",
        "Humanized Monoclonal Antibody LM609",
        "MEDI-522",
        "Monoclonal Antibody Anti-Avb3 Integrin Medi-522",
        "Monoclonal Antibody Anti-alpha V Beta 3 Integrin MEDI-522",
        "Vitaxin",
        "etaracizumab",
        "humanized monoclonal antibody MEDI-522"
      ]
    },
    {
      "fdaUniiCode": "R44IWB3RN5",
      "id": "Soy_Protein_Isolate",
      "preferredName": "Soy Protein Isolate",
      "synonyms": [
        "SOY PROTEIN",
        "Soy Protein Isolate",
        "Soybean Protein Isolate"
      ]
    },
    {
      "fdaUniiCode": "FCB9EGG971",
      "id": "Raltitrexed",
      "preferredName": "Raltitrexed",
      "synonyms": [
        "D1694",
        "ICI D1694",
        "N-(5-[N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl)-L-glutamic Acid",
        "N-[[5-[[(1,4-Dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]-L-glutamic Acid",
        "RALTITREXED",
        "Raltitrexed",
        "Tomudex",
        "ZD1694",
        "raltitrexed"
      ]
    },
    {
      "fdaUniiCode": "A49A7A5YN4",
      "id": "Alflutinib",
      "preferredName": "Alflutinib",
      "synonyms": [
        "2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)-6-(2,2,2-trifluoroethoxy)-3-pyridinyl)-",
        "ALFLUTINIB",
        "AST 2818",
        "AST-2818",
        "AST2818",
        "Alflutinib",
        "Furmonertinib"
      ]
    },
    {
      "fdaUniiCode": "M6LC47TUG3",
      "id": "Gamitrinib",
      "preferredName": "Gamitrinib",
      "synonyms": [
        "17-Demethoxy-17-((6-(triphenylphosphonio)hexyl)amino)geldanamycin",
        "G-TPP",
        "GAMITRINIB",
        "Gamitrinib",
        "Gamitrinib-TPP",
        "Geldanamycin, 17-Demethoxy-17-((6-(triphenylphosphonio)hexyl)amino)-"
      ]
    },
    {
      "fdaUniiCode": "NT3BAN5MDV",
      "id": "Zamtocabtagene_Autoleucel",
      "preferredName": "Zamtocabtagene Autoleucel",
      "synonyms": [
        "Autologous Anti-CD20/CD19-targeting Tandem CAR T Cells MB-CART2019.1",
        "Autologous pLTG1497-transduced CAR T-cells MB-CART2019.1",
        "MB CART2019.1",
        "MB-CART2019.1",
        "MBCART2019.1",
        "ZAMTOCABTAGENE AUTOLEUCEL",
        "Zamtocabtagene Autoleucel"
      ]
    },
    {
      "fdaUniiCode": "8GZG754X6M",
      "id": "Gemtuzumab_Ozogamicin",
      "preferredName": "Gemtuzumab Ozogamicin",
      "synonyms": [
        "CDP-771",
        "CMA-676",
        "Calicheamicin-Conjugated Humanized Anti-CD33 Monoclonal Antibody",
        "GEMTUZUMAB OZOGAMICIN",
        "Gemtuzumab Ozogamicin",
        "Mylotarg",
        "WAY-CMA-676",
        "gemtuzumab",
        "gemtuzumab ozogamicin",
        "hP67.6-Calicheamicin"
      ]
    },
    {
      "fdaUniiCode": "34M62WSA87",
      "id": "Temuterkib_Mesylate",
      "preferredName": "Temuterkib Mesylate",
      "synonyms": [
        "ERK1/2 Inhibitor LY3214996 Mesylate",
        "LY 3214996 Mesylate",
        "LY-3214996 Mesylate",
        "LY3214996 Mesylate",
        "TEMUTERKIB MESYLATE",
        "Temuterkib Mesylate"
      ]
    },
    {
      "fdaUniiCode": "10T6626FRK",
      "id": "Prinomastat",
      "preferredName": "Prinomastat",
      "synonyms": [
        "(3S)-N-Hydroxy-2,2-dimethyl-4-{{4-(4-piridinyloxy)phenyl}sulfonyl}-3-thiomorpholinecarboxamide",
        "AG3340",
        "PRINOMASTAT",
        "Prinomastat",
        "prinomastat"
      ]
    },
    {
      "fdaUniiCode": "QA846JAV5B",
      "id": "Yttrium_Y-90_Ibritumomab_Tiuxetan",
      "preferredName": "Yttrium Y-90 Ibritumomab Tiuxetan",
      "synonyms": [
        "IDEC-Y2B8",
        "IDEC-Y2B8 monoclonal antibody",
        "Y 90 Ibritumomab Tiuxetan",
        "Y 90 Zevalin",
        "Y 90 ibritumomab tiuxetan",
        "YTTRIUM Y-90 IBRITUMOMAB TIUXETAN",
        "Yttrium Y 90 Ibritumomab Tiuxetan",
        "Yttrium Y-90 Ibritumomab Tiuxetan",
        "yttrium Y90 ibritumomab tiuxetan"
      ]
    },
    {
      "fdaUniiCode": "50SG953SK6",
      "id": "Mitomycin",
      "preferredName": "Mitomycin",
      "synonyms": [
        "(1aS,8S,8aR,8bS)-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione",
        "Ametycine",
        "Jelmyto",
        "MITO",
        "MITO-C",
        "MITOMYCIN",
        "MITOMYCIN C",
        "Mito-C",
        "Mito-Medac",
        "Mitocin",
        "Mitocin-C",
        "Mitolem",
        "Mitomycin",
        "Mitomycin C",
        "Mitomycin-C",
        "Mitomycin-X",
        "Mitomycine C",
        "Mitosol",
        "Mitozytrex",
        "Mutamycin",
        "Mutamycine",
        "NCI-C04706",
        "[1aS-(1a alpha,8beta,8a alpha,8b alpha)]-6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione"
      ]
    },
    {
      "fdaUniiCode": "XRO4566Q4R",
      "id": "Interferon_Beta-1A",
      "preferredName": "Interferon Beta-1A",
      "synonyms": [
        "Avonex",
        "BG9418",
        "INTERFERON BETA-1A",
        "Interferon Beta-1A",
        "Rebif",
        "Recombinant interferon beta-1a"
      ]
    },
    {
      "fdaUniiCode": "I7FQ5A183L",
      "id": "Cryptophycin_52",
      "preferredName": "Cryptophycin 52",
      "synonyms": [
        "C-52",
        "CRYPTOPHYCIN-52",
        "Cryptophycin 52",
        "Cyclo[2,2-dimethyl-.beta.-alanyl-(2S)-2-hydroxy-4-methylpentanoyl-(2E,5S,6S)-5-hydroxy-6-[(2R,3R)-3-phenyloxiranyl]-2-heptenoyl-3-chloro-O-methyl-D-tyrosyl]",
        "Cyclo[2,2-dimethyl-beta-alanyl-(2S)-2-hydroxy-4-methylpentanoyl-(2E,5S,6S)-5-hydroxy-6-[(2R,3R)-3-phenyloxiranyl]-2-heptenoyl-3-chloro-O-methyl-D-tyrosyl]",
        "LY 355703"
      ]
    },
    {
      "fdaUniiCode": "HAJ1000ARC",
      "id": "Triplatin_Tetranitrate",
      "preferredName": "Triplatin Tetranitrate",
      "synonyms": [
        "BBR 3464",
        "TRIPLATIN TETRANITRATE",
        "Triplatin Tetranitrate"
      ]
    },
    {
      "fdaUniiCode": "IOW153004F",
      "id": "Lonafarnib",
      "preferredName": "Lonafarnib",
      "synonyms": [
        "4-[2-[4-(3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinyl]-2-oxoethyl]-1-piperidinecarboxamide",
        "4-[2-[4-[(11R)-3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-piperidinyl]-2-oxoethyl]-1-piperidinecarboxamide",
        "LONAFARNIB",
        "Lonafarnib",
        "SCH 66336",
        "SCH-66336",
        "SCH66336",
        "Sarasar",
        "lonafarnib"
      ]
    },
    {
      "fdaUniiCode": "71IA9S35AJ",
      "id": "Semaxanib",
      "preferredName": "Semaxanib",
      "synonyms": [
        "H-Indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-",
        "SEMAXANIB",
        "SU 5416",
        "SU5416",
        "Semaxanib",
        "Semoxind",
        "Sugen 5416",
        "semaxanib"
      ]
    },
    {
      "fdaUniiCode": "0QTW8Z7MCR",
      "id": "Rofecoxib",
      "preferredName": "Rofecoxib",
      "synonyms": [
        "4-[4'-(Methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone",
        "MK 966",
        "ROFECOXIB",
        "Rofecoxib",
        "Vioxx",
        "rofecoxib"
      ]
    },
    {
      "fdaUniiCode": "4EDF46E4GI",
      "id": "Cilengitide",
      "preferredName": "Cilengitide",
      "synonyms": [
        "CILENGITIDE",
        "Cilengitide",
        "EMD 121974",
        "EMD-121974",
        "cilengitide",
        "cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-N-methyl-L-valyl)"
      ]
    },
    {
      "fdaUniiCode": "G04B77F772",
      "id": "Batabulin_Sodium",
      "preferredName": "Batabulin Sodium",
      "synonyms": [
        "2-Fluoro-1-methoxy-4-(pentafluorophenyl-sulfonamido)benzene, Sodium Salt",
        "BATABULIN SODIUM",
        "Batabulin Sodium",
        "T138067 Sodium"
      ]
    },
    {
      "fdaUniiCode": "2A2059P49U",
      "id": "FarnesyltransferaseGeranylgeranyltransferase_Inhibitor_L-778123",
      "preferredName": "Farnesyltransferase/Geranylgeranyltransferase Inhibitor L-778,123",
      "synonyms": [
        "4-[[5-[[4-(3-Chlorophenyl)-3-oxo-1-piperazinyl]methyl]-1H-imidazol-1-yl]methyl]benzonitrile Monohydrochloride",
        "Farnesyltransferase/Geranylgeranyltransferase Inhibitor L-778,123",
        "L 778123",
        "L-778,123",
        "L-778123"
      ]
    },
    {
      "fdaUniiCode": "3811W2NBZ8",
      "id": "BMS-184476",
      "preferredName": "BMS-184476",
      "synonyms": [
        "7-O-[(Methylthio)methyl]paclitaxel",
        "BMS-184476",
        "beta-(Benzoylamino)-a-hydroxybenzenepropanoic Acid (aR,bS)-(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-4-[(methylthio)methoxy]-5-oxo-7,11-methano-1H",
        "beta-(Benzoylamino)-alpha-hydroxybenzenepropanoic Acid (aR,bS)-(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-4-[(methylthio)methoxy]-5-oxo-7,11-methano-1H"
      ]
    },
    {
      "fdaUniiCode": "624KN6GM2T",
      "id": "Temsirolimus",
      "preferredName": "Temsirolimus",
      "synonyms": [
        "42-(3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate)rapamycin",
        "CCI-779",
        "CCI-779 Rapamycin Analog",
        "Cell Cycle Inhibitor 779",
        "Rapamycin Analog",
        "Rapamycin Analog CCI-779",
        "TEMSIROLIMUS",
        "Temsirolimus",
        "Torisel",
        "temsirolimus"
      ]
    },
    {
      "fdaUniiCode": "G8RGG88B68",
      "id": "Peginterferon_Alfa-2b",
      "preferredName": "Peginterferon Alfa-2b",
      "synonyms": [
        "PEG Interferon Alpha-2b",
        "PEG Intron",
        "PEG-IFN Alfa-2b",
        "PEG-IFN-a 2b",
        "PEG-Interferon Alfa-2b",
        "PEG-Intron",
        "PEG-interferon alfa-2b",
        "PEGINTERFERON ALFA-2B",
        "Peginterferon Alfa-2b",
        "Pegylated Interferon Alpha-2b",
        "Polyethylene Glycol IFN-A2b",
        "Polyethylene Glycol Interferon Alfa-2b",
        "SCH 54031",
        "Sylatron"
      ]
    },
    {
      "fdaUniiCode": "89521262IH",
      "id": "Suramin_Sodium",
      "preferredName": "Suramin Sodium",
      "synonyms": [
        "309 F",
        "8,8'-(Carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bis-1,3,5-naphthalenetrisulfonic Acid Hexasodium Salt",
        "Antrypol",
        "Bayer 205",
        "Belganyl",
        "CI-1003",
        "Fourneau 309",
        "Germanin",
        "Metaret",
        "Moranyl",
        "Naganin",
        "Naganinum",
        "Naganol",
        "Naphuride",
        "SURAMIN SODIUM",
        "Sodium Suramin",
        "Sodium suramin",
        "Suramin Hexasodium",
        "Suramin Sodium",
        "Suramin sodium"
      ]
    },
    {
      "fdaUniiCode": "69G8BD63PP",
      "id": "Bortezomib",
      "preferredName": "Bortezomib",
      "synonyms": [
        "BORTEZOMIB",
        "Bortezomib",
        "LDP 341",
        "MLN341",
        "PS-341",
        "PS341",
        "Velcade",
        "[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid",
        "bortezomib",
        "velcade"
      ]
    },
    {
      "fdaUniiCode": "8LAP87DNSZ",
      "id": "Pyridyl_Cyanoguanidine_CHS_828",
      "preferredName": "Pyridyl Cyanoguanidine CHS 828",
      "synonyms": [
        "CHS 828",
        "CHS-828",
        "N-(6-(4-Chlorophenoxy)hexyl)-N'-Cyano-N''-4-Pyridylcyanoguanidine",
        "Pyridyl Cyanoguanidine CHS 828"
      ]
    },
    {
      "fdaUniiCode": "S65743JHBS",
      "id": "Gefitinib",
      "preferredName": "Gefitinib",
      "synonyms": [
        "4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline",
        "GEFITINIB",
        "Gefitinib",
        "Iressa",
        "N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholin) propoxy]-4-quinazolinamine",
        "ZD 1839",
        "ZD1839",
        "gefitinib"
      ]
    },
    {
      "fdaUniiCode": "L2U9GFD244",
      "id": "BMS-214662",
      "preferredName": "BMS-214662",
      "synonyms": [
        "7-Cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-Benzodiazepine",
        "BMS-214662",
        "FTI BMS 214662"
      ]
    },
    {
      "fdaUniiCode": "6A901E312A",
      "id": "Panitumumab",
      "preferredName": "Panitumumab",
      "synonyms": [
        "ABX-EGF",
        "ABX-EGF Monoclonal Antibody",
        "ABX-EGF, Clone E7.6.3",
        "MoAb ABX-EGF",
        "Monoclonal Antibody ABX-EGF",
        "PANITUMUMAB",
        "Panitumumab",
        "Vectibix",
        "panitumumab"
      ]
    },
    {
      "fdaUniiCode": "0HG7S0S581",
      "id": "BMS-188797",
      "preferredName": "BMS-188797",
      "synonyms": [
        "BMS-188797"
      ]
    },
    {
      "fdaUniiCode": "P8EJD9HI5K",
      "id": "Aclacinomycin_B",
      "preferredName": "Aclacinomycin B",
      "synonyms": [
        "1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-((2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexapyranosyl)oxy)-, methyl ester,(1R-(1-alpha,2-beta,4-beta))-",
        "ACLACINOMYCIN B",
        "Aclacinomycin B",
        "Aclarubicin B",
        "Antibiotic MA 144B1"
      ]
    },
    {
      "fdaUniiCode": "1ZNY4FKK9H",
      "id": "Entinostat",
      "preferredName": "Entinostat",
      "synonyms": [
        "Carbamic Acid, N-[[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]-, 3- pyridinylmethyl Ester",
        "Carbamic acid, [[4-[[(2-aminophenyl)amino]carbonyl]phenyl] methyl]-, 3-pyridinylmethyl ester (9CI)",
        "ENTINOSTAT",
        "Entinostat",
        "HDAC inhibitor SNDX-275",
        "MS 27-275",
        "MS-275",
        "N-(2-Aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)aminomethyl]b enzamide",
        "SNDX-275",
        "entinostat"
      ]
    },
    {
      "fdaUniiCode": "8H61Y4E29N",
      "id": "Ortataxel",
      "preferredName": "Ortataxel",
      "synonyms": [
        "(3aS,4R,5E,7R,8aS,9S,10aR,12aS,12bR,13S,13aS)-7,12a-Bis(acetyloxy)-13-(benzoyloxy)-9-hydroxy-5,8a,14,14-tetramethyl-2,8-dioxo-3a,4,7,8,8a,9,10,10a,12,12a,12b,13-dodecahydro-6,13a-methano-13aH-oxeto(2',3':5',6')benzo(1',2':4,5)cyclodeca(1,2-d)-1,3-dioxol-4-yl(2R,3S)-3-(((1,1-dimethylethoxy)carbonyl)amino)-2-hydroxy-5-methylhexanoate",
        "BAY 59-8862",
        "BAY59-8862",
        "Bay 59-8862",
        "IDN5109",
        "ORTATAXEL",
        "Ortataxel",
        "SB-T-101131"
      ]
    },
    {
      "fdaUniiCode": "5DX9U76296",
      "id": "Vatalanib",
      "preferredName": "Vatalanib",
      "synonyms": [
        "CGP 79787",
        "CGP-79787",
        "N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine",
        "PTK787",
        "PTK787/ZK 222584",
        "VATALANIB",
        "Vatalanib",
        "ZK-232934",
        "vatalanib"
      ]
    },
    {
      "fdaUniiCode": "ID912S5VON",
      "id": "Midostaurin",
      "preferredName": "Midostaurin",
      "synonyms": [
        "CGP 41251",
        "CGP41251",
        "MIDOSTAURIN",
        "Midostaurin",
        "N-Benzoyl-Staurosporine",
        "N-Benzoylstaurosporine",
        "N-benzoyl-staurosporine",
        "PKC-412",
        "PKC412",
        "Rydapt",
        "midostaurin"
      ]
    },
    {
      "fdaUniiCode": "JQ95208805",
      "id": "Apomine",
      "preferredName": "Apomine",
      "synonyms": [
        "Apomine",
        "Phosphonic acid, (2-(3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)ethylidene)bis-, tetrakis(1-methylethyl) Ester",
        "SKF 99085",
        "SR-45023A",
        "SR-45023A (Apomine)",
        "TETRAISOPROPYL 2-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)ETHYL-1,1-BIPHOSPHONATE",
        "Tetraisopropyl-2-(3,5-di-tert-butyl-4-hydroxyphenyl)ethylidene-1,1-diphosphonate"
      ]
    },
    {
      "fdaUniiCode": "TPC5Q8496G",
      "id": "Pipendoxifene",
      "preferredName": "Pipendoxifene",
      "synonyms": [
        "2-(4-Hydroxyphenyl)-3-methyl-1-[4-(2-piperidin-1-ylethoxy)benzyl]-1H-indol-5-ol Hydrochloride",
        "ERA 923",
        "ERA-923",
        "PIPENDOXIFENE",
        "Pipendoxifene"
      ]
    },
    {
      "fdaUniiCode": "1B47R6ZX4K",
      "id": "Rebimastat",
      "preferredName": "Rebimastat",
      "synonyms": [
        "BMS-275291",
        "D2163",
        "N-((2S)-2-Mercapto-1-oxo-4-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-L-leucyl-N,3-dimethyl-L-valinamide",
        "REBIMASTAT",
        "Rebimastat"
      ]
    },
    {
      "fdaUniiCode": "24R60NVC41",
      "id": "Cositecan",
      "preferredName": "Cositecan",
      "synonyms": [
        "(4S)-4-Ethyl-4-hydroxy-11-(2-(trimethylsilyl)ethyl)-1,12-dihydro-14H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H)-dione",
        "BNP1350",
        "COSITECAN",
        "Cositecan",
        "DB 172",
        "Karenitecin",
        "karenitecin"
      ]
    },
    {
      "fdaUniiCode": "ICJ93X8X90",
      "id": "Canertinib_Dihydrochloride",
      "preferredName": "Canertinib Dihydrochloride",
      "synonyms": [
        "CANERTINIB DIHYDROCHLORIDE",
        "CI-1033",
        "Canertinib Dihydrochloride",
        "N-[-4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide Dihydrochloride",
        "PD-0183805-002B",
        "PD183805",
        "canertinib",
        "canertinib dihydrochloride"
      ]
    },
    {
      "fdaUniiCode": "6433A42F4F",
      "id": "Motexafin_Gadolinium",
      "preferredName": "Motexafin Gadolinium",
      "synonyms": [
        "API-GP3",
        "Gadolinium Texaphyrin",
        "Gd (III) Texaphryin",
        "Gd-Tex",
        "MOTEXAFIN GADOLINIUM",
        "Motexafin Gadolinium",
        "PCI-0120",
        "Xcytrin",
        "gadolinium texaphyrin",
        "motexafin gadolinium"
      ]
    },
    {
      "fdaUniiCode": "O13QTC8612",
      "id": "Vitamin_D3_Analogue_ILX23-7553",
      "preferredName": "Vitamin D3 Analogue ILX23-7553",
      "synonyms": [
        "1,25-dihydroxy-16-ene-23-yne-cholecalciferol",
        "16-23-D3",
        "9,10-Secocholesta-5,7,10(19),16-tetraen-23-yne-1,3,25-triol, (1alpha,3beta,5Z,7E)-",
        "BXL 353",
        "ILEX 23-7553",
        "ILX 237553",
        "ILX-237553",
        "ILX23-7553",
        "ILX237553",
        "RO 237553",
        "RO-23-7553",
        "RO-237553",
        "RO237553",
        "Ro23-7553",
        "Vitamin D3 Analogue ILX23-7553"
      ]
    },
    {
      "fdaUniiCode": "9RL37ZZ665",
      "id": "Orantinib",
      "preferredName": "Orantinib",
      "synonyms": [
        "3-(2,4-Dimethyl-5-((2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propionic Acid",
        "ORANTINIB",
        "Orantinib",
        "Orantinibum",
        "SU 6668",
        "SU006668",
        "SU6668",
        "Sugen SU6668",
        "TSU 68"
      ]
    },
    {
      "fdaUniiCode": "DTJ7VPW43J",
      "id": "Afeletecan_Hydrochloride",
      "preferredName": "Afeletecan Hydrochloride",
      "synonyms": [
        "AFELETECAN HYDROCHLORIDE",
        "Afeletecan Hydrochloride",
        "BAY 38-3441",
        "BAY 56-3722",
        "BAY56-3722",
        "Camptothecin Glycoconjugate BAY 38-3441"
      ]
    },
    {
      "fdaUniiCode": "3062P60MH9",
      "id": "Epratuzumab",
      "preferredName": "Epratuzumab",
      "synonyms": [
        "EPRATUZUMAB",
        "Epratuzumab",
        "Humanized Anti-CD22 Monoclonal Antibody IgG1",
        "LymphoCide",
        "epratuzumab",
        "hLL2"
      ]
    },
    {
      "fdaUniiCode": "5797K23F95",
      "id": "Isocoumarin_NM-3",
      "preferredName": "Isocoumarin NM-3",
      "synonyms": [
        "Isocoumarin NM-3",
        "NM-3"
      ]
    },
    {
      "fdaUniiCode": "RPC6R41K4I",
      "id": "Brostallicin",
      "preferredName": "Brostallicin",
      "synonyms": [
        "4-(2-Bromoacrylamido)-N'''-(2-guanidinoethyl)-1,1',1',1'''-tetramethyl-N,4':N',4':N',4'''-quater(pyrrole-2-carboxamide)",
        "BROSTALLICIN",
        "Brostallicin",
        "PNU-166196"
      ]
    },
    {
      "fdaUniiCode": "E7WED276I5",
      "id": "Mercaptopurine",
      "preferredName": "Mercaptopurine",
      "synonyms": [
        "1,7-Dihydro-6H-purine-6-thione",
        "1,7-Dihydro-6H-purine-6-thione Monohydrate",
        "3H-Purine-6-thiol",
        "6 MP",
        "6 Thiohypoxanthine",
        "6 Thiopurine",
        "6-MP",
        "6-Mercaptopurine",
        "6-Mercaptopurine Monohydrate",
        "6-Purinethiol",
        "6-Thiopurine",
        "6-Thioxopurine",
        "6H-Purine-6-thione, 1,7-dihydro- (9CI)",
        "7-Mercapto-1,3,4,6-tetrazaindene",
        "Alti-Mercaptopurine",
        "Azathiopurine",
        "BW 57-323H",
        "Bw 57-323H",
        "Flocofil",
        "Ismipur",
        "Leukerin",
        "Leupurin",
        "MERCAPTOPURINE",
        "Mercaleukim",
        "Mercaleukin",
        "Mercaptina",
        "Mercapto-6-purine",
        "Mercaptopurine",
        "Mercaptopurinum",
        "Mercapurin",
        "Mern",
        "NCI-C04886",
        "Puri-Nethol",
        "Purimethol",
        "Purine, 6-mercapto-",
        "Purine-6-thiol (8CI)",
        "Purine-6-thiol Monohydrate",
        "Purine-6-thiol, Monohydrate",
        "Purine-6-thiol, monohydrate",
        "Purinethiol",
        "Purinethol",
        "U-4748",
        "WR-2785",
        "mercaptopurine"
      ]
    },
    {
      "fdaUniiCode": "47RRR83SK7",
      "id": "Recombinant_Interferon_Alfa-2a",
      "preferredName": "Recombinant Interferon Alfa-2a",
      "synonyms": [
        "Alpha 2 Interferon",
        "IFN alpha-2A",
        "IFN-Alpha 2",
        "INTERFERON ALFA-2A",
        "Interferon alfa 2a",
        "Laroferon",
        "Recombinant Interferon Alfa-2a",
        "Recombinant Interferon Alpha-2a",
        "Roceron-A",
        "Roferon A",
        "Roferon-A",
        "rHuIFN-a 2a"
      ]
    },
    {
      "fdaUniiCode": "43K1W2T1M6",
      "id": "Recombinant_Interferon_Alfa-2b",
      "preferredName": "Recombinant Interferon Alfa-2b",
      "synonyms": [
        "Alfatronol",
        "Glucoferon",
        "Heberon Alfa",
        "IFN alpha-2B",
        "INTERFERON ALFA-2B",
        "Interferon Alfa-2B",
        "Interferon Alpha-2b",
        "Interferon alfa 2b",
        "Intron A",
        "Recombinant Interferon Alfa-2b",
        "Sch 30500",
        "Urifron",
        "Viraferon",
        "interferon alfa-2b",
        "recombinant interferon alfa-2b"
      ]
    },
    {
      "fdaUniiCode": "539B57DFJF",
      "id": "Girentuximab",
      "preferredName": "Girentuximab",
      "synonyms": [
        "Chimeric Monoclonal Antibody cG250",
        "GIRENTUXIMAB",
        "Girentuximab",
        "MoAb G250",
        "Monoclonal Antibody G250",
        "Rencarex",
        "WX-G250",
        "cG250"
      ]
    },
    {
      "fdaUniiCode": "G9VYJ96FOJ",
      "id": "Deferoxamine_Hydrochloride",
      "preferredName": "Deferoxamine Hydrochloride",
      "synonyms": [
        "Ba 29837",
        "Ba-29837",
        "DEFEROXAMINE HYDROCHLORIDE",
        "Deferoxamine HCl",
        "Deferoxamine Hydrochloride",
        "Deferoxamine hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "8Q622VDR18",
      "id": "Sipuleucel-T",
      "preferredName": "Sipuleucel-T",
      "synonyms": [
        "APC8015",
        "APC8015 Vaccine",
        "PA2024 (PAP/GM-CSF)-Loaded Dendritic Cell Vaccine",
        "Provenge",
        "SIPULEUCEL-T",
        "SipT",
        "Sipuleucel-T",
        "sipuleucel-T"
      ]
    },
    {
      "fdaUniiCode": "WYQ7N0BPYC",
      "id": "Acetylcysteine",
      "preferredName": "Acetylcysteine",
      "synonyms": [
        "ACETYLCYSTEINE",
        "Acetadote",
        "Acetylcysteine",
        "Airbron",
        "Broncholysin",
        "Brunac",
        "Fabrol",
        "Fluatox",
        "Fluimucetin",
        "Fluimucil",
        "Fluprowit",
        "L-Alpha-acetamido-beta-mercaptopropionic Acid",
        "Muco Sanigen",
        "Mucocedyl",
        "Mucolator",
        "Mucolyticum",
        "Mucomyst",
        "Mucosolvin",
        "Mucret",
        "N-Acetyl Cysteine",
        "N-Acetyl-L-cysteine",
        "N-Acetylcysteine",
        "N-acetyl-3-mercaptoalanine",
        "N-acetyl-L-cysteine",
        "N-acetylcysteine",
        "NAC",
        "Neo-Fluimucil",
        "Parvolex",
        "Respaire",
        "Tixair",
        "acetylcysteine"
      ]
    },
    {
      "fdaUniiCode": "C67ORA155P",
      "id": "Brentuximab",
      "preferredName": "Brentuximab",
      "synonyms": [
        "Anti-CD30 Monoclonal Antibody",
        "BRENTUXIMAB",
        "Brentuximab",
        "CAC-10",
        "CAC10",
        "Monoclonal Antibody SGN-30",
        "SGN-30",
        "SGN30"
      ]
    },
    {
      "fdaUniiCode": "MG4M3QB242",
      "id": "Matuzumab",
      "preferredName": "Matuzumab",
      "synonyms": [
        "EMD 72000",
        "MATUZUMAB",
        "Matuzumab",
        "matuzumab"
      ]
    },
    {
      "fdaUniiCode": "W486SJ5824",
      "id": "Abarelix",
      "preferredName": "Abarelix",
      "synonyms": [
        "ABARELIX",
        "Abarelix",
        "PPI-149",
        "Plenaxis",
        "R-3827",
        "abarelix"
      ]
    },
    {
      "fdaUniiCode": "74KXF8I502",
      "id": "Aclarubicin",
      "preferredName": "Aclarubicin",
      "synonyms": [
        "(1R,2R,4S)-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl]-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy]-1-naphthacenecarboxylic acid methyl ester",
        "1-naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5, 7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl) -alpha-L-lyxo-hexopyranosyl]-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy]-, methyl ester,(1R-(1alpha,2beta,4beta))-(9CI)",
        "ACLARUBICIN",
        "ACM-A",
        "Aclacinomycin",
        "Aclacinomycin A",
        "Aclacinomycin-A",
        "Aclarubicin",
        "Antibiotic MA144-A1",
        "MA144-A1"
      ]
    },
    {
      "fdaUniiCode": "I444I66XWH",
      "id": "H-ras_Antisense_Oligodeoxynucleotide_ISIS_2503",
      "preferredName": "H-ras Antisense Oligodeoxynucleotide ISIS 2503",
      "synonyms": [
        "H-RAS Antisense",
        "H-ras Antisense Oligodeoxynucleotide ISIS 2503",
        "ISIS 2503",
        "ISIS-2503",
        "ISIS2503"
      ]
    },
    {
      "fdaUniiCode": "42NI1P5Q1X",
      "id": "Acridine",
      "preferredName": "Acridine",
      "synonyms": [
        "ACRIDINE",
        "Acridine"
      ]
    },
    {
      "fdaUniiCode": "2S9ZZM9Q9V",
      "id": "Bevacizumab",
      "preferredName": "Bevacizumab",
      "synonyms": [
        "ABP 215",
        "Anti-VEGF",
        "Anti-VEGF Humanized Monoclonal Antibody",
        "Anti-VEGF rhuMAb",
        "Avastin",
        "BEVACIZUMAB",
        "BP102",
        "BP102 Biosimilar",
        "Bevacizumab",
        "Bevacizumab Biosimilar ABP 215",
        "Bevacizumab Biosimilar BEVZ92",
        "Bevacizumab Biosimilar BI 695502",
        "Bevacizumab Biosimilar CBT 124",
        "Bevacizumab Biosimilar CT-P16",
        "Bevacizumab Biosimilar FKB238",
        "Bevacizumab Biosimilar GB-222",
        "Bevacizumab Biosimilar HD204",
        "Bevacizumab Biosimilar HLX04",
        "Bevacizumab Biosimilar IBI305",
        "Bevacizumab Biosimilar LY01008",
        "Bevacizumab Biosimilar MIL60",
        "Bevacizumab Biosimilar MYL-1402O",
        "Bevacizumab Biosimilar Mvasi",
        "Bevacizumab Biosimilar QL 1101",
        "Bevacizumab Biosimilar RPH-001",
        "Bevacizumab Biosimilar SCT501",
        "Bevacizumab Biosimilar Zirabev",
        "Bevacizumab awwb",
        "Bevacizumab-awwb",
        "Bevacizumab-bvzr",
        "HD204",
        "Immunoglobulin G1 (Human-Mouse Monoclonal rhuMab-VEGF Gamma-Chain Anti-Human Vascular Endothelial Growth Factor), Disulfide With Human-Mouse Monoclonal rhuMab-VEGF Light Chain, Dimer",
        "MYL-1402O",
        "Mvasi",
        "Recombinant Humanized Anti-VEGF Monoclonal Antibody",
        "SCT501",
        "Zirabev",
        "bevacizumab",
        "rhuMab-VEGF"
      ]
    },
    {
      "fdaUniiCode": "80K4H2RB8P",
      "id": "Indibulin",
      "preferredName": "Indibulin",
      "synonyms": [
        "D 24851",
        "D-24851",
        "INDIBULIN",
        "Indibulin",
        "N-(Pyridin-4-yl)-(1-(4-chlorobenzyl)indol-3-yl)glycoxylamide",
        "ZIO-301"
      ]
    },
    {
      "fdaUniiCode": "J5Z87L8ROA",
      "id": "Lapuleucel-T",
      "preferredName": "Lapuleucel-T",
      "synonyms": [
        "APC 8024",
        "APC8024",
        "DN24-02",
        "LAPULEUCEL-T",
        "Lapuleucel-T",
        "Neuvenge"
      ]
    },
    {
      "fdaUniiCode": "5T62Q3B36J",
      "id": "Sorafenib_Tosylate",
      "preferredName": "Sorafenib Tosylate",
      "synonyms": [
        "4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic Acid Methyamide-4-methylbenzenesulfonate Tosylate",
        "BAY 43-9006 Tosylate",
        "BAY 54-9085",
        "Nexavar",
        "SORAFENIB TOSYLATE",
        "Sorafenib Tosylate",
        "sorafenib",
        "sorafenib tosylate"
      ]
    },
    {
      "fdaUniiCode": "Q7Y026G2CX",
      "id": "Emepepimut-S",
      "preferredName": "Emepepimut-S",
      "synonyms": [
        "BLP 25",
        "BLP-25",
        "BLP-25 Liposomal Vaccine",
        "BLP25",
        "BLP25 Liposome Vaccine",
        "BP1-7-KLH",
        "EMD 531444",
        "Emepepimut-S",
        "Glycine, L-seryl-L-threonyl-L-alanyl-L-prolyl-L-prolyl-L-alanyl-L-histidylglycyl-L-valyl-L-threonyl-L-seryl-L-alanyl-L-prolyl-L-alpha-aspartyl-L-threonyl-L-arginyl-L-prolyl-L-alanyl-L-prolylglycyl-L-seryl-L-threonyl-L-alanyl-L-prolyl-L-prolyl-N6-(1-oxohexadecyl)-L-lysyl-",
        "L-BLP25",
        "Stimuvax",
        "TECEMOTIDE",
        "Tecemotide"
      ]
    },
    {
      "fdaUniiCode": "UMF554N5FG",
      "id": "Tacedinaline",
      "preferredName": "Tacedinaline",
      "synonyms": [
        "4-(Acetylamino)-N-(2-aminophenyl)benzamide",
        "Acetyldinaline",
        "CI-994",
        "GOE5549",
        "N-acetyl Dinaline",
        "N-acetyldinaline",
        "PD 123654",
        "TACEDINALINE",
        "Tacedinaline"
      ]
    },
    {
      "fdaUniiCode": "0N3V8R4E13",
      "id": "Acridine_Carboxamide",
      "preferredName": "Acridine Carboxamide",
      "synonyms": [
        "ACRIDINE CARBOXAMIDE",
        "Acridine Carboxamide",
        "DACA",
        "N-(2-(Dimehtylamino)ethyl)acridine-4-carboxamide",
        "SN 22995",
        "XR5000",
        "acridine carboxamide"
      ]
    },
    {
      "fdaUniiCode": "95HB56U8P8",
      "id": "Selective_Cytokine_Inhibitory_Drug_CC-1088",
      "preferredName": "Selective Cytokine Inhibitory Drug CC-1088",
      "synonyms": [
        "CC-1088",
        "CDC-801",
        "Selective Cytokine Inhibitory Drug CC-1088"
      ]
    },
    {
      "fdaUniiCode": "OY338X4M2P",
      "id": "Imidazole_Mustard",
      "preferredName": "Imidazole Mustard",
      "synonyms": [
        "5-(3,3-BIS(2-CHLORETHYL)-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE",
        "5-[3, 3-Bis(2-chloroethyl)-1-triazeno]-imidazole-4-carboxamide",
        "5-[3, 3-Bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide",
        "5-[3,3-Bis(2-Chloroethyl)-1-Triazeno]Imidazole-4-Carboxamide",
        "BIC",
        "Imidazole Mustard",
        "Imidazole mustard",
        "TIC Mustard",
        "TIC mustard"
      ]
    },
    {
      "fdaUniiCode": "41697D4Z5C",
      "id": "Interferon_Alfa-N1",
      "preferredName": "Interferon Alfa-N1",
      "synonyms": [
        "Humoferon",
        "INTERFERON ALFA-N1",
        "Interferon Alfa",
        "Interferon Alfa-N1",
        "Wellferon"
      ]
    },
    {
      "fdaUniiCode": "1724UJB90B",
      "id": "Iodine_I_131_Derlotuximab_Biotin",
      "preferredName": "Iodine I 131 Derlotuximab Biotin",
      "synonyms": [
        "Cotara",
        "I 131 MOAB TNT-1/B",
        "I 131 Monoclonal Antibody TNT-1/B",
        "IODINE I-131 DERLOTUXIMAB BIOTIN",
        "Iodine I 131 Derlotuximab Biotin",
        "iodine I 131 MOAB TNT-1/B"
      ]
    },
    {
      "fdaUniiCode": "G88KCP51RE",
      "id": "Apolizumab",
      "preferredName": "Apolizumab",
      "synonyms": [
        "1D10 Anti-lymphoma Antibody",
        "APOLIZUMAB",
        "Apolizumab",
        "MAbHu1D10",
        "MoAb Hu1D10",
        "MoAb: Hu1D10",
        "Monoclonal Antibody Hu1D10",
        "Monoclonal antibody 1D10",
        "Remitogen",
        "apolizumab"
      ]
    },
    {
      "fdaUniiCode": "6U7TFK75KV",
      "id": "Phenethyl_Isothiocyanate",
      "preferredName": "Phenethyl Isothiocyanate",
      "synonyms": [
        "(2-Isothiocyanatoethyl)benzene",
        "2-Phenylethyl Isothiocyanate",
        "PEITC",
        "PHENETHYL ISOTHIOCYANATE",
        "Phenethyl Isothiocyanate",
        "Phenethyl isothiocyanate",
        "phenethyl isothiocyanate"
      ]
    },
    {
      "fdaUniiCode": "TTJ03QI76T",
      "id": "Mureletecan",
      "preferredName": "Mureletecan",
      "synonyms": [
        "MAG-CPT",
        "MAG-Camptothecin",
        "MURELETECAN",
        "Mureletecan",
        "PNU 166148",
        "PNU166148"
      ]
    },
    {
      "fdaUniiCode": "54XUF2TZ7G",
      "id": "PR1_Leukemia_Peptide_Vaccine",
      "preferredName": "PR1 Leukemia Peptide Vaccine",
      "synonyms": [
        "Leukemia Peptide Vaccine, PR1",
        "PR1 LEUKEMIA PEPTIDE VACCINE",
        "PR1 Leukemia Peptide Vaccine",
        "Proteinase 3:PR1 Peptide"
      ]
    },
    {
      "fdaUniiCode": "WQQ9XZH2CC",
      "id": "Mesmulogene_Ancovacivec",
      "preferredName": "Mesmulogene Ancovacivec",
      "synonyms": [
        "MESMULOGENE ANCOVACIVEC",
        "MVA-MUC1-IL2",
        "MVA-MUC1-IL2 Vaccine",
        "Mesmulogene Ancovacivec",
        "Modified Vaccinia Ankara Encoding Human MUC-1 Antigen and Interleukin-2 Suspension",
        "TG4010"
      ]
    },
    {
      "fdaUniiCode": "U4XIL4091C",
      "id": "Triapine",
      "preferredName": "Triapine",
      "synonyms": [
        "3-AP",
        "3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone",
        "3-Apct",
        "3-aminopyridine-2-carboxaldehyde thiosemicarbazone",
        "OCX-0191",
        "OCX-191",
        "OCX191",
        "PAN-811",
        "Triapine"
      ]
    },
    {
      "fdaUniiCode": "J58862DTVD",
      "id": "Tariquidar",
      "preferredName": "Tariquidar",
      "synonyms": [
        "TARIQUIDAR",
        "Tariquidar",
        "XR9576",
        "tariquidar"
      ]
    },
    {
      "fdaUniiCode": "A8Q8I19Q20",
      "id": "Pralatrexate",
      "preferredName": "Pralatrexate",
      "synonyms": [
        "(2S)-2-[[4-[(1RS)-1-[(2, 4-Diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]pentanedioic Acid",
        "10-Propargyl-10-Deazaaminopterin",
        "10-propargyl-10-deazaaminopterin",
        "FOLOTYN",
        "Folotyn",
        "N-(4-{1-[(2,4-Diaminopteridin-6-yl)methyl]but-3-yn-1-yl}benzoyl)-L-glutamic Acid",
        "PDX",
        "PRALATREXATE",
        "Pralatrexate",
        "pralatrexate"
      ]
    },
    {
      "fdaUniiCode": "T381WW8L8Y",
      "id": "Iroplact",
      "preferredName": "Iroplact",
      "synonyms": [
        "IROPLACT",
        "Iroplact",
        "Recombinant CXCL4",
        "Recombinant Platelet Factor 4",
        "rPF4",
        "rhPF4"
      ]
    },
    {
      "fdaUniiCode": "ZQN1G5V6SR",
      "id": "Eflornithine",
      "preferredName": "Eflornithine",
      "synonyms": [
        "2-(Difluoromethyl)-DL-ornithine",
        "2-Difluoromethylornithine",
        "Alpha-Difluoromethylornithine",
        "D,L-alpha-Difluoromethylornithine",
        "DFMO",
        "Difluoromethylornithine",
        "Difluromethylornithine",
        "EFLORNITHINE",
        "Eflornithine",
        "difluoromethylornithine",
        "eflornithine"
      ]
    },
    {
      "fdaUniiCode": "6J9BLA949Q",
      "id": "Testolactone",
      "preferredName": "Testolactone",
      "synonyms": [
        "1,2,3,4,4a,4b,7,9,10,10a-Decahydro-2-hydroxy-2,4b-dimethyl-7-oxo-1-phenanthrenepropionic Acid Delta-Lactone",
        "1-Dehydrotestololactone",
        "13-Hydroxy-3-0x0-13,17-secoandrosta-1,4-dien-17-oic Acid Delta-Lactone",
        "17Alpha-oxo-D-homo-1,4-androstadiene-3,17-dione",
        "D-Homo-17a-oxaandrosta-1,4-diene-3,17-dione",
        "Delta-1-Testololactone",
        "Fludestrin",
        "SQ 9538",
        "SQ-9538",
        "TESTOLACTONE",
        "Teslac",
        "Testolactone",
        "Therapeutic Testolactone"
      ]
    },
    {
      "fdaUniiCode": "D2YCN1I522",
      "id": "Shark_Cartilage",
      "preferredName": "Shark Cartilage",
      "synonyms": [
        "BeneFin (Lane Shark Cartilage Powder)",
        "Cartilade",
        "SHARK CARTILAGE",
        "Shark Cartilage"
      ]
    },
    {
      "fdaUniiCode": "456V4159SL",
      "id": "Teroxirone",
      "preferredName": "Teroxirone",
      "synonyms": [
        "Henkel's Compound",
        "TEROXIRONE",
        "Teroxirone",
        "alpha-1,3,5-triglycidyl-s-triazinetrione",
        "alpha-TGI",
        "alpha-Triglycidyl Isocyanurate"
      ]
    },
    {
      "fdaUniiCode": "25X51I8RD4",
      "id": "Niacinamide",
      "preferredName": "Niacinamide",
      "synonyms": [
        "3-Pyridinecarboxamide",
        "NIACINAMIDE",
        "Niacinamide",
        "Nicamid",
        "Nicosedine",
        "Nicotinamide",
        "Nicotinamidum",
        "Nicotinic Acid Amide",
        "Nicotinic acid amide",
        "Nicotylamide",
        "Pellagra-Preventing Factor",
        "Vitamin PP",
        "niacinamide",
        "nicotinamide"
      ]
    },
    {
      "fdaUniiCode": "8RAS91C36W",
      "id": "Sodium_Butyrate",
      "preferredName": "Sodium Butyrate",
      "synonyms": [
        "Butyrate",
        "Butyrate sodium",
        "Butyric Acid, Sodium Salt",
        "SODIUM BUTYRATE",
        "Sodium Butyrate",
        "Sodium butanoate",
        "Sodium butyrate",
        "butyric acid, sodium salt",
        "sodium butanoate"
      ]
    },
    {
      "fdaUniiCode": "3L6CT9UWOM",
      "id": "Camptothecin_Sodium",
      "preferredName": "Camptothecin Sodium",
      "synonyms": [
        "CAMPTOTHECIN SODIUM",
        "Camptothecin Sodium",
        "Camptothecin Sodium Salt",
        "Camptothecin sodium",
        "Camptothecin, sodium salt",
        "Sodium camptothecin"
      ]
    },
    {
      "fdaUniiCode": "JYB41CTM2Q",
      "id": "Aminopterin",
      "preferredName": "Aminopterin",
      "synonyms": [
        "4-Amino-PGA",
        "4-Aminofolic Acid",
        "4-Aminofolic acid",
        "4-Aminopteroylglutamic Acid",
        "4-Aminopteroylglutamic acid",
        "AMINOPTERIN",
        "APGA",
        "Aminopterin",
        "Aminopteroylglutamic Acid",
        "aminopterin"
      ]
    },
    {
      "fdaUniiCode": "5R33Q73DYD",
      "id": "Sparfosate_Sodium",
      "preferredName": "Sparfosate Sodium",
      "synonyms": [
        "CI-882",
        "L-Aspartic Acid, N-(phosphonoacetyl)-, Disodium Salt",
        "N-Phosphonacetyl-L-aspartate Disodium",
        "PALA Disodium",
        "SPARFOSATE SODIUM",
        "Sparfosate Sodium"
      ]
    },
    {
      "fdaUniiCode": "E5913T3IBL",
      "id": "Timonacic",
      "preferredName": "Timonacic",
      "synonyms": [
        "4-Thiazolidine Carboxylic Acid",
        "4-Thiazolidinecarboxylic Acid",
        "ATC",
        "Detoxepa",
        "Hepalidine",
        "Heparegen",
        "TIMONACIC",
        "Thiaproline",
        "Thiazolidine Carboxylic Acid",
        "Thiazolidine-4-carboxylic Acid",
        "Thiazolidine-4-carboxylic acid",
        "Thiazolidinecarboxylic Acid",
        "Thioproline",
        "Tiazolidin",
        "Timonacic"
      ]
    },
    {
      "fdaUniiCode": "TC4U60XS42",
      "id": "Monoclonal_Antibody_14G2A",
      "preferredName": "Monoclonal Antibody 14G2A",
      "synonyms": [
        "14G2A",
        "14G2A, monoclonal antibody",
        "Antibody 14G2A, Monoclonal",
        "MURINE MONOCLONAL ANTI-GD2 ANTIBODY 14G2A",
        "MoAb 14G2A",
        "Monoclonal Antibody 14G2A"
      ]
    },
    {
      "fdaUniiCode": "3GFS72WN4M",
      "id": "Monoclonal_Antibody_3F8",
      "preferredName": "Monoclonal Antibody 3F8",
      "synonyms": [
        "3F8",
        "3F8 Monoclonal Antibody",
        "ANTI-GD2 MONOCLONAL ANTIBODY 3F8",
        "MoAb 3F8",
        "Monoclonal Antibody 3F8",
        "anti-Ganglioside (GD2) Monoclonal Antibody 3F8"
      ]
    },
    {
      "fdaUniiCode": "AW1UYE6Q9I",
      "id": "Vinfosiltine",
      "preferredName": "Vinfosiltine",
      "synonyms": [
        "S12363",
        "VINFOSILTINE",
        "Vincaleukoblastine, O4-Deacetyl-3-de(methoxycarbonyl)-3-(((1-(diethoxyphosphinyl)-2-methylpropyl)amin)carbonyl)-,(3(S))-,Sulfate(Salt)",
        "Vinfosiltine"
      ]
    },
    {
      "fdaUniiCode": "OP401G7OJC",
      "id": "Etanercept",
      "preferredName": "Etanercept",
      "synonyms": [
        "ETANERCEPT",
        "Enbrel",
        "Etanercept",
        "TNFR:Fc",
        "Tumor Necrosis Factor Receptor IgG Chimera",
        "etanercept"
      ]
    },
    {
      "fdaUniiCode": "1NU720978F",
      "id": "gp100_Antigen",
      "preferredName": "gp100 Antigen",
      "synonyms": [
        "GP-100 ANTIGEN",
        "glycoprotein 100",
        "gp 100",
        "gp100",
        "gp100 Antigen"
      ]
    },
    {
      "fdaUniiCode": "86AZ0G22V2",
      "id": "Liothyronine_I-131",
      "preferredName": "Liothyronine I-131",
      "synonyms": [
        "I 131 Liothyronine",
        "LIOTHYRONINE I-131",
        "Liothyronine I-131"
      ]
    },
    {
      "fdaUniiCode": "00DPD30SOY",
      "id": "Amsacrine",
      "preferredName": "Amsacrine",
      "synonyms": [
        "4'-(9-Acridinylamino)methane-sulfon-m-anisidide",
        "AMSA",
        "AMSACRINE",
        "Acridinyl Anisidide",
        "Amekrin",
        "Amsa P-D",
        "Amsacrine",
        "Amsidine",
        "Amsidyl",
        "CI-880",
        "Cain's Acridine",
        "Lamasine",
        "N-[4-(9-Acridinylamino)-3-methoxyphenyl]methanesulfonamide",
        "SN 11841",
        "SN-11841",
        "SN-21429",
        "amsacrine",
        "m-AMSA"
      ]
    },
    {
      "fdaUniiCode": "MWH8YQ1AIO",
      "id": "Octreotide_Pamoate",
      "preferredName": "Octreotide Pamoate",
      "synonyms": [
        "OCTREOTIDE PAMOATE",
        "OP LAR",
        "Octreotide Embpnate",
        "Octreotide Pamoate",
        "Octreotide pamoate",
        "OncoLar",
        "SMS 201-995 PA",
        "SMS 201-995 pa LAR"
      ]
    },
    {
      "fdaUniiCode": "UA8SE1325T",
      "id": "Gimeracil",
      "preferredName": "Gimeracil",
      "synonyms": [
        "5-Chloro-2,4-pyridinediol",
        "CDHP",
        "Chlorodihydroxypyridine",
        "GIMERACIL",
        "Gimeracil"
      ]
    },
    {
      "fdaUniiCode": "H3598Y1TLJ",
      "id": "Vitespen",
      "preferredName": "Vitespen",
      "synonyms": [
        "Autologous gp96 Heat Shock Protein Peptide Complex Vaccine",
        "HSP gp96-Peptide Complex",
        "HSPPC-96",
        "Heat Shock Protein Peptide Complex-96",
        "Oncophage",
        "Recombinant Human Tumor Rejection Antigen 1",
        "VITESPEN",
        "Vitespen",
        "gp96 HSP-Peptide Complex",
        "gp96 HSP-peptide complex",
        "gp96 Heat Shock Protein-Peptide Complex",
        "gp96 heat shock protein-peptide complex vaccine",
        "vitespen"
      ]
    },
    {
      "fdaUniiCode": "K1KT5M40JC",
      "id": "Iodine_I_131_Tositumomab",
      "preferredName": "Iodine I 131 Tositumomab",
      "synonyms": [
        "131-I-Anti-B1 Monoclonal Antibody",
        "Bexxar",
        "I 131 Monoclonal Antibody Anti-B1",
        "I 131 Tositumomab",
        "I131-MOAB-B1",
        "Iodine I 131 MOAB Anti-B1",
        "Iodine I 131 Monoclonal Antibody Anti-B1",
        "Iodine I 131 Tositumomab",
        "Iodine-131 Anti-B1 Antibody",
        "Iodine-131 Anti-CD20 Monoclonal Antibody",
        "Iodine-131 Tositumomab",
        "TOSITUMOMAB I-131",
        "iodine I 131 tositumomab"
      ]
    },
    {
      "fdaUniiCode": "21G64WZQ4I",
      "id": "Incyclinide",
      "preferredName": "Incyclinide",
      "synonyms": [
        "4-Dimethlyamino Sancycline",
        "4-Dimethlyaminosancycline",
        "4-dedimethylamino sancycline",
        "6-deoxy, 6-demethyl, 4-de-dimethylamino tetracycline",
        "6-deoxy-6-demethyl-4-dedimethylaminotetracycline",
        "CMT-3",
        "COL 3",
        "COL-3",
        "INCYCLINIDE",
        "Incyclinide",
        "Metastat",
        "Tetracycline CMT-3"
      ]
    },
    {
      "fdaUniiCode": "D4E1UP3RMV",
      "id": "Iodine_I_131_Monoclonal_Antibody_81C6",
      "preferredName": "Iodine I 131 Monoclonal Antibody 81C6",
      "synonyms": [
        "81C6-I-131",
        "I 131 Monoclonal Antibody 81C6",
        "IODINE I-131 MONOCLONAL ANTIBODY 81C6",
        "Iodine I 131 Monoclonal Antibody 81C6",
        "Neuradiab",
        "iodine I 131 MOAB 81C6"
      ]
    },
    {
      "fdaUniiCode": "CUJ6745Z9J",
      "id": "Aniline_Mustard",
      "preferredName": "Aniline Mustard",
      "synonyms": [
        ".beta.,.beta.'-Dichlorodiethylaniline",
        "A 14489",
        "Aniline Mustard",
        "Aniline mustard",
        "Benzenamine, N, N-bis(2-chloroethyl)- (9CI)",
        "Benzenamine, N, N-bis(2-chloroethyl)-(9CI)",
        "CB 1074",
        "Lymphochin",
        "Lymphocin",
        "Lymphoquin",
        "Mesylerythrol",
        "N, N-Bis(2-chloroethyl)aniline",
        "N,N-BIS(2-CHLOROETHYL)ANILINE",
        "N,N-bis(2-chloroethyl)aniline",
        "N,N-bis(2-chloroethyl)benzenamine",
        "Phenylbis(2-chloroethylamine)",
        "SK 592",
        "TL 476",
        "beta, beta'-dichlorodiethylaniline",
        "mesylerythrol",
        "phenylbis[2-chloroethylamine]"
      ]
    },
    {
      "fdaUniiCode": "1S9VO1DQG5",
      "id": "13-Deoxydoxorubicin",
      "preferredName": "13-Deoxydoxorubicin",
      "synonyms": [
        "13-DEOXYDOXORUBICIN",
        "13-Deoxydoxorubicin",
        "GPX-100",
        "GPX100"
      ]
    },
    {
      "fdaUniiCode": "702RHR475O",
      "id": "Fosbretabulin_Disodium",
      "preferredName": "Fosbretabulin Disodium",
      "synonyms": [
        "2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl Disodium Phosphate",
        "CA4DP",
        "Combretastatin A4 Disodium Phosphate",
        "FOSBRETABULIN DISODIUM",
        "Fosbretabulin Disodium",
        "Phenol, 2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-, Dihydrogen Phosphate, Disodium Salt"
      ]
    },
    {
      "fdaUniiCode": "0829J8133H",
      "id": "Vadimezan",
      "preferredName": "Vadimezan",
      "synonyms": [
        "5,6-Dimethylxanthenone-4-Acetic Acid",
        "5,6-MexXAA",
        "ASA404",
        "DMXAA",
        "Dimethyloxoxanthene Acetic Acid",
        "Dimethylxanthenone Acetic Acid",
        "VADIMEZAN",
        "Vadimezan",
        "dimethylxanthenone acetic acid"
      ]
    },
    {
      "fdaUniiCode": "DNZ11VPY7Q",
      "id": "MKC-1",
      "preferredName": "MKC-1",
      "synonyms": [
        "MKC-1",
        "R440",
        "Ro 31-7453"
      ]
    },
    {
      "fdaUniiCode": "0WZD9Y66WN",
      "id": "Anthramycin",
      "preferredName": "Anthramycin",
      "synonyms": [
        "3-(5,10,11,11a-tetrahydro-9,11-dihydroxy-8-methyl-5-oxo-1h-pyrrolo(2,1-c)(1,4)benzodiazepin-2-yl)-2-propenamide",
        "ANTHRAMYCIN",
        "Anthramycin"
      ]
    },
    {
      "fdaUniiCode": "NTY9893GD0",
      "id": "Ocaratuzumab",
      "preferredName": "Ocaratuzumab",
      "synonyms": [
        "AME-133v",
        "Anti-CD20 Monoclonal Antibody AME-133v",
        "LY 2469298",
        "MoAb CD20",
        "OCARATUZUMAB",
        "Ocaratuzumab",
        "monoclonal antibody, CD20"
      ]
    },
    {
      "fdaUniiCode": "5B622U08B3",
      "id": "Anhydrovinblastine",
      "preferredName": "Anhydrovinblastine",
      "synonyms": [
        "ANHYDROVINBLASTINE",
        "AVLB",
        "Anhydrovinblastine",
        "anhydrovinblastine"
      ]
    },
    {
      "fdaUniiCode": "71RR81V666",
      "id": "Iodine_I_131_Apamistamab",
      "preferredName": "Iodine I 131 Apamistamab",
      "synonyms": [
        "I 131 MOAB BC8",
        "I 131 Monoclonal Antibody BC8",
        "IODINE I-131 APAMISTAMAB",
        "Iodine (131I) Apamistamab",
        "Iodine I 131 Apamistamab",
        "Iomab-B",
        "MOAB BC8, iodine I 131",
        "iodine I 131 MOAB BC8",
        "iodine I 131 monoclonal antibody BC8",
        "monoclonal antibody BC8, iodine I 131"
      ]
    },
    {
      "fdaUniiCode": "0343IGH41U",
      "id": "Tositumomab",
      "preferredName": "Tositumomab",
      "synonyms": [
        "Anti-CD20 Antibody",
        "MoAb Anti-B1",
        "Monoclonal Antibody Anti-B1",
        "TOSITUMOMAB",
        "Tositumomab",
        "anti-B1",
        "tositumomab"
      ]
    },
    {
      "fdaUniiCode": "N5E5Q8249O",
      "id": "Prostatic_Acid_Phosphatase-Sargramostim_Fusion_Protein_PA2024",
      "preferredName": "Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024",
      "synonyms": [
        "PA2024",
        "PROSTATIC ACID PHOSPHATASE (PAP)-GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) FUSION PROTEIN",
        "Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024"
      ]
    },
    {
      "fdaUniiCode": "68QTV136DF",
      "id": "Palladium_Pd-103",
      "preferredName": "Palladium Pd-103",
      "synonyms": [
        "PALLADIUM PD-103",
        "Palladium Pd 103",
        "Palladium Pd-103",
        "Palladium-103",
        "Pd 103",
        "radioactive palladium"
      ]
    },
    {
      "fdaUniiCode": "Q60AU1LLNU",
      "id": "Oglufanide_Disodium",
      "preferredName": "Oglufanide Disodium",
      "synonyms": [
        "GLUFANIDE DISODIUM",
        "Glufanide Disodium",
        "IM 862",
        "IM-862",
        "IM862",
        "L-Tryptophan, L-alpha-glutamyl-, disodium salt",
        "Oglufanide Disodium",
        "Thymogen"
      ]
    },
    {
      "fdaUniiCode": "235435CH6L",
      "id": "Minretumomab",
      "preferredName": "Minretumomab",
      "synonyms": [
        "Antibody CC49, Monoclonal",
        "CC-49",
        "CC-49 Monoclonal Antibody",
        "MAb CC49",
        "MINRETUMOMAB",
        "MOAB CC-49/TAG72 (DW)",
        "Minretumomab",
        "MoAb CC49",
        "Monoclonal Antibody CC-49",
        "Monoclonal Antibody CC49"
      ]
    },
    {
      "fdaUniiCode": "IK8S1P79MU",
      "id": "Arginine_Butyrate",
      "preferredName": "Arginine Butyrate",
      "synonyms": [
        "ARGININE BUTYRATE",
        "Arginine Butyrate",
        "L-Arginine, Butanoate (3:4)",
        "VX-105",
        "arginine butyrate"
      ]
    },
    {
      "fdaUniiCode": "BQ94Z7E5OR",
      "id": "Tocladesine",
      "preferredName": "Tocladesine",
      "synonyms": [
        "8-Chloro Cyclic AMP",
        "8-Chloroadenosine Cyclic 3':5'-Monophosphate",
        "8-Cl-cAMP",
        "Adenazole",
        "TOCLADESINE",
        "Tocladesine",
        "tocladesine"
      ]
    },
    {
      "fdaUniiCode": "WJ98J3NM90",
      "id": "Indisulam",
      "preferredName": "Indisulam",
      "synonyms": [
        "E7070",
        "INDISULAM",
        "Indisulam",
        "N-(3-Chloro-7-indoyl)-1,4-Benzenedisulfonamide"
      ]
    },
    {
      "fdaUniiCode": "J36232195E",
      "id": "Yttrium_Y-90_Epratuzumab_Tetraxetan",
      "preferredName": "Yttrium Y-90 Epratuzumab Tetraxetan",
      "synonyms": [
        "Monoclonal antibody LL2, yttrium Y 90",
        "Y 90 Humanized Monoclonal Antibody LL2",
        "Y 90 MoAb LL2",
        "Y 90 monoclonal antibody LL2",
        "Y90 Humanized Epratuzumab Tetraxetan",
        "YTTRIUM Y-90 EPRATUZUMAB TETRAXETAN",
        "Yttrium Y 90 Humanized Epratuzumab Tetraxetan",
        "Yttrium Y 90 Humanized Monoclonal Antibody LL2",
        "Yttrium Y-90 Epratuzumab Tetraxetan",
        "yttrium Y 90 MOAB LL2"
      ]
    },
    {
      "fdaUniiCode": "KX2339DP44",
      "id": "Rosiglitazone_Maleate",
      "preferredName": "Rosiglitazone Maleate",
      "synonyms": [
        "(+/-)-5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, ( Z )-2-Butenedioate (1:1)",
        "Avandia",
        "BRL49653",
        "ROSIGLITAZONE MALEATE",
        "Rosiglitazone Maleate",
        "rosiglitazone maleate"
      ]
    },
    {
      "fdaUniiCode": "UFH8805FKA",
      "id": "St._Johns_Wort",
      "preferredName": "St. John's Wort",
      "synonyms": [
        "Hypericum Perforatum Extract",
        "ST. JOHN'S WORT",
        "St John's Wort",
        "St. John's Wort",
        "St. John's wort",
        "hypericum perforatum"
      ]
    },
    {
      "fdaUniiCode": "ZL04JX89M7",
      "id": "Cintredekin_Besudotox",
      "preferredName": "Cintredekin Besudotox",
      "synonyms": [
        "CINTREDEKIN BESUDOTOX",
        "Cintredekin Besudotox",
        "IL 13-PE38QQR",
        "IL-13 Toxin",
        "IL-13-PE38QQR Cytotoxin",
        "IL-13PE",
        "IL13-PE38",
        "Interleukin-13 PE38QQR Immunotoxin",
        "hIL13-PE38QQR",
        "interleukin-13 PE38QQR immunotoxin"
      ]
    },
    {
      "fdaUniiCode": "ABF7OG3FA3",
      "id": "Yttrium_Y_90-Edotreotide",
      "preferredName": "Yttrium Y 90-Edotreotide",
      "synonyms": [
        "90Y-DOTA-3-Tyr-Octreotide",
        "EDOTREOTIDE YTTRIUM Y-90",
        "OctreoTher",
        "Onalta",
        "Yttrium Y 90 -DOTATOC",
        "Yttrium Y 90 SMT 487",
        "Yttrium Y 90-DOTA-3-tyrosine-octreotide",
        "Yttrium Y 90-DOTA-Tyr3-Octreotide",
        "Yttrium Y 90-Edotreotide",
        "yttrium Y 90 SMT 487",
        "yttrium Y 90 edotreotide",
        "yttrium Y 90-DOTA-tyr3-octreotide"
      ]
    },
    {
      "fdaUniiCode": "LY583605Y8",
      "id": "Beta_Alethine",
      "preferredName": "Beta Alethine",
      "synonyms": [
        "ALETHINE",
        "Alethine",
        "Beta Alethine",
        "Beta-alanyl-cysteamine Disulfide",
        "BetaLT",
        "Betathine",
        "N,N'-(Dithiodiethylene)bis(3-aminopropionamide)",
        "beta alethine"
      ]
    },
    {
      "fdaUniiCode": "M10I9SO6RR",
      "id": "Benzoylphenylurea",
      "preferredName": "Benzoylphenylurea",
      "synonyms": [
        "BENZOYLPHENYLUREA",
        "BPU",
        "Benzoylphenylurea",
        "benzoylphenylurea"
      ]
    },
    {
      "fdaUniiCode": "4ON7FF680U",
      "id": "Tucotuzumab_Celmoleukin",
      "preferredName": "Tucotuzumab Celmoleukin",
      "synonyms": [
        "EMD 273066",
        "EMD-273066",
        "KSA-IL-2",
        "KSA-Interleukin-2 Fusion Protein",
        "KSA-interleukin-2",
        "TUCOTUZUMAB CELMOLEUKIN",
        "Tucotuzumab Celmoleukin",
        "huKS-IL2 Fusion Protein"
      ]
    },
    {
      "fdaUniiCode": "SNU299M83Q",
      "id": "Annamycin",
      "preferredName": "Annamycin",
      "synonyms": [
        "2'-iodo-3'-hydroxy-4'-epi-4-demethoxydoxorubicin",
        "5,12-naphthacenedione, 7-((2,6-dideoxy-2-iodo-alpha-l-mannopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(hydroxyacetyl)-, (7S-cis)-",
        "ANNAMYCIN",
        "Annamycin",
        "annamycin"
      ]
    },
    {
      "fdaUniiCode": "DHT6E8M4KP",
      "id": "Pelitrexol",
      "preferredName": "Pelitrexol",
      "synonyms": [
        "(2S)-2-(((5-(2-((6S)-2-Amino-4-oxo-1,4,5,6,7,8-hexahydropyrido(2,3-d)pyrimidin-6-yl)ethyl)-4-methylthiophen-2-yl)carbonyl)amino)pentanedioic Acid",
        "(2S)-2-[[[5-[2-[(6S)-2-amino-4-oxo-1,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]-4-methylthiophen-2-yl]carbonyl]amino]pentanedioic Acid",
        "AG2037",
        "PELITREXOL",
        "Pelitrexol"
      ]
    },
    {
      "fdaUniiCode": "E90NZP2L9U",
      "id": "Digitoxin",
      "preferredName": "Digitoxin",
      "synonyms": [
        "(3beta,5beta)-3-[(O-2,6-Dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy]-14-hydroxycard-20(22)-enolide",
        "CP4071",
        "Cardidigin",
        "Crystalline Digitalin",
        "Crystodigin",
        "DIGITOXIN",
        "Digitoxin"
      ]
    },
    {
      "fdaUniiCode": "D7NLD2JX7U",
      "id": "Pirfenidone",
      "preferredName": "Pirfenidone",
      "synonyms": [
        "PIRFENIDONE",
        "Pirfenidone",
        "pirfenidone"
      ]
    },
    {
      "fdaUniiCode": "DOB7Y3RSX0",
      "id": "HPPH",
      "preferredName": "HPPH",
      "synonyms": [
        "2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE A",
        "2-(1-Hexyloxyethyl)-2-Devinyl Pyropheophorbide-a",
        "2-[1-Hexyloxyethyl]-2-devinyl Pyropheophorbide-alpha",
        "HPPH",
        "Photochlor"
      ]
    },
    {
      "fdaUniiCode": "8OBZ1M4V3V",
      "id": "Taurolidine",
      "preferredName": "Taurolidine",
      "synonyms": [
        "Bis(1,1-dioxoperhydro-1,2,4-thiadiazinyl-4)-methane",
        "TAUROLIDINE",
        "Taurolidine",
        "Taurolin",
        "taurolidine"
      ]
    },
    {
      "fdaUniiCode": "1LI341K7NQ",
      "id": "Canfosfamide_Hydrochloride",
      "preferredName": "Canfosfamide Hydrochloride",
      "synonyms": [
        "CANFOSFAMIDE HYDROCHLORIDE",
        "Canfosfamide Hydrochloride",
        "TLK286",
        "Telcyta",
        "canfosfamide hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "995FT1W541",
      "id": "Idronoxil",
      "preferredName": "Idronoxil",
      "synonyms": [
        "3-(4-Hydroxyphenyl)-2H-1-benzopyran-7-ol",
        "IDRONOXIL",
        "Idronoxil",
        "NOX66",
        "NV-06",
        "Phenoxodiol",
        "phenoxodiol"
      ]
    },
    {
      "fdaUniiCode": "AYH22O1B1U",
      "id": "Iratumumab",
      "preferredName": "Iratumumab",
      "synonyms": [
        "IRATUMUMAB",
        "Iratumumab",
        "MDX-060",
        "Monoclonal Antibody MDX-060"
      ]
    },
    {
      "fdaUniiCode": "S9OX9692ZB",
      "id": "Galiximab",
      "preferredName": "Galiximab",
      "synonyms": [
        "GALIXIMAB",
        "Galiximab",
        "IDEC-114",
        "anti-B7-1",
        "anti-CD80 Antibody",
        "galiximab"
      ]
    },
    {
      "fdaUniiCode": "3YK0326U7X",
      "id": "Abagovomab",
      "preferredName": "Abagovomab",
      "synonyms": [
        "ABAGOVOMAB",
        "Abagovomab",
        "Monoclonal Antibody ACA125 Anti-Idiotype Vaccine",
        "VaccinOvar"
      ]
    },
    {
      "fdaUniiCode": "3DIZ9LF5Y9",
      "id": "Doxercalciferol",
      "preferredName": "Doxercalciferol",
      "synonyms": [
        "(1alpha,3beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol",
        "1-Alpha-Hydroxyvitamin D2",
        "DOXERCALCIFEROL",
        "Doxercalciferol",
        "Hectorol",
        "doxercalciferol"
      ]
    },
    {
      "fdaUniiCode": "OJE5810C4F",
      "id": "DHA-Paclitaxel",
      "preferredName": "DHA-Paclitaxel",
      "synonyms": [
        "DHA-Paclitaxel",
        "DHA-paclitaxel",
        "Docosahexaenoic Acid-Paclitaxel conjugate",
        "PACLITAXEL DOCOSAHEXAENOIC ACID",
        "TXP",
        "Taxoprexin"
      ]
    },
    {
      "fdaUniiCode": "2TTE6SSR0J",
      "id": "Rosopatamab",
      "preferredName": "Rosopatamab",
      "synonyms": [
        "MLN591",
        "Monoclonal Antibody huJ591",
        "ROSOPATAMAB",
        "Rosopatamab",
        "huJ591"
      ]
    },
    {
      "fdaUniiCode": "14J2G0U3NQ",
      "id": "Laromustine",
      "preferredName": "Laromustine",
      "synonyms": [
        "1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylaminocarbonyl)hydrazine",
        "101M",
        "Cloretazine",
        "LAROMUSTINE",
        "Laromustine",
        "Onrigin",
        "VNP40101M",
        "laromustine"
      ]
    },
    {
      "fdaUniiCode": "6T8C155666",
      "id": "Ipilimumab",
      "preferredName": "Ipilimumab",
      "synonyms": [
        "Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody",
        "BMS-734016",
        "IPILIMUMAB",
        "Ipilimumab",
        "Ipilimumab Biosimilar CS1002",
        "MDX-010",
        "MDX-CTLA4",
        "Yervoy",
        "ipilimumab"
      ]
    },
    {
      "fdaUniiCode": "PTC2969MV1",
      "id": "Halofuginone_Hydrobromide",
      "preferredName": "Halofuginone Hydrobromide",
      "synonyms": [
        "HALOFUGINONE HYDROBROMIDE",
        "Halofuginone Hydrobromide",
        "Halofuginone IV (intravenous)",
        "Halofuginone hydrobromide",
        "RU 19110",
        "Tempostatin",
        "halofuginone hydrobromide"
      ]
    },
    {
      "fdaUniiCode": "P8M1T4190R",
      "id": "Ethylnitrosourea",
      "preferredName": "Ethylnitrosourea",
      "synonyms": [
        "1-Ethyl-1-nitrosourea",
        "ENU",
        "Ethylnitrosourea",
        "N-ETHYL-N-NITROSOUREA",
        "N-Ethyl-N-nitrosourea",
        "N-Nitroso-N-Ethylurea",
        "Nitrosoethylurea"
      ]
    },
    {
      "fdaUniiCode": "L5L45YGP1O",
      "id": "Ertumaxomab",
      "preferredName": "Ertumaxomab",
      "synonyms": [
        "Anti-CD3 x anti-HER-2-neu Bispecific Monoclonal Antibody",
        "ERTUMAXOMAB",
        "Ertumaxomab"
      ]
    },
    {
      "fdaUniiCode": "DPR4R122E7",
      "id": "Herba_Scutellaria_Barbata",
      "preferredName": "Herba Scutellaria Barbata",
      "synonyms": [
        "Ban Zhi Lian",
        "Barbed Skullcap Herb",
        "HSB",
        "Herba Scutellaria Barbata",
        "Herba Scutellariae Barbatae",
        "SCUTELLARIA BARBATA WHOLE",
        "Scutellaria barbata",
        "Scutellaria barbata (Aqueous Extract)",
        "herba scutellaria barbatae"
      ]
    },
    {
      "fdaUniiCode": "762RDY0Y2H",
      "id": "Clofarabine",
      "preferredName": "Clofarabine",
      "synonyms": [
        "2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine",
        "2-Chloro-9-(2-deoxy-2-fluoroarabinofuranosyl)adenine",
        "CLOFARABINE",
        "Clofarabine",
        "Clofarex",
        "Clolar",
        "clofarabine"
      ]
    },
    {
      "fdaUniiCode": "AV9U0660CW",
      "id": "Eribulin_Mesylate",
      "preferredName": "Eribulin Mesylate",
      "synonyms": [
        "2-(3-Amino-2-hydroxypropyl)hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)11,15-18,21-24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo(3,2-i)furo(2',3'-5,6)pyrano(4,3-b)(1,4)dioxacyclopentacosin-5-(4H)-one",
        "B1939 Mesylate",
        "E7389",
        "ER-086526",
        "ERIBULIN MESYLATE",
        "Eribulin Mesylate",
        "Halaven",
        "Halichondrin B Analog",
        "eribulin mesylate"
      ]
    },
    {
      "fdaUniiCode": "K73E24S6X9",
      "id": "Black_Cohosh",
      "preferredName": "Black Cohosh",
      "synonyms": [
        "Actaea racemosa Root",
        "BLACK COHOSH",
        "Black Cohosh",
        "Cimicifuga racemosa Root",
        "Cimicifugae racemosae Rhizoma",
        "Fariy Candle Root",
        "Remifemin",
        "black cohosh",
        "black snakeroot",
        "bugbane",
        "bugwort",
        "rattlesnake root"
      ]
    },
    {
      "fdaUniiCode": "I05QZ0S4V3",
      "id": "HER2_Inhibitor_CP-724714",
      "preferredName": "HER2 Inhibitor CP-724,714",
      "synonyms": [
        "CP 724714",
        "CP-724,714",
        "CP-724-714",
        "CP-724714",
        "CP724714",
        "HER2 Inhibitor CP-724,714"
      ]
    },
    {
      "fdaUniiCode": "1V8X590XDP",
      "id": "Edotecarin",
      "preferredName": "Edotecarin",
      "synonyms": [
        "6-N-(1-hydroxymethyla-2-hydroxy)ethylamino-12,13-dihydro-13-(beta-D-gluco pyranosyl)-5H-indolo[2,3-a]-pyrrolol[3,4-c]-carbazole-5,7(6H)-dione",
        "EDOTECARIN",
        "Edotecarin",
        "J-107088",
        "J107088",
        "edotecarin"
      ]
    },
    {
      "fdaUniiCode": "4110YT348C",
      "id": "Flaxseed",
      "preferredName": "Flaxseed",
      "synonyms": [
        "FLAX SEED",
        "Flaxseed",
        "Flour, Flaxseed",
        "Linseed",
        "flaxseed",
        "linseed"
      ]
    },
    {
      "fdaUniiCode": "5WY0FWR2CF",
      "id": "Antisense_Oligonucleotide_GTI-2040",
      "preferredName": "Antisense Oligonucleotide GTI-2040",
      "synonyms": [
        "Antisense Oligonucleotide GTI-2040",
        "GTI-2040"
      ]
    },
    {
      "fdaUniiCode": "0VUA21238F",
      "id": "Lapatinib",
      "preferredName": "Lapatinib",
      "synonyms": [
        "GSK572016",
        "GW 2016",
        "GW2016",
        "GW572016",
        "LAPATINIB",
        "Lapatinib",
        "lapatinib"
      ]
    },
    {
      "fdaUniiCode": "G7H20TKI67",
      "id": "Hexaminolevulinate",
      "preferredName": "Hexaminolevulinate",
      "synonyms": [
        "HAL",
        "HEXAMINOLEVULINATE",
        "Hexaminolevulinate",
        "HexvixR",
        "Hexyl 5-Aminolevulinate",
        "hexyl 5-aminolevulinate"
      ]
    },
    {
      "fdaUniiCode": "6SN82Y9U73",
      "id": "Forodesine_Hydrochloride",
      "preferredName": "Forodesine Hydrochloride",
      "synonyms": [
        "BCX-1777",
        "FORODESINE HYDROCHLORIDE",
        "Forodesine Hydrochloride",
        "Immucillin-H",
        "forodesine hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "KX7K68Z2UH",
      "id": "Enzastaurin_Hydrochloride",
      "preferredName": "Enzastaurin Hydrochloride",
      "synonyms": [
        "1H-Pyrrole-2,5-dione, 3-(1-Methyl-1H-indol-3-yl)-4-(1-(1-(2-pyridinylmethyl)-4-piperidinyl)-1H-indol-3-yl)-, Monohydrochloride",
        "3-(1-Methyl-1H-indol-3-yl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-1H-indol-3-yl]-1H-pyrrole-2,5-dione Dihydrochloride",
        "ENZASTAURIN HYDROCHLORIDE",
        "Enzastaurin Hydrochloride",
        "Enzastaurin Monohydrochloride",
        "LY317615",
        "enzastaurin hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "F5SXN2KNMR",
      "id": "Pixantrone",
      "preferredName": "Pixantrone",
      "synonyms": [
        "6,9-Bis((2-aminoethyl)amino)benzo(g)isoquinoline-5,10-dione",
        "PIXANTRONE",
        "Pixantrone",
        "pixantrone"
      ]
    },
    {
      "fdaUniiCode": "99S671U9KB",
      "id": "Pomegranate_Juice",
      "preferredName": "Pomegranate Juice",
      "synonyms": [
        "POMEGRANATE JUICE",
        "Pomegranate Juice"
      ]
    },
    {
      "fdaUniiCode": "501W00OOWA",
      "id": "Tarenflurbil",
      "preferredName": "Tarenflurbil",
      "synonyms": [
        "(R)-2-Fluoro-alpha-methyl[1,1'-biphenyl]-4-acetic Acid",
        "E-7869",
        "Flurizan",
        "MPC-7869",
        "R-Flurbiprofen",
        "R-flurbiprofen",
        "TARENFLURBIL",
        "Tarenflurbil"
      ]
    },
    {
      "fdaUniiCode": "Q0OZ0D9223",
      "id": "Seocalcitol",
      "preferredName": "Seocalcitol",
      "synonyms": [
        "(1R-(1alpha(1R*,2E,4E),3abeta,4E(1R*,3S*,5Z),7aalpha))-5-((1-(6-Ethyl-6-hydroxy-1-methyl-2,4-octadienyl)octahydro-7a-methyl-4H-inden-4-ylidene)ethylidene)-4-methylene-1,3-cyclohexanediol",
        "1(S),3(R)-Dihydroxy-20(R)-(5'-ethyl-5'-hydroxyhepta-1'(E),3'(E)-dien-1'-yl)-9,10-secopregna-5(Z),7(E),10(19)-triene",
        "EB1089",
        "SEOCALCITOL",
        "Seocalcitol",
        "seocalcitol"
      ]
    },
    {
      "fdaUniiCode": "LVX8N1UT73",
      "id": "Sunitinib_Malate",
      "preferredName": "Sunitinib Malate",
      "synonyms": [
        "Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1)",
        "SU011248",
        "SU11248",
        "SUNITINIB MALATE",
        "Sunitinib Malate",
        "Sutent",
        "sunitinib",
        "sunitinib malate"
      ]
    },
    {
      "fdaUniiCode": "IC9O2HT1X1",
      "id": "T900607",
      "preferredName": "T900607",
      "synonyms": [
        "T-900607",
        "T900607"
      ]
    },
    {
      "fdaUniiCode": "L63605PZ70",
      "id": "Talaporfin_Sodium",
      "preferredName": "Talaporfin Sodium",
      "synonyms": [
        "LS11",
        "Laserphyrin",
        "ME2906",
        "Mono-L-aspartyl Chlorin e6",
        "NPe6",
        "TALAPORFIN SODIUM",
        "Talaporfin Sodium",
        "Taporfin Sodium",
        "talaporfin sodium"
      ]
    },
    {
      "fdaUniiCode": "E5SF1Z7U1S",
      "id": "Virulizin",
      "preferredName": "Virulizin",
      "synonyms": [
        "BOS TAURUS BILE IMMUNOMODULATOR",
        "Bos Taurus Bile Extract",
        "Bos Taurus Bile Immunomodulator",
        "Bovine Bile Extract",
        "Bovine Bile Immunomodulator",
        "Virulizin"
      ]
    },
    {
      "fdaUniiCode": "F0P408N6V4",
      "id": "Lenalidomide",
      "preferredName": "Lenalidomide",
      "synonyms": [
        "3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione",
        "CC-5013",
        "CC5013",
        "CDC 501",
        "LENALIDOMIDE",
        "Lenalidomide",
        "Revlimid",
        "lenalidomide"
      ]
    },
    {
      "fdaUniiCode": "BK459F050X",
      "id": "MMP_Inhibitor_S-3304",
      "preferredName": "MMP Inhibitor S-3304",
      "synonyms": [
        "MMP Inhibitor S-3304",
        "S-3304",
        "S3304"
      ]
    },
    {
      "fdaUniiCode": "WDT5V5OB9F",
      "id": "Colchicine-Site_Binding_Agent_ABT-751",
      "preferredName": "Colchicine-Site Binding Agent ABT-751",
      "synonyms": [
        "ABT-751",
        "Colchicine-Site Binding Agent ABT-751",
        "E 7010",
        "E-7010",
        "E7010",
        "N-[2-[(4-Hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide"
      ]
    },
    {
      "fdaUniiCode": "15C2VL427D",
      "id": "Ziv-Aflibercept",
      "preferredName": "Ziv-Aflibercept",
      "synonyms": [
        "AFLIBERCEPT",
        "AVE0005",
        "Aflibercept",
        "Eylea",
        "VEGF Trap",
        "VEGF Trap R1R2",
        "VEGF-Trap",
        "Vascular Endothelial Growth Factor Trap",
        "Zaltrap",
        "Ziv-Aflibercept",
        "aflibercept",
        "vascular endothelial growth factor trap"
      ]
    },
    {
      "fdaUniiCode": "DA87705X9K",
      "id": "Erlotinib_Hydrochloride",
      "preferredName": "Erlotinib Hydrochloride",
      "synonyms": [
        "CP-358,774",
        "Cp-358,774",
        "ERLOTINIB HYDROCHLORIDE",
        "Erlotinib Hydrochloride",
        "N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine Monohydrochloride",
        "OSI-774",
        "Tarceva",
        "erlotinib hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "BK9092J5MP",
      "id": "Mistletoe_Extract",
      "preferredName": "Mistletoe Extract",
      "synonyms": [
        "Abnobaviscum",
        "Apotheker Bauer's Misteltinktur",
        "Cefalektin",
        "Eurixor",
        "Helixor",
        "Iscador",
        "Isorel",
        "Isugran",
        "Lektinol",
        "Mistel Curarina",
        "Mistel- Krautertabletten",
        "Mistelol-Kapseln",
        "Mistletoe Extract",
        "Plenosol N",
        "VISCUM ALBUM FRUITING TOP",
        "Viscum",
        "Viscum Album Extract",
        "Viscum album Extract",
        "Viscysat",
        "mistletoe lectin"
      ]
    },
    {
      "fdaUniiCode": "X5DWL380Z6",
      "id": "Pelitinib",
      "preferredName": "Pelitinib",
      "synonyms": [
        "(2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide",
        "EKB 569",
        "EKB-569",
        "PELITINIB",
        "Pelitinib",
        "WAY-EKB 569"
      ]
    },
    {
      "fdaUniiCode": "6NS400BXKH",
      "id": "Nimotuzumab",
      "preferredName": "Nimotuzumab",
      "synonyms": [
        "H-R3",
        "NIMOTUZUMAB",
        "Nimotuzumab",
        "Thera-CIM-hr3",
        "TheraCim hR3",
        "Theraloc",
        "hR3",
        "nimotuzumab"
      ]
    },
    {
      "fdaUniiCode": "GBO3S6M9W7",
      "id": "Vascular_Disrupting_Agent_ZD6126",
      "preferredName": "Vascular Disrupting Agent ZD6126",
      "synonyms": [
        "ANG453",
        "N-[(5S)-6,7-Dihydro-9,10,11-trimethoxy-3-(phosphonooxy)-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide",
        "N-acetylcochinol-O-phosphate",
        "Vascular Disrupting Agent ZD6126",
        "ZD-6126",
        "ZD6126",
        "ZM-445526"
      ]
    },
    {
      "fdaUniiCode": "YO460OQ37K",
      "id": "Vandetanib",
      "preferredName": "Vandetanib",
      "synonyms": [
        "AZD6474",
        "Caprelsa",
        "VANDETANIB",
        "Vandetanib",
        "ZD-6474",
        "ZD6474",
        "Zactima",
        "vandetanib"
      ]
    },
    {
      "fdaUniiCode": "12N86DSS23",
      "id": "Pyroxamide",
      "preferredName": "Pyroxamide",
      "synonyms": [
        "PYROXAMIDE",
        "Pyroxamide",
        "Suberoyl-3-aminopyridineamide Hydroxamic Acid",
        "pyroxamide"
      ]
    },
    {
      "fdaUniiCode": "Z7T0JI2E2I",
      "id": "Verpasep_Caltespen",
      "preferredName": "Verpasep Caltespen",
      "synonyms": [
        "BCG65-E7",
        "Bovine HSP fusion with E7 of HPV16",
        "HPV 16 E7/HSP65 Vaccine",
        "HPV E7 Peptide Epitope Vaccine",
        "HspE7",
        "HspE7 Therapeutic Vaccine",
        "SGN-00101",
        "VERPASEP CALTESPEN",
        "Verpasep Caltespen"
      ]
    },
    {
      "fdaUniiCode": "4L6452S749",
      "id": "Inositol",
      "preferredName": "Inositol",
      "synonyms": [
        "Cyclohexanehexol",
        "INOSITOL",
        "Inositol",
        "cis-1,2,3,5-trans-4,6-Cyclohexanehexol",
        "inositol",
        "myo-Inositol",
        "myoinositol"
      ]
    },
    {
      "fdaUniiCode": "6751655D1D",
      "id": "Lentinan",
      "preferredName": "Lentinan",
      "synonyms": [
        "LC-33",
        "LENTINAN",
        "Lentinan",
        "lentinan"
      ]
    },
    {
      "fdaUniiCode": "R6D2UI4FLS",
      "id": "Enclomiphene",
      "preferredName": "Enclomiphene",
      "synonyms": [
        "ENCLOMIPHENE",
        "Enclomifene",
        "Enclomiphene",
        "ICI 46476",
        "RMI 16,289",
        "trans Clomiphene",
        "trans-2-(4-(2-Chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine"
      ]
    },
    {
      "fdaUniiCode": "956S425ZCY",
      "id": "Topotecan_Hydrochloride",
      "preferredName": "Topotecan Hydrochloride",
      "synonyms": [
        "(S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7] indolizino[1,2-b] quinoline-3,14-(4H,12H)-dione Monohydrochloride",
        "Hycamptamine",
        "Hycamtin",
        "SKF S-104864-A",
        "TOPOTECAN HYDROCHLORIDE",
        "Topotecan HCl",
        "Topotecan Hydrochloride",
        "Topotecan hydrochloride",
        "topotecan hydrochloride",
        "topotecan hydrochloride (oral)"
      ]
    },
    {
      "fdaUniiCode": "F1F4B2ILM1",
      "id": "Lontucirev",
      "preferredName": "Lontucirev",
      "synonyms": [
        "CI 1042",
        "CI-1042",
        "E1B 55kDa mutant adenovirus dl1520",
        "E1B-Attenuated Adenovirus",
        "LONTUCIREV",
        "Lontucirev",
        "Lontucirev (Replicating Adenovirus)",
        "ONYX-015"
      ]
    },
    {
      "fdaUniiCode": "UY5X264QZV",
      "id": "Zuclomiphene_Citrate",
      "preferredName": "Zuclomiphene Citrate",
      "synonyms": [
        "Cis-Clomiphene Citrate",
        "Cisclomiphene Citrate",
        "Clomiphene citrate, cis-",
        "ZUCLOMIPHENE CITRATE",
        "Zuclomiphene Citrate",
        "cis-Clomiphene citrate"
      ]
    },
    {
      "fdaUniiCode": "D8HJS52NSZ",
      "id": "Actinomycin_F1",
      "preferredName": "Actinomycin F1",
      "synonyms": [
        "ACTINOMYCIN F1",
        "Actinomycin F1",
        "Actinomycin KS4",
        "KS4"
      ]
    },
    {
      "fdaUniiCode": "I4Z5C8FM6H",
      "id": "Agatolimod_Sodium",
      "preferredName": "Agatolimod Sodium",
      "synonyms": [
        "(3'-5')d(P-thio)(T-C-G-T-C-G-T-T-T-T-G-T-C-G-T-T-T-T-G-T-C-G-T-T) Tricosasodium Salt",
        "AGATOLIMOD SODIUM",
        "Agatolimod Sodium",
        "CpG 7909",
        "PF-3512676",
        "ProMune"
      ]
    },
    {
      "fdaUniiCode": "G4FQ3CKY5R",
      "id": "Asparaginase",
      "preferredName": "Asparaginase",
      "synonyms": [
        "ASP-1",
        "ASPARAGINASE",
        "Asparaginase",
        "Asparaginase II",
        "Asparaginase-E.Coli",
        "Colaspase",
        "Elspar",
        "Kidrolase",
        "L-ASP",
        "L-Asnase",
        "L-Asparaginase",
        "L-Asparagine Amidohydrolase",
        "L-Asparagine amidohydrolase",
        "L-asparaginase",
        "Laspar",
        "Lcf-ASP",
        "Leucogen",
        "Leunase",
        "MK-965",
        "Paronal",
        "Re-82-TAD-15",
        "Serasa",
        "Spectrila",
        "asparaginase"
      ]
    },
    {
      "fdaUniiCode": "6N4FA2QQ6A",
      "id": "Lapachone",
      "preferredName": "Lapachone",
      "synonyms": [
        "3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione",
        "ARQ 501",
        "ARQ501",
        "Beta-Lap-WJ",
        "Beta-Lapachone",
        "LAPACHONE",
        "Lapachone",
        "beta-Lapachone"
      ]
    },
    {
      "fdaUniiCode": "K3FRN4DDOY",
      "id": "Laniquidar",
      "preferredName": "Laniquidar",
      "synonyms": [
        "LANIQUIDAR",
        "Laniquidar",
        "R101933"
      ]
    },
    {
      "fdaUniiCode": "R16CO5Y76E",
      "id": "Aspirin",
      "preferredName": "Aspirin",
      "synonyms": [
        "2-(Acetyloxy)benzoic Acid",
        "ASA",
        "ASPIRIN",
        "Acetylsalicylic Acid",
        "Acetylsalicylic acid",
        "Aspergum",
        "Aspirin",
        "Ecotrin",
        "Empirin",
        "Entericin",
        "Extren",
        "Measurin",
        "aspirin"
      ]
    },
    {
      "fdaUniiCode": "Q150359I72",
      "id": "8-Azaguanine",
      "preferredName": "8-Azaguanine",
      "synonyms": [
        "5-Amino-1,4-dihydro-7H-1,2,3-triazolo(4,5-d)pyrimidin-7-one",
        "5-Amino-1H-v-triazolo(d)pyrimidin-7-ol",
        "5-Amino-7-hydroxy-1H-v-triazolo(d)pyrimidine",
        "8 AG",
        "8-AZAGUANINE",
        "8-Azaguanine",
        "Guanazolo",
        "Pathocidin",
        "SF-337",
        "SK 1150",
        "Triazologuanine"
      ]
    },
    {
      "fdaUniiCode": "M801H13NRU",
      "id": "Azacitidine",
      "preferredName": "Azacitidine",
      "synonyms": [
        "4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one",
        "5 AZC",
        "5-AC",
        "5-AZC",
        "5-Aza-cytidine",
        "5-Azacytidine",
        "AZACITIDINE",
        "Azacitidine",
        "Azacytidine",
        "Azacytidine, 5-",
        "Ladakamycin",
        "Mylosar",
        "Onureg",
        "U-18496",
        "Vidaza",
        "azacitidine"
      ]
    },
    {
      "fdaUniiCode": "6TQY580E8M",
      "id": "Azotomycin",
      "preferredName": "Azotomycin",
      "synonyms": [
        "A 10270B",
        "AZOTOMYCIN",
        "Azotomycin",
        "Diazomycin B",
        "Duazomycin B",
        "L-Norleucine, 6-diazo-N-(6-diazo-N-L-gamma-glutamyl-5-oxo-L-norleucyl)-5-oxo- (8CI 9CI)"
      ]
    },
    {
      "fdaUniiCode": "48A5M73Z4Q",
      "id": "Atorvastatin_Calcium",
      "preferredName": "Atorvastatin Calcium",
      "synonyms": [
        "ATORVASTATIN CALCIUM TRIHYDRATE",
        "Atorvastatin Calcium",
        "CI-981",
        "Lipitor",
        "atorvastatin calcium"
      ]
    },
    {
      "fdaUniiCode": "EOF7S67HS2",
      "id": "Bactobolin",
      "preferredName": "Bactobolin",
      "synonyms": [
        "(-)-Bactobolin",
        "2-Amino-N-[3-(dichloromethyl)-3,4,4a,5,6,7- hexahydro-5,6,8-trihydroxy-3-methyl-1-oxo-1H-2- benzopyran-4-yl], Propanamide",
        "Antibiotic BN 183B",
        "BACTOBOLIN",
        "BN 183B",
        "Bactobolin",
        "Y 12278"
      ]
    },
    {
      "fdaUniiCode": "1Y1QP4AO5M",
      "id": "Breflate",
      "preferredName": "Breflate",
      "synonyms": [
        "13-(N,N-Dimethylglycyl)brefeldin A",
        "BREFLATE",
        "Breflate"
      ]
    },
    {
      "fdaUniiCode": "2J031W0YZI",
      "id": "Clomesone",
      "preferredName": "Clomesone",
      "synonyms": [
        "2-Chloroethyl (methylsulfonyl)methanesulfonate",
        "CLOMESONE",
        "Chlorethyl SOSO",
        "Clomesone",
        "SRI 6155"
      ]
    },
    {
      "fdaUniiCode": "7YFV4WN79I",
      "id": "Cyclodisone",
      "preferredName": "Cyclodisone",
      "synonyms": [
        "CYCLODISONE",
        "Cyclodisone"
      ]
    },
    {
      "fdaUniiCode": "87299V3Q9W",
      "id": "Azaserine",
      "preferredName": "Azaserine",
      "synonyms": [
        "AZASERINE",
        "AZS",
        "Azaserine",
        "CL-337",
        "CN 15757",
        "CN-15757",
        "Cl 337",
        "Diazoacetate (Ester) L-Serine",
        "Diazoacetate(ester) L-serine",
        "Diazoacetic Acid Ester with Serine",
        "Diazoacetylserine",
        "L-Azaserine",
        "L-Diazoacetate(ester) serine",
        "L-diazoacetate (ester) serine",
        "L-serine diazoacetate (ester)",
        "O-diazoacetyl-L-serine",
        "P-165",
        "Serine Diazoacetate",
        "o-Diazoacetyl-L-serine"
      ]
    },
    {
      "fdaUniiCode": "J14D49ZN55",
      "id": "Cytochlor",
      "preferredName": "Cytochlor",
      "synonyms": [
        "CYTOCHLOR",
        "Cytochlor",
        "cytochlor"
      ]
    },
    {
      "fdaUniiCode": "ZE2BI297KA",
      "id": "Dichloroallyl_Lawsone",
      "preferredName": "Dichloroallyl Lawsone",
      "synonyms": [
        "DICHLOROALLYL LAWSONE",
        "Dichloroallyl Lawsone"
      ]
    },
    {
      "fdaUniiCode": "73K4184T59",
      "id": "Digoxin",
      "preferredName": "Digoxin",
      "synonyms": [
        "12beta-Hydroxydigitoxin",
        "3beta,12beta,14-Trihydroxy-5beta,14beta-card-20(22)-enolid-3-tridigitoxosid",
        "Cardiogoxin",
        "DIGOXIN",
        "Digoxigenin-tridigitoxosid",
        "Digoxin",
        "Lanoxin",
        "digoxin"
      ]
    },
    {
      "fdaUniiCode": "O1EXJ975PT",
      "id": "Fluorodopan",
      "preferredName": "Fluorodopan",
      "synonyms": [
        "FLUORODOPAN",
        "Fluorodopan"
      ]
    },
    {
      "fdaUniiCode": "PYF7O1FV7F",
      "id": "Fluvastatin_Sodium",
      "preferredName": "Fluvastatin Sodium",
      "synonyms": [
        "(3R,5S,6E)-(+/-)-7-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoic Acid",
        "FLUVASTATIN SODIUM",
        "Fluvastatin Sodium",
        "Lescol"
      ]
    },
    {
      "fdaUniiCode": "R9QTB5E82N",
      "id": "Hexylresorcinol",
      "preferredName": "Hexylresorcinol",
      "synonyms": [
        "4-Hexylresorcinol",
        "HEXYLRESORCINOL",
        "Hexylresorcinol"
      ]
    },
    {
      "fdaUniiCode": "8F63U28T2V",
      "id": "Imexon",
      "preferredName": "Imexon",
      "synonyms": [
        "4-imino-1,3-diazabicyclo[3,1,0]-hexan-2-one",
        "Amplimexon",
        "IMEXON",
        "Imexon",
        "imexon"
      ]
    },
    {
      "fdaUniiCode": "DK61ZER6T7",
      "id": "Mitindomide",
      "preferredName": "Mitindomide",
      "synonyms": [
        "4, 8-Ethenopyrrolo[3',4':3,4]cyclobut[1,2-f]isoindole-1,3,5,7(2H, 6H)tetrone, octahydro-",
        "MITINDOMIDE",
        "Mitindomide"
      ]
    },
    {
      "fdaUniiCode": "786Z46389E",
      "id": "Metformin_Hydrochloride",
      "preferredName": "Metformin Hydrochloride",
      "synonyms": [
        "1,1-Dimethylbiguanide Hydrochloride",
        "APO-Metformin",
        "Cidophage",
        "Dimefor",
        "Glifage",
        "Glucoformin",
        "Glucophage",
        "Glucophage ER",
        "METFORMIN HYDROCHLORIDE",
        "Metformin HCl",
        "Metformin Hydrochloride",
        "N,N-Dimethylimidodicarbonimidic Diamide Monohydrochloride",
        "Riomet",
        "Siofor",
        "metformin hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "U946SH95EE",
      "id": "Milk_Thistle",
      "preferredName": "Milk Thistle",
      "synonyms": [
        "MILK THISTLE",
        "Milk Thistle",
        "milk thistle"
      ]
    },
    {
      "fdaUniiCode": "A8E516A20K",
      "id": "Talotrexin",
      "preferredName": "Talotrexin",
      "synonyms": [
        "N(alpha)-(4-Amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine",
        "PT523",
        "TALOTREXIN",
        "Talopterin",
        "Talotrexin",
        "talotrexin"
      ]
    },
    {
      "fdaUniiCode": "JQT35NPK6C",
      "id": "Pioglitazone_Hydrochloride",
      "preferredName": "Pioglitazone Hydrochloride",
      "synonyms": [
        "Actos",
        "PIOGLITAZONE HYDROCHLORIDE",
        "Pioglitazone Hydrochloride",
        "Pioglitazone.HCl"
      ]
    },
    {
      "fdaUniiCode": "3M8608UQ61",
      "id": "Pravastatin_Sodium",
      "preferredName": "Pravastatin Sodium",
      "synonyms": [
        "PRAVASTATIN SODIUM",
        "Pravastatin Sodium",
        "pravastatin sodium"
      ]
    },
    {
      "fdaUniiCode": "Y3O05I09ZK",
      "id": "3-C-ethynylcytidine",
      "preferredName": "3'-C-ethynylcytidine",
      "synonyms": [
        "1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine",
        "3'-C-Ethynylcytidine",
        "3'-C-ethynylcytidine",
        "ECdy",
        "ECyd",
        "TAS-106"
      ]
    },
    {
      "fdaUniiCode": "UST4Z70290",
      "id": "Trimelamol",
      "preferredName": "Trimelamol",
      "synonyms": [
        "BRN 4261541",
        "Methanol, ((s-triazine-2,4,6-triyl)trimethyltrinitrilo)tri-",
        "TRIMELAMOL",
        "Trimelamol",
        "Trimethyloltrimethylmelamine"
      ]
    },
    {
      "fdaUniiCode": "81BDR9Y8PS",
      "id": "Tazarotene",
      "preferredName": "Tazarotene",
      "synonyms": [
        "6-[(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]- 3-Pyridinecarboxylic Acid, Ethyl Ester",
        "AGN-190168",
        "Avage",
        "Ethyl 6-(2-(4,4-Dimethylthiochroman-6-yl)ethynyl)nicotinate",
        "TAZAROTENE",
        "Tazarotene",
        "Tazorac",
        "tazarotene"
      ]
    },
    {
      "fdaUniiCode": "08AN7WA2G0",
      "id": "Triptorelin_Pamoate",
      "preferredName": "Triptorelin Pamoate",
      "synonyms": [
        "6-D-Tryptophan-, 4,4'Mmethylenebis(3-hydroxy-2-naphthalenecarboxylate) (Salt)",
        "Decapeptyl",
        "Diphereline",
        "Pamorelin",
        "TRIPTORELIN PAMOATE",
        "Trelstar",
        "Triptorelin Pamoate"
      ]
    },
    {
      "fdaUniiCode": "614OI1Z5WI",
      "id": "Valproic_Acid",
      "preferredName": "Valproic Acid",
      "synonyms": [
        "2-Propylpentanoic Acid",
        "2-Propylvaleric Acid",
        "Depakene",
        "Di-n-propylacetic Acid",
        "Stavzor",
        "VALPROIC ACID",
        "Valproate",
        "Valproic Acid",
        "valproic acid"
      ]
    },
    {
      "fdaUniiCode": "2C8H3H4EBG",
      "id": "2-Fluoroadenine",
      "preferredName": "2-Fluoroadenine",
      "synonyms": [
        "1H-Purin-6-amine, 2-fluoro- (9CI)",
        "2-FLUOROADENINE",
        "2-Fad",
        "2-Fluoro-1H-purin-6-amine",
        "2-Fluoroadenine",
        "Adenine, 2-fluoro-",
        "BRN 0610958",
        "Purine, 6-amino-2-fluoro-",
        "SRI 774"
      ]
    },
    {
      "fdaUniiCode": "49P95BAU4Z",
      "id": "26-Diaminopurine",
      "preferredName": "2,6-Diaminopurine",
      "synonyms": [
        "1H-Purine-2,6-diamine",
        "2,6-DIAMINOPURINE",
        "2,6-Diaminopurine",
        "9h-purine-2,6-diamine",
        "DAP"
      ]
    },
    {
      "fdaUniiCode": "F7IY6HZG9D",
      "id": "Triethylenemelamine",
      "preferredName": "Triethylenemelamine",
      "synonyms": [
        "TEM",
        "TRIETHYLENEMELAMINE",
        "Tretamine",
        "Triethylene Melamine",
        "Triethylenemelamine"
      ]
    },
    {
      "fdaUniiCode": "4Q52C550XK",
      "id": "Ibritumomab_Tiuxetan",
      "preferredName": "Ibritumomab Tiuxetan",
      "synonyms": [
        "IBRITUMOMAB TIUXETAN",
        "IDEC-129",
        "IDEC-2B8",
        "Ibritumomab Tiuxetan",
        "Zevalin",
        "ibritumomab tiuxetan"
      ]
    },
    {
      "fdaUniiCode": "47BPR3V3MP",
      "id": "Interferon_Alfa-N3",
      "preferredName": "Interferon Alfa-N3",
      "synonyms": [
        "Alfa-N3 Interferon",
        "Alferon N",
        "Altemol",
        "INTERFERON ALFA-N3",
        "Interferon Alfa-3N, Human Leukocyte Derived",
        "Interferon Alfa-N3"
      ]
    },
    {
      "fdaUniiCode": "13M89UEA7W",
      "id": "Bleomycin_A2",
      "preferredName": "Bleomycin A2",
      "synonyms": [
        "BLEOMYCIN A2",
        "Bleomycin A2",
        "N1-(3-(Dimethylsulfonio)propyl)bleomycinamide",
        "Pingyangmycin A2",
        "Zhengguangmycin A2"
      ]
    },
    {
      "fdaUniiCode": "7DP3NTV15T",
      "id": "Bleomycin_Sulfate",
      "preferredName": "Bleomycin Sulfate",
      "synonyms": [
        "BLEOMYCIN SULFATE",
        "Blanoxan",
        "BleMomycine",
        "Blenoxane",
        "Bleo-S",
        "Bleo-cell",
        "Bleocin",
        "Bleolem",
        "Bleomycin Sulfas",
        "Bleomycin Sulfate",
        "Bleomycin Sulphate",
        "Bleomycin sulfate",
        "Bleomycini Sulfas",
        "Blexane",
        "Oil Bleo",
        "bleomycin sulfate"
      ]
    },
    {
      "fdaUniiCode": "40S1VHN69B",
      "id": "Bleomycin",
      "preferredName": "Bleomycin",
      "synonyms": [
        "BLEO",
        "BLEOMYCIN",
        "BLM",
        "Bleo",
        "Bleomycin",
        "bleomycin"
      ]
    },
    {
      "fdaUniiCode": "FFP983J3OD",
      "id": "Bromocriptine_Mesylate",
      "preferredName": "Bromocriptine Mesylate",
      "synonyms": [
        "2-Bromo-alpha-ergocryptine Mesylate",
        "BROMOCRIPTINE MESYLATE",
        "Bromocriptine Mesylate",
        "Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulfonate (salt), (5'alpha)-",
        "Parlodel"
      ]
    },
    {
      "fdaUniiCode": "G34N38R2N1",
      "id": "Broxuridine",
      "preferredName": "Broxuridine",
      "synonyms": [
        "5-BrdU",
        "5-Bromo-2'-deoxyuridine",
        "5-Bromodeoxyuridine",
        "5-Bromouracil Deoxyriboside",
        "5-Bromouracil deoxyriboside",
        "5-Bromouracil-2-deoxyriboside",
        "5-Budr",
        "BRDU",
        "BROXURIDINE",
        "BrdU",
        "Bromo Deoxyuridine",
        "Bromodeoxyuridine",
        "Bromouracil Deoxyriboside",
        "Bromouracil deoxyriboside",
        "Bromouridine",
        "Broxine",
        "Broxuridine",
        "Neomark",
        "Neomark-BU",
        "broxuridine"
      ]
    },
    {
      "fdaUniiCode": "PXW8U3YXDV",
      "id": "Buserelin",
      "preferredName": "Buserelin",
      "synonyms": [
        "6-[O-(1,1-Dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig)",
        "6-[O-(1,1-Dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide-luteinizing Hormone-releasing Factor (Pig)",
        "BSRL",
        "BUSERELIN",
        "Buserelin",
        "Busereline",
        "Etilamide",
        "HOE 766",
        "ICI 123215",
        "S74-6766",
        "buserelin"
      ]
    },
    {
      "fdaUniiCode": "G1LN9045DK",
      "id": "Busulfan",
      "preferredName": "Busulfan",
      "synonyms": [
        "1, 4-Bis[methanesulfonoxy]butane",
        "1,4-Bis(methanesulfonoxy)butane",
        "1,4-Bitanediol Dimethanesulfonate Esters",
        "1,4-Butanediol Dimethylsulfonate",
        "1,4-Di(methanesulfonyloxy)butane",
        "1,4-Di(methylsulfonyloxy)butane",
        "BUS",
        "BUSULFAN",
        "Bussulfam",
        "Busulfan",
        "Busulfanum",
        "Busulfex",
        "Busulphan",
        "CB 2041",
        "CB-2041",
        "GT 41",
        "GT-41",
        "Glyzophrol",
        "Joacamine",
        "Methanesulfonic Acid Tetramethylene Ester",
        "Methanesulfonic acid, tetramethylene ester",
        "Mielucin",
        "Misulban",
        "Misulfan",
        "Mitosan",
        "Myeleukon",
        "Myeloleukon",
        "Myelosan",
        "Mylecytan",
        "Myleran",
        "Sulfabutin",
        "Tetramethylene Bis(methanesulfonate)",
        "Tetramethylene bis[methanesulfonate]",
        "WR-19508",
        "busulfan"
      ]
    },
    {
      "fdaUniiCode": "FXC9231JVH",
      "id": "Calcitriol",
      "preferredName": "Calcitriol",
      "synonyms": [
        "(1alpha,3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol",
        "1,25(OH)2-D3",
        "1,25-DHCC",
        "1,25-Dihydroxycholecalciferol",
        "1,25-Dihydroxycholecaliferol",
        "CALCITRIOL",
        "Calcijex",
        "Calcitriol",
        "Rocaltrol",
        "calcitriol"
      ]
    },
    {
      "fdaUniiCode": "6AP9J91K4V",
      "id": "Calcium_Saccharate",
      "preferredName": "Calcium Saccharate",
      "synonyms": [
        "2,3,4,5-tetrahydroxy-1,6- dioxido-hexane-1,6-dione, Calcium",
        "Antacidin",
        "CALCIUM SACCHARATE",
        "CGT",
        "Calcium D-Glucarate",
        "Calcium D-Saccharate",
        "Calcium Glucarate",
        "Calcium Saccharate",
        "D-Glucaric Acid, Calcium Salt (1:1)",
        "Saccharated Lime"
      ]
    },
    {
      "fdaUniiCode": "XT3Z54Z28A",
      "id": "Camptothecin",
      "preferredName": "Camptothecin",
      "synonyms": [
        "(+)-Camptothecin",
        "(S)-4-ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolozino[1,2-b]quinoline-3,14(4H,12H)-dione",
        "1H-Pyrano[3',3'.6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4hydroxy-(S)-(9CI)",
        "20(S)-Camptothecine",
        "20-(S)-camptothecine",
        "21, 22-Secocamptothecin-21-oic acid lactone",
        "21, 22-secocamptothecin-21-oic acid lactone",
        "CAMPTOTHECIN",
        "Camptothecin",
        "camptothecin",
        "camptothecine"
      ]
    },
    {
      "fdaUniiCode": "Q46947FE7K",
      "id": "Peginterferon_Alfa-2a",
      "preferredName": "Peginterferon Alfa-2a",
      "synonyms": [
        "PEG-Interferon Alfa-2a",
        "PEG-interferon alfa-2a",
        "PEGINTERFERON ALFA-2A",
        "Pegasys",
        "Peginterferon Alfa-2a"
      ]
    },
    {
      "fdaUniiCode": "9G64RSX1XD",
      "id": "Captopril",
      "preferredName": "Captopril",
      "synonyms": [
        "(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline",
        "CAPTOPRIL",
        "Capoten",
        "Captopril",
        "captopril"
      ]
    },
    {
      "fdaUniiCode": "1CB0HBT12C",
      "id": "Carboquone",
      "preferredName": "Carboquone",
      "synonyms": [
        "CARBOQUONE",
        "Carboquone"
      ]
    },
    {
      "fdaUniiCode": "2GFP9BJD79",
      "id": "Glucarpidase",
      "preferredName": "Glucarpidase",
      "synonyms": [
        "Acetylaspartylglutamate Dipeptidase",
        "CPDG2",
        "CPG2",
        "Carboxypeptidase G2",
        "GLUCARPIDASE",
        "Glucarpidase",
        "Poly(gamma-glutamic Acid) Endohydrolase",
        "Pteroylpolygammaglutamyl Hydrolase",
        "Voraxaze",
        "carboxypeptidase-G2"
      ]
    },
    {
      "fdaUniiCode": "U68WG3173Y",
      "id": "Carmustine",
      "preferredName": "Carmustine",
      "synonyms": [
        "1,3-Bis(2-chloroethyl)-1-nitrosourea",
        "1,3-Bis(beta-chloroethyl)-1-nitrosourea",
        "BCNU",
        "Becenum",
        "Becenun",
        "BiCNU",
        "Bis(chloroethyl) Nitrosourea",
        "Bis-Chloronitrosourea",
        "CARMUSTINE",
        "Carmubris",
        "Carmustin",
        "Carmustine",
        "Carmustinum",
        "FDA 0345",
        "N,N'-Bis(2-chloroethyl)-N-nitrosourea",
        "N,N'-bis(2-chloroethyl)-N-nitrosourea",
        "Nitrourean",
        "Nitrumon",
        "SK 27702",
        "SRI 1720",
        "WR-139021",
        "carmustine"
      ]
    },
    {
      "fdaUniiCode": "E7437K3983",
      "id": "Carubicin",
      "preferredName": "Carubicin",
      "synonyms": [
        "(2S,3S)-3-acetyl-1,2,3,4,6,11-hexahydro-3,5,10,12-tetrahydroxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside",
        "(8S-cis)-acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-5,12-naphthacenedione",
        "4-O-demethyldaunorubicin",
        "5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3, 6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9, 10-tetrahydro-1,6,8,11-tetra-hydroxy- (8S-cis)- (8CI 9CI)",
        "5,12-naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-1,6,8,11-tetra-hydroxy-(8S-cis)-(8CI 9CI)",
        "5,12-naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-1,6,8,11-tetra-hydroxy-,(8S-cis)-(8CI)-(9CI)",
        "CARMINOMYCIN",
        "CARUBICIN",
        "CMM",
        "Carminomycin",
        "Carminomycin I",
        "Carubicin",
        "Demethyldaunomycin",
        "Karminomitsin",
        "Karminomycin"
      ]
    },
    {
      "fdaUniiCode": "18D0SL7309",
      "id": "Chlorambucil",
      "preferredName": "Chlorambucil",
      "synonyms": [
        ".gamma.-(p-bis(2-chloroethyl)aminophenyl)butyric acid",
        ".gamma.-[p-Di(2-chloroethyl)aminophenyl]butyric acid",
        ".gamma.-[p-bis(2-chloroethyl)aminophenyl]butyric acid",
        "4-[Bis(2-chloroethyl)amino]benzenebutanoic acid",
        "4-[bis(2-chloroethyl)amino]benzenebutanoic acid",
        "4-[p-[Bis(2-chloroethyl)amino]phenyl]butyric acid",
        "4-[p-[bis(2-chloroethyl)amino]phenyl]butyric acid",
        "Alti-chlorambucil",
        "Ambochlorin",
        "Amboclorin",
        "Aminochlorambucil",
        "Benzenebutanoic acid, 4-[bis(2-chloroethyl)amino]- (9CI)",
        "Butyric acid, 4-(p-[bis(2-chloroethyl)amino]phenyl)-",
        "Butyric acid, 4-(p-bis(2-chloroethyl)aminophenyl)-",
        "CB 1348",
        "CB-1348",
        "CHL",
        "CHLORAMBUCIL",
        "Chlorambucil",
        "Chlorambucilum",
        "Chloraminophen",
        "Chloraminophene",
        "Chlorbutin",
        "Chlorbutine",
        "Chloroambucil",
        "Chlorobutin",
        "Chlorobutine",
        "Ecloril",
        "Elcoril",
        "Leukeran",
        "Leukersan",
        "Leukoran",
        "Linfolizin",
        "Linfolysin",
        "Lympholysin",
        "N,N-Di-2-chloroethyl-.gamma.-p-aminophenylbutyric acid",
        "N,N-di-2-chloroethyl-gamma-p-aminophenylbutyric acid",
        "Phenylbutyric acid nitrogen mustard",
        "WR-139013",
        "aminochlorambucil",
        "benzenebutanoic acid, 4-[bis(2-chloroethyl)amino]- (9CI)",
        "butyric acid, 4-(p-bis(2-chloroethyl)aminophenyl)",
        "chlorambucil",
        "chlorbutinum",
        "chloroambucil",
        "gamma-(p-bis(2-chloroethyl)aminophenyl)butyric acid",
        "gamma-[p-di(2-chloroethyl)aminophenyl]butyric acid",
        "p-(N, N-Di-2-chloroethyl)aminophenyl butyric acid",
        "p-(N, N-di-2-chloroethyl)aminophenyl butyric acid",
        "p-N, N-Di-(.beta.-chloroethyl)aminophenyl butyric acid",
        "p-N, N-di-(beta-chloroethyl)aminophenyl butyric acid",
        "phenylbutyric acid nitrogen mustard"
      ]
    },
    {
      "fdaUniiCode": "80061L1WGD",
      "id": "Cimetidine",
      "preferredName": "Cimetidine",
      "synonyms": [
        "CIMETIDINE",
        "Cimetidine",
        "Guanidine, N''-Cyano-N-Methyl-N'-(2-(((5-Methyl-1H-Imidazol-4-yl)Methyl)Thio)Ethyl)-",
        "N-Cyano-N'-methyl-N''-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidine",
        "Tagamet",
        "cimetidine"
      ]
    },
    {
      "fdaUniiCode": "CRR8E37XOB",
      "id": "TSP-1_Mimetic_ABT-510",
      "preferredName": "TSP-1 Mimetic ABT-510",
      "synonyms": [
        "ABT-510",
        "ABT510",
        "L-Prolinamide, N-acetyl-N-methylglycylglycyl-L-valyl-D-alloisoleucyl-L-threonyl-L-norvalyl-L-isoleucyl-L-arginyl-N-ethyl-",
        "NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt",
        "TSP-1 Mimetic ABT-510",
        "TSP-1-mimetic Peptide ABT-510"
      ]
    },
    {
      "fdaUniiCode": "UG97LO5M8Y",
      "id": "Tesetaxel",
      "preferredName": "Tesetaxel",
      "synonyms": [
        "DJ-927",
        "TESETAXEL",
        "Tesetaxel"
      ]
    },
    {
      "fdaUniiCode": "K27005NP0A",
      "id": "Ixabepilone",
      "preferredName": "Ixabepilone",
      "synonyms": [
        "(1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione",
        "Azaepothilone B",
        "BMS 247550",
        "BMS-247550",
        "BMS247550",
        "Epothilone",
        "Epothilone-B BMS 247550",
        "IXABEPILONE",
        "Ixabepilone",
        "Ixempra",
        "ixabepilone"
      ]
    },
    {
      "fdaUniiCode": "K6KJ8AZ05F",
      "id": "Cenersen",
      "preferredName": "Cenersen",
      "synonyms": [
        "Aezea",
        "CENERSEN",
        "Cenersen",
        "EL625",
        "OL(1)p53"
      ]
    },
    {
      "fdaUniiCode": "7A9Y5SX0GY",
      "id": "Zebularine",
      "preferredName": "Zebularine",
      "synonyms": [
        "1-beta-D-Ribofuranosyl-2(1H)-pyrimidinone",
        "2-Pyrimidone-1-beta-D-riboside",
        "4-DEOXYURIDINE",
        "4-Deoxyuridine",
        "Pyrimidin-2-one beta-Ribofuranoside",
        "Zebularine"
      ]
    },
    {
      "fdaUniiCode": "7V2F1075HD",
      "id": "Hypericin",
      "preferredName": "Hypericin",
      "synonyms": [
        "4,5,7,4',5',7'-Hexahydroxy-2,2'-dimethyl-mesonapthtodianthron",
        "HYPERICIN",
        "Hypericin"
      ]
    },
    {
      "fdaUniiCode": "Q20Q21Q62J",
      "id": "Cisplatin",
      "preferredName": "Cisplatin",
      "synonyms": [
        "(SP-4-2)-Diamminedichloroplatinum",
        "Abiplatin",
        "Blastolem",
        "Briplatin",
        "CDDP",
        "CISPLATIN",
        "Cis-diammine-dichloroplatinum",
        "Cis-diamminedichloridoplatinum",
        "Cis-diamminedichloro Platinum (II)",
        "Cis-diamminedichloroplatinum",
        "Cis-dichloroammine Platinum (II)",
        "Cis-platinous Diamine Dichloride",
        "Cis-platinum",
        "Cis-platinum II",
        "Cis-platinum II Diamine Dichloride",
        "Cismaplat",
        "Cisplatin",
        "Cisplatina",
        "Cisplatinum",
        "Cisplatyl",
        "Citoplatino",
        "Citosin",
        "Cysplatyna",
        "DDP",
        "Lederplatin",
        "Metaplatin",
        "Neoplatin",
        "Peyrone's Chloride",
        "Peyrone's Salt",
        "Placis",
        "Plastistil",
        "Platamine",
        "Platiblastin",
        "Platiblastin-S",
        "Platinex",
        "Platinol",
        "Platinol- AQ",
        "Platinol-AQ",
        "Platinol-AQ VHA Plus",
        "Platinoxan",
        "Platinum",
        "Platinum Diamminodichloride",
        "Platinum, Diaminedichloro-, cis- (8CI)",
        "Platiran",
        "Platistin",
        "Platosin",
        "cisplatin"
      ]
    },
    {
      "fdaUniiCode": "4GY0AVT3L4",
      "id": "Tanespimycin",
      "preferredName": "Tanespimycin",
      "synonyms": [
        "17-(Allylamino)-17-demethoxygeldanamycin",
        "17-AAG",
        "17-Allylamino-17-demethoxygeldanamycin",
        "17-Demethoxy-17-(2-propenylamino)geldanamycin",
        "17-N-allylamino-17-demethoxy geldanamycin",
        "17-N-allylamino-17-demethoxygeldanamycin",
        "Geldanamycin, 17-allylamino-17-demethoxy-",
        "KOS-953",
        "TANESPIMYCIN",
        "Tanespimycin",
        "tanespimycin"
      ]
    },
    {
      "fdaUniiCode": "1B8447E7YI",
      "id": "Clomiphene_Citrate",
      "preferredName": "Clomiphene Citrate",
      "synonyms": [
        "2-[p-(2-Chloro-1,2-diphenylvinyl)phenoxy]triethylamine Citrate",
        "2-[p-(2-Chloro-1,2-diphenylvinyl)phenoxy]triethylamine Citrate (1:1)",
        "CLOMIPHENE CITRATE",
        "Clomid",
        "Clomiphene Citrate",
        "Serophene"
      ]
    },
    {
      "fdaUniiCode": "4G6A18707N",
      "id": "Betulinic_Acid",
      "preferredName": "Betulinic Acid",
      "synonyms": [
        "(3beta)-3-Hydroxy-lup-20(29)-en-28-oic Acid",
        "ALS-357",
        "BETULINIC ACID",
        "Betulinic Acid",
        "Mairin"
      ]
    },
    {
      "fdaUniiCode": "NA0Y2SRR29",
      "id": "Methionine_Aminopeptidase_2_Inhibitor_PPI-2458",
      "preferredName": "Methionine Aminopeptidase 2 Inhibitor PPI-2458",
      "synonyms": [
        "MetAP-2 Inhibitor PPI-2458",
        "Methionine Aminopeptidase 2 Inhibitor PPI-2458",
        "PPI-2458"
      ]
    },
    {
      "fdaUniiCode": "BKT5F9C2NI",
      "id": "Ispinesib",
      "preferredName": "Ispinesib",
      "synonyms": [
        "CK0238273",
        "ISPINESIB",
        "Ispinesib",
        "SB-715992",
        "ispinesib"
      ]
    },
    {
      "fdaUniiCode": "CVS43XG1L5",
      "id": "Talampanel",
      "preferredName": "Talampanel",
      "synonyms": [
        "(R)-(-)-1-(4-Aminophenyl)-3-acetyl-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-benzodiazepine",
        "GYKI-53773",
        "LY-300164",
        "TALAMPANEL",
        "Talampanel",
        "talampanel"
      ]
    },
    {
      "fdaUniiCode": "001L2FE0M3",
      "id": "Alvespimycin",
      "preferredName": "Alvespimycin",
      "synonyms": [
        "17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin",
        "17-DMAG",
        "17-dimethylaminoethylamino-17-demethoxygeldanamycin",
        "ALVESPIMYCIN",
        "Alvespimycin",
        "Geldanamycin,17-demethoxy-17-((2-(dimethylamino)ethyl)amino)-"
      ]
    },
    {
      "fdaUniiCode": "9T6PW6J6MA",
      "id": "Baloramotide",
      "preferredName": "Baloramotide",
      "synonyms": [
        "BALORAMOTIDE",
        "Baloramotide",
        "Cancer/testis Antigen 1, Recombinant",
        "Recombinant NY-ESO-1 Protein"
      ]
    },
    {
      "fdaUniiCode": "Q1418F39MH",
      "id": "Amsilarotene",
      "preferredName": "Amsilarotene",
      "synonyms": [
        "AMSILAROTENE",
        "Amsilarotene",
        "TAC 101",
        "TAC-101"
      ]
    },
    {
      "fdaUniiCode": "KUW1QG1ZM3",
      "id": "Siplizumab",
      "preferredName": "Siplizumab",
      "synonyms": [
        "Immunoglobulin G1, Anti-(human CD2 (Antigen))(Human-rat Monoclonal MEDI-507 G1-chain), Disulfide with Human-rat Monoclonal MEDI-507 Light Chain, Dimer",
        "MEDI-507",
        "SIPLIZUMAB",
        "Siplizumab",
        "siplizumab"
      ]
    },
    {
      "fdaUniiCode": "P2BKS6T40H",
      "id": "Muparfostat",
      "preferredName": "Muparfostat",
      "synonyms": [
        "6-O-(dihydrogen Phosphate)-2,3,4-tris-O-(hydrogen Sulfate)-alpha-d-mannopyranosyl-(1->poly(3)-2,4,6-tris-O-(hydrogen Sulfate)-alpha-d-mannopyranosyl-(1->)2)-1,3,4,6-tetrakis-O-(hydrogen Sulfate)-d-mannopyranose",
        "MUPARFOSTAT",
        "Muparfostat",
        "PI 88",
        "PI-88",
        "Phosphomannopentose Sulfate PI-88",
        "Sulfated Phosphomanno-oligosaccharide PI-88",
        "alpha-D-Mannan, (1->3)-, 6-(Dihydrogen Phosphate) Tris(Hydrogen Sulfate)"
      ]
    },
    {
      "fdaUniiCode": "K16AIQ8CTM",
      "id": "Pertuzumab",
      "preferredName": "Pertuzumab",
      "synonyms": [
        "2C4",
        "2C4 Antibody",
        "HS627",
        "Immunoglobulin G1, Anti-(Human V (Receptor)) (Human-Mouse Monoclonal 2C4 Heavy Chain), Disulfide with Human-Mouse Monoclonal 2C4 Kappa-Chain, Dimer",
        "MoAb 2C4",
        "Monoclonal Antibody 2C4",
        "Omnitarg",
        "PERTUZUMAB",
        "Perjeta",
        "Pertuzumab",
        "Pertuzumab Biosimilar HS627",
        "RO4368451",
        "pertuzumab",
        "rhuMAb2C4"
      ]
    },
    {
      "fdaUniiCode": "6702D36OG5",
      "id": "Paricalcitol",
      "preferredName": "Paricalcitol",
      "synonyms": [
        "(7e,22e)-19-Nor-9,10-Secoergosta-5,7,22-Triene-1Alpha,3Beta,25-Triol",
        "Compound 49510",
        "PARICALCITOL",
        "Paricalcitol",
        "Zemplar",
        "paricalcitol"
      ]
    },
    {
      "fdaUniiCode": "ON177ZCE7M",
      "id": "Liposome-encapsulated_OSI-7904",
      "preferredName": "Liposome-encapsulated OSI-7904",
      "synonyms": [
        "GS7904L",
        "Liposome-encapsulated OSI-7904",
        "OSI-7904",
        "OSI-7904L"
      ]
    },
    {
      "fdaUniiCode": "JB9647672Z",
      "id": "Lutetium_Lu_177_Rosopatamab_Tetraxetan",
      "preferredName": "Lutetium Lu 177 Rosopatamab Tetraxetan",
      "synonyms": [
        "177Lu-DOTA-TLX591",
        "DOTA-HUJ-591 LU-177",
        "Lu 177 MOAB J591",
        "Lutetium Lu 177 Monoclonal Antibody J591",
        "Lutetium Lu 177 Rosopatamab",
        "Lutetium Lu 177 Rosopatamab Tetraxetan",
        "Lutetium Lu 177-DOTA-Rosopatamab",
        "Lutetium Lu 177-DOTA-TLX591",
        "ROSOPATAMAB TETRAXETAN LUTETIUM LU-177"
      ]
    },
    {
      "fdaUniiCode": "V1V998DC17",
      "id": "Garlic",
      "preferredName": "Garlic",
      "synonyms": [
        "Ajo",
        "Allium Sativum",
        "Allium sativum",
        "GARLIC",
        "Garlic",
        "garlic"
      ]
    },
    {
      "fdaUniiCode": "TKG3I66TVE",
      "id": "Deslorelin",
      "preferredName": "Deslorelin",
      "synonyms": [
        "6-D-Tryptophan-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor (Swine)",
        "DESLORELIN",
        "Deslorelin",
        "Ovuplant",
        "deslorelin"
      ]
    },
    {
      "fdaUniiCode": "RBZ1571X5H",
      "id": "Dasatinib",
      "preferredName": "Dasatinib",
      "synonyms": [
        "5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-, Monohydrate",
        "BMS-354825",
        "DASATINIB",
        "Dasatinib",
        "Dasatinib Hydrate",
        "Dasatinib Monohydrate",
        "Sprycel",
        "dasatinib"
      ]
    },
    {
      "fdaUniiCode": "0IVD6ASY0W",
      "id": "Lorvotuzumab_Mertansine",
      "preferredName": "Lorvotuzumab Mertansine",
      "synonyms": [
        "Anti-Human NCAM-1 Monoclonal Antibody N901",
        "BB-10901",
        "IMGN901",
        "LORVOTUZUMAB MERTANSINE",
        "Lorvotuzumab Mertansine",
        "huN901-DM1"
      ]
    },
    {
      "fdaUniiCode": "9013DUQ28K",
      "id": "Anakinra",
      "preferredName": "Anakinra",
      "synonyms": [
        "ANAKINRA",
        "Anakinra",
        "Kinaret",
        "Kineret",
        "anakinra",
        "rIL-1ra",
        "rIL1RN"
      ]
    },
    {
      "fdaUniiCode": "C9LVQ0YUXG",
      "id": "Axitinib",
      "preferredName": "Axitinib",
      "synonyms": [
        "AG-013736",
        "AG013736",
        "AXITINIB",
        "Axitinib",
        "Inlyta",
        "N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide",
        "axitinib"
      ]
    },
    {
      "fdaUniiCode": "IT942ZTH98",
      "id": "Curcumin",
      "preferredName": "Curcumin",
      "synonyms": [
        "(E,E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione",
        "C.I. 75300",
        "C.I. Natural Yellow 3",
        "CURCUMIN",
        "Curcumin",
        "Diferuloylmethane",
        "Turmeric Yellow",
        "curcumin"
      ]
    },
    {
      "fdaUniiCode": "3T6920M469",
      "id": "Ancitabine_Hydrochloride",
      "preferredName": "Ancitabine Hydrochloride",
      "synonyms": [
        "6H-furo(2',3':4,5)oxazolo(3,2-a)pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-,(2R(2alpha,3beta,3a beta,9a beta))",
        "ANCITABINE HYDROCHLORIDE",
        "Ancid",
        "Ancitabine Hydrochloride",
        "Ancitabine hydrochloride",
        "Ancytabine Hydrochloride",
        "CycloCMP Hydrochloride",
        "CycloCMP hydrochloride",
        "Cyclocytidine",
        "Cyclocytidine HCL",
        "Cyclocytidine Hydrochloride",
        "Cyclocytidine hydrochloride",
        "U-33, 624A"
      ]
    },
    {
      "fdaUniiCode": "0TQU7668EI",
      "id": "Cycloleucine",
      "preferredName": "Cycloleucine",
      "synonyms": [
        "1-Aminocyclopentane",
        "1-Aminocyclopentanecarboxylic acid",
        "1-aminocyclopentanecarboxylic acid",
        "ACP",
        "ACPC",
        "CB 1639",
        "CB-1639",
        "CYCLOLEUCINE",
        "Cycloleucine"
      ]
    },
    {
      "fdaUniiCode": "8N3DW7272P",
      "id": "Cyclophosphamide",
      "preferredName": "Cyclophosphamide",
      "synonyms": [
        "(-)-Cyclophosphamide",
        "1-bis(2-chloroethyl)-amino-1-oxo-2-aza-5-oxaphosphoridin monohydrate",
        "2-[bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide monohydrate",
        "2-[bis(b-chloroethyl)amino]-1-oxa-3-aza-2-phosphacyclohexane-2-oxide monohydrate",
        "2-[di(chloroethyl)amino]-1-oxa-3-aza-2-phosphacyclohexane 2-oxide monohydrate",
        "2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate",
        "Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester monohydrate",
        "CP monohydrate",
        "CTX",
        "CYCLO-cell",
        "CYCLOPHOSPHAMIDE",
        "Carloxan",
        "Ciclofosfamida",
        "Ciclofosfamide",
        "Cicloxal",
        "Clafen",
        "Claphene",
        "Cycloblastin",
        "Cycloblastine",
        "Cyclophospham",
        "Cyclophosphamid monohydrate",
        "Cyclophosphamide",
        "Cyclophosphamide Monohydrate",
        "Cyclophosphamidum",
        "Cyclophosphan",
        "Cyclophosphane",
        "Cyclophosphanum",
        "Cyclostin",
        "Cyclostine",
        "Cytophosphan",
        "Cytophosphane",
        "Cytoxan",
        "Fosfaseron",
        "Genoxal",
        "Genuxal",
        "Ledoxina",
        "Mitoxan",
        "N,N-bis(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide monohydrate",
        "N,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)phosphorodiamidic acid intramolecular ester monohydrate",
        "N,N-bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide monohydrate",
        "N,N-bis(b-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide monohydrate",
        "N,N-bis(beta-chloroethyl)-N',O-propylenephosphoric acid ester diamide monohydrate",
        "N,N-bis(beta-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide monohydrate",
        "Neosar",
        "Revimmune",
        "Syklofosfamid",
        "WR- 138719",
        "bis(2-chloroethyl)phosphamide cyclic propanolamide ester monohydrate",
        "cyclophosphamide"
      ]
    },
    {
      "fdaUniiCode": "E61Q31EK2F",
      "id": "Cyproterone",
      "preferredName": "Cyproterone",
      "synonyms": [
        "CYPROTERONE",
        "Cyproterone",
        "Med Cyproterone",
        "SH-881"
      ]
    },
    {
      "fdaUniiCode": "04079A1RDZ",
      "id": "Cytarabine",
      "preferredName": "Cytarabine",
      "synonyms": [
        ".beta.-Cytosine arabinoside",
        "1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone",
        "1-.beta.-D-Arabinofuranosylcytosine",
        "1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone",
        "1-Beta-D-arabinofuranosylcytosine",
        "1.beta.-D-Arabinofuranosylcytosine",
        "2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-",
        "2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-",
        "4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone",
        "ARA-cell",
        "Alexan",
        "Ara-C",
        "Arabine",
        "Arabinofuranosylcytosine",
        "Arabinosylcytosine",
        "Aracytidine",
        "Aracytin",
        "Aracytine",
        "Beta-Cytosine Arabinoside",
        "Beta-cytosine Arabinoside",
        "CHX-3311",
        "CYTARABINE",
        "Cytarabine",
        "Cytarabinum",
        "Cytarbel",
        "Cytosar",
        "Cytosar-U",
        "Cytosine Arabinoside",
        "Cytosine-.beta.-arabinoside",
        "Cytosine-beta-arabinoside",
        "Erpalfa",
        "Starasid",
        "Tarabine PFS",
        "U 19920",
        "U-19920",
        "Udicil",
        "WR-28453",
        "cytarabine"
      ]
    },
    {
      "fdaUniiCode": "7GR28W0FJI",
      "id": "Dacarbazine",
      "preferredName": "Dacarbazine",
      "synonyms": [
        "1H-imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-",
        "4-(Dimethyltriazeno)imidazole-5-carboxamide",
        "5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide",
        "5-(3-3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide",
        "5-(Dimethyltriazeno)imidazole-4-carboxamide",
        "5-(dimethyltriazeno)imidazole-4-carboxamide",
        "Asercit",
        "Biocarbazine",
        "DACARBAZINE",
        "DIC",
        "DTIC",
        "DTIC-Dome",
        "Dacarbazina",
        "Dacarbazina Almirall",
        "Dacarbazine",
        "Dacarbazine - DTIC",
        "Dacatic",
        "Dakarbazin",
        "Deticene",
        "Detimedac",
        "Dimethyl (triazeno) imidazolecarboxamide",
        "Dimethyl Triazeno Imidazol Carboxamide",
        "Dimethyl Triazeno Imidazole Carboxamide",
        "Dimethyl-triazeno-imidazole-carboximide",
        "Fauldetic",
        "Imidazole Carboxamide",
        "Imidazole Carboxamide Dimethyltriazeno",
        "Imidazole carboxamide",
        "WR-139007",
        "dacarbazine",
        "dimethyl-triazeno-imidazole carboxamide"
      ]
    },
    {
      "fdaUniiCode": "1CC1JFE158",
      "id": "Dactinomycin",
      "preferredName": "Dactinomycin",
      "synonyms": [
        "2-bis[Cyclo(N-methyl-L-valyl-sarcosyl-L-prolyl-D-valyl-L-threonyl)]-1,9 dimethyl-4,6 3H-phenoxazinone-3",
        "ACTINOMYCIN D",
        "Actinomycin A IV",
        "Actinomycin C1",
        "Actinomycin D",
        "Actinomycin I1",
        "Actinomycin IV",
        "Actinomycin X 1",
        "Actinomycin-[thr-val-pro-sar-meval]",
        "Cosmegen",
        "DACT",
        "DACTINOMYCIN",
        "Dactinomycin",
        "Dactinomycine",
        "Lyovac Cosmegen",
        "Lyovac cosmegen",
        "Meractinomycin",
        "dactinomycin"
      ]
    },
    {
      "fdaUniiCode": "J06Y7MXW4D",
      "id": "Deferoxamine",
      "preferredName": "Deferoxamine",
      "synonyms": [
        "1-Amino-6,17-dihydroxy-7,10,18,21-tetraoxo-27-(n-acetylhydroxylamino)-6,11,17,22-tetraazaheptaeicosane",
        "DEFEROXAMINE",
        "Deferoxamine",
        "Desferrioxamine",
        "N'-[5-[[4-[[5-(Acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxybutanediamide",
        "N-[5-[3-[(5-Aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic Acid",
        "deferoxamine"
      ]
    },
    {
      "fdaUniiCode": "V9TKO7EO6K",
      "id": "Deferoxamine_Mesylate",
      "preferredName": "Deferoxamine Mesylate",
      "synonyms": [
        "DEFEROXAMINE MESYLATE",
        "DFM",
        "Deferoxamine B",
        "Deferoxamine Mesylate",
        "Deferoxamine Methanesulfonate",
        "Deferoxamine mesylate",
        "Deferrioxamine B",
        "Desferal",
        "Desferrioxamine Mesylate"
      ]
    },
    {
      "fdaUniiCode": "Z01IVE25KI",
      "id": "Demecolcine",
      "preferredName": "Demecolcine",
      "synonyms": [
        "(-)-Colchamine",
        "DEMECOLCINE",
        "Demecolcine",
        "Methylcolchicine",
        "N-Methyl-N-desacetylcolchicine",
        "Santavy's Substance F",
        "X 153"
      ]
    },
    {
      "fdaUniiCode": "7S5I7G3JQL",
      "id": "Dexamethasone",
      "preferredName": "Dexamethasone",
      "synonyms": [
        "(11Beta,16alpha)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",
        "1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone",
        "16Alpha-methyl-9alpha-fluoro-1,4-pregnadiene-11beta,17alpha,21-triol-3,20-dione",
        "16Alpha-methyl-9alpha-fluoro-delta1-hydrocortisone",
        "16Alpha-methyl-9alpha-fluoroprednisolone",
        "9Alpha-fluoro-11beta,17alpha,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione",
        "9Alpha-fluoro-16alpha-methylprednisolone",
        "9alpha-Fluoro-16alpha- methylprednisolone",
        "Aacidexam",
        "Adexone",
        "Aknichthol Dexa",
        "Alba-Dex",
        "Alin",
        "Alin Depot",
        "Alin Oftalmico",
        "Amplidermis",
        "Anemul mono",
        "Auricularum",
        "Auxiloson",
        "Baycadron",
        "Baycuten",
        "Baycuten N",
        "Cortidexason",
        "Cortisumman",
        "DEXAMETHASONE",
        "Decacort",
        "Decadrol",
        "Decadron",
        "Decadron DP",
        "Decalix",
        "Decameth",
        "Decasone R.p.",
        "Dectancyl",
        "Dekacort",
        "Deltafluorene",
        "Deronil",
        "Desamethasone",
        "Desameton",
        "Dexa-Mamallet",
        "Dexa-Rhinosan",
        "Dexa-Scheroson",
        "Dexa-sine",
        "Dexacortal",
        "Dexacortin",
        "Dexafarma",
        "Dexafluorene",
        "Dexalocal",
        "Dexamecortin",
        "Dexameth",
        "Dexamethasone",
        "Dexamethasone Intensol",
        "Dexamethasonum",
        "Dexamonozon",
        "Dexapos",
        "Dexinoral",
        "Dexone",
        "Dinormon",
        "Dxevo",
        "Fluoro-9alpha Methyl-16alpha Prednisolone",
        "Fluorodelta",
        "Fortecortin",
        "Gammacorten",
        "Hemady",
        "Hexadecadrol",
        "Hexadrol",
        "Lokalison-F",
        "Loverine",
        "Methylfluorprednisolone",
        "Millicorten",
        "Mymethasone",
        "Orgadrone",
        "Spersadex",
        "TaperDex",
        "Visumetazone",
        "ZoDex",
        "dexamethasone"
      ]
    },
    {
      "fdaUniiCode": "4S465RYF7M",
      "id": "Dianhydrogalactitol",
      "preferredName": "Dianhydrogalactitol",
      "synonyms": [
        "1,2,5,6 dianhydrogalactitol",
        "1,2:5, 6-Dianhydrogalactitol",
        "1,2:5, 6-diepoxydulcitol",
        "1,2:5,6 dianhydrogalactitol",
        "1,2:5,6-Dianhydrodulcitol",
        "1,2:5,6-Diepoxydulcitol",
        "1,2:5,6-dianhydrodulcitol",
        "DAG",
        "DIANHYDROGALACTITOL",
        "Dianhydrodulcitol",
        "Dianhydrogalactitol",
        "Dulcitol diepoxide",
        "Galactitol",
        "Galactitol, 1,2:5,6-dianhydro- (8CI 9CI)",
        "dianhydrodulcitol",
        "diepoxydulcitol",
        "diepoxygalactitol",
        "dulcitol diepoxide",
        "galactitol, 1,2:5,6-dianhydro- (8CI 9CI)"
      ]
    },
    {
      "fdaUniiCode": "6L3XT8CB3I",
      "id": "Zalcitabine",
      "preferredName": "Zalcitabine",
      "synonyms": [
        "2',3'-Dideoxycytidine",
        "Dideoxycytidine",
        "Hivid",
        "ZALCITABINE",
        "Zalcitabine",
        "ddC"
      ]
    },
    {
      "fdaUniiCode": "99Z2744345",
      "id": "Ditiocarb",
      "preferredName": "Ditiocarb",
      "synonyms": [
        "DDTC",
        "DIECA",
        "DITIOCARB",
        "DTC",
        "Diethylcarbamodithioic Acid",
        "Diethyldione",
        "Diethyldithiocarbamate",
        "Diethyldithiocarbamic Acid",
        "Diethyldithiocarbaminic Acid",
        "Diethyldithione",
        "Ditiocarb"
      ]
    },
    {
      "fdaUniiCode": "80168379AG",
      "id": "Doxorubicin",
      "preferredName": "Doxorubicin",
      "synonyms": [
        "(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroacetyl)-1-methoxy-5,12-naphthacenedione",
        "(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione",
        "14-Hydroxydaunomycin",
        "Adriablastin",
        "DOXORUBICIN",
        "Doxorubicin",
        "Hydroxydaunomycin",
        "Hydroxyl Daunorubicin",
        "Hydroxyldaunorubicin",
        "doxorubicin"
      ]
    },
    {
      "fdaUniiCode": "TG824J6RQT",
      "id": "Echinomycin",
      "preferredName": "Echinomycin",
      "synonyms": [
        "BRN 0078671",
        "Bis-Quinoline Analogue",
        "ECHINOMYCIN",
        "Echinomycin",
        "Echinomycin A",
        "Levomycin",
        "N,N'-(2,4,12,15,17,25-hexamethyl-11,24-bis(1-methylethyl)-27-(methylthio)-3,6,10,13,16,19,23,26-octaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo(12.12.3)nonacosane-7,20-diyl)bis(2-quinoxalinecarboxamide)",
        "Quinomycin A",
        "SK 302B"
      ]
    },
    {
      "fdaUniiCode": "22966TX7J5",
      "id": "Epirubicin_Hydrochloride",
      "preferredName": "Epirubicin Hydrochloride",
      "synonyms": [
        "(8S-cis)-10-((3-Amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione Hydrochloride",
        "3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside Hydrochloride",
        "EPIRUBICIN HYDROCHLORIDE",
        "Ellence",
        "Epirubicin Hydrochloride",
        "IMI-28",
        "Pharmorubicin PFS",
        "epirubicin hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "1K860WSG25",
      "id": "Cinacalcet_Hydrochloride",
      "preferredName": "Cinacalcet Hydrochloride",
      "synonyms": [
        "1-Naphthalenemethanamine, a-methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-,(aR)-, Hydrochloride",
        "CINACALCET HYDROCHLORIDE",
        "Cinacalcet Hydrochloride",
        "Mimpara",
        "Sensipar"
      ]
    },
    {
      "fdaUniiCode": "5L84T2Z6NP",
      "id": "Daunorubicin_Citrate",
      "preferredName": "Daunorubicin Citrate",
      "synonyms": [
        "5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)",
        "DAUNORUBICIN CITRATE",
        "Daunorubicin Citrate"
      ]
    },
    {
      "fdaUniiCode": "O0J6XJN02I",
      "id": "Dutasteride",
      "preferredName": "Dutasteride",
      "synonyms": [
        "Avodart",
        "Avolve,(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide",
        "DUTASTERIDE",
        "Dutasteride",
        "GG 745",
        "GG745",
        "alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide",
        "dutasteride"
      ]
    },
    {
      "fdaUniiCode": "29VCO8ACHH",
      "id": "Sodium_Iodide_I-131",
      "preferredName": "Sodium Iodide I-131",
      "synonyms": [
        "(131-I)Sodium Iodide",
        "HICON",
        "I 131 Mini",
        "Iodotope I-131",
        "Natrium Radio-iodatum(131 I)",
        "Oriodide",
        "Radiocaps-131",
        "SODIUM IODIDE I-131",
        "Sodium Iodide (131I)",
        "Sodium Iodide I-131"
      ]
    },
    {
      "fdaUniiCode": "35LT29625A",
      "id": "Estramustine",
      "preferredName": "Estramustine",
      "synonyms": [
        "17beta-(estra-1,3,5(10)-triene-3,17-diol 3-(bis(2-chloroethyl)carbamate))",
        "ESTRAMUSTINE",
        "Estradiol 3-[bis(2-chloroethyl)carbamate]",
        "Estramustine",
        "Leo 275",
        "RO 21-8837",
        "estra-1,3,5(10)triene-317beta-diol 3-[N,N-bis-(2-chloroethyl)carbamate]",
        "estradiol 3-bis(2-chloroethyl)carbamate",
        "estramustine"
      ]
    },
    {
      "fdaUniiCode": "EUL6MP8FZW",
      "id": "Amrubicin_Hydrochloride",
      "preferredName": "Amrubicin Hydrochloride",
      "synonyms": [
        "(+)-(7S,9S)-9-Acetyl-9-amino-7-((2-deoxy-beta-D-erythro-pentopyranosyl)oxy)- 6,11-dihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride",
        "AMRUBICIN HYDROCHLORIDE",
        "Amrubicin Hydrochloride",
        "Calsed",
        "SM-5887",
        "SMP-5887"
      ]
    },
    {
      "fdaUniiCode": "75F375MT2N",
      "id": "Estramustine_Phosphate_Sodium",
      "preferredName": "Estramustine Phosphate Sodium",
      "synonyms": [
        "ESTRAMUSTINE PHOSPHATE SODIUM",
        "Emcyt",
        "Estracyt",
        "Estramustine 17-(Dihydrogenphosphate) Disodium Salt",
        "Estramustine Phosphate",
        "Estramustine Phosphate Sodium",
        "Estramustine Sodium Phosphate",
        "Estramustine phosphate",
        "Estramustine sodium phosphate",
        "Leo 299",
        "Leo-299",
        "Ro-21-8837/001"
      ]
    },
    {
      "fdaUniiCode": "1VXP4V453T",
      "id": "Melphalan_Hydrochloride",
      "preferredName": "Melphalan Hydrochloride",
      "synonyms": [
        "3-(p-(bis(2-chloroethyl)amino)phenyl)-L-Alanine, Hydrochloride",
        "Alkeran",
        "Alkerana",
        "Evomela",
        "MELPHALAN HYDROCHLORIDE",
        "Melphalan Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "KZ1O2SH88Z",
      "id": "Talabostat",
      "preferredName": "Talabostat",
      "synonyms": [
        "BXCL 701",
        "BXCL-701",
        "BXCL701",
        "PT-100",
        "TALABOSTAT",
        "Talabostat",
        "[(2R)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic acid",
        "talabostat"
      ]
    },
    {
      "fdaUniiCode": "F9JLR95I3I",
      "id": "Multikinase_Inhibitor_AEE788",
      "preferredName": "Multikinase Inhibitor AEE788",
      "synonyms": [
        "AEE 788",
        "AEE-788",
        "AEE788",
        "Multikinase Inhibitor AEE788"
      ]
    },
    {
      "fdaUniiCode": "T6Q3060U91",
      "id": "Motesanib_Diphosphate",
      "preferredName": "Motesanib Diphosphate",
      "synonyms": [
        "3-Pyridinecarboxamide, N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-((4-pyridinylmethyl)amino)-, phosphate (1:2)",
        "AMG 706",
        "MOTESANIB DIPHOSPHATE",
        "Motesanib Diphosphate"
      ]
    },
    {
      "fdaUniiCode": "F41401512X",
      "id": "Nilotinib",
      "preferredName": "Nilotinib",
      "synonyms": [
        "4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide",
        "AMN 107 Base Form",
        "NILOTINIB",
        "Nilotinib",
        "nilotinib"
      ]
    },
    {
      "fdaUniiCode": "9KD24QGH76",
      "id": "Saracatinib",
      "preferredName": "Saracatinib",
      "synonyms": [
        "4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-",
        "AZD0530",
        "N-(5-Chloro-1,3-Benzodioxol-4-Yl)-7-(2-(4-Methylpiperazin-1-yl)Ethoxy)-5-((Oxan-4-yl)Oxy)Quinazolin-4-Amine",
        "SARACATINIB",
        "SRC Kinase Inhibitor AZD0530",
        "Saracatinib"
      ]
    },
    {
      "fdaUniiCode": "68AYS9A614",
      "id": "Cediranib_Maleate",
      "preferredName": "Cediranib Maleate",
      "synonyms": [
        "AZD2171",
        "AZD2171 Maleate",
        "CEDIRANIB MALEATE",
        "Cediranib Maleate",
        "Quinazoline, 4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(1-pyrrolidinyl)propoxy)-",
        "Recentin",
        "cediranib maleate"
      ]
    },
    {
      "fdaUniiCode": "7HT68L8941",
      "id": "Bardoxolone",
      "preferredName": "Bardoxolone",
      "synonyms": [
        "2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid",
        "2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oic Acid",
        "BARDOXOLONE",
        "Bardoxolone",
        "CDDO",
        "Oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-",
        "RTA 401"
      ]
    },
    {
      "fdaUniiCode": "SX0XJI3A11",
      "id": "Degarelix",
      "preferredName": "Degarelix",
      "synonyms": [
        "DEGARELIX",
        "Degarelix",
        "FE200486",
        "Firmagon",
        "N-acetyl-3-(naphtalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-4-((((4S)-2,6-dioxohexahydropyrimidin-4-yl)carbonyl)amino)-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-D-alaninamide",
        "degarelix"
      ]
    },
    {
      "fdaUniiCode": "9HW64Q8G6G",
      "id": "Everolimus",
      "preferredName": "Everolimus",
      "synonyms": [
        "(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone",
        "42-O-(2-Hydroxy)ethyl Rapamycin",
        "Afinitor",
        "Certican",
        "EVEROLIMUS",
        "Everolimus",
        "RAD 001",
        "RAD001",
        "Votubia",
        "Zortress",
        "everolimus"
      ]
    },
    {
      "fdaUniiCode": "JED5K35YGL",
      "id": "Iloprost",
      "preferredName": "Iloprost",
      "synonyms": [
        "(E)-(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-((E)-(3S,4RS)-3-hydroxy-4-methyl-1-octen-6-ynyl)-delta(sup 2(1H),delta)-pentalenevaleric Acid",
        "Ciloprost",
        "ILOPROST",
        "Iloprost",
        "Iloprost Clathrate",
        "Pentanoic Acid, 5-(hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octen-6-ynyl)-2(1H)-pentalenylidene)-",
        "Ventavis",
        "ZK 36374",
        "iloprost"
      ]
    },
    {
      "fdaUniiCode": "7686S50JAH",
      "id": "Ingenol_Mebutate",
      "preferredName": "Ingenol Mebutate",
      "synonyms": [
        "2-Butenoic acid, 2-methyl-, (1aR,2S,5R,5aS,6S,8aS,9R,10aR)-1a,2,5,5a,6,9,10,10a- octahydro-5,5a-dihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-11-oxo-1H-2,8a- methanocyclopenta[a]cyclopropa[e]cyclodecen-6-yl ester, (2Z)-",
        "I3A",
        "INGENOL MEBUTATE",
        "Ingenol Mebutate",
        "Ingenol-3-angelate",
        "PEP-005",
        "PEP005"
      ]
    },
    {
      "fdaUniiCode": "B6PMV8U3C4",
      "id": "Iodine_I_131_Omburtamab",
      "preferredName": "Iodine I 131 Omburtamab",
      "synonyms": [
        "Iodine I 131 MOAB 8H9",
        "Iodine I 131 Omburtamab",
        "OMBURTAMAB I-131"
      ]
    },
    {
      "fdaUniiCode": "928Q33Q049",
      "id": "Retaspimycin_Hydrochloride",
      "preferredName": "Retaspimycin Hydrochloride",
      "synonyms": [
        "17-Allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride",
        "Geldanamycin, 18,21-didehydro-17-demethoxy-18,21-dideoxo-18,21-dihydroxy-17-(2-propenylamino)-, monohydrochloride",
        "IPI-504",
        "RETASPIMYCIN HYDROCHLORIDE",
        "Retaspimycin Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "DO989GC5D1",
      "id": "Lestaurtinib",
      "preferredName": "Lestaurtinib",
      "synonyms": [
        "9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-",
        "CEP-701",
        "KT-5555",
        "LESTAURTINIB",
        "Lestaurtinib",
        "SPM-924",
        "lestaurtinib"
      ]
    },
    {
      "fdaUniiCode": "E1IO3ICJ9A",
      "id": "Tandutinib",
      "preferredName": "Tandutinib",
      "synonyms": [
        "1-Piperazinecarboxamide, 4-(6-Methoxy-7-(3-(1-piperidinyl)propoxy)-4-quinazolinyl)-N-(4-(1-methylethoxy)phenyl)-",
        "CT53518",
        "MLN 518",
        "MLN518",
        "TANDUTINIB",
        "Tandutinib",
        "tandutinib"
      ]
    },
    {
      "fdaUniiCode": "P0EP9VFC4R",
      "id": "Lucatumumab",
      "preferredName": "Lucatumumab",
      "synonyms": [
        "Anti-CD40 Monoclonal Antibody CHIR-12.12",
        "CHIR-12.12",
        "HCD-122",
        "LUCATUMUMAB",
        "Lucatumumab",
        "Monoclonal Antibody CHIR-12.12"
      ]
    },
    {
      "fdaUniiCode": "BPD4DGQ314",
      "id": "Veltuzumab",
      "preferredName": "Veltuzumab",
      "synonyms": [
        "Anti-CD20 Monoclonal Antibody hA20",
        "HCD20",
        "IMMU-106",
        "MoAb hA20",
        "Monoclonal Antibody hA20",
        "VELTUZUMAB",
        "Veltuzumab",
        "hA20",
        "veltuzumab"
      ]
    },
    {
      "fdaUniiCode": "B5TAN0L720",
      "id": "Picoplatin",
      "preferredName": "Picoplatin",
      "synonyms": [
        "AMD473",
        "Cis-Amminedichloro (2-Methylpyridine) Platinum (II)",
        "JM473",
        "NX-473",
        "PICOPLATIN",
        "Picoplatin",
        "Platinum, Amminedichloro(2-methylpyridine)-, (SP-4-3)-",
        "ZD0473"
      ]
    },
    {
      "fdaUniiCode": "496K5Z02NW",
      "id": "Volociximab",
      "preferredName": "Volociximab",
      "synonyms": [
        "Anti-alpha5-beta1 Integrin",
        "M200",
        "VOLOCIXIMAB",
        "Volociximab",
        "anti-a5-beta1 Integrin",
        "volociximab"
      ]
    },
    {
      "fdaUniiCode": "TWQ8K8A81Y",
      "id": "Larotaxel",
      "preferredName": "Larotaxel",
      "synonyms": [
        "LAROTAXEL",
        "Larotaxel",
        "RPR 109881A",
        "RPR-109881",
        "Taxoid-109881",
        "XRP9881"
      ]
    },
    {
      "fdaUniiCode": "GJ2416WK6Y",
      "id": "Yttrium_Y-90_Tacatuzumab_Tetraxetan",
      "preferredName": "Yttrium Y-90 Tacatuzumab Tetraxetan",
      "synonyms": [
        "AFP-Cide",
        "Y-90 hAFP-31",
        "YTTRIUM Y-90 TACATUZUMAB TETRAXETAN",
        "Yttrium (90Y) Tacatuzumab Tetraxetan",
        "Yttrium Y 90 DOTA Monoclonal Antibody HuAFP31",
        "Yttrium Y 90 Tacatuzumab Tetraxetan",
        "Yttrium Y-90 Tacatuzumab Tetraxetan",
        "yttrium Y 90 DOTA monoclonal antibody HuAFP31"
      ]
    },
    {
      "fdaUniiCode": "2L271110ED",
      "id": "Yttrium_Y-90_Clivatuzumab_Tetraxetan",
      "preferredName": "Yttrium Y-90 Clivatuzumab Tetraxetan",
      "synonyms": [
        "90Y-hPAM4",
        "IMMU-107",
        "YTTRIUM Y-90 CLIVATUZUMAB TETRAXETAN",
        "Yttrium (90Y) Clivatuzumab Tetraxetan",
        "Yttrium Y 90 Clivatuzumab Tetraxetan",
        "Yttrium Y 90 DOTA Monoclonal Antibody HuPAM4",
        "Yttrium Y-90 Clivatuzumab Tetraxetan",
        "hPAM4-Cide",
        "hPAM4-DOTA",
        "yttrium Y 90 DOTA monoclonal antibody HuPAM4"
      ]
    },
    {
      "fdaUniiCode": "8054MM4902",
      "id": "Zibotentan",
      "preferredName": "Zibotentan",
      "synonyms": [
        "3-Pyridinesulfonamide, N-(3-methoxy-5-methylpyrazinyl)-2-(4-(1,3,4-oxadiazol-2-yl)phenyl)-",
        "N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pridine-3- sulfonamide",
        "ZD-4054",
        "ZD4054",
        "ZIBOTENTAN",
        "Zibotentan"
      ]
    },
    {
      "fdaUniiCode": "423D2T571U",
      "id": "Ethinyl_Estradiol",
      "preferredName": "Ethinyl Estradiol",
      "synonyms": [
        "(17alpha)-19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol",
        "Diogyn E",
        "Diogyn-E",
        "ETHINYL ESTRADIOL",
        "Estinyl",
        "Ethinoral",
        "Ethinyl Estradiol",
        "Ethinylestradiol",
        "Eticylol",
        "Feminone",
        "Inestra",
        "Lynoral",
        "Orestralyn"
      ]
    },
    {
      "fdaUniiCode": "3J78384F61",
      "id": "Lenvatinib_Mesylate",
      "preferredName": "Lenvatinib Mesylate",
      "synonyms": [
        "4-[3-Chloro-4-(N'-cyclopropylureido)phenoxy]7-methoxyquinoline-6-carboxamide Mesylate",
        "6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]- 7-methoxy-, methanesulfonate (1:1)",
        "E7080",
        "LENVATINIB MESYLATE",
        "Lenvatinib Mesylate",
        "Lenvima",
        "Multi-Kinase Inhibitor E7080"
      ]
    },
    {
      "fdaUniiCode": "M487QF2F4V",
      "id": "Amifostine",
      "preferredName": "Amifostine",
      "synonyms": [
        "2-[(3-Aminopropyl)amino]ethanethiol Dihydrogen Phosphate Ester Trihydrate",
        "AMIFOSTINE",
        "APAETP",
        "Amifostine",
        "Amifostine Trihydrate",
        "Aminopropylaminoethylthiophosphoric Acid Trihydrate",
        "Cytofos",
        "Ethiofos",
        "Ethyol",
        "Gammaphos",
        "S-(N-(3-Aminopropyl)-2-aminoethyl)thiophosphoric Acid Trihydrate",
        "S-2-(3-Aminopropylamino)ethylphosphorothioic Acid Trihydrate",
        "WR 2721",
        "WR-2721",
        "WR2721",
        "YM-08310"
      ]
    },
    {
      "fdaUniiCode": "F4H96P17NZ",
      "id": "Belinostat",
      "preferredName": "Belinostat",
      "synonyms": [
        "BELINOSTAT",
        "Beleodaq",
        "Belinostat",
        "PXD 101",
        "PXD101",
        "belinostat"
      ]
    },
    {
      "fdaUniiCode": "3HX21A3SQF",
      "id": "Ropidoxuridine",
      "preferredName": "Ropidoxuridine",
      "synonyms": [
        "2(1H)-Pyrimidinone, 1-(2-deoxy-beta-D-erythro-pentofuranosyl)-5-iodo-",
        "5-Iodo-2-pyrimidinone 2' deoxyribonucleoside",
        "5-Iodo-2-pyrimidinone-2'-deoxyribose",
        "IPdR",
        "ROPIDOXURIDINE",
        "Ropidoxuridine"
      ]
    },
    {
      "fdaUniiCode": "4F9KUA0T4D",
      "id": "Etoglucid",
      "preferredName": "Etoglucid",
      "synonyms": [
        "1,2-Bis[2-(2, 3-epoxypropoxy)ethoxy]ethane",
        "1,2-bis[2-(2,3-epoxypropoxy)ethoxy]ethane",
        "1,2:15,16-Diepoxy-4,7,10, 13-tetraoxahexadecane",
        "1,2:15,16-diepoxy-4,7,10,13-tetraoxahexadecane",
        "2,2'-(2,5,8,11-tetraoxadodecane-1,12-diyl)bisoxirane",
        "ETOGLUCID",
        "Epodyl",
        "Ethane, 1, 2-bis[2-(2,3-epoxypropoxy)ethoxy]-",
        "Ethoglucid",
        "Etoglucid",
        "ICI 32865",
        "ICI-32865",
        "Triethylene Glycol Diglycidyl Ether",
        "Triethylene glycol diglycidyl ether"
      ]
    },
    {
      "fdaUniiCode": "48Z35KB15K",
      "id": "Ridaforolimus",
      "preferredName": "Ridaforolimus",
      "synonyms": [
        "AP23573",
        "Deforolimus",
        "MK-8669",
        "RIDAFOROLIMUS",
        "Rapamycin, 42-(dimethylphosphinate)",
        "Ridaforolimus",
        "ridaforolimus"
      ]
    },
    {
      "fdaUniiCode": "F60NE4XB53",
      "id": "Imetelstat",
      "preferredName": "Imetelstat",
      "synonyms": [
        "DNA, d(3'-amino-3'-deoxy-P-thio)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-[O-[2-hydroxy-3- [(1-oxohexadecyl)amino]propyl] hydrogen phosphorothioate]",
        "GRN 163L",
        "IMETELSTAT",
        "Imetelstat"
      ]
    },
    {
      "fdaUniiCode": "QEN1X95CIX",
      "id": "Tremelimumab",
      "preferredName": "Tremelimumab",
      "synonyms": [
        "Anti-CTLA4 Human Monoclonal Antibody CP-675,206",
        "CP-675",
        "CP-675,206",
        "CP-675206",
        "Immunoglobulin G2, Anti-(Human CTLA-4 (Antigen)) (Human Monoclonal CP-675206 Clone 11.2.1 Heavy Chain) Disulfide with Human Monoclonal CP-675206 Clone 11.2.1 Light Chain, Dimer",
        "TREMELIMUMAB",
        "Ticilimumab",
        "Tremelimumab",
        "ticilimumab"
      ]
    },
    {
      "fdaUniiCode": "Q16CT95N25",
      "id": "Bavituximab",
      "preferredName": "Bavituximab",
      "synonyms": [
        "BAVITUXIMAB",
        "Bavituximab",
        "Chimeric Anti-Phosphotidylserine Monoclonal Antibody",
        "Tarvacin"
      ]
    },
    {
      "fdaUniiCode": "JJH94R3PWB",
      "id": "Neratinib",
      "preferredName": "Neratinib",
      "synonyms": [
        "(2E)-N-(4-((3-chloro-4-((pyridin-2-yl)methoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide",
        "2-Butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-",
        "HKI 272",
        "HKI-272",
        "NERATINIB",
        "Neratinib",
        "PB 272",
        "PB-272"
      ]
    },
    {
      "fdaUniiCode": "NOE38VQA1W",
      "id": "JNK_Inhibitor_CC-401",
      "preferredName": "JNK Inhibitor CC-401",
      "synonyms": [
        "CC-401",
        "JNK Inhibitor CC-401"
      ]
    },
    {
      "fdaUniiCode": "6PLQ3CP4P3",
      "id": "Etoposide",
      "preferredName": "Etoposide",
      "synonyms": [
        "4'-Demethylepipodophyllotoxin 9-[4,6-O-ethylidene-beta-D-glucopyranoside]",
        "9-[(4,6-O-Ethylidene-beta-D-glucopyranosyl]oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one",
        "Demethyl Epipodophyllotoxin Ethylidine Glucoside",
        "EPEG",
        "ETOPOSIDE",
        "Etoposide",
        "Lastet",
        "Toposar",
        "VP 16",
        "VP 16-213",
        "VP-16",
        "VP-16-213",
        "VP16",
        "Vepesid",
        "etoposide"
      ]
    },
    {
      "fdaUniiCode": "8HIJ5G3O02",
      "id": "MK0731",
      "preferredName": "MK0731",
      "synonyms": [
        "MK-0731",
        "MK0731"
      ]
    },
    {
      "fdaUniiCode": "9JD9B4S53T",
      "id": "Notch_Signaling_Pathway_Inhibitor_MK0752",
      "preferredName": "Notch Signaling Pathway Inhibitor MK0752",
      "synonyms": [
        "MK-0752",
        "MK0752",
        "Notch Signaling Pathway Inhibitor MK0752"
      ]
    },
    {
      "fdaUniiCode": "G9ZF61LE7G",
      "id": "Palbociclib",
      "preferredName": "Palbociclib",
      "synonyms": [
        "6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-8h-pyrido(2,3-d)pyrimidin-7-one",
        "Ibrance",
        "PALBOCICLIB",
        "PD 0332991",
        "PD 332991",
        "PD 991",
        "PD-0332991",
        "Palbociclib",
        "Pyrido(2,3-d)pyrimidin-7(8H)-one, 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(1-piperazinyl)-2-pyridinyl)amino)-"
      ]
    },
    {
      "fdaUniiCode": "I3NPL1V48Q",
      "id": "Inosine_Monophosphate_Dehydrogenase_Inhibitor_AVN944",
      "preferredName": "Inosine Monophosphate Dehydrogenase Inhibitor AVN944",
      "synonyms": [
        "AVN-944",
        "AVN944",
        "Inosine Monophosphate Dehydrogenase Inhibitor AVN944"
      ]
    },
    {
      "fdaUniiCode": "V9GU1EM8SF",
      "id": "Recombinant_Interferon_Beta",
      "preferredName": "Recombinant Interferon Beta",
      "synonyms": [
        "Beta Interferon",
        "Betantrone",
        "Feron",
        "HUMAN INTERFERON BETA",
        "Human Interferon Beta",
        "Interferon Beta",
        "Interferon, Beta",
        "Interferon-B",
        "Interferon-beta",
        "Naferon",
        "Recombinant Interferon Beta"
      ]
    },
    {
      "fdaUniiCode": "039LU44I5M",
      "id": "Floxuridine",
      "preferredName": "Floxuridine",
      "synonyms": [
        "1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil",
        "2'-Deoxy-5-fluorouridine",
        "2-Deoxy-5-fluorouridine",
        "5-FUDR",
        "5-FUdR",
        "5-Fluoro-2'-deoxy-beta-uridine",
        "5-Fluoro-2'-deoxyuridine",
        "5-Fluorodeoxyuridine",
        "5-Fluorouracil Deoxyriboside",
        "5-Fluorouracil deoxyriboside",
        "5-Fluorouridine Deoxyribose",
        "FDUR",
        "FLOXURIDINE",
        "FUDR",
        "FUdR",
        "Floxuridin",
        "Floxuridine",
        "Fluorodeoxyuridine",
        "Fluorouridine Deoxyribose",
        "Fluoruridine Deoxyribose",
        "Fluoruridine deoxyribose",
        "WR-138720",
        "floxuridine"
      ]
    },
    {
      "fdaUniiCode": "U3P01618RT",
      "id": "Fluorouracil",
      "preferredName": "Fluorouracil",
      "synonyms": [
        "2,4-Dioxo-5-fluoropyrimidine",
        "5 FU",
        "5 Fluorouracil",
        "5 Fluorouracilum",
        "5-FU",
        "5-Fluoro-2,4(1H, 3H)-pyrimidinedione",
        "5-Fluoro-2,4(1H,3H)-pyrimidinedione",
        "5-Fluorouracil",
        "5-Fluracil",
        "5-Fu",
        "5-fluorouracil",
        "5FU",
        "AccuSite",
        "Adrucil",
        "Carac",
        "FLUOROURACIL",
        "Fluoro Uracil",
        "Fluorouracil",
        "Fluouracil",
        "Flurablastin",
        "Fluracedyl",
        "Fluracil",
        "Fluril",
        "Fluroblastin",
        "Ribofluor",
        "Ro 2-9757",
        "Ro-2-9757",
        "fluorouracil"
      ]
    },
    {
      "fdaUniiCode": "9JU12S4YFY",
      "id": "Fluoxymesterone",
      "preferredName": "Fluoxymesterone",
      "synonyms": [
        "(11Beta,17beta)-9-fluoro-11,17-dihydroxy-17-methylandrost-4-en-3-one",
        "11Beta,17beta-dihydroxy-9alpha-fluoro-17alpha-methyl-4-androsten-3-one",
        "9Alpha-fluoro-11beta-hydroxy-17alpha-methyltestosterone",
        "Androfluorene",
        "Android-F",
        "Androsterolo",
        "Androxy",
        "FLUOXYMESTERONE",
        "FXM",
        "Fluoxymesterone",
        "Halodrin",
        "Halotestin",
        "Ora Testryl",
        "Ora-Testryl",
        "Ora-testryl",
        "Oratestin",
        "Stenox",
        "Testoral",
        "Ultandren"
      ]
    },
    {
      "fdaUniiCode": "76W6J0943E",
      "id": "Flutamide",
      "preferredName": "Flutamide",
      "synonyms": [
        "2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide",
        "4'-Nitro-3'-trifluoromethylisobutyranilide",
        "Alpha,alpha,alpha-trifluoro-2-methy-4'-nitro-m-propionotoluidide",
        "Apimid",
        "Cebatrol",
        "Chimax",
        "Cytomid",
        "Drogenil",
        "Euflex",
        "Eulexin",
        "Eulexine",
        "FLUT",
        "FLUTAMIDE",
        "Flucinom",
        "Flucinome",
        "Flugerel",
        "Fluken",
        "Flulem",
        "Fluta-Gry",
        "Flutabene",
        "Flutacan",
        "Flutamex",
        "Flutamide",
        "Flutamin",
        "Flutan",
        "Flutaplex",
        "Fugerel",
        "Grisetin",
        "Niftolide",
        "Oncosal",
        "Profamid",
        "Propanamide, 2-Methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-",
        "Prostacur",
        "Prostadirex",
        "Prostica",
        "Prostogenat",
        "SCH 13521",
        "Sch 13521",
        "Tafenil",
        "Tecnoflut",
        "Testotard",
        "flutamide"
      ]
    },
    {
      "fdaUniiCode": "1548R74NSZ",
      "id": "Tegafur",
      "preferredName": "Tegafur",
      "synonyms": [
        "5-Fluoro-1-(tetrahydro-2-furanyl)-2,4(1H,3H)-pyrimidinedione",
        "5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-(1H,3H)-pyrimidinedione",
        "5-Fluoro-1-(tetrahydro-2-furyl)-uracil",
        "Citofur",
        "Coparogin",
        "Exonal",
        "FT",
        "FT-207",
        "Fental",
        "Florafur",
        "Fluorofur",
        "Ftorafur",
        "Ftoral",
        "Ftoralon",
        "Fulaid",
        "Fulfeel",
        "Furafluor",
        "Furofutran",
        "Futraful",
        "Lamar",
        "Lifril",
        "MJF-12264",
        "N1-(2'-Furanidyl)-5-fluorouracil",
        "Neberk",
        "Nitobanil",
        "Riol",
        "Sinoflurol",
        "Sunfural",
        "TEGAFUR",
        "Tefsiel",
        "Tegafur",
        "Uracil, 5-fluoro-1-(tetrahydro-2-furyl)-",
        "Utefos",
        "WR-220066",
        "tegafur"
      ]
    },
    {
      "fdaUniiCode": "926F8X7TNO",
      "id": "CDK124_Inhibitor_AG-024322",
      "preferredName": "CDK1/2/4 Inhibitor AG-024322",
      "synonyms": [
        "AG-024322",
        "AG-24322",
        "CDK1/2/4 Inhibitor AG-024322"
      ]
    },
    {
      "fdaUniiCode": "MG7D3QD743",
      "id": "Atiprimod",
      "preferredName": "Atiprimod",
      "synonyms": [
        "ATIPRIMOD",
        "Atiprimod",
        "Azaspirane SK&F106615",
        "N,N-Diethyl-8,8-dipropyl-2-azaspiro(4.5)decane-2-propanamine",
        "SK&F106615",
        "atiprimod",
        "azaspirane"
      ]
    },
    {
      "fdaUniiCode": "XW0H5LE42K",
      "id": "Alpha_V_Beta_1_Inhibitor_ATN-161",
      "preferredName": "Alpha V Beta 1 Inhibitor ATN-161",
      "synonyms": [
        "ATN-161",
        "Alpha V Beta 1 Inhibitor ATN-161"
      ]
    },
    {
      "fdaUniiCode": "VE267FC2UB",
      "id": "Figitumumab",
      "preferredName": "Figitumumab",
      "synonyms": [
        "CP-751,871",
        "CP-751871",
        "FIGITUMUMAB",
        "Figitumumab"
      ]
    },
    {
      "fdaUniiCode": "WRX4NFY03R",
      "id": "Etoricoxib",
      "preferredName": "Etoricoxib",
      "synonyms": [
        "5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl) Pyridine",
        "Arcoxia",
        "ETORICOXIB",
        "Etoricoxib",
        "L-791456",
        "MK-0663"
      ]
    },
    {
      "fdaUniiCode": "27Y876D139",
      "id": "Menatetrenone",
      "preferredName": "Menatetrenone",
      "synonyms": [
        "2-Methyl-3-trans-tetraprenyl-1,4-naphthoquinone",
        "E0167",
        "MENATETRENONE",
        "Menaquinone K4",
        "Menaquinone-4",
        "Menatetrenone",
        "Vitamin MK 4"
      ]
    },
    {
      "fdaUniiCode": "86K0J5AK6M",
      "id": "Mirdametinib",
      "preferredName": "Mirdametinib",
      "synonyms": [
        "MEK Inhibitor PD0325901",
        "MIRDAMETINIB",
        "Mirdametinib",
        "PD 901",
        "PD-0325901"
      ]
    },
    {
      "fdaUniiCode": "72X6E3J5AR",
      "id": "Carfilzomib",
      "preferredName": "Carfilzomib",
      "synonyms": [
        "(2S)-N-((1S)-1-Benzyl-2-(((1S)-3-methyl-1-(((2R)-2-methyloxiran-2-yl)carbonyl)butyl)amino)-2-oxoethyl)-4-methyl-2-(((2S)-2-((morpholin-4-ylacetyl)amino)-4-phenylbutanoyl)amino)pentanamide",
        "CARFILZOMIB",
        "Carfilzomib",
        "Kyprolis",
        "PR-171"
      ]
    },
    {
      "fdaUniiCode": "24DSZ1VN92",
      "id": "KSP_Inhibitor_SB-743921",
      "preferredName": "KSP Inhibitor SB-743921",
      "synonyms": [
        "KSP Inhibitor SB-743921",
        "SB 743921",
        "SB-743921"
      ]
    },
    {
      "fdaUniiCode": "1C39JW444G",
      "id": "Cabozantinib",
      "preferredName": "Cabozantinib",
      "synonyms": [
        "1,1-Cyclopropanedicarboxamide, N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- fluorophenyl)-",
        "CABOZANTINIB",
        "Cabozantinib",
        "N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1- dicarboxamide"
      ]
    },
    {
      "fdaUniiCode": "KAV15B369O",
      "id": "Gossypol",
      "preferredName": "Gossypol",
      "synonyms": [
        "(+/-)-Gossypol",
        "(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6'7, 7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-",
        "1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)[2,2'-binaphthalene]-8,8'-dicarboxaldehyde",
        "1,1',6,6',7,7'-Hexahydroxy-5,5'-diisopropyl-3-3'-dimethyl[2,2'-binaphthalene]-8,8'-dicarboxaldehyde",
        "2,2'-bis(1,6,7-trihydroxy-4-methyl-5-isopropyl-8-aldehydonaphthalene)",
        "2,2'-bis[8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene]",
        "BL-193",
        "Cottonseed Meal Toxin",
        "GOSSYPOL",
        "Gossypol",
        "No Fertil",
        "Pogosin",
        "Tash 1",
        "cottonseed meal toxin",
        "gossypol"
      ]
    },
    {
      "fdaUniiCode": "ZDR4QSJ43F",
      "id": "Cytokine-based_Biologic_Agent_IRX-2",
      "preferredName": "Cytokine-based Biologic Agent IRX-2",
      "synonyms": [
        "Cytokine-based Biologic Agent IRX-2",
        "IRX-2"
      ]
    },
    {
      "fdaUniiCode": "U2Y5OFN795",
      "id": "Brivanib_Alaninate",
      "preferredName": "Brivanib Alaninate",
      "synonyms": [
        "BMS 582664",
        "BMS-582664",
        "BRIVANIB ALANINATE",
        "Brivanib Alaninate",
        "brivanib alaninate"
      ]
    },
    {
      "fdaUniiCode": "5092U85G58",
      "id": "Dacomitinib",
      "preferredName": "Dacomitinib",
      "synonyms": [
        "(2E)-N-(4-((3-Chloro-4-Fluorophenyl)Amino)-7-Methoxyquinazolin-6-yl)-4-Piperidin-1-ylbut-2-Enamide",
        "DACOMITINIB",
        "Dacomitinib",
        "EGFR Inhibitor PF-00299804",
        "PF-00299804",
        "PF-00299804-03",
        "PF-299804",
        "Vizimpro"
      ]
    },
    {
      "fdaUniiCode": "B058ME29VU",
      "id": "ADH-1",
      "preferredName": "ADH-1",
      "synonyms": [
        "ADH-1",
        "Exherin"
      ]
    },
    {
      "fdaUniiCode": "TA7WJG93AR",
      "id": "Elacytarabine",
      "preferredName": "Elacytarabine",
      "synonyms": [
        "4-amino-1-[5-O-[(9E)-octadec-9-enoyl]-beta-D-arabinofuranosyl]pyrimidin-2(1H)-one",
        "CP-4055",
        "ELACYTARABINE",
        "Elacyt",
        "Elacytarabine"
      ]
    },
    {
      "fdaUniiCode": "G7407IV2FS",
      "id": "Recombinant_Interferon_Alfa-1b",
      "preferredName": "Recombinant Interferon Alfa-1b",
      "synonyms": [
        "IFN-alfa-1b",
        "INTERFERON ALFA-1B",
        "Interferon Alfa-1b",
        "Recombinant Interferon Alfa-1b",
        "Recombinant Interferon Alpha-1b"
      ]
    },
    {
      "fdaUniiCode": "SSZ9HQT61Z",
      "id": "Diindolylmethane",
      "preferredName": "Diindolylmethane",
      "synonyms": [
        "3,3'-DIINDOLYLMETHANE",
        "3,3'-Diindolymethane",
        "3,3'-Methylenebis-1H-indole",
        "CCRIS 5806",
        "DIM",
        "DIM-Plus",
        "DIMPRO",
        "Di-Indoly Methane",
        "Diindolylmethane",
        "diindolylmethane"
      ]
    },
    {
      "fdaUniiCode": "Q8BIH59O7H",
      "id": "Altretamine",
      "preferredName": "Altretamine",
      "synonyms": [
        "2,4,6-Tris(dimethylamino)-s-triazine",
        "2,4,6-tris(dimethylamino)-s-triazine",
        "ALTRETAMINE",
        "Altretamine",
        "ENT 50852",
        "ENT-50852",
        "HMM",
        "HXM",
        "Hemel",
        "Hexalen",
        "Hexaloids",
        "Hexamethylamine",
        "Hexamethylmelamine",
        "Hexastat",
        "Hexinawas",
        "N,N,N',N',N\",N\"-hexamethyl-1,3,5-triazine-2,4,6-triamine",
        "N,n,n',N\"N\"-hexamethyl-1,3,5,-triazine-2,4,6,-triamine",
        "RB-1515",
        "WR-95704",
        "altretamine",
        "s-Triazine, 2,4,6-tris(dimethylamino)-"
      ]
    },
    {
      "fdaUniiCode": "LHQ7J5KV9B",
      "id": "Pibenzimol",
      "preferredName": "Pibenzimol",
      "synonyms": [
        "Bisbenzimidazole",
        "HOE 33258",
        "Hoe 33258",
        "Hoechst 33258",
        "Hoechst Dye 33258",
        "Hoechst dye 33258",
        "PIBENZIMOL",
        "Phenol, 4-(5-(4-methyl-1-piperazinyl)(2,5'-bi-1H-benzimidazol)-2'-yl)-, Trihydrochloride",
        "Phenol, p-[5-[5-(4-methyl-1-piperazinyl)-2-benzimidazolyl]-2- benzimidazolyl]-, Trihydrochloride",
        "Pibenzimol",
        "Pibenzimol Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "2BXX5EVN2A",
      "id": "Hycanthone",
      "preferredName": "Hycanthone",
      "synonyms": [
        "Etrenol",
        "HYC",
        "HYCANTHONE",
        "Hycanthone",
        "Hycanthone Mesylate",
        "Hycanthone mesylate"
      ]
    },
    {
      "fdaUniiCode": "FD171B778Y",
      "id": "Hydralazine_Hydrochloride",
      "preferredName": "Hydralazine Hydrochloride",
      "synonyms": [
        "Apresoline",
        "Apressin",
        "HYDRALAZINE HYDROCHLORIDE",
        "Hydralazine Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "4QWG6N8QKH",
      "id": "Hydroxychloroquine",
      "preferredName": "Hydroxychloroquine",
      "synonyms": [
        "HYDROXYCHLOROQUINE",
        "Hydroxychloroquine",
        "hydroxychloroquine"
      ]
    },
    {
      "fdaUniiCode": "X6Q56QN5QC",
      "id": "Hydroxyurea",
      "preferredName": "Hydroxyurea",
      "synonyms": [
        "Droxia",
        "HYDROXYUREA",
        "Hydrea",
        "Hydroxycarbamide",
        "Hydroxyurea",
        "Litalir",
        "Onco-Carbide",
        "Onco-carbide",
        "Oncocarbide",
        "Oxeron",
        "SQ 1089",
        "SQ-1089",
        "Syrea",
        "WR 83799",
        "hydroxyurea"
      ]
    },
    {
      "fdaUniiCode": "ZRP63D75JW",
      "id": "Idarubicin",
      "preferredName": "Idarubicin",
      "synonyms": [
        "(1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-trideoxy-alpha-L-hexopyranoside",
        "(7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione",
        "4-DMDR",
        "4-Demethoxydaunomycin",
        "4-Demethoxydaunorubicin",
        "4-demethoxydaunorubicin",
        "IDARUBICIN",
        "Idarubicin",
        "idarubicin"
      ]
    },
    {
      "fdaUniiCode": "UM20QQM95Y",
      "id": "Ifosfamide",
      "preferredName": "Ifosfamide",
      "synonyms": [
        "2-oxo-N,3-bis-(2-chloroethyl) tetrahydro-2H-1,3,2-oxazaphosphorin- 2-amine",
        "3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorin-2-oxide",
        "Asta Z 4942",
        "Asta Z-4942",
        "Cyfos",
        "Holoxan",
        "Holoxane",
        "IFO",
        "IFO-Cell",
        "IFOSFAMIDE",
        "IFX",
        "Ifex",
        "Ifolem",
        "Ifomida",
        "Ifomide",
        "Ifosfamide",
        "Ifosfamidum",
        "Ifoxan",
        "Iphosphamid",
        "Iphosphamide",
        "Iso-Endoxan",
        "Isoendoxan",
        "Isophosphamide",
        "MJF 9325",
        "MJF-9325",
        "Mitoxana",
        "N,3-bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide",
        "Naxamide",
        "Seromida",
        "Tronoxal",
        "Z 4942",
        "Z-4942",
        "ifosfamide"
      ]
    },
    {
      "fdaUniiCode": "XXE1CET956",
      "id": "Indomethacin",
      "preferredName": "Indomethacin",
      "synonyms": [
        "1-(4-chlorobenzoyl)-5-methoxy- 2-methyl-1-H-indole-3-acetic acid",
        "INDOMETHACIN",
        "Indocin",
        "Indometacin",
        "Indomethacin",
        "indomethacin"
      ]
    },
    {
      "fdaUniiCode": "P050J5FWC5",
      "id": "Recombinant_Interferon_Gamma",
      "preferredName": "Recombinant Interferon Gamma",
      "synonyms": [
        "Gamma Interferon (GEN)",
        "Gamma Interferon-SCH",
        "Gamma-Interferon",
        "Ginterferon",
        "IFN-g",
        "INTERFERON-.GAMMA.",
        "Interferon Gamma",
        "Interferon Gamma (BIO)",
        "Interferon, Gamma",
        "Recombinant Interferon Gamma"
      ]
    },
    {
      "fdaUniiCode": "751635Z921",
      "id": "Binetrakin",
      "preferredName": "Binetrakin",
      "synonyms": [
        "B Cell Proliferating Factor",
        "B-Cell Growth Factor",
        "B-Cell Stimulating Factor",
        "B-Cell Stimulatory Factor 1",
        "BCGF",
        "BCSF 1",
        "BINETRAKIN",
        "Binetrakin",
        "IL-4",
        "Interleukin 4 (Human) 129",
        "Interleukin-4",
        "MCGF 2",
        "Mast Cell Growth Factor-2",
        "RHIL-4",
        "Recombinant Human IL-4",
        "SCH 93400",
        "T-Cell Growth Factor 2"
      ]
    },
    {
      "fdaUniiCode": "4O4QWG0B3C",
      "id": "Recombinant_Interleukin-6",
      "preferredName": "Recombinant Interleukin-6",
      "synonyms": [
        "B Cell Differentiation Factor 2",
        "B-Cell Stimulatory Factor-2",
        "HPGF",
        "HSF",
        "HUMAN INTERLEUKIN-6",
        "Hepatocyte Stimulating Factor",
        "Hybridoma Growth Factor",
        "IFN Beta 2",
        "IL-6",
        "Interleukin-6",
        "Myeloid Differentiation Inducing Protein",
        "Plasmacytoma Growth Factor",
        "Recombinant Interleukin-6",
        "Sigosix"
      ]
    },
    {
      "fdaUniiCode": "54V905V6AT",
      "id": "Ionomycin",
      "preferredName": "Ionomycin",
      "synonyms": [
        "IONOMYCIN",
        "Ionomycin",
        "ionomycin"
      ]
    },
    {
      "fdaUniiCode": "EH28UP18IF",
      "id": "Isotretinoin",
      "preferredName": "Isotretinoin",
      "synonyms": [
        "13-cRA",
        "13-cis retinoic acid",
        "13-cis-Retinoate",
        "13-cis-Retinoic Acid",
        "13-cis-Vitamin A Acid",
        "3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic Acid",
        "Absorica",
        "Accure",
        "Accutane",
        "Amnesteem",
        "Cistane",
        "Claravis",
        "ISOTRETINOIN",
        "Isotretinoin",
        "Isotretinoinum",
        "Isotrex",
        "Isotrexin",
        "Myorisan",
        "Neovitamin A",
        "Neovitamin A Acid",
        "Oratane",
        "Retinoicacid-13-cis",
        "Ro 4-3780",
        "Ro-4-3780",
        "Roaccutan",
        "Roaccutane",
        "Roacutan",
        "Sotret",
        "ZENATANE",
        "cis-Retinoic Acid",
        "isotretinoin"
      ]
    },
    {
      "fdaUniiCode": "R9400W927I",
      "id": "Ketoconazole",
      "preferredName": "Ketoconazole",
      "synonyms": [
        "Cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazole-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine",
        "Fungarest",
        "Fungoral",
        "KETOCONAZOLE",
        "Ketoconazole",
        "Ketoderm",
        "Ketoisdin",
        "Nizoral",
        "Orifungal M",
        "Panfungol",
        "R-41400",
        "Xolegel",
        "ketoconazole"
      ]
    },
    {
      "fdaUniiCode": "RPR1R4C0P4",
      "id": "Leucovorin_Calcium",
      "preferredName": "Leucovorin Calcium",
      "synonyms": [
        "5-Formyl Tetrahydrofolate",
        "5-Formyl-5,6,7,8-tetrahydrofolic Acid",
        "5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic Acid",
        "Adinepar",
        "Calcifolin",
        "Calcium (6S)-Folinate",
        "Calcium Folinate",
        "Calcium Leucovorin",
        "Calcium N-(p-((((6RS)-2-amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamate (1:1)",
        "Calfolex",
        "Calinat",
        "Cehafolin",
        "Citofolin",
        "Citrec",
        "Citrovorum Factor",
        "Cromatonbic Folinico",
        "Dalisol",
        "Disintox",
        "Divical",
        "Ecofol",
        "Emovis",
        "FOLI-cell",
        "Factor, Citrovorum",
        "Flynoken A",
        "Folaren",
        "Folaxin",
        "Foliben",
        "Folidan",
        "Folidar",
        "Folinac",
        "Folinate Calcium",
        "Folinic Acid Calcium Salt Pentahydrate",
        "Folinoral",
        "Folinvit",
        "Foliplus",
        "Folix",
        "Imo",
        "LEUCOVORIN CALCIUM",
        "Lederfolat",
        "Lederfolin",
        "Leucosar",
        "Leucovorin Calcium",
        "N-[4-[[(2-Amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl]amnio]benzoyl]-L-glutamic Acid, Calcium Salt (1:1)",
        "N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]glutamic Acid",
        "Rescufolin",
        "Rescuvolin",
        "Tonofolin",
        "Wellcovorin",
        "citrovorum factor",
        "folinic acid",
        "leucovorin",
        "leucovorin calcium"
      ]
    },
    {
      "fdaUniiCode": "01O4K0631N",
      "id": "Veliparib",
      "preferredName": "Veliparib",
      "synonyms": [
        "2-((R)-2-Methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide",
        "ABT-888",
        "PARP-1 inhibitor ABT-888",
        "VELIPARIB",
        "Veliparib",
        "veliparib"
      ]
    },
    {
      "fdaUniiCode": "0E0K1H745W",
      "id": "Hedgehog_Inhibitor_IPI-609",
      "preferredName": "Hedgehog Inhibitor IPI-609",
      "synonyms": [
        "Hedgehog Inhibitor IPI-609",
        "IPI 269609",
        "IPI 609",
        "IPI-269609",
        "IPI-609",
        "IPI269609",
        "IPI609"
      ]
    },
    {
      "fdaUniiCode": "S9J80L3D1U",
      "id": "Pelareorep",
      "preferredName": "Pelareorep",
      "synonyms": [
        "PELAREOREP",
        "PO BB0209",
        "PO-BB0209",
        "Pelareorep",
        "Reolysin",
        "Reovirus Serotype 3",
        "Wild-type Reovirus"
      ]
    },
    {
      "fdaUniiCode": "33Y9ANM545",
      "id": "Pazopanib_Hydrochloride",
      "preferredName": "Pazopanib Hydrochloride",
      "synonyms": [
        "5-((4-((2,3-Dimethyl-2h-Indazol-6-Yl)Methylamino)Pyrimidin-2-yl)Amino)-2-Methylbenzenesulfonamide Monohydrochloride",
        "GW786034B",
        "PAZOPANIB HYDROCHLORIDE",
        "Pazopanib Hydrochloride",
        "Votrient",
        "pazopanib hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "5018V4AEZ0",
      "id": "Bosutinib",
      "preferredName": "Bosutinib",
      "synonyms": [
        "4-Anilino-3-quinolinecarbonitrile",
        "4-Anilinobenzo(g)quinoline-3-carbonitrile",
        "4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile",
        "BOSUTINIB",
        "Bosulif",
        "Bosutinib",
        "SKI 606",
        "SKI-606"
      ]
    },
    {
      "fdaUniiCode": "3S182ET3UA",
      "id": "Tinzaparin_Sodium",
      "preferredName": "Tinzaparin Sodium",
      "synonyms": [
        "Enzyme Depolymerized Heparin (MW 6500)",
        "Inno-hep",
        "Innohep",
        "LNH-1",
        "Logiparin",
        "TINZAPARIN SODIUM",
        "Tinzaparin",
        "Tinzaparin Sodium",
        "Tinzaparin Sodium Injection",
        "tinzaparin sodium"
      ]
    },
    {
      "fdaUniiCode": "GQE1BJE2NI",
      "id": "Intetumumab",
      "preferredName": "Intetumumab",
      "synonyms": [
        "CNTO 095",
        "CNTO-95",
        "Human Anti-Alpha-5 Integrin Monoclonal Antibody",
        "Human Monoclonal CNTO 95 gamma1 heavy chain (222-215')-disulfide with Human Monoclonal CNTO 95 kappa light chain dimer (228-228'':231-231'')-bisdisulfide",
        "INTETUMUMAB",
        "Immunoglobulin G1, anti-(human integrin alpha-V (vitronectin receptor subunit alpha or CD51))",
        "Intetumumab"
      ]
    },
    {
      "fdaUniiCode": "KY72JU32FO",
      "id": "Sagopilone",
      "preferredName": "Sagopilone",
      "synonyms": [
        "(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,12,16-tetramethyl-3-(2-methyl-1,3-benzothiazol-5-yl)-10-(prop-2-enyl)-4,17-dioxabicyclo(14.1.0)heptadecane-5,9-dione",
        "DE-03757",
        "Epothilone ZK219477",
        "SAGOPILONE",
        "SH-Y03757A",
        "Sagopilone",
        "ZK-219477",
        "ZK-EPO",
        "ZK-Epothilone",
        "epothilone ZK219477"
      ]
    },
    {
      "fdaUniiCode": "13H90KC831",
      "id": "Viagenpumatucel-L",
      "preferredName": "Viagenpumatucel-L",
      "synonyms": [
        "Gp96-Ig Fusion Protein-Expressing Non-Small Cell Lung Cancer Cell Vaccine",
        "HS-110",
        "HS110",
        "VIAGENPUMATUCEL-L",
        "Viagenpumatucel-L"
      ]
    },
    {
      "fdaUniiCode": "BX854EHD63",
      "id": "Aurora_Kinase_Inhibitor_MLN8054",
      "preferredName": "Aurora Kinase Inhibitor MLN8054",
      "synonyms": [
        "Aurora Kinase Inhibitor MLN8054",
        "Benzoic Acid, 4-((9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)-",
        "MLN 8054",
        "MLN-8054",
        "MLN8054"
      ]
    },
    {
      "fdaUniiCode": "25DT549L0G",
      "id": "ISS_1018_CpG_Oligodeoxynucleotide",
      "preferredName": "ISS 1018 CpG Oligodeoxynucleotide",
      "synonyms": [
        "1018 ISS",
        "CPG 1018",
        "DNA, D(P-THIO)(T-G-A-C-T-G-T-G-A-A-C-G-T-T-C-G-A-G-A-T-G-A)",
        "ISS 1018 CpG Oligodeoxynucleotide"
      ]
    },
    {
      "fdaUniiCode": "I6HAD3HP89",
      "id": "Algenpantucel-L",
      "preferredName": "Algenpantucel-L",
      "synonyms": [
        "ALGENPANTUCEL-L",
        "Algenpantucel-L",
        "Alpha (1,3) Galactosyltransferase Tumor Vaccine",
        "Alpha-1,3-Galactosyltransferase-expressing Allogeneic Pancreatic Tumor Cell Vaccine",
        "HAPa",
        "HyperAcute-Pancreas Immunotherapy",
        "Hyperacute Pancreatic Cancer Vaccine"
      ]
    },
    {
      "fdaUniiCode": "V083S0159D",
      "id": "Sodium_Stibogluconate",
      "preferredName": "Sodium Stibogluconate",
      "synonyms": [
        "Antimony Sodium Gluconate",
        "Lenocta",
        "Myostibin",
        "Pentostam",
        "SODIUM STIBOGLUCONATE ANHYDROUS",
        "SSG",
        "Sodium Stibogluconate",
        "Solustibosan",
        "Solustin",
        "VQD001",
        "sodium stibogluconate"
      ]
    },
    {
      "fdaUniiCode": "T4H8FMA7IM",
      "id": "Siltuximab",
      "preferredName": "Siltuximab",
      "synonyms": [
        "Anti-IL-6 Chimeric Monoclonal Antibody",
        "CNTO 328",
        "CNTO-328",
        "SILTUXIMAB",
        "Siltuximab",
        "Sylvant",
        "anti-IL-6 chimeric monoclonal antibody",
        "cCLB8"
      ]
    },
    {
      "fdaUniiCode": "7H5Q4J1CM5",
      "id": "Sepantronium_Bromide",
      "preferredName": "Sepantronium Bromide",
      "synonyms": [
        "1H-Naphth(2,3-d)imidazolium, 4,9-dihydro-1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazinylmethyl)-, Bromide",
        "SEPANTRONIUM BROMIDE",
        "Sepantronium Bromide",
        "Survivin Inhibitor YM155",
        "YM-155"
      ]
    },
    {
      "fdaUniiCode": "M76FX2JZRM",
      "id": "Ecromeximab",
      "preferredName": "Ecromeximab",
      "synonyms": [
        "Chimeric Monoclonal Antibody KW-2871",
        "ECROMEXIMAB",
        "Ecromeximab",
        "Immunoglobulin G1, Anti-(Gd3 Ganglioside) (Human-Mouse Monoclonal Km871 Gamma-1-Chain), Disulfide with Human-Mouse Monoclonal KM871 Kappa-Chain, Dimer",
        "KM871",
        "KW-2871",
        "Monoclonal Antibody KW-2871"
      ]
    },
    {
      "fdaUniiCode": "8UQ3W6JXAN",
      "id": "Nedaplatin",
      "preferredName": "Nedaplatin",
      "synonyms": [
        "(Glycolato-O,O')diammineplatinum(II)",
        "254-S",
        "CDGP",
        "NDP",
        "NEDAPLATIN",
        "Nedaplatin",
        "cis-Diammine(glucolato)platinum"
      ]
    },
    {
      "fdaUniiCode": "TTN62ITH9I",
      "id": "Noscapine_Hydrochloride",
      "preferredName": "Noscapine Hydrochloride",
      "synonyms": [
        "1(3H)Isobenzofuranone,6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3,-dioxolo(4,5-g)isoquinolin-5-yl)-hydrochloride",
        "NOSCAPINE HYDROCHLORIDE",
        "Narcotine hydrochloride",
        "Noscapine HCl",
        "Noscapine Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "0SXY5ET48B",
      "id": "Folitixorin",
      "preferredName": "Folitixorin",
      "synonyms": [
        "5,10-Methylenetetrahydrofolate",
        "5,10-methylene-5,6,7,8-tetrahydrofolic Acid",
        "CoFactor",
        "FOLITIXORIN",
        "Folitixorin",
        "N-(4-(3-Amino-1,2,5,6,6a,7-hexahydro-1-oxoimidazo(1,5-f)pteridin-8(9H)-yl)benzoyl)-L-glutamic Acid",
        "Tetrahydromethylenefolate"
      ]
    },
    {
      "fdaUniiCode": "XAV05295I5",
      "id": "Sivifene",
      "preferredName": "Sivifene",
      "synonyms": [
        "4,4'-Dihydroxybenzophenone 2,4-dinitrophenylhydrazone",
        "A-007",
        "Aryl Hydrazone A-007 Gel",
        "SIVIFENE",
        "Sivifene"
      ]
    },
    {
      "fdaUniiCode": "LI06Q37TEG",
      "id": "Amonafide_L-Malate",
      "preferredName": "Amonafide L-Malate",
      "synonyms": [
        "5-amino-2-[2-(dimethylamino)ethyl]-1H-benz[de]isoquinoline-1,3(2H)-dione (2S)-2-ydroxybutanedioate",
        "AMONAFIDE L-MALATE",
        "AS1413",
        "Amonafide L-Malate",
        "Butanedioic Acid, 2-hydroxy-, (2S)-, compd. with 5-amino-2-(2-(dimethylamino)ethyl)-1h-benz[de]isoquinoline-1,3(2h)-dione (1:1)",
        "XAN-02",
        "Xanafide"
      ]
    },
    {
      "fdaUniiCode": "945CY7ZMI2",
      "id": "Oportuzumab_Monatox",
      "preferredName": "Oportuzumab Monatox",
      "synonyms": [
        "OPORTUZUMAB MONATOX",
        "Oportuzumab Monatox",
        "Proxinium",
        "VB4 845",
        "VB4-845",
        "Vicinium",
        "anti-EpCAM-Pseudomonas-exotoxin fusion protein"
      ]
    },
    {
      "fdaUniiCode": "4EQZ6YO2HI",
      "id": "Denosumab",
      "preferredName": "Denosumab",
      "synonyms": [
        "AMG 162",
        "AMG-162",
        "DENOSUMAB",
        "Denosumab",
        "Denosumab Biosimilar MW032",
        "Denosumab Biosimilar QL1206",
        "Denosumab Biosimilar TK-006",
        "Prolia",
        "TK-006",
        "Xgeva",
        "denosumab"
      ]
    },
    {
      "fdaUniiCode": "07730V90L6",
      "id": "Talimogene_Laherparepvec",
      "preferredName": "Talimogene Laherparepvec",
      "synonyms": [
        "ICP34.5-, ICP47-deleted Herpes Simplex Virus 1 (HSV-1) Incorporating the Human GM-CSF Gene",
        "Imlygic",
        "JS1 34.5-hGMCSF 47- pA-",
        "OncoVEX GM-CSF",
        "T-VEC",
        "TALIMOGENE LAHERPAREPVEC",
        "Talimogene Laherparepvec"
      ]
    },
    {
      "fdaUniiCode": "55E08EN074",
      "id": "INO-1001",
      "preferredName": "INO-1001",
      "synonyms": [
        "INO 1001",
        "INO-1001"
      ]
    },
    {
      "fdaUniiCode": "W733B0S9SD",
      "id": "Methazolamide",
      "preferredName": "Methazolamide",
      "synonyms": [
        "Glauctabs",
        "METHAZOLAMIDE",
        "MZM",
        "Methazolamide",
        "N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]-acetamide",
        "Neptazane"
      ]
    },
    {
      "fdaUniiCode": "CN8EF9N084",
      "id": "Tozasertib_Lactate",
      "preferredName": "Tozasertib Lactate",
      "synonyms": [
        "Aurora Kinase Inhibitor MK-0457",
        "L-001281814",
        "MK-0457",
        "Propanoic acid, 2-hydroxy-, (2S)-, compd. with N-(4-((4-(4-methyl-1-piperazinyl)-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)thio)phenyl)cyclopropanecarboxamide",
        "TOZASERTIB LACTATE",
        "Tozasertib Lactate",
        "VX-680"
      ]
    },
    {
      "fdaUniiCode": "OIH1H7CJCJ",
      "id": "Padoporfin",
      "preferredName": "Padoporfin",
      "synonyms": [
        "(Hydrogen 3-((2(sup 2)R,7R,8R,17S,18S)-12-acetyl-7-ethyl-2(sup 2)-(methoxycarbonyl)-3,8,13,17-tetramethyl-2(sup 1)-oxo-2(sup 1),2(sup 2),7,8,17,18-hexahydrocyclopenta(at)porphyrin-18-yl)propanoato-kappa4N(sup 21),N(sup 22),N(sup 23),N(sup 24))palladium",
        "PADOPORFIN",
        "Padoporfin",
        "Tookad",
        "WST09"
      ]
    },
    {
      "fdaUniiCode": "AVX3D5A4LM",
      "id": "Recombinant_Thyrotropin_Alfa",
      "preferredName": "Recombinant Thyrotropin Alfa",
      "synonyms": [
        "Recombinant TSH Alpha",
        "Recombinant Thyrotropin Alfa",
        "Recombinant Thyrotropin Alpha",
        "THYROTROPIN ALFA",
        "TSH-alpha",
        "Thyrogen",
        "Thyroid Stimulating Hormone Alpha",
        "Thyrotropin Alfa",
        "thyrotropin alfa"
      ]
    },
    {
      "fdaUniiCode": "GZ3I1DMI8Q",
      "id": "Nastorazepide_Calcium",
      "preferredName": "Nastorazepide Calcium",
      "synonyms": [
        "Gastrin/cholecystokinin Type B Receptor Inhibitor Z-360",
        "NASTORAZEPIDE CALCIUM",
        "Nastorazepide Calcium",
        "Z-360"
      ]
    },
    {
      "fdaUniiCode": "61ZBX54883",
      "id": "Licorice",
      "preferredName": "Licorice",
      "synonyms": [
        "Glycyrrhiza",
        "Glycyrrhizae Radix",
        "LICORICE",
        "Licorice",
        "Licorice Root Extract",
        "licorice root extract"
      ]
    },
    {
      "fdaUniiCode": "ZL9780F883",
      "id": "Alacizumab_Pegol",
      "preferredName": "Alacizumab Pegol",
      "synonyms": [
        "ALACIZUMAB PEGOL",
        "Alacizumab Pegol",
        "CDP-791"
      ]
    },
    {
      "fdaUniiCode": "53YET703F2",
      "id": "Terameprocol",
      "preferredName": "Terameprocol",
      "synonyms": [
        "1,1'-(2,3-Dimethyl-1,4-butanediyl)bis(3,4-dimethoxybenzene)",
        "EM-1421",
        "M4N",
        "TERAMEPROCOL",
        "TMNDGA",
        "Terameprocol",
        "Tetra-O-methyl Nordihydroguaiaretic Acid",
        "Tetra-O-methyl-NDGA",
        "Tetramethoxynordihydroguaiaretic Acid",
        "tetra-O-methyl NDGA",
        "tetra-O-methyl nordihydroguaiaretic acid"
      ]
    },
    {
      "fdaUniiCode": "9XX54M675G",
      "id": "Darinaparsin",
      "preferredName": "Darinaparsin",
      "synonyms": [
        "DARINAPARSIN",
        "DMAIII(SG)",
        "Darinaparsin",
        "S-Dimethylarsino-Glutathione",
        "ZIO-101"
      ]
    },
    {
      "fdaUniiCode": "4B57CWT710",
      "id": "Coxsackievirus_V937",
      "preferredName": "Coxsackievirus V937",
      "synonyms": [
        "CAVATAK",
        "COXSACKIEVIRUS A21",
        "CVA21",
        "Coxsackievirus A21",
        "Coxsackievirus V937",
        "V 937",
        "V-937",
        "V937"
      ]
    },
    {
      "fdaUniiCode": "9B29N23K7E",
      "id": "Selective_Estrogen_Receptor_Modulator_TAS-108",
      "preferredName": "Selective Estrogen Receptor Modulator TAS-108",
      "synonyms": [
        "(7)-21-[4-[(diethylamino)methyl]-2-methoxyphenoxy]-7-methyl-19-norpregna-1,3,5(10)-trien-3-ol 2-hydroxy-1,2,3-propanetricarboxylate",
        "SR 16234",
        "SR16234",
        "Selective Estrogen Receptor Modulator TAS-108",
        "TAS-108"
      ]
    },
    {
      "fdaUniiCode": "TVH5K7949N",
      "id": "Integrin_alpha-2_Inhibitor_E7820",
      "preferredName": "Integrin alpha-2 Inhibitor E7820",
      "synonyms": [
        "E-7820",
        "Integrin alpha-2 Inhibitor E7820"
      ]
    },
    {
      "fdaUniiCode": "WZ1025JPGR",
      "id": "Mapatumumab",
      "preferredName": "Mapatumumab",
      "synonyms": [
        "Anti-TRAIL R1-mAb",
        "HGS-ETR1",
        "MAPATUMUMAB",
        "Mapatumumab",
        "TRM-1 mAb",
        "anti-TRAIL R1-mAb"
      ]
    },
    {
      "fdaUniiCode": "2O09BG0OWA",
      "id": "Farletuzumab",
      "preferredName": "Farletuzumab",
      "synonyms": [
        "FARLETUZUMAB",
        "Farletuzumab",
        "MORAb-003"
      ]
    },
    {
      "fdaUniiCode": "JOS53KRJ01",
      "id": "Inulin",
      "preferredName": "Inulin",
      "synonyms": [
        "INULIN",
        "Inulin"
      ]
    },
    {
      "fdaUniiCode": "ZZ6VH5MZ17",
      "id": "VEGFR2PDGFRc-KitFlt-3_Inhibitor_SU014813",
      "preferredName": "VEGFR2/PDGFR/c-Kit/Flt-3 Inhibitor SU014813",
      "synonyms": [
        "SU-14813",
        "VEGFR2/PDGFR/c-Kit/Flt-3 Inhibitor SU014813"
      ]
    },
    {
      "fdaUniiCode": "5BF646324K",
      "id": "Vinflunine",
      "preferredName": "Vinflunine",
      "synonyms": [
        "4'-Deoxy-20',20'-difluoro-C'-norvincaleukoblastine",
        "VINFLUNINE",
        "Vinflunine",
        "vinflunine"
      ]
    },
    {
      "fdaUniiCode": "981Y8SX18M",
      "id": "Bendamustine_Hydrochloride",
      "preferredName": "Bendamustine Hydrochloride",
      "synonyms": [
        "2-Benzimidazolinebutryric acid, 1-methyl-5-bis(2-chloroethyl)amino-, hydrochloride",
        "BENDAMUSTINE HYDROCHLORIDE",
        "Belrapzo",
        "Bendamustin Hydrochloride",
        "Bendamustine Hydrochloride",
        "Bendeka",
        "Cytostasan Hydrochloride",
        "Levact",
        "Ribomustin",
        "SyB L-0501",
        "Treanda",
        "bendamustine hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "7BA3X03948",
      "id": "Berubicin_Hydrochloride",
      "preferredName": "Berubicin Hydrochloride",
      "synonyms": [
        "(8S,10S)-10-((3-amino-4-O-benzyl-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)- 6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride",
        "BERUBICIN HYDROCHLORIDE",
        "Berubicin Hydrochloride",
        "RTA 744",
        "WP744",
        "topoisomerase II inhibitor RTA 744"
      ]
    },
    {
      "fdaUniiCode": "RNQ8JQ4R9P",
      "id": "Cantuzumab_Ravtansine",
      "preferredName": "Cantuzumab Ravtansine",
      "synonyms": [
        "CANTUZUMAB RAVTANSINE",
        "Cantuzumab Ravtansine",
        "HuC242-DM4",
        "IMGN242",
        "Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242",
        "huC242-DM4",
        "maytansinoid DM4-conjugated humanized monoclonal antibody huC242"
      ]
    },
    {
      "fdaUniiCode": "M3X659D0FY",
      "id": "Danusertib",
      "preferredName": "Danusertib",
      "synonyms": [
        "Benzamide, 4-(4-methyl-1-piperazinyl)-N-(1,4,5,6-tetrahydro-5-((2R)- methoxyphenylacetyl)pyrrolo(3,4-c)pyrazol-3-yl)-",
        "DANUSERTIB",
        "Danusertib",
        "PHA-739358"
      ]
    },
    {
      "fdaUniiCode": "V16D2ZT7DT",
      "id": "Nitrogen_Mustard_Prodrug_PR-104",
      "preferredName": "Nitrogen Mustard Prodrug PR-104",
      "synonyms": [
        "((2-Bromoethyl)-2,4-dinitro-6-(((2-(phosphonooxy)ethyl)amino)-carbonyl)anilino)ethyl Methanesulphonate",
        "Nitrogen Mustard Prodrug PR-104",
        "PR-104",
        "PR104"
      ]
    },
    {
      "fdaUniiCode": "1HRS458QU2",
      "id": "Clomiphene",
      "preferredName": "Clomiphene",
      "synonyms": [
        "2-[p-(2-Chloro-1,2-diphenylvinyl)phenoxy]triethylamine",
        "CLOMIPHENE",
        "Clomiphene"
      ]
    },
    {
      "fdaUniiCode": "04Q9AIZ7NO",
      "id": "Pemetrexed",
      "preferredName": "Pemetrexed",
      "synonyms": [
        "L-Glutamic Acid, N-(4-(2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)",
        "MTA",
        "Multitargeted Antifolate",
        "PEMETREXED",
        "Pemetrexed",
        "Pemfexy"
      ]
    },
    {
      "fdaUniiCode": "0H43101T0J",
      "id": "7-Ethyl-10-Hydroxycamptothecin",
      "preferredName": "7-Ethyl-10-Hydroxycamptothecin",
      "synonyms": [
        "7-ETHYL-10-HYDROXYCAMPTOTHECIN",
        "7-Ethyl-10-Hydroxycamptothecin",
        "7-Ethyl-10-hydroxy-20(S)-camptothecin",
        "SN 38",
        "SN-38"
      ]
    },
    {
      "fdaUniiCode": "410105JHGR",
      "id": "Andrographolide",
      "preferredName": "Andrographolide",
      "synonyms": [
        "(1R-(1-alpha(E(S)),4a-beta,5alpha,6alpha,8a-alpha))-3-(2-(decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl)ethylidene)dihydro-4-hydroxy-2(3H)-furanone",
        "(3E,4S)-3-[2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethylidene]-4-hydroxyoxolan-2-one",
        "(3E,4S)-4-hydroxy-3-{2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidenedecahydronaphthalen-1-yl]ethylidene}dihydrofuran-2(3H)-one",
        "2(3H)-Furanone, 3-(2-(decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl)ethylidene)dihydro-4-hydroxy-, (1R-(1-alpha(E(S*)),4a-beta,5-alpha,6-alpha,8a-alpha))-",
        "3-(2-(decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenenaphthyl)ethylidene)dihydro-4-hydroxyfuran-2(3H)-one",
        "3alpha,14,15,18-tetrahydroxy-5b,9bH,10a-labda-8(20),12-dien-16-oic acid gamma-Lactone",
        "ANDROGRAPHOLIDE",
        "Andrographis",
        "Andrographolide"
      ]
    },
    {
      "fdaUniiCode": "886U3H6UFF",
      "id": "Chloroquine",
      "preferredName": "Chloroquine",
      "synonyms": [
        "CHLOROQUINE",
        "Chloroquine"
      ]
    },
    {
      "fdaUniiCode": "6UXW23996M",
      "id": "Cyclophosphamide_Anhydrous",
      "preferredName": "Cyclophosphamide Anhydrous",
      "synonyms": [
        "2H-1,3,2-oxazaphosphorin-2-amine, N,N-is(2-chloroethyl)tetrahydro-,2-oxide",
        "CYCLOPHOSPHAMIDE ANHYDROUS",
        "Cyclophosphamide Anhydrous",
        "N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-Oxide"
      ]
    },
    {
      "fdaUniiCode": "7BRF0Z81KG",
      "id": "Lomustine",
      "preferredName": "Lomustine",
      "synonyms": [
        "1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea",
        "1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea",
        "1-Nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-",
        "Belustin",
        "Belustine",
        "CCNU",
        "Cecenu",
        "CeeNU",
        "Chloroethylcyclo- hexylnitrosourea",
        "Chloroethylcyclohexylnitrosourea",
        "Citostal",
        "Gleostine",
        "LOMUSTINE",
        "Lomeblastin",
        "Lomustine",
        "Lomustinum",
        "Lucostin",
        "Lucostine",
        "N-(2-Chloroethyl)-N'-cyclohexyl-N-nitrosourea",
        "N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea",
        "Prava",
        "RB-1509",
        "WR-139017",
        "lomustine"
      ]
    },
    {
      "fdaUniiCode": "9MC3I34447",
      "id": "Limonene_--",
      "preferredName": "Limonene, (+/-)-",
      "synonyms": [
        "(+/-)-1-methyl-4-(1-methylethenyl)cyclohexene",
        "1-methyl-4-(1-methylethenyl)cyclohexene",
        "1-methyl-4-prop-1-en-2-yl-cyclohexene",
        "Cajeputene",
        "Cinene",
        "DL-Limonene",
        "Dipentene",
        "Eulimen",
        "LIMONENE, (+/-)-",
        "Limonene",
        "Limonene, (+/-)-",
        "Nesol"
      ]
    },
    {
      "fdaUniiCode": "GFD7C86Q1W",
      "id": "Limonene_-",
      "preferredName": "Limonene, (+)-",
      "synonyms": [
        "(+)-(R)-4-isopropenyl-1-methylcyclohexene",
        "(+)-alpha-Limonene",
        "(+)-limonene",
        "(4R)-1-methyl-4-(1-methylethenyl)cyclohexene",
        "(4R)-1-methyl-4-prop-1-en-2-yl-cyclohexene",
        "(R)-(+)-limonene",
        "(R)-1-Methyl-4-(1-methylethenyl)cyclohexene",
        "(R)-4-isopropenyl-1-methylcyclohexene",
        "1-methyl-4-isopropenyl-1-cyclohexene",
        "Alda 341",
        "Alda-341",
        "Alda341",
        "Cyclohexene, 1-methyl-4-(1-methylethenyl)-, (4R)-",
        "D-Limonene",
        "LIMONENE, (+)-",
        "Limonene",
        "Limonene, (+)-",
        "Limonene, D-"
      ]
    },
    {
      "fdaUniiCode": "699121PHCA",
      "id": "Docetaxel_Anhydrous",
      "preferredName": "Docetaxel Anhydrous",
      "synonyms": [
        "DOCEFREZ",
        "DOCETAXEL ANHYDROUS",
        "Docetaxel Anhydrous"
      ]
    },
    {
      "fdaUniiCode": "NW1291F1W8",
      "id": "Doxazosin",
      "preferredName": "Doxazosin",
      "synonyms": [
        "DOXAZOSIN",
        "Doxazosin"
      ]
    },
    {
      "fdaUniiCode": "J303A6U9Y6",
      "id": "Enclomiphene_Citrate",
      "preferredName": "Enclomiphene Citrate",
      "synonyms": [
        "ENCLOMIPHENE CITRATE",
        "Enclomiphene Citrate"
      ]
    },
    {
      "fdaUniiCode": "4L066368AS",
      "id": "Fluvastatin",
      "preferredName": "Fluvastatin",
      "synonyms": [
        "FLUVASTATIN",
        "Fluvastatin"
      ]
    },
    {
      "fdaUniiCode": "PKK6MUZ20G",
      "id": "Mercaptopurine_Anhydrous",
      "preferredName": "Mercaptopurine Anhydrous",
      "synonyms": [
        "MERCAPTOPURINE ANHYDROUS",
        "Mercaptopurine Anhydrous"
      ]
    },
    {
      "fdaUniiCode": "N824AOU5XV",
      "id": "Pegvisomant",
      "preferredName": "Pegvisomant",
      "synonyms": [
        "PEGVISOMANT",
        "Pegvisomant",
        "Somatotropin (18-Aspartic Acid, 21-Asparagine, 120-Lysine, 167-Asparagine, 168-Alanine, 171-Serine, 172-Arginine, 174-Serine, 179-Threonine) (Human), Pegylated",
        "Somavert",
        "Trovert"
      ]
    },
    {
      "fdaUniiCode": "9ZOQ3TZI87",
      "id": "Sorafenib",
      "preferredName": "Sorafenib",
      "synonyms": [
        "BA4 43 9006",
        "BAY 43-9006",
        "Bay-439006",
        "SORAFENIB",
        "Sorafenib",
        "sorafenib"
      ]
    },
    {
      "fdaUniiCode": "WIX31ZPX66",
      "id": "Thioguanine_Anhydrous",
      "preferredName": "Thioguanine Anhydrous",
      "synonyms": [
        "THIOGUANINE ANHYDROUS",
        "Thioguanine Anhydrous"
      ]
    },
    {
      "fdaUniiCode": "7ZAT6ES870",
      "id": "Tranylcypromine_Sulfate",
      "preferredName": "Tranylcypromine Sulfate",
      "synonyms": [
        "(+-)-Trans-2-Phenylcyclopropylamine Sulfate (2:1)",
        "1-Amino-2-phenylcyclopropane Sulfate",
        "Parnate",
        "TRANYLCYPROMINE SULFATE",
        "Tranylcypromine Sulfate"
      ]
    },
    {
      "fdaUniiCode": "HC3NX54582",
      "id": "Trientine_Hydrochloride",
      "preferredName": "Trientine Hydrochloride",
      "synonyms": [
        "N,N-bis (2-aminoethyl)-1,2-ethanediamine Dihydrochloride",
        "Syprine",
        "TRIENTINE HYDROCHLORIDE",
        "Trientine Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "9LHU78OQFD",
      "id": "Lovastatin",
      "preferredName": "Lovastatin",
      "synonyms": [
        "(2S)-2-Methylbutanoic Acid, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester",
        "LOVASTATIN",
        "Lovastatin",
        "Lovastatin Sodium",
        "Mevacor",
        "Mevinolin",
        "Monacolin K",
        "lovastatin"
      ]
    },
    {
      "fdaUniiCode": "3Z8479ZZ5X",
      "id": "Epirubicin",
      "preferredName": "Epirubicin",
      "synonyms": [
        "(8S-cis)-10-((3-Amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione",
        "3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside",
        "4'-Epiadriamycin",
        "4'-Epidoxorubicin",
        "4'-epi DX",
        "EPIRUBICIN",
        "Epi DX",
        "Epidoxorubicin",
        "Epirubicin",
        "Pidorubicin",
        "epirubicin"
      ]
    },
    {
      "fdaUniiCode": "BKJ8M8G5HI",
      "id": "Imatinib",
      "preferredName": "Imatinib",
      "synonyms": [
        "4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide",
        "IMATINIB",
        "Imatinib"
      ]
    },
    {
      "fdaUniiCode": "7673326042",
      "id": "Irinotecan",
      "preferredName": "Irinotecan",
      "synonyms": [
        "(+)-(4S)-4,11-diethyl-4-hydroxy-9-[(4-piperidino-piperidino)carbonyloxy]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinol-3,14,(4H,12H)-dione",
        "(+)-7-ethyl-10-hydroxycamptothecine 10-[1,4'-bipiperidine]-1'-carboxylate",
        "7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin",
        "IRINOTECAN",
        "Irinotecan",
        "[1,4'-bipiperidine]-1'-carboxylic acid (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester",
        "irinotecan"
      ]
    },
    {
      "fdaUniiCode": "EFY6W0M8TG",
      "id": "Leuprolide",
      "preferredName": "Leuprolide",
      "synonyms": [
        "6-D-Leucine-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor (Pig)",
        "6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig)",
        "LEUPROLIDE",
        "Leuprolide",
        "Leuprorelin",
        "leuprolide"
      ]
    },
    {
      "fdaUniiCode": "BZ114NVM5P",
      "id": "Mitoxantrone",
      "preferredName": "Mitoxantrone",
      "synonyms": [
        "1,3-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9, 10-anthracenedione",
        "1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9, 10-anthroquinone",
        "Dihydroxyanthracenedione",
        "MITOXANTRONE",
        "Mitoxantrone",
        "Mitozantrone",
        "mitoxantrone"
      ]
    },
    {
      "fdaUniiCode": "50D9XSG0VR",
      "id": "Mechlorethamine",
      "preferredName": "Mechlorethamine",
      "synonyms": [
        "Bis(2-chloroethyl)methylamine",
        "Chlorethazine",
        "Chlormethine",
        "HN 2",
        "HN2",
        "MECHLORETHAMINE",
        "Mechlorethamine",
        "Methylbis(beta-chloroethyl)amine",
        "Mustard",
        "Mustine",
        "NITROGEN MUSTARD HN-2",
        "Nitrogen Mustard",
        "chlorethazine",
        "chloromethine",
        "ethanamine,2-chloro-N-(2-chloroethyl)-N-methyl",
        "methylchlorethamine"
      ]
    },
    {
      "fdaUniiCode": "35S93Y190K",
      "id": "Procarbazine",
      "preferredName": "Procarbazine",
      "synonyms": [
        "Benzethyzin",
        "Ibenzmethyzin",
        "N-(1-methylethyl)-4-[(2-methylhydrazino)methyl]benzamide",
        "N-4-isopropylcarbamoylbenzyl-N'-methylhydrazine",
        "N-Methylhydrazine",
        "N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide",
        "PROCARBAZINE",
        "Procarbazin",
        "Procarbazine",
        "p-(N'-methylhydrazinomethyl)-N-isopropylbenzamide",
        "procarbazine"
      ]
    },
    {
      "fdaUniiCode": "094ZI81Y45",
      "id": "Tamoxifen",
      "preferredName": "Tamoxifen",
      "synonyms": [
        "1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene",
        "TAMOXIFEN",
        "Tamoxifen",
        "tamoxifen"
      ]
    },
    {
      "fdaUniiCode": "ZS7284E0ZP",
      "id": "Daunorubicin",
      "preferredName": "Daunorubicin",
      "synonyms": [
        "(8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione",
        "5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-",
        "DAUNOMYCIN",
        "DAUNORUBICIN",
        "DNR",
        "Daunomycin",
        "Daunorrubicina",
        "Daunorubicin",
        "L-lyxo-Hexopyranoside, 3beta-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-metldioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-,alpha-",
        "Leukaemomycin C",
        "RUBOMYCIN C",
        "Rubidomycin",
        "Rubomycin C",
        "daunomycin",
        "daunorubicin"
      ]
    },
    {
      "fdaUniiCode": "UT59FF4T5X",
      "id": "Dacetuzumab",
      "preferredName": "Dacetuzumab",
      "synonyms": [
        "Anti-huCD40 mAb",
        "DACETUZUMAB",
        "Dacetuzumab",
        "Monoclonal Antibody SGN-40",
        "SGN-40",
        "huS2C6"
      ]
    },
    {
      "fdaUniiCode": "69VKY8P7EA",
      "id": "Dovitinib_Lactate",
      "preferredName": "Dovitinib Lactate",
      "synonyms": [
        "4-Amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one mono 2-hydroxypropanoate Hydrate",
        "CHIR-258",
        "DOVITINIB LACTATE",
        "Dovitinib Lactate",
        "RTK Inhibitor TKI258",
        "TKI258"
      ]
    },
    {
      "fdaUniiCode": "PJ4H73IL17",
      "id": "Tivantinib",
      "preferredName": "Tivantinib",
      "synonyms": [
        "(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo(3,2,1-ij)quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione",
        "ARQ 197",
        "ARQ-197",
        "TIVANTINIB",
        "Tivantinib",
        "c-Met Inhibitor ARQ 197"
      ]
    },
    {
      "fdaUniiCode": "986FY7F8XR",
      "id": "Plinabulin",
      "preferredName": "Plinabulin",
      "synonyms": [
        "(3Z,6Z)-6-benzylidene-3-{[5-(1,1-dimethylethyl)-1H-imidazol-4-yl]methylidene}piperazine-2,5-dione",
        "NPI-2358",
        "PLINABULIN",
        "Plinabulin"
      ]
    },
    {
      "fdaUniiCode": "M2HPV837HO",
      "id": "Catumaxomab",
      "preferredName": "Catumaxomab",
      "synonyms": [
        "CATUMAXOMAB",
        "Catumaxomab",
        "Removab"
      ]
    },
    {
      "fdaUniiCode": "230902QLLC",
      "id": "Urelumab",
      "preferredName": "Urelumab",
      "synonyms": [
        "BMS-663513",
        "Immunoglobulin G4, Anti-(Human Receptor 4-1BB) (Human Gamma-Chain), Disulfide with Human Kappa-Chain, Dimer",
        "URELUMAB",
        "Urelumab"
      ]
    },
    {
      "fdaUniiCode": "V7YQ6134AE",
      "id": "Folate-FITC",
      "preferredName": "Folate-FITC",
      "synonyms": [
        "EC-17",
        "EC17",
        "Folate Fluorescein Isothiocyanate Conjugate",
        "Folate-FITC",
        "L-glutamine, N2-(4-(((2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-n-(2-((((3',6'-dihydroxy-3-oxospiro(isobenzofuran-1(3h),9'-(9h)xanthen)-5-yl)amino)thioxomethyl)amino)ethyl)-"
      ]
    },
    {
      "fdaUniiCode": "237GB6IDKO",
      "id": "Tigatuzumab",
      "preferredName": "Tigatuzumab",
      "synonyms": [
        "Anti-DR5 MoAb",
        "Anti-TRAIL-R2 MoAb",
        "CS-1008",
        "TIGATUZUMAB",
        "Tigatuzumab",
        "anti-[Homo sapiens TNFRSF10B (Tumor Necrosis Factor Receptor Superfamily Member 10B, DR5, TRAIL-R2, CD262)] Humanized Monoclonal TRA-8"
      ]
    },
    {
      "fdaUniiCode": "6HP0354G04",
      "id": "Amatuximab",
      "preferredName": "Amatuximab",
      "synonyms": [
        "AMATUXIMAB",
        "Amatuximab",
        "Anti-Mesothelin Monoclonal Antibody MORAb-009",
        "Immunoglobulin G1, Anti-(mesothelin) (Human-Mouse Monoclonal MORAb-009 Heavy Chain), Disulfide with Human-Mouse Monoclonal MORAb-009 Kappa-Chain, Dimer",
        "MORAb-009",
        "anti-mesothelin monoclonal antibody MORAb-009"
      ]
    },
    {
      "fdaUniiCode": "A4LY1V9F0H",
      "id": "Denenicokin",
      "preferredName": "Denenicokin",
      "synonyms": [
        "DENENICOKIN",
        "Denenicokin",
        "IL-21",
        "L-methionyl(Human Interleukin-21)",
        "Recombinant Human Interleukin-21",
        "rIL-21",
        "rhIL-21"
      ]
    },
    {
      "fdaUniiCode": "F6XM2TN5A1",
      "id": "Tesevatinib",
      "preferredName": "Tesevatinib",
      "synonyms": [
        "4-Quinazolinamine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-(((3aalpha,5beta,6aalpha)-octahydro-2-methylcyclopenta(c)pyrrol-5-yl)methoxy)-",
        "EXEL 7647",
        "KD 019",
        "KD019",
        "TESEVATINIB",
        "Tesevatinib",
        "XL647"
      ]
    },
    {
      "fdaUniiCode": "16XC2U7W8N",
      "id": "Barasertib",
      "preferredName": "Barasertib",
      "synonyms": [
        "1h-pyrazole-3-acetamide, 5-((7-(3-(ethyl(2-(phosphonooxy)ethyl)amino)propoxy)-4-quinazolinyl)amino)-n-(3-fluorophenyl)-",
        "AZD-1152",
        "AZD1152",
        "Aurora Kinase Inhibitor AZD1152",
        "BARASERTIB",
        "Barasertib"
      ]
    },
    {
      "fdaUniiCode": "YPH994Y0RF",
      "id": "Diazepinomicin",
      "preferredName": "Diazepinomicin",
      "synonyms": [
        "11h-dibenzo(B,E)(1,4)diazepin-11-one, 5,10-dihydro-4,6,8-trihydroxy-10-((2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl)-",
        "BU-4664L",
        "DIAZEPINOMICIN",
        "Diazepinomicin",
        "ECO-4601",
        "TLN-4601"
      ]
    },
    {
      "fdaUniiCode": "SJ82PK3HWA",
      "id": "Eftilagimod_Alpha",
      "preferredName": "Eftilagimod Alpha",
      "synonyms": [
        "EFTILAGIMOD ALFA",
        "Eftilagimod Alpha",
        "IMP321",
        "Immufact"
      ]
    },
    {
      "fdaUniiCode": "YI437801BE",
      "id": "Mogamulizumab",
      "preferredName": "Mogamulizumab",
      "synonyms": [
        "Immunoglobulin G1, Anti-(CC Chemokine Receptor CCR4) (Human-Mouse Monoclonal KW-0761 Heavy Chain), Disulfide With Human-Mouse Monoclonal KW-0761 Kappa-Chain, Dimer",
        "KM8761",
        "KW-0761",
        "MOGAMULIZUMAB",
        "Mogamulizumab",
        "Mogamulizumab-kpkc",
        "Poteligeo"
      ]
    },
    {
      "fdaUniiCode": "FD57A79R4P",
      "id": "Tiomolibdate_Choline",
      "preferredName": "Tiomolibdate Choline",
      "synonyms": [
        "ALXN-1840",
        "ATN 224",
        "ATN-224",
        "Bis(choline)tetrathiomolybdate",
        "Ethanaminium, 2-Hydroxy-N,N,N-Trimethyl-, (T-4)-Tetrathioxomolybdate(2-) (2:1)",
        "SOD1 Inhibitor ATN-224",
        "SOD1 inhibitor ATN-224",
        "TIOMOLIBDATE CHOLINE",
        "Tiomolibdate Choline",
        "WTX-101",
        "WTX101"
      ]
    },
    {
      "fdaUniiCode": "NVW4Z03I9B",
      "id": "Bafetinib",
      "preferredName": "Bafetinib",
      "synonyms": [
        "BAFETINIB",
        "Bafetinib",
        "Benzamide, N-[3-([4,5'-bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3- (dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)-",
        "CNS-9",
        "Dual Bcr-Abl/Lyn Tyrosine Kinase Inhibitor INNO-406",
        "INNO-406",
        "NS-187"
      ]
    },
    {
      "fdaUniiCode": "851B9FQ7Q0",
      "id": "Hsp90_Inhibitor_BIIB021",
      "preferredName": "Hsp90 Inhibitor BIIB021",
      "synonyms": [
        "BIIB-021",
        "BIIB021",
        "CNF2024",
        "Hsp90 Antagonist CNF2024",
        "Hsp90 Inhibitor BIIB021"
      ]
    },
    {
      "fdaUniiCode": "A6GWB8T96J",
      "id": "Mocetinostat",
      "preferredName": "Mocetinostat",
      "synonyms": [
        "Benzamide, N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]-",
        "MG-0103",
        "MGCD0103",
        "MOCETINOSTAT",
        "Mocetinostat",
        "N-(2-aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamide",
        "mocetinostat"
      ]
    },
    {
      "fdaUniiCode": "36O410ZD4I",
      "id": "Vintafolide",
      "preferredName": "Vintafolide",
      "synonyms": [
        "EC145",
        "Folate-Vinca Alkaloid Conjugate EC145",
        "VINTAFOLIDE",
        "Vintafolide"
      ]
    },
    {
      "fdaUniiCode": "2ZWI7KHK8F",
      "id": "Iniparib",
      "preferredName": "Iniparib",
      "synonyms": [
        "4-Iodo-3-Nitrobenzamide",
        "BSI-201",
        "INIPARIB",
        "Iniparib",
        "PARP-1 Inhibitor BSI-201",
        "PARP-1 inhibitor BSI-201",
        "SAR240550",
        "iniparib"
      ]
    },
    {
      "fdaUniiCode": "4FR53SIF3A",
      "id": "Blinatumomab",
      "preferredName": "Blinatumomab",
      "synonyms": [
        "Anti-CD19 x Anti-CD3 Bispecific Monoclonal Antibody",
        "Anti-CD19/Anti-CD3 Recombinant Bispecific Monoclonal Antibody MT103",
        "BLINATUMOMAB",
        "Blinatumomab",
        "Blincyto",
        "MEDI-538",
        "MT-103"
      ]
    },
    {
      "fdaUniiCode": "846Y8197W1",
      "id": "Varlitinib",
      "preferredName": "Varlitinib",
      "synonyms": [
        "ARRY-334543",
        "VARLITINIB",
        "Varlitinib"
      ]
    },
    {
      "fdaUniiCode": "RJ00KV3VTG",
      "id": "Radium_Ra_223_Dichloride",
      "preferredName": "Radium Ra 223 Dichloride",
      "synonyms": [
        "Alpharadin",
        "BAY 88-8223",
        "BAY88-8223",
        "RADIUM RA-223 DICHLORIDE",
        "Radium 223 Dichloride",
        "Radium Ra 223 Dichloride",
        "Radium-223 Dichloride",
        "Xofigo"
      ]
    },
    {
      "fdaUniiCode": "14083FR882",
      "id": "Maytansine",
      "preferredName": "Maytansine",
      "synonyms": [
        "Alanine, N-acetyl-N-methyl-, 6-ester with 11-chloro-6, 21-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-4,24-dioxa-9, 22-diazatetracyclo[19.3.1.1(10,24).0(3,5)]hexacosa-10,12,14[26], 16,18-pentaene-8,23-dione",
        "L-Alanine, N-acetyl-N-methyl-, 11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8, 23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03, 5]hexacosa-10,12,14(26),16,18-pentaen-6-yl ester, [1S-(1R*,2S*, 3R*,5R*,6R*,16E,18E,20S*,21R*)]-",
        "L-alanine, N-acetyl-N-methyl-, 11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03, 5]hexacosa-10,12,14(26),16,18-pentaen-6-yl ester, [1S-(1R*,2S*,3R*,5R*,6R*,16E,18E,20S*,21R*)]",
        "MAYTANSINE",
        "Maitansine",
        "Maysanine",
        "Maytansin",
        "Maytansine",
        "alanine, N-acetyl-N-methyl-, 6-ester with 11-chloro-6, 21-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1(10,24).0(3,5)]hexacosa-10,12,14[26], 16,18-pentaene-8,23-dione"
      ]
    },
    {
      "fdaUniiCode": "NFH8D7ZGF5",
      "id": "Davamotecan_Pegadexamer",
      "preferredName": "Davamotecan Pegadexamer",
      "synonyms": [
        "CRLX101",
        "Camptothecin-Polymer Conjugate IT-101",
        "Cyclodextrin-Based Polymer-Camptothecin CRLX101",
        "DAVAMOTECAN PEGADEXAMER",
        "Davamotecan Pegadexamer",
        "EP0057",
        "IT-101",
        "Linear Cyclodextrin-cysteine-PEG Based Polymer Conjugate of Camptothecin"
      ]
    },
    {
      "fdaUniiCode": "UQC681JJIV",
      "id": "BMS-275183",
      "preferredName": "BMS-275183",
      "synonyms": [
        "BMS-275183"
      ]
    },
    {
      "fdaUniiCode": "L0MR697HHI",
      "id": "Mechlorethamine_Hydrochloride",
      "preferredName": "Mechlorethamine Hydrochloride",
      "synonyms": [
        "Bis(2-chloroethyl)methylamine Hydrochloride",
        "Caryolysine",
        "Chlorethamine HCl",
        "Chlorethazine Hydrochloride",
        "Chlormethine Hydrochloride",
        "Chlormethine hydrochloride",
        "Chloromethine HCl",
        "Chloromethine Hydrochloride",
        "Cloramin",
        "Erasol",
        "HN 2 Hydrochloride",
        "MECHLORETHAMINE HYDROCHLORIDE",
        "Mechlorethamine Hydrochloride",
        "Mechlorethamine hydrochloride",
        "Methylbis(beta-chloroethyl)amine Hydrochloride",
        "Methylchlorethamine Hydrochloride",
        "Mustargen",
        "Mustargen HCl",
        "Mustargen Hydrochloride",
        "Mustargen hydrochloride",
        "Mustine Hydrochloride",
        "Mustine hydrochloride",
        "N-Lost",
        "Onco-Cloramin",
        "WR-147650",
        "chlorethamine hydrochloride",
        "ethanamine,2-chloro-N-(2-chloroethyl)-N-methyl Hydrochloride",
        "mechlorethamine HCl",
        "mechlorethamine hydrochloride",
        "mustine"
      ]
    },
    {
      "fdaUniiCode": "55R7RG342O",
      "id": "Tertomotide",
      "preferredName": "Tertomotide",
      "synonyms": [
        "GV 1001",
        "GV-1001",
        "GV1001",
        "Human Telomerase Reverse Transcriptase (EC 2.7.7.49)-(611-626)-Peptide (Telomerase Catalytic Subunit Fragment)",
        "PrimoVax",
        "TERTOMOTIDE",
        "Tertomotide"
      ]
    },
    {
      "fdaUniiCode": "C21EZR41AY",
      "id": "Synthetic_Alkaloid_PM00104",
      "preferredName": "Synthetic Alkaloid PM00104",
      "synonyms": [
        "PM-00104",
        "PM00104",
        "Synthetic Alkaloid PM00104",
        "Zalypsis"
      ]
    },
    {
      "fdaUniiCode": "G6HRD2P839",
      "id": "Nintedanib",
      "preferredName": "Nintedanib",
      "synonyms": [
        "BIBF 1120",
        "BIBF-1120",
        "Intedanib",
        "Methyl (3Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylidene)-2-oxo-2,3-dihydro-1H-indole-6-carboxylate",
        "Multitargeted Tyrosine Kinase Inhibitor BIBF 1120",
        "NINTEDANIB",
        "Nintedanib",
        "Vargatef",
        "tyrosine kinase inhibitor BIBF 1120"
      ]
    },
    {
      "fdaUniiCode": "39200FJ43J",
      "id": "Obatoclax_Mesylate",
      "preferredName": "Obatoclax Mesylate",
      "synonyms": [
        "2-(2-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylidene]-3-methoxy-2H-pyrrol-5-yl)-1H-indole Monomethanesulfonate",
        "GX15-070MS",
        "OBATOCLAX MESYLATE",
        "Obatoclax Mesylate",
        "obatoclax mesylate"
      ]
    },
    {
      "fdaUniiCode": "0ES1C2KQ94",
      "id": "Seliciclib",
      "preferredName": "Seliciclib",
      "synonyms": [
        "CYC202",
        "R-roscovitine",
        "SELICICLIB",
        "Seliciclib"
      ]
    },
    {
      "fdaUniiCode": "KUA4693H5W",
      "id": "5-Fluoro-2-Deoxycytidine",
      "preferredName": "5-Fluoro-2-Deoxycytidine",
      "synonyms": [
        "5-FLUORO-2'-DEOXYCYTIDINE",
        "5-Fluoro-2-Deoxycytidine",
        "5-fluoro-2-deoxycytidine",
        "Cytidine, 2'-deoxy-5-fluoro-",
        "FdCyd",
        "Ro 5-1090"
      ]
    },
    {
      "fdaUniiCode": "SSB56T0M0L",
      "id": "Pegdinetanib",
      "preferredName": "Pegdinetanib",
      "synonyms": [
        "Angiocept",
        "BMS-844203",
        "CT-322",
        "PEGDINETANIB",
        "Pegdinetanib",
        "VEGFR-2 inhibitor CT-322"
      ]
    },
    {
      "fdaUniiCode": "1YC4W9MSLJ",
      "id": "Tasisulam",
      "preferredName": "Tasisulam",
      "synonyms": [
        "LY-573636",
        "LY573636",
        "N-(2,4-Dichlorobenzoyl)-5-bromothiophene-2-sulfonamide",
        "TASISULAM",
        "Tasisulam"
      ]
    },
    {
      "fdaUniiCode": "HSU1C9YRES",
      "id": "Medroxyprogesterone",
      "preferredName": "Medroxyprogesterone",
      "synonyms": [
        "(6Alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione",
        "17Alpha-hydroxy-6alpha-methylprogesterone",
        "6Alpha-methyl-17alpha-hydroxyprogesterone",
        "6Alpha-methyl-4-pregnen-17alpha-ol-3,20-dione",
        "Curretab",
        "MEDROXYPROGESTERONE",
        "Medroxyprogesterone",
        "medroxyprogesterone"
      ]
    },
    {
      "fdaUniiCode": "Q41OR9510P",
      "id": "Melphalan",
      "preferredName": "Melphalan",
      "synonyms": [
        "4-[bis(2-chloroethyl)amino]-L-phenylalanine",
        "Alanine Nitrogen Mustard",
        "CB-3025",
        "L-PAM",
        "L-Phenylalanine Mustard",
        "L-Phenylalanine mustard",
        "L-Sarcolysin",
        "L-Sarcolysin Phenylalanine mustard",
        "L-Sarcolysine",
        "L-sarcolysin",
        "MELPHALAN",
        "Melphalan",
        "Melphalanum",
        "Phenylalanine Mustard",
        "Phenylalanine Nitrogen Mustard",
        "Phenylalanine nitrogen mustard",
        "Sarcoclorin",
        "Sarkolysin",
        "WR-19813",
        "melphalan",
        "p-di(chloroethyl)amino-L-phenylalanine"
      ]
    },
    {
      "fdaUniiCode": "375142VBIA",
      "id": "Fresolimumab",
      "preferredName": "Fresolimumab",
      "synonyms": [
        "Anti-TGF-Beta Monoclonal Antibody GC1008",
        "FRESOLIMUMAB",
        "Fresolimumab",
        "GC1008",
        "Human Anti-TGF-Beta Monoclonal Antibody GC1008",
        "Immunoglobulin G4, anti-(transforming growth factor beta) (human monoclonal GC-1008 heavy chain), disulfide with human monoclonal GC-1008 light chain, Dimer",
        "anti-TGF-beta monoclonal antibody GC1008"
      ]
    },
    {
      "fdaUniiCode": "8K3CVY8F8V",
      "id": "Mofarotene",
      "preferredName": "Mofarotene",
      "synonyms": [
        "(E)-4-[2-[4-[2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]phenoxy]ethyl]morpholine",
        "MOFAROTENE",
        "Mofarontene",
        "Mofarotene",
        "Ro 40-8757"
      ]
    },
    {
      "fdaUniiCode": "TWK220499Z",
      "id": "Methylselenocysteine",
      "preferredName": "Methylselenocysteine",
      "synonyms": [
        "3-(Methylseleno)-l-alanine",
        "L-Se-Methylselenocysteine",
        "METHYLSELENOCYSTEINE",
        "MSC",
        "Methylselenocycteine",
        "Methylselenocysteine",
        "Se-Methyl-seleno-L-cysteine",
        "Se-Methylselenocysteine",
        "Se-methyl-seleno-L-cysteine",
        "SeMSC",
        "Selenium-methylselenocystine",
        "l-Se-Methylselenocysteine"
      ]
    },
    {
      "fdaUniiCode": "QEU0NE4O90",
      "id": "Hydroxytyrosol",
      "preferredName": "Hydroxytyrosol",
      "synonyms": [
        "2-(3,4-Dihydroxyphenyl)ethanol",
        "3,4-DHPEA",
        "3,4-Dihydroxyphenylethanol",
        "4-(2-Hydroxyethyl)-1,2-benzenediol",
        "HYDROXYTYROSOL",
        "Hydroxytyrosol"
      ]
    },
    {
      "fdaUniiCode": "G960R9S5SK",
      "id": "Caffeic_Acid_Phenethyl_Ester",
      "preferredName": "Caffeic Acid Phenethyl Ester",
      "synonyms": [
        "2-Phenylethyl 3-(3,4-dihydroxyphenyl)-2-propenoate",
        "3-(3,4-Dihydroxyphenyl)-2-propenoic Acid, 2-Phenylethyl Ester",
        "CAFFEIC ACID PHENETHYL ESTER",
        "CAPE",
        "Caffeic Acid Phenethyl Ester"
      ]
    },
    {
      "fdaUniiCode": "UQS3A06ILY",
      "id": "2-Hydroxyestrone",
      "preferredName": "2-Hydroxyestrone",
      "synonyms": [
        "1,3,5(10)-Estratrien-2,3-diol-17-one",
        "2-HYDROXYESTRONE",
        "2-Hydroxyestrone",
        "2-OHE(1)",
        "2-OHE1",
        "Catecholestrone",
        "Estra-1,3,5(1)-Trien-17-One, 2,3-Dihydroxy-"
      ]
    },
    {
      "fdaUniiCode": "A28G39IJ7K",
      "id": "Temarotene",
      "preferredName": "Temarotene",
      "synonyms": [
        "1,2,3,4-Tetrahydro-1,1,4,4-tetramethyl-6-[(1E)-1-methyl-2-phenylethenyl]naphthalene",
        "Ro 15-0778",
        "TEMAROTENE",
        "TTNPB, Decarboxylated Analog",
        "Temaroten",
        "Temarotene"
      ]
    },
    {
      "fdaUniiCode": "V3DMU7PVXF",
      "id": "Resiquimod",
      "preferredName": "Resiquimod",
      "synonyms": [
        "4-Amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol",
        "R848",
        "RESIQUIMOD",
        "Resiquimod",
        "S 28463",
        "resiquimod"
      ]
    },
    {
      "fdaUniiCode": "YL5FZ2Y5U1",
      "id": "Methotrexate",
      "preferredName": "Methotrexate",
      "synonyms": [
        "4-Amino-10-methylfolic Acid",
        "4-Amino-4-deoxy-10-methylpteroyl-L-glutamic Acid",
        "Abitrexate",
        "Alpha-Methopterin",
        "Amethopterin",
        "Brimexate",
        "CL 14377",
        "CL-14377",
        "Emtexate",
        "Emthexat",
        "Emthexate",
        "Farmitrexat",
        "Fauldexato",
        "Folex",
        "Folex PFS",
        "Lantarel",
        "Ledertrexate",
        "Lumexon",
        "METHOTREXATE",
        "MTX",
        "Maxtrex",
        "Medsatrexate",
        "Metex",
        "Methoblastin",
        "Methotrexate",
        "Methotrexate LPF",
        "Methotrexate Methylaminopterin",
        "Methotrexatum",
        "Metotrexato",
        "Metrotex",
        "Mexate",
        "Mexate-AQ",
        "N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic Acid",
        "Novatrex",
        "Rheumatrex",
        "Texate",
        "Tremetex",
        "Trexeron",
        "Trixilem",
        "WR-19039",
        "amethopterin",
        "methotrexate"
      ]
    },
    {
      "fdaUniiCode": "D733ET3F9O",
      "id": "Asparaginase_Erwinia_chrysanthemi",
      "preferredName": "Asparaginase Erwinia chrysanthemi",
      "synonyms": [
        "ASPARAGINASE ERWINIA CHRYSANTHEMI",
        "Asparaginase Erwinia chrysanthemi",
        "Crisantaspase",
        "Crisantaspasum",
        "Erwinase",
        "Erwinaze",
        "L-asparginase (Erwinia )"
      ]
    },
    {
      "fdaUniiCode": "U4VJ29L7BQ",
      "id": "Methoxsalen",
      "preferredName": "Methoxsalen",
      "synonyms": [
        "8-MOP",
        "8-Methoxypsoralen",
        "9-Methoxy-7H-furo[3,2-g][1]benzopyran-7-one",
        "Ammoidin",
        "Deltasoralen",
        "Dermox",
        "Geralen",
        "Geroxalen",
        "METHOXSALEN",
        "Meladinina",
        "Meladinine",
        "Methoxsalen",
        "Methoxypsoralen",
        "Metoxaleno",
        "Mopsoralen",
        "Oxsoralen",
        "Oxsoralen-Ultra",
        "Puvasoralen",
        "Ultramop",
        "Uvadex",
        "XANTHOTOXIN",
        "Xanthotoxin",
        "methoxsalen"
      ]
    },
    {
      "fdaUniiCode": "5277GPA358",
      "id": "Cenisertib",
      "preferredName": "Cenisertib",
      "synonyms": [
        "AS703569",
        "Aurora Kinase Inhibitor AS703569",
        "CENISERTIB",
        "Cenisertib",
        "R763"
      ]
    },
    {
      "fdaUniiCode": "W335P73C3L",
      "id": "Sapacitabine",
      "preferredName": "Sapacitabine",
      "synonyms": [
        "CS-682",
        "CYC682",
        "N-(1-(2-Cyano-2-deoxy-beta-D-arabinofuranosyl)-2-oxo-1,2-dihydropyrimidin-4-yl)-hexadecanamide",
        "SAPACITABINE",
        "Sapacitabine"
      ]
    },
    {
      "fdaUniiCode": "T61871RKRI",
      "id": "CDK_Inhibitor_R547",
      "preferredName": "CDK Inhibitor R547",
      "synonyms": [
        "CDK Inhibitor R547",
        "Cyclin Dependent Kinase Inhibitor R547",
        "Cyclin-Dependent Kinase Inhibitor R547",
        "R 547",
        "R-547",
        "R547",
        "RO 4584820",
        "RO-4584820",
        "RO4584820"
      ]
    },
    {
      "fdaUniiCode": "DA709Q5020",
      "id": "Zalutumumab",
      "preferredName": "Zalutumumab",
      "synonyms": [
        "2FB",
        "HuMax-EGFr, 2F8",
        "ZALUTUMUMAB",
        "Zalutumumab"
      ]
    },
    {
      "fdaUniiCode": "967Q0SJD77",
      "id": "Lexatumumab",
      "preferredName": "Lexatumumab",
      "synonyms": [
        "Anti-TRAIL Receptor 2 Monoclonal Antibody HGS-ETR2",
        "HGS-ETR2",
        "HGS1018",
        "LEXATUMUMAB",
        "Lexatumumab",
        "Monoclonal Antibody HGS-ETR2",
        "anti-TRAIL R2 mAb HGS-ETR2",
        "lexatumumab"
      ]
    },
    {
      "fdaUniiCode": "Z541VW0W40",
      "id": "EGFRHER2_Inhibitor_AV-412",
      "preferredName": "EGFR/HER2 Inhibitor AV-412",
      "synonyms": [
        "AV 412",
        "AV-412",
        "AV412",
        "EGFR/HER2 Inhibitor AV-412",
        "MP 412",
        "MP-412"
      ]
    },
    {
      "fdaUniiCode": "703P9YDP7F",
      "id": "Marizomib",
      "preferredName": "Marizomib",
      "synonyms": [
        "(1R,4R,5S)-4-(2-chloroethyl)-1-{(S)-[(1S)-cyclohex-2-en-1-yl]hydroxymethyl}-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione",
        "MARIZOMIB",
        "ML 858",
        "Marizomib",
        "NPI-0052",
        "Salinosporamide A",
        "Salinosporin A"
      ]
    },
    {
      "fdaUniiCode": "LQF7I567TQ",
      "id": "Crenolanib",
      "preferredName": "Crenolanib",
      "synonyms": [
        "4-Piperidinamine, 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1Hbenzimidazol-1-yl]-8-quinolinyl]-",
        "CP-868,596",
        "CP-868596",
        "CRENOLANIB",
        "Crenolanib",
        "PDGFR Inhibitor CP-868596",
        "[1-[2-[5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine"
      ]
    },
    {
      "fdaUniiCode": "X4W7ZR7023",
      "id": "Methylprednisolone",
      "preferredName": "Methylprednisolone",
      "synonyms": [
        "(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione",
        "6Alpha-Methylprednisolone",
        "Adlone",
        "Caberdelta M",
        "DepMedalone",
        "Depo Moderin",
        "Depo-Nisolone",
        "Duralone",
        "Emmetipi",
        "Esametone",
        "Firmacort",
        "METHYLPREDNISOLONE",
        "Medlone 21",
        "Medrate",
        "Medrol",
        "Medrol Veriderm",
        "Medrone",
        "Mega-Star",
        "Meprolone",
        "Methylprednisolone",
        "Methylprednisolonum",
        "Metilbetasone Solubile",
        "Metrocort",
        "Metypresol",
        "Metysolon",
        "Predni-M-Tablinen",
        "Prednilen",
        "Radilem",
        "Sieropresol",
        "Solpredone",
        "Summicort",
        "Urbason",
        "Veriderm Medrol",
        "Wyacort",
        "methylprednisolone"
      ]
    },
    {
      "fdaUniiCode": "X1BF92PW9T",
      "id": "CDK_Inhibitor_AT7519",
      "preferredName": "CDK Inhibitor AT7519",
      "synonyms": [
        "AT-7519",
        "AT7519",
        "AT7519M",
        "CDK Inhibitor AT7519",
        "CDK inhibitor AT7519M",
        "CDKI AT7519",
        "Cyclin-Dependent Kinase Inhibitor AT7519M"
      ]
    },
    {
      "fdaUniiCode": "9EK26WE8QN",
      "id": "Riviciclib",
      "preferredName": "Riviciclib",
      "synonyms": [
        "Cyclin Dependent Kinase Inhibitor P276",
        "P-276-00 Free Base",
        "P276",
        "P276-00",
        "RIVICICLIB",
        "Riviciclib"
      ]
    },
    {
      "fdaUniiCode": "76B44WEA8O",
      "id": "Efatutazone_Dihydrochloride",
      "preferredName": "Efatutazone Dihydrochloride",
      "synonyms": [
        "2,4-thiazolidinedione, 5-((4-((6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1h-benzimidazol-2-yl)methoxy)phenyl)methyl)-, Hydrochloride (1:2)",
        "CS-7017",
        "EFATUTAZONE DIHYDROCHLORIDE",
        "Efatutazone Dihydrochloride",
        "Inolitazone Dihydrochloride"
      ]
    },
    {
      "fdaUniiCode": "207SMY3FQT",
      "id": "Vemurafenib",
      "preferredName": "Vemurafenib",
      "synonyms": [
        "1-propanesulfonamide, n-(3-((5-(4-chlorophenyl)-1h-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-",
        "BRAF (V600E) kinase inhibitor RO5185426",
        "BRAF(V600E) Kinase Inhibitor RO5185426",
        "PLX-4032",
        "PLX4032",
        "RG 7204",
        "RG7204",
        "RO 5185426",
        "VEMURAFENIB",
        "Vemurafenib",
        "Zelboraf"
      ]
    },
    {
      "fdaUniiCode": "8ZHS5657EH",
      "id": "Tagraxofusp-erzs",
      "preferredName": "Tagraxofusp-erzs",
      "synonyms": [
        "DT(388)-IL3 Fusion Protein",
        "DT388IL3 fusion protein",
        "Diphtheria Toxin(388)-Interleukin-3 Fusion Protein",
        "Elzonris",
        "IL3R-targeting Fusion Protein SL-401",
        "S)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol",
        "SL-401",
        "TAGRAXOFUSP",
        "Tagraxofusp",
        "Tagraxofusp ERZS",
        "Tagraxofusp-erzs"
      ]
    },
    {
      "fdaUniiCode": "7G0Y719Q80",
      "id": "Tenifatecan",
      "preferredName": "Tenifatecan",
      "synonyms": [
        "(4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin- 9-yl (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-1-benzopyran-6-yl Butanedioate",
        "SN-2310",
        "SN2310",
        "TENIFATECAN",
        "Tenifatecan",
        "Tocopherol Succinate 7-Ethyl-10-Hydroxycamptothecin"
      ]
    },
    {
      "fdaUniiCode": "XKJ5VVK2WD",
      "id": "Navitoclax",
      "preferredName": "Navitoclax",
      "synonyms": [
        "A-855071.0",
        "ABT-263",
        "BcI-2 Family Protein Inhibitor ABT-263",
        "NAVITOCLAX",
        "Navitoclax",
        "navitoclax"
      ]
    },
    {
      "fdaUniiCode": "LSA9D0A43Q",
      "id": "Topsalysin",
      "preferredName": "Topsalysin",
      "synonyms": [
        "PORxin 302",
        "PRX 302",
        "PSA-PAH1",
        "Pore-forming Protein (Synthetic Proaerolysin) Fusion Protein with Prostate-specific Antigen (Human)",
        "TOPSALYSIN",
        "Topsalysin"
      ]
    },
    {
      "fdaUniiCode": "33380QZ0QW",
      "id": "Verubulin_Hydrochloride",
      "preferredName": "Verubulin Hydrochloride",
      "synonyms": [
        "Azixa",
        "MPC-6827",
        "Microtubule Inhibitor MPC-6827",
        "N-(4-methoxyphenyl)-n,2-dimethylquinazolin-4-amine Hydrochloride",
        "VERUBULIN HYDROCHLORIDE",
        "Verubulin Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "71B37NR06D",
      "id": "Soy_Isoflavones",
      "preferredName": "Soy Isoflavones",
      "synonyms": [
        "NovaSoy",
        "SOY ISOFLAVONES",
        "Solgen 40",
        "Soy Isoflavone",
        "Soy Isoflavones",
        "Soybean Isoflavone Mixture"
      ]
    },
    {
      "fdaUniiCode": "KXC7811DBY",
      "id": "Acolbifene_Hydrochloride",
      "preferredName": "Acolbifene Hydrochloride",
      "synonyms": [
        "ACOLBIFENE HYDROCHLORIDE",
        "Acolbifene Hydrochloride",
        "acolbifene hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "ELK3V90G6C",
      "id": "Alefacept",
      "preferredName": "Alefacept",
      "synonyms": [
        "ALEFACEPT",
        "Alefacept",
        "Amevive",
        "LFA3TIP",
        "alefacept"
      ]
    },
    {
      "fdaUniiCode": "3H04W2810V",
      "id": "Auranofin",
      "preferredName": "Auranofin",
      "synonyms": [
        "AURANOFIN",
        "Auranofin",
        "Ridaura"
      ]
    },
    {
      "fdaUniiCode": "7BHQ856EJ5",
      "id": "Clioquinol",
      "preferredName": "Clioquinol",
      "synonyms": [
        "5-Chloro-7-iodo-8-hydroxyquinoline",
        "5-Chloro-7-iodo-quinolin-8-ol",
        "AI3-16451",
        "CLIOQUINOL",
        "Clioquinol",
        "Iodochlorohydroxyquinoline",
        "Mycoquin"
      ]
    },
    {
      "fdaUniiCode": "320T6RNW1F",
      "id": "Mifepristone",
      "preferredName": "Mifepristone",
      "synonyms": [
        "(aa Beta, 17 beta)-11-[4-(dimethylamino)-phenyl]-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one",
        "11 Beta-[4-(N,N-dimethylamino)phenyl]-17alpha-(propyl-1-ynyl)-delta-4,9-estradiene-17 beta-ol-3-one",
        "11-((4-dimethylamino) phenyl)-17-Hydroxy-17-(1-propynyl) Estra-4,9- dien-3-one",
        "Korlym",
        "MIFEPRISTONE",
        "Mifegyne",
        "Mifeprex",
        "Mifepristone",
        "RU 486",
        "RU-38486",
        "RU-486",
        "mifepristone"
      ]
    },
    {
      "fdaUniiCode": "J4T82NDH7E",
      "id": "Erlotinib",
      "preferredName": "Erlotinib",
      "synonyms": [
        "ERLOTINIB",
        "Erlotinib",
        "erlotinib"
      ]
    },
    {
      "fdaUniiCode": "101V0R1N2E",
      "id": "Febuxostat",
      "preferredName": "Febuxostat",
      "synonyms": [
        "2-(3-Cyano-4-(2-methylpropoxy)phenyl)-4-methylthiazole-5-carboxylic Acid",
        "Adenuric",
        "FEBUXOSTAT",
        "Febuxostat",
        "TMX 67",
        "Uloric"
      ]
    },
    {
      "fdaUniiCode": "8FE7LTN8XE",
      "id": "Misonidazole",
      "preferredName": "Misonidazole",
      "synonyms": [
        "1-(alpha-methoxymethyl ethanol)-2-Nitroimidazole",
        "MISONIDAZOLE",
        "Misonidazole",
        "RO 7-0582",
        "Ro-07-0582",
        "Ro-7-0582"
      ]
    },
    {
      "fdaUniiCode": "426X066ELK",
      "id": "Forodesine",
      "preferredName": "Forodesine",
      "synonyms": [
        "FORODESINE",
        "Forodesine",
        "forodesine"
      ]
    },
    {
      "fdaUniiCode": "7Z7670589C",
      "id": "Fotretamine",
      "preferredName": "Fotretamine",
      "synonyms": [
        "2,2,4,4,6-Pentaethylenimino-6-morpholino-cyclotriphosphazatrien",
        "FOTRETAMINE",
        "Fotretamine",
        "Fotrin",
        "Photrin",
        "Photrine"
      ]
    },
    {
      "fdaUniiCode": "NIJ123W41V",
      "id": "Plicamycin",
      "preferredName": "Plicamycin",
      "synonyms": [
        "A-2371",
        "Aureolic acid",
        "MTH",
        "Mithracin",
        "Mithracine",
        "Mithramycin",
        "PA-144",
        "PLICAMYCIN",
        "Plicamycin",
        "mithramycin",
        "plicamycin"
      ]
    },
    {
      "fdaUniiCode": "7KKS9R192F",
      "id": "Gimatecan",
      "preferredName": "Gimatecan",
      "synonyms": [
        "7-t-Butoxyiminomethylcamptothecin",
        "GIMATECAN",
        "Gimatecan",
        "LBQ707",
        "ST1481",
        "STI481",
        "gimatecan"
      ]
    },
    {
      "fdaUniiCode": "443O19GK1A",
      "id": "Guanabenz_Acetate",
      "preferredName": "Guanabenz Acetate",
      "synonyms": [
        "3-((2,6-Dichlorophenyl)methylene)carbazamidine Monoacetate",
        "GUANABENZ ACETATE",
        "Guanabenz Acetate",
        "Wytensin"
      ]
    },
    {
      "fdaUniiCode": "5UP30YED7N",
      "id": "Mitobronitol",
      "preferredName": "Mitobronitol",
      "synonyms": [
        "1,6-Dibromo-1,6-dideoxy-D-mannitol",
        "DBM",
        "Dibromomannitol",
        "MITOBRONITOL",
        "Mitobronitol",
        "Myelobromol"
      ]
    },
    {
      "fdaUniiCode": "C6Y700V0M4",
      "id": "Inproquone",
      "preferredName": "Inproquone",
      "synonyms": [
        "INPROQUONE",
        "Inproquone"
      ]
    },
    {
      "fdaUniiCode": "OD5Q0L447W",
      "id": "Mitoguazone",
      "preferredName": "Mitoguazone",
      "synonyms": [
        "1,1'-((methylethanediylidene)dinitrilo)diguanidine",
        "2,2\"-(methyl-1,2-ethanediylidene)bis[hydrazinecarboximidamide]",
        "DRG-0223",
        "MGBG",
        "MITOGUAZONE",
        "Me-GAG",
        "Methyl GAG",
        "Methyl-G",
        "Methyl-GAG",
        "Methylglyoxal Bisguanylhydrazone",
        "Methylglyoxal bis(amidinohydrazone)",
        "Mitoguazone",
        "Zyrkamine",
        "methylglyoxal bis(guanylhydrazone)",
        "pyruvaldehyde bis(amidinohydrazone)"
      ]
    },
    {
      "fdaUniiCode": "02DQX562CR",
      "id": "Mitoclomine",
      "preferredName": "Mitoclomine",
      "synonyms": [
        "MITOCLOMINE",
        "Mitoclomine",
        "N,N-bis(2-chloroethyl)4-amino-2-methyl-1-methoxy-naphthalene"
      ]
    },
    {
      "fdaUniiCode": "2879S26V4P",
      "id": "Mitotenamine",
      "preferredName": "Mitotenamine",
      "synonyms": [
        "MITOTENAMINE",
        "Mitotenamine"
      ]
    },
    {
      "fdaUniiCode": "LJ2P1SIK8Y",
      "id": "Mitolactol",
      "preferredName": "Mitolactol",
      "synonyms": [
        "6-Dibromodideoxydulcitol",
        "6-Dibromodulcitol",
        "DBD",
        "Dibromdicil",
        "Dibromodulcitol",
        "Elobromol",
        "MITOLACTOL",
        "Mitolac",
        "Mitolactol",
        "mitolactol"
      ]
    },
    {
      "fdaUniiCode": "8KK8CQ2K8G",
      "id": "Niclosamide",
      "preferredName": "Niclosamide",
      "synonyms": [
        "Benzamide, 5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxy-",
        "NICLOSAMIDE",
        "Niclosamide",
        "Salicylanilide, 2',5-Dichloro-4'-nitro-"
      ]
    },
    {
      "fdaUniiCode": "A10SJL62JY",
      "id": "Ocrelizumab",
      "preferredName": "Ocrelizumab",
      "synonyms": [
        "OCRELIZUMAB",
        "Ocrelizumab",
        "PR070769",
        "PRO-70769",
        "PRO70769",
        "RO4964913",
        "rhuMAb 2H7"
      ]
    },
    {
      "fdaUniiCode": "VB67O9FBGM",
      "id": "Pentamustine",
      "preferredName": "Pentamustine",
      "synonyms": [
        "1-(2-Chloroethyl)-3-neopentyl-1-nitrosourea",
        "NCNU",
        "Neptamustine",
        "PENTAMUSTINE",
        "Pentamustine",
        "Salisburystin"
      ]
    },
    {
      "fdaUniiCode": "78E4J5IB5J",
      "id": "Mitotane",
      "preferredName": "Mitotane",
      "synonyms": [
        "(o,p)-DDD",
        "1, 1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane",
        "1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane",
        "1-Chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene",
        "2, 2-Bis(2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane",
        "2, 4'-Dichlorodiphenyldichloroethane",
        "2,2-Bis(2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane",
        "2,4'-Dichlorodiphenyldichloroethane",
        "2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethane",
        "CB 313",
        "CB-313",
        "Chloditan",
        "Chlodithane",
        "DDD",
        "Ethane, 2-(o-chlorophenyl)-2-(p-chlorophenyl)-1,1-dichloro-",
        "Khloditan",
        "Lisodren",
        "Lysodren",
        "MITOTANE",
        "Mitotane",
        "Mytotan",
        "Ortho,para-DDD",
        "WR-13045",
        "mitotane",
        "o,p' - DDD",
        "o,p'-DDD"
      ]
    },
    {
      "fdaUniiCode": "U6USW86RD0",
      "id": "Mitoxantrone_Hydrochloride",
      "preferredName": "Mitoxantrone Hydrochloride",
      "synonyms": [
        "1,3-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9, 10-anthracenedione Dihydrochloride",
        "1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9, 10-anthroquinone Dihydrochloride",
        "CL 232315",
        "DHAD",
        "DHAQ",
        "Dihydroxyanthracenedione Dihydrochloride",
        "MITOXANTRONE HYDROCHLORIDE",
        "Mitoxantrone Dihydrochloride",
        "Mitoxantrone Hydrochloride",
        "Mitoxantroni Hydrochloridum",
        "Mitozantrone Hydrochloride",
        "Mitroxone",
        "Neotalem",
        "Novantrone",
        "Onkotrone",
        "Pralifan"
      ]
    },
    {
      "fdaUniiCode": "A6IEZ5M406",
      "id": "Ranolazine",
      "preferredName": "Ranolazine",
      "synonyms": [
        "1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-(2-hydroxy- 3-(2-methoxyphenoxy)propyl)-",
        "RANOLAZINE",
        "Ranexa",
        "Ranolazine"
      ]
    },
    {
      "fdaUniiCode": "U604E1NB3K",
      "id": "Reparixin",
      "preferredName": "Reparixin",
      "synonyms": [
        "2-(4-Isobutylphenyl)propionylmethanesulfonamide",
        "Benzeneacetamide, Alpha-methyl-4-(2-methylpropyl)-N- (methylsulfonyl)- (alphaR)-",
        "DF 1681Y",
        "REPARIXIN",
        "Reparixin",
        "Repertaxin"
      ]
    },
    {
      "fdaUniiCode": "413KH5ZJ73",
      "id": "Rosuvastatin",
      "preferredName": "Rosuvastatin",
      "synonyms": [
        "ROSUVASTATIN",
        "Rosuvastatin"
      ]
    },
    {
      "fdaUniiCode": "R1308VH37P",
      "id": "Sobuzoxane",
      "preferredName": "Sobuzoxane",
      "synonyms": [
        "1,2-Bis(4-isobutoxycarbonyloxymethyl-3,5-dioxo-piperazin-1-yl)ethane",
        "MST-16",
        "SOBUZOXANE",
        "Sobuzoxane"
      ]
    },
    {
      "fdaUniiCode": "SH55B0RQ9K",
      "id": "Oblimersen_Sodium",
      "preferredName": "Oblimersen Sodium",
      "synonyms": [
        "Anticode G3139",
        "Augmerosen",
        "BCL-2 Antisense Oligodeoxynucleotide G3139",
        "BCL-2 Antisense/G3139",
        "G3139",
        "G3139 Antisense Oligonucleotide",
        "G3139 BCL-2 Antisense Oligo",
        "G3139 BCL-2 Antisense Oligodeoxynucleotide",
        "G3139 BCL-2 Antisense Oligonucleotide",
        "Genasense",
        "OBLIMERSEN SODIUM",
        "Oblimersen Sodium",
        "augmerosen",
        "bcl-2 antisense oligodeoxynucleotide G3139",
        "oblimersen sodium"
      ]
    },
    {
      "fdaUniiCode": "B76N6SBZ8R",
      "id": "Gemcitabine",
      "preferredName": "Gemcitabine",
      "synonyms": [
        "1-(2-Oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose",
        "2'Deoxy-2',2'-Difluorocytidine",
        "Difluorodeoxycytidine",
        "GEMCITABINE",
        "Gemcitabine",
        "dFdC",
        "dFdCyd",
        "gemcitabine"
      ]
    },
    {
      "fdaUniiCode": "G873GX646R",
      "id": "Lapatinib_Ditosylate",
      "preferredName": "Lapatinib Ditosylate",
      "synonyms": [
        "4-Quinazolinamine, N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl), bis(4-methylbenzenesulfonate), Monohydrate",
        "LAPATINIB DITOSYLATE",
        "Lapatinib Ditosylate",
        "Tykerb",
        "lapatinib ditosylate"
      ]
    },
    {
      "fdaUniiCode": "3KY0EUQ36S",
      "id": "Gataparsen_Sodium",
      "preferredName": "Gataparsen Sodium",
      "synonyms": [
        "Antisurvivin Antisense Oligonucleotide LY2181308",
        "GATAPARSEN SODIUM",
        "Gataparsen Sodium",
        "LY 2181308",
        "LY-2181308",
        "LY2181308",
        "LY2181308 Heptadecasodium Salt"
      ]
    },
    {
      "fdaUniiCode": "51F690397J",
      "id": "Cabazitaxel",
      "preferredName": "Cabazitaxel",
      "synonyms": [
        "1-hydroxy-7beta,10beta-dimethoxy-9-oxo-5beta,20-epoxytax-11-ene-2alpha,4,13alpha-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-{[(tertbutoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoate]",
        "CABAZITAXEL",
        "Cabazitaxel",
        "Jevtana",
        "RPR-116258A",
        "Taxoid XRP6258",
        "XRP-6258",
        "cabazitaxel",
        "taxoid XRP6258"
      ]
    },
    {
      "fdaUniiCode": "9ENT43KY91",
      "id": "Crolibulin",
      "preferredName": "Crolibulin",
      "synonyms": [
        "CROLIBULIN",
        "Crolibulin",
        "EPC2407",
        "Microtubule Inhibitor EPC2407"
      ]
    },
    {
      "fdaUniiCode": "6UH91I579U",
      "id": "Selumetinib",
      "preferredName": "Selumetinib",
      "synonyms": [
        "ARRY-142886",
        "AZD6244",
        "MEK Inhibitor AZD6244",
        "MEK inhibitor AZD6244",
        "SELUMETINIB",
        "Selumetinib"
      ]
    },
    {
      "fdaUniiCode": "41UD74L59M",
      "id": "Afatinib",
      "preferredName": "Afatinib",
      "synonyms": [
        "(2e)-N-(4-(3-Chloro-4-Fluoroanilino)-7-(((3s)-Oxolan-3-yl)Oxy)Quinoxazolin-6-yl)-4-(Dimethylamino)But-2-Enamide",
        "AFATINIB",
        "Afatinib",
        "BIBW 2992",
        "BIBW2992"
      ]
    },
    {
      "fdaUniiCode": "7XL5ISS668",
      "id": "Brentuximab_Vedotin",
      "preferredName": "Brentuximab Vedotin",
      "synonyms": [
        "ADC SGN-35",
        "Adcetris",
        "Anti-CD30 Antibody-Drug Conjugate SGN-35",
        "Anti-CD30 Monoclonal Antibody-MMAE SGN-35",
        "Anti-CD30 Monoclonal Antibody-Monomethylauristatin E SGN-35",
        "BRENTUXIMAB VEDOTIN",
        "Brentuximab Vedotin",
        "SGN-35",
        "cAC10-vcMMAE"
      ]
    },
    {
      "fdaUniiCode": "5346058Q7S",
      "id": "Dexrazoxane_Hydrochloride",
      "preferredName": "Dexrazoxane Hydrochloride",
      "synonyms": [
        "Cardioxane",
        "DEXRAZOXANE HYDROCHLORIDE",
        "Dexrazoxane Hydrochloride",
        "Totect",
        "Zinecard",
        "dexrazoxane hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "9647FM7Y3Z",
      "id": "Panobinostat",
      "preferredName": "Panobinostat",
      "synonyms": [
        "(2E)-N-hydroxy-3-(4-(((2-(2-methyl-1h-indol-3-yl)ethyl)amino)methyl)phenyl)prop-2-enamide",
        "Faridak",
        "LBH589",
        "PANOBINOSTAT",
        "Panobinostat",
        "panobinostat"
      ]
    },
    {
      "fdaUniiCode": "0FWR494EC9",
      "id": "Elisidepsin",
      "preferredName": "Elisidepsin",
      "synonyms": [
        "Depsipeptide PM02734",
        "ELISIDEPSIN",
        "Elisidepsin",
        "L-Valine, N-((4S)-4-methyl-1-oxohexyl)-D-valyl-L-threonyl-L-valyl-D-valyl-D-prolyl-L-ornithyl-D-alloisoleucyl-D-allothreonyl-D-alloisoleucyl-D-valyl-L-phenylalanyl-(2Z)-2-amino-2-butenoyl-, (13-8)-lactone, 2,2,2-trifluoroacetate (1:1)",
        "PM02734"
      ]
    },
    {
      "fdaUniiCode": "M95KG522R0",
      "id": "Ofatumumab",
      "preferredName": "Ofatumumab",
      "synonyms": [
        "Arzerra",
        "GSK1841157",
        "HuMax-CD20",
        "HuMax-CD20, 2F2",
        "Kesimpta",
        "OFATUMUMAB",
        "Ofatumumab",
        "ofatumumab"
      ]
    },
    {
      "fdaUniiCode": "01DZ4127G7",
      "id": "Belotecan_Hydrochloride",
      "preferredName": "Belotecan Hydrochloride",
      "synonyms": [
        "BELOTECAN HYDROCHLORIDE",
        "Belotecan Hydrochloride",
        "CKD602 HCl",
        "belotecan hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "1351PE5UGS",
      "id": "Elotuzumab",
      "preferredName": "Elotuzumab",
      "synonyms": [
        "BMS-901608",
        "ELOTUZUMAB",
        "Elotuzumab",
        "Empliciti",
        "HuLuc-63",
        "HuLuc63",
        "PDL-063",
        "PDL063"
      ]
    },
    {
      "fdaUniiCode": "2OP4E0GC6V",
      "id": "Milatuzumab",
      "preferredName": "Milatuzumab",
      "synonyms": [
        "Humanized Anti-CD74 Monoclonal Antibody hLL1",
        "IMMU-115",
        "MILATUZUMAB",
        "Milatuzumab",
        "Monoclonal Antibody hLL1",
        "hLL1",
        "milatuzumab"
      ]
    },
    {
      "fdaUniiCode": "E780TX33D2",
      "id": "Daniquidone",
      "preferredName": "Daniquidone",
      "synonyms": [
        "8-Aminoisoindolo(1,2-b)quinazolin-12(10H)-one",
        "Batracylin",
        "Bay H 2049",
        "DANIQUIDONE",
        "Daniquidone",
        "batracylin"
      ]
    },
    {
      "fdaUniiCode": "6A4U6NN813",
      "id": "Palifosfamide",
      "preferredName": "Palifosfamide",
      "synonyms": [
        "IPM-Lysine",
        "Isophosphoramide Mustard-Lysine",
        "N,N'-Di-(2-chloroethyl)phosphorodiamidic Acid",
        "PALIFOSFAMIDE",
        "Palifosfamide",
        "ZIO-201"
      ]
    },
    {
      "fdaUniiCode": "DDU33B674I",
      "id": "Brivanib",
      "preferredName": "Brivanib",
      "synonyms": [
        "(R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol",
        "BMS-540215",
        "BRIVANIB",
        "Brivanib",
        "VEGFR2 Inhibitor BMS-540215",
        "brivanib"
      ]
    },
    {
      "fdaUniiCode": "V71TF6V9M7",
      "id": "Daporinad",
      "preferredName": "Daporinad",
      "synonyms": [
        "(2E)-N-(4-(1-Benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)prop-2-enamide",
        "APO866",
        "DAPORINAD",
        "Daporinad",
        "FK-866",
        "K 22.175",
        "NMPRTase Inhibitor APO866"
      ]
    },
    {
      "fdaUniiCode": "W2ZU1RY8B0",
      "id": "Green_Tea",
      "preferredName": "Green Tea",
      "synonyms": [
        "GREEN TEA LEAF",
        "Green Tea"
      ]
    },
    {
      "fdaUniiCode": "G6242H2NAA",
      "id": "Quinacrine_Hydrochloride",
      "preferredName": "Quinacrine Hydrochloride",
      "synonyms": [
        "6-Chloro-9-((4-(diethylamino)-1-methylbutyl)amino)-2-methoxyacridine Dihydrochloride",
        "Atabrine Dihydrochloride",
        "Mepacrine Dihydrochloride",
        "QUINACRINE HYDROCHLORIDE",
        "Quinacrine Dihydrochloride",
        "Quinacrine Hydrochloride",
        "SN 390"
      ]
    },
    {
      "fdaUniiCode": "51WEW898IJ",
      "id": "Rilotumumab",
      "preferredName": "Rilotumumab",
      "synonyms": [
        "AMG 102",
        "Anti-HGF Monoclonal Antibody AMG 102",
        "Fully Human Anti-HGF Monoclonal Antibody AMG 102",
        "RILOTUMUMAB",
        "Rilotumumab",
        "anti-HGF monoclonal antibody AMG 102"
      ]
    },
    {
      "fdaUniiCode": "2M3055079H",
      "id": "Brivudine",
      "preferredName": "Brivudine",
      "synonyms": [
        "(E)-5-(2-Bromovinyl)-deoxyuridine",
        "BRIVUDINE",
        "BVDU",
        "Brivudine",
        "Bromovinyl-Deoxyuridine",
        "Helpin",
        "RP101",
        "Trans-5-(2-Bromovinyl)-2'-deoxyuridine",
        "brivudine"
      ]
    },
    {
      "fdaUniiCode": "HU9DX48N0T",
      "id": "Mycophenolic_Acid",
      "preferredName": "Mycophenolic Acid",
      "synonyms": [
        "4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (E)-",
        "4-Hexenoic acid, 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-, (E)-",
        "Acide mycophenolique",
        "Acido micofenolico",
        "Acidum mycophenolicum",
        "Lilly-68618",
        "Ly 68618",
        "MPA",
        "MYCOPHENOLIC ACID",
        "Mycophenolic Acid",
        "Myfortic"
      ]
    },
    {
      "fdaUniiCode": "ZL1R02VT79",
      "id": "Ranibizumab",
      "preferredName": "Ranibizumab",
      "synonyms": [
        "Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor) Fab Fragment (Human-Mouse Monoclonal rhuFab V2 Gamma1 Chain), Disulfide With Human-Mouse Monoclonal rhuFab V2 Light Chain",
        "Lucentis",
        "RANIBIZUMAB",
        "Ranibizumab"
      ]
    },
    {
      "fdaUniiCode": "PP082U6W1L",
      "id": "Zinostatin",
      "preferredName": "Zinostatin",
      "synonyms": [
        "A 8544527G1",
        "Holoneocarzinostatin",
        "NCS",
        "Neocarzinostatin",
        "Vinostatin",
        "ZINOSTATIN",
        "Zinostatin"
      ]
    },
    {
      "fdaUniiCode": "G2SH0XKK91",
      "id": "Retinol",
      "preferredName": "Retinol",
      "synonyms": [
        "3,7-Dimethyl-9-(2,6, 6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol",
        "3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol",
        "3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-nona-2,4,6,8-tetraen-1-ol",
        "All Trans Retinol",
        "RETINOL",
        "Retinol",
        "retinol"
      ]
    },
    {
      "fdaUniiCode": "0867I0N41V",
      "id": "Tocotrienol",
      "preferredName": "Tocotrienol",
      "synonyms": [
        "TOCOTRIENOL",
        "Tocotrienol",
        "alpha-Tocotrienol"
      ]
    },
    {
      "fdaUniiCode": "31YO63LBSN",
      "id": "Nivolumab",
      "preferredName": "Nivolumab",
      "synonyms": [
        "BMS-936558",
        "CMAB819",
        "MDX-1106",
        "NIVO",
        "NIVOLUMAB",
        "Nivolumab",
        "Nivolumab Biosimilar CMAB819",
        "ONO-4538",
        "Opdivo"
      ]
    },
    {
      "fdaUniiCode": "2NDX4B6N8F",
      "id": "Moxetumomab_Pasudotox",
      "preferredName": "Moxetumomab Pasudotox",
      "synonyms": [
        "Anti-CD22 Immunotoxin CAT-8015",
        "CAT-8015",
        "GCR-8015",
        "HA22",
        "Immunotoxin CAT-8015",
        "Lumoxiti",
        "MOXETUMOMAB PASUDOTOX",
        "Moxetumomab Pasudotox",
        "Moxetumomab Pasudotox-TDFK",
        "anti-CD22 immunotoxin CAT-8015"
      ]
    },
    {
      "fdaUniiCode": "EM5OCB9YJ6",
      "id": "Abiraterone_Acetate",
      "preferredName": "Abiraterone Acetate",
      "synonyms": [
        "17-(3-Pyridyl)-5,16-androstadien-3beta-acetate",
        "ABIRATERONE ACETATE",
        "Abiraterone Acetate",
        "Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, acetate (ester), (3beta)-",
        "BR9004",
        "BR9004-1",
        "CB7630",
        "JNJ-212082",
        "Yonsa",
        "Zytiga",
        "abiraterone acetate"
      ]
    },
    {
      "fdaUniiCode": "IYO470654U",
      "id": "Abexinostat",
      "preferredName": "Abexinostat",
      "synonyms": [
        "2-benzofurancarboxamide, 3-((dimethylamino)methyl)-n-(2-(4-((hydroxyamino)carbonyl)phenoxy)ethyl)-",
        "3-((dimethylamino)methyl)-N-(2-(4-(hydroxycarbamoyl)phenoxy)ethyl)-1-benzofuran-2-carboxamide",
        "ABEXINOSTAT",
        "Abexinostat",
        "CRA-024781",
        "HDAC Inhibitor PCI-24781",
        "PCI-24781"
      ]
    },
    {
      "fdaUniiCode": "C28MV4IM0B",
      "id": "Aldoxorubicin",
      "preferredName": "Aldoxorubicin",
      "synonyms": [
        "ALDOXORUBICIN",
        "Aldoxorubicin",
        "DOXO-EMCH",
        "Doxorubicin-EMCH",
        "INNO-206"
      ]
    },
    {
      "fdaUniiCode": "ER29L26N1X",
      "id": "Cobimetinib",
      "preferredName": "Cobimetinib",
      "synonyms": [
        "COBIMETINIB",
        "Cobimetinib",
        "Cotellic",
        "GDC-0973",
        "MEK Inhibitor GDC-0973",
        "XL518"
      ]
    },
    {
      "fdaUniiCode": "D6V5QYX9MZ",
      "id": "Teglarinad_Chloride",
      "preferredName": "Teglarinad Chloride",
      "synonyms": [
        "CHS828 Prodrug",
        "EB1627",
        "GMX1777",
        "Pyridinium, 4-[[[[6-(4-chlorophenoxy)hexyl]amino](cyanoamino) methylene]amino]-1-(3-oxo-2,4,7,10,13,16-hexaoxaheptadec-1-yl)-, chloride",
        "TEGLARINAD CHLORIDE",
        "Teglarinad Chloride"
      ]
    },
    {
      "fdaUniiCode": "7LA4O6Q0D3",
      "id": "Quizartinib",
      "preferredName": "Quizartinib",
      "synonyms": [
        "(2E)-N-(4-(3-Chloro-4-Fluoroanilino)-7-(((3S)-Oxolan-3-Yl)Oxy)Quinoxazolin-6-yl)-4-(Dimethylamino)but-2-Enamide",
        "AC-220",
        "AC010220",
        "AC220",
        "N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo [2,1-b] [1,3] benzothiazol 2-yl]phenyl}urea",
        "QUIZARTINIB",
        "Quizartinib"
      ]
    },
    {
      "fdaUniiCode": "8A49OSO368",
      "id": "Filanesib",
      "preferredName": "Filanesib",
      "synonyms": [
        "1,3,4-Thiadiazole-3(2H)-carboxamide, 2-(3-Aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-, (2S)-",
        "ARRY-520",
        "ARRY520",
        "FILANESIB",
        "Filanesib"
      ]
    },
    {
      "fdaUniiCode": "IJ3FUK8MOF",
      "id": "Therapeutic_Angiotensin-1-7",
      "preferredName": "Therapeutic Angiotensin-(1-7)",
      "synonyms": [
        "ANGIOTENSIN 1-7",
        "Ang 1-7",
        "Angiotensin 1-7",
        "TXA 127",
        "TXA-127",
        "TXA127",
        "Therapeutic Angiotensin-(1-7)",
        "therapeutic angiotensin-(1-7)"
      ]
    },
    {
      "fdaUniiCode": "R60DZX1E2N",
      "id": "Pladienolide_Derivative_E7107",
      "preferredName": "Pladienolide Derivative E7107",
      "synonyms": [
        "E7107",
        "Pladienolide Derivative E7107"
      ]
    },
    {
      "fdaUniiCode": "K3L4X0501F",
      "id": "Rindopepimut",
      "preferredName": "Rindopepimut",
      "synonyms": [
        "Anti-EGFRvIII Vaccine CDX-110",
        "CDX-110",
        "L-Cysteine, L-leucyl-L-alpha-glutamyl-L-alpha-glutamyl-L-lysyl-L-lysylglycyl-L-asparaginyl-L-tyrosyl-L-valyl-L-valyl-L-threonyl-L-alpha-aspartyl-L-histidyl-S-(1-((4-carboxycyclohexyl)methyl)-2,5-dioxo-3-pyrrolidinyl)-, complex with hemocyanin (Megathura crenulata)",
        "PF-04948568",
        "RINDOPEPIMUT",
        "Rindopepimut"
      ]
    },
    {
      "fdaUniiCode": "3TTT9ZD93F",
      "id": "Recombinant_Nematode_Anticoagulant_Protein_c2",
      "preferredName": "Recombinant Nematode Anticoagulant Protein c2",
      "synonyms": [
        "RECOMBINANT NEMATODE ANTICOAGULANT PROTEIN C2",
        "Recombinant Nematode Anticoagulant Protein c2",
        "rNAPc2"
      ]
    },
    {
      "fdaUniiCode": "O3571H3R8N",
      "id": "Enobosarm",
      "preferredName": "Enobosarm",
      "synonyms": [
        "ENOBOSARM",
        "Enobosarm",
        "Gtx-024",
        "Ostarine",
        "Propanamide, 3-(4-cyanophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methyl-, (2S)-"
      ]
    },
    {
      "fdaUniiCode": "57WA9QZ5WH",
      "id": "Nimodipine",
      "preferredName": "Nimodipine",
      "synonyms": [
        "NIMO",
        "NIMODIPINE",
        "Nimodipine",
        "Nimotop",
        "nimodipine"
      ]
    },
    {
      "fdaUniiCode": "0S726V972K",
      "id": "Nimustine",
      "preferredName": "Nimustine",
      "synonyms": [
        "3-((4-Amino-2-Methyl-5-Pyrimidinyl)Methyl)-1-(2-Chloroethyl)-1-Nitrosourea",
        "ACNU",
        "N'-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitrosourea",
        "NIMUSTINE",
        "Nidran",
        "Nimustine",
        "nimustine"
      ]
    },
    {
      "fdaUniiCode": "L059DCD6IP",
      "id": "Nogalamycin",
      "preferredName": "Nogalamycin",
      "synonyms": [
        "Antibiotic 205T3",
        "NOGALAMYCIN",
        "Nogalamycin",
        "U 15167",
        "U-15167",
        "[2R-(2alpha,3beta,4alpha,5beta,6alpha,11beta,13alpha,14alpha)]-11-[(6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-alpha-L-mannopyranosyl)oxy]-4(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-2,6-epoxy-2H-naphthaceno[1,2-b]oxocin-14-carboxylic acid methyl ester"
      ]
    },
    {
      "fdaUniiCode": "7BO8G1BYQU",
      "id": "Masoprocol",
      "preferredName": "Masoprocol",
      "synonyms": [
        "4,4'-(2,3-Dimethyl-1,4-butanediyl)bis[1,2-benzenediol]",
        "Actinex",
        "MASOPROCOL",
        "Masoprocol",
        "NDGA",
        "NDHGA",
        "Nordihydroguaiaretic Acid",
        "Nordihydroguaiaretic acid",
        "masoprocol"
      ]
    },
    {
      "fdaUniiCode": "3J8Q1747Z2",
      "id": "Norgestrel",
      "preferredName": "Norgestrel",
      "synonyms": [
        "(+/-)-13-Ethyl-17alpha-hydroxy-18,19-dinorpregn-4-en-20-yne-3-one",
        "(17alpha)-(+/-)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yne-3-one",
        "NORGESTREL",
        "Neogest",
        "Norgestrel",
        "Ovrette",
        "Wy-3707"
      ]
    },
    {
      "fdaUniiCode": "KZK563J2UW",
      "id": "Tosedostat",
      "preferredName": "Tosedostat",
      "synonyms": [
        "Aminopeptidase inhibitor CHR-2797",
        "CHR-2797",
        "Cyclopentyl (2S)-2-{(2R)-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl]-4- methylpentanamido}-2-phenylacetate",
        "TOSEDOSTAT",
        "Tosedostat"
      ]
    },
    {
      "fdaUniiCode": "WC4978T687",
      "id": "Firtecan_Pegol",
      "preferredName": "Firtecan Pegol",
      "synonyms": [
        "EZN-2208",
        "FIRTECAN PEGOL",
        "Firtecan Pegol",
        "PEG-SN38",
        "Poly(oxy-1,2-ethanediyl), alpha,alpha',alpha'',alpha'''-(oxydi-3,1,2-propanetriyl)tetrakis(omega-(2-((2-(((4S)- 4,11-diethyl-9-hydroxy-3,4,12,14-tetrahydro-3,14-dioxo-1H-pyrano(3',4':6,7) indolizino(1,2-b)quinolin-4-yl)oxy)-2-oxoethyl)amino)-2-oxoethoxy)-"
      ]
    },
    {
      "fdaUniiCode": "O43472U9X8",
      "id": "Obinutuzumab",
      "preferredName": "Obinutuzumab",
      "synonyms": [
        "Afutuzumab",
        "Anti-CD20 Monoclonal Antibody R7159",
        "GA-101",
        "GA101",
        "Gazyva",
        "OBINUTUZUMAB",
        "Obinutuzumab",
        "R7159",
        "RO 5072759",
        "RO-5072759",
        "RO5072759",
        "huMAB(CD20)"
      ]
    },
    {
      "fdaUniiCode": "D99YVK4L0X",
      "id": "Ramucirumab",
      "preferredName": "Ramucirumab",
      "synonyms": [
        "Anti-VEGFR-2 Fully Human Monoclonal Antibody IMC-1121B",
        "Cyramza",
        "IMC-1121B",
        "LY3009806",
        "Monoclonal Antibody HGS-ETR2",
        "RAMUCIRUMAB",
        "Ramucirumab",
        "anti-VEGFR-2 fully human monoclonal antibody IMC-1121B",
        "ramucirumab"
      ]
    },
    {
      "fdaUniiCode": "T23U22X160",
      "id": "HIF-1alpha_Inhibitor_PX-478",
      "preferredName": "HIF-1alpha Inhibitor PX-478",
      "synonyms": [
        "(S)-4-(2-Amino-2-carboxyethyl)-N,N-bis(2-chloroethyl)aniline Oxide Dihydrochloride",
        "HIF-1alpha Inhibitor PX-478",
        "Hypoxia Inducible Factor 1-Alpha PX-478",
        "L-Phenylalanine, 4-[Bis(2-chloroethyl)oxidoamino]-, Dihydrochloride",
        "L-Phenylalanine, 4-[Bis(2-chloroethyl)oxidoamino]-, Hydrochloride (1:2)",
        "PX-478"
      ]
    },
    {
      "fdaUniiCode": "15A52GPT8T",
      "id": "Linsitinib",
      "preferredName": "Linsitinib",
      "synonyms": [
        "Cyclobutanol, 3-[8-amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-methyl, cis-",
        "IGF-1R inhibitor OSI-906",
        "LINSITINIB",
        "Linsitinib",
        "OSI-906",
        "OSI-906AA",
        "cis-3-(8-Amino-1-(2-Phenylquinolin-7-yl)Imidazo(1,5-A)Pyrazin-3-yl)-1-Methylcyclobutanol"
      ]
    },
    {
      "fdaUniiCode": "3HO3IZ2ILX",
      "id": "Apoptosis_Inducer_GCS-100",
      "preferredName": "Apoptosis Inducer GCS-100",
      "synonyms": [
        "Apoptosis Inducer GCS-100",
        "GCS-100"
      ]
    },
    {
      "fdaUniiCode": "MRS84YT9L2",
      "id": "Coltuximab_Ravtansine",
      "preferredName": "Coltuximab Ravtansine",
      "synonyms": [
        "Anti-CD19-DM4 Immunoconjugate SAR3419",
        "COLTUXIMAB RAVTANSINE",
        "Coltuximab Ravtansine",
        "SAR3419"
      ]
    },
    {
      "fdaUniiCode": "6TC1BB2EV9",
      "id": "Carlumab",
      "preferredName": "Carlumab",
      "synonyms": [
        "Anti-human Small-inducible Cytokine A2 Monoclonal Antibody CNTO 888",
        "CARLUMAB",
        "CNTO 888",
        "Carlumab",
        "Immunoglobulin G1, anti-(human monocyte chemoattractant protein-1) (human monoclonal CNTO888 gamma 1-chain), disulfide with human monoclonal CNTO888 kappa-chain, dimer"
      ]
    },
    {
      "fdaUniiCode": "0OOS09O1FH",
      "id": "Nadofaragene_Firadenovec",
      "preferredName": "Nadofaragene Firadenovec",
      "synonyms": [
        "Instiladrin",
        "NADOFARAGENE FIRADENOVEC",
        "Nadofaragene Firadenovec",
        "Recombinant Adenovirus-Interferon SCH 721015",
        "SCH 721015",
        "rAd-IFN",
        "rAd-IFN-2b"
      ]
    },
    {
      "fdaUniiCode": "B932PAQ1BQ",
      "id": "Pidilizumab",
      "preferredName": "Pidilizumab",
      "synonyms": [
        "CT 011",
        "CT-011",
        "Immunoglobulin G1, Anti-(Human Programmed Cell Death 1); Humanized Mouse Monoclonal CT-011 Gamma1 Heavy Chain (220-213')-disulfide with Humanized Mouse Monoclonal CT-011 Kappa Light Chain Dimer (226-226'':229-229'')-bisdisulfide, Glycosylated (CT-011 is Expressed in NSO Cells)",
        "MDV9300",
        "PIDILIZUMAB",
        "Pidilizumab"
      ]
    },
    {
      "fdaUniiCode": "1P48L61KM0",
      "id": "Conatumumab",
      "preferredName": "Conatumumab",
      "synonyms": [
        "AMG 655",
        "Anti-TRAIL Receptor 2 Monoclonal Antibody AMG 655",
        "CONATUMUMAB",
        "Conatumumab",
        "Immunoglobulin G1, Anti-(Human Tumor Necrosis Factor Receptor Superfamily Member 10b (Death Receptor 5, Trail-R2, CD262 Antigen))",
        "Monoclonal XG1-048 (Arg(Sup 219),Glu(Sup 361),Met(Sup 363))Gamma-1 Heavy Chain (225-215')-Disulphide With Kappa Light Chain (231-231'':234-234'')-Bisdisulphide Dimer"
      ]
    },
    {
      "fdaUniiCode": "08V52GZ3H9",
      "id": "Tamibarotene",
      "preferredName": "Tamibarotene",
      "synonyms": [
        "4-((5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl)",
        "Am-80",
        "Am80",
        "Benzoic Acid, 4-(((5,6,7,8-tetrahydro-5,5,8,8-Tetramethyl-2-naphthalenyl)amino)carbonyl)-",
        "INNO-507",
        "N-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)terephthalamic Acid",
        "Retinobenzoic Acid",
        "SY-1425",
        "TAMIBAROTENE",
        "TM-411",
        "TOS-80T",
        "Tamibarotene",
        "Z-208"
      ]
    },
    {
      "fdaUniiCode": "RWM8CCW8GP",
      "id": "Octreotide",
      "preferredName": "Octreotide",
      "synonyms": [
        "D-Phenylalanyl-L-cysteinyl-L-phenyl-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide Cyclic (2->7)-Disulfide",
        "D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol Cyclic (2->7)-Disulfide",
        "D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hyroxymethyl)propyl]-L-cysteinamide, Cyclic (2->7)-disulfide",
        "OCTREOTIDE",
        "Octreotide",
        "SMS-201-995",
        "octreotide"
      ]
    },
    {
      "fdaUniiCode": "MZH0OM550M",
      "id": "Salirasib",
      "preferredName": "Salirasib",
      "synonyms": [
        "2-(((2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl)sulfanyl)benzoic Acid",
        "S-Farnesylthiosalicylic Acid",
        "SALIRASIB",
        "Salirasib"
      ]
    },
    {
      "fdaUniiCode": "Q400352CM2",
      "id": "Magnesium_Valproate",
      "preferredName": "Magnesium Valproate",
      "synonyms": [
        "Magnesium Dipropylacetate",
        "Magnesium Valproate",
        "Pentanoic acid, 2-propyl-, Magnesium Salt",
        "VALPROATE MAGNESIUM",
        "Valproate Magnesium"
      ]
    },
    {
      "fdaUniiCode": "L0505LPC7O",
      "id": "Anti-PSCA_Monoclonal_Antibody_AGS-1C4D4",
      "preferredName": "Anti-PSCA Monoclonal Antibody AGS-1C4D4",
      "synonyms": [
        "AGS-1C4D4",
        "Anti-PSCA Monoclonal Antibody AGS-1C4D4",
        "MK-4721",
        "MK4721"
      ]
    },
    {
      "fdaUniiCode": "406FL5G00V",
      "id": "Rigosertib_Sodium",
      "preferredName": "Rigosertib Sodium",
      "synonyms": [
        "ON 01910.Na",
        "Polo-like kinase 1 Inhibitor ON 01910.Na",
        "RIGOSERTIB SODIUM",
        "Rigosertib Sodium"
      ]
    },
    {
      "fdaUniiCode": "C6V1DAR5EB",
      "id": "Luminespib",
      "preferredName": "Luminespib",
      "synonyms": [
        "AUY922",
        "Hsp90 Inhibitor AUY922",
        "LUMINESPIB",
        "Luminespib",
        "NVP AUY 922",
        "NVP-AUY 922"
      ]
    },
    {
      "fdaUniiCode": "44003517D1",
      "id": "Olivomycin",
      "preferredName": "Olivomycin",
      "synonyms": [
        "OLIVOMYCIN",
        "Oligomycin A, mixt. with oligomycin B",
        "Olivomycin",
        "Olivomycins",
        "Toyomycin R"
      ]
    },
    {
      "fdaUniiCode": "V983921H3B",
      "id": "Robatumumab",
      "preferredName": "Robatumumab",
      "synonyms": [
        "Anti-IGF-1R Recombinant Monoclonal Antibody SCH 717454",
        "Immunoglobulin G1, Anti-(Human Insulin-Like Growth Factor I Receptor) (Human Monoclonal SCH 717454 Heavy Chain), Disulfide with Human Monoclonal SCH 717454 Light Chain, Dimer",
        "ROBATUMUMAB",
        "Robatumumab",
        "Sch717454"
      ]
    },
    {
      "fdaUniiCode": "XH2662798I",
      "id": "SerineThreonine_Kinase_Inhibitor_CBP501",
      "preferredName": "Serine/Threonine Kinase Inhibitor CBP501",
      "synonyms": [
        "CBP 501",
        "CBP-501",
        "CBP501",
        "Cdc25C Phosphatase (211-221)",
        "D-Arginine, 4-Benzoyl-D-phenylalanyl-D-seryl-D-tryptophyl-D-seryl-2,3,4,5,6-pentafluoro-D-phenylalanyl-3-cyclohexyl-D-alanyl-D-arginyl-D- arginyl-D-arginyl-D-glutaminyl-D-arginyl-",
        "Serine/Threonine Kinase Inhibitor CBP501"
      ]
    },
    {
      "fdaUniiCode": "Y60655Y65T",
      "id": "Anti-IGF-1R_Recombinant_Monoclonal_Antibody_BIIB022",
      "preferredName": "Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022",
      "synonyms": [
        "Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022",
        "BIIB-022",
        "BIIB022"
      ]
    },
    {
      "fdaUniiCode": "CK1441RCZ8",
      "id": "Ganitumab",
      "preferredName": "Ganitumab",
      "synonyms": [
        "AMG 479",
        "Anti-IGF-1R Human Monoclonal Antibody AMG-479",
        "GANITUMAB",
        "Ganitumab"
      ]
    },
    {
      "fdaUniiCode": "K82DG47I0G",
      "id": "Pexastimogene_Devacirepvec",
      "preferredName": "Pexastimogene Devacirepvec",
      "synonyms": [
        "JX 594",
        "JX-594",
        "JX594",
        "PEXASTIMOGENE DEVACIREPVEC",
        "Pexa-vec",
        "Pexastimogene Devacirepvec",
        "TG-6006",
        "Thymidine Kinase (-) Vaccinia-GM-CSF JX-594 Vaccine",
        "Thymidine Kinase-deleted Vaccinia-hGM-CSF",
        "VAC GM-CSF"
      ]
    },
    {
      "fdaUniiCode": "TX5CYN1KMZ",
      "id": "Indoximod",
      "preferredName": "Indoximod",
      "synonyms": [
        "1-MT",
        "1-Methyl-D-tryptophan",
        "1-methyl-d-tryptophan",
        "D-(+)-1-Methyltryptophan",
        "D-1MT",
        "INDOXIMOD",
        "Indoximod"
      ]
    },
    {
      "fdaUniiCode": "5Q5PRH05GI",
      "id": "Ofranergene_Obadenovec",
      "preferredName": "Ofranergene Obadenovec",
      "synonyms": [
        "GT-111",
        "OFRANERGENE OBADENOVEC",
        "Ofranergene Obadenovec",
        "VB-111"
      ]
    },
    {
      "fdaUniiCode": "P93RUU11P7",
      "id": "Inotuzumab_Ozogamicin",
      "preferredName": "Inotuzumab Ozogamicin",
      "synonyms": [
        "Besponsa",
        "CMC-544",
        "INOTUZUMAB OZOGAMICIN",
        "Inotuzumab Ozogamicin",
        "WAY-207294",
        "Way 207294"
      ]
    },
    {
      "fdaUniiCode": "V99T50803M",
      "id": "Sunitinib",
      "preferredName": "Sunitinib",
      "synonyms": [
        "1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-",
        "SUNITINIB",
        "Sunitinib",
        "sunitinib"
      ]
    },
    {
      "fdaUniiCode": "6D7W9EAH22",
      "id": "Acodazole_Hydrochloride",
      "preferredName": "Acodazole Hydrochloride",
      "synonyms": [
        "ACODAZOLE HYDROCHLORIDE",
        "Acetamide, N-methyl-N-[4-[(7-methyl-1H-imidazo[4, 5-f]quinolin-9-yl)amino]phenyl]-, monohydrochloride (9CI)",
        "Acodazole Hydrochloride",
        "acetamide, N-methyl-N-[4-[(7-methyl-1H-imidazo[4, 5-f]quinolin-9-yl)amino]phenyl]-, monohydrochloride (9CI)"
      ]
    },
    {
      "fdaUniiCode": "X4OV71U42S",
      "id": "Pioglitazone",
      "preferredName": "Pioglitazone",
      "synonyms": [
        "PIOGLITAZONE",
        "Pioglitazone",
        "pioglitazone"
      ]
    },
    {
      "fdaUniiCode": "703KLX5LXZ",
      "id": "Apomab",
      "preferredName": "Apomab",
      "synonyms": [
        "APOMAB",
        "Apomab"
      ]
    },
    {
      "fdaUniiCode": "23J303Z5CA",
      "id": "Citatuzumab_Bogatox",
      "preferredName": "Citatuzumab Bogatox",
      "synonyms": [
        "Anti-EpCAM Antibody Fragment-Bouganin Fusion Protein",
        "CITATUZUMAB BOGATOX",
        "Citatuzumab Bogatox",
        "VB6-845"
      ]
    },
    {
      "fdaUniiCode": "CVL1685GPH",
      "id": "Voxtalisib",
      "preferredName": "Voxtalisib",
      "synonyms": [
        "SAR-245409",
        "SAR245409",
        "VOXTALISIB",
        "Voxtalisib",
        "XL-765",
        "XL765"
      ]
    },
    {
      "fdaUniiCode": "60ES45KTMK",
      "id": "Pilaralisib",
      "preferredName": "Pilaralisib",
      "synonyms": [
        "2-Amino-N-(3-(N-(3-((2-chloro-5-methoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-2-methylpropanamide",
        "PILARALISIB",
        "Pilaralisib",
        "SAR245408",
        "XL 147",
        "XL-147",
        "XL147"
      ]
    },
    {
      "fdaUniiCode": "GPO2JN4UON",
      "id": "Pracinostat",
      "preferredName": "Pracinostat",
      "synonyms": [
        "2-propenamide, 3-(2-butyl-1-(2-(diethylamino)ethyl)-1h-benzimidazol-5-yl)-N-hydroxy-, (2E)-",
        "HDAC Inhibitor SB939",
        "PRACINOSTAT",
        "Pracinostat",
        "SB939",
        "kaempferol 3-o-beta-d-(6-E-P-coumaroylglucoside)"
      ]
    },
    {
      "fdaUniiCode": "5P60F84FBH",
      "id": "Givinostat",
      "preferredName": "Givinostat",
      "synonyms": [
        "GIVINOSTAT",
        "Gavinostat",
        "Givinostat",
        "ITF2357"
      ]
    },
    {
      "fdaUniiCode": "T66ES73M18",
      "id": "Alisertib",
      "preferredName": "Alisertib",
      "synonyms": [
        "ALISERTIB",
        "Alisertib",
        "Aurora A Kinase Inhibitor MLN8237",
        "Benzoic Acid, 4-((9-Chloro-7-(2-Fluoro-6-Methoxyphenyl)-5H-Pyrimido(5,4-d)(2)Benzazepin-2-yl)Amino)-2-Methoxy-",
        "MLN-8237",
        "MLN8237"
      ]
    },
    {
      "fdaUniiCode": "WOH1JD9AR8",
      "id": "Olaparib",
      "preferredName": "Olaparib",
      "synonyms": [
        "AZD 2281",
        "AZD-2281",
        "AZD2281",
        "KU-0059436",
        "Lynparza",
        "OLAPARIB",
        "Olaparib",
        "PARP Inhibitor AZD2281",
        "PARP inhibitor AZD2281",
        "olaparib"
      ]
    },
    {
      "fdaUniiCode": "8A9RZ3HN8W",
      "id": "Evofosfamide",
      "preferredName": "Evofosfamide",
      "synonyms": [
        "EVOFOSFAMIDE",
        "Evofosfamide",
        "HAP TH-302",
        "Hypoxia-Activated Prodrug TH-302",
        "Phosphorodiamidic Acid, N,N'-bis(2-bromoethyl)-, (1-methyl-2-nitro-1H-imidazol-5-yl)methyl Ester",
        "TH-302"
      ]
    },
    {
      "fdaUniiCode": "8M31J5031Q",
      "id": "Quarfloxin",
      "preferredName": "Quarfloxin",
      "synonyms": [
        "3H-Benzo(b)pyrido(3,2,1-kl)phenoxazine-2-carboxamide, 5-fluoro-N-(2-((2S)- 1-methyl-2-pyrrolidinyl)ethyl)-3-oxo-6-(3-pyrazinyl-1-pyrrolidinyl)-",
        "5-Fluoro-N-(2-((2S)-1-methylpyrrolidin-2-yl)ethyl)-3-oxo-6-(3-(pyrazin-2- yl)pyrrolidin-1-yl)-3H-benzo(b)pyrido(3,2,1-kl)phenoxazine-2-carboxamide",
        "CX-3543",
        "QUARFLOXIN",
        "Quarfloxacin",
        "Quarfloxin"
      ]
    },
    {
      "fdaUniiCode": "M84I3K7C2O",
      "id": "Nifurtimox",
      "preferredName": "Nifurtimox",
      "synonyms": [
        "4-((5-Nitrofurfurylidene)amino)-3-methylthiomorpholine-1,1-dioxide",
        "BAY 2502",
        "BAYER 2502",
        "Lampit",
        "NIFURTIMOX",
        "Nifurtimox"
      ]
    },
    {
      "fdaUniiCode": "IFJ6X26JW6",
      "id": "Apatorsen",
      "preferredName": "Apatorsen",
      "synonyms": [
        "APATORSEN",
        "Apatorsen",
        "ISIS 306053",
        "OGX-427"
      ]
    },
    {
      "fdaUniiCode": "93T0T9GKNU",
      "id": "Enzalutamide",
      "preferredName": "Enzalutamide",
      "synonyms": [
        "ASP9785",
        "Benzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-",
        "ENZALUTAMIDE",
        "Enzalutamide",
        "MDV3100",
        "Xtandi"
      ]
    },
    {
      "fdaUniiCode": "SO9S6QZB4R",
      "id": "Amuvatinib",
      "preferredName": "Amuvatinib",
      "synonyms": [
        "AMUVATINIB",
        "Amuvatinib",
        "HPK56",
        "MP470",
        "Receptor Tyrosine Kinase Inhibitor MP470"
      ]
    },
    {
      "fdaUniiCode": "CO93X137CW",
      "id": "Linifanib",
      "preferredName": "Linifanib",
      "synonyms": [
        "ABT-869",
        "LINIFANIB",
        "Linifanib",
        "multitargeted receptor tyrosine kinase inhibitor ABT-869"
      ]
    },
    {
      "fdaUniiCode": "U1JK633AYI",
      "id": "Motesanib",
      "preferredName": "Motesanib",
      "synonyms": [
        "MOTESANIB",
        "Motesanib"
      ]
    },
    {
      "fdaUniiCode": "W6E275IURX",
      "id": "Losoxantrone_Hydrochloride",
      "preferredName": "Losoxantrone Hydrochloride",
      "synonyms": [
        "LOSOXANTRONE HYDROCHLORIDE",
        "Losoxantrone HCl",
        "Losoxantrone Hydrochloride",
        "Losoxantrone Hydrochloride Hydrate"
      ]
    },
    {
      "fdaUniiCode": "FGE8818GWA",
      "id": "Bromebric_Acid",
      "preferredName": "Bromebric Acid",
      "synonyms": [
        "(E)-3-p-Anisoyl-3-bromoacrylic Acid",
        "BROMEBRIC ACID",
        "Bromebric Acid"
      ]
    },
    {
      "fdaUniiCode": "D2UX06XLB5",
      "id": "Pomalidomide",
      "preferredName": "Pomalidomide",
      "synonyms": [
        "3-Amino-N-(2,6-dioxo-3-piperidyl)phthalimide",
        "4-Amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione",
        "4-Aminothalidomide",
        "Actimid",
        "CC-4047",
        "Imnovid",
        "POMALIDOMIDE",
        "Pomalidomide",
        "Pomalyst",
        "pomalidomide"
      ]
    },
    {
      "fdaUniiCode": "8XBV72641V",
      "id": "Nanafrocin",
      "preferredName": "Nanafrocin",
      "synonyms": [
        "(1S,3R)-3,4,5,10-Tetrahydro-9-hydroxy-1-methyl-5,10-dioxo-1H-naphtho[2,3-c]pyran-3-acetic Acid",
        "NANAFROCIN",
        "Nanafrocin",
        "Nanaomycin A",
        "OS 3966-A"
      ]
    },
    {
      "fdaUniiCode": "BYK4592A3Q",
      "id": "Ambazone",
      "preferredName": "Ambazone",
      "synonyms": [
        "AMBAZONE",
        "Ambazone",
        "Faringosept",
        "p-Benzoquinone Amidinohydrazone Thiosemicarbazone"
      ]
    },
    {
      "fdaUniiCode": "T4NP8G3K6Q",
      "id": "Batabulin",
      "preferredName": "Batabulin",
      "synonyms": [
        "2-Fluoro-1-methoxy-4-pentafluorophenylsulfonamidobenzene",
        "BATABULIN",
        "Batabulin",
        "T138067"
      ]
    },
    {
      "fdaUniiCode": "0U575HR16Q",
      "id": "Denibulin_Hydrochloride",
      "preferredName": "Denibulin Hydrochloride",
      "synonyms": [
        "DENIBULIN HYDROCHLORIDE",
        "Denibulin Hydrochloride",
        "MN-029"
      ]
    },
    {
      "fdaUniiCode": "PS51OZG63Z",
      "id": "Piroxantrone_Hydrochloride",
      "preferredName": "Piroxantrone Hydrochloride",
      "synonyms": [
        "PIROXANTRONE HYDROCHLORIDE",
        "Piroxantrone Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "GNN1DV99GX",
      "id": "Penicillamine",
      "preferredName": "Penicillamine",
      "synonyms": [
        ".beta.,.beta.-Dimethylcysteine",
        "3-Mercapto-D-valine",
        "Alpha-amino-beta-methyl-beta-mercaptobutyric Acid",
        "Atamir",
        "Beta,Beta-dimethylcysteine",
        "Beta-thiovaline",
        "Cuprenil",
        "Cuprimine",
        "Cupripen",
        "D-Mercaptovaline",
        "D-Penicillamine",
        "Depamine",
        "Depen",
        "Distamine",
        "Kelatin",
        "Mercaptyl",
        "Metalcaptase",
        "PENICILLAMINE",
        "Pendramine",
        "Penicillamine",
        "Perdolat",
        "Sufortan",
        "Trolovol",
        "penicillamine"
      ]
    },
    {
      "fdaUniiCode": "60W3249T9M",
      "id": "Artesunate",
      "preferredName": "Artesunate",
      "synonyms": [
        "4-oxo-4-{[(3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j]-1,2-benzodioxepin-10-yl]oxy}butanoic acid",
        "ARTESUNATE",
        "Artesunate",
        "WR 256283"
      ]
    },
    {
      "fdaUniiCode": "395575MZO7",
      "id": "Pentostatin",
      "preferredName": "Pentostatin",
      "synonyms": [
        "(R)-3-(2-Deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7, 8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol",
        "(R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol",
        "2'-Deoxycoformycin",
        "CI-825",
        "Co-Vidarabine",
        "Co-vidarabine",
        "Covidarabine",
        "DCF",
        "Deoxycoformycin",
        "Nipent",
        "PD-81565",
        "PENTOSTATIN",
        "Pentostatin",
        "Pentostatine",
        "pentostatin"
      ]
    },
    {
      "fdaUniiCode": "6EEL176LGY",
      "id": "Benaxibine",
      "preferredName": "Benaxibine",
      "synonyms": [
        "4-Aminobenzoic acid-N-xyloside",
        "BENAXIBINE",
        "Benaxibine"
      ]
    },
    {
      "fdaUniiCode": "406PGU9KGI",
      "id": "Etoprine",
      "preferredName": "Etoprine",
      "synonyms": [
        "2,4-Diamino-5-(3,4-dichlorophenyl)-6-ethylpyrimidine",
        "AI3-25008",
        "DDEP",
        "ETOPRINE",
        "Ethodichlorophen",
        "Etoprine"
      ]
    },
    {
      "fdaUniiCode": "7AYY495RE0",
      "id": "Pumitepa",
      "preferredName": "Pumitepa",
      "synonyms": [
        "Fopurin",
        "PUMITEPA",
        "Pumitepa"
      ]
    },
    {
      "fdaUniiCode": "SZ0F94M68J",
      "id": "Retelliptine",
      "preferredName": "Retelliptine",
      "synonyms": [
        "1-((3-(Diethylamino)propyl)amino)-5,11-dimethyl-9-methoxy-6H-pyrido(4,3-b)carbazole",
        "RETELLIPTINE",
        "Retelliptine"
      ]
    },
    {
      "fdaUniiCode": "X9788XI79O",
      "id": "Galocitabine",
      "preferredName": "Galocitabine",
      "synonyms": [
        "GALOCITABINE",
        "Galocitabine",
        "Ro 09-1390"
      ]
    },
    {
      "fdaUniiCode": "78XGN2K5RX",
      "id": "Erbulozole",
      "preferredName": "Erbulozole",
      "synonyms": [
        "Carbamic acid, (4-(((2-(1H-imidazol-1-ylmethyl)-2-(4-methoxyphenyl)-1,3-dioxolan-4-yl)methyl)thio)phenyl)-,ethyl ester, cis-(+-)-",
        "ERBULOZOLE",
        "Erbulozole",
        "R55104"
      ]
    },
    {
      "fdaUniiCode": "173648DEO8",
      "id": "Bromacrylide",
      "preferredName": "Bromacrylide",
      "synonyms": [
        "BROMACRYLIDE",
        "Bromacrylide"
      ]
    },
    {
      "fdaUniiCode": "9266D9P3PQ",
      "id": "Bendamustine",
      "preferredName": "Bendamustine",
      "synonyms": [
        "5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric Acid",
        "BENDAMUSTINE",
        "Bendamustine",
        "SDX-105",
        "bendamustine"
      ]
    },
    {
      "fdaUniiCode": "NAT2FD82D7",
      "id": "Elmustine",
      "preferredName": "Elmustine",
      "synonyms": [
        "1-(2-Chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea",
        "1-Nitroso-1-chloroethyl-3-hydroxyethylurea",
        "ELMUSTINE",
        "Elmustine",
        "HeCNU",
        "Hydroxyethyl CNU"
      ]
    },
    {
      "fdaUniiCode": "SD6QCT3TSU",
      "id": "Pentoxifylline",
      "preferredName": "Pentoxifylline",
      "synonyms": [
        "3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione",
        "Oxpentifylline",
        "PENTOXIFYLLINE",
        "PTX",
        "Pentoxifylline",
        "Pentoxyphylline",
        "Trental",
        "pentoxifylline"
      ]
    },
    {
      "fdaUniiCode": "J30IBO0LMA",
      "id": "Bisnafide_Dimesylate",
      "preferredName": "Bisnafide Dimesylate",
      "synonyms": [
        "BISNAFIDE DIMESYLATE",
        "Bisnafide Dimesylate"
      ]
    },
    {
      "fdaUniiCode": "IB1H345F24",
      "id": "Ambamustine",
      "preferredName": "Ambamustine",
      "synonyms": [
        "AMBAMUSTINE",
        "Ambamustine",
        "N-(3-(m-(Bis(2-chloroethyl)amino)phenyl)-N-(3-(p-fluorophenyl)-L-alanyl)-L-alanyl)-L-methionine, Ethyl Ester",
        "PTT-119"
      ]
    },
    {
      "fdaUniiCode": "42932X67B5",
      "id": "Sodium_Dichloroacetate",
      "preferredName": "Sodium Dichloroacetate",
      "synonyms": [
        "CPC 211",
        "Dichloroacetic Acid, Sodium Salt",
        "SODIUM DICHLOROACETATE",
        "Sodium Dichloroacetate"
      ]
    },
    {
      "fdaUniiCode": "Q16TT9C5BK",
      "id": "Bazedoxifene",
      "preferredName": "Bazedoxifene",
      "synonyms": [
        "1H-Indol-5-ol, 1-((4-(2-(hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-",
        "BAZEDOXIFENE",
        "Bazedoxifene",
        "TSE-424",
        "WAY 140424"
      ]
    },
    {
      "fdaUniiCode": "62H4W26906",
      "id": "Bisnafide",
      "preferredName": "Bisnafide",
      "synonyms": [
        "BISNAFIDE",
        "Bisnafide",
        "DMP 840"
      ]
    },
    {
      "fdaUniiCode": "Q380BYV049",
      "id": "Cevipabulin_Fumarate",
      "preferredName": "Cevipabulin Fumarate",
      "synonyms": [
        "CEVIPABULIN FUMARATE",
        "Cevipabulin Fumarate",
        "TTI-237",
        "[1,2,4]Triazolo[1,5-a]pyrimidin-7-amine, 5-chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-, (2E)-2-butenedioate (1:1), dihydrate"
      ]
    },
    {
      "fdaUniiCode": "0481JCC90T",
      "id": "Pibrozelesin_Hydrobromide",
      "preferredName": "Pibrozelesin Hydrobromide",
      "synonyms": [
        "PIBROZELESIN HYDROBROMIDE",
        "Pibrozelesin Hydrobromide"
      ]
    },
    {
      "fdaUniiCode": "S5M7KW6U17",
      "id": "Upamostat",
      "preferredName": "Upamostat",
      "synonyms": [
        "1-Piperazinecarboxylic Acid, 4-((2S)-3-(3-((E)-Amino(hydroxyimino)methyl)phenyl)-1-oxo-2-(((2,4,6-tris(1-methylethyl)phenyl)sulfonyl)amino)propyl)-, Ethyl Ester",
        "UPAMOSTAT",
        "Upamostat",
        "WX-671"
      ]
    },
    {
      "fdaUniiCode": "5Z72SSS34W",
      "id": "Aglatimagene_Besadenovec",
      "preferredName": "Aglatimagene Besadenovec",
      "synonyms": [
        "ADV-tk",
        "AGLATIMAGENE BESADENOVEC",
        "Aglatimagene Besadenovec",
        "GliAtak",
        "ProstAtak",
        "Virafir"
      ]
    },
    {
      "fdaUniiCode": "4V6I63LW1E",
      "id": "Tiomolibdate_Diammonium",
      "preferredName": "Tiomolibdate Diammonium",
      "synonyms": [
        "ATTM",
        "Ammonium Molybdenum Sulfide",
        "Ammonium Tetrathiomolybdate",
        "Coprexa",
        "Diammonium Tetrathiomolybdate",
        "Molybdate(2-), Tetrathioxo-, Ammonium (1:2), (T-4)-",
        "Molybdate(2-), Tetrathioxo-, Diammonium, (T-4)-",
        "TIOMOLIBDATE DIAMMONIUM",
        "Tiomolibdate Diammonium",
        "ammonium tetrathiomolybdate"
      ]
    },
    {
      "fdaUniiCode": "P7MQ9ZOQ82",
      "id": "Anti-CD3_Immunotoxin_A-dmDT390-bisFvUCHT1",
      "preferredName": "Anti-CD3 Immunotoxin A-dmDT390-bisFv(UCHT1)",
      "synonyms": [
        "A-dmDT390-bisFv(UCHT1)",
        "Anti-CD3 Immunotoxin A-dmDT390-bisFv(UCHT1)",
        "RESIMMUNE",
        "Resimmune"
      ]
    },
    {
      "fdaUniiCode": "33VWC847G8",
      "id": "Anti-CD30_Monoclonal_Antibody_XmAb2513",
      "preferredName": "Anti-CD30 Monoclonal Antibody XmAb2513",
      "synonyms": [
        "Anti-CD30 Monoclonal Antibody XmAb2513",
        "XMAB-2513",
        "XmAb2513"
      ]
    },
    {
      "fdaUniiCode": "2MZ3L2664T",
      "id": "Otlertuzumab",
      "preferredName": "Otlertuzumab",
      "synonyms": [
        "Immunoglobulin, Anti-(Human CD Antigen CD37) (Synthetic Human-Mus Musculus Fragment TRU-016), Dimer",
        "OTLERTUZUMAB",
        "Otlertuzumab",
        "TRU 016",
        "TRU-016"
      ]
    },
    {
      "fdaUniiCode": "4Z63YK6E0E",
      "id": "Daratumumab",
      "preferredName": "Daratumumab",
      "synonyms": [
        "Anti-CD38 Monoclonal Antibody",
        "DARATUMUMAB",
        "Daratumumab",
        "Darzalex",
        "HuMax-CD38",
        "JNJ-54767414"
      ]
    },
    {
      "fdaUniiCode": "YB2EWE6139",
      "id": "Carotuximab",
      "preferredName": "Carotuximab",
      "synonyms": [
        "CAROTUXIMAB",
        "Carotuximab",
        "TRC 105",
        "TRC-105",
        "TRC105"
      ]
    },
    {
      "fdaUniiCode": "6YI1L648RH",
      "id": "Dalotuzumab",
      "preferredName": "Dalotuzumab",
      "synonyms": [
        "Anti-IGF-1R Recombinant Monoclonal Antibody MK-0646",
        "DALOTUZUMAB",
        "Dalotuzumab",
        "MK-0646",
        "anti-IGF1R recombinant monoclonal antibody MK-0646"
      ]
    },
    {
      "fdaUniiCode": "TK02X14ASJ",
      "id": "Rivoceranib_Mesylate",
      "preferredName": "Rivoceranib Mesylate",
      "synonyms": [
        "Apatinib Mesylate",
        "RIVOCERANIB MESYLATE",
        "Rivoceranib Mesylate",
        "YN-968D1",
        "YN968D1"
      ]
    },
    {
      "fdaUniiCode": "5X5HB3VZ3Z",
      "id": "Apricoxib",
      "preferredName": "Apricoxib",
      "synonyms": [
        "APRICOXIB",
        "Apricoxib",
        "COX-2 Inhibitor TG01",
        "CS-706",
        "R-109339",
        "TG01",
        "TP2001"
      ]
    },
    {
      "fdaUniiCode": "27844X2J29",
      "id": "Zoptarelin_Doxorubicin",
      "preferredName": "Zoptarelin Doxorubicin",
      "synonyms": [
        "AEZS-108",
        "AEZS108",
        "AN 152",
        "AN-152",
        "Doxorubicin-GNRH Agonist Conjugate AEZS-108",
        "ZEN-008",
        "ZOPTARELIN DOXORUBICIN",
        "Zoptarelin Doxorubicin"
      ]
    },
    {
      "fdaUniiCode": "E4768ZY6GM",
      "id": "Gold_Sodium_Thiomalate",
      "preferredName": "Gold Sodium Thiomalate",
      "synonyms": [
        "Aurolate",
        "Aurothiomalate Disodium",
        "GOLD SODIUM THIOMALATE",
        "Gold Sodium Thiomalate",
        "Myochrysine"
      ]
    },
    {
      "fdaUniiCode": "25X868M3DS",
      "id": "Vismodegib",
      "preferredName": "Vismodegib",
      "synonyms": [
        "2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide",
        "Erivedge",
        "GDC-0449",
        "Hedgehog Antagonist GDC-0449",
        "VISMODEGIB",
        "Vismodegib"
      ]
    },
    {
      "fdaUniiCode": "W9E3353E8J",
      "id": "Dual_IGF-1RInsR_Inhibitor_BMS-754807",
      "preferredName": "Dual IGF-1R/InsR Inhibitor BMS-754807",
      "synonyms": [
        "BMS-754807",
        "Dual IGF-1R/InsR Inhibitor BMS-754807"
      ]
    },
    {
      "fdaUniiCode": "JPX07AFM0N",
      "id": "Refametinib",
      "preferredName": "Refametinib",
      "synonyms": [
        "BAY 869766",
        "BAY86-9766",
        "MEK Inhibitor RDEA119",
        "RDEA119",
        "REFAMETINIB",
        "Refametinib"
      ]
    },
    {
      "fdaUniiCode": "53AH36668S",
      "id": "Crizotinib",
      "preferredName": "Crizotinib",
      "synonyms": [
        "(R)-3-(1-(2,6-Dichloro-3-Fluorophenyl)Ethoxy)-5-(1-(Piperidin-4-Yl)-1h-Pyrazol-4-Yl)Pyridin-2-Amine",
        "2-Pyridinamine, 3-((1R)-1-(2,6-Dichloro-3-Fluorophenyl)Ethoxy)-5-(1-(4-Piperidinyl)-1H-Pyrazol-4-yl)-",
        "CRIZOTINIB",
        "Crizotinib",
        "MET Tyrosine Kinase Inhibitor PF-02341066",
        "MET tyrosine kinase inhibitor PF-02341066",
        "PF-02341066",
        "PF-2341066",
        "Xalkori"
      ]
    },
    {
      "fdaUniiCode": "79ME7DT193",
      "id": "Tasadenoturev",
      "preferredName": "Tasadenoturev",
      "synonyms": [
        "Ad5-Delta24RGD",
        "DNX-2401",
        "DNX2401",
        "Oncolytic Ad5-Delta 24RGD",
        "Oncolytic Adenovirus Ad5-DNX-2401",
        "Oncolytic Adenovirus Ad5-Delta 24RGD",
        "TASADENOTUREV",
        "Tasadenoturev"
      ]
    },
    {
      "fdaUniiCode": "LJ16641SFT",
      "id": "Etirinotecan_Pegol",
      "preferredName": "Etirinotecan Pegol",
      "synonyms": [
        "ETIRINOTECAN PEGOL",
        "Etirinotecan Pegol",
        "NKTR 102",
        "NKTR-102",
        "Onzeald",
        "PEG-Irinotecan"
      ]
    },
    {
      "fdaUniiCode": "RUJ6Z9Y0DT",
      "id": "Dactolisib",
      "preferredName": "Dactolisib",
      "synonyms": [
        "BEZ235",
        "Benzeneacetonitrile, 4-(2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo(4,5-c)quinolin-1-yl)-alpha,alpha-dimethyl-",
        "DACTOLISIB",
        "Dactolisib",
        "NVPBEZ235"
      ]
    },
    {
      "fdaUniiCode": "6IF28942WO",
      "id": "Delanzomib",
      "preferredName": "Delanzomib",
      "synonyms": [
        "((1R)-1-((2S,3R)-3-hydroxy-2-(6-phenylpyridine-2-carboxamido)butanamido)-3-methylbutyl)boronic Acid",
        "CEP 18770",
        "CEP-18770",
        "CT-47098",
        "DELANZOMIB",
        "Delanzomib",
        "NPH-007098",
        "NPH007098",
        "Proteasome Inhibitor CEP 18770"
      ]
    },
    {
      "fdaUniiCode": "877M97Z38Y",
      "id": "Rexinoid_NRX_194204",
      "preferredName": "Rexinoid NRX 194204",
      "synonyms": [
        "AGN194204",
        "NRX194204",
        "Rexinoid NRX 194204",
        "VTP-194204"
      ]
    },
    {
      "fdaUniiCode": "4V9848RS5G",
      "id": "Tirbanibulin",
      "preferredName": "Tirbanibulin",
      "synonyms": [
        "2-Pyridineacetamide, 5-(4-(2-(4-Morpholinyl)ethoxy)phenyl)-n-(phenylmethyl)-",
        "KX01",
        "KX2-391",
        "TIRBANIBULIN",
        "Tirbanibulin"
      ]
    },
    {
      "fdaUniiCode": "756U07KN1R",
      "id": "Tasquinimod",
      "preferredName": "Tasquinimod",
      "synonyms": [
        "ABR-215050",
        "TASQ",
        "TASQUINIMOD",
        "Tasquinimod"
      ]
    },
    {
      "fdaUniiCode": "S68632MB2G",
      "id": "Elpamotide",
      "preferredName": "Elpamotide",
      "synonyms": [
        "ELPAMOTIDE",
        "Elpamotide",
        "L-Arginyl-L-phenylalanyl-L-valyl-L-prolyl-L-alpha-aspartylglycyl-L-asparaginyl-L-arginyl-L-isoleucine Human Soluble (Vascular Endothelial Growth Factor Receptor) VEGFR2-(169-177)-peptide",
        "VEGFR2-169",
        "VEGFR2-169 Peptide Vaccine"
      ]
    },
    {
      "fdaUniiCode": "2F42BH7X2L",
      "id": "Picibanil",
      "preferredName": "Picibanil",
      "synonyms": [
        "OK-432",
        "Picibanil"
      ]
    },
    {
      "fdaUniiCode": "7ZQK8VIO6V",
      "id": "Teloxantrone_Hydrochloride",
      "preferredName": "Teloxantrone Hydrochloride",
      "synonyms": [
        "Anthra(1,9-cd)pyrazol-6(2H)-one,7,10-dihydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)-5-((2-(methylamino)ethyl)amino) Dihydrochloride",
        "CI-937 Hydrochloride",
        "DUP 937",
        "Moxantrazole Hydrochloride",
        "TELOXANTRONE HYDROCHLORIDE",
        "Teloxantrone Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "7RN5DR86CK",
      "id": "Pazopanib",
      "preferredName": "Pazopanib",
      "synonyms": [
        "Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-",
        "GW786034",
        "PAZOPANIB",
        "Pazopanib"
      ]
    },
    {
      "fdaUniiCode": "FZU1QI13O9",
      "id": "Aminopterin_Sodium",
      "preferredName": "Aminopterin Sodium",
      "synonyms": [
        "AMINOPTERIN SODIUM",
        "Aminopterin Sodium",
        "Sodium Aminopterin"
      ]
    },
    {
      "fdaUniiCode": "IEU56G3J9C",
      "id": "Lanreotide_Acetate",
      "preferredName": "Lanreotide Acetate",
      "synonyms": [
        "AT-1001",
        "L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide, acetate",
        "LANREOTIDE ACETATE",
        "Lanreotide Acetate",
        "Somatuline Depot"
      ]
    },
    {
      "fdaUniiCode": "L7C92IOE65",
      "id": "Nutlin-3a",
      "preferredName": "Nutlin-3a",
      "synonyms": [
        "NUTLIN-3A",
        "Nutlin-3a"
      ]
    },
    {
      "fdaUniiCode": "NY7PTD1862",
      "id": "Axalimogene_Filolisbac",
      "preferredName": "Axalimogene Filolisbac",
      "synonyms": [
        "ADXS11-001",
        "ADXS11-001 Vaccine",
        "AXALIMOGENE FILOLISBAC",
        "Attenuated Live Listeria Encoding HPV 16 E7 Vaccine",
        "Attenuated Live Listeria Encoding Human Papilloma Virus 16 E7 Vaccine",
        "Axalimogene Filolisbac",
        "Lm-LLO-E7",
        "Lovaxin-C"
      ]
    },
    {
      "fdaUniiCode": "45AD6X575G",
      "id": "Alvocidib",
      "preferredName": "Alvocidib",
      "synonyms": [
        "(-)-cis-5,7-Dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one",
        "ALVOCIDIB",
        "Alvocidib",
        "Alvocidib Freebase",
        "Flavopiridol",
        "alvocidib",
        "flavopiridol"
      ]
    },
    {
      "fdaUniiCode": "2UB1JJT82D",
      "id": "Esorubicin_Hydrochloride",
      "preferredName": "Esorubicin Hydrochloride",
      "synonyms": [
        "(2S-(2alpha(8R*,10R*),4beta,6beta))-10-((4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione Hydrochloride",
        "4'-Deoxyadriamycin HCl",
        "4'-Deoxydoxorubicin HCl",
        "Deoxydoxorubicin HCI",
        "ESORUBICIN HYDROCHLORIDE",
        "Esorubicin Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "V5FUB77031",
      "id": "Vatalanib_Succinate",
      "preferredName": "Vatalanib Succinate",
      "synonyms": [
        "1-[4-Chloroanilino]-4-[4-pyridylmethyl]phthalazine Succinate",
        "Butanedioic Acid, Compd. with N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine (1:1)",
        "CGP 79787D",
        "PTK 787",
        "PTK-787",
        "PTK787",
        "VATALANIB SUCCINATE",
        "Vatalanib Succinate",
        "ZK 222584"
      ]
    },
    {
      "fdaUniiCode": "6Q99RDT97R",
      "id": "Pipobroman",
      "preferredName": "Pipobroman",
      "synonyms": [
        "Amedel",
        "PIPOBROMAN",
        "Pipobroman",
        "Vercyte"
      ]
    },
    {
      "fdaUniiCode": "C5MKX7XOYA",
      "id": "Amustaline_Dihydrochloride",
      "preferredName": "Amustaline Dihydrochloride",
      "synonyms": [
        "AMUSTALINE DIHYDROCHLORIDE",
        "Amustaline Dihydrochloride"
      ]
    },
    {
      "fdaUniiCode": "R40RXC296C",
      "id": "Topixantrone",
      "preferredName": "Topixantrone",
      "synonyms": [
        "BBR 3576",
        "Indazolo(4,3-gh)isoquinolin-6(2H)-one, 5-((2-(dimethylamino)ethyl)amino)-2-(2-((2-hydroxyethyl)amino)ethyl)-",
        "TOPIXANTRONE",
        "Topixantrone"
      ]
    },
    {
      "fdaUniiCode": "PGN54228S5",
      "id": "Puromycin_Hydrochloride",
      "preferredName": "Puromycin Hydrochloride",
      "synonyms": [
        "PUROMYCIN HYDROCHLORIDE",
        "Puromycin Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "SH1WY3R615",
      "id": "Nocodazole",
      "preferredName": "Nocodazole",
      "synonyms": [
        "Methyl (5-(2-thienylcarbonyl))-1H-benzimidazol-2-yl",
        "NOCODAZOLE",
        "Nocodazole"
      ]
    },
    {
      "fdaUniiCode": "LIX7OM008P",
      "id": "Taurultam",
      "preferredName": "Taurultam",
      "synonyms": [
        "TAURULTAM",
        "Taurultam"
      ]
    },
    {
      "fdaUniiCode": "6UK191M53P",
      "id": "Elesclomol",
      "preferredName": "Elesclomol",
      "synonyms": [
        "1-N'-benzenecarbothioyl-3-(2-benzenecarbothioyl-2-methylhydrazinyl)-N'-methyl- oxopropanehydrazidide",
        "ELESCLOMOL",
        "Elesclomol",
        "Propanedioic Acid, Bis[2-methyl-2-(phenylthioxomethyl)hydrazide]"
      ]
    },
    {
      "fdaUniiCode": "WUF1DL156G",
      "id": "Terfluranol",
      "preferredName": "Terfluranol",
      "synonyms": [
        "TERFLURANOL",
        "Terfluranol"
      ]
    },
    {
      "fdaUniiCode": "Z5M7SC6D5P",
      "id": "Tolnidamine",
      "preferredName": "Tolnidamine",
      "synonyms": [
        "1b Indozadole",
        "TOLNIDAMINE",
        "Tolnidamine"
      ]
    },
    {
      "fdaUniiCode": "YIY0662KX9",
      "id": "Ritrosulfan",
      "preferredName": "Ritrosulfan",
      "synonyms": [
        "Lycurim",
        "R-74",
        "RITROSULFAN",
        "Ritrosulfan"
      ]
    },
    {
      "fdaUniiCode": "9BW5T43J04",
      "id": "Thiodiglycol",
      "preferredName": "Thiodiglycol",
      "synonyms": [
        "Bis(2-hydroxyethyl)sulfide",
        "THIODIGLYCOL",
        "Thiodiethylene Glycol",
        "Thiodiglycol",
        "beta-Hydroxyethyl Sulfide"
      ]
    },
    {
      "fdaUniiCode": "QE0G097358",
      "id": "Acronine",
      "preferredName": "Acronine",
      "synonyms": [
        "ACRONINE",
        "Acronine",
        "Acronycine"
      ]
    },
    {
      "fdaUniiCode": "6SQ8M7ZSFV",
      "id": "Cemadotin",
      "preferredName": "Cemadotin",
      "synonyms": [
        "CEMADOTIN",
        "Cemadotin",
        "LU-103793",
        "LU103793"
      ]
    },
    {
      "fdaUniiCode": "25571657UW",
      "id": "Amustaline",
      "preferredName": "Amustaline",
      "synonyms": [
        "(N,N-bis(2-chloroethyl))-2-aminoethyl-3-((acridin-9-yl)amino)propionate",
        "AMUSTALINE",
        "Amustaline",
        "S-303"
      ]
    },
    {
      "fdaUniiCode": "J6D6912BXS",
      "id": "Taltobulin",
      "preferredName": "Taltobulin",
      "synonyms": [
        "HTI-286",
        "SPA-110",
        "TALTOBULIN",
        "Taltobulin"
      ]
    },
    {
      "fdaUniiCode": "2YF82QN5RY",
      "id": "Corticorelin_Acetate",
      "preferredName": "Corticorelin Acetate",
      "synonyms": [
        "CORTICORELIN ACETATE",
        "Corticorelin Acetate",
        "Human Corticotropin-Releasing Factor",
        "Xerecept",
        "hCRF",
        "human corticotropin-releasing factor"
      ]
    },
    {
      "fdaUniiCode": "V9YL6NEJ3G",
      "id": "Aderbasib",
      "preferredName": "Aderbasib",
      "synonyms": [
        "5-Azaspiro(2.5)octane-5-carboxylic Acid, 7-((Hydroxyamino)carbonyl)-6-((4-phenyl-1-piperazinyl)carbonyl)-, Methyl Ester, (6S,7S)-",
        "ADERBASIB",
        "Aderbasib",
        "INCB007839",
        "INCB7839",
        "Methyl (6S,7S)-7-(Hhydroxyamino)carbonyl)-6-((4-phenylpiperazin-1-yl)carbonyl)-5-azaspiro(2.5)octane-5-carboxylate"
      ]
    },
    {
      "fdaUniiCode": "I35H55G906",
      "id": "Dovitinib",
      "preferredName": "Dovitinib",
      "synonyms": [
        "DOVITINIB",
        "Dovitinib"
      ]
    },
    {
      "fdaUniiCode": "33MG53C7XW",
      "id": "Vinflunine_Ditartrate",
      "preferredName": "Vinflunine Ditartrate",
      "synonyms": [
        "Javlor",
        "VINFLUNINE DITARTRATE",
        "Vinflunine Ditartrate"
      ]
    },
    {
      "fdaUniiCode": "H1WK901OA6",
      "id": "Porfiromycin",
      "preferredName": "Porfiromycin",
      "synonyms": [
        "Azirino[2',3':3,4]pyrrolo[1, 2-a]indole-4,7-dione, 6-amino-1,1a,2,8,8a, 8b-hexahydro-8-(hydroxymethyl)-8a- methoxy-1,5-dimethyl-, carbamate (ester) (8CI)",
        "Azirino[2',3':3,4]pyrrolo[1, 2-a]indole-4,7-dione, 6-amino-1,1a,2,8,8a, 8b-hexahydro-8-(hydroxymethyl)-8a- methoxy-1,5-dimethyl-, carbamate (ester)(8CI)",
        "Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b- hexahydro-8a-methoxy-1,5-dimethyl-,[1aR-(1a.alpha.,8.beta., 8a.alpha.,8b.alpha.)]- (9CI)",
        "Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-1,5-dimethyl-,[1aR-(1a-alpha,8beta, 8a-alpha,8b-alpha)]- (9CI)",
        "ENT-50825",
        "MITOMYCIN, METHYL",
        "Methyl Mitomycin",
        "Methyl Mitomycin C",
        "Methyl mitomycin C",
        "Methylmitomycin",
        "Mitomycin, methyl-",
        "N-Methylmitomycin C",
        "N-methylmitomycin C",
        "PORFIROMYCIN",
        "Porfiromycin",
        "Porfiromycine",
        "Porphyromycin",
        "Promycin",
        "U-14,743",
        "U-14743",
        "[1aS-(1a alpha,8beta,8a alpha,8b alpha)]-6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-1,5-dimethylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione",
        "porfiromycin"
      ]
    },
    {
      "fdaUniiCode": "637C487Y09",
      "id": "Golotimod",
      "preferredName": "Golotimod",
      "synonyms": [
        "(2R)-2-Amino-5-(((1S)-1-carboxy-2-(1H-indol-3-yl)ethyl)amino)-5-oxopentanoic Acid",
        "GOLOTIMOD",
        "Gamma-D-Glutamyl-L-Tryptophan",
        "Golotimod",
        "SCV 07",
        "SCV-07",
        "SCV07",
        "gamma-D-Glu-L-trp"
      ]
    },
    {
      "fdaUniiCode": "612K359T69",
      "id": "Alvespimycin_Hydrochloride",
      "preferredName": "Alvespimycin Hydrochloride",
      "synonyms": [
        "17-DMAG HCl",
        "ALVESPIMYCIN HYDROCHLORIDE",
        "Alvespimycin Hydrochloride",
        "BMS-826476",
        "Geldanamycin,17-demethoxy-17-((2-(dimethylamino)ethyl)amino)-, Monohydrochloride",
        "KOS-1022"
      ]
    },
    {
      "fdaUniiCode": "P771FDQ1WJ",
      "id": "Galamustine",
      "preferredName": "Galamustine",
      "synonyms": [
        "GALAMUSTINE",
        "Galamustine"
      ]
    },
    {
      "fdaUniiCode": "9403SIO2S8",
      "id": "Prednimustine",
      "preferredName": "Prednimustine",
      "synonyms": [
        "11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-[4-[p-[bis(3-chloroethyl)amino]phenyl]butyrate]",
        "11beta-21-[4-[4-[bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy]-11,17-dihydroxypregna-1,4-diene-3,20-dione",
        "Chlorambucil Prednisolone Ester",
        "LEO-1031",
        "Leo 1031",
        "PREDNIMUSTINE",
        "Prednimustine",
        "Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-,21-(4-(p-(bis(2-chloroethyl)amino)phenyl)butyrate)",
        "Sterecyt",
        "Stereocyt"
      ]
    },
    {
      "fdaUniiCode": "0P6C6ZOP5U",
      "id": "Roflumilast",
      "preferredName": "Roflumilast",
      "synonyms": [
        "3-Cyclopropylmethoxy-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide",
        "B9302-107",
        "BY217",
        "BYK20869",
        "Daliresp",
        "ROFLUMILAST",
        "Roflumilast"
      ]
    },
    {
      "fdaUniiCode": "9PHQ9Y1OLM",
      "id": "Prednisolone",
      "preferredName": "Prednisolone",
      "synonyms": [
        "(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione",
        ".delta.1-Hydrocortisone",
        "1,2-Dehydrohydrocortisone",
        "Adnisolone",
        "Aprednislon",
        "Capsoid",
        "Cortalone",
        "Cortisolone",
        "Dacortin H",
        "Decaprednil",
        "Decortin H",
        "Delta(1)Hydrocortisone",
        "Delta- Cortef",
        "Delta-Cortef",
        "Delta-Diona",
        "Delta-F",
        "Delta-Phoricol",
        "Delta1-dehydro-hydrocortisone",
        "Deltacortril",
        "Deltahydrocortisone",
        "Deltasolone",
        "Deltidrosol",
        "Dhasolone",
        "Di-Adreson-F",
        "Dontisolon D",
        "Estilsona",
        "Fisopred",
        "Frisolona",
        "Gupisone",
        "Hostacortin H",
        "Hydeltra",
        "Hydeltrasol",
        "Klismacort",
        "Kuhlprednon",
        "Lenisolone",
        "Lepi-Cortinolo",
        "Linola-H N",
        "Linola-H-Fett N",
        "Longiprednil",
        "Metacortandralone",
        "Meti Derm",
        "Meticortelone",
        "Opredsone",
        "PREDNISOLONE",
        "Panafcortelone",
        "Precortisyl",
        "Pred-Clysma",
        "Predeltilone",
        "Predni-Coelin",
        "Predni-Helvacort",
        "Prednicortelone",
        "Prednisolone",
        "Prednisolonum",
        "Prelone",
        "Prenilone",
        "Sterane",
        "prednisolone"
      ]
    },
    {
      "fdaUniiCode": "O12I24570R",
      "id": "Atiprimod_Dihydrochloride",
      "preferredName": "Atiprimod Dihydrochloride",
      "synonyms": [
        "ATIPRIMOD DIHYDROCHLORIDE",
        "Atiprimod Dihydrochloride"
      ]
    },
    {
      "fdaUniiCode": "YNU265SSR3",
      "id": "Atiprimod_Dimaleate",
      "preferredName": "Atiprimod Dimaleate",
      "synonyms": [
        "ATIPRIMOD DIMALEATE",
        "Atiprimod Dimaleate"
      ]
    },
    {
      "fdaUniiCode": "VB0R961HZT",
      "id": "Prednisone",
      "preferredName": "Prednisone",
      "synonyms": [
        ".delta.1-Cortisone",
        "1, 2-Dehydrocortisone",
        "1,2-Dehydrocortisone",
        "17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",
        "Adasone",
        "Cortancyl",
        "Dacortin",
        "DeCortin",
        "Decortisyl",
        "Decorton",
        "Delta 1-Cortisone",
        "Delta-Dome",
        "Deltacortene",
        "Deltacortisone",
        "Deltadehydrocortisone",
        "Deltasone",
        "Deltison",
        "Deltra",
        "Econosone",
        "Liquid Pred",
        "Lisacort",
        "Meprosona-F",
        "Metacortandracin",
        "Meticorten",
        "Ofisolona",
        "Orasone",
        "PRED",
        "PREDNISONE",
        "Panafcort",
        "Panasol-S",
        "Paracort",
        "Perrigo Prednisone",
        "Predeltin",
        "Predicor",
        "Predicorten",
        "Prednicen-M",
        "Prednicort",
        "Prednidib",
        "Prednilonga",
        "Predniment",
        "Prednisone",
        "Prednisone Intensol",
        "Prednisonum",
        "Prednitone",
        "Promifen",
        "Rayos",
        "SK-Prednisone",
        "Servisone",
        "Sk-Prednisone",
        "Sterapred",
        "prednisone"
      ]
    },
    {
      "fdaUniiCode": "P14M0DWS2J",
      "id": "Cevipabulin",
      "preferredName": "Cevipabulin",
      "synonyms": [
        "CEVIPABULIN",
        "Cevipabulin",
        "Cevipabulinum"
      ]
    },
    {
      "fdaUniiCode": "K7037M241U",
      "id": "Denibulin",
      "preferredName": "Denibulin",
      "synonyms": [
        "DENIBULIN",
        "Denibulin"
      ]
    },
    {
      "fdaUniiCode": "6Z674O12T6",
      "id": "Rosabulin",
      "preferredName": "Rosabulin",
      "synonyms": [
        "3-[(4-Cyanophenyl)methyl]-N-(3-methyl-5-isothiazolyl)-alpha-oxo-1-indolizineacetamide",
        "ROSABULIN",
        "Rosabulin",
        "STA-5312"
      ]
    },
    {
      "fdaUniiCode": "05G07285DK",
      "id": "Tasidotin",
      "preferredName": "Tasidotin",
      "synonyms": [
        "ILX651",
        "TASIDOTIN",
        "Tasidotin"
      ]
    },
    {
      "fdaUniiCode": "74GNV897RO",
      "id": "Bisantrene_Hydrochloride",
      "preferredName": "Bisantrene Hydrochloride",
      "synonyms": [
        "9,10,Anthracenedicarboxaldehyde Dihydrochloride",
        "9,10-Anthracenedicarboxakdehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] Dihydrochloride",
        "9,10-Anthracenedicarboxaldehyde Bis(2-imidazolin-2-yl)hydrazone Dihydrochloride",
        "BISANTRENE HYDROCHLORIDE",
        "Bisantrene Dihydrochloride",
        "Bisantrene Hydrochloride",
        "CL 216942",
        "CL-216942",
        "Orange Crush",
        "Zantrene"
      ]
    },
    {
      "fdaUniiCode": "XH0NPH5ZX8",
      "id": "Procarbazine_Hydrochloride",
      "preferredName": "Procarbazine Hydrochloride",
      "synonyms": [
        "Benzamide, N-(1-methylethyl)-4-[(2-methylhydrazino) methyl]-, monohydrochloride (9CI)",
        "Ibenzmethyzine hydrochloride",
        "MIH hydrochloride",
        "Matulane",
        "N-(1-methylethyl)-4-[(2-methylhydrazino)methyl]benzamide Hydrochloride",
        "N-4-isopropylcarbamoylbenzyl-N'-methylhydrazine Hydrochloride",
        "N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide Hydrochloride",
        "NCI-C01810",
        "Natulan",
        "Natulanar",
        "Natunalar",
        "PCB",
        "PCB Hydrochloride",
        "PCB hydrochloride",
        "PCZ",
        "PROCARBAZINE HYDROCHLORIDE",
        "Procarbazine Hydrochloride",
        "Ro 4 6467/1",
        "Ro 4-6467/1",
        "benzamide, N-(1-methylethyl)-4-[(2-methylhydrazino) methyl]-, monohydrochloride (9CI)",
        "p-(N'-methylhydrazinomethyl)-N-isopropylbenzamide hydrochloride",
        "p-Toluamide, N-isopropyl-.alpha.-(2-methylhydrazino)-, monohydrochloride (8CI)",
        "p-toluamide, N-isopropyl-alpha-(2-methylhydrazino)-, monohydrochloride (8CI)",
        "procarbazine hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "G819A456D0",
      "id": "Abiraterone",
      "preferredName": "Abiraterone",
      "synonyms": [
        "17-(3-Pyridyl)androsta-5,16-dien-3beta-ol",
        "ABIRATERONE",
        "Abiraterone",
        "CB 7598"
      ]
    },
    {
      "fdaUniiCode": "81U8A51CHK",
      "id": "Alestramustine",
      "preferredName": "Alestramustine",
      "synonyms": [
        "ALESTRAMUSTINE",
        "Alestramustine"
      ]
    },
    {
      "fdaUniiCode": "504RN634MM",
      "id": "Ketotrexate",
      "preferredName": "Ketotrexate",
      "synonyms": [
        "KETOTREXATE",
        "Ketotrexate"
      ]
    },
    {
      "fdaUniiCode": "QMG7HLD1ZE",
      "id": "Histrelin_Acetate",
      "preferredName": "Histrelin Acetate",
      "synonyms": [
        "HISTRELIN ACETATE",
        "Histrelin Acetate",
        "Supprelin",
        "Vantas"
      ]
    },
    {
      "fdaUniiCode": "R6ZMD4UH3D",
      "id": "Ispinesib_Mesylate",
      "preferredName": "Ispinesib Mesylate",
      "synonyms": [
        "ISPINESIB MESYLATE",
        "Ispinesib Mesylate"
      ]
    },
    {
      "fdaUniiCode": "I9O4Z8CE5L",
      "id": "Yttrium_Y_90_DOTA_Anti-CEA_Monoclonal_Antibody_M5A",
      "preferredName": "Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A",
      "synonyms": [
        "Y90-DOTA-M5A",
        "YTTRIUM Y-90 DOTA ANTI-CEA MONOCLONAL ANTIBODY M5A",
        "Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A",
        "yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A"
      ]
    },
    {
      "fdaUniiCode": "ZQQ51B5708",
      "id": "Solitomab",
      "preferredName": "Solitomab",
      "synonyms": [
        "Anti-EpCAM BiTE",
        "MT110",
        "SOLITOMAB",
        "Solitomab"
      ]
    },
    {
      "fdaUniiCode": "L9TIM50J8N",
      "id": "Tyroserleutide",
      "preferredName": "Tyroserleutide",
      "synonyms": [
        "CMS 024",
        "TYROSERLEUTIDE",
        "Tyroserleutide",
        "YSL"
      ]
    },
    {
      "fdaUniiCode": "3JB47N2Q2P",
      "id": "Natalizumab",
      "preferredName": "Natalizumab",
      "synonyms": [
        "AN100226",
        "Antegren",
        "Anti-VLA4",
        "Anti-alph4 Integrin Monoclonal Antibody AN100226",
        "NATALIZUMAB",
        "Natalizumab",
        "Tysabri"
      ]
    },
    {
      "fdaUniiCode": "2E8412Y946",
      "id": "Ganetespib",
      "preferredName": "Ganetespib",
      "synonyms": [
        "3-(2,4-dihydroxy-5-isopropylphenyl)-4-(1-methylindol-5-yl)-5-hydroxy-4h-1,2,4-triazole 3h-1,2,4-triazol-3-one",
        "5-(2,4-dihydroxy-5-(1-methylethyl)phenyl)-2,4-dihydro-4-(1-methyl-1h-indol-5-yl)-",
        "GANETESPIB",
        "Ganetespib",
        "Hsp90 Inhibitor STA-9090",
        "STA-9090"
      ]
    },
    {
      "fdaUniiCode": "7Q29OXD98N",
      "id": "Glesatinib",
      "preferredName": "Glesatinib",
      "synonyms": [
        "GLESATINIB",
        "Glesatinib",
        "MG90265",
        "MG90265X",
        "MGCD265",
        "TKI MGCD265"
      ]
    },
    {
      "fdaUniiCode": "J41Q4S20GS",
      "id": "Milataxel",
      "preferredName": "Milataxel",
      "synonyms": [
        "MAC-321",
        "MILATAXEL",
        "Milataxel",
        "TL-00139",
        "TL139"
      ]
    },
    {
      "fdaUniiCode": "2GTU230HA1",
      "id": "Lexibulin",
      "preferredName": "Lexibulin",
      "synonyms": [
        "1-ethyl-3-(2-methoxy-4-(5-methyl-4-(((1s)-1-(pyridin-3-yl)butyl)amino)pyrimidin-2-yl)phenyl)urea",
        "CYT997",
        "LEXIBULIN",
        "Lexibulin",
        "Tubulin Inhibitor CYT997"
      ]
    },
    {
      "fdaUniiCode": "M4PN1DW08K",
      "id": "TLR_Agonist_CADI-05",
      "preferredName": "TLR Agonist CADI-05",
      "synonyms": [
        "CADI-05",
        "MYCOBACTERIUM INDICUS PRANII (HEAT KILLED)",
        "Mycobacterium Indicus Pranii (Heat Killed)",
        "TLR Agonist CADI-05",
        "Toll-like Receptor Agonist CADI-05"
      ]
    },
    {
      "fdaUniiCode": "3499328002",
      "id": "Sapitinib",
      "preferredName": "Sapitinib",
      "synonyms": [
        "2-(4-((4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)-n-methylacetamide",
        "AZD8931",
        "ErbB Kinase Inhibitor AZD8931",
        "SAPITINIB",
        "Sapitinib"
      ]
    },
    {
      "fdaUniiCode": "82S8X8XX8H",
      "id": "Ruxolitinib",
      "preferredName": "Ruxolitinib",
      "synonyms": [
        "(3R)-3-cyclopentyl-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)propanenitrile",
        "INCB-18424",
        "INCB18424",
        "Jakafi",
        "Oral JAK Inhibitor INCB18424",
        "RUXOLITINIB",
        "Ruxolitinib"
      ]
    },
    {
      "fdaUniiCode": "64EUX713G6",
      "id": "Samalizumab",
      "preferredName": "Samalizumab",
      "synonyms": [
        "ALXN6000",
        "Anti-(CD200 (Antigen)) (Human-mouse Monoclonal ALXN6000 Heavy Chain), Disulfide with Human-mouse Monoclonal ALXN6000 Kappa-chain, Dimer",
        "SAMALIZUMAB",
        "Samalizumab"
      ]
    },
    {
      "fdaUniiCode": "234248D0HH",
      "id": "Tucatinib",
      "preferredName": "Tucatinib",
      "synonyms": [
        "ARRY-380",
        "Irbinitinib",
        "N6-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)quinazoline-4,6-diamine",
        "ONT-380",
        "TUCATINIB",
        "Tucatinib",
        "Tukysa"
      ]
    },
    {
      "fdaUniiCode": "RC87L028HU",
      "id": "RARalpha_Agonist_IRX5183",
      "preferredName": "RARalpha Agonist IRX5183",
      "synonyms": [
        "AGN 195183",
        "AGN-195183",
        "IRX 5183",
        "IRX-5183",
        "IRX5183",
        "NRX 195183",
        "NRX195183",
        "RARa Agonist IRX5183",
        "RARalpha Agonist IRX5183",
        "VTP 195183",
        "VTP-195183"
      ]
    },
    {
      "fdaUniiCode": "ID6YB4W3V8",
      "id": "Serdemetan",
      "preferredName": "Serdemetan",
      "synonyms": [
        "JNJ 26854165",
        "JNJ-26854165",
        "N-(2-(1H-Indol-3-yl)ethyl)-n'-(pyridin-4-yl)benzene-1,4-diamine",
        "SERDEMETAN",
        "Serdemetan"
      ]
    },
    {
      "fdaUniiCode": "S3AZD8D215",
      "id": "Pevonedistat",
      "preferredName": "Pevonedistat",
      "synonyms": [
        "((1S,2S,4R)-4-(4-((1S)-2,3-Dihydro-1H-inden-1-ylamino)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl Sulphamate",
        "MLN4924",
        "Nedd8-Activating Enzyme Inhibitor MLN4924",
        "PEVONEDISTAT",
        "Pevonedistat"
      ]
    },
    {
      "fdaUniiCode": "8I9S6401XZ",
      "id": "Rocapuldencel-T",
      "preferredName": "Rocapuldencel-T",
      "synonyms": [
        "AGS-003",
        "CMN-001",
        "ROCAPULDENCEL-T",
        "Rocapuldencel-T"
      ]
    },
    {
      "fdaUniiCode": "33E86K87QN",
      "id": "Trametinib",
      "preferredName": "Trametinib",
      "synonyms": [
        "GSK1120212",
        "JTP-74057",
        "MEK Inhibitor GSK1120212",
        "N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide",
        "TRAMETINIB",
        "Trametinib"
      ]
    },
    {
      "fdaUniiCode": "D8W2DVO5ZJ",
      "id": "Bizalimogene_Ralaplasmid",
      "preferredName": "Bizalimogene Ralaplasmid",
      "synonyms": [
        "BIZALIMOGENE RALAPLASMID",
        "Bizalimogene Ralaplasmid",
        "HPV DNA Plasmids Therapeutic Vaccine VGX-3100",
        "VGX-3100",
        "pGX3002"
      ]
    },
    {
      "fdaUniiCode": "9BJ85K1J8S",
      "id": "Quisinostat",
      "preferredName": "Quisinostat",
      "synonyms": [
        "HDAC Inhibitor JNJ-26481585",
        "JNJ-26481585",
        "QUISINOSTAT",
        "Quisinostat"
      ]
    },
    {
      "fdaUniiCode": "CTG26PRE5S",
      "id": "FGF_Receptor_Antagonist_HGS1036",
      "preferredName": "FGF Receptor Antagonist HGS1036",
      "synonyms": [
        "FGF Receptor Antagonist HGS1036",
        "FP-1039",
        "GSK3052230",
        "HGS1036"
      ]
    },
    {
      "fdaUniiCode": "81HH79X39W",
      "id": "Cedefingol",
      "preferredName": "Cedefingol",
      "synonyms": [
        "CEDEFINGOL",
        "Cedefingol"
      ]
    },
    {
      "fdaUniiCode": "KAM54NKT1Q",
      "id": "Clanfenur",
      "preferredName": "Clanfenur",
      "synonyms": [
        "CLANFENUR",
        "Clanfenur"
      ]
    },
    {
      "fdaUniiCode": "T3RCY5OD7A",
      "id": "Epipropidine",
      "preferredName": "Epipropidine",
      "synonyms": [
        "EPIPROPIDINE",
        "Epipropidine"
      ]
    },
    {
      "fdaUniiCode": "9TZH4WY30J",
      "id": "Methoxyamine",
      "preferredName": "Methoxyamine",
      "synonyms": [
        "METHOXYAMINE",
        "Methoxyamine",
        "TRC102 Base"
      ]
    },
    {
      "fdaUniiCode": "203546OLMF",
      "id": "Methoxyamine_Hydrochloride",
      "preferredName": "Methoxyamine Hydrochloride",
      "synonyms": [
        "METHOXYAMINE HYDROCHLORIDE",
        "Methoxyamine Hydrochloride",
        "TRC 102",
        "TRC-102",
        "methoxyamine hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "H3M9955244",
      "id": "Rucaparib_Phosphate",
      "preferredName": "Rucaparib Phosphate",
      "synonyms": [
        "AG014699",
        "PARP-1 inhibitor AG014699",
        "PARP1 Inhibitor PF-01367338",
        "PF-01367338",
        "RUCAPARIB PHOSPHATE",
        "Rucaparib Phosphate"
      ]
    },
    {
      "fdaUniiCode": "4B18YVW82N",
      "id": "Aviscumine",
      "preferredName": "Aviscumine",
      "synonyms": [
        "AVISCUMINE",
        "Aviscumine",
        "CY 503",
        "CY-503",
        "CY503",
        "Toxin ML-I (Mistletoe Lectin I) (Viscum album)"
      ]
    },
    {
      "fdaUniiCode": "96R6PU3D8J",
      "id": "Ponatinib_Hydrochloride",
      "preferredName": "Ponatinib Hydrochloride",
      "synonyms": [
        "AP24534 HCl",
        "Benzamide, 3-(2-Imidazo(1,2-B)Pyridazin-3-Ylethynyl)-4-Methyl-N-(4-((4-Methyl-1- Piperazinyl)Methyl)-3-(Trifluoromethyl)Phenyl)-, Hydrochloride (1:1)",
        "Iclusig",
        "PONATINIB HYDROCHLORIDE",
        "Ponatinib Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "O4T5UXS4P2",
      "id": "Sonepcizumab",
      "preferredName": "Sonepcizumab",
      "synonyms": [
        "Asonep",
        "LT1009",
        "SONEPCIZUMAB",
        "Sonepcizumab"
      ]
    },
    {
      "fdaUniiCode": "T9FVH03HMZ",
      "id": "Calaspargase_Pegol-mknl",
      "preferredName": "Calaspargase Pegol-mknl",
      "synonyms": [
        "Asparaginase (Escherichia coli Isoenzyme II), Conjugate with alpha-(((2,5-Dioxo-1-pyrrolidinyl)oxy)carbonyl)-omega-methoxypoly(oxy-1,2-ethanediyl)",
        "Asparlas",
        "CALASPARGASE PEGOL",
        "Calaspargase Pegol",
        "Calaspargase Pegol-mknl",
        "EZN-2285",
        "SC-PEG E. Coli L-Asparaginase",
        "SC-PEG E. coli L-asparaginase",
        "Succinimidyl Carbonate Monomethoxypolyethylene Glycol E. coli L-Asparaginase"
      ]
    },
    {
      "fdaUniiCode": "24T2A1DOYB",
      "id": "Regorafenib",
      "preferredName": "Regorafenib",
      "synonyms": [
        "4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide",
        "BAY 73-4506",
        "REGORAFENIB",
        "Regorafenib",
        "Stivarga"
      ]
    },
    {
      "fdaUniiCode": "U9GNI6VT5N",
      "id": "R---Gossypol_Acetic_Acid",
      "preferredName": "R-(-)-Gossypol Acetic Acid",
      "synonyms": [
        "(-)-Gossypol Acetic Acid",
        "(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-(R)-5,5'-bis(1-methylethyl)-, (2R)-, compd. with acetic acid (1:1)",
        "AT 101",
        "AT-101",
        "GOSSYPOL ACETIC ACID, (R)-",
        "R-(-)-Gossypol Acetic Acid"
      ]
    },
    {
      "fdaUniiCode": "4QW4AN84NQ",
      "id": "Semuloparin",
      "preferredName": "Semuloparin",
      "synonyms": [
        "AVE-5026",
        "AVE5026",
        "SEMULOPARIN",
        "Semuloparin",
        "ULMW heparin AVE5026",
        "Ultra-low-molecular-weight Heparin (2000-3000 MW; Phosphazene Depolymerization)",
        "Ultralow-Molecular-Weight Heparin AVE5026"
      ]
    },
    {
      "fdaUniiCode": "1568H6A58U",
      "id": "Glembatumumab_Vedotin",
      "preferredName": "Glembatumumab Vedotin",
      "synonyms": [
        "Antibody-Drug Conjugate CR011-vcMMAE",
        "CDX-011",
        "CR011-vcMMAE",
        "CR011-vcMMAE Immunotoxin",
        "GLEMBATUMUMAB VEDOTIN",
        "Glembatumumab Vedotin"
      ]
    },
    {
      "fdaUniiCode": "8PQK3QPW4P",
      "id": "DI-Leu16-IL2_Immunocytokine",
      "preferredName": "DI-Leu16-IL2 Immunocytokine",
      "synonyms": [
        "DI-LEU16-IL2",
        "DI-Leu16-IL-2",
        "DI-Leu16-IL2 Immunocytokine",
        "De-Immunized Anti-CD20-IL-2 Immunocytokine DI-Leu16-IL-2"
      ]
    },
    {
      "fdaUniiCode": "7A055A9QRR",
      "id": "Talactoferrin_Alfa",
      "preferredName": "Talactoferrin Alfa",
      "synonyms": [
        "Oral Recombinant Human Lactoferrin",
        "Oral rhLF",
        "TALACTOFERRIN ALFA",
        "TLF",
        "Talactoferrin Alfa",
        "talactoferrin",
        "talactoferrin alfa"
      ]
    },
    {
      "fdaUniiCode": "1WZ6S45S94",
      "id": "Tigapotide",
      "preferredName": "Tigapotide",
      "synonyms": [
        "PCK3145",
        "Prostate-Secretory Protein-94-Derived Peptide PCK3145",
        "TIGAPOTIDE",
        "Tigapotide"
      ]
    },
    {
      "fdaUniiCode": "YTL7A418KQ",
      "id": "Nanatinostat",
      "preferredName": "Nanatinostat",
      "synonyms": [
        "5-Pyrimidinecarboxamide, 2-((1Alpha,5alpha,6alpha)-6-(((6-fluoro-2-quinolinyl)methyl)amino)-3-azabicyclo(3.1.0)hex-3-yl)-N-hydroxy-",
        "CHR 3996",
        "CHR-3996",
        "HDAC Inhibitor VRx-3996",
        "Histone Deacetylase Inhibitor VRx-3996",
        "NANATINOSTAT",
        "Nanatinostat",
        "VRx 3996",
        "VRx-3996",
        "VRx3996",
        "WHO 10911"
      ]
    },
    {
      "fdaUniiCode": "25MKH1SZ0M",
      "id": "mTOR_Kinase_Inhibitor_OSI-027",
      "preferredName": "mTOR Kinase Inhibitor OSI-027",
      "synonyms": [
        "Mammalian Target of Rapamycin Kinase Inhibitor OSI-027",
        "OSI-027",
        "mTOR Kinase Inhibitor OSI-027"
      ]
    },
    {
      "fdaUniiCode": "50I23C5UOR",
      "id": "Astuprotimut-R",
      "preferredName": "Astuprotimut-R",
      "synonyms": [
        "ASTUPROTIMUT-R",
        "Astuprotimut-R",
        "GSK1203486A",
        "MAGE-A3",
        "Recombinant MAGE-A3 ASCI GSK1203486A"
      ]
    },
    {
      "fdaUniiCode": "82JB1524Q6",
      "id": "Ombrabulin",
      "preferredName": "Ombrabulin",
      "synonyms": [
        "(2S)-2-amino-3-hydroxy-n-(2-methoxy-5-((1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl)phenyl)propanamide",
        "AC7700",
        "AVE8062",
        "Combretastatin A4 Analogue AVE8062",
        "OMBRABULIN",
        "Ombrabulin"
      ]
    },
    {
      "fdaUniiCode": "EEO29FZT86",
      "id": "Padeliporfin",
      "preferredName": "Padeliporfin",
      "synonyms": [
        "PADELIPORFIN",
        "Padeliporfin",
        "Palladium-Bacteriochlorophyll Derivative WST11",
        "WST11"
      ]
    },
    {
      "fdaUniiCode": "CYJ9ATV1IJ",
      "id": "MET_Tyrosine_Kinase_Inhibitor_PF-04217903",
      "preferredName": "MET Tyrosine Kinase Inhibitor PF-04217903",
      "synonyms": [
        "2-(4-(1-(Quinolin-6-ylmethyl)-1H-(1,2,3)triazolo(4,5-b)pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol",
        "MET Tyrosine Kinase Inhibitor PF-04217903",
        "PF-04217903"
      ]
    },
    {
      "fdaUniiCode": "46MVG4H2LF",
      "id": "Anti-PLGF_Monoclonal_Antibody_TB-403",
      "preferredName": "Anti-PLGF Monoclonal Antibody TB-403",
      "synonyms": [
        "Anti-PLGF Monoclonal Antibody TB-403",
        "Anti-Placental Growth Factor Monoclonal Antibody TB-403",
        "RG7334",
        "TB-403"
      ]
    },
    {
      "fdaUniiCode": "DN43058TIV",
      "id": "Atorvastatin_Sodium",
      "preferredName": "Atorvastatin Sodium",
      "synonyms": [
        "ATORVASTATIN SODIUM",
        "Atorvastatin Sodium"
      ]
    },
    {
      "fdaUniiCode": "4A6ZS6Q2CL",
      "id": "Puromycin",
      "preferredName": "Puromycin",
      "synonyms": [
        "Adenosine, 3'-((2-amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-N,N-dimethyl-, (S)-",
        "Adenosine, 3'-(alpha-amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyl-, L-",
        "CL 16536",
        "L-3'-(alpha-Amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyladenosine",
        "P-638",
        "PUROMYCIN",
        "Puromicina",
        "Puromycin",
        "Puromycine",
        "Puromycinum",
        "Stillomycin",
        "Stylomycin"
      ]
    },
    {
      "fdaUniiCode": "YG57I8T5M0",
      "id": "Idelalisib",
      "preferredName": "Idelalisib",
      "synonyms": [
        "5-Fluoro-3-phenyl-2-((S)-1-(9H-purin-6-ylamino)-propyl)-3H- quinazolin-4-one",
        "CAL-101",
        "GS 1101",
        "GS-1101",
        "IDELALISIB",
        "Idelalisib",
        "Phosphoinositide-3 Kinase Delta Inhibitor CAL-101",
        "Zydelig"
      ]
    },
    {
      "fdaUniiCode": "G22N65IL3O",
      "id": "Pacritinib",
      "preferredName": "Pacritinib",
      "synonyms": [
        "Oral JAK2 Inhibitor SB1518",
        "PACRITINIB",
        "Pacritinib",
        "SB 1518",
        "SB-1518",
        "SB1518"
      ]
    },
    {
      "fdaUniiCode": "V77J4WJF9Z",
      "id": "Imgatuzumab",
      "preferredName": "Imgatuzumab",
      "synonyms": [
        "Anti-Epidermal Growth Factor Receptor Monoclonal Antibody RO5083945",
        "GA-201",
        "GA201",
        "IMGATUZUMAB",
        "Imgatuzumab",
        "RG 7160",
        "RG-7160",
        "RG7160"
      ]
    },
    {
      "fdaUniiCode": "XGL4M23834",
      "id": "Indatuximab_Ravtansine",
      "preferredName": "Indatuximab Ravtansine",
      "synonyms": [
        "Anti-Myeloma Monoclonal Antibody-DM4 Immunoconjugate BT-062",
        "BT-062",
        "BT062",
        "INDATUXIMAB RAVTANSINE",
        "Indatuximab Ravtansine",
        "Maytansinoid-Conjugated Anti-Myeloma Monoclonal Antibody BT062"
      ]
    },
    {
      "fdaUniiCode": "G2Z7R4P95M",
      "id": "Tubulin_Inhibitor_ALB_109564_Dihydrochloride",
      "preferredName": "Tubulin Inhibitor ALB 109564 Dihydrochloride",
      "synonyms": [
        "ALB-109564 DIHYDROCHLORIDE",
        "ALB-109564 dihydrochloride",
        "Alb-109564(a)",
        "Tubulin Inhibitor ALB 109564 Dihydrochloride"
      ]
    },
    {
      "fdaUniiCode": "77E89833TG",
      "id": "Ficlatuzumab",
      "preferredName": "Ficlatuzumab",
      "synonyms": [
        "AV-299",
        "Anti-HGF Monoclonal Antibody SCH900105",
        "FICLATUZUMAB",
        "Ficlatuzumab",
        "SCH 900105"
      ]
    },
    {
      "fdaUniiCode": "987796874T",
      "id": "Sonolisib",
      "preferredName": "Sonolisib",
      "synonyms": [
        "(4E)-4-(((Bis(prop-2-en-1-yl)amino)methylidene)-6-hydroxy-1alpha-(methoxymethyl)-3,7,17-trioxo-2-oxaandrosta-5,8-dien-11alpha-yl Acetate",
        "PX 866",
        "PX-866",
        "PX866",
        "SONOLISIB",
        "Sonolisib",
        "acetic acid (1S,4E,10R,11R,13S,14R)-4-diallylaminomethylene-6-hydroxy-1-methoxymethyl-10,13-dimethyl-3,7,17-trioxo-1,3,4,7,10,11,12,13,14,15,16,17-dodecahydro-2-oxa-cyclopenta[a]phenanthren-11-yl ester",
        "acetic acid 4-diallylaminomethylene-6-hydroxy-1-alpha 12-methoxymethyl-10beta,13beta-dimethyl-3,7,17-trioxo-1,3,4,7,10,11beta,12,13,14alpha,15,16,17-dodecahydro-2-oxa-cyclopenta[a]phenanthren-11-yl ester"
      ]
    },
    {
      "fdaUniiCode": "86780VJI1Q",
      "id": "Patritumab",
      "preferredName": "Patritumab",
      "synonyms": [
        "AMG 888",
        "PATRITUMAB",
        "Patritumab",
        "U3-1287"
      ]
    },
    {
      "fdaUniiCode": "4V8ECV0NBQ",
      "id": "Dinaciclib",
      "preferredName": "Dinaciclib",
      "synonyms": [
        "2-Piperidineethanol, 1-[3-ethyl-7-[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5- a]pyrimidin-5-yl]-, (2S)-",
        "CDK Inhibitor SCH 727965",
        "CDK inhibitor SCH 727965",
        "DINACICLIB",
        "Dinaciclib",
        "MK-7965",
        "SCH 727965",
        "dinaciclib"
      ]
    },
    {
      "fdaUniiCode": "1N3L70MDFX",
      "id": "Seribantumab",
      "preferredName": "Seribantumab",
      "synonyms": [
        "MM-121",
        "SAR 256212",
        "SERIBANTUMAB",
        "Seribantumab"
      ]
    },
    {
      "fdaUniiCode": "VI79RD8VNN",
      "id": "Camsirubicin",
      "preferredName": "Camsirubicin",
      "synonyms": [
        "5-Imino-13-deoxydoxoubicin",
        "CAMSIRUBICIN",
        "Camsirubicin",
        "GPX-150",
        "GPX150"
      ]
    },
    {
      "fdaUniiCode": "P52EO36K90",
      "id": "Pomegranate_Liquid_Extract",
      "preferredName": "Pomegranate Liquid Extract",
      "synonyms": [
        "Dadima Fruit Water",
        "POMEGRANATE FRUIT VOLATILE OIL",
        "Pomegranate Liquid Extract",
        "Punica granatum Fruit Volatile Oil"
      ]
    },
    {
      "fdaUniiCode": "A7V27PHC7A",
      "id": "Quinine",
      "preferredName": "Quinine",
      "synonyms": [
        "(-)-Quinine",
        "QUIN",
        "QUININE",
        "Quinine"
      ]
    },
    {
      "fdaUniiCode": "W5H7E45YT3",
      "id": "Banoxantrone",
      "preferredName": "Banoxantrone",
      "synonyms": [
        "9,10-Anthracenedione, 1,4-bis((2-(dimethylamino)ethyl)amino)-5,8-dihydroxy-, N,N'-dioxide",
        "AQ 4N",
        "Aq4N",
        "BANOXANTRONE",
        "Banoxantrone"
      ]
    },
    {
      "fdaUniiCode": "Z9U2SS9ZC8",
      "id": "Anti-IGF-1R_Monoclonal_Antibody_AVE1642",
      "preferredName": "Anti-IGF-1R Monoclonal Antibody AVE1642",
      "synonyms": [
        "AVE-1642",
        "AVE1642",
        "Anti-IGF-1R Monoclonal Antibody AVE1642",
        "anti-CD122 monoclonal antibody AVE1642"
      ]
    },
    {
      "fdaUniiCode": "231C73W7LG",
      "id": "Gemcitabine_Elaidate",
      "preferredName": "Gemcitabine Elaidate",
      "synonyms": [
        "CP-4126",
        "GEMCITABINE ELAIDATE",
        "Gemcitabine 5'-Elaidic Acid Ester",
        "Gemcitabine Elaidate"
      ]
    },
    {
      "fdaUniiCode": "T7H0B1R64U",
      "id": "Icrucumab",
      "preferredName": "Icrucumab",
      "synonyms": [
        "Anti-VEGFR-1 Monoclonal Antibody IMC-18F1",
        "Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody IMC-18F1",
        "ICRUCUMAB",
        "IMC-18F1",
        "IMC18F1",
        "Icrucumab"
      ]
    },
    {
      "fdaUniiCode": "53O87HA2QU",
      "id": "Defactinib",
      "preferredName": "Defactinib",
      "synonyms": [
        "Benzamide, N-methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)-2-pyrazinyl)methyl)amino)-5-(trifluoromethyl)-2-pyrimidinyl)amino)-",
        "DEFACTINIB",
        "Defactinib"
      ]
    },
    {
      "fdaUniiCode": "TT6HN20MVF",
      "id": "Olaratumab",
      "preferredName": "Olaratumab",
      "synonyms": [
        "Anti-PDGFR alpha Monoclonal Antibody IMC-3G3",
        "Anti-Platelet-Derived Growth Factor Receptor alpha Monoclonal Antibody IMC-3G3",
        "IMC-3G3",
        "Lartruvo",
        "OLARATUMAB",
        "Olaratumab",
        "anti-PDGFR alpha monoclonal antibody IMC-3G3",
        "anti-platelet-derived growth factor receptor alpha monoclonal antibody IMC-3G3"
      ]
    },
    {
      "fdaUniiCode": "Z07JR07J6C",
      "id": "Namodenoson",
      "preferredName": "Namodenoson",
      "synonyms": [
        "2-Chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide",
        "2-Cl-IB-MECA",
        "A3AdR Agonist CF102",
        "Adenosine Receptor A3 Agonist CF102",
        "C-Ibza-MU",
        "CF102",
        "NAMODENOSON",
        "Namodenoson",
        "beta-D-Ribofuranuronamide, 1-(2-Chloro-6-(((3-iodophenyl)methyl)amino)-9H-purin-9-yl)-1-deoxy-N-methyl-"
      ]
    },
    {
      "fdaUniiCode": "366037O6O7",
      "id": "Irosustat",
      "preferredName": "Irosustat",
      "synonyms": [
        "667 Coumate",
        "BN83495",
        "IROSUSTAT",
        "Irosustat",
        "STX 64",
        "Steroid Sulfatase Inhibitor BN 83495"
      ]
    },
    {
      "fdaUniiCode": "2285XW22DR",
      "id": "Cixutumumab",
      "preferredName": "Cixutumumab",
      "synonyms": [
        "Anti-IGF-1R Recombinant Monoclonal Antibody IMC-A12",
        "CIXUTUMUMAB",
        "Cixutumumab",
        "IMC-A12",
        "cixutumumab"
      ]
    },
    {
      "fdaUniiCode": "ZK89EG3A18",
      "id": "Masitinib_Mesylate",
      "preferredName": "Masitinib Mesylate",
      "synonyms": [
        "4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)benzamide Mesylate",
        "AB1010",
        "MASITINIB MESYLATE",
        "Masitinib Mesylate"
      ]
    },
    {
      "fdaUniiCode": "CF19SF72O5",
      "id": "Olvimulogene_Nanivacirepvec",
      "preferredName": "Olvimulogene Nanivacirepvec",
      "synonyms": [
        "GL-ONC1",
        "GLV-1h68",
        "OLVIMULOGENE NANIVACIREPVEC",
        "Olvimulogene Nanivacirepvec"
      ]
    },
    {
      "fdaUniiCode": "D21E6RU881",
      "id": "Anti-EphA2_Monoclonal_Antibody-MMAF_Immunoconjugate_MEDI-547",
      "preferredName": "Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547",
      "synonyms": [
        "1C1-mcMMAF",
        "Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547",
        "MEDI-547",
        "Medi-547"
      ]
    },
    {
      "fdaUniiCode": "L219C7807V",
      "id": "Elesclomol_Sodium",
      "preferredName": "Elesclomol Sodium",
      "synonyms": [
        "1-N'-benzenecarbothioyl-3-(2-benzenecarbothioyl-2-methylhydrazinyl)-N'-methyl- oxopropanehydrazidide Sodium",
        "ELESCLOMOL SODIUM",
        "Elesclomol Sodium",
        "Propanedioic Acid, Bis[2-methyl-2-(phenylthioxomethyl)hydrazide], Sodium Salt",
        "STA-4783",
        "elesclomol sodium"
      ]
    },
    {
      "fdaUniiCode": "B1E00KQ6NT",
      "id": "Talmapimod",
      "preferredName": "Talmapimod",
      "synonyms": [
        "1H-indole-3-acetamide, 6-Chloro-5-[[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1- piperazinyl]carbonyl]-N,N,1-trimethyl-alpha-oxo-",
        "2-[6-Chloro-5-[[(2R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazin-1-yl]carbonyl]-1- methyl-1H-indol-3-yl]-N,N-dimethyl-2-oxoacetamide",
        "SCIO 469",
        "TALMAPIMOD",
        "Talmapimod"
      ]
    },
    {
      "fdaUniiCode": "FRY3MOL2QU",
      "id": "IL4-Pseudomonas_Exotoxin_Fusion_Protein_MDNA55",
      "preferredName": "IL4-Pseudomonas Exotoxin Fusion Protein MDNA55",
      "synonyms": [
        "IL4-PE",
        "IL4-Pseudomonas Exotoxin Fusion Protein MDNA55",
        "INxin",
        "MDNA55",
        "PRX-321",
        "PRX321"
      ]
    },
    {
      "fdaUniiCode": "6EM57086EA",
      "id": "Volasertib",
      "preferredName": "Volasertib",
      "synonyms": [
        "BI 6727",
        "BI-6727",
        "Benzamide, N-(Trans-4-(4-(Cyclopropylmethyl)-1-Piperazinyl)Cyclohexyl)-4-(((7r)-7-Ethyl-5,6,7,8-Tetrahydro-5-Methyl-8-(1-Methylethyl)-6-Oxo-2-Pteridinyl)Amino)-3-Methoxy-",
        "Polo-like Kinase 1 Inhibitor BI 6727",
        "VOLASERTIB",
        "Volasertib"
      ]
    },
    {
      "fdaUniiCode": "K2ZSF0992C",
      "id": "CHK1_Inhibitor_MK-8776",
      "preferredName": "CHK1 Inhibitor MK-8776",
      "synonyms": [
        "(R)-6-Bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(piperidin-3-yl)pyrazolo[1,5-a]pyrimidin-7-amine",
        "CHK1 Inhibitor MK-8776",
        "MK-8776",
        "MK8776",
        "SCH 900776",
        "SCH-900776"
      ]
    },
    {
      "fdaUniiCode": "7O62J06F18",
      "id": "Combretastatin",
      "preferredName": "Combretastatin",
      "synonyms": [
        "3-Hydroxy-4-methoxy-alpha-(3,4,5-trimethoxyphenyl)benzeneethanol",
        "COMBRETASTATIN",
        "Combretastatin",
        "Combretastatin, (+-)"
      ]
    },
    {
      "fdaUniiCode": "K7386OMP29",
      "id": "2-F-ara-deoxyuridine",
      "preferredName": "2'-F-ara-deoxyuridine",
      "synonyms": [
        "1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl) Uracil",
        "1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl) uracil",
        "1-(2-DEOXY-2-FLUORO-.BETA.-D-ARABINOFURANOSYL)URACIL",
        "2'-F-ara-deoxyuridine",
        "FAU"
      ]
    },
    {
      "fdaUniiCode": "E76113IR49",
      "id": "Devimistat",
      "preferredName": "Devimistat",
      "synonyms": [
        "6,8-Bis(benzylthio)octanoic Acid",
        "Alpha-Lipoic Acid Analogue CPI-613",
        "CPI 613",
        "CPI-613",
        "DEVIMISTAT",
        "Devimistat"
      ]
    },
    {
      "fdaUniiCode": "IS3ESI44W5",
      "id": "Anti-DKK1_Monoclonal_Antibody_BHQ880",
      "preferredName": "Anti-DKK1 Monoclonal Antibody BHQ880",
      "synonyms": [
        "Anti-DKK1 Monoclonal Antibody BHQ880",
        "BHQ-880",
        "BHQ880"
      ]
    },
    {
      "fdaUniiCode": "SF168W7FW0",
      "id": "Demcizumab",
      "preferredName": "Demcizumab",
      "synonyms": [
        "Anti-DLL4 Monoclonal Antibody OMP-21M18",
        "Anti-Delta-like 4 Monoclonal Antibody OMP-21M18",
        "DEMCIZUMAB",
        "Demcizumab",
        "OMP-21M18"
      ]
    },
    {
      "fdaUniiCode": "U9I0PLD4HT",
      "id": "Codrituzumab",
      "preferredName": "Codrituzumab",
      "synonyms": [
        "Anti-Glypican 3 Monoclonal Antibody GC33",
        "CODRITUZUMAB",
        "Codrituzumab",
        "GC-33",
        "GC33",
        "RG 7686",
        "RO 5137382",
        "RO-5137382",
        "RO5137382"
      ]
    },
    {
      "fdaUniiCode": "914910XFBB",
      "id": "Enavatuzumab",
      "preferredName": "Enavatuzumab",
      "synonyms": [
        "Anti-tumor Necrosis Factor-like Weak Inducer of Apoptosis Monoclonal Antibody PDL192",
        "ENAVATUZUMAB",
        "Enavatuzumab",
        "PDL 192"
      ]
    },
    {
      "fdaUniiCode": "RV823G6G67",
      "id": "Copper_Gluconate",
      "preferredName": "Copper Gluconate",
      "synonyms": [
        "COPPER GLUCONATE",
        "Copper Gluconate",
        "Cupric Gluconate"
      ]
    },
    {
      "fdaUniiCode": "65O1D58Z6V",
      "id": "Ioflubenzamide_I-131",
      "preferredName": "Ioflubenzamide I-131",
      "synonyms": [
        "IOFLUBENZAMIDE I-131",
        "Ioflubenzamide (131I)",
        "Ioflubenzamide I-131",
        "MIP-1145",
        "N-(2-(diethylamino)ethyl)-4-((4-fluorobenzoyl)amino)-5-((sup 131)I)iodo-2-methoxybenzamide"
      ]
    },
    {
      "fdaUniiCode": "81FH7VK1C4",
      "id": "Foretinib",
      "preferredName": "Foretinib",
      "synonyms": [
        "FORETINIB",
        "Foretinib",
        "GSK1363089",
        "MET/VEGFR-2 inhibitor GSK1363089",
        "Multitargeted Tyrosine Kinase Inhibitor GSK1363089",
        "N-(3-Fluoro-4-((6-methoxy-7-(3-(morpholin-4-yl)propoxy)quinolin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide",
        "XL880",
        "foretinib"
      ]
    },
    {
      "fdaUniiCode": "HMC2H89N35",
      "id": "Niraparib",
      "preferredName": "Niraparib",
      "synonyms": [
        "MK-4827",
        "MK4827",
        "NIRAPARIB",
        "Niraparib"
      ]
    },
    {
      "fdaUniiCode": "PFP09575EX",
      "id": "Retinoid_9cUAB30",
      "preferredName": "Retinoid 9cUAB30",
      "synonyms": [
        "(9Z)-UAB-30",
        "9cUAB30",
        "Retinoid 9cUAB30",
        "UAB-30"
      ]
    },
    {
      "fdaUniiCode": "JT96FPU35X",
      "id": "Patidegib",
      "preferredName": "Patidegib",
      "synonyms": [
        "FIN-5",
        "IP9 Free Base",
        "IPI-926",
        "IPI-926 Free Base",
        "PATIDEGIB",
        "Patidegib",
        "Saridegib",
        "Smoothened Antagonist IPI-926"
      ]
    },
    {
      "fdaUniiCode": "98OYR854NY",
      "id": "Trabedersen",
      "preferredName": "Trabedersen",
      "synonyms": [
        "AP 12009",
        "TRABEDERSEN",
        "Trabedersen"
      ]
    },
    {
      "fdaUniiCode": "93N13LB4Z2",
      "id": "Amrubicin",
      "preferredName": "Amrubicin",
      "synonyms": [
        "(+)-(7S,9S)-9-Acetyl-9-amino-7-((2-deoxy-beta-D-erythro-pentopyranosyl)oxy)- 6,11-dihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione",
        "AMRUBICIN",
        "Amrubicin",
        "amrubicin"
      ]
    },
    {
      "fdaUniiCode": "5AR83PR647",
      "id": "Razoxane",
      "preferredName": "Razoxane",
      "synonyms": [
        "ICI 59118",
        "ICRF 159",
        "ICRF-159",
        "ICRF159",
        "RAZOXANE",
        "Razoxane",
        "Razoxin"
      ]
    },
    {
      "fdaUniiCode": "686WJT9102",
      "id": "Talotrexin_Ammonium",
      "preferredName": "Talotrexin Ammonium",
      "synonyms": [
        "2-(((4S)-4-Carboxy-4-((4-(((2,4-diaminopteridin-6-yl)methyl)amino)benzoyl)amino)butyl)carbamoyl)benzoic Acid Monoammonium Salt",
        "PT-523",
        "PT523",
        "TALOTREXIN AMMONIUM",
        "Talotrexin Ammonium"
      ]
    },
    {
      "fdaUniiCode": "29T7S2IB97",
      "id": "Liarozole_Hydrochloride",
      "preferredName": "Liarozole Hydrochloride",
      "synonyms": [
        "(+-)-5-(m-Chloro-alpha-imidazol-1-ylbenzyl)benzimidazole Monohydrochloride",
        "1H-Benzimidazole, 5-((3-chlorophenyl)-1H-imidazol-1-ylmethyl)-, Monohydrochloride, (+-)-",
        "LIAROZOLE HYDROCHLORIDE",
        "Liarozole HCl",
        "Liarozole Hydrochloride",
        "R 75251"
      ]
    },
    {
      "fdaUniiCode": "BZF2ZM0I5Z",
      "id": "Retaspimycin",
      "preferredName": "Retaspimycin",
      "synonyms": [
        "17-Allylamino-17-demethoxygeldanamycin Hydroquinone",
        "Geldanamycin, 18,21-didehydro-17-demethoxy-18,21-dideoxo-18,21-dihydroxy-17-(2-propenylamino)-",
        "RETASPIMYCIN",
        "Retaspimycin"
      ]
    },
    {
      "fdaUniiCode": "I18S89P20R",
      "id": "Degarelix_Acetate",
      "preferredName": "Degarelix Acetate",
      "synonyms": [
        "D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3- pyridinyl)-D-alanyl-L- seryl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]- L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-leucyl-N6-(1-methylethyl)-L- lysyl-L-prolyl, Acetate, Hydrate",
        "DEGARELIX ACETATE",
        "Degarelix Acetate",
        "FE200486 Acetate Hydrate"
      ]
    },
    {
      "fdaUniiCode": "WP6PY72ZH3",
      "id": "Motolimod",
      "preferredName": "Motolimod",
      "synonyms": [
        "MOTOLIMOD",
        "Motolimod",
        "Toll-like Receptor 8 Agonist VTX-2337",
        "VTX-2337",
        "VTX-378"
      ]
    },
    {
      "fdaUniiCode": "8V32U4AOQU",
      "id": "Noscapine",
      "preferredName": "Noscapine",
      "synonyms": [
        "NOSCAPINE",
        "Noscapine"
      ]
    },
    {
      "fdaUniiCode": "7I279E1NZ8",
      "id": "Sotrastaurin",
      "preferredName": "Sotrastaurin",
      "synonyms": [
        "SOTRASTAURIN",
        "Sotrastaurin"
      ]
    },
    {
      "fdaUniiCode": "R1SIA15KZ1",
      "id": "Sotrastaurin_Acetate",
      "preferredName": "Sotrastaurin Acetate",
      "synonyms": [
        "3-(1H-Indol-3-yl)-4-(2-(4-methylpiperazin-1-yl)quinazolin-4- yl)-1H-pyrrole-2,5-dione Acetate",
        "AEB 071",
        "AEB071",
        "SOTRASTAURIN ACETATE",
        "Sotrastaurin Acetate"
      ]
    },
    {
      "fdaUniiCode": "H56TJ4554M",
      "id": "Dezaguanine_Mesylate",
      "preferredName": "Dezaguanine Mesylate",
      "synonyms": [
        "3-Deazaguanine Mesylate",
        "DEZAGUANINE MESYLATE",
        "Dezaguanine Mesylate"
      ]
    },
    {
      "fdaUniiCode": "DO2D32W0VC",
      "id": "Ancitabine",
      "preferredName": "Ancitabine",
      "synonyms": [
        "ANCITABINE",
        "Ancitabine"
      ]
    },
    {
      "fdaUniiCode": "V8ZG4Y1B51",
      "id": "Talabostat_Mesylate",
      "preferredName": "Talabostat Mesylate",
      "synonyms": [
        "((2R)-1-((2S)-2-amino-3-methylbutanoyl)pyrrolidin-2-yl)boronic Acid Methanesulfonate",
        "TALABOSTAT MESYLATE",
        "Talabostat Mesylate",
        "Val-boro-Pro",
        "talabostat mesylate"
      ]
    },
    {
      "fdaUniiCode": "NQU9IPY4K9",
      "id": "Cediranib",
      "preferredName": "Cediranib",
      "synonyms": [
        "4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline",
        "AZD2171",
        "CEDIRANIB",
        "Cediranib"
      ]
    },
    {
      "fdaUniiCode": "GRX5L9Y3Z3",
      "id": "Dibrospidium_Chloride",
      "preferredName": "Dibrospidium Chloride",
      "synonyms": [
        "DIBROSPIDIUM CHLORIDE",
        "Dibrospidium Chloride"
      ]
    },
    {
      "fdaUniiCode": "1Z20MGK851",
      "id": "Leurubicin",
      "preferredName": "Leurubicin",
      "synonyms": [
        "LEURUBICIN",
        "Leurubicin"
      ]
    },
    {
      "fdaUniiCode": "6F39648E92",
      "id": "Galarubicin",
      "preferredName": "Galarubicin",
      "synonyms": [
        "(8S,10S)-10-((2.6-Dideoxy-2-fluoro-alpha-L-talopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione 8(sup 2)-ester with Beta-alanine",
        "GALARUBICIN",
        "Galarubicin"
      ]
    },
    {
      "fdaUniiCode": "PH2639TAB4",
      "id": "Nortopixantrone",
      "preferredName": "Nortopixantrone",
      "synonyms": [
        "NORTOPIXANTRONE",
        "Nortopixantrone"
      ]
    },
    {
      "fdaUniiCode": "7865D5D01M",
      "id": "Tretazicar",
      "preferredName": "Tretazicar",
      "synonyms": [
        "CB1954",
        "TRETAZICAR",
        "Tretazicar"
      ]
    },
    {
      "fdaUniiCode": "DV05VZD83V",
      "id": "Budotitane",
      "preferredName": "Budotitane",
      "synonyms": [
        "BUDOTITANE",
        "Budotitane"
      ]
    },
    {
      "fdaUniiCode": "E833KT807K",
      "id": "Ifetroban",
      "preferredName": "Ifetroban",
      "synonyms": [
        "IFETROBAN",
        "Ifetroban"
      ]
    },
    {
      "fdaUniiCode": "1DCO35D4OR",
      "id": "Almurtide",
      "preferredName": "Almurtide",
      "synonyms": [
        "2-Acetamido-3-O-((((1S)-1-(((1R)-1-carbamoyl-3- carboxypropyl)carbamoyl)ethyl)carbamoyl)methyl)-2-deoxy-D- glucopyranose",
        "ALMURTIDE",
        "Almurtide",
        "Cgp-11637",
        "N-Acetyl-nor-muramyl-L-alanyl-D-isoglutamine",
        "nor-MDP",
        "norMDP"
      ]
    },
    {
      "fdaUniiCode": "M62KK37O40",
      "id": "Bleomycin_B2",
      "preferredName": "Bleomycin B2",
      "synonyms": [
        "BLEOMYCIN B2",
        "Bleomycin B2",
        "Bleomycinamide, N1-(4-((aminoiminomethyl)amino)butyl)-",
        "Dehydrophleomycin D1",
        "N1-(4-((Aminoiminomethyl)amino)butyl)bleomycinamide",
        "Phleomycin D2"
      ]
    },
    {
      "fdaUniiCode": "1X70OSD4VX",
      "id": "Ibrutinib",
      "preferredName": "Ibrutinib",
      "synonyms": [
        "2-Propen-1-one, 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)-",
        "BTK Inhibitor PCI-32765",
        "CRA-032765",
        "IBRUTINIB",
        "Ibrutinib",
        "Imbruvica",
        "PCI-32765"
      ]
    },
    {
      "fdaUniiCode": "3S9L1NU6U7",
      "id": "Rabusertib",
      "preferredName": "Rabusertib",
      "synonyms": [
        "1-[5-bromo-4-methyl-2-S-(morpholin-2-yl-methoxy)-phenyl]-3-(5-methyl-pyrazin-2-yl)-urea",
        "Checkpoint Kinase 2 Inhibitor LY2603618",
        "LY2603618",
        "RABUSERTIB",
        "Rabusertib"
      ]
    },
    {
      "fdaUniiCode": "F43I396OIS",
      "id": "Alpha-1-Proteinase_Inhibitor_Human",
      "preferredName": "Alpha-1-Proteinase Inhibitor Human",
      "synonyms": [
        ".ALPHA.1-PROTEINASE INHIBITOR HUMAN",
        "A1AT",
        "A1PI",
        "AAT",
        "Alpha 1 Antitrypsin",
        "Alpha-1 Antitrypsin",
        "Alpha-1-Antiproteinase",
        "Alpha-1-Proteinase Inhibitor Human",
        "Aralast",
        "Prolastin-C"
      ]
    },
    {
      "fdaUniiCode": "MS1J9720WC",
      "id": "Onartuzumab",
      "preferredName": "Onartuzumab",
      "synonyms": [
        "Anti-MET Monoclonal Antibody MetMAb",
        "MetMAb",
        "OA-5D5",
        "ONARTUZUMAB",
        "Onartuzumab",
        "PRO 143966"
      ]
    },
    {
      "fdaUniiCode": "000705ZASD",
      "id": "Adecatumumab",
      "preferredName": "Adecatumumab",
      "synonyms": [
        "ADECATUMUMAB",
        "Adecatumumab",
        "Anti-EpCAM Monoclonal Antibody MT201",
        "MT201"
      ]
    },
    {
      "fdaUniiCode": "516Z3YP58E",
      "id": "Golvatinib",
      "preferredName": "Golvatinib",
      "synonyms": [
        "1,1-cyclopropanedicarboxamide, N-(2-fluoro-4-((2-(((4-(4-methyl-1-piperazinyl)-1-piperidinyl)carbonyl)amino)-4-pyridinyl)oxy)phenyl)-N'-(4-fluorophenyl)-",
        "E7050",
        "GOLVATINIB",
        "Golvatinib",
        "c-Met/VEGFR-2 Kinase Inhibitor E7050"
      ]
    },
    {
      "fdaUniiCode": "B59DCD0F7D",
      "id": "Enoticumab",
      "preferredName": "Enoticumab",
      "synonyms": [
        "Anti-Delta-Like 4 Monoclonal Antibody REGN421",
        "ENOTICUMAB",
        "Enoticumab",
        "REGN421",
        "SAR153192"
      ]
    },
    {
      "fdaUniiCode": "I5590ES2QZ",
      "id": "Fosbretabulin",
      "preferredName": "Fosbretabulin",
      "synonyms": [
        "2-Methoxy-5-((1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl)phenyl Phosphate",
        "Combretastatin A-4 Phosphate",
        "FOSBRETABULIN",
        "Fosbretabulin",
        "Phenol, 2-methoxy-5-((1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-, Dihydrogen Phosphate"
      ]
    },
    {
      "fdaUniiCode": "J8AY0Z4CBP",
      "id": "Pan-VEGFRTIE2_Tyrosine_Kinase_Inhibitor_CEP-11981",
      "preferredName": "Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981",
      "synonyms": [
        "4H-Indazolo(5,4-a)pyrrolo(3,4-C)carbazol-4-one, 2,5,6,11,12,13-Hexahydro-2-methyl-11-(2-methylpropyl)-8-(2-pyrimidinylamino)-",
        "BOL-303213X",
        "CEP 11981",
        "CEP-11981",
        "ESK 981",
        "ESK-981",
        "ESK981",
        "Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981"
      ]
    },
    {
      "fdaUniiCode": "G3D7HF2GS9",
      "id": "Pictilisib_Bismesylate",
      "preferredName": "Pictilisib Bismesylate",
      "synonyms": [
        "2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1- ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine, bimesylate salt",
        "GDC-0941 Bismesylate",
        "GDC-0941 Dimesylate",
        "PICTILISIB BISMESYLATE",
        "Pictilisib Bismesylate",
        "Pictilisib Dimesylate",
        "Thieno(3,2-d)pyrimidine, 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)-1-piperazinyl)methyl)-4-(4-morpholinyl)-, Methanesulfonate (1:2)"
      ]
    },
    {
      "fdaUniiCode": "2CN60TN6ZS",
      "id": "Lurbinectedin",
      "preferredName": "Lurbinectedin",
      "synonyms": [
        "LURBINECTEDIN",
        "Lurbinectedin",
        "PM01183",
        "Zepzelca"
      ]
    },
    {
      "fdaUniiCode": "QZ62892OFJ",
      "id": "Nirogacestat",
      "preferredName": "Nirogacestat",
      "synonyms": [
        "(S)-2-(((S)-6,8-Difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide",
        "NIROGACESTAT",
        "Nirogacestat",
        "PF-03084014"
      ]
    },
    {
      "fdaUniiCode": "0RLU3VTK5M",
      "id": "Sonidegib",
      "preferredName": "Sonidegib",
      "synonyms": [
        "(1,1'-Biphenyl)-3-carboxamide, N-(6-((2R,6S)-2,6-dimethyl-4-morpholinyl)-3-pyridinyl)-2- methyl-4'-(trifluoromethoxy)-, rel-",
        "Erismodegib",
        "LDE-225",
        "LDE225",
        "Odomzo",
        "SONIDEGIB",
        "Smoothened Antagonist LDE225",
        "Sonidegib"
      ]
    },
    {
      "fdaUniiCode": "QGP4HA4G1B",
      "id": "Dabrafenib",
      "preferredName": "Dabrafenib",
      "synonyms": [
        "BRAF Inhibitor GSK2118436",
        "Benzenesulfonamide, N-(3-(5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl)-2-fluorophenyl)-2,6-difluoro-",
        "DABRAFENIB",
        "Dabrafenib",
        "GSK-2118436",
        "GSK-2118436A",
        "GSK2118436"
      ]
    },
    {
      "fdaUniiCode": "8739X25QI3",
      "id": "Afuresertib",
      "preferredName": "Afuresertib",
      "synonyms": [
        "2-Thiophenecarboxamide, N-((1S)-2-amino-1-((3-fluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-",
        "AFURESERTIB",
        "Afuresertib",
        "GSK2110183"
      ]
    },
    {
      "fdaUniiCode": "P0R64C4CR9",
      "id": "Pixantrone_Dimaleate",
      "preferredName": "Pixantrone Dimaleate",
      "synonyms": [
        "6,9-Bis((2-Aminoethyl)Amino)Benzo(g)Isoquinoline-5,10-Dione (2z)-But-2-Enedioate (1:2)",
        "BBR 2778",
        "Benz(g)Isoquinoline-5,10-Dione, 6,9-Bis((2-Aminoethyl)Amino)-, (2z)-2-Butenedioate (1:2)",
        "Benz(g)isoquinoline-5,10-dione, 6,9-bis((2-aminoethyl)amino)-, (2Z)-2-butenedioate (1:2)",
        "PIXANTRONE DIMALEATE",
        "Pixantrone Dimaleate",
        "Pixantrone Maleate"
      ]
    },
    {
      "fdaUniiCode": "7F763NNC9X",
      "id": "Sizofiran",
      "preferredName": "Sizofiran",
      "synonyms": [
        "MC-Glucan",
        "Poly(3-(O-beta-D-glucopyranosyl-(1-3)-O-(beta-D-glucopyranosyl-(1-6))-O-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl)-1)",
        "SIZOFIRAN",
        "Schizophyllan",
        "Schizophyllane",
        "Sixofilan",
        "Sizofiran",
        "Sonifilan"
      ]
    },
    {
      "fdaUniiCode": "0M2XT000YC",
      "id": "Ontuxizumab",
      "preferredName": "Ontuxizumab",
      "synonyms": [
        "Immunoglobulin G1, Anti-(Human Protein TEM1 (Tumor Endothelial Marker 1)) (Human-Mouse Monoclonal MORAb-004 Heavy Chain), Disulfide with Human-Mouse Monoclonal MORAb-004 kappa-chain, Dimer",
        "MORAb-004",
        "ONTUXIZUMAB",
        "Ontuxizumab"
      ]
    },
    {
      "fdaUniiCode": "EI74F49ZLJ",
      "id": "Immunocytokine_NHS-IL2-LT",
      "preferredName": "Immunocytokine NHS-IL2-LT",
      "synonyms": [
        "Ch.14.18-IL2",
        "EMD 521873",
        "Immunocytokine NHS-IL2-LT",
        "SELECTIKINE",
        "Selectikine"
      ]
    },
    {
      "fdaUniiCode": "980M4N37DH",
      "id": "Angiogenesis_Inhibitor_JI-101",
      "preferredName": "Angiogenesis Inhibitor JI-101",
      "synonyms": [
        "Angiogenesis Inhibitor JI-101",
        "JI-101"
      ]
    },
    {
      "fdaUniiCode": "V860J30J9N",
      "id": "Actinium_Ac_225_Lintuzumab",
      "preferredName": "Actinium Ac 225 Lintuzumab",
      "synonyms": [
        "225Ac-HuM195",
        "Actinium (225Ac) Lintuzumab Satetraxetan",
        "Actinium Ac 225 Lintuzumab",
        "Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195",
        "LINTUZUMAB SATETRAXETAN AC-225",
        "SGN-33 AC-225"
      ]
    },
    {
      "fdaUniiCode": "724QD330RD",
      "id": "Abituzumab",
      "preferredName": "Abituzumab",
      "synonyms": [
        "ABITUZUMAB",
        "Abituzumab",
        "EMD 525797"
      ]
    },
    {
      "fdaUniiCode": "SE2KH7T06F",
      "id": "Trastuzumab_Emtansine",
      "preferredName": "Trastuzumab Emtansine",
      "synonyms": [
        "ADO-TRASTUZUMAB EMTANSINE",
        "ADO-Trastuzumab Emtansine",
        "Ado Trastuzumab Emtansine",
        "Immunoglobulin G1, Anti-(Human p185neu Receptor) (Human-Mouse Monoclonal RhuMab HER2 Gamma1-Chain), Disulfide with Human-Mouse Monoclonal RhuMab HER2 Light Chain, Dimer, Tetraamide with N2'-(3-((1-((4-carboxycyclohexyl)methyl)-2,5-dioxo-3-pyrrolidinyl)thio)-1-oxopropyl)-N2'-deacetylMaytansine",
        "Kadcyla",
        "PRO132365",
        "RO5304020",
        "T-DM1",
        "Trastuzumab Emtansine",
        "Trastuzumab-DM1",
        "Trastuzumab-MCC-DM1",
        "Trastuzumab-MCC-DM1 Antibody-Drug Conjugate",
        "Trastuzumab-MCC-DM1 Immunoconjugate"
      ]
    },
    {
      "fdaUniiCode": "679007NR5C",
      "id": "Deslorelin_Acetate",
      "preferredName": "Deslorelin Acetate",
      "synonyms": [
        "5-Oxo-L-Prolyl-L-Histidyl-L-Tryptophyl-L-Seryl-L-Tyrosyl-D-Tryptophyl-L-Leucyl-L-Arginyl-N-Ethyl-L-Prolinamide Acetate",
        "6-D-Tryptophan-9-(N-Ethyl-L-Prolinamide)-1-9-Luteinizing Hormone-Releasing Factor (Swine) Acetate",
        "DESLORELIN ACETATE",
        "Deslorelin Acetate"
      ]
    },
    {
      "fdaUniiCode": "46CWK97Z3K",
      "id": "Ixazomib_Citrate",
      "preferredName": "Ixazomib Citrate",
      "synonyms": [
        "1,3,2-dioxaborinane-4-acetic acid, 4-carboxy-2-((1r)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-6-oxo-",
        "IXAZOMIB CITRATE",
        "Ixazomib Citrate",
        "MLN-9708",
        "MLN9708",
        "Ninlaro"
      ]
    },
    {
      "fdaUniiCode": "P01I4980ZS",
      "id": "Pegvorhyaluronidase_Alfa",
      "preferredName": "Pegvorhyaluronidase Alfa",
      "synonyms": [
        "PEGPH20",
        "PEGVORHYALURONIDASE ALFA",
        "PH20",
        "Pegvorhyaluronidase Alfa",
        "Pegylated Recombinant Human Hyaluronidase PH20",
        "Pegylated Recombinant Human PH20",
        "Pegylated rHuPH20"
      ]
    },
    {
      "fdaUniiCode": "OL741S3N8B",
      "id": "Irinotecan_Sucrosofate",
      "preferredName": "Irinotecan Sucrosofate",
      "synonyms": [
        "IRINOTECAN SUCROSOFATE",
        "Irinotecan Liposome",
        "Irinotecan Sucrosofate",
        "MM-398",
        "Nanoliposomal Irinotecan",
        "Nanoparticle Liposome Formulation of Irinotecan",
        "Onivyde",
        "PEP02",
        "nal-IRI"
      ]
    },
    {
      "fdaUniiCode": "0Z70DT5PRX",
      "id": "Dusigitumab",
      "preferredName": "Dusigitumab",
      "synonyms": [
        "Anti-Insulin-Like Growth Factor 1/2 Monoclonal Antibody MEDI-573",
        "DUSIGITUMAB",
        "Dusigitumab",
        "Immunoglobulin G2, Anti-(Human Insulin-like Growth Factor I/Insulin-like Growth Factor II); Human Monoclonal MEDI-573 gamma Heavy Chain (134-216')-Disulfide with Human Monoclonal MEDI-573 lambda Light Chain Dimer (222-222'':223-223'':226-226'':229-229'')-Tetrakisdisulfide",
        "MEDI-573"
      ]
    },
    {
      "fdaUniiCode": "2XY62K75UV",
      "id": "Tovetumab",
      "preferredName": "Tovetumab",
      "synonyms": [
        "Anti-PDGFR Alpha Monoclonal Antibody MEDI-575",
        "Anti-Platelet-Derived Growth Factor Receptor Alpha Monoclonal Antibody MEDI-575",
        "MEDI-575",
        "TOVETUMAB",
        "Tovetumab"
      ]
    },
    {
      "fdaUniiCode": "042A5NJE6B",
      "id": "Rebastinib_Tosylate",
      "preferredName": "Rebastinib Tosylate",
      "synonyms": [
        "DCC-2036",
        "DP-1919.TO",
        "REBASTINIB TOSYLATE",
        "Rebastinib Tosylate"
      ]
    },
    {
      "fdaUniiCode": "YP57637WMX",
      "id": "Trans_Sodium_Crocetinate",
      "preferredName": "Trans Sodium Crocetinate",
      "synonyms": [
        "2,4,6,8,10,12,14-Hexadecaheptaenedioic Acid, 2,6,11,15-Tetramethyl-, Sodium Salt (1:2), (2E,4E,6E,8E,10E,12E,14E)-",
        "TRANSCROCETINATE SODIUM",
        "TSC",
        "Trans Sodium Crocetinate"
      ]
    },
    {
      "fdaUniiCode": "00M634HD2V",
      "id": "Radgocitabine",
      "preferredName": "Radgocitabine",
      "synonyms": [
        "4-Amino-L-(2-cyano-2-deoxy-beta-D-arabinofuranosyl)- 2(1H)-pyrimidinone",
        "CNDAC",
        "Deoxycytidine Analogue TAS-109",
        "RADGOCITABINE",
        "Radgocitabine",
        "TAS-109"
      ]
    },
    {
      "fdaUniiCode": "6YY7T1T567",
      "id": "Semustine",
      "preferredName": "Semustine",
      "synonyms": [
        "1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea",
        "1-(2-Chloroethyl)-3-(Trans-4-Methylcyclohexane)-1-Nitrosourea",
        "1-(2-Chloroethyl)-3-(trans-4-methylcyclohexane)-1-nitrosourea",
        "1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea",
        "Lomustine, Methyl",
        "Lomustine, methyl",
        "MCCNU",
        "MeCCNU",
        "Methyl CCNU",
        "Methyl Lomustine",
        "SEMUSTINE",
        "Semustine",
        "Urea, 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitroso-, trans- (8CI)",
        "Urea, N-(2-chloroethyl)-N'-(4-methylcyclohexyl)-N-nitroso-, trans- (9CI)",
        "methyl-CCNU",
        "semustine",
        "trans-Methyl-CCNU",
        "urea, 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitroso-, trans- (8CI)",
        "urea, N-(2-chloroethyl)-N'-(4-methylcyclohexyl)-N-nitroso-, trans- (9CI)"
      ]
    },
    {
      "fdaUniiCode": "WIQ1H85SYP",
      "id": "Sodium_Salicylate",
      "preferredName": "Sodium Salicylate",
      "synonyms": [
        "Benzoic acid, 2-hydroxy-, monosodium salt",
        "SODIUM SALICYLATE",
        "Salicylate, sodium",
        "Sodium Salicylate",
        "Sodium salicylate",
        "sodium salicylate"
      ]
    },
    {
      "fdaUniiCode": "1RS284BFUI",
      "id": "Canfosfamide",
      "preferredName": "Canfosfamide",
      "synonyms": [
        "(2R)-L-gamma-Glutamyl-3-((2-((bis(bis(2-chloroethyl)amino)phosphinyl)oxy)ethyl)sulfonyl)-L-alanyl-2-phenylglycine",
        "CANFOSFAMIDE",
        "Canfosfamide",
        "Ter 286"
      ]
    },
    {
      "fdaUniiCode": "HBS2850E4H",
      "id": "Enpromate",
      "preferredName": "Enpromate",
      "synonyms": [
        "1,1-Diphenyl-2-propynyl-N-cyclohexylcarbamate",
        "Acetylenic Carbamate",
        "ENPROMATE",
        "Enpromate",
        "Lilly 59156"
      ]
    },
    {
      "fdaUniiCode": "GBW044919E",
      "id": "Fosbretabulin_Tromethamine",
      "preferredName": "Fosbretabulin Tromethamine",
      "synonyms": [
        "1,3-Dihydroxy-2-(Hydroxymethyl)Propan-2-Aminium 2-Methoxy-5-((1z)-2-(3,4,5-Trimethoxyphenyl)Ethenyl)Phenyl Hydrogen Phosphate",
        "1,3-Propanediol, 2-Amino-2-(Hydroxymethyl)-, Compd. With 2-Methoxy-5-((1z)-2-(3,4,5-Trimethoxyphenyl)Ethenyl)Phenyl Dihydrogen Phosphate (1:1)",
        "CA4P",
        "FOSBRETABULIN TROMETHAMINE",
        "Fosbretabulin Tromethamine",
        "Zybrestat"
      ]
    },
    {
      "fdaUniiCode": "05FZV98342",
      "id": "Inecalcitol",
      "preferredName": "Inecalcitol",
      "synonyms": [
        "(7E)-19-Nor-9,10-seco-14beta-cholesta-5,7-dien-23-yne-1alpha,3beta,25-triol",
        "ICC",
        "INECALCITOL",
        "Inecalcitol",
        "TX 522"
      ]
    },
    {
      "fdaUniiCode": "M17ILL71MC",
      "id": "Efatutazone",
      "preferredName": "Efatutazone",
      "synonyms": [
        "2,4-Thiazolidinedione, 5-((4-((6-(4-Amino-3,5-Dimethylphenoxy)-1-Methyl-1H-Benzimidazol-2-yl)Methoxy)Phenyl)Methyl)-",
        "EFATUTAZONE",
        "Efatutazone",
        "Inolitazone",
        "Rac-5-((4-((6-(4-Amino-3,5-Dimethylphenoxy)-1-Methyl-1H-Benzimidazol-2-yl)Methoxy)Phenyl)Methyl)-1,3-Thiazolidine-2,4-Dione"
      ]
    },
    {
      "fdaUniiCode": "G5067X5156",
      "id": "Intiquinatine",
      "preferredName": "Intiquinatine",
      "synonyms": [
        "(2R)-2-(4-((7-Bromoquinolin-2-yl)Oxy)Phenoxy)Propanoic Acid",
        "INTIQUINATINE",
        "Intiquinatine",
        "Tiliquinatine"
      ]
    },
    {
      "fdaUniiCode": "U395ERO49H",
      "id": "Ladirubicin",
      "preferredName": "Ladirubicin",
      "synonyms": [
        "4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin",
        "FCE 28729",
        "Idarubicin Analog PNU-159548",
        "LADIRUBICIN",
        "Ladirubicin",
        "PNU 159548",
        "PNU-159548",
        "PNU159548"
      ]
    },
    {
      "fdaUniiCode": "135FQ40L36",
      "id": "Mannosulfan",
      "preferredName": "Mannosulfan",
      "synonyms": [
        "MANNOSULFAN",
        "Mannosulfan"
      ]
    },
    {
      "fdaUniiCode": "FC6D57000M",
      "id": "Lucanthone",
      "preferredName": "Lucanthone",
      "synonyms": [
        "LUCANTHONE",
        "Lucanthone"
      ]
    },
    {
      "fdaUniiCode": "3B30XBE7S2",
      "id": "Metamelfalan",
      "preferredName": "Metamelfalan",
      "synonyms": [
        "METAMELFALAN",
        "Metamelfalan"
      ]
    },
    {
      "fdaUniiCode": "1FG8FGL0YI",
      "id": "Namirotene",
      "preferredName": "Namirotene",
      "synonyms": [
        "NAMIROTENE",
        "Namirotene"
      ]
    },
    {
      "fdaUniiCode": "7618O47BQM",
      "id": "Nemorubicin",
      "preferredName": "Nemorubicin",
      "synonyms": [
        "NEMORUBICIN",
        "Nemorubicin"
      ]
    },
    {
      "fdaUniiCode": "2Q6F8JYX76",
      "id": "Nemorubicin_Hydrochloride",
      "preferredName": "Nemorubicin Hydrochloride",
      "synonyms": [
        "5,12-Naphthacenedione, 7,8,9,10-Tetrahydro-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-Methoxy-10-((2,3,6-Trideoxy-3-((2S)-2-Methoxy-4-Morpholinyl)-Alpha-L-Lyxo-Hexopyranosyl)Oxy)-, Hydrochloride, (8S,10S)-",
        "NEMORUBICIN HYDROCHLORIDE",
        "Nemorubicin Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "I031V2H011",
      "id": "Tocilizumab",
      "preferredName": "Tocilizumab",
      "synonyms": [
        "Actemra",
        "Immunoglobulin G1, Anti-(Human Interleukin 6 Receptor) (Human-Mouse Monoclonal MRA Heavy Chain), Disulfide with Human-Mouse Monoclonal MRA Kappa-Chain, Dimer",
        "MRA",
        "R-1569",
        "RoActemra",
        "TOCILIZUMAB",
        "Tocilizumab"
      ]
    },
    {
      "fdaUniiCode": "261Q3JB310",
      "id": "Streptonigrin",
      "preferredName": "Streptonigrin",
      "synonyms": [
        "5-Amino-6-(7-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methyl-2-pyridinecarboxylic Acid",
        "5-Amino-6-(70-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpicolinic Acid",
        "BA-163",
        "Bruneomycin",
        "PC-501",
        "Rufocromomycin",
        "STN",
        "STREPTONIGRIN",
        "Streptonigrin"
      ]
    },
    {
      "fdaUniiCode": "5W494URQ81",
      "id": "Streptozocin",
      "preferredName": "Streptozocin",
      "synonyms": [
        "2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose",
        "2-deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose",
        "2-deoxy-2-[[(methylnitrosamino)-carbonyl]amino]-D-glucopyranose",
        "STREPTOZOCIN",
        "STZ",
        "Streptozocin",
        "Streptozotocin",
        "U 9889",
        "U-9889",
        "Zanosar",
        "streptozocin"
      ]
    },
    {
      "fdaUniiCode": "2AW48LAZ4I",
      "id": "Imetelstat_Sodium",
      "preferredName": "Imetelstat Sodium",
      "synonyms": [
        "DNA, d(3'-amino-3'-deoxy-P-thio)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-[O-[2-hydroxy-3- [(1-oxohexadecyl)amino]propyl] hydrogen phosphorothioate], Sodium Salt (1:13)",
        "GRN163L",
        "GRN163L, Sodium Salt",
        "IMETELSTAT SODIUM",
        "Imetelstat Sodium"
      ]
    },
    {
      "fdaUniiCode": "1578EUB98L",
      "id": "Resminostat",
      "preferredName": "Resminostat",
      "synonyms": [
        "4SC-201",
        "RESMINOSTAT",
        "Resminostat"
      ]
    },
    {
      "fdaUniiCode": "5J61HSP0QJ",
      "id": "MEK_Inhibitor_TAK-733",
      "preferredName": "MEK Inhibitor TAK-733",
      "synonyms": [
        "MEK Inhibitor TAK-733",
        "TAK-733"
      ]
    },
    {
      "fdaUniiCode": "UF1EL37E41",
      "id": "Membrane-Disrupting_Peptide_EP-100",
      "preferredName": "Membrane-Disrupting Peptide EP-100",
      "synonyms": [
        "EP-100",
        "Membrane-Disrupting Peptide EP-100"
      ]
    },
    {
      "fdaUniiCode": "K673DMO5H9",
      "id": "Glasdegib",
      "preferredName": "Glasdegib",
      "synonyms": [
        "GLASDEGIB",
        "Glasdegib",
        "PF 04449913",
        "PF-04449913",
        "PF04449913"
      ]
    },
    {
      "fdaUniiCode": "6ON9RK82AL",
      "id": "Pimasertib",
      "preferredName": "Pimasertib",
      "synonyms": [
        "AS703026",
        "EMD 1036239",
        "MSC1936369",
        "N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4- iodophenyl)amino]isonicotinamide Hydrochloride",
        "PIMASERTIB",
        "Pimasertib"
      ]
    },
    {
      "fdaUniiCode": "181R97MR71",
      "id": "Binimetinib",
      "preferredName": "Binimetinib",
      "synonyms": [
        "ARRY-162",
        "ARRY-438162",
        "BINIMETINIB",
        "Binimetinib",
        "MEK162",
        "Mektovi"
      ]
    },
    {
      "fdaUniiCode": "WA33E149SW",
      "id": "Galeterone",
      "preferredName": "Galeterone",
      "synonyms": [
        "Androsta-5,16-dien-3-ol, 17-(1h-benzimidazol-1-yl)-, (3beta)-",
        "GALETERONE",
        "Galeterone",
        "Specific Androgen Receptor Modulator/CYP17 Lyase Inhibitor TOK-001",
        "TOK-001",
        "VN/124",
        "VN/124-1"
      ]
    },
    {
      "fdaUniiCode": "JH6Z94GLUD",
      "id": "Combretastatin_A1_Diphosphate",
      "preferredName": "Combretastatin A1 Diphosphate",
      "synonyms": [
        "1,2-Benzenediol, 3-methoxy-6-((1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-, 1,2-bis(dihydrogen Phosphate)",
        "CA1P",
        "Combretastatin A-1 bis(phosphate)",
        "Combretastatin A1 Diphosphate",
        "OXI 4503",
        "OXI-4503",
        "OXi4503"
      ]
    },
    {
      "fdaUniiCode": "ZXM835LQ5E",
      "id": "Uprosertib",
      "preferredName": "Uprosertib",
      "synonyms": [
        "2-Furancarboxamide, N-((1S)-2-Amino-1-((3,4-difluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-",
        "GSK2141795",
        "Oral Akt Inhibitor GSK2141795",
        "UPROSERTIB",
        "Uprosertib"
      ]
    },
    {
      "fdaUniiCode": "184SNS8VUH",
      "id": "Sulindac",
      "preferredName": "Sulindac",
      "synonyms": [
        "(Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid",
        "Aflodac",
        "Algocetil",
        "Apo-Sulin",
        "Arthrocine",
        "Artribid",
        "Citireuma",
        "Clinoril",
        "Clisundac",
        "Imbaral",
        "MK-231",
        "Novo-Sundac",
        "Reumofil",
        "Reumyl",
        "SULINDAC",
        "Sudac",
        "Sulindac",
        "Sulindac Sulfoxide",
        "Sulinol",
        "Sulreuma",
        "cis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid",
        "sulindac"
      ]
    },
    {
      "fdaUniiCode": "6032D45BEM",
      "id": "Suramin",
      "preferredName": "Suramin",
      "synonyms": [
        "SURAMIN",
        "Suramin",
        "suramin"
      ]
    },
    {
      "fdaUniiCode": "172030934T",
      "id": "Tivozanib",
      "preferredName": "Tivozanib",
      "synonyms": [
        "AV-951",
        "TIVOZANIB",
        "Tivozanib",
        "Urea, N-[2-chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)-"
      ]
    },
    {
      "fdaUniiCode": "FA2I4Z873U",
      "id": "Alunacedase_Alfa",
      "preferredName": "Alunacedase Alfa",
      "synonyms": [
        "ALUNACEDASE ALFA",
        "APN01",
        "Alunacedase Alfa",
        "rhACE2 APN01"
      ]
    },
    {
      "fdaUniiCode": "Q7Y33N57ZZ",
      "id": "Onalespib",
      "preferredName": "Onalespib",
      "synonyms": [
        "(2,4-Dihydroxy-5-isopropylphenyl)-(5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl)methanone",
        "AT 13387",
        "AT-13387",
        "AT13387",
        "ONALESPIB",
        "Onalespib"
      ]
    },
    {
      "fdaUniiCode": "N1E607PU86",
      "id": "Silmitasertib_Sodium",
      "preferredName": "Silmitasertib Sodium",
      "synonyms": [
        "5-((3-chlorophenyl)amino)-benzo(c)-2,6-naphthyridine-8-carboxylic Acid Sodium Salt",
        "CK2 Inhibitor CX-4945",
        "CX 4945 Sodium",
        "CX-4945 Sodium",
        "CX4945 Sodium",
        "SILMITASERTIB SODIUM",
        "Silmitasertib Sodium"
      ]
    },
    {
      "fdaUniiCode": "Z41TGB4080",
      "id": "Eprenetapopt",
      "preferredName": "Eprenetapopt",
      "synonyms": [
        "APR-246",
        "EPRENETAPOPT",
        "Eprenetapopt",
        "PRIMA-1MET"
      ]
    },
    {
      "fdaUniiCode": "DL0Q912033",
      "id": "pan-PI3KmTOR_Inhibitor_SF1126",
      "preferredName": "pan-PI3K/mTOR Inhibitor SF1126",
      "synonyms": [
        "SF-1126",
        "SF1126",
        "pan-PI3K/mTOR Inhibitor SF1126"
      ]
    },
    {
      "fdaUniiCode": "TF5MPQ8WGY",
      "id": "Zolbetuximab",
      "preferredName": "Zolbetuximab",
      "synonyms": [
        "Claudiximab",
        "IMAB 362",
        "IMAB-362",
        "IMAB362",
        "ZOLBETUXIMAB",
        "Zolbetuximab"
      ]
    },
    {
      "fdaUniiCode": "9DMG482P0R",
      "id": "Demplatin_Pegraglumer",
      "preferredName": "Demplatin Pegraglumer",
      "synonyms": [
        "DEMPLATIN PEGRAGLUMER",
        "Demplatin Pegraglumer",
        "NC-6004",
        "Nanoplatin"
      ]
    },
    {
      "fdaUniiCode": "H4QZU9L323",
      "id": "Azurin50-77_Cell_Penetrating_Peptide_p28",
      "preferredName": "Azurin:50-77 Cell Penetrating Peptide p28",
      "synonyms": [
        "AZURIN-P28",
        "Azurin-Derived Cell Penetrating Peptide p28",
        "Azurin:50-77 CPP p28",
        "Azurin:50-77 Cell Penetrating Peptide p28"
      ]
    },
    {
      "fdaUniiCode": "3750D0U8B5",
      "id": "Pexmetinib",
      "preferredName": "Pexmetinib",
      "synonyms": [
        "ARRY-614",
        "N-(3-tert-Butyl-1-p-tolyl-1H-pyrazol-5-yl)-N'-(5-fluoro-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea",
        "PEXMETINIB",
        "Pexmetinib"
      ]
    },
    {
      "fdaUniiCode": "7FRV7310N6",
      "id": "Tamoxifen_Citrate",
      "preferredName": "Tamoxifen Citrate",
      "synonyms": [
        "(Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine 2-Hydroxy-1,2,3-propanetricarboxylate",
        "(Z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine citrate",
        "1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene Citrate",
        "Apo-Tamox",
        "Clonoxifen",
        "Dignotamoxi",
        "Ebefen",
        "Emblon",
        "Estroxyn",
        "Fentamox",
        "Gen-Tamoxifen",
        "Genox",
        "ICI 46,474",
        "ICI-46474",
        "Jenoxifen",
        "Kessar",
        "Ledertam",
        "Lesporene",
        "Nolgen",
        "Noltam",
        "Nolvadex",
        "Nolvadex-D",
        "Nourytam",
        "Novo-Tamoxifen",
        "Novofen",
        "Noxitem",
        "Oestrifen",
        "Oncotam",
        "PMS-Tamoxifen",
        "Soltamox",
        "TAM",
        "TAMOXIFEN CITRATE",
        "Tamax",
        "Tamaxin",
        "Tamifen",
        "Tamizam",
        "Tamofen",
        "Tamoxasta",
        "Tamoxifen Citrate",
        "Tamoxifen citrate",
        "Tamoxifeni Citras",
        "Zemide",
        "tamoxifen citrate"
      ]
    },
    {
      "fdaUniiCode": "957E6438QA",
      "id": "Teniposide",
      "preferredName": "Teniposide",
      "synonyms": [
        "4'-Demethylepipodophyllotoxin 9-(4,6-O-2-Thenylidene-beta-D-glucopyranoside)",
        "4'-Demethylepipodophyllotoxin-beta-D-thenylidine Glucoside",
        "EPT",
        "PTG",
        "TENIPOSIDE",
        "Teniposide",
        "Thenylidene Lignan",
        "VM 26",
        "VM-26",
        "Vehem",
        "Vumon",
        "[5R-[5Alpha,5a beta,8a alpha, 9beta(R*)]]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-[[4,6-O-(2-thienylmethylene)-beta-D-glucopyranosyl]oxy]furo[3',4':6,7]-naphtho[2,3-d]-1,3-dioxol-6(5aH)-one",
        "teniposide"
      ]
    },
    {
      "fdaUniiCode": "NI40JAQ945",
      "id": "Tetradecanoylphorbol_Acetate",
      "preferredName": "Tetradecanoylphorbol Acetate",
      "synonyms": [
        "12-O-tetradecanoylphorbol-13-acetate",
        "Lonomycin",
        "PHORBOL 12-MYRISTATE 13-ACETATE DIESTER",
        "PMA",
        "Phorbol Myristate Acetate",
        "TPA",
        "TPA (Phorbol Ester)",
        "Tetradecanoylphorbol Acetate",
        "tetradecanoylphorbol acetate"
      ]
    },
    {
      "fdaUniiCode": "0NIZ8H6OL8",
      "id": "Tetrahydrouridine",
      "preferredName": "Tetrahydrouridine",
      "synonyms": [
        "2(1H)-pyrimidinone, tetrahydro-4-hydroxy-1-beta-D-ribofuranosyl-",
        "TETRAHYDROURIDINE",
        "THU",
        "Tetrahydrouridine",
        "tetrahydrouridine"
      ]
    },
    {
      "fdaUniiCode": "8X1D791RF6",
      "id": "Thalicarpine",
      "preferredName": "Thalicarpine",
      "synonyms": [
        "4H-Dibenzo[de,g]quinoline, 5,6,6a, 7-tetrahydro-9-[4,5-dimethoxy-2-[(1,2,3,4-tetrahydro-6, 7-dimethoxy-2-methyl-1-isoquinolinyl)methyl]phenoxy]-1,2, 10-trimethoxy-6-methyl-",
        "4H-Dibenzo[de,g]quinoline, 5,6,6a, 7-tetrahydro-9-[4,5-dimethoxy-2-[(1,2,3,4-tetrahydro-6, 7-dimethoxy-2-methyl-1-isoquinolinyl)methyl]phenoxy]-1,2,10-trimethoxy-6-methyl-",
        "4H-Dibenzo[de,g]quinoline, 9-[4, 5-dimethoxy-2-[(1,2,3,4-tetrahydro-6, 7-dimethoxy-2-methyl-1-isoquinolinyl)methyl]phenoxy]-5,6,6a, 7-tetrahydro-1,2,10-trimethoxy-6-methyl-, [S-(R*,R*)]- (9CI)",
        "4H-dibenzo[de,g]quinoline, 9-[4, 5-dimethoxy-2-[(1,2,3,4-tetrahydro-6, 7-dimethoxy-2-methyl-1-isoquinolinyl)methyl]phenoxy]-5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-, [S-(R*,R*)]- (9CI)",
        "6a-Alpha-aporphine, 9-[[4, 5-dimethoxy-alpha-(1beta,2,3,4-tetrahydro-6, 7-dimethoxy-2-methyl-1-isoquinolyl)-o-tolyl]oxy]-1,2, 10-trimethoxy- (8CI)",
        "6a-Alpha-aporphine, 9-[[4,5-dimethoxy-alpha-((S)-1,2,3, 4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl)-o-tolyl]oxy]-1, 2,10-trimethoxy-",
        "6a.alpha.-Aporphine, 9-[[4, 5-dimethoxy-.alpha.-(1.beta.,2,3,4-tetrahydro-6, 7-dimethoxy-2-methyl-1-isoquinolyl)-o-tolyl]oxy]-1,2, 10-trimethoxy- (8CI)",
        "6a.alpha.-Aporphine, 9-[[4,5-dimethoxy-.alpha.-((S)-1,2,3, 4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl)-o-tolyl]oxy]-1, 2,10-trimethoxy-",
        "THALICARPINE",
        "Taliblastine",
        "Thaliblastine",
        "Thalicarpin",
        "Thalicarpine",
        "[S-(R*,R*)]-9-[4,5-dimethoxy-2-[(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl)-methyl]phenoxy]-5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-4H-dibenzo[de,g]quinoline"
      ]
    },
    {
      "fdaUniiCode": "4Z8R6ORS6L",
      "id": "Thalidomide",
      "preferredName": "Thalidomide",
      "synonyms": [
        "(+)-Thalidomide",
        "(-)-Thalidomide",
        ".alpha.-Phthalimidoglutarimide",
        "2, 6-Dioxo-3-phthalimidopiperidine",
        "2,6-Dioxo-3-phthalimidopiperidine",
        "2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione",
        "3-Phthalimidoglutarimide",
        "Alpha-Phthalimidoglutarimide",
        "Contergan",
        "Distaval",
        "Kevadon",
        "N-(2,6-Dioxo-3-piperidyl)phthalimide",
        "N-Phthaloylglutamimide",
        "N-Phthalylglutamic Acid Imide",
        "N-Phthalylglutamic acid imide",
        "Neurosedyn",
        "Pantosediv",
        "Phthalimide, N-(2, 6-dioxo-3-piperidyl)-, (+)-",
        "Phthalimide, N-(2, 6-dioxo-3-piperidyl)-, (-)-",
        "Sedalis",
        "Sedoval K-17",
        "Softenon",
        "Synovir",
        "THALIDOMIDE",
        "Talimol",
        "Thalidomide",
        "Thalomid",
        "thalidomide"
      ]
    },
    {
      "fdaUniiCode": "11ALM7A4RV",
      "id": "Peretinoin",
      "preferredName": "Peretinoin",
      "synonyms": [
        "(2E,4E,6E,10E)-3,7,11,15-Tetramethylhexadeca-2,4,6,10,14-Pentaenoic Acid",
        "NIK-333",
        "PERETINOIN",
        "Peretinoin"
      ]
    },
    {
      "fdaUniiCode": "46M3EV8HHE",
      "id": "Dienogest",
      "preferredName": "Dienogest",
      "synonyms": [
        "17-Hydroxy-3-Oxo-19-Nor-17Alpha-Pregna-4,9-Diene-21-Nitrile",
        "19-Norpregna-4,9-Diene-21-Nitrile, 17-Hydroxy-3-Oxo-, (17Alpha)-",
        "DIENOGEST",
        "Dienogest",
        "M 18575",
        "MJR-35",
        "STS 557",
        "ZK 37659"
      ]
    },
    {
      "fdaUniiCode": "78NZ2PMP25",
      "id": "Vinzolidine_Sulfate",
      "preferredName": "Vinzolidine Sulfate",
      "synonyms": [
        "2h-3,7-Methanoazacycloundecino(5,4-Beta)Indole-9-Carboxylic Acid, 9-((2Beta,3Beta,4Beta,5Alpha,12Beta,19Alpha)-4-(Acetyloxy)-3'-(2-Chloroethyl)-6,7-Didehydro-16-Methoxy-1-Methyl-2',4'-Dioxospiro(Aspidospermidine-3,5'-Oxazolidin)-15-Yl)-5-Ethy",
        "LY104208",
        "Methyl (3R,5S,7R,9S)-9-[3'-(2-Chloroethyl)-6,7-Didehydro-4Beta-Hydroxy-16-Methoxy-1-Methyl-2',4'-Dioxo-2Beta,3Beta,5Alpha,12Beta,19Alpha-Spiro(Aspidospermidine-3,5'-Oxazolidin]-15-yl)-5-Ethyl-1,4,5,6,7,8,9,10-Octahydro-5-Hydroxy-2H-3,7-Methano",
        "VINZOLIDINE SULFATE",
        "Vinzolidine Sulfate"
      ]
    },
    {
      "fdaUniiCode": "UOT4O1BYV8",
      "id": "Berberine_Chloride",
      "preferredName": "Berberine Chloride",
      "synonyms": [
        "5,6-Dihydro-9,10-Dimethoxybenzo(G)-1,3-Benzodioxolo(5,6-A)Quinolizinium Chloride",
        "BERBERINE CHLORIDE",
        "Berberine Chloride",
        "Berberine Chloride Dihydrate",
        "Berberine Hydrochloride",
        "Berberinum Chloride"
      ]
    },
    {
      "fdaUniiCode": "HIW548RQ3W",
      "id": "Sodium_Selenite",
      "preferredName": "Sodium Selenite",
      "synonyms": [
        "Disodium Selenium Trioxide",
        "SODIUM SELENITE",
        "Selenious Acid Disodium Salt",
        "Selenious Acid, Sodium Salt (1:2)",
        "Sodium Selenite"
      ]
    },
    {
      "fdaUniiCode": "TDH73L8XQD",
      "id": "Pseudoisocytidine",
      "preferredName": "Pseudoisocytidine",
      "synonyms": [
        "4(1H)-Pyrimidinone, 2-Amino-5-Beta-D-Ribofuranosyl-",
        "5-(Beta-D-Ribofuranosyl)Isocytosine",
        "PSEUDOISOCYTIDINE",
        "Pseudoisocytidine",
        "psi Icyd"
      ]
    },
    {
      "fdaUniiCode": "905Z5W3GKH",
      "id": "Thiotepa",
      "preferredName": "Thiotepa",
      "synonyms": [
        "1,1',1\"-phosphinothioylidynetrisaziridine",
        "1,1',1''-Phosphinothioyldynetrisaziridine",
        "1,1',1''-Phosphinothioylidynetrisaziridine",
        "Girostan",
        "N,N', N''-Triethylenethiophosphoramide",
        "N,N',N''-triethylenethiophosphoramide",
        "Oncotiotepa",
        "STEPA",
        "TESPA",
        "THIOTEPA",
        "TIO TEF",
        "TSPA",
        "Tepadina",
        "Tespamin",
        "Tespamine",
        "Thio-Tepa",
        "Thiofosfamide",
        "Thiofozil",
        "Thiophosphamide",
        "Thiophosphoramide",
        "Thioplex",
        "Thiotef",
        "Thiotepa",
        "Tifosyl",
        "Tio-tef",
        "Triethylene Thiophosphoramide",
        "Triethylene thiophosphoramide",
        "Triethylenethiophosphoramide",
        "Tris(1-aziridinyl)phosphine sulfide",
        "WR 45312",
        "thiotepa",
        "triethylenethiophosphoramide",
        "tris(1-aziridinyl)phosphine sulfide"
      ]
    },
    {
      "fdaUniiCode": "NU158DGH9E",
      "id": "Medorubicin",
      "preferredName": "Medorubicin",
      "synonyms": [
        "(1S,3S)-3-Glycoloyl-1,2,3,4,6,11-Hexahydro-3,5,12-Trihydroxy-6,11-Dioxo-1-Naphthacenyl 3-Amino-2,3,6-Trideoxy-Alpha-L-Lyxo-Hexopyranoside",
        "4-Demethoxydoxorubicin",
        "MEDORUBICIN",
        "Medorubicin"
      ]
    },
    {
      "fdaUniiCode": "FTK8U1GZNX",
      "id": "Thioguanine",
      "preferredName": "Thioguanine",
      "synonyms": [
        "2-Amino 6MP",
        "2-Amino-1,7-dihydro-6H-purine-6-thione",
        "2-Amino-6-mercaptopurine",
        "2-Amino-6-purinethiol",
        "2-Aminopurin-6-thiol",
        "2-Aminopurine-6(1H)-thione",
        "2-Aminopurine-6-thiol",
        "2-Aminopurine-6-thiol Hemihydrate",
        "2-Mercapto-6-aminopurine",
        "6 Mercaptoguanine",
        "6 Thioguanine",
        "6-Amino-2-mercaptopurine",
        "6-Mercapto-2-aminopurine",
        "6-Mercaptoguanine",
        "6-TG",
        "6-Thioguanine",
        "6H-Purine-6-thione, 2-amino-1,7-dihydro- (9CI)",
        "BW 5071",
        "Lanvis",
        "THIOGUANINE",
        "Tabloid",
        "Thioguanine",
        "Thioguanine Hemihydrate",
        "Thioguanine Hydrate",
        "Tioguanin",
        "Tioguanine",
        "WR-1141",
        "Wellcome U3B",
        "X 27",
        "thioguanine"
      ]
    },
    {
      "fdaUniiCode": "27B90X776A",
      "id": "Mibefradil",
      "preferredName": "Mibefradil",
      "synonyms": [
        "(1S,2S)-(2-((3-(2-Benzimidazolyl)Propyl)Methylamino)Ethyl)-6-Fluoro-1,2,3,4-Tetrahydro-1-Isopropyl-2-Naphthyl Methoxyacetate",
        "Acetic acid, methoxy-, 2-(2-((3-(1H-benzimidazol-2-yl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, (1S-cis)-",
        "MIBEFRADIL",
        "Mibefradil"
      ]
    },
    {
      "fdaUniiCode": "842TUP3PQ8",
      "id": "Mibefradil_Dihydrochloride",
      "preferredName": "Mibefradil Dihydrochloride",
      "synonyms": [
        "(1S,2S)-(2-((3-(2-Benzimidazolyl)Propyl)Methylamino)Ethyl)-6-Fluoro-1,2,3,4-Tetrahydro-1-Isopropyl-2-Naphthyl Methoxyacetate, Dihydrochloride",
        "Acetic Acid, Methoxy-, 2-(2-((3-(1H-Benzimidazol-2-yl)Propyl)Methylamino)Ethyl)-6-Fluoro-1,2,3,4-Tetrahydro-1-(1-Methylethyl)-2-Naphthalenyl Ester, Dihydrochloride, (1S-cis)-",
        "MIBEFRADIL DIHYDROCHLORIDE",
        "Mibefradil Dihydrochloride",
        "RO 40-5967/001"
      ]
    },
    {
      "fdaUniiCode": "96U5LG549X",
      "id": "Mivobulin",
      "preferredName": "Mivobulin",
      "synonyms": [
        "Carbamic Acid, (5-Amino-1,2-Dihydro-2-Methyl-3-Phenylpyrido(3,4-B)Pyrazin-7-Yl) Ethyl Ester, (S)-",
        "Ethyl (S)-5-Amino-1,2-Dihydro-2-Methyl-3-Phenylpyrido(3,4-B)Pyrazine-7-Carbamate",
        "MIVOBULIN",
        "Mivobulin"
      ]
    },
    {
      "fdaUniiCode": "46S541971T",
      "id": "Thioinosine",
      "preferredName": "Thioinosine",
      "synonyms": [
        "6-Mercaptopurine ribonucleoside",
        "6-Mercaptopurine riboside",
        "6-mercaptopurine ribonucleoside",
        "6-mercaptopurine riboside",
        "Mercaptopurine Riboside",
        "THIOINOSINE",
        "Thioinosine",
        "inosine, 6-thio",
        "ribosyl-6-mercaptopurine"
      ]
    },
    {
      "fdaUniiCode": "Z9K9Y9WMVL",
      "id": "Macitentan",
      "preferredName": "Macitentan",
      "synonyms": [
        "ACT-064992",
        "Actelion-1",
        "MACITENTAN",
        "Macitentan",
        "N-(5-(4-Bromophenyl)-6-(2-((5-Bromopyrimidin-2-Yl)Oxi)Ethoxy)Pyrimidin-4-Yl)-N'-Propylsulfuric Diamide"
      ]
    },
    {
      "fdaUniiCode": "0F35AOI227",
      "id": "Picropodophyllin",
      "preferredName": "Picropodophyllin",
      "synonyms": [
        "AXL1717",
        "Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one,5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-,(5R-(5-alpha,5a-alpha,8a-alpha,9-alpha))-",
        "PICROPODOPHYLLIN",
        "Picropodophyllin",
        "Picropodophyllotoxin"
      ]
    },
    {
      "fdaUniiCode": "571LVA9UMS",
      "id": "Telatinib_Mesylate",
      "preferredName": "Telatinib Mesylate",
      "synonyms": [
        "17-Demethoxy-17-Allylaminogeldanamycin Mesylate",
        "TELATINIB MESYLATE",
        "Telatinib Mesylate"
      ]
    },
    {
      "fdaUniiCode": "1X8F5A3NA0",
      "id": "Omipalisib",
      "preferredName": "Omipalisib",
      "synonyms": [
        "Benzenesulfonamide, 2,4-Difluoro-N-(2-methoxy-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)-",
        "GSK2126458",
        "OMIPALISIB",
        "Omipalisib"
      ]
    },
    {
      "fdaUniiCode": "EX3O2Q61UV",
      "id": "PDK1_Inhibitor_AR-12",
      "preferredName": "PDK1 Inhibitor AR-12",
      "synonyms": [
        "AR-12",
        "PDK1 Inhibitor AR-12"
      ]
    },
    {
      "fdaUniiCode": "RGO812Q0C8",
      "id": "Lutetium_Lu_177-Edotreotide",
      "preferredName": "Lutetium Lu 177-Edotreotide",
      "synonyms": [
        "177Lu-DOTATOC",
        "177Lu-Edo",
        "177Lu-Edotreotide",
        "EDOTREOTIDE LUTETIUM LU-177",
        "Lutetium 177Lu-Edotreotide",
        "Lutetium Lu 177 DOTA-Tyr3-octreotide",
        "Lutetium Lu 177-Edotreotide",
        "[177LuDOTA]-TOC"
      ]
    },
    {
      "fdaUniiCode": "2BT4C47RUI",
      "id": "Necitumumab",
      "preferredName": "Necitumumab",
      "synonyms": [
        "Anti-Epidermal Growth Factor Receptor Monoclonal Antibody IMC-11F8",
        "IMC-11F8",
        "Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor (Receptor Tyrosine-Protein Kinase ErbB-1, EC 2.7.10.1)); Human Monoclonal IMC-11F8 Gamma1 Heavy Chain (224-214')-Disulfide with Human Monoclonal IMC-11F8 Kappa Light Chain, Dimer (230- 230'':233-233'')-Bisdisulfide",
        "NECITUMUMAB",
        "Necitumumab",
        "Portrazza"
      ]
    },
    {
      "fdaUniiCode": "74T7185BMM",
      "id": "Inebilizumab",
      "preferredName": "Inebilizumab",
      "synonyms": [
        "INEBILIZUMAB",
        "Inebilizumab",
        "MEDI-551"
      ]
    },
    {
      "fdaUniiCode": "S3HC6XX81X",
      "id": "Pegylated_Recombinant_Human_Arginase_I_BCT-100",
      "preferredName": "Pegylated Recombinant Human Arginase I BCT-100",
      "synonyms": [
        "BCT-100",
        "Pegylated Recombinant Human Arginase I BCT-100",
        "rhArgIpeg5000"
      ]
    },
    {
      "fdaUniiCode": "6L1XP550I6",
      "id": "Fedratinib",
      "preferredName": "Fedratinib",
      "synonyms": [
        "Benzenesulfonamide, N-(1,1-dimethylethyl)-3-((5-methyl-2-((4-(2-(1-pyrrolidinyl)ethoxy)phenyl)amino)-4-pyrimidinyl)amino)-",
        "FEDRATINIB",
        "Fedratinib",
        "SAR302503",
        "TG101348"
      ]
    },
    {
      "fdaUniiCode": "6O4Z07B57R",
      "id": "Birinapant",
      "preferredName": "Birinapant",
      "synonyms": [
        "BIRINAPANT",
        "Birinapant",
        "Propanamide, N,N'-[(6,6'-difluoro[2,2'-bi-1H-indole]-3,3'-diyl)bis[methylene[(2R,4S)-4-hydroxy-2,1-pyrrolidinediyl][(1S)-1-ethyl-2-oxo-2,1-ethanediyl]]]bis[2-(methylamino)-,(2S,2'S)-",
        "TL32711"
      ]
    },
    {
      "fdaUniiCode": "EGC16R10V0",
      "id": "Dalantercept",
      "preferredName": "Dalantercept",
      "synonyms": [
        "ACE-041",
        "ALK1-Fc Fusion Protein ACE-041",
        "Activin Receptor-like Kinase 1 Inhibitor ACE-041",
        "DALANTERCEPT",
        "Dalantercept"
      ]
    },
    {
      "fdaUniiCode": "3RM68C5CTG",
      "id": "Ang2VEGF-Binding_Peptides-Antibody_Fusion_Protein_CVX-241",
      "preferredName": "Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241",
      "synonyms": [
        "Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241",
        "CVX-241",
        "PF-05057459"
      ]
    },
    {
      "fdaUniiCode": "A4055ME1VK",
      "id": "Infigratinib",
      "preferredName": "Infigratinib",
      "synonyms": [
        "3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-1-methylurea",
        "BGJ-398",
        "BGJ398",
        "INFIGRATINIB",
        "Infigratinib"
      ]
    },
    {
      "fdaUniiCode": "6783M2LV5X",
      "id": "Pexidartinib",
      "preferredName": "Pexidartinib",
      "synonyms": [
        "3-Pyridinemethanamine, N-(5-((5-chloro-1H-pyrrolo(2,3-b)pyridin-3-yl)methyl)-2-pyridinyl)-6-(trifluoromethyl)-",
        "CML-261",
        "PEXIDARTINIB",
        "PLX3397",
        "Pexidartinib"
      ]
    },
    {
      "fdaUniiCode": "O3955SHR9J",
      "id": "Tasisulam_Sodium",
      "preferredName": "Tasisulam Sodium",
      "synonyms": [
        "Benzamide, N-[(5-Bromo-2-thienyl)sulfonyl]-2,4-dichloro-, Sodium Salt",
        "LY-573636.Na",
        "LY573636-Sodium",
        "TASISULAM SODIUM",
        "Tasisulam Sodium"
      ]
    },
    {
      "fdaUniiCode": "4XG66BMN0D",
      "id": "Plozalizumab",
      "preferredName": "Plozalizumab",
      "synonyms": [
        "Immunoglobulin G1, Anti-(Human CC Chemokine Receptor CCR2) (Human-mus musculus Monoclonal 1d9 Heavy Chain), Disulfide with Human-mus musculus Monoclonal 1d9 kappa-chain, Dimer",
        "MLN1202",
        "PLOZALIZUMAB",
        "Plozalizumab",
        "anti-CCR2 monoclonal antibody MLN1202"
      ]
    },
    {
      "fdaUniiCode": "DA9G065962",
      "id": "Motixafortide",
      "preferredName": "Motixafortide",
      "synonyms": [
        "4F-Benzoyl-TN14003",
        "BKT140",
        "BL-8040",
        "MOTIXAFORTIDE",
        "Motixafortide",
        "N-(4-fluoro-benzoyl)-l-arginyl-l-arginyl-(l-3-(naphthyl)alanyl)-l-cysteinyl-l-tyrosyl-l-citrullinyl-l-lysyl-d-lysyl-l-prolyl-l-tyrosyl-l-arginyl-l-citrullinyl-l-cysteinyl-l-arginine Amide,Cyclic (4-13)-disulfide",
        "TF 14016"
      ]
    },
    {
      "fdaUniiCode": "6O01GMS00P",
      "id": "Momelotinib",
      "preferredName": "Momelotinib",
      "synonyms": [
        "CYT387",
        "GS-0387",
        "MOMELOTINIB",
        "Momelotinib",
        "N-(Cyanomethyl)-4-(2-((4-(morpholin-4-yl)phenyl)amino)pyrimidin-4-yl)benzamide"
      ]
    },
    {
      "fdaUniiCode": "82W826FL6S",
      "id": "Milciclib_Maleate",
      "preferredName": "Milciclib Maleate",
      "synonyms": [
        "1H-Pyrazolo(4,3-H)quinazoline-3-carboxamide, 4,5-dihydro-N,1,4,4-tetramethyl-8-((4-(4-methyl-1-piperazinyl)phenyl)amino)-, (2Z)-2-Butenedioate (1:1)",
        "MILCICLIB MALEATE",
        "Milciclib Maleate",
        "N,1,4,4-Tetramethyl-8-[[4-(4-methylpiperazin-1-yl)phenyl]amino]-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide",
        "PHA-848125 AC"
      ]
    },
    {
      "fdaUniiCode": "1IJV77EI07",
      "id": "Tepotinib",
      "preferredName": "Tepotinib",
      "synonyms": [
        "Benzonitrile, 3-(1,6-Dihydro-1-((3-(5-((1-methyl-4-piperidinyl)methoxy)-2-pyrimidinyl)phenyl)methyl)-6-oxo-3-pyridazinyl)-",
        "EMD 1214063",
        "EMD-1214063",
        "EMD1214063",
        "TEPOTINIB",
        "Tepotinib"
      ]
    },
    {
      "fdaUniiCode": "699619YVTQ",
      "id": "Vorsetzumab_Mafodotin",
      "preferredName": "Vorsetzumab Mafodotin",
      "synonyms": [
        "Anti-CD70 MoAb SGN70-MMAF Conjugate",
        "SGN 75",
        "SGN-75",
        "VORSETUZUMAB MAFODOTIN",
        "Vorsetzumab Mafodotin"
      ]
    },
    {
      "fdaUniiCode": "O3F5D10T4M",
      "id": "Canerpaturev",
      "preferredName": "Canerpaturev",
      "synonyms": [
        "CANERPATUREV",
        "Canerpaturev",
        "HF10",
        "HSV1 HF10",
        "Herpes Simplex Virus Type 1 HF10",
        "Msc 2",
        "TBI-1401"
      ]
    },
    {
      "fdaUniiCode": "2G17Y0Q20G",
      "id": "Burixafor",
      "preferredName": "Burixafor",
      "synonyms": [
        "BURIXAFOR",
        "Burixafor",
        "Phosphonic Acid, p-(2-(4-(6-Amino-2-(((trans-4-(((3-(cyclohexylamino)propyl)amino)methyl)cyclohexyl)methyl)amino)-4-pyrimidinyl)-1-piperazinyl)ethyl)-",
        "TG-0054"
      ]
    },
    {
      "fdaUniiCode": "P34L5Y2SR5",
      "id": "Tipapkinogene_Sovacivec",
      "preferredName": "Tipapkinogene Sovacivec",
      "synonyms": [
        "HPV16 E6/E7-encoding MVA Vaccine TG4001",
        "MVA-HPV-IL2",
        "MVA-HPV16E6/E7-IL2",
        "R3484",
        "RG3484",
        "RO5217790",
        "TG 4001",
        "TG-4001",
        "TG4001",
        "TIPAPKINOGENE SOVACIVEC",
        "Tipapkinogene Sovacivec"
      ]
    },
    {
      "fdaUniiCode": "MP3N1L4OR6",
      "id": "Bersanlimab",
      "preferredName": "Bersanlimab",
      "synonyms": [
        "BERSANLIMAB",
        "BI-505",
        "Bersanlimab"
      ]
    },
    {
      "fdaUniiCode": "6611F8KYCV",
      "id": "Litronesib",
      "preferredName": "Litronesib",
      "synonyms": [
        "KF89617",
        "LITRONESIB",
        "LY2523355",
        "Litronesib",
        "Propanamide, N-[4-(2,2-dimethyl-1-oxopropyl)-5-[[[[2-(ethylamino)ethyl]sulfonyl] amino]methyl]-4,5-dihydro-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethyl-, (-)-"
      ]
    },
    {
      "fdaUniiCode": "0BSC3P4H5X",
      "id": "Vistusertib",
      "preferredName": "Vistusertib",
      "synonyms": [
        "AZD 2014",
        "AZD-2014",
        "AZD2014",
        "Benzamide, 3-(2,4-Bis((3S)-3-methyl-4-morpholinyl)pyrido(2,3-d)pyrimidin-7-yl)-N-methyl-",
        "VISTUSERTIB",
        "Vistusertib"
      ]
    },
    {
      "fdaUniiCode": "4TEW51C830",
      "id": "Archexin",
      "preferredName": "Archexin",
      "synonyms": [
        "ARCHEXIN",
        "Akt-1 Antisense Oligonucleotide RX-0201",
        "Archexin",
        "RX-0201"
      ]
    },
    {
      "fdaUniiCode": "JK03C8HWHK",
      "id": "CpG_Oligodeoxynucleotide_GNKG168",
      "preferredName": "CpG Oligodeoxynucleotide GNKG168",
      "synonyms": [
        "CpG ODN GNKG168",
        "CpG Oligodeoxynucleotide GNKG168",
        "GNKG-168",
        "GNKG168"
      ]
    },
    {
      "fdaUniiCode": "P4BBY8S91N",
      "id": "Fimaporfin_A",
      "preferredName": "Fimaporfin A",
      "synonyms": [
        "Amphinex",
        "Disulfonated Tetraphenylchlorin",
        "FIMAPORFIN A",
        "Fimaporfin A",
        "TPCS2a",
        "Tetraphenyl Chlorin Disulfonate"
      ]
    },
    {
      "fdaUniiCode": "L32IM11DV4",
      "id": "Onzigolide",
      "preferredName": "Onzigolide",
      "synonyms": [
        "BIM-23A760",
        "Dopamine-Somatostatin Chimeric Molecule TBR-760",
        "ONZIGOLIDE",
        "Onzigolide",
        "TBR 760",
        "TBR-760",
        "TBR760"
      ]
    },
    {
      "fdaUniiCode": "NN2P9VPL7M",
      "id": "Recombinant_Thyroglobulin",
      "preferredName": "Recombinant Thyroglobulin",
      "synonyms": [
        "Proloid",
        "Recombinant Thyroglobulin",
        "THYROGLOBULIN",
        "Therapeutic TG",
        "Thyroglobulin"
      ]
    },
    {
      "fdaUniiCode": "RGU8A332UL",
      "id": "Clivatuzumab",
      "preferredName": "Clivatuzumab",
      "synonyms": [
        "CLIVATUZUMAB",
        "Clivatuzumab"
      ]
    },
    {
      "fdaUniiCode": "DVW027E7NL",
      "id": "Chromomycin_A3",
      "preferredName": "Chromomycin A3",
      "synonyms": [
        "3B-O-(4-O-Acetyl-2,6-dideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-7-methylolivomycin D",
        "Aburamycin B",
        "Antibiotic 69895 A",
        "Antibiotic B 599",
        "Antibiotic from Streptomyces griseus",
        "CHROMOMYCIN A3",
        "Chromomycin A3",
        "Olivomycin D, 3B-O-(4-O-Acetyl-2, 6-dideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-7-methyl- (9CI)",
        "Olivomycin D, 3B-O-(4-O-acetyl-2, 6-dideoxy-3-C-methyl-.alpha.-L-arabino-hexopyranosyl)-7-methyl- (9CI)",
        "TOYOMYCIN",
        "Toyomycin"
      ]
    },
    {
      "fdaUniiCode": "5688UTC01R",
      "id": "Tretinoin",
      "preferredName": "Tretinoin",
      "synonyms": [
        "(All-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic Acid",
        "2,4,6,8-Nonatetraenoic acid, 3, 7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-",
        "ATRA",
        "Aberel",
        "Airol",
        "Aknoten",
        "All-trans Retinoic Acid",
        "All-trans Vitamin A Acid",
        "Avita",
        "Cordes Vas",
        "Dermairol",
        "Epi-Aberel",
        "Eudyna",
        "Renova",
        "Retin-A",
        "Retin-A MICRO",
        "Retin-A-Micro",
        "Retinoic Acid",
        "Retisol-A",
        "Ro 5488",
        "Stieva-A",
        "Stieva-A Forte",
        "TRETINOIN",
        "Trans Retinoic Acid",
        "Trans Vitamin A Acid",
        "Tretinoin",
        "Tretinoinum",
        "Vesanoid",
        "Vitamin A Acid",
        "Vitamin A acid",
        "Vitamin A acid, all-trans-",
        "Vitinoin",
        "all trans-Retinoic acid",
        "all-trans retinoic acid",
        "all-trans-Retinoic acid",
        "all-trans-Vitamin A acid",
        "beta-Retinoic Acid",
        "retinoic acid",
        "trans-Retinoic Acid",
        "trans-Retinoic acid",
        "tretinoin",
        "vitamin A acid"
      ]
    },
    {
      "fdaUniiCode": "CNN7Y60164",
      "id": "PI3KamTOR_Inhibitor_PKI-179",
      "preferredName": "PI3Ka/mTOR Inhibitor PKI-179",
      "synonyms": [
        "PI3Ka/mTOR Inhibitor PKI-179",
        "PKI-179"
      ]
    },
    {
      "fdaUniiCode": "F3D5D9P25I",
      "id": "Triaziquone",
      "preferredName": "Triaziquone",
      "synonyms": [
        "TRIAZIQUONE",
        "Triaziquone"
      ]
    },
    {
      "fdaUniiCode": "1F1959S062",
      "id": "Elliptinium",
      "preferredName": "Elliptinium",
      "synonyms": [
        "9-Hydroxy-2,5,11-trimethyl-6H-pyrido[4,3-b]carbazolium",
        "9-Hydroxy-2-methylellipticinium",
        "ELLIPTINIUM",
        "Elliptinium",
        "N-2-Methyl-9-hydroxyellipticinium",
        "NMHE"
      ]
    },
    {
      "fdaUniiCode": "RMW9V5RW38",
      "id": "Trifluridine",
      "preferredName": "Trifluridine",
      "synonyms": [
        "2'-Deoxy-5-trifluoromethyluridine",
        "F3TdR",
        "TRIFLURIDINE",
        "Triflorothymidine",
        "Trifluridine"
      ]
    },
    {
      "fdaUniiCode": "F988K568V2",
      "id": "Ensituximab",
      "preferredName": "Ensituximab",
      "synonyms": [
        "Anti-CPAA Monoclonal Antibody NPC-1C",
        "Anti-Colorectal and Pancreatic Carcinoma-Associated Antigen Monoclonal Antibody NPC-1C",
        "ENSITUXIMAB",
        "Ensituximab",
        "NPC-1C"
      ]
    },
    {
      "fdaUniiCode": "1S83F4T2WE",
      "id": "DM-CHOC-PEN",
      "preferredName": "DM-CHOC-PEN",
      "synonyms": [
        "4-DEMETHYL-4-CHOLESTERYLOXYCARBONYLPENCLOMEDINE",
        "4-Demethylcholesteryloxycarbonylpenclomedine",
        "DM-CHOC-PEN"
      ]
    },
    {
      "fdaUniiCode": "7C9N0VM8NR",
      "id": "Briciclib_Sodium",
      "preferredName": "Briciclib Sodium",
      "synonyms": [
        "2-Methoxy-5-(((2-(2,4,6-trimethoxyphenyl)ethenyl)sulfonyl)methyl)phenyl Disodium Phosphate",
        "BRICICLIB SODIUM",
        "Briciclib Sodium",
        "ON 013105",
        "Phenol, 2-Methoxy-5-((((1E)-2-(2,4,6-trimethoxyphenyl)ethenyl)sulfonyl)methyl)-, 1-(Dihydrogen Phosphate), Sodium Salt (1:2)"
      ]
    },
    {
      "fdaUniiCode": "2OQ3OPV2F8",
      "id": "Darleukin",
      "preferredName": "Darleukin",
      "synonyms": [
        "DARLEUKIN",
        "Darleukin",
        "L19-IL2",
        "L19-IL2 Monoclonal Antibody-Cytokine Fusion Protein"
      ]
    },
    {
      "fdaUniiCode": "75FBL12IZ7",
      "id": "Ruxotemitide",
      "preferredName": "Ruxotemitide",
      "synonyms": [
        "LTX-315",
        "Oncopore",
        "RUXOTEMITIDE",
        "Ruxotemitide"
      ]
    },
    {
      "fdaUniiCode": "JGH0DF1U03",
      "id": "Sapanisertib",
      "preferredName": "Sapanisertib",
      "synonyms": [
        "INK-128",
        "INK128",
        "MLN-0128",
        "MLN0128",
        "SAPANISERTIB",
        "Sapanisertib",
        "TAK-228"
      ]
    },
    {
      "fdaUniiCode": "27RU78H2H9",
      "id": "Gemogenovatucel-T",
      "preferredName": "Gemogenovatucel-T",
      "synonyms": [
        "FANG Vaccine",
        "GEMOGENOVATUCEL-T",
        "Gemogenovatucel-T",
        "Vigil",
        "bi-shRNA-Furin and Granulocyte Macrophage Colony Stimulating Factor Augmented Autologous Tumor Cell Vaccine",
        "bi-shRNA-Furin/GM-CSF-Expressing Autologous Tumor Cell Vaccine"
      ]
    },
    {
      "fdaUniiCode": "Q032I35QMX",
      "id": "Mipsagargin",
      "preferredName": "Mipsagargin",
      "synonyms": [
        "G-202",
        "MIPSAGARGIN",
        "Mipsagargin"
      ]
    },
    {
      "fdaUniiCode": "F333OQQ9UV",
      "id": "Asunercept",
      "preferredName": "Asunercept",
      "synonyms": [
        "APG-101",
        "APG101",
        "ASUNERCEPT",
        "Apocept",
        "Asunercept",
        "CAN-008",
        "CAN008",
        "CD95-Fc Fusion Protein CAN008",
        "Fas-Fc Fusion Protein CAN008"
      ]
    },
    {
      "fdaUniiCode": "TY34L4F9OZ",
      "id": "Capmatinib",
      "preferredName": "Capmatinib",
      "synonyms": [
        "2-Fluoro-N-methyl-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzamide",
        "CAPMATINIB",
        "Capmatinib",
        "INC-280",
        "INC280",
        "INCB 28060",
        "INCB028060",
        "INCB28060"
      ]
    },
    {
      "fdaUniiCode": "0ZM2Z182GD",
      "id": "Buparlisib",
      "preferredName": "Buparlisib",
      "synonyms": [
        "AN2025",
        "BKM120",
        "BUPARLISIB",
        "Buparlisib",
        "PI3K Inhibitor BKM120"
      ]
    },
    {
      "fdaUniiCode": "435M4HCP2M",
      "id": "Parsatuzumab",
      "preferredName": "Parsatuzumab",
      "synonyms": [
        "Anti-Epidermal Growth Factor-like Domain 7 Monoclonal Antibody MEGF0444A",
        "MEGF 0444A",
        "MEGF0444A",
        "PARSATUZUMAB",
        "Parsatuzumab",
        "RG 7414",
        "RG7414"
      ]
    },
    {
      "fdaUniiCode": "N65WC8PXDD",
      "id": "Xevinapant",
      "preferredName": "Xevinapant",
      "synonyms": [
        "AT-406",
        "D1143",
        "Debio 1143",
        "Debio-1143",
        "Debio1143",
        "IAPs Antagonist Debio 1143",
        "IAPs Inhibitor Debio 1143",
        "Pyrrolo(1,2-a)(1,5)diazocine-8-carboxamide, n-((1,1'-biphenyl)-2-ylmethyl)decahydro-5-(((2s)-2-(methylamino)-1-oxopropyl)amino)-3-(3-methyl-1-oxobutyl)-6-oxo-, (5s,8s,10ar)",
        "SM-406",
        "SMAC Mimetic Debio 1143",
        "Second Mitochondrial-derived Activator of Caspases Mimetic Debio 1143",
        "XEVINAPANT",
        "Xevinapant"
      ]
    },
    {
      "fdaUniiCode": "R30772KCU0",
      "id": "Isatuximab",
      "preferredName": "Isatuximab",
      "synonyms": [
        "Hu 38SB19",
        "ISATUXIMAB",
        "Immunoglobulin G1, Anti-(Human CD38 Antigen) (Human-mus musculus Monoclonal HU38SB19 Heavy Chain), Disulfide with Human-mus musculus Monoclonal HU38SB19 Light Chain, Dimer",
        "Isatuximab",
        "Isatuximab-irfc",
        "SAR 650984",
        "SAR650984",
        "Sarclisa"
      ]
    },
    {
      "fdaUniiCode": "51HZG6MP1K",
      "id": "Akt_Inhibitor_MK2206",
      "preferredName": "Akt Inhibitor MK2206",
      "synonyms": [
        "1,2,4-Triazolo(3,4-f)(1,6)naphthyridin-3(2H)-one, 8-(4-(1-aminocyclobutyl)phenyl)-9-phenyl-",
        "Akt Inhibitor MK2206",
        "Akt inhibitor MK2206",
        "MK 2206",
        "MK-2206",
        "MK-2206 FREE BASE",
        "MK2206"
      ]
    },
    {
      "fdaUniiCode": "UE5K2FNS92",
      "id": "Orteronel",
      "preferredName": "Orteronel",
      "synonyms": [
        "6-((7S)-7-hydroxy-6,7-dihydro-5h-pyrrolo(1,2-c)imidazol-7-yl)-N-methyl-2-naphthalenecarboxamide",
        "Androgen Synthesis Inhibitor TAK-700",
        "CYP17A1 Lyase Inhibitor TAK-700",
        "ORTERONEL",
        "Orteronel",
        "TAK-700"
      ]
    },
    {
      "fdaUniiCode": "H8J407531S",
      "id": "Aurora_A_Kinase_Inhibitor_MK5108",
      "preferredName": "Aurora A Kinase Inhibitor MK5108",
      "synonyms": [
        "Aurora A Kinase Inhibitor MK5108",
        "MK 5108",
        "MK-5108",
        "MK5108"
      ]
    },
    {
      "fdaUniiCode": "II95UDU7I4",
      "id": "Oleandrin",
      "preferredName": "Oleandrin",
      "synonyms": [
        "OLEANDRIN",
        "Oleandrin",
        "PBI-05204"
      ]
    },
    {
      "fdaUniiCode": "8B5KCA0GAK",
      "id": "Amolimogene_Bepiplasmid",
      "preferredName": "Amolimogene Bepiplasmid",
      "synonyms": [
        "AMOLIMOGENE BEPIPLASMID",
        "Amolimogene",
        "Amolimogene Bepiplasmid",
        "Bacterially Derived DNA and Microparticles Made of Poly(D,L-lactide-co-glydolide)",
        "DNA (synthetic Plasmid p3kDRalphaHPV16-18)",
        "ZYC101a"
      ]
    },
    {
      "fdaUniiCode": "US81N1145T",
      "id": "Lometrexol_Sodium",
      "preferredName": "Lometrexol Sodium",
      "synonyms": [
        "LOMETREXOL SODIUM",
        "LY264618 Disodium",
        "Lometrexol Sodium"
      ]
    },
    {
      "fdaUniiCode": "MVR3JL3B2V",
      "id": "Mirabegron",
      "preferredName": "Mirabegron",
      "synonyms": [
        "2-(2-Aminothiazol-4-yl)-N-[4-(2-{[(2R)-2-hydroxy-2-phenylethyl]amino}ethyl)phenyl] Acetamide",
        "4-Thiazoleacetamide, 2-Amino-N-(4-(2-(((2R)-2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)-",
        "Betanis",
        "MIRABEGRON",
        "Mirabegron",
        "Myrbetriq",
        "YM-178",
        "YM178"
      ]
    },
    {
      "fdaUniiCode": "NUG9P5GWZB",
      "id": "Teglarinad",
      "preferredName": "Teglarinad",
      "synonyms": [
        "Pyridinium, 4-[[[[6-(4-chlorophenoxy)hexyl]amino](cyanoamino)methylene]amino]-1-(3-oxo-2,4,7,10,13,16-hexaoxaheptadec-1-yl)-",
        "TEGLARINAD",
        "Teglarinad"
      ]
    },
    {
      "fdaUniiCode": "K3BO8V06RM",
      "id": "Hsp90_Inhibitor_SNX-5422_Mesylate",
      "preferredName": "Hsp90 Inhibitor SNX-5422 Mesylate",
      "synonyms": [
        "Hsp90 Inhibitor SNX-5422 Mesylate",
        "SNX-5422",
        "SNX-5422 MESYLATE",
        "SNX-5422 Mesylate",
        "SNX-5422 mesylate"
      ]
    },
    {
      "fdaUniiCode": "524Y3IB4HQ",
      "id": "Ipatasertib",
      "preferredName": "Ipatasertib",
      "synonyms": [
        "(2S)-2-(4-chlorophenyl)-1-(4-((5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta(d)pyrimidin-4-yl)piperazin-1-yl(-3-((propan-2-yl)amino)propan-1-one",
        "GDC-0068",
        "IPATASERTIB",
        "Ipatasertib",
        "RG-7440"
      ]
    },
    {
      "fdaUniiCode": "716FQ5REVO",
      "id": "Ascrinvacumab",
      "preferredName": "Ascrinvacumab",
      "synonyms": [
        "ASCRINVACUMAB",
        "Anti-Activin Receptor-like Kinase 1 Monoclonal Antibody PF-03446962",
        "Ascrinvacumab",
        "PF-03446962"
      ]
    },
    {
      "fdaUniiCode": "U59UGK3IPC",
      "id": "Ublituximab",
      "preferredName": "Ublituximab",
      "synonyms": [
        "LFB-R603",
        "TG-1101",
        "TG-20",
        "TGTX-1101",
        "UBLITUXIMAB",
        "Ublituximab"
      ]
    },
    {
      "fdaUniiCode": "072702W9QD",
      "id": "CENP-E_Inhibitor_GSK-923295A",
      "preferredName": "CENP-E Inhibitor GSK-923295A",
      "synonyms": [
        "CENP-E Inhibitor GSK-923295A",
        "Centromere-Associated Protein E Inhibitor GSK-923295",
        "GSK 923295",
        "GSK 923295A",
        "GSK-923295",
        "GSK-923295A",
        "GSK923295",
        "GSK923295A"
      ]
    },
    {
      "fdaUniiCode": "776C212QQH",
      "id": "Carboxyamidotriazole_Orotate",
      "preferredName": "Carboxyamidotriazole Orotate",
      "synonyms": [
        "1,2,3-Carboxyamido-triazole Orotate",
        "CARBOXYAMIDOTRIAZOLE OROTATE",
        "CTO",
        "Carboxyamidotriazole Orotate"
      ]
    },
    {
      "fdaUniiCode": "PRC974M49B",
      "id": "Balixafortide",
      "preferredName": "Balixafortide",
      "synonyms": [
        "Ala-cys-ser-ala-pro-arg-tyr-cys-tyr-gln-lys-pro-pro-tyr-his Cyclic (2->9)-disulfide",
        "BALIXAFORTIDE",
        "Balixafortide",
        "POL6326"
      ]
    },
    {
      "fdaUniiCode": "48OVY2OC72",
      "id": "Sodium_Metaarsenite",
      "preferredName": "Sodium Metaarsenite",
      "synonyms": [
        "KML-001",
        "SODIUM ARSENITE",
        "Sodium Arsenite",
        "Sodium Metaarsenite"
      ]
    },
    {
      "fdaUniiCode": "M351LCX45Y",
      "id": "Tubercidin",
      "preferredName": "Tubercidin",
      "synonyms": [
        "4-Amino-7-.beta.-D-ribofuranosyl-7H-pyrrolo[2, 3-d]pyrimidine",
        "4-Amino-7.beta.-D-ribofuranosyl-7H-pyrrolo(2, 3-d)pyrimidine",
        "4-amino-7-beta-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidine",
        "7-Deazaadenosine",
        "7-beta-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine",
        "7-deazaadenosine",
        "7H-Pyrrolo(2,3-d)pyrimidine, 4-amino-7.beta.-D-ribofuranosyl-",
        "7H-Pyrrolo[2,3-d]pyrimidine, 4-amino-7-.beta.-D-ribofuranosyl-",
        "TUBERCIDIN",
        "Tubercidin",
        "U 10071",
        "U-10071"
      ]
    },
    {
      "fdaUniiCode": "053QD2I96A",
      "id": "Emvododstat",
      "preferredName": "Emvododstat",
      "synonyms": [
        "EMVODODSTAT",
        "Emvododstat",
        "PTC299"
      ]
    },
    {
      "fdaUniiCode": "X2C8Z061MB",
      "id": "Recombinant_Tumor_Necrosis_Factor-Alpha",
      "preferredName": "Recombinant Tumor Necrosis Factor-Alpha",
      "synonyms": [
        "Cachectin",
        "Recombinant Tumor Necrosis Factor-Alpha",
        "SONERMIN",
        "TNF-Alpha",
        "TNFA",
        "Tumor Necrosis Factor (TNF-alpha)"
      ]
    },
    {
      "fdaUniiCode": "V25F9362OP",
      "id": "Zorubicin",
      "preferredName": "Zorubicin",
      "synonyms": [
        "(2S-cis)-Benzoic Acid[1-[4-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide",
        "Benzoic Acid Hydrazide 3-Hydrazone with Daunorubicin",
        "Benzoylhydrazone Daunorubicin",
        "Daunomycin Benzoylhydrazone",
        "Rubidazon",
        "Rubidazone",
        "ZORUBICIN",
        "Zorubicin"
      ]
    },
    {
      "fdaUniiCode": "R42YK40U9M",
      "id": "Narnatumab",
      "preferredName": "Narnatumab",
      "synonyms": [
        "Anti-RON Monoclonal Antibody IMC-RON8",
        "IMC-RON8",
        "NARNATUMAB",
        "Narnatumab"
      ]
    },
    {
      "fdaUniiCode": "ZNV4738BS6",
      "id": "Flanvotumab",
      "preferredName": "Flanvotumab",
      "synonyms": [
        "Anti-gp75 Monoclonal Antibody IMC-20D7S",
        "FLANVOTUMAB",
        "Flanvotumab",
        "IMC-20D7S",
        "IMC20D7S"
      ]
    },
    {
      "fdaUniiCode": "73B0K5S26A",
      "id": "Belimumab",
      "preferredName": "Belimumab",
      "synonyms": [
        "BELIMUMAB",
        "Belimumab",
        "Benlysta",
        "Immunoglobulin G1, anti-(Human Cytokine BAFF) (Human Monoclonal LymphoStat-B Heavy Chain), Disulfide with Human Monoclonal LymphoStat-B lambda-chain, Dimer",
        "LymphoStat-B"
      ]
    },
    {
      "fdaUniiCode": "MZ37792Y8J",
      "id": "Oprozomib",
      "preferredName": "Oprozomib",
      "synonyms": [
        "O-methyl-N-((2-methylthiazol-5-yl)carbonyl)-l-seryl-O-methyl-N-((1S)-1-benzyl-2-((2R)-2-methyloxiran-2-yl)-2-oxoethyl)-l-serinamide",
        "OPROZOMIB",
        "Oprozomib",
        "PR-047",
        "Proteasome Inhibitor ONX 0912"
      ]
    },
    {
      "fdaUniiCode": "820NH671E6",
      "id": "Prexasertib",
      "preferredName": "Prexasertib",
      "synonyms": [
        "2-Pyrazinecarbonitrile, 5-((5-(2-(3-Aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-yl)amino)-",
        "LY2606368",
        "PREXASERTIB",
        "Prexasertib"
      ]
    },
    {
      "fdaUniiCode": "V77I71FH72",
      "id": "Piritrexim_Isethionate",
      "preferredName": "Piritrexim Isethionate",
      "synonyms": [
        "2,4-Diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido(2,3-d)pyrimidine mono(2-hydroxyethanesulfonate)",
        "BW-301U Isethionate",
        "PIRITREXIM ISETHIONATE",
        "Piritrexim Isethionate",
        "Piritrexim isethionate"
      ]
    },
    {
      "fdaUniiCode": "NNI098FX5Q",
      "id": "Mitoguazone_Dihydrochloride",
      "preferredName": "Mitoguazone Dihydrochloride",
      "synonyms": [
        "1,1'-((Methylethanediylidene)Dinitrilo)Diguanidine Dihydrochloride",
        "2,2'-(1-Methyl-1,2-Ethanediylidene)Bis(Hydrazinecarboximidamide) Dihydrochloride",
        "MGBG 2HCl",
        "MITOGUAZONE DIHYDROCHLORIDE",
        "Methylglyoxal Bis(amidinohydrazone) Dihydrochloride",
        "Mitoguazone Dihydrochloride",
        "Pyruvaldehyde Bis(amidinohydrazone) Hydrochloride",
        "mitoguazone dihydrochloride"
      ]
    },
    {
      "fdaUniiCode": "EJ27X76M46",
      "id": "Coenzyme_Q10",
      "preferredName": "Coenzyme Q10",
      "synonyms": [
        "2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecanyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione",
        "Co-Q10",
        "CoQ10",
        "Coenzyme Q10",
        "Q10",
        "UBIDECARENONE",
        "Ubidecarenone",
        "Ubiquinone 10",
        "coenzyme Q10",
        "ubiquinone",
        "vitamin Q10"
      ]
    },
    {
      "fdaUniiCode": "HG3L8885M0",
      "id": "Zanolimumab",
      "preferredName": "Zanolimumab",
      "synonyms": [
        "Anti-CD4 Monoclonal Antibody HuMax",
        "HuMax-CD4",
        "ZANOLIMUMAB",
        "Zanolimumab"
      ]
    },
    {
      "fdaUniiCode": "0B7PYQ9YRT",
      "id": "Pegargiminase",
      "preferredName": "Pegargiminase",
      "synonyms": [
        "ADI-PEG 20",
        "PEGARGIMINASE",
        "Pegargiminase",
        "pegylated arginine deiminase"
      ]
    },
    {
      "fdaUniiCode": "YCB6D9ELEQ",
      "id": "Kanglaite",
      "preferredName": "Kanglaite",
      "synonyms": [
        "COIX LACRYMA-JOBI VAR. MA-YUEN SEED OIL",
        "Coicis Semen Oil",
        "KLT",
        "Kanglaite"
      ]
    },
    {
      "fdaUniiCode": "LD93JWY9D9",
      "id": "Quaratusugene_Ozeplasmid",
      "preferredName": "Quaratusugene Ozeplasmid",
      "synonyms": [
        "GPX 001",
        "GPX-001",
        "GPX001",
        "INGN 401",
        "QUARATUSUGENE OZEPLASMID",
        "Quaratusugene Ozeplasmid",
        "Reqorsa"
      ]
    },
    {
      "fdaUniiCode": "X8Y5U6NC7E",
      "id": "Trebananib",
      "preferredName": "Trebananib",
      "synonyms": [
        "AMG 386",
        "AMG386",
        "Angiopoietin 1/2-Neutralizing Peptibody AMG 386",
        "TREBANANIB",
        "Trebananib"
      ]
    },
    {
      "fdaUniiCode": "LPW79O1J5Z",
      "id": "P-cadherin_Antagonist_PF-03732010",
      "preferredName": "P-cadherin Antagonist PF-03732010",
      "synonyms": [
        "P-cadherin Antagonist PF-03732010",
        "PF-03732010"
      ]
    },
    {
      "fdaUniiCode": "Q8MI0X869M",
      "id": "MDM2_Antagonist_RO5045337",
      "preferredName": "MDM2 Antagonist RO5045337",
      "synonyms": [
        "MDM2 Antagonist RO5045337",
        "R7112",
        "RO-5045337",
        "RO5045337"
      ]
    },
    {
      "fdaUniiCode": "K2T6HJX3I3",
      "id": "Adavosertib",
      "preferredName": "Adavosertib",
      "synonyms": [
        "2-Allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one",
        "ADAVOSERTIB",
        "AZD-1775",
        "AZD1775",
        "Adavosertib",
        "MK-1775",
        "MK1775"
      ]
    },
    {
      "fdaUniiCode": "PQP8VH3MJW",
      "id": "Tabalumab",
      "preferredName": "Tabalumab",
      "synonyms": [
        "Anti-BAFF Monoclonal Antibody LY2127399",
        "LY2127399",
        "TABALUMAB",
        "Tabalumab"
      ]
    },
    {
      "fdaUniiCode": "7SF22186WT",
      "id": "Vesencumab",
      "preferredName": "Vesencumab",
      "synonyms": [
        "Immunoglobulin GL, Anti-(Human Neuropilin 1) (Human Monoclonal MNRP1685a Heavy Chain), Disulfide with Human Monoclonal MNRP1685a Light Chain, Dimer",
        "MNRP-1685A",
        "MNRP1685A",
        "VESENCUMAB",
        "Vesencumab"
      ]
    },
    {
      "fdaUniiCode": "1C854K1MIJ",
      "id": "Apitolisib",
      "preferredName": "Apitolisib",
      "synonyms": [
        "APITOLISIB",
        "Apitolisib",
        "GDC 0980",
        "GDC-0980",
        "GNE 390",
        "RG 7422"
      ]
    },
    {
      "fdaUniiCode": "96265TNH2R",
      "id": "Gedatolisib",
      "preferredName": "Gedatolisib",
      "synonyms": [
        "1-(4-[[4-(dimethylamino)piperidin-1-yl]carbonyl]phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea",
        "GEDATOLISIB",
        "Gedatolisib",
        "PF 05212384",
        "PF-05212384",
        "PKI 587",
        "PKI-587",
        "Urea, N-(4-((4-(dimethylamino)-1-piperidinyl)carbonyl)phenyl)-N'-(4-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)phenyl)-"
      ]
    },
    {
      "fdaUniiCode": "K911R84KEW",
      "id": "Margetuximab",
      "preferredName": "Margetuximab",
      "synonyms": [
        "Immunoglobulin G1, Anti-(human Neu (Receptor)) (Human-Mus musculus Monoclonal MGAH22 Clone ch4D5 Heavy Chain), Disulfide with Human-Mus musculus Monoclonal MGAH22 Clone ch4D5 Light Chain, Dimer",
        "MARGETUXIMAB",
        "MGAH-22",
        "MGAH22",
        "Margenza",
        "Margetuximab"
      ]
    },
    {
      "fdaUniiCode": "DC4WO3WA4Q",
      "id": "Vocimagene_Amiretrorepvec",
      "preferredName": "Vocimagene Amiretrorepvec",
      "synonyms": [
        "DNA (Synthetic Toca 511-encoding Retroviral Vector AC3-yCD2(V))",
        "Toca 511",
        "VOCIMAGENE AMIRETROREPVEC",
        "Vocimagene Amiretrorepvec"
      ]
    },
    {
      "fdaUniiCode": "11Z5AIU653",
      "id": "Simtuzumab",
      "preferredName": "Simtuzumab",
      "synonyms": [
        "AB-0024",
        "AB0024",
        "GS 6624",
        "GS-6624",
        "SIMTUZUMAB",
        "Simtuzumab"
      ]
    },
    {
      "fdaUniiCode": "8W1O4Y961B",
      "id": "Prexigebersen",
      "preferredName": "Prexigebersen",
      "synonyms": [
        "BP-100-1.01",
        "BP-1001",
        "BP1001",
        "Liposomal Grb2 AS ODN",
        "Liposome-Incorporated Grb2 Antisense Oligodeoxynucleotide",
        "PREXIGEBERSEN",
        "Prexigebersen"
      ]
    },
    {
      "fdaUniiCode": "S8P50T62B6",
      "id": "Asulacrine",
      "preferredName": "Asulacrine",
      "synonyms": [
        "4-Acridinecarboxamide,9-((2-methoxy-4-((methylsulfonyl)amino)phenyl)amino)-N,5-dimethyl",
        "ASULACRINE",
        "Amsalog",
        "Asulacrine"
      ]
    },
    {
      "fdaUniiCode": "0V278OKN9G",
      "id": "Hsp90_Inhibitor_Debio_0932",
      "preferredName": "Hsp90 Inhibitor Debio 0932",
      "synonyms": [
        "CUDC-305",
        "Debio 0932",
        "Debio-0932",
        "Hsp90 Inhibitor Debio 0932"
      ]
    },
    {
      "fdaUniiCode": "4T36H88UA7",
      "id": "Apalutamide",
      "preferredName": "Apalutamide",
      "synonyms": [
        "4-(7-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro(3.4)octan-5-yl)-2-fluoro-N-methylbenzamide",
        "APALUTAMIDE",
        "ARN 509",
        "ARN-509",
        "ARN509",
        "Apalutamide",
        "Erleada",
        "JNJ 56021927",
        "JNJ-56021927"
      ]
    },
    {
      "fdaUniiCode": "I8RA3543SY",
      "id": "Onatasertib",
      "preferredName": "Onatasertib",
      "synonyms": [
        "ATG-008",
        "CC-223",
        "ONATASERTIB",
        "Onatasertib",
        "TORKi",
        "WHO 11237"
      ]
    },
    {
      "fdaUniiCode": "QS5F6VTS0O",
      "id": "Pamrevlumab",
      "preferredName": "Pamrevlumab",
      "synonyms": [
        "Anti-Connective Tissue Growth Factor Monoclonal Antibody FG-3019",
        "FG-3019",
        "FG3019",
        "PAMREVLUMAB",
        "Pamrevlumab"
      ]
    },
    {
      "fdaUniiCode": "0W9Q8U337A",
      "id": "Roniciclib",
      "preferredName": "Roniciclib",
      "synonyms": [
        "BAY1000394",
        "RONICICLIB",
        "Roniciclib"
      ]
    },
    {
      "fdaUniiCode": "71596A9R13",
      "id": "Epacadostat",
      "preferredName": "Epacadostat",
      "synonyms": [
        "1,2,5-Oxadiazole-3-carboximidamide, 4-((2-((Aminosulfonyl)amino)ethyl)amino)-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-, (C(Z))-",
        "EPACADOSTAT",
        "Epacadostat",
        "INCB 024360",
        "INCB024360"
      ]
    },
    {
      "fdaUniiCode": "YCO2764D5Z",
      "id": "Thiarabine",
      "preferredName": "Thiarabine",
      "synonyms": [
        "4-thio-araC",
        "GS7836",
        "OSI-7836",
        "THIARABINE",
        "Thiarabine"
      ]
    },
    {
      "fdaUniiCode": "CJ0O37KU29",
      "id": "Verapamil",
      "preferredName": "Verapamil",
      "synonyms": [
        "VERAPAMIL",
        "Verapamil",
        "alpha-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile"
      ]
    },
    {
      "fdaUniiCode": "5V9KLZ54CY",
      "id": "Vinblastine",
      "preferredName": "Vinblastine",
      "synonyms": [
        "VINBLASTINE",
        "VLB",
        "Vinblastine",
        "Vincaleucoblastine",
        "vinblastine"
      ]
    },
    {
      "fdaUniiCode": "N00W22YO2B",
      "id": "Vinblastine_Sulfate",
      "preferredName": "Vinblastine Sulfate",
      "synonyms": [
        "29060 LE",
        "29060-LE",
        "Exal",
        "VINBLASTINE SULFATE",
        "VINCALEUKOBLASTINE",
        "Velban",
        "Velbe",
        "Velsar",
        "Vinblastine Sulfate",
        "vinblastine sulfate"
      ]
    },
    {
      "fdaUniiCode": "5J49Q6B70F",
      "id": "Vincristine",
      "preferredName": "Vincristine",
      "synonyms": [
        "22-Oxovincaleukoblastine",
        "LEUROCRISTINE",
        "Leurocristine",
        "VCR",
        "VINCRISTINE",
        "Vincristine",
        "Vincrystine",
        "vincristine"
      ]
    },
    {
      "fdaUniiCode": "RSA8KO39WH",
      "id": "Vindesine",
      "preferredName": "Vindesine",
      "synonyms": [
        "3-(Aminocarbonyl)-O4-deacetyl-3-de-(methoxycarbonyl)vincaleukoblastine",
        "Compound 112531",
        "DAVA",
        "DVA",
        "Deacetyl Vinblastine Carboxamide",
        "Deacetylvinblastine Carboxamide",
        "Desacetylvinblastine Amide",
        "Lilly CT-3231",
        "VDS",
        "VINDESINE",
        "Vindesine",
        "vindesine"
      ]
    },
    {
      "fdaUniiCode": "6SO72A12FN",
      "id": "Lefitolimod",
      "preferredName": "Lefitolimod",
      "synonyms": [
        "LEFITOLIMOD",
        "Lefitolimod",
        "MGN-1703",
        "MGN1703",
        "dSLIM-30L1"
      ]
    },
    {
      "fdaUniiCode": "N658GY6L3E",
      "id": "Tebentafusp",
      "preferredName": "Tebentafusp",
      "synonyms": [
        "IMCgp100",
        "ImmTAC-gp100",
        "Monoclonal T-cell Receptor Anti-CD3 scFv Fusion Protein IMCgp100",
        "TEBENTAFUSP",
        "Tebentafusp"
      ]
    },
    {
      "fdaUniiCode": "WX2ZW10GHO",
      "id": "Allogeneic_Natural_Killer_Cell_Line_MG4101",
      "preferredName": "Allogeneic Natural Killer Cell Line MG4101",
      "synonyms": [
        "Allogeneic NK Cell Line MG4101",
        "Allogeneic Natural Killer Cell Line MG4101",
        "MG-4101",
        "MG4101"
      ]
    },
    {
      "fdaUniiCode": "KC1UXA6R4Z",
      "id": "Choline_Kinase_Alpha_Inhibitor_TCD-717",
      "preferredName": "Choline Kinase Alpha Inhibitor TCD-717",
      "synonyms": [
        "CHKA Inhibitor TCD-717",
        "Choline Kinase Alpha Inhibitor TCD-717",
        "RSM-932A",
        "TCD-717"
      ]
    },
    {
      "fdaUniiCode": "08W5N2C97Q",
      "id": "Alpelisib",
      "preferredName": "Alpelisib",
      "synonyms": [
        "ALPELISIB",
        "Alpelisib",
        "BYL719",
        "Phosphoinositide 3-kinase Inhibitor BYL719",
        "Piqray"
      ]
    },
    {
      "fdaUniiCode": "85V55ZLV2Z",
      "id": "Gatipotuzumab",
      "preferredName": "Gatipotuzumab",
      "synonyms": [
        "GATIPOTUZUMAB",
        "Gatipotuzumab",
        "PankoMab",
        "PankoMab-GEX"
      ]
    },
    {
      "fdaUniiCode": "Y2H4S74Y8U",
      "id": "BRAF_Inhibitor_ARQ_736",
      "preferredName": "BRAF Inhibitor ARQ 736",
      "synonyms": [
        "AQ 736",
        "ARQ-736",
        "BRAF Inhibitor ARQ 736"
      ]
    },
    {
      "fdaUniiCode": "4I8MLM7L2H",
      "id": "Ivaltinostat",
      "preferredName": "Ivaltinostat",
      "synonyms": [
        "(E)-N(1)-(3-(dimethylamino)propyl)-N(8)-hydroxy-2-((naphthalene-1-loxy)methyl)oct-2-enediamide",
        "CG200745",
        "HDAC inhibitor CG200745",
        "IVALTINOSTAT",
        "Ivaltinostat"
      ]
    },
    {
      "fdaUniiCode": "06UV5RFW57",
      "id": "Chlorotoxin",
      "preferredName": "Chlorotoxin",
      "synonyms": [
        "CHLOROTOXIN",
        "CTX",
        "Chlorotoxin",
        "TM-601",
        "chlorotoxin"
      ]
    },
    {
      "fdaUniiCode": "36R61Y789T",
      "id": "Anaxirone",
      "preferredName": "Anaxirone",
      "synonyms": [
        "1,2,4-triglycidylurazol",
        "ANAXIRONE",
        "Anaxirone",
        "TGU",
        "Triglycidylurazol"
      ]
    },
    {
      "fdaUniiCode": "AE221IM3BB",
      "id": "Lutetium_Lu_177_Dotatate",
      "preferredName": "Lutetium Lu 177 Dotatate",
      "synonyms": [
        "177 Lu-DOTA-TATE",
        "177 Lu-DOTA-Tyr3-Octreotate",
        "177Lu-DOTA0-Tyr3-Octreotate",
        "LUTETIUM OXODOTREOTIDE LU-177",
        "Lutathera",
        "Lutetium Lu 177 DOTA(0)-Tyr(3)-Octreotate",
        "Lutetium Lu 177 Dotatate",
        "Lutetium Lu 177-DOTA-Tyr3-Octreotate",
        "Lutetium Oxodotreotide Lu-177",
        "lutetium Lu 177-DOTATATE"
      ]
    },
    {
      "fdaUniiCode": "T9PSN4R8IR",
      "id": "Cinobufagin",
      "preferredName": "Cinobufagin",
      "synonyms": [
        "CINOBUFAGIN",
        "Cinobufacini",
        "Cinobufagin"
      ]
    },
    {
      "fdaUniiCode": "52G405U1E5",
      "id": "Racotumomab",
      "preferredName": "Racotumomab",
      "synonyms": [
        "Anti-P3 Antibody Idiotype Monoclonal Antibody 1E10",
        "MoAb 1E10",
        "RACOTUMOMAB",
        "Racotumomab"
      ]
    },
    {
      "fdaUniiCode": "HMI5GR78FR",
      "id": "Tegafur-Uracil",
      "preferredName": "Tegafur-Uracil",
      "synonyms": [
        "Oral Fluorouracil-Uracil",
        "TEGAFUR-URACIL",
        "Tegafur-Uracil",
        "UFT",
        "Uftoral",
        "Uracil and Ftorafur",
        "Uracil and Tegafur",
        "Uracil and Tetrahydrofuranyl-5-Fluorouracil",
        "Uracil/Tegafur (UFT)",
        "tegafur-uracil"
      ]
    },
    {
      "fdaUniiCode": "8680B21W73",
      "id": "Macimorelin",
      "preferredName": "Macimorelin",
      "synonyms": [
        "AEZS-130",
        "D-Tryptophanamide,2-methylalanyl-N-[(1R)-1-(formylamino)-2-(1H-indol-3-yl)ethyl]-",
        "EP 1572",
        "JMV 1843",
        "MACIMORELIN",
        "Macimorelin",
        "Solorel"
      ]
    },
    {
      "fdaUniiCode": "EE083865G2",
      "id": "Lenvatinib",
      "preferredName": "Lenvatinib",
      "synonyms": [
        "6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]- 7-methoxy-",
        "E7080",
        "ER-203492-00",
        "LENVATINIB",
        "Lenvatinib",
        "Multi-Kinase Inhibitor E7080"
      ]
    },
    {
      "fdaUniiCode": "K6A90IIZ19",
      "id": "Vosaroxin",
      "preferredName": "Vosaroxin",
      "synonyms": [
        "1,4-Dihydro-7-(3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid",
        "AG-7352",
        "SNS 595",
        "SNS-595",
        "SPC 595",
        "VOSAROXIN",
        "Voreloxin",
        "Vosaroxin"
      ]
    },
    {
      "fdaUniiCode": "719U3YSA1F",
      "id": "Actinomycin_C2",
      "preferredName": "Actinomycin C2",
      "synonyms": [
        "ACTINOMYCIN C2",
        "Actinomycin C2",
        "Actinomycin D, 2a-D-Alloisoleucine-"
      ]
    },
    {
      "fdaUniiCode": "66QR34C83N",
      "id": "Pixatimod",
      "preferredName": "Pixatimod",
      "synonyms": [
        "PG545",
        "PIXATIMOD",
        "Pixatimod"
      ]
    },
    {
      "fdaUniiCode": "W984C353CG",
      "id": "Depatuxizumab",
      "preferredName": "Depatuxizumab",
      "synonyms": [
        "ABT-806",
        "DEPATUXIZUMAB",
        "Depatuxizumab",
        "Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor) (Human-mus musculus Monoclonal ABT-806 Heavy Chain), Disulfide with Human-mus musculus Monoclonal ABT-806 Light Chain, Dimer",
        "anti-EGFR MoAb ABT-806",
        "anti-EGFR mAb ABT-806",
        "mAb-806"
      ]
    },
    {
      "fdaUniiCode": "2KT4YN1DP7",
      "id": "Guadecitabine",
      "preferredName": "Guadecitabine",
      "synonyms": [
        "DNMT inhibitor SGI-110",
        "GUADECITABINE",
        "Guadecitabine",
        "S110",
        "SGI-110"
      ]
    },
    {
      "fdaUniiCode": "Q1IF8M2YL3",
      "id": "Ozarelix",
      "preferredName": "Ozarelix",
      "synonyms": [
        "D 63153",
        "D-63 153",
        "D63 153",
        "D63153",
        "LHRH antagonist SPI-153",
        "OZARELIX",
        "Ozarelix",
        "SPI-153"
      ]
    },
    {
      "fdaUniiCode": "K37N7BYX3X",
      "id": "Nilotinib_Hydrochloride_Anhydrous",
      "preferredName": "Nilotinib Hydrochloride Anhydrous",
      "synonyms": [
        "NILOTINIB HYDROCHLORIDE ANHYDROUS",
        "Nilotinib Hydrochloride Anhydrous"
      ]
    },
    {
      "fdaUniiCode": "8R1DYT4EAW",
      "id": "Saracatinib_Difumarate",
      "preferredName": "Saracatinib Difumarate",
      "synonyms": [
        "4-Quinazolinamine, N-(5-Chloro-1,3-Benzodioxol-4-yl)-7-(2-(4-Methyl-1-Piperazinyl)Ethoxy)-5-((Tetrahydro-2H-Pyran-4-yl)Oxy)-, (2e)-2-Butenedioate (1:2)",
        "AZD-0530 Difumarate",
        "AZD0530 Difumarate",
        "N-(5-Chloro-1,3-Benzodioxol-4-yl)-7-(2-(4-Methylpiperazin-1-yl)Ethoxy)-5-(Tetrahydro-2H-Pyran-4-yloxy)Quinazolin-4-Amine Di((2e)-but-2-Enedioate)",
        "SARACATINIB DIFUMARATE",
        "Saracatinib Difumarate"
      ]
    },
    {
      "fdaUniiCode": "807ME4B7IJ",
      "id": "Selumetinib_Sulfate",
      "preferredName": "Selumetinib Sulfate",
      "synonyms": [
        "1H-Benzimidazole-6-Carboxamide, 5-((4-Bromo-2-Chlorophenyl)Amino)-4-Fluoro-N-(2- Hydroxyethoxy)-1-Methyl-, Sulfate (1:1)",
        "1h-Benzimidazole-6-Carboxamide,5-((4-Bromo-2-Chlorophenyl)Amino)-4-Fluoro-N-(2- Hydroxyethoxy)-1-Methyl-, Sulphate (1:1)",
        "5-((4-Bromo-2-Chlorophenyl)amino)-4-Fluoro-N-(2-Hydroxyethoxy)-1-Methyl-1H- Benzimidazole-6-Carboxamide Sulfate",
        "5-((4-Bromo-2-Chlorophenyl)amino)-4-Fluoro-N-(2-Hydroxyethoxy)-1-Methyl-1H- Benzimidazole-6-Carboxamide Sulphate",
        "AZD-6244 Hydrogen Sulfate",
        "AZD6244 Hydrogen Sulfate",
        "AZD6244 Hydrogen Sulphate",
        "Koselugo",
        "SELUMETINIB SULFATE",
        "Selumetinib Sulfate",
        "Selumetinib Sulphate"
      ]
    },
    {
      "fdaUniiCode": "V4M8FWS152",
      "id": "Varlitinib_Tosylate",
      "preferredName": "Varlitinib Tosylate",
      "synonyms": [
        "4,6-Quinazolinediamine, N(Sup 4)-(3-Chloro-4-(2-Thiazolylmethoxy)Phenyl)-N(Sup 6)-((4r)-4,5-Dihydro-4-Methyl-2-Oxazolyl)-, 4-Methylbenzenesulphonate (1:2)",
        "4-N-(3-Chloro-4-(Thiazol-2-Ylmethoxy)Phenyl)-6-N-((4r)-4-Methyl-4,5-Dihydrooxazol-2- Yl)Quinazoline-4,6-Diamine Bis(4-Methylbenzenesulphonate)",
        "AR00334543 Ditosilate",
        "AR00334543 Ditosylate",
        "ARRY-334543 Ditosylate",
        "ARRY-543 Ditosilate",
        "ARRY-543 Ditosylate",
        "VARLITINIB TOSYLATE",
        "Varlitinib Tosylate"
      ]
    },
    {
      "fdaUniiCode": "5JHU0N1R6K",
      "id": "Nilotinib_Hydrochloride_Monohydrate",
      "preferredName": "Nilotinib Hydrochloride Monohydrate",
      "synonyms": [
        "4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzamide, Monohydrochloride",
        "AMN107",
        "NILOTINIB HYDROCHLORIDE MONOHYDRATE",
        "Nilotinib Hydrochloride Monohydrate",
        "Nilotinib Monohydrochloride Monohydrate",
        "Tasigna"
      ]
    },
    {
      "fdaUniiCode": "E7V83174BE",
      "id": "Pirarubicin_Hydrochloride",
      "preferredName": "Pirarubicin Hydrochloride",
      "synonyms": [
        "(2\"R)-4'-O-Tetrahydropyranyladriamycin Hydrochloride",
        "4'-O-Tetrahydropyranyl Doxorubicin HCl",
        "PIRARUBICIN HYDROCHLORIDE",
        "Pirarubicin Hydrochloride",
        "THP-ADM",
        "THP-adriamycin Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "C7HT2IO79H",
      "id": "Enloplatin",
      "preferredName": "Enloplatin",
      "synonyms": [
        "CL 287,110",
        "CL-287110",
        "Cis-(1,1-Cyclobutanedicarboxylato)(Tetrahydro-4H-Pyran-4,4-Bis(Methylamine))Platinum",
        "ENLOPLATIN",
        "Enloplatin",
        "Platinum, (1,1-Cyclobutanedicarboxylato(2-))(Tetrahydro-4h-Pyran-4,4-Dimethanamine-N,N')-, (Sp-4-2)-"
      ]
    },
    {
      "fdaUniiCode": "DFR965WKBU",
      "id": "Nimustine_Hydrochloride",
      "preferredName": "Nimustine Hydrochloride",
      "synonyms": [
        "3-((4-Amino-2-Methyl-5-Pyrimidinyl)Methyl)-1-(2-Chloroethyl)-1-Nitrosourea Hydrochloride",
        "ACNU HCl",
        "CS 439 HCl",
        "N'-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitrosourea Hydrochloride",
        "NIMUSTINE HYDROCHLORIDE",
        "Nidran HCl",
        "Nimustine Hydrochloride",
        "Nimustine hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "511F69K76Y",
      "id": "Tauromustine",
      "preferredName": "Tauromustine",
      "synonyms": [
        "1-(2-Chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea",
        "LS-2667",
        "TAUROMUSTINE",
        "TCNU",
        "Tauromustine"
      ]
    },
    {
      "fdaUniiCode": "HA82M3RAB2",
      "id": "Carmofur",
      "preferredName": "Carmofur",
      "synonyms": [
        "1(2H)-Pyrimidinecarboxamide, 5-fluoro-N-hexyl-3,4-dihydro-2,4-dioxo-",
        "1-Hexylcarbamoyl-5-Fluorouracil",
        "CARMOFUR",
        "Carmofur",
        "HCFU"
      ]
    },
    {
      "fdaUniiCode": "1Y6SNA8L5S",
      "id": "Edelfosine",
      "preferredName": "Edelfosine",
      "synonyms": [
        "1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine",
        "1-Octadecyl-2-methoxy-rac-glycero-3-phosphocholine",
        "EDELFOSINE",
        "ET-18-OCH3",
        "Edelfosine",
        "Edelfosinum",
        "Et-18-OCH3"
      ]
    },
    {
      "fdaUniiCode": "B77R96LJLK",
      "id": "10-Deacetyltaxol",
      "preferredName": "10-Deacetyltaxol",
      "synonyms": [
        "10-DEACETYLPACLITAXEL",
        "10-Deacetylpaclitaxel",
        "10-Deacetyltaxol",
        "benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alphaR*,betaS*),11alpha,12alpha,12aalpha,12balpha))-"
      ]
    },
    {
      "fdaUniiCode": "TK8ERE8P56",
      "id": "Ribociclib",
      "preferredName": "Ribociclib",
      "synonyms": [
        "7-Cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide",
        "Kisqali",
        "LEE-011",
        "LEE011",
        "RIBOCICLIB",
        "Ribociclib"
      ]
    },
    {
      "fdaUniiCode": "7N03P021J8",
      "id": "JAK2_Inhibitor_BMS-911543",
      "preferredName": "JAK2 Inhibitor BMS-911543",
      "synonyms": [
        "BMS 911543",
        "BMS-911543",
        "JAK2 Inhibitor BMS-911543"
      ]
    },
    {
      "fdaUniiCode": "0X5A3C04ID",
      "id": "Palifosfamide_Tromethamine",
      "preferredName": "Palifosfamide Tromethamine",
      "synonyms": [
        "PALIFOSFAMIDE TROMETHAMINE",
        "Palifosfamide Tris",
        "Palifosfamide Tromethamine",
        "Phosphorodiamidic Acid, N,N'-bis(2-chloroethyl)-, Compd. with 2-Amino-2-(hydroxymethyl)-1,3-propanediol (1:1)",
        "ZIO-201-T"
      ]
    },
    {
      "fdaUniiCode": "6RH6DL8R4L",
      "id": "Anti-ANG2_Monoclonal_Antibody_MEDI-3617",
      "preferredName": "Anti-ANG2 Monoclonal Antibody MEDI-3617",
      "synonyms": [
        "Anti-ANG2 MoAb MEDI-3617",
        "Anti-ANG2 Monoclonal Antibody MEDI-3617",
        "MEDI-3617"
      ]
    },
    {
      "fdaUniiCode": "N6SVN735GY",
      "id": "Bermekimab",
      "preferredName": "Bermekimab",
      "synonyms": [
        "BERMEKIMAB",
        "Bermekimab",
        "CA-18C3",
        "CV 18C3",
        "CV-18C3",
        "MABp1",
        "RA 18C3",
        "RA-18C3"
      ]
    },
    {
      "fdaUniiCode": "8E3HI6QQ9J",
      "id": "Labetuzumab_Govitecan",
      "preferredName": "Labetuzumab Govitecan",
      "synonyms": [
        "ADC IMMU-130",
        "Antibody-Drug Conjugate IMMU-130",
        "LABETUZUMAB GOVITECAN",
        "Labetuzumab Govitecan",
        "Labetuzumab-SN-38 Immunoconjugate IMMU-130",
        "hMN14-SN38"
      ]
    },
    {
      "fdaUniiCode": "WX8293WGLC",
      "id": "Nesvacumab",
      "preferredName": "Nesvacumab",
      "synonyms": [
        "Anti-ANG2 MOAB REGN910",
        "NESVACUMAB",
        "Nesvacumab",
        "REGN910",
        "SAR307746"
      ]
    },
    {
      "fdaUniiCode": "308PA1L567",
      "id": "Endoxifen_Hydrochloride",
      "preferredName": "Endoxifen Hydrochloride",
      "synonyms": [
        "4-Hydroxy-N-Desmethyltamoxifen Hydrochloride",
        "ENDOXIFEN HYDROCHLORIDE",
        "Endoxifen Hydrochloride",
        "Z-Endoxifen HCl",
        "Z-Endoxifen Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "333YMY788E",
      "id": "Tarextumab",
      "preferredName": "Tarextumab",
      "synonyms": [
        "MoAb OMP-59R5",
        "OMP 59R5",
        "OMP-59R5",
        "TAREXTUMAB",
        "Tarextumab"
      ]
    },
    {
      "fdaUniiCode": "111EN0IJ7C",
      "id": "Anti-HB-EGF_Monoclonal_Antibody_KHK2866",
      "preferredName": "Anti-HB-EGF Monoclonal Antibody KHK2866",
      "synonyms": [
        "Anti-HB-EGF MoAb KHK2866",
        "Anti-HB-EGF Monoclonal Antibody KHK2866",
        "KHK-2866",
        "KHK2866"
      ]
    },
    {
      "fdaUniiCode": "5YSY733NA3",
      "id": "MUC1-targeted_Peptide_GO-203-2C",
      "preferredName": "MUC1-targeted Peptide GO-203-2C",
      "synonyms": [
        "GO-203-2C",
        "MUC1-targeted Peptide GO-203-2C"
      ]
    },
    {
      "fdaUniiCode": "K0068GK39A",
      "id": "PI3K_Inhibitor_ZSTK474",
      "preferredName": "PI3K Inhibitor ZSTK474",
      "synonyms": [
        "PI3K Inhibitor ZSTK474",
        "Phosphatidylinositol 3-kinase Inhibitor ZSTK474",
        "ZSTK-474",
        "ZSTK474"
      ]
    },
    {
      "fdaUniiCode": "266N56YWTZ",
      "id": "MTF-1_Inhibitor_APTO-253_HCl",
      "preferredName": "MTF-1 Inhibitor APTO-253 HCl",
      "synonyms": [
        "2-(6-Fluoro-2-methyl-1H-indol-3-yl)-1H-imidazo[4,5-f][1,10]phenanthroline Hydrochloride",
        "APTO-253 HCl",
        "APTO-253 HYDROCHLORIDE",
        "LOR-253 HCl",
        "LT-253 HCl",
        "MTF-1 Inhibitor APTO-253 HCl"
      ]
    },
    {
      "fdaUniiCode": "PP449XA4BH",
      "id": "Lucitanib",
      "preferredName": "Lucitanib",
      "synonyms": [
        "1-Naphthalenecarboxamide, 6-((7-((1-aminocyclopropyl)methoxy)-6-methoxy-4-quinolinyl)oxy)-n-methyl-",
        "AL3810",
        "E-3810",
        "LUCITANIB",
        "Lucitanib"
      ]
    },
    {
      "fdaUniiCode": "5OGS5K699E",
      "id": "Merestinib",
      "preferredName": "Merestinib",
      "synonyms": [
        "3-Pyridinecarboxamide, N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl)oxy)phenyl)-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-",
        "LY-2801653",
        "LY2801653",
        "MERESTINIB",
        "Merestinib"
      ]
    },
    {
      "fdaUniiCode": "MO4K3GDN1I",
      "id": "Emibetuzumab",
      "preferredName": "Emibetuzumab",
      "synonyms": [
        "Anti-c-MET Monoclonal Antibody LY2875358",
        "EMIBETUZUMAB",
        "Emibetuzumab",
        "LA-480",
        "LY2875358"
      ]
    },
    {
      "fdaUniiCode": "9QHX048FRV",
      "id": "Talazoparib",
      "preferredName": "Talazoparib",
      "synonyms": [
        "BMN 673",
        "BMN-673",
        "TALAZOPARIB",
        "Talazoparib"
      ]
    },
    {
      "fdaUniiCode": "7KNP87L4X4",
      "id": "Ulocuplumab",
      "preferredName": "Ulocuplumab",
      "synonyms": [
        "BMS 936564",
        "MDX-1338",
        "ULOCUPLUMAB",
        "Ulocuplumab"
      ]
    },
    {
      "fdaUniiCode": "UFB8CT84JS",
      "id": "Anti-CA6-DM4_Immunoconjugate_SAR566658",
      "preferredName": "Anti-CA6-DM4 Immunoconjugate SAR566658",
      "synonyms": [
        "Anti-CA6-DM4 Immunoconjugate SAR566658",
        "SAR-566658",
        "SAR566658",
        "huDs6-DM4"
      ]
    },
    {
      "fdaUniiCode": "QQA9MLH692",
      "id": "Tafasitamab",
      "preferredName": "Tafasitamab",
      "synonyms": [
        "Immunoglobulin, Anti-(Human Cd19 Antigen) (Human-mus musculus Monoclonal MOR00208 Heavy Chain), Disulfide with Human-mus musculus Monoclonal MOR00208 .Kappa.-chain, Dimer",
        "MOR-00208",
        "MOR00208",
        "MOR208",
        "Monjuvi",
        "TAFASITAMAB",
        "Tafasitamab",
        "Tafasitamab-cxix",
        "XmAb5574"
      ]
    },
    {
      "fdaUniiCode": "NNQ0PKZ9EV",
      "id": "siG12D_LODER",
      "preferredName": "siG12D LODER",
      "synonyms": [
        "SIG12D LODER",
        "siG12D LODER"
      ]
    },
    {
      "fdaUniiCode": "14L8O2K12B",
      "id": "Amuvatinib_Hydrochloride",
      "preferredName": "Amuvatinib Hydrochloride",
      "synonyms": [
        "1-Piperazinecarbothioamide, N-(1,3-Benzodioxol-5-Ylmethyl)-4-Benzofuro(3,2-D)Pyrimidin-4-Yl-, Hydrochloride (1:1)",
        "AMUVATINIB HYDROCHLORIDE",
        "Amuvatinib Hydrochloride",
        "HPK56 HCl",
        "MP-470 HCI",
        "MP470 HCl",
        "N-(1,3-Benzodioxol-5-Ylmethyl)-4-(Benzofuro(3,2-D)Pyrimidin-4-Yl)Piperazine-1- Carbothioamide Monohydrochloride"
      ]
    },
    {
      "fdaUniiCode": "4340891KFS",
      "id": "Ponatinib",
      "preferredName": "Ponatinib",
      "synonyms": [
        "AP-24534",
        "AP24534",
        "Benzamide, 3-(2-Imidazo(1,2-B)Pyridazin-3-Ylethynyl)-4-Methyl-N-(4-((4-Methyl-1- Piperazinyl)Methyl)-3-(Trifluoromethyl)Phenyl)",
        "PONATINIB",
        "Ponatinib"
      ]
    },
    {
      "fdaUniiCode": "SQ67484MA7",
      "id": "Drozitumab",
      "preferredName": "Drozitumab",
      "synonyms": [
        "Anti-DR5 Monoclonal Antibody",
        "DROZITUMAB",
        "Drozitumab",
        "Immunoglobulin G1, anti-(human tumor necrosis factor receptor superfamily member 10B (death receptor 5, TRAIL-R2, CD262 antigen)); [113-lysine,116-threonine,360-glutamic acid,362-methionine]human monoclonal gamma-1 heavy chain (224-212')-disulfide with human monoclonal lambda-3 light chain (230-230'':233-233'')-bisdisulfide dimer",
        "PRO95780",
        "rhuMAb DR5"
      ]
    },
    {
      "fdaUniiCode": "93T929W6LC",
      "id": "Naptumomab_Estafenatox",
      "preferredName": "Naptumomab Estafenatox",
      "synonyms": [
        "ABR-217620",
        "NAPTUMOMAB ESTAFENATOX",
        "Naptumomab Estafenatox"
      ]
    },
    {
      "fdaUniiCode": "Y64GQ0KC0A",
      "id": "Teprotumumab",
      "preferredName": "Teprotumumab",
      "synonyms": [
        "Anti-IGF-1R Monoclonal Antibody R1507",
        "Immunoglobulin G1, Anti-(Human Insulin-like Growth Factor I Receptor)(Human Monoclonal Heavy Chain), Disulfide with Human Monoclonal Light Chain, Dimer",
        "R1507",
        "RG1507",
        "RO4858696-000",
        "RV001 Monoclonal",
        "TEPROTUMUMAB",
        "Teprotumumab"
      ]
    },
    {
      "fdaUniiCode": "9RV78Q2002",
      "id": "Vedolizumab",
      "preferredName": "Vedolizumab",
      "synonyms": [
        "Entyvio",
        "Immunoglobulin G1, Anti-(Human Integrin LPAM-1 (Lymphocyte Peyer's Patch Adhesion Molecule 1)) (Human-Mus musculus Heavy Chain), Disulfide with Human-Mus musculus kappa-chain, Dimer",
        "Immunoglobulin G1, anti-(human integrin LPAM-1 (lymphocyte Peyer's patch adhesion molecule 1)) (human-Mus musculus heavy chain), disulfide with human-Mus musculus kappa-chain, dimer",
        "LDP 02",
        "LDP-02",
        "LDP02",
        "MLN0002",
        "MLN02",
        "VEDOLIZUMAB",
        "Vedolizumab"
      ]
    },
    {
      "fdaUniiCode": "JT4X6Z1HRR",
      "id": "Edatrexate",
      "preferredName": "Edatrexate",
      "synonyms": [
        "10-EDAM",
        "10-EdAM",
        "10-Ethyl-10-deaza-aminopterin",
        "CGP-30694",
        "EDAM",
        "EDATREXATE",
        "Edatrexate",
        "N-[4-[1-[(2, 4-Diamino-6-pteridinyl)-methyl]propyl]benzoyl]-L-glutamic acid",
        "N-[4-[1-[(2,4-Diamino-6-pteridinyl)-methyl]propyl]benzoyl]-L-glutamic Acid",
        "edatrexate"
      ]
    },
    {
      "fdaUniiCode": "52Y8L60CR7",
      "id": "Plocabulin",
      "preferredName": "Plocabulin",
      "synonyms": [
        "PLOCABULIN",
        "PM-060184",
        "PM060184",
        "Plocabulin"
      ]
    },
    {
      "fdaUniiCode": "19DG7G1U5Q",
      "id": "PI3K-delta_Inhibitor_AMG_319",
      "preferredName": "PI3K-delta Inhibitor AMG 319",
      "synonyms": [
        "ACP-319",
        "AMG 319",
        "AMG-319",
        "PI3K Inhibitor ACP-319",
        "PI3K-delta Inhibitor AMG 319"
      ]
    },
    {
      "fdaUniiCode": "43Y934BBZ6",
      "id": "Foscenvivint",
      "preferredName": "Foscenvivint",
      "synonyms": [
        "CBP/beta-catenin Antagonist PRI-724",
        "FOSCENVIVINT",
        "Foscenvivint",
        "PRI-724"
      ]
    },
    {
      "fdaUniiCode": "YP8G3I74EL",
      "id": "Vorolanib",
      "preferredName": "Vorolanib",
      "synonyms": [
        "(S,Z)-N-(1-(dimethylcarbamoyl)pyrrolidin-3-yl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide",
        "CM 082",
        "CM-082",
        "CM082",
        "VOROLANIB",
        "Vorolanib",
        "X 82",
        "X-82"
      ]
    },
    {
      "fdaUniiCode": "7607Y95N9S",
      "id": "Tezacitabine_Anhydrous",
      "preferredName": "Tezacitabine Anhydrous",
      "synonyms": [
        "2'-Deoxy-2'-(fluoromethylene)cytidine Anhydrous",
        "FMdC Anhydrous",
        "TEZACITABINE ANHYDROUS",
        "Tezacitabine Anhydrous"
      ]
    },
    {
      "fdaUniiCode": "276F2O42F5",
      "id": "Hydroxyprogesterone_Caproate",
      "preferredName": "Hydroxyprogesterone Caproate",
      "synonyms": [
        "17-[(1-Oxohexyl)oxy]pregn-4-ene-3,20-dione",
        "17alpha-Hydroxyprogesterone Caproate",
        "Delalutin",
        "HYDROXYPROGESTERONE CAPROATE",
        "Hydroxyprogesterone Caproate",
        "Hydroxyprogesterone caproate",
        "Makena"
      ]
    },
    {
      "fdaUniiCode": "U347PV74IL",
      "id": "Gemcitabine_Hydrochloride",
      "preferredName": "Gemcitabine Hydrochloride",
      "synonyms": [
        "1-(2-Oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose, hydrochloride",
        "2'Deoxy-2',2'-Difluorocytidine, Hydrochloride",
        "Difluorodeoxycytidine Hydrochloride",
        "FF 10832",
        "FF-10832",
        "FF10832",
        "GEMCITABINE HYDROCHLORIDE",
        "Gemcitabine HCI",
        "Gemcitabine Hydrochloride",
        "Gemzar",
        "LY-188011",
        "LY188011",
        "dFdCyd",
        "gemcitabine hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "BPZ4A29SYE",
      "id": "Pepinemab",
      "preferredName": "Pepinemab",
      "synonyms": [
        "PEPINEMAB",
        "Pepinemab",
        "VX15/2503",
        "moAb VX15/2503"
      ]
    },
    {
      "fdaUniiCode": "7O8V7H6P2J",
      "id": "NG-nitro-L-arginine",
      "preferredName": "NG-nitro-L-arginine",
      "synonyms": [
        "L-NNA",
        "NG-nitro-L-arginine",
        "NITROARGININE",
        "NOLA"
      ]
    },
    {
      "fdaUniiCode": "BHB013S3MO",
      "id": "SarCNU",
      "preferredName": "SarCNU",
      "synonyms": [
        "2-CHLOROETHYL-3-SARCOSINAMIDE-1-NITROSOUREA",
        "2-Chloroethyl-3-Sarcosinamide-1-Nitrosourea",
        "SarCNU",
        "sarCNU",
        "sarcosinamide nitrosourea"
      ]
    },
    {
      "fdaUniiCode": "Z1HHM49K7O",
      "id": "Napabucasin",
      "preferredName": "Napabucasin",
      "synonyms": [
        "2-Acetylnaphtho(2,3-b)furan-4,9-dione",
        "BB608",
        "BBI-608",
        "BBI608",
        "NAPABUCASIN",
        "Napabucasin"
      ]
    },
    {
      "fdaUniiCode": "WKT909C62B",
      "id": "Ricolinostat",
      "preferredName": "Ricolinostat",
      "synonyms": [
        "2-(Diphenylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide",
        "ACY-1215",
        "Histone Deacetylase 6 InhibitorACY-1215",
        "RICOLINOSTAT",
        "Ricolinostat"
      ]
    },
    {
      "fdaUniiCode": "6I2QW73SR5",
      "id": "2-Methoxyestradiol",
      "preferredName": "2-Methoxyestradiol",
      "synonyms": [
        "(17beta)-2-Methoxyestra-1,3,5(10)-triene-3,17-diol",
        "2-METHOXYESTRADIOL",
        "2-MeE2",
        "2-MeOE2",
        "2-Methoxy Estradiol",
        "2-Methoxyestradiol",
        "2-methoxyestradiol",
        "2ME2",
        "Panzem"
      ]
    },
    {
      "fdaUniiCode": "59P84ZU54H",
      "id": "Cordycepin_Triphosphate",
      "preferredName": "Cordycepin Triphosphate",
      "synonyms": [
        "3'-Deoxyadenosine-5'-(tetrahydrogen triphosphate)",
        "CORDYCEPIN TRIPHOSPHATE",
        "Cordycepin Triphosphate",
        "Cordycepin-5'-triphosphate"
      ]
    },
    {
      "fdaUniiCode": "PD3817FE9N",
      "id": "Etarotene",
      "preferredName": "Etarotene",
      "synonyms": [
        "6-((E)-p-(Ethylsulfonyl)-alpha-methylstyryl)-1,2,3,4-tetrahydronaphthalene",
        "Arotinoid Ethyl Sulfone",
        "Arotinoid Ethyl Sulphone",
        "ETAROTENE",
        "Etarotene",
        "Naphthalene, 6-(2-(4-(ethylsulfonyl)phenyl)-1-methylethenyl)-1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-, (E)-",
        "Ro 15-1570/000"
      ]
    },
    {
      "fdaUniiCode": "8XI0CX98LY",
      "id": "Cevipabulin_Succinate",
      "preferredName": "Cevipabulin Succinate",
      "synonyms": [
        "5-chloro-6-(2,6-difluoro-4-(3-(methylamino)propoxy)phenyl)-N-((1S)-2,2,2-trifluoro-1-methylethyl)(1,2,4)triazolo(1,5-a)pyrimidin-7-amine succinate dihydrate",
        "CEVIPABULIN SUCCINATE",
        "Cevipabulin Succinate",
        "TTI-237 Succinate Dihydrate"
      ]
    },
    {
      "fdaUniiCode": "X97O9FTB92",
      "id": "Verubulin",
      "preferredName": "Verubulin",
      "synonyms": [
        "4-quinazolinamine, N-(4-methoxyphenyl)-N,2-dimethyl-",
        "MX-128495",
        "N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine",
        "VERUBULIN",
        "Verubulin"
      ]
    },
    {
      "fdaUniiCode": "LR24G6354G",
      "id": "Eribulin",
      "preferredName": "Eribulin",
      "synonyms": [
        "2-(3-Amino-2-hydroxypropyl)hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)11,15-18,21-24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo(3,2-i)furo(2',3'-5,6)pyrano(4,3-b)(1,4)dioxacyclopentacosin-5-(4H)-one",
        "ER-086526",
        "ERIBULIN",
        "Eribulin"
      ]
    },
    {
      "fdaUniiCode": "959PWE0Q2E",
      "id": "Amsacrine_Lactate",
      "preferredName": "Amsacrine Lactate",
      "synonyms": [
        "AMSACRINE LACTATE",
        "Amsacrine Lactate",
        "Methanesulfon-m-anisidide, 4'-(9-acridinylamino)-, compd. with Lactic Acid",
        "N-(4-(9-Acridinylamino)-3-methoxyphenyl)methanesulfonamide compd. with Lactic Acid",
        "m-AMSA lactate"
      ]
    },
    {
      "fdaUniiCode": "WI6V529FZ9",
      "id": "Copanlisib",
      "preferredName": "Copanlisib",
      "synonyms": [
        "BAY 80-6946",
        "COPANLISIB",
        "Copanlisib",
        "PI3K Inhibitor BAY 80-6946"
      ]
    },
    {
      "fdaUniiCode": "264ARM7UXX",
      "id": "Domatinostat",
      "preferredName": "Domatinostat",
      "synonyms": [
        "2-Propenamide, N-(2-aminophenyl)-3-(1-((4-(1-methyl-1H-pyrazol-4-yl)phenyl)sulfonyl)-1H-pyrrol-3-yl)-, (2E)-",
        "4SC-202",
        "DOMATINOSTAT",
        "Domatinostat"
      ]
    },
    {
      "fdaUniiCode": "88WBI2D80S",
      "id": "Vantictumab",
      "preferredName": "Vantictumab",
      "synonyms": [
        "OMP-18R5",
        "VANTICTUMAB",
        "Vantictumab"
      ]
    },
    {
      "fdaUniiCode": "9DRB973HUI",
      "id": "Dezaguanine",
      "preferredName": "Dezaguanine",
      "synonyms": [
        "3-Deazaguanine",
        "CI-908",
        "DEZAGUANINE",
        "Deazaguanine",
        "Dezaguanine"
      ]
    },
    {
      "fdaUniiCode": "B3C86E80A0",
      "id": "Paclitaxel_Ceribate",
      "preferredName": "Paclitaxel Ceribate",
      "synonyms": [
        "7beta-((2RS)-2,3-dihydroxypropoxycarbonyloxy)-1-hydroxy-9-oxo-5beta,20-epoxytax-11-ene-2alpha,4,10beta,13alpha-tetrayl 4,10-diacetate 2-benzoate 13-((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoate)",
        "PACLITAXEL CERIBATE",
        "Paclitaxel Ceribate"
      ]
    },
    {
      "fdaUniiCode": "Q461L7AK4R",
      "id": "Iobenguane_I-131",
      "preferredName": "Iobenguane I-131",
      "synonyms": [
        "(131)I-MIBG",
        "131I-MIBG",
        "I 131 Meta-iodobenzylguanidine",
        "I-131 Metaiodobenzylguanidine",
        "IOBENGUANE I-131",
        "Iobenguane (131I)",
        "Iobenguane I 131",
        "Iobenguane I-131",
        "Iodine I 131 Metaiodobenzylguanidine",
        "MIBG I-131",
        "iodine I 131 metaiodobenzylguanidine"
      ]
    },
    {
      "fdaUniiCode": "DRU6NG543J",
      "id": "Spebrutinib",
      "preferredName": "Spebrutinib",
      "synonyms": [
        "2-Propenamide, N-(3-((5-fluoro-2-((4-(2-methoxyethoxy)phenyl)amino)-4-pyrimidinyl)amino)phenyl)-",
        "AVL-292",
        "Bruton's Tyrosine Kinase Inhibitor CC-292",
        "CC-292",
        "SPEBRUTINIB",
        "Spebrutinib"
      ]
    },
    {
      "fdaUniiCode": "SKF3JJJ5QA",
      "id": "Anti-PD-1_Fusion_Protein_AMP-224",
      "preferredName": "Anti-PD-1 Fusion Protein AMP-224",
      "synonyms": [
        "AMP-224",
        "Anti-PD-1 Fusion Protein AMP-224"
      ]
    },
    {
      "fdaUniiCode": "65JH75I9JX",
      "id": "4-Iodo-4-Deoxydoxorubicin",
      "preferredName": "4'-Iodo-4'-Deoxydoxorubicin",
      "synonyms": [
        "4'-Deoxy-4'-Iododoxorubicin",
        "4'-Iodo-4'-Deoxydoxorubicin",
        "IDOX",
        "IODODOXORUBICIN",
        "Iodo-Doxorubicin",
        "Iododoxorubicin",
        "iododoxorubicin"
      ]
    },
    {
      "fdaUniiCode": "RMC41L2WQ3",
      "id": "Esorubicin",
      "preferredName": "Esorubicin",
      "synonyms": [
        "4'-Deoxyadriamycin",
        "4'-Deoxydoxorubicin",
        "Deoxyadriamycin",
        "Deoxydoxorubicin",
        "ESORUBICIN",
        "Esorubicin",
        "IMI-58"
      ]
    },
    {
      "fdaUniiCode": "87CIC980Y0",
      "id": "Tucidinostat",
      "preferredName": "Tucidinostat",
      "synonyms": [
        "CS-055",
        "CS055",
        "Chidamide",
        "Epidaza",
        "HBI-8000",
        "N-(2-amino-5-fluorine benzyl)-4-[N-(pyridine-3-acrylyl) ammonia methyl] Benzamide",
        "N-(2-amino-5-fluorophenyl)-4-[[[1-oxo-3-(3-pyridinyl)-2-propen-1-yl]amino]methyl]-benzamide",
        "TUCIDINOSTAT",
        "Tucidinostat"
      ]
    },
    {
      "fdaUniiCode": "V1T5K7RZ0B",
      "id": "Afatinib_Dimaleate",
      "preferredName": "Afatinib Dimaleate",
      "synonyms": [
        "(2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydrofuran-3-yl)oxy)quinazolin- 6-yl)-4-(dimethylamino)but-2-enamide bis(hydrogen (2Z)-but-2-enedioate)",
        "2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-,(2E)-, (2Z)-2-Butenedioate (1:2)",
        "AFATINIB DIMALEATE",
        "Afatinib Dimaleate",
        "BIBW 2992MA2",
        "BIBW2992 MA2",
        "Gilotrif"
      ]
    },
    {
      "fdaUniiCode": "XCZ4D2241Y",
      "id": "Rodorubicin",
      "preferredName": "Rodorubicin",
      "synonyms": [
        "Cytorhodin S",
        "HLB 817",
        "RODORUBICIN",
        "Rodorubicin"
      ]
    },
    {
      "fdaUniiCode": "6MUO20693U",
      "id": "Iso-fludelone",
      "preferredName": "Iso-fludelone",
      "synonyms": [
        "17-Iso-oxazole-26-F3-9,10-dehydro-12,13-desoxy-epothilone B",
        "17-Iso-oxazole-fludelone",
        "Iso-fludelone",
        "KOS-1803",
        "KOSN-1724"
      ]
    },
    {
      "fdaUniiCode": "PUB9T8T355",
      "id": "Formestane",
      "preferredName": "Formestane",
      "synonyms": [
        "4-Hydroxyandrost-4-ene-3,17-dione",
        "4-Hydroxyandrostenedione",
        "4-OHA",
        "4-OHAD",
        "CGP-32349",
        "FORMESTANE",
        "Formestane",
        "Lentaron"
      ]
    },
    {
      "fdaUniiCode": "17197F0KYM",
      "id": "Afimoxifene",
      "preferredName": "Afimoxifene",
      "synonyms": [
        "4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol",
        "4-Hydroxy-Tamoxifen",
        "4-Hydroxytamoxifen",
        "4-OHT",
        "4-hydroxytamoxifen",
        "AFIMOXIFENE",
        "Afimoxifene"
      ]
    },
    {
      "fdaUniiCode": "M6030H73N9",
      "id": "Enoblituzumab",
      "preferredName": "Enoblituzumab",
      "synonyms": [
        "ENOBLITUZUMAB",
        "Enoblituzumab",
        "MGA271"
      ]
    },
    {
      "fdaUniiCode": "768FW21J3L",
      "id": "Famitinib",
      "preferredName": "Famitinib",
      "synonyms": [
        "4H-pyrrolo(3,2-c)pyridin-4-one, 5-(2-(diethylamino)ethyl)-2-((5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-1,5,6,7-tetrahydro-3-methyl-",
        "FAMITINIB",
        "Famitinib",
        "SHR-1020",
        "SHR1020"
      ]
    },
    {
      "fdaUniiCode": "37NT056AT4",
      "id": "Remetinostat",
      "preferredName": "Remetinostat",
      "synonyms": [
        "Methyl 4-((8-(Hydroxyamino)-8-Oxooctanoyl)oxy)benzoate",
        "Methylparaben Suberohydroxamic Acid Phenyl Ester",
        "REMETINOSTAT",
        "Remetinostat",
        "SHAPE",
        "SHP-141"
      ]
    },
    {
      "fdaUniiCode": "60UAB198HK",
      "id": "Abemaciclib",
      "preferredName": "Abemaciclib",
      "synonyms": [
        "2-Pyrimidinamine, N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)",
        "ABEMACICLIB",
        "Abemaciclib",
        "LY-2835219",
        "LY2835219",
        "Verzenio"
      ]
    },
    {
      "fdaUniiCode": "5PT0QP06X5",
      "id": "Lisavanbulin",
      "preferredName": "Lisavanbulin",
      "synonyms": [
        "(2S)-2,6-Diamino-N-(4-(2-(2-(4-((2-cyanoethyl)amino)-1,2,5-oxadiazol-3-yl)-1H-benzimidazol-1-yl)acetyl)phenyl)hexanamide",
        "BAL-101553",
        "BAL101553",
        "LISAVANBULIN",
        "Lisavanbulin"
      ]
    },
    {
      "fdaUniiCode": "G484L3U0O2",
      "id": "4-Nitroestrone_3-Methyl_Ether",
      "preferredName": "4-Nitroestrone 3-Methyl Ether",
      "synonyms": [
        "3-METHOXY-4-NITRO-ESTRA-1,3,5(10)-TRIEN-17-ONE",
        "3-Methoxy-4-nitro-estra-1,3,5(10)-trien-17-one",
        "4-Nitroestrone",
        "4-Nitroestrone 3-Methyl Ether",
        "4-Nitroestrone 3-methyl ether"
      ]
    },
    {
      "fdaUniiCode": "7SUK7876BG",
      "id": "Ansamitomicin_P-3",
      "preferredName": "Ansamitomicin P-3",
      "synonyms": [
        "ANSAMITOMICIN P-3",
        "Ansamitomicin P-3",
        "Maytansine, 3-o-de(2-(acetylmethylamino)-1-oxopropyl)-3-o-(1-oxobutyl)-"
      ]
    },
    {
      "fdaUniiCode": "V1JK16Y2JP",
      "id": "Doxifluridine",
      "preferredName": "Doxifluridine",
      "synonyms": [
        "5'-Deoxy-5-fluorouridine",
        "5-DFUR",
        "DOXIFLURIDINE",
        "Doxifluridine"
      ]
    },
    {
      "fdaUniiCode": "6P3AVY8A7Q",
      "id": "Lometrexol",
      "preferredName": "Lometrexol",
      "synonyms": [
        "(6R)-DDATHF",
        "6R-5,10-Dideazatetrahydrofolate",
        "L-Glutamic acid, N-(4-(2-((6R)-2-amino-1,4,5,6,7,8-hexahydro-4-oxopyrido(2,3-d)pyrimidin-6-yl)ethyl)benzoyl)-",
        "L-Glutamic acid, N-(4-(2-(2-amino-1,4,5,6,7,8-hexahydro-4-oxopyrido(2,3-d)pyrimidin-6-yl)ethyl)benzoyl)-, (R)-",
        "LOMETREXOL",
        "Lometrexol",
        "Pyrido[2,3-d]pyrimidine, L-glutamic acid derivative (9CI)",
        "lometrexol"
      ]
    },
    {
      "fdaUniiCode": "436LRU32H5",
      "id": "Ruxolitinib_Phosphate",
      "preferredName": "Ruxolitinib Phosphate",
      "synonyms": [
        "(3R)-3-cyclopentyl-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)propanenitrile Phosphate (1:1)",
        "1H-Pyrazole-1-propanenitrile, beta-cyclopentyl-4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-,(betaR)-, phosphate (1:1)",
        "INCB-18424 Phosphate",
        "Jakafi",
        "RUXOLITINIB PHOSPHATE",
        "Ruxolitinib Phosphate"
      ]
    },
    {
      "fdaUniiCode": "DR7ST46X58",
      "id": "Cabozantinib_S-malate",
      "preferredName": "Cabozantinib S-malate",
      "synonyms": [
        "BMS-907351",
        "Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1)",
        "CABOZANTINIB S-MALATE",
        "Cabometyx",
        "Cabozantinib S-malate",
        "Cometriq",
        "XL-184",
        "XL184"
      ]
    },
    {
      "fdaUniiCode": "71050168A2",
      "id": "Ixazomib",
      "preferredName": "Ixazomib",
      "synonyms": [
        "IXAZOMIB",
        "Ixazomib",
        "MLN-2238",
        "MLN2238",
        "{(1R)-1-[(2,5-dichlorobenzamido)acetamido]-3-methylbutyl}boronic Acid"
      ]
    },
    {
      "fdaUniiCode": "3O9FA4XC02",
      "id": "Felzartamab",
      "preferredName": "Felzartamab",
      "synonyms": [
        "Anti-CD38 Monoclonal Antibody MOR03087",
        "FELZARTAMAB",
        "Felzartamab",
        "MOR03087",
        "MOR202",
        "TJ-202"
      ]
    },
    {
      "fdaUniiCode": "6CX4AEX3KR",
      "id": "Avadomide_Hydrochloride",
      "preferredName": "Avadomide Hydrochloride",
      "synonyms": [
        "2,6-Piperidinedione, 3-(5-Amino-2-methyl-4-oxo-3(4H)-quinazolinyl)-, Hydrochloride (1:1)",
        "AVADOMIDE HYDROCHLORIDE",
        "Avadomide Hydrochloride",
        "CC-122 Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "KF6D9Z1MER",
      "id": "Immunocytokine_NHS-IL12",
      "preferredName": "Immunocytokine NHS-IL12",
      "synonyms": [
        "IMMUNOCYTOKINE NHS-IL12",
        "Immunocytokine NHS-IL12",
        "M-9241",
        "M9241",
        "NHS-IL-12",
        "NHS-IL12"
      ]
    },
    {
      "fdaUniiCode": "0627D8VG1C",
      "id": "Dihydro-5-Azacytidine",
      "preferredName": "Dihydro-5-Azacytidine",
      "synonyms": [
        "1,3,5-triazin-2(1H)-one, 4-amino-3, 6-dihydro-1-beta-D-ribofuranosyl monohydrochloride",
        "5,6-DIHYDRO-5-AZACYTIDINE",
        "5,6-Dihydro-5-azacytidine hydrochloride",
        "5,6-dihydro-5-azacytidine HCl",
        "5,6-dihydro-5-azacytidine hydrochloride",
        "DHAC",
        "Dihydro-5-Azacytidine"
      ]
    },
    {
      "fdaUniiCode": "776B62CQ27",
      "id": "Decitabine",
      "preferredName": "Decitabine",
      "synonyms": [
        "2'-Deoxy-5-azacytidine",
        "4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one",
        "5-Aza-2'-deoxycytidine",
        "5-Aza-2'deoxycytidine",
        "5-Aza-2-deoxycytidine",
        "5-Azadeoxycytidine",
        "DECITABINE",
        "Dacogen",
        "Decitabine",
        "Decitabine for Injection",
        "Deoxyazacytidine",
        "Dezocitidine",
        "decitabine"
      ]
    },
    {
      "fdaUniiCode": "56R994WX4L",
      "id": "Ilginatinib",
      "preferredName": "Ilginatinib",
      "synonyms": [
        "(S)-N-(1-(4-Fluorophenyl)ethyl)-4-(1-methyl-1H-pyrazol-4-yl)-N'-(pyrazin-2-yl)pyridine-2,6-diamine",
        "2,6-Pyridinediamine, N2-((1S)-1-(4-fluorophenyl)ethyl)-4-(1-methyl-1H-pyrazol-4-yl)-N6-2-pyrazinyl-",
        "ILGINATINIB",
        "Ilginatinib",
        "NS-018"
      ]
    },
    {
      "fdaUniiCode": "O0408QB48D",
      "id": "Chloroquinoxaline_Sulfonamide",
      "preferredName": "Chloroquinoxaline Sulfonamide",
      "synonyms": [
        "Benzenesulfonamide, 4-amino-N-(5-chloro-2-quinoxalinyl)-",
        "Benzenesulfonamide, 4-amino-N-[5-chloro-2-quinoxalinyl]-",
        "CHLORSULFAQUINOXALINE",
        "CQS",
        "Chloroquinoxaline Sulfonamide",
        "Chloroquinoxaline sulfonamide",
        "Chlorsulfaquinoxaline",
        "chloroquinoxaline sulfonamide",
        "chlorosulfaquinoxaline"
      ]
    },
    {
      "fdaUniiCode": "CEG1Q6OGU1",
      "id": "Bardoxolone_Methyl",
      "preferredName": "Bardoxolone Methyl",
      "synonyms": [
        "(+)-methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate",
        "2-cyano-3,12-dioxoolean-1,9-dien-28-oic Acid Methyl Ester",
        "BARDOXOLONE METHYL",
        "Bardoxolone Methyl",
        "CDDO Methyl Ester",
        "CDDO-Me",
        "RTA 402"
      ]
    },
    {
      "fdaUniiCode": "DRG21OQ517",
      "id": "Opaganib",
      "preferredName": "Opaganib",
      "synonyms": [
        "4-Pyridinylmethyl-3-(4-chlorophenyl) Adamantane Carboxamide",
        "ABC 294640",
        "ABC294640",
        "OPAGANIB",
        "Opaganib",
        "SK2 inhibitor ABC294640",
        "Tricyclo(3.3.1.13,7)decane-1-carboxamide, 3-(4-Chlorophenyl)-N-(4-pyridinylmethyl)-",
        "Yeliva"
      ]
    },
    {
      "fdaUniiCode": "8L7891MRB6",
      "id": "Encorafenib",
      "preferredName": "Encorafenib",
      "synonyms": [
        "Braftovi",
        "ENCORAFENIB",
        "Encorafenib",
        "LGX 818",
        "LGX-818",
        "LGX818"
      ]
    },
    {
      "fdaUniiCode": "M170940PMI",
      "id": "Anetumab_Ravtansine",
      "preferredName": "Anetumab Ravtansine",
      "synonyms": [
        "ANETUMAB RAVTANSINE",
        "Anetumab Ravtansine",
        "BAY 94-9343"
      ]
    },
    {
      "fdaUniiCode": "9350121Z8S",
      "id": "Nagrestipen",
      "preferredName": "Nagrestipen",
      "synonyms": [
        "26-L-Alaninelymphokine MIP 1alpha (Human clone pAT464 MacrophageIinflammatory)",
        "BB-10010",
        "ECI301",
        "NAGRESTIPEN",
        "Nagrestipen",
        "eMIP"
      ]
    },
    {
      "fdaUniiCode": "347Q3OOJ13",
      "id": "Aceglatone",
      "preferredName": "Aceglatone",
      "synonyms": [
        "ACEGLATONE",
        "Aceglatone",
        "Glucaron"
      ]
    },
    {
      "fdaUniiCode": "LCH760E9T7",
      "id": "Acitretin",
      "preferredName": "Acitretin",
      "synonyms": [
        "(All-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic Acid",
        "ACITRETIN",
        "Acitretin",
        "Etretin",
        "Neotigason",
        "Ro 10-1670",
        "Ro-10-1670",
        "Soriatane",
        "Trimethylmethoxyphenyl-retinoic acid",
        "acitretin"
      ]
    },
    {
      "fdaUniiCode": "O0X60K76I6",
      "id": "Acivicin",
      "preferredName": "Acivicin",
      "synonyms": [
        "(S-(R*,R*))-4,5-Dihydro-alpha-amino-3-chloro-5-isoxazoleacetic Acid",
        "ACIVICIN",
        "AT-125",
        "Acivicin",
        "U-42126"
      ]
    },
    {
      "fdaUniiCode": "8M28A9O41G",
      "id": "Acodazole",
      "preferredName": "Acodazole",
      "synonyms": [
        "1H-imidazo[4,5-f]quinoline, acetamide deriv",
        "ACODAZOLE",
        "Acodazole",
        "acetamide, N-methyl-N-[4-[(7-methyl-1H-imidazo[4, 5-f]quinolin-9-yl)amino]phenyl]-"
      ]
    },
    {
      "fdaUniiCode": "HYW8DB273J",
      "id": "Brigatinib",
      "preferredName": "Brigatinib",
      "synonyms": [
        "(2-((5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethyl-,delta5-phosphanone",
        "5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine",
        "AP 26113",
        "AP-26113",
        "AP26113",
        "Alunbrig",
        "BRIGATINIB",
        "Brigatinib"
      ]
    },
    {
      "fdaUniiCode": "OEI6OOU6IK",
      "id": "Poziotinib",
      "preferredName": "Poziotinib",
      "synonyms": [
        "HM781-36",
        "NOV120101",
        "POZIOTINIB",
        "Poziotinib"
      ]
    },
    {
      "fdaUniiCode": "43J9Q56T3W",
      "id": "Serabelisib",
      "preferredName": "Serabelisib",
      "synonyms": [
        "(6-(2-Amino-5-benzoxazolyl)imidazo(1,2-a)pyridin-3-yl)-4-morpholinylmethanone",
        "INK1117",
        "MLN-1117",
        "MLN1117",
        "SERABELISIB",
        "Serabelisib",
        "TAK 117",
        "TAK-117"
      ]
    },
    {
      "fdaUniiCode": "RM898LZ4SI",
      "id": "DKK1-Neutralizing_Monoclonal_Antibody_DKN-01",
      "preferredName": "DKK1-Neutralizing Monoclonal Antibody DKN-01",
      "synonyms": [
        "DKK1-Neutralizing Monoclonal Antibody DKN-01",
        "DKK1-neutralizing Monoclonal Antibody DKN-01",
        "DKN-01",
        "LY2812176"
      ]
    },
    {
      "fdaUniiCode": "5LM7WD7VIC",
      "id": "cis-Urocanic_Acid",
      "preferredName": "cis-Urocanic Acid",
      "synonyms": [
        "CIS-UROCANIC ACID",
        "cis-UCA",
        "cis-Urocanic Acid"
      ]
    },
    {
      "fdaUniiCode": "0125DUV5XC",
      "id": "Varlilumab",
      "preferredName": "Varlilumab",
      "synonyms": [
        "CDX 1127",
        "CDX-1127",
        "Immunoglobulin G1, Anti-(Human CD Antigen CD27) (Human Monoclonal CDX-1127 Clone 1f5 Heavy Chain), Disulfide with Human Monoclonal CDX-1127 Clone 1f5 Kappa-chain, Dimer",
        "VARLILUMAB",
        "Varlilumab"
      ]
    },
    {
      "fdaUniiCode": "4O75889WF4",
      "id": "Dociparstat_sodium",
      "preferredName": "Dociparstat sodium",
      "synonyms": [
        "2,3-o-Desulfated Heparin (12000 da)",
        "CX 01",
        "CX-01",
        "CX01",
        "DOCIPARSTAT SODIUM",
        "Dociparstat sodium",
        "O-desulfated Heparin",
        "ODSH",
        "PGX-100",
        "PGX-ODSH",
        "PGX100"
      ]
    },
    {
      "fdaUniiCode": "QSQ883V35U",
      "id": "Idasanutlin",
      "preferredName": "Idasanutlin",
      "synonyms": [
        "IDASANUTLIN",
        "Idasanutlin",
        "RG-7388",
        "RG7388",
        "RO-5503781",
        "RO5503781"
      ]
    },
    {
      "fdaUniiCode": "JTD32I0J83",
      "id": "Icotinib_Hydrochloride",
      "preferredName": "Icotinib Hydrochloride",
      "synonyms": [
        "(1,4,7,10)Tetraoxacyclododecino(2,3-g)quinazolin-4-amine, N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-, Hydrochloride (1:1)",
        "BPI-2009H",
        "Conmana",
        "ICOTINIB HYDROCHLORIDE",
        "Icotinib HCl",
        "Icotinib Hydrochloride"
      ]
    },
    {
      "fdaUniiCode": "R1UQ6D1ECM",
      "id": "Entolimod",
      "preferredName": "Entolimod",
      "synonyms": [
        "CBLB502",
        "ENTOLIMOD",
        "Entolimod",
        "TLR5 Agonist CBLB502"
      ]
    },
    {
      "fdaUniiCode": "T1DQI1B52Y",
      "id": "Miransertib",
      "preferredName": "Miransertib",
      "synonyms": [
        "2-Pyridinamine, 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo(4,5-b)pyridin-2-yl)-",
        "ARQ 092",
        "MIRANSERTIB",
        "Miransertib",
        "WHO 10490"
      ]
    },
    {
      "fdaUniiCode": "610V23S0JI",
      "id": "Duvelisib",
      "preferredName": "Duvelisib",
      "synonyms": [
        "1(2H)-Isoquinolinone, 8-Chloro-2-phenyl-3-((1S)-1-(9H-purin-6-ylamino)ethyl)-",
        "8-Chloro-2-phenyl-3-((1S)-1-(7H-purin-6-ylamino)ethyl)isoquinolin-1(2H)-one",
        "Copiktra",
        "DUVELISIB",
        "Duvelisib",
        "INK-1197",
        "IPI-145"
      ]
    },
    {
      "fdaUniiCode": "MTM792B442",
      "id": "Olaptesed_Pegol",
      "preferredName": "Olaptesed Pegol",
      "synonyms": [
        "NOX-A12",
        "OLAPTESED PEGOL",
        "Olaptesed Pegol"
      ]
    },
    {
      "fdaUniiCode": "R6VT8U5372",
      "id": "Dexanabinol",
      "preferredName": "Dexanabinol",
      "synonyms": [
        "1,1-Dimethylheptyl-11-hydroxytetrahydrocannabinol",
        "7-Hydroxy-delta-6-tetrahydrocannabinoldimethylheptyl",
        "DEXANABINOL",
        "Dexanabinol",
        "HU-211"
      ]
    },
    {
      "fdaUniiCode": "2CNI71214Y",
      "id": "Alanosine",
      "preferredName": "Alanosine",
      "synonyms": [
        "3-(Hydroxynitrosoamino)-L-alanine",
        "ALANOSINE",
        "Alanosine",
        "L-2-Amino-3-(hydroxynitrosoamino)propionic Acid",
        "L-2-Amino-3-[(N-nitroso)hydroxylamino]propionic Acid",
        "L-2-Amino-3-[(N-nitroso)hydroxylamino]propionic acid",
        "L-Alanosine",
        "L-Alanosine Sodium",
        "SDX-102",
        "alanosine"
      ]
    },
    {
      "fdaUniiCode": "8P77G99D3P",
      "id": "Paclitaxel_Trevatide",
      "preferredName": "Paclitaxel Trevatide",
      "synonyms": [
        "ANG-1005",
        "ANG1005",
        "GRN1005",
        "PACLITAXEL TREVATIDE",
        "Paclitaxel Trevatide"
      ]
    },
    {
      "fdaUniiCode": "6Z5DS38J6F",
      "id": "Actinomycin_C3",
      "preferredName": "Actinomycin C3",
      "synonyms": [
        "2104-L-I",
        "ACTINOMYCIN C3",
        "AY 3",
        "Actinomycin AY1",
        "Actinomycin C3",
        "Actinomycin I3",
        "Actinomycin VII",
        "Aurathin-A3"
      ]
    },
    {
      "fdaUniiCode": "0TG7ZQ45R5",
      "id": "pbi-shRNA_STMN1_Lipoplex",
      "preferredName": "pbi-shRNA STMN1 Lipoplex",
      "synonyms": [
        "DNA PLASMID (PBI-SHRNA STMN1)",
        "pbi-shRNA STMN1 LP",
        "pbi-shRNA STMN1 Lipoplex"
      ]
    },
    {
      "fdaUniiCode": "B1792M902R",
      "id": "Landogrozumab",
      "preferredName": "Landogrozumab",
      "synonyms": [
        "Anti-myostatin Monoclonal Antibody LY2495655",
        "LANDOGROZUMAB",
        "LY2495655",
        "Landogrozumab"
      ]
    },
    {
      "fdaUniiCode": "RJ12A315RN",
      "id": "Anti-VEGFC_Monoclonal_Antibody_VGX-100",
      "preferredName": "Anti-VEGFC Monoclonal Antibody VGX-100",
      "synonyms": [
        "Anti-VEGFC Monoclonal Antibody VGX-100",
        "VEGF-C mAb VGX-100",
        "VGX-100"
      ]
    },
    {
      "fdaUniiCode": "UCG949AA7Z",
      "id": "Adagloxad_Simolenin",
      "preferredName": "Adagloxad Simolenin",
      "synonyms": [
        "ADAGLOXAD SIMOLENIN",
        "Adagloxad Simolenin",
        "OBI 822",
        "OBI-822",
        "OBI822"
      ]
    },
    {
      "fdaUniiCode": "PY29292DVJ",
      "id": "Ilixadencel",
      "preferredName": "Ilixadencel",
      "synonyms": [
        "COMBIG-DC",
        "ILIXADENCEL",
        "Ilixadencel",
        "Intuvax"
      ]
    },
    {
      "fdaUniiCode": "72AH61702G",
      "id": "Rociletinib",
      "preferredName": "Rociletinib",
      "synonyms": [
        "CO-1686",
        "N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)prop-2-enamide",
        "ROCILETINIB",
        "Rociletinib"
      ]
    }
  ],
  "release": "2021-10"
}